1	The	DT	O	the	det	4	SENT_1	[p1l427t81r465b103],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l477t83r557b103],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l571t83r746b103],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l760t83r926b110],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_1	[p1l940t81r1156b109],

1	1	CD	NUMBER	1	num	3	SENT_2	[p1l92t187r94b312],
2	ORIGINAL	NNP	O	ORIGINAL	nn	3	SENT_2	[p1l563t234r805b261],
3	ARTICLE	NN	O	article	_	0	SENT_2	[p1l821t235r1020b261],
4	1	CD	NUMBER	1	dep	3	SENT_2	[p1l1492t187r1494b312],

1	Erlotinib	NNP	O	Erlotinib	_	0	SENT_3	[p1l232t387r492b442],
2	in	IN	O	in	_	0	SENT_3	[p1l509t388r566b441],
3	Lung	NN	O	lung	nn	4	SENT_3	[p1l583t392r736b457],
4	Cancer	NN	O	cancer	prep_in	1	SENT_3	[p1l751t391r957b442],
5	—	CD	NUMBER	—	number	6	SENT_3	[p1l970t418r1045b424],
6	Molecular	JJ	O	molecular	dep	1	SENT_3	[p1l1058t387r1357b442],
7	and	CC	O	and	_	0	SENT_3	[p1l280t470r388b524],
8	Clinical	JJ	O	clinical	amod	9	SENT_3	[p1l406t470r630b524],
9	Predictors	NNS	O	predictor	dep	1	SENT_3	[p1l646t470r943b524],
10	of	IN	O	of	_	0	SENT_3	[p1l963t469r1032b524],
11	Outcome	NN	O	outcome	prep_of	6	SENT_3	[p1l1037t474r1307b525],

1	Ming-Sound	NNP	PERSON	Ming-Sound	nn	2	SENT_4	[p1l125t600r332b641],
2	Tsao	NNP	PERSON	Tsao	_	0	SENT_4	[p1l345t603r431b637],
3	,	,	O	,	_	0	SENT_4	[p1l345t603r431b637],
4	M.D.	NNP	O	M.D.	appos	2	SENT_4	[p1l449t603r539b637],
5	,	,	O	,	_	0	SENT_4	[p1l449t603r539b637],
6	Akira	NNP	PERSON	Akira	nn	7	SENT_4	[p1l552t600r637b631],
7	Sakurada	NNP	PERSON	Sakurada	appos	4	SENT_4	[p1l651t600r816b637],
8	,	,	O	,	_	0	SENT_4	[p1l651t600r816b637],
9	M.D.	NNP	O	M.D.	appos	4	SENT_4	[p1l833t603r923b637],
10	,	,	O	,	_	0	SENT_4	[p1l833t603r923b637],
11	Ph.D.,jean-Claude	NNP	O	Ph.D.,jean-Claude	nn	12	SENT_4	[p1l941t600r1257b640],
12	Cutz	NNP	O	Cutz	appos	4	SENT_4	[p1l1270t602r1355b637],
13	,	,	O	,	_	0	SENT_4	[p1l1270t602r1355b637],
14	M.D.	NNP	O	M.D.	appos	4	SENT_4	[p1l1372t603r1462b637],
15	,	,	O	,	_	0	SENT_4	[p1l1372t603r1462b637],
16	Chang	NNP	PERSON	Chang	appos	4	SENT_4	[p1l123t649r283b690],
17	.	.	O	.	_	0	SENT_4	[p1l123t649r283b690],

1	—	NN	O	—	_	0	SENT_5	[p1l123t649r283b690],
2	.	.	O	.	_	0	SENT_5	[p1l123t649r283b690],

1	Qi	NNP	PERSON	Qi	nn	2	SENT_6	[p1l123t649r283b690],
2	Zhu	NNP	PERSON	Zhu	_	0	SENT_6	[p1l297t649r373b686],
3	,	,	O	,	_	0	SENT_6	[p1l297t649r373b686],
4	M.D.	NNP	O	M.D.	appos	2	SENT_6	[p1l390t652r480b686],
5	,	,	O	,	_	0	SENT_6	[p1l390t652r480b686],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_6	[p1l497t649r596b686],
7	,	,	O	,	_	0	SENT_6	[p1l497t649r596b686],
8	Suzanne	NNP	PERSON	Suzanne	nn	9	SENT_6	[p1l611t651r756b680],
9	Kamel-Reid	NNP	PERSON	Kamel-Reid	appos	2	SENT_6	[p1l772t649r971b686],
10	,	,	O	,	_	0	SENT_6	[p1l772t649r971b686],
11	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_6	[p1l989t649r1218b690],
12	,	,	O	,	_	0	SENT_6	[p1l989t649r1218b690],
13	jeremy	NNP	PERSON	jeremy	nn	14	SENT_6	[p1l989t649r1218b690],
14	Squire	NNP	PERSON	Squire	appos	2	SENT_6	[p1l1230t651r1346b689],
15	,	,	O	,	_	0	SENT_6	[p1l1230t651r1346b689],
16	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_6	[p1l1363t649r1462b686],
17	,	,	O	,	_	0	SENT_6	[p1l1363t649r1462b686],
18	lan	JJ	O	lan	amod	19	SENT_6	[p1l97t701r145b729],
19	Lorimer	NNP	PERSON	Lorimer	appos	2	SENT_6	[p1l160t701r296b735],
20	,	,	O	,	_	0	SENT_6	[p1l160t701r296b735],
21	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_6	[p1l312t698r410b735],
22	,	,	O	,	_	0	SENT_6	[p1l312t698r410b735],
23	Tong	NNP	PERSON	Tong	nn	24	SENT_6	[p1l422t701r505b739],
24	Zhang	NNP	PERSON	Zhang	appos	2	SENT_6	[p1l515t698r632b739],
25	,	,	O	,	_	0	SENT_6	[p1l515t698r632b739],
26	M.D.	NNP	O	M.D.	appos	2	SENT_6	[p1l647t701r737b735],
27	,	,	O	,	_	0	SENT_6	[p1l647t701r737b735],
28	Ni	NNP	PERSON	Ni	nn	29	SENT_6	[p1l753t701r787b729],
29	Liu	NNP	PERSON	Liu	appos	2	SENT_6	[p1l803t701r859b735],
30	,	,	O	,	_	0	SENT_6	[p1l803t701r859b735],
31	M.	NNP	PERSON	M.	nn	32	SENT_6	[p1l875t700r976b735],
32	Sc.	NNP	PERSON	Sc.	appos	2	SENT_6	[p1l875t700r976b735],
33	,	,	O	,	_	0	SENT_6	[p1l875t700r976b735],
34	Manijeh	NNP	PERSON	Manijeh	nn	35	SENT_6	[p1l991t698r1125b739],
35	Daneshmand	NNP	PERSON	Daneshmand	appos	2	SENT_6	[p1l1141t698r1377b735],
36	,	,	O	,	_	0	SENT_6	[p1l1141t698r1377b735],
37	M.D.	NNP	O	M.D.	appos	2	SENT_6	[p1l1392t701r1482b735],
38	,	,	O	,	_	0	SENT_6	[p1l1392t701r1482b735],
39	Paula	NNP	PERSON	Paula	nn	40	SENT_6	[p1l101t747r190b778],
40	Marrano	NNP	PERSON	Marrano	appos	2	SENT_6	[p1l206t750r358b784],
41	,	,	O	,	_	0	SENT_6	[p1l206t750r358b784],
42	M.	NNP	PERSON	M.	nn	43	SENT_6	[p1l375t749r476b784],
43	Sc.	NNP	PERSON	Sc.	appos	2	SENT_6	[p1l375t749r476b784],
44	,	,	O	,	_	0	SENT_6	[p1l375t749r476b784],
45	Gilda	NNP	PERSON	Gilda	nn	48	SENT_6	[p1l490t747r578b778],
46	da	NNP	PERSON	da	nn	48	SENT_6	[p1l591t747r630b778],
47	Cunha	NNP	PERSON	Cunha	nn	48	SENT_6	[p1l643t747r751b778],
48	Santos	NNP	PERSON	Santos	appos	2	SENT_6	[p1l765t749r889b784],
49	,	,	O	,	_	0	SENT_6	[p1l765t749r889b784],
50	M.D.	NNP	O	M.D.	appos	2	SENT_6	[p1l906t750r996b784],
51	,	,	O	,	_	0	SENT_6	[p1l906t750r996b784],
52	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_6	[p1l1012t747r1111b784],
53	,	,	O	,	_	0	SENT_6	[p1l1012t747r1111b784],
54	Alain	NNP	PERSON	Alain	nn	57	SENT_6	[p1l1124t747r1208b778],
55	Lagarde	NNP	PERSON	Lagarde	nn	57	SENT_6	[p1l1225t747r1365b788],
56	,	,	O	,	_	0	SENT_6	[p1l1225t747r1365b788],
57	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_6	[p1l1382t747r1481b784],
58	,	,	O	,	_	0	SENT_6	[p1l1382t747r1481b784],

1	Frank	NNP	PERSON	Frank	nn	2	SENT_7	[p1l262t796r351b827],
2	Richardson	NNP	PERSON	Richardson	_	0	SENT_7	[p1l366t796r564b833],
3	,	,	O	,	_	0	SENT_7	[p1l366t796r564b833],
4	D.V.M.	NNP	LOCATION	D.V.M.	dep	2	SENT_7	[p1l582t799r702b833],
5	,	,	O	,	_	0	SENT_7	[p1l582t799r702b833],
6	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_7	[p1l719t796r818b833],
7	,	,	O	,	_	0	SENT_7	[p1l719t796r818b833],
8	Lesley	NNP	PERSON	Lesley	nn	9	SENT_7	[p1l835t796r935b837],
9	Seymour	NNP	PERSON	Seymour	appos	4	SENT_7	[p1l948t798r1102b837],
10	,	,	O	,	_	0	SENT_7	[p1l948t798r1102b837],
11	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l1120t799r1210b833],
12	,	,	O	,	_	0	SENT_7	[p1l1120t799r1210b833],
13	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_7	[p1l1227t796r1326b833],
14	,	,	O	,	_	0	SENT_7	[p1l1227t796r1326b833],
15	Marlo	NNP	PERSON	Marlo	nn	16	SENT_7	[p1l248t845r344b876],
16	Whitehead	NNP	PERSON	Whitehead	appos	4	SENT_7	[p1l356t845r548b882],
17	,	,	O	,	_	0	SENT_7	[p1l356t845r548b882],
18	M.	NNP	PERSON	M.	nn	19	SENT_7	[p1l565t847r667b882],
19	Sc.	NNP	PERSON	Sc.	appos	4	SENT_7	[p1l565t847r667b882],
20	,	,	O	,	_	0	SENT_7	[p1l565t847r667b882],
21	Keyue	NNP	PERSON	Keyue	nn	22	SENT_7	[p1l684t848r780b886],
22	Ding	NNP	PERSON	Ding	appos	4	SENT_7	[p1l796t848r882b886],
23	,	,	O	,	_	0	SENT_7	[p1l796t848r882b886],
24	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_7	[p1l900t845r1126b885],
25	,	,	O	,	_	0	SENT_7	[p1l900t845r1126b885],
26	Joseph	NNP	PERSON	Joseph	nn	27	SENT_7	[p1l900t845r1126b885],
27	Pater	NNP	PERSON	Pater	appos	4	SENT_7	[p1l1144t848r1232b882],
28	,	,	O	,	_	0	SENT_7	[p1l1144t848r1232b882],
29	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l1250t848r1340b882],
30	,	,	O	,	_	0	SENT_7	[p1l1250t848r1340b882],

1	and	CC	O	and	dep	4	SENT_8	[p1l528t894r588b925],
2	Frances	NNP	PERSON	Frances	nn	4	SENT_8	[p1l605t897r731b925],
3	A.	NNP	PERSON	A.	nn	4	SENT_8	[p1l743t896r775b925],
4	Shepherd	NNP	PERSON	Shepherd	_	0	SENT_8	[p1l790t894r960b935],
5	,	,	O	,	_	0	SENT_8	[p1l790t894r960b935],
6	M.D.	NNP	O	M.D.	appos	4	SENT_8	[p1l978t897r1057b925],

1	ABSTRACT	NN	O	abstract	_	0	SENT_9	[p1l681t1042r900b1065],

1	BAC	NN	O	bac	nn	11	SENT_10	[p1l96t1168r153b1188],
2	K	NN	O	k	nn	11	SENT_10	[p1l160t1168r174b1188],
3	G	NN	O	g	nn	11	SENT_10	[p1l180t1168r198b1188],
4	R	NN	O	r	nn	11	SENT_10	[p1l206t1168r220b1188],
5	o	NN	O	o	nn	11	SENT_10	[p1l226t1168r247b1188],
6	u	NN	O	u	nn	11	SENT_10	[p1l253t1168r270b1188],
7	N	NN	O	n	nn	11	SENT_10	[p1l279t1168r296b1188],
8	D	NN	O	d	nn	11	SENT_10	[p1l305t1169r323b1188],
9	A	NN	O	a	nn	11	SENT_10	[p1l93t1210r118b1238],
10	clinical	JJ	O	clinical	amod	11	SENT_10	[p1l129t1207r246b1238],
11	trial	NN	O	trial	_	0	SENT_10	[p1l258t1208r322b1238],
12	that	IN	O	that	nsubj	13	SENT_10	[p1l334t1208r399b1238],
13	compared	VBN	O	compare	rcmod	11	SENT_10	[p1l409t1207r573b1247],
14	erlotinib	NN	O	erlotinib	dobj	13	SENT_10	[p1l585t1207r724b1238],
15	with	IN	O	with	_	0	SENT_10	[p1l735t1207r808b1239],
16	a	DT	O	a	det	17	SENT_10	[p1l820t1218r837b1238],
17	placebo	NN	O	placebo	prep_with	13	SENT_10	[p1l848t1207r974b1247],
18	for	IN	O	for	_	0	SENT_10	[p1l987t1207r1034b1238],
19	non	JJ	O	non	amod	25	SENT_10	[p1l1045t1207r1290b1238],
20	—	JJ	O	—	amod	25	SENT_10	[p1l1045t1207r1290b1238],
21	small	JJ	O	small	amod	25	SENT_10	[p1l1045t1207r1290b1238],
22	—	NN	O	—	nn	25	SENT_10	[p1l1045t1207r1290b1238],
23	cell	NN	O	cell	nn	25	SENT_10	[p1l1045t1207r1290b1238],
24	lung	NN	O	lung	nn	25	SENT_10	[p1l1301t1207r1377b1247],
25	cancer	NN	O	cancer	prep_for	13	SENT_10	[p1l1387t1217r1494b1238],
26	From	IN	O	from	dep	11	SENT_10	[p1l1534t1217r1596b1239],
27	the	DT	O	the	det	30	SENT_10	[p1l1605t1215r1645b1239],
28	University	NNP	ORGANIZATION	University	nn	30	SENT_10	[p1l1655t1217r1782b1246],
29	Health	NNP	ORGANIZATION	Health	nn	30	SENT_10	[p1l1792t1215r1874b1239],
30	Network	NNP	ORGANIZATION	Network	pobj	26	SENT_10	[p1l1886t1215r1999b1243],
31	,	,	O	,	_	0	SENT_10	[p1l1886t1215r1999b1243],
32	Prindemonstrated	NNP	O	Prindemonstrated	dep	35	SENT_10	[p1l2010t1217r2067b1238, p1l95t1257r322b1288],
33	a	DT	O	a	det	35	SENT_10	[p1l330t1268r347b1288],
34	survival	NN	O	survival	nn	35	SENT_10	[p1l355t1257r479b1288],
35	beneﬁt	NN	O	beneﬁt	ccomp	11	SENT_10	[p1l487t1257r602b1288],
36	for	IN	O	for	_	0	SENT_10	[p1l608t1257r656b1288],
37	erlotinib	NN	O	erlotinib	prep_for	35	SENT_10	[p1l663t1257r812b1288],
38	.	.	O	.	_	0	SENT_10	[p1l663t1257r812b1288],

1	We	PRP	O	we	nsubj	2	SENT_11	[p1l821t1260r873b1288],
2	used	VBD	O	use	_	0	SENT_11	[p1l881t1257r957b1288],
3	tumor-biopsy	JJ	O	tumor-biopsy	amod	4	SENT_11	[p1l965t1257r1189b1297],
4	samples	NNS	O	sample	dobj	2	SENT_11	[p1l1196t1257r1329b1296],
5	from	IN	O	from	_	0	SENT_11	[p1l1338t1257r1419b1288],
6	par	JJ	O	par	amod	8	SENT_11	[p1l1426t1268r1492b1297],
7	—	NN	O	—	nn	8	SENT_11	[p1l1426t1268r1492b1297],
8	Ce	NN	O	ce	prep_from	2	SENT_11	[p1l1532t1260r1585b1295],
9	?	.	O	?	_	0	SENT_11	[p1l1532t1260r1585b1295],

1	‘	NN	O	‘	nn	3	SENT_12	[p1l1532t1260r1585b1295],
2	Mmgalel	NN	O	mmgalel	nn	3	SENT_12	[p1l1599t1254r1714b1283],
3	H	NN	O	h	_	0	SENT_12	[p1l1727t1252r1833b1295],
4	_	CD	NUMBER	_	number	5	SENT_12	[p1l1727t1252r1833b1295],
5	°	CD	NUMBER	°	dep	3	SENT_12	[p1l1727t1252r1833b1295],
6	5P	NN	O	5p	dep	5	SENT_12	[p1l1727t1252r1833b1295],
7	"	''	O	"	punct	6	SENT_12	[p1l1727t1252r1833b1295],
8	a	DT	O	a	dep	3	SENT_12	[p1l1727t1252r1833b1295],
9	'	''	O	'	_	0	SENT_12	[p1l1727t1252r1833b1295],
10	Sllev	NNP	O	Sllev	dep	8	SENT_12	[p1l1846t1254r1899b1295],
11	‘	CD	NUMBER	‘	num	10	SENT_12	[p1l1912t1252r1957b1295],
12	_	CD	NUMBER	_	number	13	SENT_12	[p1l1912t1252r1957b1295],
13	*	CD	NUMBER	*	dep	3	SENT_12	[p1l1912t1252r1957b1295],
14	“	NN	O	“	nn	15	SENT_12	[p1l1912t1252r1957b1295],
15	d	NN	O	d	dep	13	SENT_12	[p1l1912t1252r1957b1295],
16	the	DT	O	the	det	18	SENT_12	[p1l1969t1252r2009b1276],
17	o	NN	O	o	nn	18	SENT_12	[p1l2020t1254r2067b1276],
18	“	NN	O	“	dep	3	SENT_12	[p1l2020t1254r2067b1276],
19	'	''	O	'	_	0	SENT_12	[p1l2020t1254r2067b1276],
20	. . . . .	CD	NUMBER	. . . . .	number	21	SENT_12	[p1l388t1308r393b1313],[p1l109t1308r114b1313],
21	. . . . .	CD	NUMBER	. . . . .	dep	18	SENT_12	[p1l1221t1308r1226b1313],[p1l480t1308r485b1313],
22	.	.	O	.	_	0	SENT_12	[p1l1334t1308r1339b1313],

1	.	.	O	.	_	0	SENT_13	[p1l1383t1308r1388b1313],

1	tario	NNP	O	tario	nn	3	SENT_14	[p1l1531t1294r1589b1313],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_14	[p1l1598t1292r1686b1313],
3	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_14	[p1l1696t1292r1807b1318],
4	,	,	O	,	_	0	SENT_14	[p1l1696t1292r1807b1318],
5	University	NNP	ORGANIZATION	University	nn	6	SENT_14	[p1l1819t1292r1946b1321],
6	ofToronticipants	NNPS	O	ofToronticipants	appos	3	SENT_14	[p1l1954t1289r2067b1313, p1l94t1314r234b1363],
7	in	IN	O	in	_	0	SENT_14	[p1l246t1318r277b1338],
8	this	DT	O	this	det	9	SENT_14	[p1l288t1308r348b1338],
9	trial	NN	O	trial	prep_in	6	SENT_14	[p1l360t1308r424b1338],
10	to	TO	O	to	prep	9	SENT_14	[p1l435t1314r470b1363],
11	.	.	O	.	_	0	SENT_14	[p1l435t1314r470b1363],

1	investigate	VB	O	investigate	ccomp	27	SENT_15	[p1l477t1314r652b1363],
2	whether	IN	O	whether	_	0	SENT_15	[p1l662t1308r798b1363],
3	responsiveness	NN	O	responsiveness	prep_whether	1	SENT_15	[p1l808t1318r1055b1347],
4	to	TO	O	to	_	0	SENT_15	[p1l1067t1314r1098b1338],
5	erlotinib	NN	O	erlotinib	prep_to	1	SENT_15	[p1l1110t1308r1249b1364],
6	and	CC	O	and	_	0	SENT_15	[p1l1260t1308r1321b1338],
7	its	PRP$	O	its	poss	8	SENT_15	[p1l1332t1314r1369b1338],
8	impact	NN	O	impact	conj_and	5	SENT_15	[p1l1381t1314r1495b1347],
9	to	TO	O	to	prep	1	SENT_15	[p1l1531t1332r1563b1355],
10	,	,	O	,	_	0	SENT_15	[p1l1531t1332r1563b1355],
11	Toronto	NNP	LOCATION	Toronto	nn	15	SENT_15	[p1l1574t1330r1674b1351],
12	(	NNP	O	(	nn	15	SENT_15	[p1l1688t1329r1791b1358],
13	M.	NNP	O	M.	nn	15	SENT_15	[p1l1688t1329r1791b1358],
14	_	NNP	O	_	nn	15	SENT_15	[p1l1688t1329r1791b1358],
15	S.T.	NNP	O	S.T.	dobj	1	SENT_15	[p1l1688t1329r1791b1358],
16	,	,	O	,	_	0	SENT_15	[p1l1688t1329r1791b1358],
17	AS	JJ	O	as	amod	18	SENT_15	[p1l1803t1329r1859b1355],
18	”	NN	O	”	appos	15	SENT_15	[p1l1803t1329r1859b1355],
19	J	NN	O	j	nn	21	SENT_15	[p1l1867t1329r1955b1358],
20	__	CD	NUMBER	__	num	21	SENT_15	[p1l1867t1329r1955b1358],
21	C.C.	NNP	O	C.C.	dep	18	SENT_15	[p1l1867t1329r1955b1358],
22	,	,	O	,	_	0	SENT_15	[p1l1867t1329r1955b1358],
23	C	NNP	O	C	nn	26	SENT_15	[p1l1968t1329r2066b1358],
24	__	NNP	O	__	nn	26	SENT_15	[p1l1968t1329r2066b1358],
25	Q.	NNP	O	Q.	nn	26	SENT_15	[p1l1968t1329r2066b1358],
26	Z	NNP	O	Z	nsubj	27	SENT_15	[p1l1968t1329r2066b1358],
27	_	VBD	O	_	_	0	SENT_15	[p1l1968t1329r2066b1358],
28	’	CD	NUMBER	’	nsubjpass	32	SENT_15	[p1l1968t1329r2066b1358],
29	on	IN	O	on	_	0	SENT_15	[p1l95t1368r136b1388],
30	survival	NN	O	survival	prep_on	28	SENT_15	[p1l148t1358r272b1389],
31	were	VBD	O	be	auxpass	32	SENT_15	[p1l282t1368r360b1389],
32	associated	VBN	O	associate	ccomp	27	SENT_15	[p1l372t1358r541b1388],
33	with	IN	O	with	_	0	SENT_15	[p1l551t1358r625b1389],
34	expression	NN	O	expression	prep_with	32	SENT_15	[p1l637t1368r813b1397],
35	by	IN	O	by	_	0	SENT_15	[p1l825t1358r862b1397],
36	the	DT	O	the	det	37	SENT_15	[p1l873t1358r923b1388],
37	tumor	NN	O	tumor	agent	32	SENT_15	[p1l935t1364r1037b1389],
38	of	IN	O	of	_	0	SENT_15	[p1l1048t1357r1087b1388],
39	epidermal	JJ	O	epidermal	amod	44	SENT_15	[p1l1092t1358r1257b1397],
40	growth	NN	O	growth	nn	44	SENT_15	[p1l1269t1358r1387b1397],
41	factor	NN	O	factor	nn	44	SENT_15	[p1l1398t1357r1494b1388],
42	S.K.-R.	NNP	O	S.K.-R.	nn	44	SENT_15	[p1l1532t1367r1617b1393],
43	,	,	O	,	_	0	SENT_15	[p1l1532t1367r1617b1393],
44	j.S.	NNP	O	j.S.	prep_of	37	SENT_15	[p1l1624t1367r1672b1395],
45	,	,	O	,	_	0	SENT_15	[p1l1624t1367r1672b1395],
46	'	''	O	'	_	0	SENT_15	[p1l1682t1367r1733b1393],
47	|	NN	O	|	dep	44	SENT_15	[p1l1682t1367r1733b1393],
48	'	''	O	'	_	0	SENT_15	[p1l1682t1367r1733b1393],
49	.	.	O	.	_	0	SENT_15	[p1l1682t1367r1733b1393],

1	Z.	NNP	O	Z.	nn	9	SENT_16	[p1l1682t1367r1733b1393],
2	,	,	O	,	_	0	SENT_16	[p1l1682t1367r1733b1393],
3	N.L.	NNP	O	N.L.	appos	9	SENT_16	[p1l1746t1367r1801b1393],
4	,	,	O	,	_	0	SENT_16	[p1l1746t1367r1801b1393],
5	P.M.	NNP	O	P.M.	appos	9	SENT_16	[p1l1814t1367r1874b1393],
6	,	,	O	,	_	0	SENT_16	[p1l1814t1367r1874b1393],
7	G.C.S.	NNP	O	G.C.S.	appos	9	SENT_16	[p1l1885t1367r1968b1393],
8	,	,	O	,	_	0	SENT_16	[p1l1885t1367r1968b1393],
9	F.A.S.	NNP	O	F.A.S.	_	0	SENT_16	[p1l1980t1367r2066b1396],
10	)	CD	NUMBER	)	num	9	SENT_16	[p1l1980t1367r2066b1396],
11	;	:	O	;	_	0	SENT_16	[p1l1980t1367r2066b1396],
12	receptor	NN	O	receptor	nn	15	SENT_16	[p1l94t1414r231b1447],
13	(	CD	NUMBER	(	num	15	SENT_16	[p1l241t1410r360b1443],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_16	[p1l241t1410r360b1443],
15	)	NN	O	)	dep	9	SENT_16	[p1l241t1410r360b1443],
16	and	CC	O	and	_	0	SENT_16	[p1l371t1407r432b1438],
17	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_16	[p1l440t1410r523b1439],
18	gene	NN	O	gene	nn	19	SENT_16	[p1l530t1417r607b1447],
19	ampliﬁcation	NN	O	ampliﬁcation	dep	9	SENT_16	[p1l616t1407r836b1447],
20	and	CC	O	and	_	0	SENT_16	[p1l845t1407r906b1438],
21	mutations	NNS	O	mutation	conj_and	19	SENT_16	[p1l915t1408r1092b1438],
22	.	.	O	.	_	0	SENT_16	[p1l915t1408r1092b1438],

1	the	DT	O	the	det	4	SENT_17	[p1l1531t1402r1570b1426],
2	Ottawa	NNP	ORGANIZATION	Ottawa	nn	4	SENT_17	[p1l1581t1404r1669b1426],
3	Health	NNP	ORGANIZATION	Health	nn	4	SENT_17	[p1l1683t1402r1762b1426],
4	Res	NNP	ORGANIZATION	Res	_	0	SENT_17	[p1l1776t1402r1884b1426],
5	‘	SYM	O	‘	dep	4	SENT_17	[p1l1776t1402r1884b1426],
6	-	:	O	-	_	0	SENT_17	[p1l1776t1402r1884b1426],
7	‘	NN	O	‘	dep	4	SENT_17	[p1l1776t1402r1884b1426],
8	a	DT	O	a	det	11	SENT_17	[p1l1776t1402r1884b1426],
9	"	``	O	"	punct	11	SENT_17	[p1l1776t1402r1884b1426],
10	3l	NN	O	3l	nn	11	SENT_17	[p1l1776t1402r1884b1426],
11	‘	NN	O	‘	dep	7	SENT_17	[p1l1776t1402r1884b1426],
12	'	''	O	'	_	0	SENT_17	[p1l1898t1404r2004b1430],
13	“	CD	NUMBER	“	number	14	SENT_17	[p1l1898t1404r2004b1430],
14	5	CD	NUMBER	5	dep	7	SENT_17	[p1l1898t1404r2004b1430],
15	‘”	NN	O	‘”	dep	14	SENT_17	[p1l1898t1404r2004b1430],
16	“	CD	NUMBER	“	num	15	SENT_17	[p1l1898t1404r2004b1430],
17	te	NN	O	te	nn	19	SENT_17	[p1l1898t1404r2004b1430],
18	»	CD	NUMBER	»	num	19	SENT_17	[p1l1898t1404r2004b1430],
19	U	NNP	O	U	dep	14	SENT_17	[p1l2018t1404r2068b1426],
20	“	CD	NUMBER	“	num	22	SENT_17	[p1l2018t1404r2068b1426],
21	l'	NN	O	l'	nn	22	SENT_17	[p1l2018t1404r2068b1426],
22	versity	NN	O	versity	dep	19	SENT_17	[p1l1531t1442r1610b1471],
23	of	IN	O	of	_	0	SENT_17	[p1l1620t1440r1647b1464],
24	Ottawa	NNP	LOCATION	Ottawa	prep_of	22	SENT_17	[p1l1653t1442r1748b1468],
25	,	,	O	,	_	0	SENT_17	[p1l1653t1442r1748b1468],
26	Ottawa	NNP	LOCATION	Ottawa	nn	28	SENT_17	[p1l1760t1442r1848b1464],
27	(	CD	NUMBER	(	num	28	SENT_17	[p1l1862t1442r1912b1471],
28	|	NN	O	|	appos	22	SENT_17	[p1l1862t1442r1912b1471],
29	.	.	O	.	_	0	SENT_17	[p1l1862t1442r1912b1471],

1	L.	NNP	O	L.	nsubjpass	30	SENT_18	[p1l1862t1442r1912b1471],
2	,	,	O	,	_	0	SENT_18	[p1l1862t1442r1912b1471],
3	M.D.	NNP	O	M.D.	appos	1	SENT_18	[p1l1926t1442r1992b1468],
4	,	,	O	,	_	0	SENT_18	[p1l1926t1442r1992b1468],
5	A.L.	NNP	O	A.L.	nn	6	SENT_18	[p1l2002t1441r2066b1471],
6	)	NN	O	)	appos	3	SENT_18	[p1l2002t1441r2066b1471],
7	;	:	O	;	_	0	SENT_18	[p1l2002t1441r2066b1471],
8	OSI	NNP	ORGANIZATION	OSI	nn	9	SENT_18	[p1l1532t1479r1577b1501],
9	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	dep	3	SENT_18	[p1l1589t1477r1800b1505],
10	,	,	O	,	_	0	SENT_18	[p1l1589t1477r1800b1505],
11	Boulder	NNP	LOCATION	Boulder	dep	16	SENT_18	[p1l1811t1477r1910b1505],
12	,	,	O	,	_	0	SENT_18	[p1l1811t1477r1910b1505],
13	Colo.	NNP	LOCATION	Colo.	dep	11	SENT_18	[p1l1919t1477r1982b1501],
14	(	NNP	O	(	nn	16	SENT_18	[p1l1993t1479r2066b1508],
15	F.R.	NNP	LOCATION	F.R.	nn	16	SENT_18	[p1l1993t1479r2066b1508],
16	)	NNP	O	)	appos	9	SENT_18	[p1l1993t1479r2066b1508],
17	;	:	O	;	_	0	SENT_18	[p1l1993t1479r2066b1508],
18	M	NN	O	m	nn	21	SENT_18	[p1l97t1513r117b1532],
19	ETH	NN	O	eth	nn	21	SENT_18	[p1l127t1512r184b1532],
20	o	NN	O	o	nn	21	SENT_18	[p1l191t1512r212b1532],
21	DS	NN	O	d	dep	3	SENT_18	[p1l219t1512r256b1532],
22	and	CC	O	and	_	0	SENT_18	[p1l1532t1509r1577b1533],
23	the	DT	O	the	det	28	SENT_18	[p1l1586t1509r1626b1533],
24	National	NNP	ORGANIZATION	National	nn	28	SENT_18	[p1l1637t1509r1743b1533],
25	Cancer	NNP	ORGANIZATION	Cancer	nn	28	SENT_18	[p1l1754t1511r1841b1533],
26	Institute	NNP	ORGANIZATION	Institute	nn	28	SENT_18	[p1l1851t1511r1955b1533],
27	ofCanaEGFR	NN	O	ofcanaegfr	nn	28	SENT_18	[p1l1964t1509r2067b1533, p1l94t1555r194b1585],
28	expression	NN	O	expression	dep	3	SENT_18	[p1l202t1553r378b1591],
29	was	VBD	O	be	auxpass	30	SENT_18	[p1l388t1563r450b1583],
30	evaluated	VBN	O	evaluate	_	0	SENT_18	[p1l463t1552r615b1583],
31	immunohistochemically	RB	O	immunohistochemically	advmod	30	SENT_18	[p1l627t1552r1029b1591],
32	in	IN	O	in	_	0	SENT_18	[p1l1039t1553r1070b1583],
33	non	JJ	O	non	amod	36	SENT_18	[p1l1082t1552r1327b1583],
34	—	JJ	O	—	amod	36	SENT_18	[p1l1082t1552r1327b1583],
35	small	JJ	O	small	amod	36	SENT_18	[p1l1082t1552r1327b1583],
36	—	NN	O	—	prepc_in	30	SENT_18	[p1l1082t1552r1327b1583],
37	cell	NN	O	cell	nn	38	SENT_18	[p1l1082t1552r1327b1583],
38	lung	NN	O	lung	nsubj	39	SENT_18	[p1l1338t1553r1413b1592],
39	can	MD	O	can	rcmod	36	SENT_18	[p1l1424t1562r1492b1583],
40	-	:	O	-	_	0	SENT_18	[p1l1424t1562r1492b1583],
41	da	NN	O	da	nn	42	SENT_18	[p1l1532t1547r1561b1571],
42	C	NN	O	c	nn	49	SENT_18	[p1l1571t1547r1663b1590],
43	_	CD	NUMBER	_	number	44	SENT_18	[p1l1571t1547r1663b1590],
44	“”	CD	NUMBER	“”	num	45	SENT_18	[p1l1571t1547r1663b1590],
45	iC	NN	O	ic	npadvmod	46	SENT_18	[p1l1571t1547r1663b1590],
46	=	JJ	O	=	amod	42	SENT_18	[p1l1571t1547r1663b1590],
47	jil	NN	ORGANIZATION	jil	nn	49	SENT_18	[p1l1571t1547r1663b1590],
48	Trials	NNP	ORGANIZATION	Trials	nn	49	SENT_18	[p1l1673t1547r1739b1571],
49	Group	NNP	ORGANIZATION	Group	dep	66	SENT_18	[p1l1750t1549r1831b1578],
50	and	CC	O	and	_	0	SENT_18	[p1l1841t1547r1886b1571],
51	Queen	NNP	O	Queen	poss	55	SENT_18	[p1l1898t1549r2004b1577],
52	's	POS	O	's	_	0	SENT_18	[p1l1898t1549r2004b1577],
53	Uni	NNP	O	Uni	nn	55	SENT_18	[p1l2016t1549r2067b1571, p1l233t1603r238b1608],
54	. . . .	NNP	O	. . . .	nn	55	SENT_18	[p1l913t1603r918b1608],[p1l2016t1549r2067b1571, p1l233t1603r238b1608],
55	versity	NN	O	versity	dep	66	SENT_18	[p1l1531t1589r1617b1616],
56	,	,	O	,	_	0	SENT_18	[p1l1531t1589r1617b1616],
57	Kingston	NNP	LOCATION	Kingston	nn	63	SENT_18	[p1l1630t1587r1746b1616],
58	,	,	O	,	_	0	SENT_18	[p1l1630t1587r1746b1616],
59	Ont.	NNP	LOCATION	Ont.	appos	63	SENT_18	[p1l1756t1587r1817b1613],
60	,	,	O	,	_	0	SENT_18	[p1l1756t1587r1817b1613],
61	Canada	NNP	LOCATION	Canada	appos	63	SENT_18	[p1l1827t1585r1917b1608],
62	(	NNP	O	(	nn	63	SENT_18	[p1l1929t1587r1988b1616],
63	L.S.	NNP	LOCATION	L.S.	appos	55	SENT_18	[p1l1929t1587r1988b1616],
64	,	,	O	,	_	0	SENT_18	[p1l1929t1587r1988b1616],
65	M.	NNP	O	M.	nn	66	SENT_18	[p1l2000t1587r2066b1613],
66	Vl	NNP	O	Vl	parataxis	36	SENT_18	[p1l2000t1587r2066b1613],
67	/	:	O	/	punct	66	SENT_18	[p1l2000t1587r2066b1613],
68	.	.	O	.	_	0	SENT_18	[p1l2000t1587r2066b1613],

1	,	,	O	,	_	0	SENT_19	[p1l2000t1587r2066b1613],

1	cer	NN	O	cer	nn	2	SENT_20	[p1l95t1613r144b1633],
2	specimens	NNS	O	specimen	nsubjpass	15	SENT_20	[p1l155t1613r332b1642],
3	from	IN	O	from	_	0	SENT_20	[p1l345t1602r427b1633],
4	325	CD	NUMBER	325	number	6	SENT_20	[p1l439t1605r499b1633],
5	of	IN	O	of	quantmod	6	SENT_20	[p1l512t1602r552b1633],
6	731	CD	NUMBER	731	num	7	SENT_20	[p1l557t1605r617b1633],
7	patients	NNS	O	patient	prep_from	2	SENT_20	[p1l629t1609r763b1642],
8	in	IN	O	in	_	0	SENT_20	[p1l775t1613r807b1633],
9	the	DT	O	the	det	10	SENT_20	[p1l819t1603r871b1633],
10	trial	NN	O	trial	prep_in	7	SENT_20	[p1l883t1603r960b1640],
11	;	:	O	;	_	0	SENT_20	[p1l883t1603r960b1640],
12	197	CD	NUMBER	197	num	13	SENT_20	[p1l975t1605r1034b1633],
13	samples	NNS	O	sample	dep	7	SENT_20	[p1l1047t1603r1183b1642],
14	were	VBD	O	be	auxpass	15	SENT_20	[p1l1194t1613r1274b1634],
15	analyzed	VBN	O	analyze	_	0	SENT_20	[p1l1286t1603r1433b1642],
16	for	IN	O	for	_	0	SENT_20	[p1l1444t1602r1493b1633],
17	K.	NNP	O	K.	nn	23	SENT_20	[p1l1534t1624r1583b1646],
18	D	NNP	O	D	nn	23	SENT_20	[p1l1534t1624r1583b1646],
19	_	NNP	O	_	nn	23	SENT_20	[p1l1534t1624r1583b1646],
20	J.	NNP	O	J.	nn	23	SENT_20	[p1l1595t1624r1656b1653],
21	P	NN	O	p	nn	23	SENT_20	[p1l1595t1624r1656b1653],
22	_	CD	NUMBER	_	num	23	SENT_20	[p1l1595t1624r1656b1653],
23	)	NN	O	)	prep_for	15	SENT_20	[p1l1595t1624r1656b1653],
24	.	.	O	.	_	0	SENT_20	[p1l1595t1624r1656b1653],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_21	[p1l94t1655r178b1684],
2	mutations	NNS	O	mutation	nsubjpass	8	SENT_21	[p1l186t1653r367b1690],
3	;	:	O	;	_	0	SENT_21	[p1l186t1653r367b1690],
4	and	CC	O	and	_	0	SENT_21	[p1l378t1653r439b1683],
5	221	CD	NUMBER	221	num	6	SENT_21	[p1l448t1655r508b1683],
6	samples	NNS	O	sample	conj_and	2	SENT_21	[p1l518t1653r651b1692],
7	were	VBD	O	be	auxpass	8	SENT_21	[p1l660t1663r738b1684],
8	analyzed	VBN	O	analyze	_	0	SENT_21	[p1l747t1653r890b1692],
9	for	IN	O	for	_	0	SENT_21	[p1l899t1652r947b1683],
10	the	DT	O	the	det	11	SENT_21	[p1l956t1653r1006b1683],
11	number	NN	O	number	prep_for	8	SENT_21	[p1l1016t1653r1146b1684],
12	of	IN	O	of	_	0	SENT_21	[p1l1155t1652r1194b1683],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_21	[p1l1195t1655r1278b1684],
14	genes	NNS	O	gene	prep_of	11	SENT_21	[p1l1285t1663r1388b1692],
15	.	.	O	.	_	0	SENT_21	[p1l1285t1663r1388b1692],

1	Drs.	NNP	O	Drs.	nn	2	SENT_22	[p1l1534t1699r1583b1721],
2	Sakurada	NNP	PERSON	Sakurada	nsubj	8	SENT_22	[p1l1594t1697r1718b1725],
3	,	,	O	,	_	0	SENT_22	[p1l1594t1697r1718b1725],
4	Cutz	NNP	PERSON	Cutz	conj_and	2	SENT_22	[p1l1729t1699r1793b1725],
5	,	,	O	,	_	0	SENT_22	[p1l1729t1699r1793b1725],
6	and	CC	O	and	_	0	SENT_22	[p1l1804t1697r1849b1721],
7	Zhu	NNP	PERSON	Zhu	nsubj	8	SENT_22	[p1l1860t1697r1909b1721],
8	contributed	VBD	O	contribute	_	0	SENT_22	[p1l1920t1697r2066b1721],
9	equally	RB	O	equally	advmod	8	SENT_22	[p1l1532t1734r1621b1765],
10	to	TO	O	to	_	0	SENT_22	[p1l1628t1739r1653b1758],
11	this	DT	O	this	det	12	SENT_22	[p1l1662t1734r1708b1758],
12	article	NN	O	article	prep_to	8	SENT_22	[p1l1719t1734r1802b1758],
13	.	.	O	.	_	0	SENT_22	[p1l1719t1734r1802b1758],

1	R	NN	O	r	nn	3	SENT_23	[p1l96t1763r110b1782],
2	ESU	NNP	O	ESU	nn	3	SENT_23	[p1l117t1763r173b1782],
3	LTS	NNP	O	LTS	dep	9	SENT_23	[p1l181t1763r231b1782],
4	In	IN	O	in	_	0	SENT_23	[p1l94t1805r128b1832],
5	univariate	JJ	O	univariate	amod	6	SENT_23	[p1l138t1802r303b1833],
6	analyses	NNS	O	analysis	prep_in	9	SENT_23	[p1l313t1802r462b1841],
7	,	,	O	,	_	0	SENT_23	[p1l313t1802r462b1841],
8	survival	NN	O	survival	nsubj	9	SENT_23	[p1l476t1802r602b1833],
9	was	VBD	O	be	_	0	SENT_23	[p1l611t1812r674b1833],
10	longer	RBR	O	longer	advmod	9	SENT_23	[p1l685t1802r795b1841],
11	in	IN	O	in	_	0	SENT_23	[p1l804t1802r836b1832],
12	the	DT	O	the	det	14	SENT_23	[p1l847t1802r898b1832],
13	erlotinib	JJ	O	erlotinib	amod	14	SENT_23	[p1l909t1802r1052b1832],
14	group	NN	O	group	prep_in	9	SENT_23	[p1l1063t1812r1162b1841],
15	than	IN	O	than	mark	22	SENT_23	[p1l1173t1802r1248b1832],
16	in	IN	O	in	_	0	SENT_23	[p1l1258t1802r1290b1832],
17	the	DT	O	the	det	19	SENT_23	[p1l1301t1802r1352b1832],
18	placebo	NN	O	placebo	nn	19	SENT_23	[p1l1363t1802r1492b1841],
19	N	NN	O	n	prep_in	22	SENT_23	[p1l1534t1811r1551b1833],
20	Engl	NNP	O	Engl	nn	21	SENT_23	[p1l1565t1809r1616b1840],
21	J	NNP	O	J	nsubj	22	SENT_23	[p1l1623t1811r1632b1839],
22	Med	VBD	O	med	advcl	9	SENT_23	[p1l1646t1809r1699b1833],
23	2005	CD	DATE	2005	dobj	22	SENT_23	[p1l1710t1811r1927b1837],
24	;	:	O	;	_	0	SENT_23	[p1l1710t1811r1927b1837],
25	353:133	CD	NUMBER	353:133	num	26	SENT_23	[p1l1710t1811r1927b1837],
26	-44	CD	NUMBER	-44	dep	23	SENT_23	[p1l1710t1811r1927b1837],
27	.	.	O	.	_	0	SENT_23	[p1l1710t1811r1927b1837],

1	group	NN	O	group	_	0	SENT_24	[p1l94t1861r192b1890],
2	when	WRB	O	when	advmod	4	SENT_24	[p1l200t1851r291b1882],
3	EGFRwas	NN	O	egfrwa	nsubj	4	SENT_24	[p1l300t1853r467b1883],
4	expressed	VBD	O	express	dep	1	SENT_24	[p1l478t1851r638b1890],
5	(	CD	NUMBER	(	num	7	SENT_24	[p1l650t1851r773b1886],
6	hazard	NN	O	hazard	nn	7	SENT_24	[p1l650t1851r773b1886],
7	ratio	NN	O	ratio	dobj	4	SENT_24	[p1l782t1851r857b1881],
8	for	IN	O	for	_	0	SENT_24	[p1l867t1851r915b1881],
9	death	NN	O	death	prep_for	4	SENT_24	[p1l923t1851r1022b1888],
10	,	,	O	,	_	0	SENT_24	[p1l923t1851r1022b1888],
11	0.68	CD	NUMBER	0.68	appos	9	SENT_24	[p1l1034t1853r1115b1888],
12	;	:	O	;	_	0	SENT_24	[p1l1034t1853r1115b1888],
13	P	NN	O	p	dep	11	SENT_24	[p1l1125t1853r1258b1886],
14	=	JJ	O	=	amod	13	SENT_24	[p1l1125t1853r1258b1886],
15	0.02	CD	NUMBER	0.02	num	16	SENT_24	[p1l1125t1853r1258b1886],
16	)	CD	NUMBER	)	dep	13	SENT_24	[p1l1125t1853r1258b1886],
17	or	CC	O	or	_	0	SENT_24	[p1l1270t1861r1305b1881],
18	there	EX	O	there	expl	19	SENT_24	[p1l1313t1851r1396b1881],
19	was	VBD	O	be	dep	1	SENT_24	[p1l1404t1861r1466b1882],
20	a	DT	O	a	det	25	SENT_24	[p1l1476t1861r1493b1881],
21	C	NN	O	c	nn	25	SENT_24	[p1l1532t1850r1625b1875],
22	°	CD	NUMBER	°	num	25	SENT_24	[p1l1532t1850r1625b1875],
23	F	NN	O	f	nn	25	SENT_24	[p1l1532t1850r1625b1875],
24	’	CD	NUMBER	’	num	25	SENT_24	[p1l1532t1850r1625b1875],
25	V	NN	O	v	nsubj	19	SENT_24	[p1l1532t1850r1625b1875],
26	"	''	O	"	punct	19	SENT_24	[p1l1532t1850r1625b1875],
27	'	''	O	'	_	0	SENT_24	[p1l1532t1850r1625b1875],
28	El	NNP	O	El	dep	1	SENT_24	[p1l1532t1850r1625b1875],
29	"	``	O	"	punct	31	SENT_24	[p1l1532t1850r1625b1875],
30	©	CD	NUMBER	©	num	31	SENT_24	[p1l1633t1852r1654b1873],
31	2005	CD	DATE	2005	nsubj	38	SENT_24	[p1l1663t1851r1712b1869],
32	"	``	O	"	punct	31	SENT_24	[p1l1720t1850r1860b1869],
33	””	NN	O	””	nn	34	SENT_24	[p1l1720t1850r1860b1869],
34	‘	NN	O	‘	dep	31	SENT_24	[p1l1720t1850r1860b1869],
35	5	CD	NUMBER	5	number	36	SENT_24	[p1l1720t1850r1860b1869],
36	“‘	CD	NUMBER	“‘	num	38	SENT_24	[p1l1720t1850r1860b1869],
37	l'	NN	O	l'	nn	38	SENT_24	[p1l1720t1850r1860b1869],
38	“‘	NN	O	“‘	rcmod	28	SENT_24	[p1l1720t1850r1860b1869],
39	5	CD	NUMBER	5	number	40	SENT_24	[p1l1720t1850r1860b1869],
40	“‘	CD	NUMBER	“‘	num	38	SENT_24	[p1l1720t1850r1860b1869],
41	Me	PRP	O	I	nsubj	42	SENT_24	[p1l1868t1850r1945b1869],
42	”	VBP	O	”	rcmod	38	SENT_24	[p1l1868t1850r1945b1869],
43	"	``	O	"	punct	52	SENT_24	[p1l1868t1850r1945b1869],
44	“’	NN	O	“’	nn	52	SENT_24	[p1l1868t1850r1945b1869],
45	5	CD	NUMBER	5	num	52	SENT_24	[p1l1951t1851r2023b1875],
46	°	CD	NUMBER	°	num	52	SENT_24	[p1l1951t1851r2023b1875],
47	"	``	O	"	punct	52	SENT_24	[p1l1951t1851r2023b1875],
48	“	CD	NUMBER	“	num	52	SENT_24	[p1l1951t1851r2023b1875],
49	Y	NN	O	y	nn	52	SENT_24	[p1l1951t1851r2023b1875],
50	~	CD	NUMBER	~	num	52	SENT_24	[p1l1951t1851r2023b1875],
51	high	JJ	O	high	amod	52	SENT_24	[p1l94t1900r169b1940],
52	number	NN	O	number	dep	42	SENT_24	[p1l178t1901r309b1932],
53	of	IN	O	of	_	0	SENT_24	[p1l317t1900r356b1931],
54	copies	NNS	O	copy	prep_of	38	SENT_24	[p1l359t1901r461b1940],
55	of	IN	O	of	_	0	SENT_24	[p1l472t1900r511b1931],
56	EGFR	NN	ORGANIZATION	egfr	nn	59	SENT_24	[p1l512t1903r595b1932],
57	(	CD	NUMBER	(	num	59	SENT_24	[p1l603t1900r727b1936],
58	hazard	NN	O	hazard	nn	59	SENT_24	[p1l603t1900r727b1936],
59	ratio	NN	O	ratio	prep_of	54	SENT_24	[p1l736t1901r820b1938],
60	,	,	O	,	_	0	SENT_24	[p1l736t1901r820b1938],
61	0.44	CD	NUMBER	0.44	nn	66	SENT_24	[p1l831t1903r912b1938],
62	;	:	O	;	_	0	SENT_24	[p1l831t1903r912b1938],
63	P	NN	O	p	dep	61	SENT_24	[p1l923t1903r1087b1936],
64	=	JJ	O	=	amod	66	SENT_24	[p1l923t1903r1087b1936],
65	0.008	CD	NUMBER	0.008	tmod	64	SENT_24	[p1l923t1903r1087b1936],
66	)	NN	O	)	dobj	38	SENT_24	[p1l923t1903r1087b1936],
67	.	.	O	.	_	0	SENT_24	[p1l923t1903r1087b1936],

1	In	IN	O	in	_	0	SENT_25	[p1l1098t1903r1132b1931],
2	multivariate	JJ	O	multivariate	amod	3	SENT_25	[p1l1141t1901r1336b1932],
3	analyses	NNS	O	analysis	nsubj	14	SENT_25	[p1l1345t1900r1491b1940],
4	,	,	O	,	_	0	SENT_25	[p1l1345t1900r1491b1940],
5	adenocarcinoma	NN	O	adenocarcinoma	nn	7	SENT_25	[p1l94t1950r373b1981],
6	(	CD	NUMBER	(	num	7	SENT_25	[p1l385t1953r544b1988],
7	P	NN	O	p	appos	3	SENT_25	[p1l385t1953r544b1988],
8	=	JJ	O	=	amod	10	SENT_25	[p1l385t1953r544b1988],
9	0.01	CD	NUMBER	0.01	tmod	8	SENT_25	[p1l385t1953r544b1988],
10	)	NN	O	)	dep	7	SENT_25	[p1l385t1953r544b1988],
11	,	,	O	,	_	0	SENT_25	[p1l385t1953r544b1988],
12	never	RB	O	never	neg	14	SENT_25	[p1l557t1960r647b1981],
13	having	VBG	O	have	aux	14	SENT_25	[p1l656t1950r769b1990],
14	smoked	VBN	O	smoke	prepc_in	31	SENT_25	[p1l779t1950r910b1982],
15	(	CD	NUMBER	(	num	16	SENT_25	[p1l923t1953r1096b1988],
16	P	NN	O	p	npadvmod	17	SENT_25	[p1l923t1953r1096b1988],
17	<	JJR	O	<	acomp	14	SENT_25	[p1l923t1953r1096b1988],
18	0.001	CD	NUMBER	0.001	num	19	SENT_25	[p1l923t1953r1096b1988],
19	)	NN	O	)	dep	17	SENT_25	[p1l923t1953r1096b1988],
20	,	,	O	,	_	0	SENT_25	[p1l923t1953r1096b1988],
21	and	CC	O	and	_	0	SENT_25	[p1l1108t1950r1170b1981],
22	expression	NN	O	expression	dep	17	SENT_25	[p1l1181t1951r1360b1990],
23	of	IN	O	of	_	0	SENT_25	[p1l1371t1950r1411b1981],
24	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_25	[p1l1413t1953r1495b1982],
25	(	CD	NUMBER	(	num	26	SENT_25	[p1l96t2002r240b2036],
26	P	NN	O	p	prep_of	22	SENT_25	[p1l96t2002r240b2036],
27	=	JJ	O	=	amod	29	SENT_25	[p1l96t2002r240b2036],
28	0.03	CD	NUMBER	0.03	num	29	SENT_25	[p1l96t2002r240b2036],
29	)	NN	O	)	nsubjpass	31	SENT_25	[p1l96t2002r240b2036],
30	were	VBD	O	be	auxpass	31	SENT_25	[p1l250t2010r329b2031],
31	associated	VBN	O	associate	_	0	SENT_25	[p1l339t2000r508b2031],
32	with	IN	O	with	_	0	SENT_25	[p1l516t2000r590b2031],
33	an	DT	O	a	det	35	SENT_25	[p1l600t2010r639b2031],
34	objective	JJ	O	objective	amod	35	SENT_25	[p1l649t2000r791b2039],
35	response	NN	O	response	prep_with	31	SENT_25	[p1l802t2010r958b2039],
36	.	.	O	.	_	0	SENT_25	[p1l802t2010r958b2039],

1	In	IN	O	in	_	0	SENT_26	[p1l970t2003r1004b2030],
2	multivariate	JJ	O	multivariate	amod	3	SENT_26	[p1l1014t2000r1209b2031],
3	analysis	NN	O	analysis	prep_in	12	SENT_26	[p1l1219t2000r1357b2039],
4	,	,	O	,	_	0	SENT_26	[p1l1219t2000r1357b2039],
5	survival	NN	O	survival	nsubjpass	12	SENT_26	[p1l1370t2000r1493b2031],
6	after	IN	O	after	_	0	SENT_26	[p1l94t2049r169b2080],
7	treatment	NN	O	treatment	prep_after	5	SENT_26	[p1l177t2056r338b2080],
8	with	IN	O	with	_	0	SENT_26	[p1l343t2050r417b2080],
9	erlotinib	NN	O	erlotinib	prep_with	7	SENT_26	[p1l426t2049r565b2080],
10	was	VBD	O	be	auxpass	12	SENT_26	[p1l573t2060r635b2080],
11	not	RB	O	not	neg	12	SENT_26	[p1l645t2056r701b2080],
12	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_26	[p1l707t2049r881b2080],
13	by	IN	O	by	_	0	SENT_26	[p1l890t2050r928b2088],
14	the	DT	O	the	det	15	SENT_26	[p1l935t2050r985b2080],
15	status	NN	O	status	agent	12	SENT_26	[p1l995t2056r1090b2080],
16	of	IN	O	of	_	0	SENT_26	[p1l1100t2049r1139b2080],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_26	[p1l1141t2052r1241b2082],
18	expression	NN	O	expression	prep_of	15	SENT_26	[p1l1246t2050r1431b2088],
19	,	,	O	,	_	0	SENT_26	[p1l1246t2050r1431b2088],
20	the	DT	O	the	det	21	SENT_26	[p1l1443t2049r1493b2080],
21	number	NN	O	number	agent	12	SENT_26	[p1l94t2099r225b2129],
22	of	IN	O	of	_	0	SENT_26	[p1l233t2098r272b2129],
23	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_26	[p1l274t2101r357b2129],
24	copies	NNS	O	copy	prep_of	21	SENT_26	[p1l364t2099r477b2137],
25	,	,	O	,	_	0	SENT_26	[p1l364t2099r477b2137],
26	or	CC	O	or	_	0	SENT_26	[p1l489t2108r523b2129],
27	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_26	[p1l531t2101r614b2129],
28	mutation	NN	O	mutation	agent	12	SENT_26	[p1l621t2099r781b2129],
29	.	.	O	.	_	0	SENT_26	[p1l621t2099r781b2129],

1	c	NN	O	c	nn	3	SENT_27	[p1l95t2208r111b2228],
2	o	NN	O	o	nn	3	SENT_27	[p1l116t2208r137b2228],
3	N	NN	O	n	nsubj	11	SENT_27	[p1l145t2208r161b2228],
4	c	NN	O	c	nn	7	SENT_27	[p1l169t2208r186b2228],
5	L	NN	O	l	nn	7	SENT_27	[p1l192t2208r204b2228],
6	u	NN	O	u	nn	7	SENT_27	[p1l210t2208r227b2228],
7	s	NNS	O	s	dep	3	SENT_27	[p1l233t2208r247b2228],
8	I	PRP	O	I	dep	3	SENT_27	[p1l254t2208r259b2228],
9	o	NN	O	o	nn	10	SENT_27	[p1l266t2208r287b2228],
10	N	NN	O	n	dep	8	SENT_27	[p1l295t2208r312b2228],
11	s	VBZ	O	s	_	0	SENT_27	[p1l319t2208r333b2228],
12	Among	IN	O	among	_	0	SENT_27	[p1l93t2250r217b2287],
13	patients	NNS	O	patient	prep_among	33	SENT_27	[p1l223t2248r353b2287],
14	with	IN	O	with	_	0	SENT_27	[p1l361t2247r434b2279],
15	non	JJ	O	non	amod	21	SENT_27	[p1l443t2247r687b2278],
16	—	JJ	O	—	amod	21	SENT_27	[p1l443t2247r687b2278],
17	small	JJ	O	small	amod	21	SENT_27	[p1l443t2247r687b2278],
18	—	NN	O	—	nn	21	SENT_27	[p1l443t2247r687b2278],
19	cell	NN	O	cell	nn	21	SENT_27	[p1l443t2247r687b2278],
20	lung	NN	O	lung	nn	21	SENT_27	[p1l695t2247r771b2287],
21	cancer	NN	O	cancer	prep_with	13	SENT_27	[p1l778t2258r885b2278],
22	who	WP	O	who	nsubj	23	SENT_27	[p1l890t2247r961b2279],
23	receive	VBP	O	receive	rcmod	13	SENT_27	[p1l970t2248r1081b2279],
24	erlotinib	NN	O	erlotinib	dobj	23	SENT_27	[p1l1090t2247r1239b2285],
25	,	,	O	,	_	0	SENT_27	[p1l1090t2247r1239b2285],
26	the	DT	O	the	det	27	SENT_27	[p1l1249t2248r1299b2278],
27	presence	NN	O	presence	nsubj	33	SENT_27	[p1l1307t2258r1452b2287],
28	of	IN	O	of	_	0	SENT_27	[p1l1461t2247r1500b2278],
29	an	DT	O	a	det	31	SENT_27	[p1l94t2308r133b2328],
30	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_27	[p1l141t2300r225b2329],
31	mutation	NN	O	mutation	prep_of	27	SENT_27	[p1l232t2298r386b2329],
32	may	MD	O	may	aux	33	SENT_27	[p1l395t2308r465b2337],
33	increase	VB	O	increase	ccomp	11	SENT_27	[p1l472t2298r609b2328],
34	responsiveness	NN	O	responsiveness	dobj	33	SENT_27	[p1l619t2298r872b2337],
35	to	TO	O	to	_	0	SENT_27	[p1l882t2304r913b2328],
36	the	DT	O	the	det	37	SENT_27	[p1l923t2297r974b2328],
37	agent	NN	O	agent	prep_to	33	SENT_27	[p1l984t2304r1085b2337],
38	,	,	O	,	_	0	SENT_27	[p1l984t2304r1085b2337],
39	but	CC	O	but	_	0	SENT_27	[p1l1097t2297r1152b2329],
40	it	PRP	O	it	nsubj	43	SENT_27	[p1l1159t2298r1183b2328],
41	is	VBZ	O	be	cop	43	SENT_27	[p1l1190t2298r1216b2328],
42	not	RB	O	not	neg	43	SENT_27	[p1l1226t2304r1283b2328],
43	indicative	JJ	O	indicative	conj_but	11	SENT_27	[p1l1290t2297r1450b2329],
44	of	IN	O	of	_	0	SENT_27	[p1l1460t2297r1500b2328],
45	a	DT	O	a	det	47	SENT_27	[p1l94t2358r111b2378],
46	survival	NN	O	survival	nn	47	SENT_27	[p1l122t2348r248b2378],
47	beneﬁt	NN	O	beneﬁt	prep_of	43	SENT_27	[p1l257t2347r379b2378],
48	.	.	O	.	_	0	SENT_27	[p1l257t2347r379b2378],

1	N	NN	O	n	nn	3	SENT_28	[p1l434t2455r447b2470],
2	ENGLJ	NN	O	englj	nn	3	SENT_28	[p1l463t2454r547b2476],
3	MED	NN	O	med	nsubj	9	SENT_28	[p1l562t2455r614b2470],
4	353	CD	NUMBER	353	num	6	SENT_28	[p1l626t2454r690b2476],
5	;	:	O	;	_	0	SENT_28	[p1l626t2454r690b2476],
6	2	CD	NUMBER	2	dep	3	SENT_28	[p1l626t2454r690b2476],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_28	[p1l725t2454r936b2476],
8	JULY	NNP	DATE	JULY	dep	3	SENT_28	[p1l970t2455r1030b2476],
9	‘	VBD	O	‘	_	0	SENT_28	[p1l1043t2454r1077b2476],
10	I4	NN	O	i4	dobj	9	SENT_28	[p1l1043t2454r1077b2476],
11	,	,	O	,	_	0	SENT_28	[p1l1043t2454r1077b2476],
12	2005	CD	DATE	2005	num	13	SENT_28	[p1l1090t2454r1153b2476],
13	133	CD	NUMBER	133	appos	10	SENT_28	[p1l2011t2453r2066b2475],

1	The	DT	O	the	det	4	SENT_29	[p1l752t2551r803b2575],
2	New	NNP	O	New	nn	4	SENT_29	[p1l812t2552r874b2575],
3	England	NNP	O	England	nn	4	SENT_29	[p1l884t2551r994b2582],
4	Journal	NNP	O	Journal	_	0	SENT_29	[p1l1003t2551r1100b2575],
5	of	IN	O	of	_	0	SENT_29	[p1l1110t2551r1139b2575],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_29	[p1l1146t2551r1271b2575],

1	Downloaded	VBN	O	download	_	0	SENT_30	[p1l195t2592r364b2615],
2	from	IN	O	from	_	0	SENT_30	[p1l373t2592r438b2615],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_30	[p1l446t2592r565b2622],
4	at	IN	O	at	_	0	SENT_30	[p1l575t2596r598b2615],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_30	[p1l607t2592r789b2615],
6	on	IN	O	on	_	0	SENT_30	[p1l799t2599r831b2615],
7	January	NNP	DATE	January	prep_on	1	SENT_30	[p1l840t2592r942b2622],
8	5	CD	DATE	5	num	7	SENT_30	[p1l952t2592r975b2619],
9	,	,	DATE	,	_	0	SENT_30	[p1l952t2592r975b2619],
10	2014	CD	DATE	2014	num	7	SENT_30	[p1l986t2592r1058b2615],
11	.	.	O	.	_	0	SENT_30	[p1l986t2592r1058b2615],

1	For	IN	O	for	_	0	SENT_31	[p1l1068t2592r1115b2615],
2	personal	JJ	O	personal	amod	3	SENT_31	[p1l1123t2592r1235b2622],
3	use	NN	O	use	pobj	1	SENT_31	[p1l1245t2599r1288b2615],
4	only	RB	O	only	advmod	3	SENT_31	[p1l1298t2592r1362b2622],
5	.	.	O	.	_	0	SENT_31	[p1l1298t2592r1362b2622],

1	No	DT	O	no	det	3	SENT_32	[p1l1373t2592r1413b2615],
2	other	JJ	O	other	amod	3	SENT_32	[p1l1423t2592r1491b2615],
3	uses	NNS	O	use	_	0	SENT_32	[p1l1499t2599r1555b2615],
4	without	IN	O	without	_	0	SENT_32	[p1l1565t2592r1666b2615],
5	permission	NN	O	permission	prep_without	3	SENT_32	[p1l1675t2592r1827b2622],
6	.	.	O	.	_	0	SENT_32	[p1l1675t2592r1827b2622],

1	The	DT	O	the	det	4	SENT_33	[p1l715t2739r752b2760],
2	NEW	NNP	O	NEW	nn	4	SENT_33	[p1l764t2741r845b2760],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_33	[p1l859t2741r1034b2760],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_33	[p1l1048t2741r1214b2767],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_33	[p1l1228t2739r1444b2766],

1	HE	PRP	O	he	_	0	SENT_34	[p1l382t2976r509b3031],
2	EPIDERMAL	NNP	O	EPIDERMAL	dep	1	SENT_34	[p1l550t2976r1095b3032],
3	GROWTH	NN	O	growth	nn	5	SENT_34	[p1l1131t2975r1544b3032],
4	FACTOR	NN	O	factor	nn	5	SENT_34	[p1l1587t2975r1947b3032],
5	REceptor	NN	O	receptor	dep	1	SENT_34	[p1l1982t2976r2131b3032, p1l379t3099r654b3183],

1	family	NN	O	family	nsubj	7	SENT_35	[p1l701t3082r973b3183],
2	of	IN	O	of	_	0	SENT_35	[p1l1019t3082r1120b3161],
3	genes	NNS	O	gene	nn	6	SENT_35	[p1l1151t3108r1398b3183],
4	(	JJ	O	(	amod	6	SENT_35	[p1l1454t3090r1725b3174],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_35	[p1l1454t3090r1725b3174],
6	)	NN	O	)	prep_of	1	SENT_35	[p1l1454t3090r1725b3174],
7	encodes	VBZ	O	encode	_	0	SENT_35	[p1l1780t3083r2129b3161],
8	Widely	RB	O	widely	advmod	9	SENT_35	[p1l373t3212r656b3312],
9	expressed	VBN	O	express	ccomp	7	SENT_35	[p1l703t3212r1118b3312],
10	transmembrane	NN	O	transmembrane	nn	11	SENT_35	[p1l1166t3212r1840b3290],
11	molecules	NNS	O	molecule	dobj	9	SENT_35	[p1l1889t3212r2133b3290, p1l11t3341r220b3420],
12	that	WDT	O	that	nsubjpass	15	SENT_35	[p1l245t3340r412b3419],
13	have	VBP	O	have	aux	15	SENT_35	[p1l430t3341r618b3420],
14	been	VBN	O	be	auxpass	15	SENT_35	[p1l642t3341r841b3419],
15	implicated	VBN	O	implicate	rcmod	11	SENT_35	[p1l863t3340r1310b3441],
16	in	IN	O	in	_	0	SENT_35	[p1l1332t3341r1413b3418],
17	the	DT	O	the	det	18	SENT_35	[p1l1436t3341r1565b3419],
18	development	NN	O	development	prep_in	15	SENT_35	[p1l1589t3340r2139b3441],
19	and	CC	O	and	_	0	SENT_35	[p1l9t3469r165b3547],
20	progression	NN	O	progression	conj_and	18	SENT_35	[p1l187t3470r696b3569],
21	of	IN	O	of	_	0	SENT_35	[p1l720t3468r821b3547],
22	cancer	NN	O	cancer	prep_of	18	SENT_35	[p1l827t3463r1232b3547],
23	.	.	O	.	_	0	SENT_35	[p1l827t3463r1232b3547],

1	“	NN	O	“	npadvmod	14	SENT_36	[p1l827t3463r1232b3547],
2	After	IN	O	after	_	0	SENT_36	[p1l1251t3468r1465b3547],
3	ligand	NN	O	ligand	nn	4	SENT_36	[p1l1485t3469r1751b3569],
4	binding	NN	O	binding	prep_after	14	SENT_36	[p1l1775t3469r2128b3569],
5	,	,	O	,	_	0	SENT_36	[p1l1775t3469r2128b3569],
6	the	DT	O	the	det	9	SENT_36	[p1l11t3596r139b3675],
7	transmembrane	NN	O	transmembrane	nn	9	SENT_36	[p1l184t3596r858b3675],
8	receptor	NN	O	receptor	nn	9	SENT_36	[p1l902t3613r1253b3697],
9	forms	NNS	O	form	dep	10	SENT_36	[p1l1294t3596r1542b3675],
10	homodimers	NNS	O	homodimer	ccomp	14	SENT_36	[p1l1588t3596r2132b3675],
11	or	CC	O	or	_	0	SENT_36	[p2l11t46r100b99],
12	heterodimers	NNS	O	heterodimer	ccomp	14	SENT_36	[p2l129t20r730b116],
13	,	,	O	,	_	0	SENT_36	[p2l129t20r730b116],
14	internalizes	VBZ	O	internalize	_	0	SENT_36	[p2l768t21r1297b116],
15	,	,	O	,	_	0	SENT_36	[p2l768t21r1297b116],
16	and	CC	O	and	_	0	SENT_36	[p2l1334t20r1492b99],
17	autophospho	NN	O	autophospho	nn	18	SENT_36	[p2l1524t21r2132b121],
18	—	NN	O	—	nsubj	19	SENT_36	[p2l1524t21r2132b121],
19	rylates	VBZ	O	rylate	conj_and	14	SENT_36	[p2l10t149r285b249],
20	tyrosine	NN	O	tyrosine	nn	21	SENT_36	[p2l310t149r645b249],
21	residues	NNS	O	residue	dobj	19	SENT_36	[p2l666t148r1013b228],
22	in	IN	O	in	_	0	SENT_36	[p2l1036t149r1117b226],
23	its	PRP$	O	its	poss	25	SENT_36	[p2l1138t149r1234b227],
24	cytoplasmic	JJ	O	cytoplasmic	amod	25	SENT_36	[p2l1258t148r1760b249],
25	domain	NN	O	domain	prep_in	19	SENT_36	[p2l1781t148r2129b244],
26	,	,	O	,	_	0	SENT_36	[p2l1781t148r2129b244],
27	thereby	RB	O	thereby	advmod	28	SENT_36	[p2l11t276r331b377],
28	triggering	VBG	O	trigger	partmod	19	SENT_36	[p2l358t277r793b377],
29	a	DT	O	a	det	30	SENT_36	[p2l821t303r865b355],
30	cascade	NN	O	cascade	dobj	28	SENT_36	[p2l896t277r1225b355],
31	that	WDT	O	that	nsubj	32	SENT_36	[p2l1257t277r1427b355],
32	leads	VBZ	O	lead	rcmod	30	SENT_36	[p2l1452t276r1670b355],
33	to	TO	O	to	_	0	SENT_36	[p2l1704t293r1783b355],
34	cellular	JJ	O	cellular	amod	35	SENT_36	[p2l1817t277r2136b356],
35	proliferation	NN	O	proliferation	prep_to	32	SENT_36	[p2l8t404r580b505],
36	,	,	O	,	_	0	SENT_36	[p2l8t404r580b505],
37	angiogenesis	NN	O	angiogenesis	appos	35	SENT_36	[p2l611t405r1202b505],
38	,	,	O	,	_	0	SENT_36	[p2l611t405r1202b505],
39	metastasis	NN	O	metastasis	conj_and	37	SENT_36	[p2l1233t405r1715b500],
40	,	,	O	,	_	0	SENT_36	[p2l1233t405r1715b500],
41	and	CC	O	and	_	0	SENT_36	[p2l1746t404r1903b483],
42	inhibition	NN	O	inhibition	conj_and	37	SENT_36	[p2l1928t404r2132b482, p2l11t531r264b609],
43	of	IN	O	of	_	0	SENT_36	[p2l290t531r390b609],
44	apoptosis	NN	O	apoptosis	nn	45	SENT_36	[p2l396t527r875b631],
45	.2	NN	NUMBER	.2	prep_of	37	SENT_36	[p2l396t527r875b631],

1	The	DT	O	the	det	3	SENT_37	[p2l136t660r300b738],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_37	[p2l328t666r544b739],
3	gene	NN	O	gene	nsubjpass	6	SENT_37	[p2l566t685r768b760],
4	is	VBZ	O	be	auxpass	6	SENT_37	[p2l797t660r863b738],
5	frequently	RB	O	frequently	advmod	6	SENT_37	[p2l894t659r1336b760],
6	expressed	VBN	O	express	_	0	SENT_37	[p2l1361t660r1785b760],
7	in	IN	O	in	_	0	SENT_37	[p2l1813t660r1895b737],
8	solid	JJ	O	solid	amod	9	SENT_37	[p2l1926t660r2133b738],
9	tumors	NNS	O	tumor	prep_in	6	SENT_37	[p2l11t804r332b883],
10	,	,	O	,	_	0	SENT_37	[p2l11t804r332b883],
11	and	CC	O	and	_	0	SENT_37	[p2l357t788r511b866],
12	in	IN	O	in	_	0	SENT_37	[p2l530t788r611b865],
13	some	DT	O	some	det	14	SENT_37	[p2l632t813r854b866],
14	tumors	NNS	O	tumor	prep_in	20	SENT_37	[p2l875t804r1196b883],
15	,	,	O	,	_	0	SENT_37	[p2l875t804r1196b883],
16	expression	NN	O	expression	nsubj	20	SENT_37	[p2l1223t788r1668b888],
17	of	IN	O	of	_	0	SENT_37	[p2l1689t787r1789b866],
18	the	DT	O	the	det	19	SENT_37	[p2l1791t788r1918b866],
19	gene	NN	O	gene	prep_of	16	SENT_37	[p2l1938t813r2134b888],
20	correlates	VBZ	O	correlate	conj_and	6	SENT_37	[p2l11t915r404b992],
21	with	IN	O	with	_	0	SENT_37	[p2l420t915r604b994],
22	a	DT	O	a	det	25	SENT_37	[p2l622t941r666b992],
23	poor	JJ	O	poor	amod	25	SENT_37	[p2l681t940r878b1014],
24	clinical	JJ	O	clinical	amod	25	SENT_37	[p2l893t915r1183b992],
25	outcome	NN	O	outcome	prep_with	20	SENT_37	[p2l1201t910r1622b993],
26	.5	CD	NUMBER	.5	num	27	SENT_37	[p2l1201t910r1622b993],
27	N	NN	O	n	dobj	20	SENT_37	[p2l1641t921r1716b993],
28	on	IN	O	on	_	0	SENT_37	[p2l1719t915r2131b992],
29	—	CD	NUMBER	—	num	34	SENT_37	[p2l1719t915r2131b992],
30	small	JJ	O	small	amod	34	SENT_37	[p2l1719t915r2131b992],
31	—	JJ	O	—	amod	34	SENT_37	[p2l1719t915r2131b992],
32	cell	NN	O	cell	nn	34	SENT_37	[p2l11t1042r154b1120],
33	lung	NN	O	lung	nn	34	SENT_37	[p2l181t1042r372b1142],
34	cancer	NN	O	cancer	prep_on	27	SENT_37	[p2l399t1067r670b1120],
35	frequently	RB	O	frequently	advmod	36	SENT_37	[p2l696t1041r1123b1142],
36	expresses	VBZ	O	express	dep	34	SENT_37	[p2l1147t1068r1543b1142],
37	EGFR	NN	ORGANIZATION	egfr	dobj	36	SENT_37	[p2l1572t1035r1952b1137],
38	,6	CD	NUMBER	,6	number	39	SENT_37	[p2l1572t1035r1952b1137],
39	‘	CD	NUMBER	‘	num	40	SENT_37	[p2l1572t1035r1952b1137],
40	14	CD	NUMBER	14	dobj	20	SENT_37	[p2l1572t1035r1952b1137],
41	and	CC	O	and	_	0	SENT_37	[p2l1979t1042r2134b1120],
42	for	IN	O	for	_	0	SENT_37	[p2l10t1169r131b1248],
43	this	DT	O	this	det	44	SENT_37	[p2l170t1170r326b1247],
44	reason	NN	O	reason	prep_for	47	SENT_37	[p2l369t1195r679b1264],
45	,	,	O	,	_	0	SENT_37	[p2l369t1195r679b1264],
46	it	PRP	O	it	nsubj	47	SENT_37	[p2l725t1170r786b1247],
47	is	VBZ	O	be	conj_and	20	SENT_37	[p2l822t1170r888b1247],
48	of	IN	O	of	_	0	SENT_37	[p2l932t1169r1034b1248],
49	considerable	JJ	O	considerable	amod	50	SENT_37	[p2l1057t1169r1605b1248],
50	interest	NN	O	interest	prep_of	47	SENT_37	[p2l1646t1170r1975b1247],
51	for	IN	O	for	_	0	SENT_37	[p2l2011t1169r2136b1248],
52	clinical	JJ	O	clinical	amod	53	SENT_37	[p2l11t1297r319b1376],
53	trials	NNS	O	trial	prep_for	50	SENT_37	[p2l346t1297r554b1376],
54	of	IN	O	of	_	0	SENT_37	[p2l583t1297r683b1376],
55	inhibitors	NNS	O	inhibitor	prep_of	53	SENT_37	[p2l689t1298r1104b1376],
56	of	IN	O	of	_	0	SENT_37	[p2l1132t1297r1232b1376],
57	the	DT	O	the	det	63	SENT_37	[p2l1240t1298r1369b1376],
58	tyrosine	NN	O	tyrosine	nn	59	SENT_37	[p2l1395t1298r1729b1398],
59	kinase	NN	O	kinase	npadvmod	63	SENT_37	[p2l1755t1298r2026b1377],
60	of	IN	O	of	_	0	SENT_37	[p2l2052t1297r2152b1376],
61	EGFR	NN	ORGANIZATION	egfr	prep_of	59	SENT_37	[p2l8t1419r428b1508],
62	.4	CD	NUMBER	.4	num	61	SENT_37	[p2l8t1419r428b1508],
63	>	JJR	O	>	prep_of	55	SENT_37	[p2l8t1419r428b1508],
64	15	CD	NUMBER	15	dep	70	SENT_37	[p2l8t1419r428b1508],
65	The	DT	O	the	det	67	SENT_37	[p2l452t1425r613b1503],
66	kinase	NN	O	kinase	nn	67	SENT_37	[p2l638t1425r908b1504],
67	inhibitors	NNS	O	inhibitor	dep	64	SENT_37	[p2l932t1425r1346b1503],
68	erlotinib	NN	O	erlotinib	dep	70	SENT_37	[p2l1373t1425r1731b1503],
69	(	CD	NUMBER	(	num	68	SENT_37	[p2l1762t1431r2128b1520],
70	Tarceva	NNP	O	Tarceva	dep	84	SENT_37	[p2l1762t1431r2128b1520],
71	,	,	O	,	_	0	SENT_37	[p2l1762t1431r2128b1520],
72	OSI	NNP	ORGANIZATION	OSI	nn	74	SENT_37	[p2l10t1559r166b1632],
73	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	74	SENT_37	[p2l197t1554r920b1645],
74	)	NN	O	)	appos	70	SENT_37	[p2l197t1554r920b1645],
75	and	CC	O	and	_	0	SENT_37	[p2l959t1554r1115b1632],
76	geﬁtinib	NN	O	geﬁtinib	nn	78	SENT_37	[p2l1148t1553r1503b1654],
77	(	CD	NUMBER	(	num	78	SENT_37	[p2l1543t1560r1842b1649],
78	Iressa	NNP	O	Iressa	dep	84	SENT_37	[p2l1543t1560r1842b1649],
79	,	,	O	,	_	0	SENT_37	[p2l1543t1560r1842b1649],
80	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	78	SENT_37	[p2l1877t1561r2133b1632, p2l8t1688r332b1773],
81	)	CD	NUMBER	)	nsubjpass	84	SENT_37	[p2l1877t1561r2133b1632, p2l8t1688r332b1773],
82	have	VBP	O	have	aux	84	SENT_37	[p2l362t1682r550b1761],
83	been	VBN	O	be	auxpass	84	SENT_37	[p2l574t1682r773b1760],
84	studied	VBN	O	study	ccomp	63	SENT_37	[p2l799t1681r1106b1761],
85	most	RBS	O	most	advmod	84	SENT_37	[p2l1130t1698r1346b1760],
86	extensively	RB	O	extensively	advmod	84	SENT_37	[p2l1366t1682r1823b1782],
87	in	IN	O	in	_	0	SENT_37	[p2l1841t1682r1923b1759],
88	clinical	JJ	O	clinical	amod	89	SENT_37	[p2l1947t1682r2133b1760, p2l9t1810r153b1888],
89	trials	NNS	O	trial	prep_in	84	SENT_37	[p2l178t1804r604b1888],
90	.15	CD	NUMBER	.15	number	91	SENT_37	[p2l178t1804r604b1888],
91	'18	CD	NUMBER	'18	num	63	SENT_37	[p2l178t1804r604b1888],

1	Somatic	JJ	MISC	somatic	amod	2	SENT_38	[p2l141t1938r475b2016],
2	mutations	NNS	O	mutation	nsubj	34	SENT_38	[p2l498t1938r922b2017],
3	in	IN	O	in	_	0	SENT_38	[p2l946t1938r1026b2015],
4	the	DT	O	the	det	5	SENT_38	[p2l1049t1938r1177b2016],
5	region	NN	O	region	prep_in	2	SENT_38	[p2l1200t1938r1468b2038],
6	of	IN	O	of	_	0	SENT_38	[p2l1493t1937r1591b2016],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	5	SENT_38	[p2l1594t1944r1804b2017],
8	that	WDT	O	that	nsubj	9	SENT_38	[p2l1821t1937r1985b2016],
9	encodes	VBZ	O	encode	rcmod	5	SENT_38	[p2l2004t1963r2133b2016, p2l11t2065r244b2144],
10	the	DT	O	the	det	13	SENT_38	[p2l284t2066r412b2144],
11	tyrosine	NN	O	tyrosine	nn	13	SENT_38	[p2l450t2066r785b2166],
12	kinase	NN	O	kinase	nn	13	SENT_38	[p2l823t2065r1094b2145],
13	domain	NN	O	domain	dobj	9	SENT_38	[p2l1133t2066r1457b2144],
14	of	IN	O	of	_	0	SENT_38	[p2l1497t2065r1597b2144],
15	the	DT	O	the	det	18	SENT_38	[p2l1618t2065r1747b2144],
16	receptor	NN	O	receptor	nn	18	SENT_38	[p2l1786t2082r2137b2166],
17	(	NN	O	(	nn	18	SENT_38	[p2l15t2200r286b2285],
18	exons	NNS	O	exon	prep_of	13	SENT_38	[p2l15t2200r286b2285],
19	18	CD	NUMBER	18	nsubjpass	25	SENT_38	[p2l318t2199r412b2272],
20	through	IN	O	through	_	0	SENT_38	[p2l441t2193r783b2294],
21	21	CD	NUMBER	21	num	22	SENT_38	[p2l808t2199r938b2285],
22	)	CD	NUMBER	)	prep_through	19	SENT_38	[p2l808t2199r938b2285],
23	have	VBP	O	have	aux	25	SENT_38	[p2l970t2193r1158b2273],
24	been	VBN	O	be	auxpass	25	SENT_38	[p2l1185t2194r1384b2272],
25	identiﬁed	VBN	O	identiﬁed	rcmod	13	SENT_38	[p2l1409t2193r1813b2272],
26	in	IN	O	in	_	0	SENT_38	[p2l1837t2194r1919b2271],
27	lung	NN	O	lung	nn	28	SENT_38	[p2l1943t2194r2137b2294],
28	cancer	NN	O	cancer	prep_in	25	SENT_38	[p2l11t2316r505b2417],
29	,19	CD	NUMBER	,19	number	30	SENT_38	[p2l11t2316r505b2417],
30	'21	CD	NUMBER	'21	dep	28	SENT_38	[p2l11t2316r505b2417],
31	and	CC	O	and	_	0	SENT_38	[p2l549t2322r706b2400],
32	many	JJ	O	many	amod	33	SENT_38	[p2l751t2347r988b2422],
33	studies	NNS	O	study	conj_and	28	SENT_38	[p2l1029t2322r1329b2401],
34	suggest	VBP	O	suggest	_	0	SENT_38	[p2l1377t2338r1709b2422],
35	that	IN	O	that	complm	39	SENT_38	[p2l1748t2322r1918b2400],
36	they	PRP	O	they	nsubjpass	39	SENT_38	[p2l1957t2322r2137b2422],
37	can	MD	O	can	aux	39	SENT_38	[p2l11t2475r157b2528],
38	be	VB	O	be	auxpass	39	SENT_38	[p2l186t2450r282b2528],
39	used	VBN	O	use	ccomp	34	SENT_38	[p2l311t2450r509b2529],
40	to	TO	O	to	aux	41	SENT_38	[p2l537t2466r617b2528],
41	predict	VB	O	predict	xcomp	39	SENT_38	[p2l646t2450r953b2550],
42	responsiveness	NN	O	responsiveness	dobj	41	SENT_38	[p2l976t2450r1627b2550],
43	to	TO	O	to	_	0	SENT_38	[p2l1659t2466r1738b2528],
44	geﬁtinib	NN	O	geﬁtinib	nn	47	SENT_38	[p2l1768t2449r2132b2550],
45	and	CC	O	and	_	0	SENT_38	[p2l9t2578r163b2656],
46	erlotinib	NN	O	erlotinib	conj_and	44	SENT_38	[p2l195t2572r762b2656],
47	.19	NN	NUMBER	.19	prep_to	41	SENT_38	[p2l195t2572r762b2656],
48	'	''	O	'	_	0	SENT_38	[p2l195t2572r762b2656],
49	3	CD	NUMBER	3	number	50	SENT_38	[p2l195t2572r762b2656],
50	°	CD	NUMBER	°	num	52	SENT_38	[p2l195t2572r762b2656],
51	Such	JJ	O	such	amod	52	SENT_38	[p2l795t2578r995b2657],
52	mutations	NNS	O	mutation	nsubj	53	SENT_38	[p2l1026t2578r1450b2657],
53	occur	VBP	O	occur	ccomp	39	SENT_38	[p2l1484t2603r1715b2657],
54	more	RBR	O	more	advmod	55	SENT_38	[p2l1743t2603r1960b2656],
55	frequently	RB	O	frequently	advmod	53	SENT_38	[p2l1991t2577r2133b2656, p2l11t2705r330b2806],

1	in	IN	O	in	_	0	SENT_39	[p2l364t2706r447b2783],
2	patients	NNS	O	patient	prep_in	15	SENT_39	[p2l485t2706r827b2806],
3	with	IN	O	with	_	0	SENT_39	[p2l865t2706r1057b2785],
4	adenocarcinoma	NN	O	adenocarcinoma	prep_with	2	SENT_39	[p2l1097t2706r1840b2801],
5	,	,	O	,	_	0	SENT_39	[p2l1097t2706r1840b2801],
6	women	NNS	O	woman	nsubj	15	SENT_39	[p2l1881t2731r2131b2785, p2l11t2859r134b2929],
7	,	,	O	,	_	0	SENT_39	[p2l1881t2731r2131b2785, p2l11t2859r134b2929],
8	Asians	NNPS	MISC	Asians	nsubj	15	SENT_39	[p2l165t2834r478b2929],
9	,	,	O	,	_	0	SENT_39	[p2l165t2834r478b2929],
10	and	CC	O	and	_	0	SENT_39	[p2l512t2834r670b2912],
11	patients	NNS	O	patient	conj_and	6	SENT_39	[p2l698t2834r1040b2934],
12	who	WP	O	who	rcmod	11	SENT_39	[p2l1067t2834r1252b2913],
13	have	VBP	O	have	aux	15	SENT_39	[p2l1283t2833r1474b2913],
14	never	RB	O	never	neg	15	SENT_39	[p2l1504t2859r1736b2913],
15	smoked	VBN	O	smoke	_	0	SENT_39	[p2l1764t2834r2127b2913],
16	.	.	O	.	_	0	SENT_39	[p2l1764t2834r2127b2913],

1	Whether	IN	O	whether	complm	7	SENT_40	[p2l7t2961r377b3040],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_40	[p2l394t2968r604b3041],
3	mutations	NNS	O	mutation	nsubj	7	SENT_40	[p2l619t2962r1048b3041],
4	are	VBP	O	be	cop	7	SENT_40	[p2l1073t2988r1199b3040],
5	more	RBR	O	more	advmod	6	SENT_40	[p2l1222t2987r1442b3040],
6	accurate	JJ	O	accurate	amod	7	SENT_40	[p2l1464t2978r1813b3041],
7	predictors	NNS	O	predictor	csubjpass	22	SENT_40	[p2l1836t2961r2133b3062, p2l11t3106r169b3168],
8	of	IN	O	of	_	0	SENT_40	[p2l211t3089r311b3168],
9	responsiveness	NN	O	responsiveness	prep_of	7	SENT_40	[p2l331t3090r969b3190],
10	to	TO	O	to	_	0	SENT_40	[p2l1010t3106r1088b3168],
11	inhibitors	NNS	O	inhibitor	prep_to	7	SENT_40	[p2l1128t3090r1542b3168],
12	of	IN	O	of	_	0	SENT_40	[p2l1583t3089r1683b3168],
13	EGFR	NN	ORGANIZATION	egfr	prep_of	11	SENT_40	[p2l1700t3096r1913b3169],
14	than	IN	O	than	mark	18	SENT_40	[p2l1945t3089r2133b3168],
15	are	VBP	O	be	cop	18	SENT_40	[p2l9t3245r135b3297],
16	these	DT	O	these	det	18	SENT_40	[p2l165t3219r384b3297],
17	clinical	JJ	O	clinical	amod	18	SENT_40	[p2l413t3218r714b3297],
18	factors	NNS	O	factor	advcl	7	SENT_40	[p2l742t3218r1027b3297],
19	has	VBZ	O	have	aux	22	SENT_40	[p2l1058t3219r1199b3297],
20	not	RB	O	not	neg	22	SENT_40	[p2l1230t3235r1373b3297],
21	been	VBN	O	be	auxpass	22	SENT_40	[p2l1398t3219r1597b3297],
22	established	VBN	O	establish	_	0	SENT_40	[p2l1627t3218r2129b3297],
23	.	.	O	.	_	0	SENT_40	[p2l1627t3218r2129b3297],

1	The	DT	O	the	det	2	SENT_41	[p2l7t3347r168b3425],
2	effect	NN	O	effect	nsubj	18	SENT_41	[p2l203t3346r437b3425],
3	of	IN	O	of	_	0	SENT_41	[p2l467t3346r567b3425],
4	an	DT	O	a	det	6	SENT_41	[p2l582t3372r683b3425],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_41	[p2l715t3353r928b3426],
6	mutation	NN	O	mutation	prep_of	2	SENT_41	[p2l956t3347r1345b3426],
7	on	IN	O	on	_	0	SENT_41	[p2l1380t3372r1487b3425],
8	prognosis	NN	O	prognosis	prep_on	6	SENT_41	[p2l1520t3347r1942b3447],
9	and	CC	O	and	_	0	SENT_41	[p2l1978t3346r2134b3425],
10	survival	NN	O	survival	prep_on	6	SENT_41	[p2l12t3475r330b3554],
11	after	IN	O	after	_	0	SENT_41	[p2l362t3474r555b3553],
12	treatment	NN	O	treatment	prep_after	8	SENT_41	[p2l586t3491r1001b3553],
13	with	IN	O	with	_	0	SENT_41	[p2l1025t3475r1214b3554],
14	an	DT	O	a	det	16	SENT_41	[p2l1247t3500r1347b3553],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_41	[p2l1379t3480r1639b3558],
16	inhibitor	NN	O	inhibitor	prep_with	12	SENT_41	[p2l1662t3475r2037b3553],
17	is	VBZ	O	be	cop	18	SENT_41	[p2l2067t3475r2132b3553],
18	unclear	JJ	O	unclear	_	0	SENT_41	[p2l10t3601r349b3696],
19	,	,	O	,	_	0	SENT_41	[p2l10t3601r349b3696],
20	since	IN	O	since	mark	26	SENT_41	[p2l396t3602r616b3679],
21	studies	NNS	O	study	nsubj	26	SENT_41	[p2l657t3602r960b3680],
22	to	TO	O	to	_	0	SENT_41	[p2l1002t3618r1083b3680],
23	date	NN	O	date	prep_to	21	SENT_41	[p2l1124t3602r1302b3680],
24	have	VBP	O	have	aux	26	SENT_41	[p2l1343t3602r1536b3680],
25	not	RB	O	not	neg	26	SENT_41	[p2l1575t3618r1722b3680],
26	included	VBN	O	include	advcl	18	SENT_41	[p2l1756t3601r2133b3680],
27	an	DT	O	a	det	30	SENT_41	[p3l9t49r111b102],
28	untreated	JJ	O	untreated	amod	30	SENT_41	[p3l142t23r553b103],
29	control	NN	O	control	nn	30	SENT_41	[p3l585t24r894b102],
30	group	NN	O	group	dobj	26	SENT_41	[p3l924t49r1205b124],
31	.	.	O	.	_	0	SENT_41	[p3l924t49r1205b124],

1	The	DT	O	the	det	2	SENT_42	[p3l1238t24r1402b102],
2	presence	NN	O	presence	nsubj	18	SENT_42	[p3l1432t49r1813b124],
3	of	IN	O	of	_	0	SENT_42	[p3l1845t23r1946b102],
4	mutations	NNS	O	mutation	prep_of	2	SENT_42	[p3l1958t50r2131b103, p3l11t152r308b230],
5	that	WDT	O	that	nsubj	6	SENT_42	[p3l358t152r530b230],
6	affect	VBP	O	affect	rcmod	4	SENT_42	[p3l572t151r816b230],
7	extracellular	JJ	O	extracellular	amod	8	SENT_42	[p3l859t151r1398b231],
8	domains	NNS	O	domain	dobj	6	SENT_42	[p3l1444t151r1818b230],
9	of	IN	O	of	_	0	SENT_42	[p3l1869t151r1971b230],
10	the	DT	O	the	det	11	SENT_42	[p3l2001t152r2133b230],
11	receptor	NN	O	receptor	prep_of	8	SENT_42	[p3l10t274r446b380],
12	-	:	O	-	_	0	SENT_42	[p3l10t274r446b380],
13	‘	CD	NUMBER	‘	num	14	SENT_42	[p3l10t274r446b380],
14	*	NN	O	*	dep	8	SENT_42	[p3l10t274r446b380],
15	1	CD	NUMBER	1	dep	14	SENT_42	[p3l10t274r446b380],
16	does	VBZ	O	do	aux	18	SENT_42	[p3l473t280r668b358],
17	not	RB	O	not	neg	18	SENT_42	[p3l698t296r843b358],
18	predict	VB	O	predict	_	0	SENT_42	[p3l866t280r1172b380],
19	outcome	NN	O	outcome	dobj	18	SENT_42	[p3l1196t296r1594b375],
20	,	,	O	,	_	0	SENT_42	[p3l1196t296r1594b375],
21	and	CC	O	and	_	0	SENT_42	[p3l1627t280r1786b358],
22	it	PRP	O	it	nsubjpass	25	SENT_42	[p3l1813t281r1874b358],
23	is	VBZ	O	be	auxpass	25	SENT_42	[p3l1896t281r1962b358],
24	not	RB	O	not	neg	25	SENT_42	[p3l1992t296r2138b358],
25	known	VBN	O	know	conj_and	18	SENT_42	[p3l9t407r305b487],
26	whether	IN	O	whether	complm	39	SENT_42	[p3l335t408r691b487],
27	some	DT	O	some	nsubj	39	SENT_42	[p3l722t433r946b486],
28	of	IN	O	of	_	0	SENT_42	[p3l979t407r1079b486],
29	the	DT	O	the	det	32	SENT_42	[p3l1093t408r1222b486],
30	newly	RB	O	newly	advmod	31	SENT_42	[p3l1254t408r1501b508],
31	identiﬁed	JJ	O	identiﬁed	amod	32	SENT_42	[p3l1527t407r1931b486],
32	mutations	NNS	O	mutation	prep_of	27	SENT_42	[p3l1962t434r2133b487, p3l11t536r304b614],
33	of	IN	O	of	_	0	SENT_42	[p3l339t535r441b614],
34	the	DT	O	the	det	37	SENT_42	[p3l455t536r586b614],
35	tyrosine	NN	O	tyrosine	nn	37	SENT_42	[p3l619t536r962b636],
36	kinase	NN	O	kinase	nn	37	SENT_42	[p3l994t535r1270b615],
37	region	NN	O	region	prep_of	32	SENT_42	[p3l1303t536r1581b636],
38	are	VBP	O	be	cop	39	SENT_42	[p3l1612t562r1741b614],
39	superior	JJ	O	superior	ccomp	25	SENT_42	[p3l1774t536r2136b636],
40	to	TO	O	to	_	0	SENT_42	[p3l11t680r91b742],
41	others	NNS	O	other	prep_to	39	SENT_42	[p3l127t664r394b742],
42	in	IN	O	in	_	0	SENT_42	[p3l430t664r512b741],
43	predicting	VBG	O	predict	prepc_in	41	SENT_42	[p3l544t664r991b764],
44	responsiveness	NN	O	responsiveness	dobj	43	SENT_42	[p3l1022t664r1701b764],
45	.	.	O	.	_	0	SENT_42	[p3l1022t664r1701b764],

1	Stephens	NNP	PERSON	Stephens	nsubj	33	SENT_43	[p3l1743t664r2131b764],
2	et	FW	O	et	nn	3	SENT_43	[p3l11t806r88b868],
3	al.	FW	O	al.	dep	1	SENT_43	[p3l116t786r301b868],
4	32	CD	NUMBER	32	npadvmod	5	SENT_43	[p3l116t786r301b868],
5	recently	RB	DATE	recently	advmod	6	SENT_43	[p3l334t791r668b890],
6	identified	VBN	O	identify	partmod	1	SENT_43	[p3l693t790r1097b868],
7	mutations	NNS	O	mutation	dobj	6	SENT_43	[p3l1128t791r1558b869],
8	in	IN	O	in	_	0	SENT_43	[p3l1591t791r1672b867],
9	the	DT	O	the	det	11	SENT_43	[p3l1703t791r1832b868],
10	kinase	NN	O	kinase	nn	11	SENT_43	[p3l1863t791r2134b870],
11	domain	NN	O	domain	prep_in	6	SENT_43	[p3l11t918r335b997],
12	of	IN	O	of	_	0	SENT_43	[p3l366t918r466b997],
13	the	DT	O	the	det	14	SENT_43	[p3l479t919r608b997],
14	gene	NN	O	gene	prep_of	11	SENT_43	[p3l638t944r837b1019],
15	for	IN	O	for	_	0	SENT_43	[p3l868t918r990b997],
16	the	DT	O	the	det	20	SENT_43	[p3l1018t919r1147b997],
17	growth	NN	O	growth	nn	20	SENT_43	[p3l1178t918r1481b1019],
18	factor	NN	O	factor	nn	20	SENT_43	[p3l1512t918r1758b997],
19	receptor	NN	O	receptor	nn	20	SENT_43	[p3l1786t935r2137b1019],
20	HER2	NN	O	her2	prep_for	14	SENT_43	[p3l9t1052r257b1130],
21	in	IN	O	in	_	0	SENT_43	[p3l294t1047r376b1124],
22	4	CD	PERCENT	4	num	23	SENT_43	[p3l411t1052r460b1125],
23	percent	NN	PERCENT	percent	prep_in	6	SENT_43	[p3l496t1063r816b1147],
24	of	IN	O	of	_	0	SENT_43	[p3l848t1046r949b1125],
25	non	JJ	O	non	amod	32	SENT_43	[p3l967t1046r1599b1125],
26	—	JJ	O	—	amod	32	SENT_43	[p3l967t1046r1599b1125],
27	small	JJ	O	small	amod	32	SENT_43	[p3l967t1046r1599b1125],
28	—	NN	O	—	nn	32	SENT_43	[p3l967t1046r1599b1125],
29	cell	NN	O	cell	nn	32	SENT_43	[p3l967t1046r1599b1125],
30	lung	NN	O	lung	nn	32	SENT_43	[p3l1633t1046r1827b1147],
31	cancer	NN	O	cancer	nn	32	SENT_43	[p3l1862t1072r2137b1125],
32	tumors	NNS	O	tumor	prep_of	23	SENT_43	[p3l11t1191r311b1254],
33	(	VBP	O	(	_	0	SENT_43	[p3l342t1180r473b1266],
34	10	CD	PERCENT	10	num	35	SENT_43	[p3l342t1180r473b1266],
35	percent	NN	PERCENT	percent	dobj	33	SENT_43	[p3l497t1191r817b1275],
36	of	IN	O	of	_	0	SENT_43	[p3l837t1174r937b1253],
37	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	35	SENT_43	[p3l942t1175r1748b1270],
38	)	RB	O	)	advmod	33	SENT_43	[p3l942t1175r1748b1270],
39	,	,	O	,	_	0	SENT_43	[p3l942t1175r1748b1270],
40	but	CC	O	but	_	0	SENT_43	[p3l1779t1175r1920b1254],
41	their	PRP$	O	they	poss	43	SENT_43	[p3l1939t1175r2137b1253],
42	clinical	JJ	O	clinical	amod	43	SENT_43	[p3l11t1303r311b1381],
43	significance	NN	O	significance	nsubj	45	SENT_43	[p3l337t1302r843b1403],
44	is	VBZ	O	be	cop	45	SENT_43	[p3l867t1303r932b1381],
45	unknown	JJ	O	unknown	conj_but	33	SENT_43	[p3l960t1303r1386b1382],
46	.	.	O	.	_	0	SENT_43	[p3l960t1303r1386b1382],

1	The	DT	O	the	det	4	SENT_44	[p3l136t1431r297b1509],
2	National	NNP	ORGANIZATION	National	nn	4	SENT_44	[p3l328t1431r695b1509],
3	Cancer	NNP	ORGANIZATION	Cancer	nn	4	SENT_44	[p3l727t1436r1022b1509],
4	Institute	NNP	ORGANIZATION	Institute	dep	7	SENT_44	[p3l1050t1431r1403b1510],
5	of	IN	ORGANIZATION	of	_	0	SENT_44	[p3l1437t1430r1537b1509],
6	Canada	NNP	ORGANIZATION	Canada	prep_of	4	SENT_44	[p3l1552t1431r1867b1509],
7	Clinical	JJ	ORGANIZATION	clinical	_	0	SENT_44	[p3l1898t1430r2133b1509, p3l11t1558r126b1637],

1	Trials	NNP	O	Trials	nn	2	SENT_45	[p3l154t1558r389b1637],
2	Group	NNP	O	Group	dep	10	SENT_45	[p3l423t1564r696b1659],
3	(	CD	NUMBER	(	num	6	SENT_45	[p3l734t1566r837b1650],
4	N	NNP	O	N	nn	6	SENT_45	[p3l734t1566r837b1650],
5	CIC	NNP	O	CIC	nn	6	SENT_45	[p3l840t1564r995b1637],
6	CTG	NNP	O	CTG	dep	2	SENT_45	[p3l1030t1564r1255b1650],
7	)	CD	NUMBER	)	num	8	SENT_45	[p3l1030t1564r1255b1650],
8	BR	NN	O	br	dep	10	SENT_45	[p3l1291t1564r1549b1642],
9	.21	CD	NUMBER	.21	num	10	SENT_45	[p3l1291t1564r1549b1642],
10	placebo	NN	O	placebo	dep	13	SENT_45	[p3l1580t1558r2133b1659],
11	—	CD	NUMBER	—	num	12	SENT_45	[p3l1580t1558r2133b1659],
12	con	NN	O	con	dep	10	SENT_45	[p3l1580t1558r2133b1659],
13	—	CD	NUMBER	—	_	0	SENT_45	[p3l1580t1558r2133b1659],
14	trolled	VBD	O	troll	rcmod	13	SENT_45	[p3l11t1686r285b1765],
15	study	NN	O	study	nsubj	16	SENT_45	[p3l309t1687r534b1787],
16	demonstrated	VBD	O	demonstrate	ccomp	14	SENT_45	[p3l552t1686r1139b1765],
17	a	DT	O	a	det	19	SENT_45	[p3l1160t1713r1204b1765],
18	survival	NN	O	survival	nn	19	SENT_45	[p3l1227t1687r1545b1766],
19	advantage	NN	O	advantage	dobj	16	SENT_45	[p3l1565t1686r1992b1787],
20	for	IN	O	for	_	0	SENT_45	[p3l2014t1686r2137b1765],
21	patients	NNS	O	patient	prep_for	16	SENT_45	[p3l8t1815r343b1915],
22	with	IN	O	with	_	0	SENT_45	[p3l377t1815r566b1894],
23	non	JJ	O	non	amod	29	SENT_45	[p3l603t1815r1234b1893],
24	—	JJ	O	—	amod	29	SENT_45	[p3l603t1815r1234b1893],
25	small	JJ	O	small	amod	29	SENT_45	[p3l603t1815r1234b1893],
26	—	NN	O	—	nn	29	SENT_45	[p3l603t1815r1234b1893],
27	cell	NN	O	cell	nn	29	SENT_45	[p3l603t1815r1234b1893],
28	lung	NN	O	lung	nn	29	SENT_45	[p3l1269t1815r1463b1915],
29	cancer	NN	O	cancer	prep_with	13	SENT_45	[p3l1497t1840r1772b1893],
30	who	WP	O	who	nsubj	31	SENT_45	[p3l1800t1814r1983b1894],
31	received	VBD	O	receive	rcmod	29	SENT_45	[p3l2021t1841r2133b1893, p3l11t1942r268b2022],
32	erlotinib	NN	O	erlotinib	dobj	31	SENT_45	[p3l292t1943r651b2021],
33	after	IN	O	after	mark	37	SENT_45	[p3l675t1942r869b2021],
34	other	JJ	O	other	amod	35	SENT_45	[p3l890t1943r1114b2021],
35	treatments	NNS	O	treatment	nsubj	37	SENT_45	[p3l1135t1959r1586b2021],
36	had	VBD	O	have	aux	37	SENT_45	[p3l1612t1942r1768b2021],
37	failed	VBN	O	fail	advcl	31	SENT_45	[p3l1791t1938r2131b2021],
38	.33	CD	NUMBER	.33	dobj	37	SENT_45	[p3l1791t1938r2131b2021],

1	Women	NNS	O	woman	nsubj	17	SENT_46	[p3l7t2078r371b2166],
2	,	,	O	,	_	0	SENT_46	[p3l7t2078r371b2166],
3	Asians	NNPS	MISC	Asians	appos	1	SENT_46	[p3l409t2071r724b2166],
4	,	,	O	,	_	0	SENT_46	[p3l409t2071r724b2166],
5	patients	NNS	O	patient	conj_and	3	SENT_46	[p3l766t2071r1111b2171],
6	with	IN	O	with	_	0	SENT_46	[p3l1146t2071r1340b2150],
7	adenocarcinoma	NN	O	adenocarcinoma	prep_with	5	SENT_46	[p3l1377t2071r2126b2166],
8	,	,	O	,	_	0	SENT_46	[p3l1377t2071r2126b2166],
9	and	CC	O	and	_	0	SENT_46	[p3l10t2199r167b2277],
10	patients	NNS	O	patient	conj_and	3	SENT_46	[p3l207t2199r549b2299],
11	who	WP	O	who	nsubj	14	SENT_46	[p3l589t2199r774b2278],
12	had	VBD	O	have	aux	14	SENT_46	[p3l817t2198r974b2277],
13	never	RB	O	never	neg	14	SENT_46	[p3l1016t2224r1248b2278],
14	smoked	VBN	O	smoke	rcmod	10	SENT_46	[p3l1288t2198r1627b2278],
15	were	VBD	O	be	cop	17	SENT_46	[p3l1664t2225r1868b2278],
16	more	RBR	O	more	advmod	17	SENT_46	[p3l1910t2224r2134b2277],
17	likely	JJ	O	likely	_	0	SENT_46	[p3l9t2327r241b2427],
18	than	IN	O	than	_	0	SENT_46	[p3l263t2327r454b2405],
19	other	JJ	O	other	amod	20	SENT_46	[p3l482t2327r709b2405],
20	patients	NNS	O	patient	prep_than	17	SENT_46	[p3l732t2327r1074b2427],
21	to	TO	O	to	aux	22	SENT_46	[p3l1103t2343r1183b2405],
22	have	VB	O	have	xcomp	17	SENT_46	[p3l1211t2327r1402b2406],
23	a	DT	O	a	det	24	SENT_46	[p3l1428t2353r1473b2405],
24	response	NN	O	response	dobj	22	SENT_46	[p3l1497t2352r1884b2427],
25	to	TO	O	to	_	0	SENT_46	[p3l1911t2343r1991b2405],
26	erlotinib	NN	O	erlotinib	prep_to	24	SENT_46	[p3l2020t2353r2133b2405, p3l9t2454r320b2548],
27	;	:	O	;	_	0	SENT_46	[p3l2020t2353r2133b2405, p3l9t2454r320b2548],
28	however	RB	O	however	advmod	35	SENT_46	[p3l348t2454r720b2548],
29	,	,	O	,	_	0	SENT_46	[p3l348t2454r720b2548],
30	those	DT	O	those	nsubj	35	SENT_46	[p3l748t2453r975b2531],
31	who	WP	O	who	nsubj	34	SENT_46	[p3l993t2453r1175b2533],
32	had	VBD	O	have	aux	34	SENT_46	[p3l1199t2453r1354b2531],
33	never	RB	O	never	neg	34	SENT_46	[p3l1376t2479r1604b2532],
34	smoked	VBN	O	smoke	rcmod	30	SENT_46	[p3l1624t2454r1958b2533],
35	had	VBD	O	have	parataxis	17	SENT_46	[p3l1980t2454r2135b2532],
36	a	DT	O	a	det	39	SENT_46	[p3l10t2608r54b2660],
37	signiﬁcant	JJ	O	signiﬁcant	amod	39	SENT_46	[p3l77t2581r516b2682],
38	survival	NN	O	survival	nn	39	SENT_46	[p3l535t2582r845b2661],
39	benefit	NN	O	benefit	dobj	35	SENT_46	[p3l868t2581r1157b2660],
40	from	IN	O	from	_	0	SENT_46	[p3l1175t2581r1379b2660],
41	erlotinib	JJ	O	erlotinib	prep_from	35	SENT_46	[p3l1402t2581r1775b2660],
42	.	.	O	.	_	0	SENT_46	[p3l1402t2581r1775b2660],

1	To	TO	O	to	aux	2	SENT_47	[p3l1800t2587r1904b2660],
2	clarify	VB	O	clarify	purpcl	18	SENT_47	[p3l1928t2582r2135b2660, p3l10t2709r85b2810],
3	the	DT	O	the	det	4	SENT_47	[p3l110t2710r237b2788],
4	role	NN	O	role	dobj	2	SENT_47	[p3l268t2710r427b2788],
5	of	IN	O	of	_	0	SENT_47	[p3l461t2709r561b2788],
6	EGFR	NN	ORGANIZATION	egfr	prep_of	4	SENT_47	[p3l575t2715r834b2793],
7	in	IN	O	in	_	0	SENT_47	[p3l855t2710r937b2787],
8	the	DT	O	the	det	9	SENT_47	[p3l970t2710r1099b2788],
9	outcome	NN	O	outcome	prep_in	2	SENT_47	[p3l1134t2726r1501b2789],
10	of	IN	O	of	_	0	SENT_47	[p3l1535t2709r1636b2788],
11	non	JJ	O	non	amod	15	SENT_47	[p3l1650t2709r2134b2788, p3l11t2838r157b2916],
12	—	NN	O	—	nn	15	SENT_47	[p3l1650t2709r2134b2788, p3l11t2838r157b2916],
13	smallcell	NN	O	smallcell	nn	15	SENT_47	[p3l1650t2709r2134b2788, p3l11t2838r157b2916],
14	lung	NN	O	lung	nn	15	SENT_47	[p3l194t2838r393b2938],
15	cancer	NN	O	cancer	prep_of	9	SENT_47	[p3l428t2863r729b2933],
16	,	,	O	,	_	0	SENT_47	[p3l428t2863r729b2933],
17	we	PRP	O	we	nsubj	18	SENT_47	[p3l768t2864r888b2917],
18	evaluated	VBD	O	evaluate	_	0	SENT_47	[p3l927t2837r1333b2917],
19	the	DT	O	the	det	20	SENT_47	[p3l1371t2837r1504b2916],
20	expression	NN	O	expression	dobj	18	SENT_47	[p3l1543t2838r2011b2938],
21	of	IN	O	of	_	0	SENT_47	[p3l2050t2837r2152b2916],
22	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_47	[p3l9t2971r273b3049],
23	protein	NN	O	protein	prep_of	20	SENT_47	[p3l287t2966r628b3066],
24	,	,	O	,	_	0	SENT_47	[p3l287t2966r628b3066],
25	the	DT	O	the	det	26	SENT_47	[p3l660t2965r793b3044],
26	number	NN	O	number	conj_and	20	SENT_47	[p3l819t2965r1164b3045],
27	of	IN	O	of	_	0	SENT_47	[p3l1188t2965r1290b3044],
28	copies	NNS	O	copy	prep_of	26	SENT_47	[p3l1298t2966r1571b3066],
29	of	IN	O	of	_	0	SENT_47	[p3l1599t2965r1702b3044],
30	EGFR	NN	ORGANIZATION	egfr	prep_of	28	SENT_47	[p3l1707t2972r1944b3061],
31	,	,	O	,	_	0	SENT_47	[p3l1707t2972r1944b3061],
32	and	CC	O	and	_	0	SENT_47	[p3l1974t2965r2133b3044],
33	mutation	NN	O	mutation	nn	34	SENT_47	[p3l10t3094r411b3173],
34	status	NN	O	status	conj_and	20	SENT_47	[p3l448t3110r693b3173],
35	of	IN	O	of	_	0	SENT_47	[p3l731t3093r832b3172],
36	the	DT	O	the	det	37	SENT_47	[p3l850t3094r979b3172],
37	gene	NN	O	gene	prep_of	34	SENT_47	[p3l1015t3119r1213b3194],
38	in	IN	O	in	_	0	SENT_47	[p3l1248t3094r1330b3171],
39	a	DT	O	a	det	40	SENT_47	[p3l1364t3120r1409b3172],
40	subgroup	NN	O	subgroup	prep_in	18	SENT_47	[p3l1444t3094r1847b3194],
41	of	IN	O	of	_	0	SENT_47	[p3l1885t3093r1985b3172],
42	patients	NNS	O	patient	prep_of	40	SENT_47	[p3l2001t3120r2134b3194, p3l11t3222r240b3300],
43	in	IN	O	in	_	0	SENT_47	[p3l267t3222r348b3299],
44	the	DT	O	the	det	47	SENT_47	[p3l374t3221r503b3300],
45	BR	NN	O	br	nn	47	SENT_47	[p3l527t3227r784b3305],
46	.21	CD	NUMBER	.21	num	47	SENT_47	[p3l527t3227r784b3305],
47	study	NN	O	study	prep_in	42	SENT_47	[p3l811t3222r1049b3322],
48	.	.	O	.	_	0	SENT_47	[p3l811t3222r1049b3322],

1	METHODS	NNS	O	method	_	0	SENT_48	[p3l790t3537r1340b3596],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_49	[p3l11t3760r397b3809],
2	STUDY	NN	O	study	_	0	SENT_49	[p3l435t3760r701b3809],

1	The	DT	O	the	det	4	SENT_50	[p4l7t45r170b124],
2	BR	NN	O	br	nn	4	SENT_50	[p4l193t51r455b129],
3	.21	CD	NUMBER	.21	num	4	SENT_50	[p4l193t51r455b129],
4	study	NN	O	study	nsubj	9	SENT_50	[p4l481t45r710b146],
5	was	VBD	O	be	cop	9	SENT_50	[p4l725t72r887b125],
6	a	DT	O	a	det	9	SENT_50	[p4l913t72r957b124],
7	phase	NN	O	phase	nn	9	SENT_50	[p4l977t46r1228b146],
8	3	CD	NUMBER	3	num	9	SENT_50	[p4l1252t51r1296b124],
9	trial	NN	O	trial	dep	33	SENT_50	[p4l1324t46r1494b124],
10	of	IN	O	of	_	0	SENT_50	[p4l1518t45r1619b124],
11	erlotinib	NN	O	erlotinib	prep_of	9	SENT_50	[p4l1625t45r1992b124],
12	involving	VBG	O	involve	_	0	SENT_50	[p4l2016t46r2133b123, p4l6t174r326b274],
13	patients	NNS	O	patient	prep_involving	11	SENT_50	[p4l362t174r708b274],
14	who	WP	O	who	nsubj	16	SENT_50	[p4l746t174r933b253],
15	had	VBD	O	have	aux	16	SENT_50	[p4l975t173r1134b252],
16	had	VBN	O	have	rcmod	13	SENT_50	[p4l1174t174r1332b252],
17	progression	NN	O	progression	dobj	16	SENT_50	[p4l1372t174r1896b274],
18	after	IN	O	after	_	0	SENT_50	[p4l1936t173r2136b252],
19	standard	JJ	O	standard	amod	20	SENT_50	[p4l12t302r390b380],
20	chemotherapy	NN	O	chemotherapy	prep_after	16	SENT_50	[p4l433t302r1051b402],
21	for	IN	O	for	_	0	SENT_50	[p4l1089t301r1214b380],
22	non	JJ	O	non	amod	28	SENT_50	[p4l1253t301r1899b380],
23	—	JJ	O	—	amod	28	SENT_50	[p4l1253t301r1899b380],
24	small	JJ	O	small	amod	28	SENT_50	[p4l1253t301r1899b380],
25	—	NN	O	—	nn	28	SENT_50	[p4l1253t301r1899b380],
26	cell	NN	O	cell	nn	28	SENT_50	[p4l1253t301r1899b380],
27	lung	NN	O	lung	nn	28	SENT_50	[p4l1940t302r2137b402],
28	cancer	NN	O	cancer	prep_for	16	SENT_50	[p4l11t426r392b509],
29	.33	CD	NUMBER	.33	num	30	SENT_50	[p4l11t426r392b509],
30	Patients	NNS	O	patient	nsubjpass	33	SENT_50	[p4l419t431r751b509],
31	were	VBD	O	be	auxpass	33	SENT_50	[p4l775t457r976b510],
32	randomly	RB	O	randomly	advmod	33	SENT_50	[p4l1003t431r1412b531],
33	assigned	VBN	O	assign	_	0	SENT_50	[p4l1433t431r1804b531],
34	in	IN	O	in	_	0	SENT_50	[p4l1829t431r1910b508],
35	a	DT	O	a	det	37	SENT_50	[p4l1936t457r1980b509],
36	2:1	CD	NUMBER	2:1	num	37	SENT_50	[p4l2004t436r2134b509],
37	ratio	NN	O	ratio	prep_in	33	SENT_50	[p4l10t559r202b637],
38	to	TO	O	to	aux	39	SENT_50	[p4l228t575r307b637],
39	receive	VB	O	receive	xcomp	33	SENT_50	[p4l334t559r619b638],
40	150	CD	NUMBER	150	num	41	SENT_50	[p4l647t564r797b637],
41	mg	NN	O	mg	dobj	39	SENT_50	[p4l823t585r963b659],
42	of	IN	O	of	_	0	SENT_50	[p4l985t558r1085b637],
43	erlotinib	JJ	O	erlotinib	amod	47	SENT_50	[p4l1092t558r1450b637],
44	daily	JJ	SET	daily	amod	47	SENT_50	[p4l1477t559r1677b659],
45	(	NN	O	(	nn	47	SENT_50	[p4l1702t564r1887b650],
46	OSI	NNP	ORGANIZATION	OSI	nn	47	SENT_50	[p4l1702t564r1887b650],
47	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_of	41	SENT_50	[p4l1909t559r2135b637, p4l10t687r527b778],
48	)	CD	NUMBER	)	num	47	SENT_50	[p4l1909t559r2135b637, p4l10t687r527b778],
49	or	CC	O	or	_	0	SENT_50	[p4l556t712r645b765],
50	placebo	NN	O	placebo	prep_of	41	SENT_50	[p4l663t686r1008b787],
51	.	.	O	.	_	0	SENT_50	[p4l663t686r1008b787],

1	The	DT	O	the	det	4	SENT_51	[p4l1033t687r1192b765],
2	primary	JJ	O	primary	amod	4	SENT_51	[p4l1214t687r1545b787],
3	end	NN	O	end	nn	4	SENT_51	[p4l1564t686r1716b765],
4	point	NN	O	point	nsubj	7	SENT_51	[p4l1736t687r1961b787],
5	was	VBD	O	be	cop	7	SENT_51	[p4l1975t713r2134b766],
6	overall	JJ	O	overall	amod	7	SENT_51	[p4l11t815r295b895],
7	survival	NN	O	survival	_	0	SENT_51	[p4l328t816r677b895],
8	.	.	O	.	_	0	SENT_51	[p4l328t816r677b895],

1	Response34	NN	O	response34	nsubj	6	SENT_52	[p4l714t811r1214b916],
2	was	VBD	O	be	cop	6	SENT_52	[p4l1241t842r1404b895],
3	a	DT	O	a	det	6	SENT_52	[p4l1438t842r1482b894],
4	secondary	JJ	O	secondary	amod	6	SENT_52	[p4l1514t816r1949b916],
5	end	NN	O	end	nn	6	SENT_52	[p4l1978t816r2134b894],
6	point	NN	O	point	_	0	SENT_52	[p4l9t944r264b1044],
7	.	.	O	.	_	0	SENT_52	[p4l9t944r264b1044],

1	Separate	JJ	O	separate	dep	2	SENT_53	[p4l301t949r668b1044],
2	written	VBN	O	write	amod	3	SENT_53	[p4l694t944r1007b1023],
3	consent	NN	O	consent	nsubjpass	5	SENT_53	[p4l1038t960r1382b1022],
4	was	VBD	O	be	auxpass	5	SENT_53	[p4l1402t970r1566b1023],
5	obtained	VBN	O	obtain	_	0	SENT_53	[p4l1599t943r1982b1022],
6	for	IN	O	for	_	0	SENT_53	[p4l2012t943r2138b1022],
7	optional	JJ	O	optional	amod	9	SENT_53	[p4l11t1072r362b1172],
8	tissue	NN	O	tissue	nn	9	SENT_53	[p4l388t1072r628b1151],
9	banking	NN	O	banking	prep_for	5	SENT_53	[p4l655t1072r1005b1172],
10	and	CC	O	and	_	0	SENT_53	[p4l1025t1071r1182b1150],
11	correlative	JJ	O	correlative	amod	12	SENT_53	[p4l1207t1071r1644b1151],
12	studies	NNS	O	study	prep_for	5	SENT_53	[p4l1670t1071r1989b1151],
13	.	.	O	.	_	0	SENT_53	[p4l1670t1071r1989b1151],

1	All	DT	O	all	det	2	SENT_54	[p4l2016t1071r2135b1149],
2	studies	NNS	O	study	nsubjpass	9	SENT_54	[p4l12t1200r312b1279],
3	were	VBD	O	be	auxpass	4	SENT_54	[p4l338t1226r543b1279],
4	designed	VBN	O	design	_	0	SENT_54	[p4l572t1199r984b1300],
5	,	,	O	,	_	0	SENT_54	[p4l572t1199r984b1300],
6	executed	VBN	O	execute	conj_and	4	SENT_54	[p4l1019t1200r1417b1295],
7	,	,	O	,	_	0	SENT_54	[p4l1019t1200r1417b1295],
8	and	CC	O	and	_	0	SENT_54	[p4l1451t1199r1609b1278],
9	analyzed	VBN	O	analyze	conj_and	4	SENT_54	[p4l1637t1200r2011b1300],
10	by	IN	O	by	_	0	SENT_54	[p4l2041t1200r2138b1300],
11	the	DT	O	the	det	14	SENT_54	[p4l11t1327r142b1406],
12	N	NN	O	n	nn	14	SENT_54	[p4l163t1335r238b1406],
13	CIC	NNP	ORGANIZATION	CIC	nn	14	SENT_54	[p4l241t1333r397b1406],
14	CTG	NNP	ORGANIZATION	CTG	prep_by	9	SENT_54	[p4l420t1333r641b1423],
15	;	:	O	;	_	0	SENT_54	[p4l420t1333r641b1423],
16	the	DT	O	the	det	17	SENT_54	[p4l666t1327r796b1406],
17	database	NN	O	database	nsubjpass	19	SENT_54	[p4l817t1327r1187b1406],
18	was	VBD	O	be	auxpass	19	SENT_54	[p4l1203t1354r1365b1407],
19	maintained	VBN	O	maintain	conj_and	4	SENT_54	[p4l1388t1328r1871b1406],
20	by	IN	O	by	_	0	SENT_54	[p4l1892t1328r1988b1428],
21	the	DT	O	the	det	25	SENT_54	[p4l2006t1327r2135b1406],
22	N	NN	O	n	nn	25	SENT_54	[p4l8t1463r83b1534],
23	CIC	NN	ORGANIZATION	cic	nn	25	SENT_54	[p4l88t1461r247b1534],
24	CT	NN	O	ct	nn	25	SENT_54	[p4l292t1461r416b1534],
25	G	NN	O	g	agent	19	SENT_54	[p4l420t1461r517b1551],
26	;	:	O	;	_	0	SENT_54	[p4l420t1461r517b1551],
27	and	CC	O	and	_	0	SENT_54	[p4l564t1456r723b1534],
28	the	DT	O	the	det	29	SENT_54	[p4l766t1455r899b1534],
29	manuscript	NN	O	manuscript	nsubjpass	31	SENT_54	[p4l942t1456r1444b1556],
30	was	VBD	O	be	auxpass	31	SENT_54	[p4l1478t1482r1642b1535],
31	written	VBN	O	write	conj_and	4	SENT_54	[p4l1683t1456r1996b1535],
32	by	IN	O	by	_	0	SENT_54	[p4l2040t1456r2139b1556],
33	members	NNS	O	member	agent	31	SENT_54	[p4l10t1584r409b1662],
34	of	IN	O	of	_	0	SENT_54	[p4l446t1583r547b1662],
35	the	DT	O	the	det	38	SENT_54	[p4l562t1584r691b1662],
36	N	NN	O	n	nn	38	SENT_54	[p4l723t1591r798b1662],
37	CIC	NNP	ORGANIZATION	CIC	nn	38	SENT_54	[p4l802t1589r958b1662],
38	CTG	NNP	ORGANIZATION	CTG	prep_of	33	SENT_54	[p4l994t1589r1214b1662],
39	.	.	O	.	_	0	SENT_54	[p4l994t1589r1214b1662],

1	OSI	NNP	ORGANIZATION	OSI	nn	2	SENT_55	[p4l1253t1589r1409b1662],
2	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nsubj	3	SENT_55	[p4l1440t1584r2133b1663],
3	reviewed	VBD	O	review	_	0	SENT_55	[p4l10t1712r380b1791],
4	the	DT	O	the	det	6	SENT_55	[p4l405t1712r534b1790],
5	ﬁnal	JJ	O	ﬁnal	amod	6	SENT_55	[p4l559t1711r748b1790],
6	manuscript	NN	O	manuscript	dobj	3	SENT_55	[p4l773t1712r1279b1812],
7	.	.	O	.	_	0	SENT_55	[p4l773t1712r1279b1812],

1	PATHOLOGY	NN	O	pathology	nsubjpass	18	SENT_56	[p4l16t2006r552b2071],
2	,	,	O	,	_	0	SENT_56	[p4l16t2006r552b2071],
3	ANALYSIS	NNP	O	ANALYSIS	appos	1	SENT_56	[p4l588t2006r988b2057],
4	OF	IN	O	of	_	0	SENT_56	[p4l1025t2006r1130b2057],
5	EXPRESSION	NNP	O	EXPRESSION	prep_of	3	SENT_56	[p4l1171t2006r1681b2057],
6	OF	IN	O	of	_	0	SENT_56	[p4l1725t2006r1829b2057],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	5	SENT_56	[p4l1870t2006r2103b2071],
8	,	,	O	,	_	0	SENT_56	[p4l1870t2006r2103b2071],
9	AND	CC	O	and	_	0	SENT_56	[p4l9t2091r186b2140],
10	MOLECULAR	NN	O	molecular	nn	12	SENT_56	[p4l233t2091r732b2140],
11	ANALYSES	NNS	O	analysis	nn	12	SENT_56	[p4l770t2091r1188b2140],
12	Interpretation	NN	O	interpretation	conj_and	3	SENT_56	[p4l9t2192r602b2292],
13	of	IN	O	of	_	0	SENT_56	[p4l648t2191r749b2270],
14	all	DT	O	all	det	16	SENT_56	[p4l776t2192r875b2270],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_56	[p4l919t2197r1178b2275],
16	analyses	NNS	O	analysis	prep_of	12	SENT_56	[p4l1213t2191r1562b2292],
17	was	VBD	O	be	auxpass	18	SENT_56	[p4l1606t2218r1766b2271],
18	blinded	VBN	O	blind	_	0	SENT_56	[p4l1815t2191r2135b2270],
19	with	IN	O	with	_	0	SENT_56	[p4l6t2320r195b2399],
20	respect	NN	O	respect	prep_with	18	SENT_56	[p4l221t2336r527b2420],
21	to	TO	O	to	_	0	SENT_56	[p4l549t2336r628b2398],
22	clinical	JJ	O	clinical	amod	23	SENT_56	[p4l657t2319r957b2398],
23	response	NN	O	response	prep_to	18	SENT_56	[p4l984t2345r1363b2420],
24	and	CC	O	and	_	0	SENT_56	[p4l1389t2320r1545b2398],
25	demographic	JJ	O	demographic	amod	26	SENT_56	[p4l1572t2319r2135b2420],
26	information	NN	O	information	conj_and	23	SENT_56	[p4l10t2447r544b2526],
27	.	.	O	.	_	0	SENT_56	[p4l10t2447r544b2526],

1	Parafﬁn	NN	O	parafﬁn	nsubj	2	SENT_57	[p4l576t2447r909b2526],
2	blocks	VBZ	O	block	_	0	SENT_57	[p4l937t2447r1209b2527],
3	or	CC	O	or	_	0	SENT_57	[p4l1238t2473r1327b2526],
4	10	CD	NUMBER	10	number	6	SENT_57	[p4l1355t2453r1452b2526],
5	to	TO	O	to	dep	6	SENT_57	[p4l1481t2464r1560b2526],
6	20	CD	NUMBER	20	num	8	SENT_57	[p4l1588t2453r1689b2526],
7	unstained	JJ	O	unstained	amod	8	SENT_57	[p4l1717t2448r2135b2527],
8	slides	NNS	O	slide	nsubjpass	10	SENT_57	[p4l12t2575r247b2654],
9	were	VBD	O	be	auxpass	10	SENT_57	[p4l278t2602r479b2655],
10	collected	VBN	O	collect	conj_or	2	SENT_57	[p4l513t2575r886b2654],
11	from	IN	O	from	_	0	SENT_57	[p4l919t2575r1126b2654],
12	diagnostic	JJ	O	diagnostic	amod	15	SENT_57	[p4l1160t2576r1599b2676],
13	or	CC	O	or	_	0	SENT_57	[p4l1632t2601r1721b2654],
14	resection	NN	O	resection	amod	15	SENT_57	[p4l1751t2576r2135b2654],
15	specimens	NNS	O	specimen	prep_from	10	SENT_57	[p4l12t2704r481b2804],
16	.	.	O	.	_	0	SENT_57	[p4l12t2704r481b2804],

1	The	DT	O	the	det	2	SENT_58	[p4l509t2704r671b2782],
2	presence	NN	O	presence	nsubjpass	8	SENT_58	[p4l695t2729r1068b2804],
3	of	IN	O	of	_	0	SENT_58	[p4l1095t2703r1196b2782],
4	adequate	JJ	O	adequate	amod	6	SENT_58	[p4l1203t2704r1581b2804],
5	tumor	NN	O	tumor	nn	6	SENT_58	[p4l1607t2720r1870b2783],
6	tissue	NN	O	tissue	prep_of	2	SENT_58	[p4l1893t2704r2135b2783],
7	was	VBD	O	be	auxpass	8	SENT_58	[p4l6t2858r166b2911],
8	veriﬁed	VBN	O	veriﬁed	_	0	SENT_58	[p4l198t2831r514b2911],
9	by	IN	O	by	_	0	SENT_58	[p4l548t2831r645b2932],
10	the	DT	O	the	det	12	SENT_58	[p4l675t2832r804b2910],
11	study	NN	O	study	nn	12	SENT_58	[p4l839t2831r1065b2932],
12	pathologist	NN	O	pathologist	agent	8	SENT_58	[p4l1093t2832r1598b2932],
13	.	.	O	.	_	0	SENT_58	[p4l1093t2832r1598b2932],

1	The	DT	O	the	det	2	SENT_59	[p4l1634t2831r1796b2910],
2	expression	NN	O	expression	nsubjpass	7	SENT_59	[p4l1830t2858r2134b2932, p4l12t2960r188b3038],
3	of	IN	O	of	_	0	SENT_59	[p4l216t2959r317b3038],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_59	[p4l323t2965r583b3043],
5	protein	NN	O	protein	prep_of	2	SENT_59	[p4l598t2960r904b3060],
6	Was	VBD	O	be	auxpass	7	SENT_59	[p4l927t2986r1088b3039],
7	determined	VBN	O	determine	_	0	SENT_59	[p4l1118t2960r1602b3038],
8	by	IN	O	by	_	0	SENT_59	[p4l1630t2960r1726b3060],
9	means	NNS	O	means	_	0	SENT_59	[p4l1749t2985r2023b3038],
10	of	IN	O	of	_	0	SENT_59	[p4l2053t2959r2153b3038],
11	immunohistochemistry	NN	O	immunohistochemistry	prep_by_means_of	7	SENT_59	[p4l10t3088r996b3188],
12	with	IN	O	with	_	0	SENT_59	[p4l1012t3088r1199b3167],
13	the	DT	O	the	det	14	SENT_59	[p4l1224t3088r1352b3166],
14	use	NN	O	use	prep_with	7	SENT_59	[p4l1376t3114r1514b3167],
15	of	IN	O	of	_	0	SENT_59	[p4l1540t3087r1640b3166],
16	Dako	NNP	PERSON	Dako	nn	19	SENT_59	[p4l1645t3088r1864b3167],
17	EGFR	NN	O	egfr	nn	19	SENT_59	[p4l1890t3093r2146b3171],
18	PharmDX	NN	O	pharmdx	nn	19	SENT_59	[p4l9t3216r406b3294],
19	kits	NNS	O	kit	nn	24	SENT_59	[p4l429t3216r575b3295],
20	(	CD	NUMBER	(	num	21	SENT_59	[p4l607t3216r1402b3316],
21	Dal	NN	O	dal	npadvmod	22	SENT_59	[p4l607t3216r1402b3316],
22	<	JJR	O	<	amod	24	SENT_59	[p4l607t3216r1402b3316],
23	oCytomation	NN	O	ocytomation	nn	24	SENT_59	[p4l607t3216r1402b3316],
24	)	NN	O	)	prep_of	14	SENT_59	[p4l607t3216r1402b3316],
25	.	.	O	.	_	0	SENT_59	[p4l607t3216r1402b3316],

1	When	WRB	O	when	advmod	9	SENT_60	[p4l1430t3216r1681b3294],
2	more	JJR	O	more	mwe	3	SENT_60	[p4l1707t3241r1924b3294],
3	than	IN	O	than	quantmod	4	SENT_60	[p4l1950t3216r2135b3294],
4	10	CD	PERCENT	10	num	5	SENT_60	[p4l14t3349r109b3422],
5	percent	NN	PERCENT	percent	nsubj	9	SENT_60	[p4l141t3360r462b3444],
6	of	IN	O	of	_	0	SENT_60	[p4l492t3343r593b3422],
7	tumor	NN	O	tumor	nn	8	SENT_60	[p4l610t3360r872b3423],
8	cells	NNS	O	cell	prep_of	5	SENT_60	[p4l904t3343r1087b3422],
9	demonstrated	VBD	O	demonstrate	advcl	24	SENT_60	[p4l1124t3343r1711b3422],
10	membranous	JJ	O	membranous	acomp	9	SENT_60	[p4l1745t3343r2134b3422, p4l10t3497r214b3551],
11	(	NN	O	(	dep	12	SENT_60	[p4l242t3472r542b3572],
12	partial	JJ	O	partial	dep	10	SENT_60	[p4l242t3472r542b3572],
13	or	CC	O	or	_	0	SENT_60	[p4l564t3497r654b3550],
14	complete	JJ	O	complete	amod	16	SENT_60	[p4l673t3471r1090b3572],
15	)	NN	O	)	nn	16	SENT_60	[p4l673t3471r1090b3572],
16	staining	NN	O	staining	dep	10	SENT_60	[p4l1119t3472r1465b3572],
17	of	IN	O	of	_	0	SENT_60	[p4l1485t3471r1585b3550],
18	any	DT	O	any	det	19	SENT_60	[p4l1588t3497r1735b3572],
19	intensity	NN	O	intensity	prep_of	12	SENT_60	[p4l1753t3472r2130b3572],
20	,	,	O	,	_	0	SENT_60	[p4l1753t3472r2130b3572],
21	the	DT	O	the	det	22	SENT_60	[p4l11t3600r139b3678],
22	tumor	NN	O	tumor	nsubjpass	24	SENT_60	[p4l166t3616r428b3679],
23	was	VBD	O	be	auxpass	24	SENT_60	[p4l446t3626r607b3679],
24	considered	VBN	O	consider	_	0	SENT_60	[p4l635t3600r1098b3678],
25	positive	JJ	O	positive	acomp	24	SENT_60	[p4l1121t3600r1446b3700],
26	for	IN	O	for	_	0	SENT_60	[p4l1472t3599r1595b3678],
27	EGFR	NN	ORGANIZATION	egfr	prep_for	24	SENT_60	[p4l1616t3605r1888b3683],
28	.	.	O	.	_	0	SENT_60	[p4l1616t3605r1888b3683],

1	The	DT	O	the	det	7	SENT_61	[p5l136t20r299b99],
2	entire	JJ	O	entire	amod	7	SENT_61	[p5l346t21r591b99],
3	5	CD	NUMBER	5	number	4	SENT_61	[p5l638t28r858b121],
4	—	CD	NUMBER	—	num	7	SENT_61	[p5l638t28r858b121],
5	pm	NN	O	pm	nn	7	SENT_61	[p5l638t28r858b121],
6	tissue	NN	O	tissue	nn	7	SENT_61	[p5l904t21r1151b100],
7	section	NN	O	section	nsubjpass	18	SENT_61	[p5l1198t21r1503b99],
8	of	IN	O	of	_	0	SENT_61	[p5l1549t20r1651b99],
9	specimens	NNS	O	specimen	prep_of	7	SENT_61	[p5l1679t21r2131b121],
10	with	IN	O	with	_	0	SENT_61	[p5l6t149r192b228],
11	cellularity	NN	O	cellularity	prep_with	9	SENT_61	[p5l215t149r620b249],
12	of	IN	O	of	_	0	SENT_61	[p5l638t148r738b227],
13	more	JJR	O	more	mwe	14	SENT_61	[p5l740t174r957b227],
14	than	IN	O	than	quantmod	15	SENT_61	[p5l979t148r1165b227],
15	50	CD	PERCENT	50	num	16	SENT_61	[p5l1188t154r1285b227],
16	percent	NN	PERCENT	percent	prep_of	11	SENT_61	[p5l1306t165r1621b249],
17	was	VBD	O	be	auxpass	18	SENT_61	[p5l1633t175r1792b228],
18	scraped	VBN	O	scrape	_	0	SENT_61	[p5l1817t148r2136b249],
19	from	IN	O	from	_	0	SENT_61	[p5l10t276r220b355],
20	the	DT	O	the	det	21	SENT_61	[p5l256t276r387b355],
21	slide	NN	O	slide	prep_from	18	SENT_61	[p5l424t276r622b355],
22	for	IN	O	for	_	0	SENT_61	[p5l656t276r782b355],
23	DNA	NN	MISC	dna	nn	24	SENT_61	[p5l812t283r1027b356],
24	isolation	NN	O	isolation	prep_for	21	SENT_61	[p5l1057t277r1433b355],
25	and	CC	O	and	_	0	SENT_61	[p5l1468t277r1625b355],
26	mutational	JJ	O	mutational	amod	27	SENT_61	[p5l1660t277r2134b356],
27	analyses	NNS	O	analysis	prep_for	21	SENT_61	[p5l10t405r392b505],
28	.	.	O	.	_	0	SENT_61	[p5l10t405r392b505],

1	For	IN	O	for	_	0	SENT_62	[p5l421t412r568b483],
2	specimens	NNS	O	specimen	prep_for	21	SENT_62	[p5l592t405r1044b505],
3	With	IN	O	with	_	0	SENT_62	[p5l1066t405r1259b484],
4	lesser	JJR	O	lesser	amod	5	SENT_62	[p5l1282t405r1531b483],
5	degrees	NNS	O	degree	prep_with	2	SENT_62	[p5l1554t405r1881b505],
6	of	IN	O	of	_	0	SENT_62	[p5l1908t404r2010b483],
7	tu	FW	O	tu	prep_of	5	SENT_62	[p5l2016t421r2133b484],
8	—	FW	O	—	nn	10	SENT_62	[p5l2016t421r2133b484],
9	mor	FW	O	mor	nn	10	SENT_62	[p5l10t558r191b611],
10	cellularity	NN	O	cellularity	dep	7	SENT_62	[p5l231t532r662b633],
11	or	CC	O	or	_	0	SENT_62	[p5l700t558r791b611],
12	uneven	JJ	O	uneven	amod	13	SENT_62	[p5l830t558r1138b612],
13	distribution	NN	O	distribution	prep_of	5	SENT_62	[p5l1181t532r1698b612],
14	of	IN	O	of	_	0	SENT_62	[p5l1741t532r1842b611],
15	tumor	NN	O	tumor	nn	16	SENT_62	[p5l1867t549r2136b612],
16	cells	NNS	O	cell	prep_of	13	SENT_62	[p5l11t660r224b754],
17	,	,	O	,	_	0	SENT_62	[p5l11t660r224b754],
18	enriched	JJ	O	enriched	amod	19	SENT_62	[p5l259t659r631b738],
19	DNA	NN	O	dna	nsubjpass	21	SENT_62	[p5l656t666r868b738],
20	Was	VBD	O	be	auxpass	21	SENT_62	[p5l886t686r1047b738],
21	isolated	VBN	O	isolate	dep	30	SENT_62	[p5l1075t659r1404b738],
22	from	IN	O	from	_	0	SENT_62	[p5l1430t659r1637b738],
23	tumor	NN	O	tumor	nn	24	SENT_62	[p5l1664t676r1926b739],
24	cells	NNS	O	cell	prep_from	21	SENT_62	[p5l1950t659r2133b737],
25	that	WDT	O	that	nsubjpass	27	SENT_62	[p5l11t788r175b866],
26	were	VBD	O	be	auxpass	27	SENT_62	[p5l187t814r385b867],
27	microdissected	VBN	O	microdissect	rcmod	24	SENT_62	[p5l407t787r1032b866],
28	from	IN	O	from	_	0	SENT_62	[p5l1053t787r1256b866],
29	sections	NNS	O	section	prep_from	27	SENT_62	[p5l1279t788r1611b866],
30	stained	VBD	O	stain	_	0	SENT_62	[p5l1637t788r1934b866],
31	With	IN	O	with	dep	37	SENT_62	[p5l1950t788r2136b867],
32	toluidine	NN	O	toluidine	pobj	31	SENT_62	[p5l11t916r396b996],
33	blue	JJ	O	blue	amod	37	SENT_62	[p5l435t917r617b996],
34	(	NN	O	(	nn	37	SENT_62	[p5l661t917r960b1008],
35	Fisher	NNP	LOCATION	Fisher	nn	37	SENT_62	[p5l661t917r960b1008],
36	Canada	NNP	LOCATION	Canada	nn	37	SENT_62	[p5l997t916r1346b1008],
37	)	NN	O	)	dep	30	SENT_62	[p5l997t916r1346b1008],
38	with	IN	O	with	_	0	SENT_62	[p5l1386t917r1579b996],
39	the	DT	O	the	det	40	SENT_62	[p5l1617t917r1749b995],
40	use	NN	O	use	prep_with	37	SENT_62	[p5l1788t943r1930b996],
41	of	IN	O	of	_	0	SENT_62	[p5l1970t916r2071b995],
42	a	DT	O	a	det	45	SENT_62	[p5l2091t943r2135b995],
43	dissecting	VBG	O	dissect	amod	45	SENT_62	[p5l11t1045r450b1145],
44	microscope	NN	O	microscope	nn	45	SENT_62	[p5l471t1045r972b1145],
45	(	NN	O	(	prep_of	40	SENT_62	[p5l1002t1044r1303b1136],
46	model	NN	O	model	nn	47	SENT_62	[p5l1002t1044r1303b1136],
47	SZPT40	NN	O	szpt40	nsubj	30	SENT_62	[p5l1330t1050r1681b1140],
48	,	,	O	,	_	0	SENT_62	[p5l1330t1050r1681b1140],
49	Olympus	NNP	ORGANIZATION	Olympus	appos	47	SENT_62	[p5l1710t1045r2129b1145],
50	)	CD	NUMBER	)	num	49	SENT_62	[p5l1710t1045r2129b1145],
51	at	IN	O	at	_	0	SENT_62	[p5l10t1189r90b1251],
52	40x	CD	NUMBER	40x	num	53	SENT_62	[p5l118t1178r272b1251],
53	magniﬁcation	NN	O	magniﬁcation	prep_at	49	SENT_62	[p5l307t1172r908b1273],
54	.	.	O	.	_	0	SENT_62	[p5l307t1172r908b1273],

1	In	IN	O	in	_	0	SENT_63	[p5l941t1180r1027b1250],
2	some	DT	O	some	det	3	SENT_63	[p5l1058t1198r1278b1251],
3	cases	NNS	O	case	prep_in	6	SENT_63	[p5l1309t1199r1546b1268],
4	,	,	O	,	_	0	SENT_63	[p5l1309t1199r1546b1268],
5	We	PRP	O	we	nsubj	6	SENT_63	[p5l1576t1199r1694b1252],
6	used	VBD	O	use	_	0	SENT_63	[p5l1723t1172r1915b1252],
7	laser	NN	O	laser	dobj	6	SENT_63	[p5l1944t1173r2139b1251],

1	134	CD	NUMBER	134	num	3	SENT_64	[p5l149t1348r205b1370],
2	N	NN	O	n	nn	3	SENT_64	[p5l918t1350r932b1365],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_64	[p5l947t1349r1031b1371],
4	MED	VBD	O	med	_	0	SENT_64	[p5l1046t1350r1099b1365],
5	35	CD	NUMBER	35	number	6	SENT_64	[p5l1111t1349r1136b1371],
6	:2	CD	NUMBER	:2	num	8	SENT_64	[p5l1155t1349r1175b1369],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	8	SENT_64	[p5l1210t1349r1421b1371],
8	JULY14	NN	O	july14	dobj	4	SENT_64	[p5l1455t1349r1562b1371],
9	,	,	O	,	_	0	SENT_64	[p5l1455t1349r1562b1371],
10	2005	CD	DATE	2005	appos	8	SENT_64	[p5l1575t1349r1638b1371],

1	The	DT	O	the	det	4	SENT_65	[p5l935t1382r986b1406],
2	New	NNP	O	New	nn	4	SENT_65	[p5l995t1383r1057b1406],
3	Englan	NNP	O	Englan	nn	4	SENT_65	[p5l1066t1382r1160b1413],
4	oumal	NN	O	oumal	_	0	SENT_65	[p5l1200t1382r1283b1406],
5	of	IN	O	of	_	0	SENT_65	[p5l1293t1382r1322b1406],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_65	[p5l1329t1382r1454b1406],

1	Downloaded	VBN	O	download	_	0	SENT_66	[p5l377t1423r547b1446],
2	from	IN	O	from	_	0	SENT_66	[p5l556t1423r620b1446],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_66	[p5l629t1423r747b1453],
4	at	IN	O	at	_	0	SENT_66	[p5l758t1427r781b1446],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_66	[p5l789t1423r972b1446],
6	on	IN	O	on	_	0	SENT_66	[p5l981t1430r1014b1446],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_66	[p5l1022t1423r1083b1446],
8	5	CD	DATE	5	num	7	SENT_66	[p5l1135t1423r1158b1450],
9	,	,	DATE	,	_	0	SENT_66	[p5l1135t1423r1158b1450],
10	2014	CD	DATE	2014	num	7	SENT_66	[p5l1168t1423r1240b1446],
11	.	.	O	.	_	0	SENT_66	[p5l1168t1423r1240b1446],

1	For	IN	O	for	_	0	SENT_67	[p5l1251t1423r1298b1446],
2	personal	JJ	O	personal	amod	3	SENT_67	[p5l1306t1423r1418b1453],
3	use	NN	O	use	pobj	1	SENT_67	[p5l1427t1430r1471b1446],
4	only	RB	O	only	advmod	3	SENT_67	[p5l1481t1423r1545b1453],
5	.	.	O	.	_	0	SENT_67	[p5l1481t1423r1545b1453],

1	No	DT	O	no	det	3	SENT_68	[p5l1556t1423r1596b1446],
2	other	JJ	O	other	amod	3	SENT_68	[p5l1606t1423r1674b1446],
3	uses	NNS	O	use	_	0	SENT_68	[p5l1682t1430r1738b1446],
4	without	IN	O	without	_	0	SENT_68	[p5l1748t1423r1849b1446],
5	permission	NN	O	permission	prep_without	3	SENT_68	[p5l1858t1423r2010b1453],
6	.	.	O	.	_	0	SENT_68	[p5l1858t1423r2010b1453],

1	Copyright	NN	O	copyright	nsubj	6	SENT_69	[p5l727t1464r862b1495],
2	©	CD	NUMBER	©	num	1	SENT_69	[p5l871t1464r895b1488],
3	2005	CD	DATE	2005	num	5	SENT_69	[p5l905t1464r969b1488],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_69	[p5l979t1465r1064b1488],
5	u	NN	O	u	dep	1	SENT_69	[p5l1096t1472r1112b1488],
6	etts	VBZ	O	ett	_	0	SENT_69	[p5l1126t1468r1170b1488],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_69	[p5l1180t1464r1288b1488],
8	Society	NNP	ORGANIZATION	Society	dobj	6	SENT_69	[p5l1299t1464r1404b1495],
9	.	.	O	.	_	0	SENT_69	[p5l1299t1464r1404b1495],

1	All	DT	O	all	det	2	SENT_70	[p5l1415t1464r1456b1488],
2	rights	NNS	O	rights	nsubj	3	SENT_70	[p5l1465t1464r1540b1495],
3	reserved	VBN	O	reserve	_	0	SENT_70	[p5l1550t1464r1669b1488],
4	.	.	O	.	_	0	SENT_70	[p5l1550t1464r1669b1488],

1	ERLOTINIB	JJ	O	erlotinib	amod	2	SENT_71	[p5l591t1508r778b1527],
2	THERAPY	NN	O	therapy	_	0	SENT_71	[p5l791t1508r943b1527],
3	FOR	IN	O	for	_	0	SENT_71	[p5l956t1508r1022b1527],
4	LUNG	NN	O	lung	prep_for	2	SENT_71	[p5l1035t1508r1129b1527],
5	CANCER	NNP	O	CANCER	dep	2	SENT_71	[p5l1143t1508r1279b1527],

1	Table	NNP	O	Table	_	0	SENT_72	[p6l118t29r189b54],
2	1	CD	NUMBER	1	dep	1	SENT_72	[p6l199t31r221b54],
3	.	.	O	.	_	0	SENT_72	[p6l199t31r221b54],

1	Baseline	NN	O	baseline	nn	3	SENT_73	[p6l233t29r346b54],
2	Demographic	JJ	O	demographic	amod	3	SENT_73	[p6l356t29r541b62],
3	Characteristics	NNS	O	characteristic	_	0	SENT_73	[p6l550t29r753b54],
4	of	IN	O	of	_	0	SENT_73	[p6l762t29r793b54],
5	All	DT	O	all	det	6	SENT_73	[p6l796t29r830b54],
6	Patients	NNS	O	patient	prep_of	3	SENT_73	[p6l842t30r950b54],
7	and	CC	O	and	_	0	SENT_73	[p6l960t29r1009b54],
8	the	DT	O	the	det	9	SENT_73	[p6l1018t29r1062b54],
9	Patients	NNS	O	patient	prep_of	3	SENT_73	[p6l1073t30r1181b54],
10	Who	WP	O	who	nsubj	11	SENT_73	[p6l1190t29r1254b54],
11	Underwent	VBD	O	undergo	rcmod	9	SENT_73	[p6l1264t29r1416b54],
12	lmmunohistochemical	JJ	O	lmmunohistochemical	amod	14	SENT_73	[p6l1426t29r1733b54],
13	(	NN	O	(	nn	14	SENT_73	[p6l1745t31r1816b62],
14	IHC	NN	ORGANIZATION	ihc	dobj	11	SENT_73	[p6l1745t31r1816b62],
15	)	CD	NUMBER	)	num	16	SENT_73	[p6l1745t31r1816b62],
16	Analysis	NN	O	analysis	dep	14	SENT_73	[p6l1826t29r1948b62],
17	,	,	O	,	_	0	SENT_73	[p6l1826t29r1948b62],
18	Fluorescence	NN	O	fluorescence	dobj	11	SENT_73	[p6l121t71r299b96],
19	in	IN	O	in	_	0	SENT_73	[p6l309t71r332b96],
20	Situ	NNP	O	Situ	nn	21	SENT_73	[p6l342t71r394b96],
21	Hybridization	NNP	O	Hybridization	prep_in	18	SENT_73	[p6l406t71r598b104],
22	,	,	O	,	_	0	SENT_73	[p6l406t71r598b104],
23	and	CC	O	and	_	0	SENT_73	[p6l608t71r657b96],
24	Mutational	JJ	O	mutational	amod	25	SENT_73	[p6l669t71r816b96],
25	Analysis	NN	O	analysis	conj_and	14	SENT_73	[p6l825t71r964b104],
26	.	.	O	.	_	0	SENT_73	[p6l825t71r964b104],

1	*	NN	O	*	dep	7	SENT_74	[p6l825t71r964b104],
2	Characteristic	JJ	MISC	characteristic	amod	4	SENT_74	[p6l119t135r308b160],
3	IHC	NNP	MISC	IHC	nn	4	SENT_74	[p6l701t137r754b160],
4	Analysis	NN	MISC	analysis	dep	1	SENT_74	[p6l762t135r876b168],
5	(	CD	NUMBER	(	num	6	SENT_74	[p6l887t137r1002b168],
6	N	NN	O	n	dep	7	SENT_74	[p6l887t137r1002b168],
7	=	JJ	O	=	dep	18	SENT_74	[p6l887t137r1002b168],
8	325	CD	NUMBER	325	number	9	SENT_74	[p6l887t137r1002b168],
9	)	CD	NUMBER	)	num	10	SENT_74	[p6l887t137r1002b168],
10	FISH	NN	O	fish	dep	7	SENT_74	[p6l1059t137r1125b160],
11	(	CD	NUMBER	(	num	12	SENT_74	[p6l1138t138r1253b168],
12	N	NN	O	n	npadvmod	13	SENT_74	[p6l1138t138r1253b168],
13	=	JJ	O	=	amod	10	SENT_74	[p6l1138t138r1253b168],
14	125	CD	NUMBER	125	number	15	SENT_74	[p6l1138t138r1253b168],
15	)	CD	NUMBER	)	num	18	SENT_74	[p6l1138t138r1253b168],
16	Mutational	JJ	O	mutational	amod	18	SENT_74	[p6l1310t135r1457b160],
17	Analysis	NN	O	analysis	nn	18	SENT_74	[p6l1467t135r1580b168],
18	(	NN	O	(	dep	22	SENT_74	[p6l1591t138r1706b168],
19	N	NN	O	n	prep	18	SENT_74	[p6l1591t138r1706b168],
20	=	JJ	O	=	amod	21	SENT_74	[p6l1591t138r1706b168],
21	177	CD	NUMBER	177	dep	19	SENT_74	[p6l1591t138r1706b168],
22	)	CD	NUMBER	)	_	0	SENT_74	[p6l1591t138r1706b168],
23	All	DT	O	all	det	24	SENT_74	[p6l1748t135r1782b160],
24	Patients	NNS	O	patient	nsubj	25	SENT_74	[p6l1794t136r1902b160],
25	(	VBP	O	(	rcmod	22	SENT_74	[p6l1913t137r2028b168],
26	N	NN	O	n	dobj	25	SENT_74	[p6l1913t137r2028b168],
27	=	JJ	O	=	dep	26	SENT_74	[p6l1913t137r2028b168],
28	731	CD	NUMBER	731	iobj	27	SENT_74	[p6l1913t137r2028b168],
29	)	NN	O	)	nn	31	SENT_74	[p6l1913t137r2028b168],
30	Hazard	NN	O	hazard	nn	31	SENT_74	[p6l121t195r218b220],
31	ratio	NN	O	ratio	dobj	27	SENT_74	[p6l230t197r290b220],
32	for	IN	O	for	_	0	SENT_74	[p6l300t194r337b220],
33	death	NN	O	death	amod	37	SENT_74	[p6l346t195r420b220],
34	(	CD	PERCENT	(	num	33	SENT_74	[p6l435t196r503b228],
35	95	CD	PERCENT	95	num	36	SENT_74	[p6l435t196r503b228],
36	%	NN	PERCENT	%	dep	33	SENT_74	[p6l435t196r503b228],
37	cI	NN	O	ci	prep_for	31	SENT_74	[p6l514t197r572b228],
38	)	SYM	O	)	dep	31	SENT_74	[p6l514t197r572b228],
39	-	:	O	-	_	0	SENT_74	[p6l514t197r572b228],
40	(	SYM	O	(	dep	43	SENT_74	[p6l514t197r572b228],
41	-	:	O	-	_	0	SENT_74	[p6l514t197r572b228],
42	0.76	CD	NUMBER	0.76	num	43	SENT_74	[p6l741t196r797b220],
43	(	CD	NUMBER	(	dep	31	SENT_74	[p6l810t196r960b228],
44	0.59	CD	NUMBER	0.59	num	45	SENT_74	[p6l810t196r960b228],
45	—	NN	O	—	dep	53	SENT_74	[p6l810t196r960b228],
46	0.97	CD	NUMBER	0.97	dep	45	SENT_74	[p6l810t196r960b228],
47	)	CD	NUMBER	)	number	48	SENT_74	[p6l810t196r960b228],
48	0.63	CD	NUMBER	0.63	dep	46	SENT_74	[p6l1045t196r1099b220],
49	(	NN	O	(	dep	53	SENT_74	[p6l1114t196r1264b228],
50	0.42	CD	NUMBER	0.42	num	49	SENT_74	[p6l1114t196r1264b228],
51	—	CD	NUMBER	—	num	53	SENT_74	[p6l1114t196r1264b228],
52	0.96	CD	NUMBER	0.96	num	53	SENT_74	[p6l1114t196r1264b228],
53	)	NN	O	)	dep	57	SENT_74	[p6l1114t196r1264b228],
54	0.71	CD	NUMBER	0.71	num	55	SENT_74	[p6l1397t196r1452b220],
55	(	CD	NUMBER	(	dep	53	SENT_74	[p6l1466t196r1616b228],
56	0.50	CD	NUMBER	0.50	num	57	SENT_74	[p6l1466t196r1616b228],
57	—	NN	O	—	dep	59	SENT_74	[p6l1466t196r1616b228],
58	0.99	CD	NUMBER	0.99	num	59	SENT_74	[p6l1466t196r1616b228],
59	)	CD	NUMBER	)	dep	65	SENT_74	[p6l1466t196r1616b228],
60	0.70	CD	NUMBER	0.70	num	61	SENT_74	[p6l1778t196r1835b220],
61	(	NN	O	(	dep	59	SENT_74	[p6l1848t196r1997b228],
62	0.58	CD	NUMBER	0.58	number	63	SENT_74	[p6l1848t196r1997b228],
63	—	CD	NUMBER	—	dep	61	SENT_74	[p6l1848t196r1997b228],
64	0.85	CD	NUMBER	0.85	num	65	SENT_74	[p6l1848t196r1997b228],
65	)	NN	O	)	dep	25	SENT_74	[p6l1848t196r1997b228],

1	number	NN	O	number	_	0	SENT_75	[p6l1178t256r1281b281],
2	of	IN	O	of	_	0	SENT_75	[p6l1288t256r1319b289],
3	patients	NNS	O	patient	prep_of	1	SENT_75	[p6l1319t257r1423b289],
4	(	CD	PERCENT	(	num	6	SENT_75	[p6l1435t258r1548b289],
5	percent	NN	PERCENT	percent	nn	6	SENT_75	[p6l1435t258r1548b289],
6	)	NN	O	)	dep	1	SENT_75	[p6l1435t258r1548b289],

1	Age	NN	O	age	_	0	SENT_76	[p6l118t306r169b337],

1	<	JJR	O	<	dep	10	SENT_77	[p6l169t354r219b377],
2	60	CD	DURATION	60	num	3	SENT_77	[p6l169t354r219b377],
3	yr	NN	DURATION	yr	dep	1	SENT_77	[p6l228t361r252b385],
4	149	CD	NUMBER	149	number	5	SENT_77	[p6l797t354r843b377],
5	(	CD	NUMBER	(	num	6	SENT_77	[p6l856t354r905b385],
6	46	CD	NUMBER	46	dep	3	SENT_77	[p6l856t354r905b385],
7	)	NN	O	)	dep	10	SENT_77	[p6l856t354r905b385],
8	49	CD	NUMBER	49	num	7	SENT_77	[p6l1116t354r1147b377],
9	(	CD	NUMBER	(	num	10	SENT_77	[p6l1160t354r1210b385],
10	39	CD	NUMBER	39	dep	15	SENT_77	[p6l1160t354r1210b385],
11	)	NN	O	)	dep	10	SENT_77	[p6l1160t354r1210b385],
12	79	CD	NUMBER	79	num	11	SENT_77	[p6l1470t354r1499b377],
13	(	CD	NUMBER	(	number	14	SENT_77	[p6l1512t354r1562b385],
14	45	CD	NUMBER	45	dep	11	SENT_77	[p6l1512t354r1562b385],
15	)	NN	O	)	dep	17	SENT_77	[p6l1512t354r1562b385],
16	260	CD	DURATION	260	num	15	SENT_77	[p6l169t402r219b425],
17	yr	NN	DURATION	yr	dep	19	SENT_77	[p6l228t409r252b433],
18	176	CD	NUMBER	176	num	17	SENT_77	[p6l797t402r843b425],
19	(	NN	O	(	dep	23	SENT_77	[p6l856t402r905b433],
20	54	CD	NUMBER	54	num	19	SENT_77	[p6l856t402r905b433],
21	)	CD	NUMBER	)	num	23	SENT_77	[p6l856t402r905b433],
22	76	CD	NUMBER	76	num	23	SENT_77	[p6l1118t402r1147b425],
23	(	NN	O	(	dep	27	SENT_77	[p6l1160t402r1210b433],
24	61	CD	NUMBER	61	number	25	SENT_77	[p6l1160t402r1210b433],
25	)	CD	NUMBER	)	dep	23	SENT_77	[p6l1160t402r1210b433],
26	98	CD	NUMBER	98	dep	25	SENT_77	[p6l1469t402r1499b425],
27	(	NN	O	(	dep	30	SENT_77	[p6l1512t402r1562b433],
28	55	CD	NUMBER	55	num	27	SENT_77	[p6l1512t402r1562b433],
29	)	CD	NUMBER	)	num	30	SENT_77	[p6l1512t402r1562b433],
30	Sex	NN	O	sex	_	0	SENT_77	[p6l120t450r165b473],

1	Female	JJ	O	female	amod	2	SENT_78	[p6l172t496r267b521],
2	115	CD	NUMBER	115	dep	9	SENT_78	[p6l797t498r841b521],
3	(	CD	NUMBER	(	num	4	SENT_78	[p6l856t498r905b529],
4	35	CD	NUMBER	35	dep	2	SENT_78	[p6l856t498r905b529],
5	)	NN	O	)	dep	9	SENT_78	[p6l856t498r905b529],
6	44	CD	NUMBER	44	num	5	SENT_78	[p6l1116t498r1147b521],
7	(	CD	NUMBER	(	num	9	SENT_78	[p6l1160t498r1210b529],
8	35	CD	NUMBER	35	num	9	SENT_78	[p6l1160t498r1210b529],
9	)	NN	O	)	dep	14	SENT_78	[p6l1160t498r1210b529],
10	66	CD	NUMBER	66	num	11	SENT_78	[p6l1469t498r1499b521],
11	(	NN	O	(	dep	9	SENT_78	[p6l1512t498r1562b529],
12	37	CD	NUMBER	37	number	13	SENT_78	[p6l1512t498r1562b529],
13	)	CD	NUMBER	)	dep	11	SENT_78	[p6l1512t498r1562b529],
14	Male	NN	O	male	dep	18	SENT_78	[p6l171t544r236b569],
15	210	CD	NUMBER	210	num	14	SENT_78	[p6l795t545r843b569],
16	(	CD	NUMBER	(	num	18	SENT_78	[p6l856t546r905b577],
17	65	CD	NUMBER	65	num	18	SENT_78	[p6l856t546r905b577],
18	)	NN	O	)	dep	24	SENT_78	[p6l856t546r905b577],
19	81	CD	NUMBER	81	number	20	SENT_78	[p6l1116t545r1146b569],
20	(	CD	NUMBER	(	dep	18	SENT_78	[p6l1160t546r1210b577],
21	65	CD	NUMBER	65	num	22	SENT_78	[p6l1160t546r1210b577],
22	)	NN	O	)	dep	20	SENT_78	[p6l1160t546r1210b577],
23	111	CD	NUMBER	111	num	24	SENT_78	[p6l1454t546r1498b569],
24	(	NN	O	(	dep	26	SENT_78	[p6l1512t546r1562b577],
25	63	CD	NUMBER	63	num	26	SENT_78	[p6l1512t546r1562b577],
26	)	NN	O	)	_	0	SENT_78	[p6l1512t546r1562b577],

1	Performance	NNP	O	Performance	nn	3	SENT_79	[p6l121t591r294b617],
2	status	NN	O	status	nn	3	SENT_79	[p6l304t596r385b617],
3	o	NN	O	o	dep	11	SENT_79	[p6l169t641r184b665],
4	or	CC	O	or	_	0	SENT_79	[p6l194t648r222b665],
5	1	CD	NUMBER	1	num	6	SENT_79	[p6l232t642r244b664],
6	203	CD	NUMBER	203	conj_or	3	SENT_79	[p6l795t641r841b665],
7	(	NN	O	(	dep	11	SENT_79	[p6l856t642r905b673],
8	62	CD	NUMBER	62	num	7	SENT_79	[p6l856t642r905b673],
9	)	CD	NUMBER	)	num	11	SENT_79	[p6l856t642r905b673],
10	91	CD	NUMBER	91	num	11	SENT_79	[p6l1116t642r1146b665],
11	(	NN	O	(	dep	15	SENT_79	[p6l1160t642r1210b673],
12	73	CD	NUMBER	73	num	13	SENT_79	[p6l1160t642r1210b673],
13	)	NN	O	)	dep	11	SENT_79	[p6l1160t642r1210b673],
14	127	CD	NUMBER	127	num	15	SENT_79	[p6l1453t642r1499b665],
15	(	NN	O	(	dep	26	SENT_79	[p6l1512t642r1562b673],
16	72	CD	NUMBER	72	num	17	SENT_79	[p6l1512t642r1562b673],
17	)	NN	O	)	dep	15	SENT_79	[p6l1512t642r1562b673],
18	2	CD	NUMBER	2	number	21	SENT_79	[p6l169t690r183b712],
19	or	CC	O	or	_	0	SENT_79	[p6l194t696r222b713],
20	3	CD	NUMBER	3	conj_or	21	SENT_79	[p6l231t690r243b713],
21	122	CD	NUMBER	122	num	22	SENT_79	[p6l797t690r842b712],
22	(	NN	O	(	dep	17	SENT_79	[p6l856t689r905b720],
23	38	CD	NUMBER	38	number	24	SENT_79	[p6l856t689r905b720],
24	)	CD	NUMBER	)	num	22	SENT_79	[p6l856t689r905b720],
25	34	CD	NUMBER	34	num	26	SENT_79	[p6l1117t690r1147b713],
26	(	NN	O	(	dep	28	SENT_79	[p6l1160t690r1210b720],
27	27	CD	NUMBER	27	num	28	SENT_79	[p6l1160t690r1210b720],
28	)	NN	O	)	dep	34	SENT_79	[p6l1160t690r1210b720],
29	50	CD	NUMBER	50	number	30	SENT_79	[p6l1469t689r1500b713],
30	(	CD	NUMBER	(	dep	28	SENT_79	[p6l1512t689r1562b720],
31	28	CD	NUMBER	28	num	33	SENT_79	[p6l1512t689r1562b720],
32	)	NN	O	)	nn	33	SENT_79	[p6l1512t689r1562b720],
33	P	NN	O	p	dep	30	SENT_79	[p6l171t738r186b760],
34	value	NN	O	value	dep	37	SENT_79	[p6l195t735r266b761],
35	0.04	CD	NUMBER	0.04	num	34	SENT_79	[p6l823t737r880b761],
36	—	CD	NUMBER	—	num	37	SENT_79	[p6l1139t751r1173b753],
37	—	NN	O	—	_	0	SENT_79	[p6l1491t751r1525b753],

1	Histopathological	JJ	O	histopathological	amod	3	SENT_80	[p6l121t783r362b817],
2	subtype	NN	O	subtype	nn	3	SENT_80	[p6l374t783r479b816],
3	Adenocarcinoma	NN	O	adenocarcinoma	dep	13	SENT_80	[p6l168t831r401b856],
4	164	CD	NUMBER	164	num	5	SENT_80	[p6l797t833r843b857],
5	(	NN	O	(	dep	3	SENT_80	[p6l856t833r905b864],
6	50	CD	NUMBER	50	number	7	SENT_80	[p6l856t833r905b864],
7	)	CD	NUMBER	)	num	8	SENT_80	[p6l856t833r905b864],
8	67	CD	NUMBER	67	dep	5	SENT_80	[p6l1117t833r1147b857],
9	(	NN	O	(	dep	13	SENT_80	[p6l1160t833r1210b864],
10	54	CD	NUMBER	54	num	9	SENT_80	[p6l1160t833r1210b864],
11	)	CD	NUMBER	)	num	13	SENT_80	[p6l1160t833r1210b864],
12	95	CD	NUMBER	95	num	13	SENT_80	[p6l1469t833r1498b857],
13	(	NN	O	(	dep	22	SENT_80	[p6l1512t833r1562b864],
14	54	CD	NUMBER	54	number	15	SENT_80	[p6l1512t833r1562b864],
15	)	CD	NUMBER	)	num	16	SENT_80	[p6l1512t833r1562b864],
16	Other	JJ	O	other	dep	13	SENT_80	[p6l170t879r249b904],
17	161	CD	NUMBER	161	number	18	SENT_80	[p6l797t881r841b904],
18	(	CD	NUMBER	(	num	20	SENT_80	[p6l856t881r905b912],
19	50	CD	NUMBER	50	number	20	SENT_80	[p6l856t881r905b912],
20	)	CD	NUMBER	)	dep	16	SENT_80	[p6l856t881r905b912],
21	58	CD	NUMBER	58	num	22	SENT_80	[p6l1117t881r1147b905],
22	(	NN	O	(	dep	29	SENT_80	[p6l1160t881r1210b912],
23	46	CD	NUMBER	46	number	24	SENT_80	[p6l1160t881r1210b912],
24	)	CD	NUMBER	)	dep	22	SENT_80	[p6l1160t881r1210b912],
25	82	CD	NUMBER	82	num	26	SENT_80	[p6l1468t881r1499b905],
26	(	NN	O	(	dep	24	SENT_80	[p6l1512t881r1562b912],
27	46	CD	NUMBER	46	number	28	SENT_80	[p6l1512t881r1562b912],
28	)	CD	NUMBER	)	num	29	SENT_80	[p6l1512t881r1562b912],
29	Race	NN	O	race	dep	37	SENT_80	[p6l121t929r183b952],
30	or	CC	O	or	_	0	SENT_80	[p6l193t936r221b952],
31	ethnic	JJ	O	ethnic	amod	32	SENT_80	[p6l230t927r313b952],
32	group	NN	O	group	dep	37	SENT_80	[p6l323t936r402b960],
33	Asian	JJ	O	asian	amod	32	SENT_80	[p6l168t977r243b1000],
34	20	CD	NUMBER	20	number	35	SENT_80	[p6l812t977r843b1000],
35	(	CD	NUMBER	(	dep	33	SENT_80	[p6l856t977r889b1008],
36	6	CD	NUMBER	6	num	37	SENT_80	[p6l856t977r889b1008],
37	)	NN	O	)	dep	39	SENT_80	[p6l856t977r889b1008],
38	8	CD	NUMBER	8	num	39	SENT_80	[p6l1133t977r1147b1000],
39	(	NN	O	(	dep	41	SENT_80	[p6l1160t977r1193b1008],
40	6	CD	NUMBER	6	num	41	SENT_80	[p6l1160t977r1193b1008],
41	)	NN	O	)	dep	50	SENT_80	[p6l1160t977r1193b1008],
42	12	CD	NUMBER	12	num	43	SENT_80	[p6l1470t977r1499b1000],
43	(	NN	O	(	dep	41	SENT_80	[p6l1512t977r1545b1008],
44	7	CD	NUMBER	7	number	45	SENT_80	[p6l1512t977r1545b1008],
45	)	CD	NUMBER	)	num	46	SENT_80	[p6l1512t977r1545b1008],
46	Other	JJ	O	other	dep	43	SENT_80	[p6l170t1023r249b1048],
47	305	CD	NUMBER	305	number	48	SENT_80	[p6l796t1025r841b1048],
48	(	CD	NUMBER	(	num	46	SENT_80	[p6l856t1025r905b1056],
49	94	CD	NUMBER	94	num	50	SENT_80	[p6l856t1025r905b1056],
50	)	NN	O	)	dep	52	SENT_80	[p6l856t1025r905b1056],
51	117	CD	NUMBER	117	num	52	SENT_80	[p6l1101t1025r1147b1048],
52	(	NN	O	(	dep	54	SENT_80	[p6l1160t1025r1210b1056],
53	94	CD	NUMBER	94	num	54	SENT_80	[p6l1160t1025r1210b1056],
54	)	NN	O	)	dep	62	SENT_80	[p6l1160t1025r1210b1056],
55	165	CD	NUMBER	165	num	56	SENT_80	[p6l1453t1025r1498b1048],
56	(	NN	O	(	dep	54	SENT_80	[p6l1512t1025r1562b1056],
57	93	CD	NUMBER	93	number	58	SENT_80	[p6l1512t1025r1562b1056],
58	)	CD	NUMBER	)	num	60	SENT_80	[p6l1512t1025r1562b1056],
59	P	NN	O	p	nn	60	SENT_80	[p6l171t1073r186b1096],
60	value	NN	O	value	npadvmod	61	SENT_80	[p6l195t1071r266b1096],
61	<	JJR	O	<	amod	56	SENT_80	[p6l806t1072r896b1096],
62	0.001	CD	NUMBER	0.001	dep	64	SENT_80	[p6l806t1072r896b1096],
63	0.03	CD	NUMBER	0.03	num	64	SENT_80	[p6l1129t1073r1184b1096],
64	0.01	CD	NUMBER	0.01	_	0	SENT_80	[p6l1481t1072r1536b1096],

1	Smoking	NN	MISC	smoking	nn	2	SENT_81	[p6l120t1119r240b1152],
2	history	NN	O	history	_	0	SENT_81	[p6l250t1119r342b1152],

1	Current	JJ	DATE	current	amod	2	SENT_82	[p6l170t1169r272b1192],
2	49	CD	NUMBER	49	dep	11	SENT_82	[p6l811t1169r843b1192],
3	(	CD	NUMBER	(	number	4	SENT_82	[p6l856t1169r905b1200],
4	15	CD	NUMBER	15	dep	2	SENT_82	[p6l856t1169r905b1200],
5	)	CD	NUMBER	)	num	6	SENT_82	[p6l856t1169r905b1200],
6	15	CD	NUMBER	15	dep	4	SENT_82	[p6l1118t1169r1146b1192],
7	(	NN	O	(	dep	11	SENT_82	[p6l1160t1169r1210b1200],
8	12	CD	NUMBER	12	num	7	SENT_82	[p6l1160t1169r1210b1200],
9	)	CD	NUMBER	)	num	11	SENT_82	[p6l1160t1169r1210b1200],
10	20	CD	NUMBER	20	num	11	SENT_82	[p6l1468t1168r1500b1192],
11	(	NN	O	(	dep	16	SENT_82	[p6l1512t1169r1562b1200],
12	11	CD	NUMBER	11	num	13	SENT_82	[p6l1512t1169r1562b1200],
13	)	NN	O	)	dep	11	SENT_82	[p6l1512t1169r1562b1200],
14	(	CD	NUMBER	(	number	15	SENT_82	[p6l856t1217r905b1248],
15	56	CD	NUMBER	56	dep	13	SENT_82	[p6l856t1217r905b1248],
16	)	NN	O	)	dep	20	SENT_82	[p6l856t1217r905b1248],
17	74	CD	NUMBER	74	num	16	SENT_82	[p6l1118t1217r1147b1240],
18	(	CD	NUMBER	(	num	20	SENT_82	[p6l1160t1217r1210b1248],
19	59	CD	NUMBER	59	num	20	SENT_82	[p6l1160t1217r1210b1248],
20	)	NN	O	)	dep	29	SENT_82	[p6l1160t1217r1210b1248],
21	104	CD	NUMBER	104	num	22	SENT_82	[p6l1453t1216r1499b1240],
22	(	NN	O	(	dep	20	SENT_82	[p6l1512t1217r1562b1248],
23	59	CD	NUMBER	59	number	24	SENT_82	[p6l1512t1217r1562b1248],
24	)	CD	NUMBER	)	num	25	SENT_82	[p6l1512t1217r1562b1248],
25	(	NN	O	(	dep	22	SENT_82	[p6l856t1265r863b1296],
26	1	CD	NUMBER	1	number	27	SENT_82	[p6l884t1265r905b1296],
27	)	CD	NUMBER	)	num	25	SENT_82	[p6l884t1265r905b1296],
28	32	CD	NUMBER	32	num	29	SENT_82	[p6l1117t1265r1147b1288],
29	(	NN	O	(	dep	38	SENT_82	[p6l1160t1265r1210b1296],
30	26	CD	NUMBER	26	dep	29	SENT_82	[p6l1160t1265r1210b1296],
31	)	CD	NUMBER	)	number	32	SENT_82	[p6l1160t1265r1210b1296],
32	42	CD	NUMBER	42	num	33	SENT_82	[p6l1468t1265r1499b1287],
33	(	NN	O	(	npadvmod	36	SENT_82	[p6l1512t1265r1562b1296],
34	24	CD	NUMBER	24	number	35	SENT_82	[p6l1512t1265r1562b1296],
35	)	CD	NUMBER	)	num	33	SENT_82	[p6l1512t1265r1562b1296],
36	Unknown	JJ	O	unknown	amod	30	SENT_82	[p6l171t1311r299b1336],
37	8	CD	NUMBER	8	num	38	SENT_82	[p6l865t1312r889b1343],
38	)	NN	O	)	dep	40	SENT_82	[p6l865t1312r889b1343],
39	4	CD	NUMBER	4	num	40	SENT_82	[p6l1132t1313r1147b1335],
40	(	NN	O	(	dep	42	SENT_82	[p6l1160t1313r1193b1344],
41	3	CD	NUMBER	3	num	42	SENT_82	[p6l1160t1313r1193b1344],
42	)	NN	O	)	dep	44	SENT_82	[p6l1160t1313r1193b1344],
43	11	CD	NUMBER	11	num	44	SENT_82	[p6l1470t1313r1498b1335],
44	(	NN	O	(	dep	48	SENT_82	[p6l1512t1313r1545b1344],
45	6	CD	NUMBER	6	num	47	SENT_82	[p6l1512t1313r1545b1344],
46	)	NN	O	)	nn	47	SENT_82	[p6l1512t1313r1545b1344],
47	P	NN	O	p	dep	44	SENT_82	[p6l172t1361r186b1383],
48	value	NN	O	value	dep	51	SENT_82	[p6l195t1358r266b1384],
49	—	CD	NUMBER	—	num	48	SENT_82	[p6l835t1374r869b1376],
50	0.02	CD	NUMBER	0.02	num	51	SENT_82	[p6l1129t1360r1185b1384],
51	—	NN	O	—	_	0	SENT_82	[p6l1491t1374r1525b1376],

1	Prior	RB	O	prior	dep	9	SENT_83	[p6l121t1409r185b1432],
2	cisplatin	NN	O	cisplatin	dep	1	SENT_83	[p6l194t1406r307b1439],
3	Yes	UH	O	yes	dep	5	SENT_83	[p6l168t1457r212b1480],
4	301	CD	NUMBER	301	num	5	SENT_83	[p6l796t1456r841b1480],
5	(	CD	NUMBER	(	rcmod	2	SENT_83	[p6l856t1456r905b1487],
6	93	CD	NUMBER	93	num	7	SENT_83	[p6l856t1456r905b1487],
7	)	NN	O	)	dep	9	SENT_83	[p6l856t1456r905b1487],
8	118	CD	NUMBER	118	num	9	SENT_83	[p6l1101t1456r1147b1480],
9	(	NN	O	(	dep	13	SENT_83	[p6l1160t1456r1210b1487],
10	94	CD	NUMBER	94	num	11	SENT_83	[p6l1160t1456r1210b1487],
11	)	NN	O	)	dep	9	SENT_83	[p6l1160t1456r1210b1487],
12	166	CD	NUMBER	166	num	13	SENT_83	[p6l1454t1456r1499b1480],
13	(	NN	O	(	_	0	SENT_83	[p6l1512t1456r1562b1487],
14	94	CD	NUMBER	94	num	15	SENT_83	[p6l1512t1456r1562b1487],
15	)	CD	NUMBER	)	dep	13	SENT_83	[p6l1512t1456r1562b1487],
16	No	DT	O	no	det	28	SENT_83	[p6l171t1505r210b1527],
17	24	CD	NUMBER	24	num	28	SENT_83	[p6l812t1505r843b1527],
18	(	NN	O	(	nn	28	SENT_83	[p6l856t1504r889b1535],
19	7	CD	NUMBER	7	num	28	SENT_83	[p6l856t1504r889b1535],
20	)	NN	O	)	nn	28	SENT_83	[p6l856t1504r889b1535],
21	7	CD	NUMBER	7	num	28	SENT_83	[p6l1134t1505r1147b1527],
22	(	NN	O	(	nn	28	SENT_83	[p6l1160t1504r1193b1535],
23	6	CD	NUMBER	6	num	28	SENT_83	[p6l1160t1504r1193b1535],
24	)	NN	O	)	nn	28	SENT_83	[p6l1160t1504r1193b1535],
25	11	CD	NUMBER	11	num	28	SENT_83	[p6l1470t1505r1498b1527],
26	(	NN	O	(	nn	28	SENT_83	[p6l1512t1504r1545b1535],
27	6	CD	NUMBER	6	num	28	SENT_83	[p6l1512t1504r1545b1535],
28	)	NN	O	)	rcmod	15	SENT_83	[p6l1512t1504r1545b1535],

1	No.	NN	O	no.	_	0	SENT_84	[p6l121t1552r167b1575],
2	ofprior	NN	O	ofprior	nn	3	SENT_84	[p6l179t1550r279b1583],
3	regimens	NNS	O	regimen	dep	1	SENT_84	[p6l289t1553r414b1583],

1	1	CD	NUMBER	1	num	3	SENT_85	[p6l171t1600r182b1623],
2	140	CD	NUMBER	140	num	3	SENT_85	[p6l797t1600r843b1623],
3	(	NN	O	(	dep	11	SENT_85	[p6l856t1600r905b1631],
4	43	CD	NUMBER	43	number	5	SENT_85	[p6l856t1600r905b1631],
5	)	CD	NUMBER	)	dep	3	SENT_85	[p6l856t1600r905b1631],
6	44	CD	NUMBER	44	dep	5	SENT_85	[p6l1116t1600r1147b1623],
7	(	NN	O	(	dep	11	SENT_85	[p6l1160t1600r1210b1631],
8	35	CD	NUMBER	35	num	7	SENT_85	[p6l1160t1600r1210b1631],
9	)	CD	NUMBER	)	num	11	SENT_85	[p6l1160t1600r1210b1631],
10	61	CD	NUMBER	61	num	11	SENT_85	[p6l1469t1600r1498b1623],
11	(	NN	O	(	dep	22	SENT_85	[p6l1512t1600r1562b1631],
12	34	CD	NUMBER	34	num	13	SENT_85	[p6l1512t1600r1562b1631],
13	)	NN	O	)	dep	11	SENT_85	[p6l1512t1600r1562b1631],
14	2	CD	NUMBER	2	number	17	SENT_85	[p6l169t1648r183b1671],
15	or	CC	O	or	_	0	SENT_85	[p6l194t1655r222b1671],
16	3	CD	NUMBER	3	conj_or	17	SENT_85	[p6l231t1648r243b1671],
17	185	CD	NUMBER	185	num	18	SENT_85	[p6l797t1648r841b1671],
18	(	NN	O	(	dep	13	SENT_85	[p6l856t1648r905b1679],
19	57	CD	NUMBER	57	number	20	SENT_85	[p6l856t1648r905b1679],
20	)	CD	NUMBER	)	num	18	SENT_85	[p6l856t1648r905b1679],
21	81	CD	NUMBER	81	num	22	SENT_85	[p6l1116t1648r1146b1671],
22	(	NN	O	(	dep	24	SENT_85	[p6l1160t1648r1210b1679],
23	65	CD	NUMBER	65	num	24	SENT_85	[p6l1160t1648r1210b1679],
24	)	NN	O	)	dep	32	SENT_85	[p6l1160t1648r1210b1679],
25	116	CD	NUMBER	116	num	26	SENT_85	[p6l1454t1648r1499b1671],
26	(	NN	O	(	dep	24	SENT_85	[p6l1512t1648r1562b1679],
27	66	CD	NUMBER	66	number	28	SENT_85	[p6l1512t1648r1562b1679],
28	)	CD	NUMBER	)	num	30	SENT_85	[p6l1512t1648r1562b1679],
29	P	NN	O	p	nn	30	SENT_85	[p6l171t1696r186b1719],
30	value	NN	O	value	dep	26	SENT_85	[p6l195t1694r266b1719],
31	0.001	CD	NUMBER	0.001	num	32	SENT_85	[p6l824t1696r896b1719],
32	<	JJR	O	<	dep	35	SENT_85	[p6l1110t1696r1200b1719],
33	0.001	CD	NUMBER	0.001	num	34	SENT_85	[p6l1110t1696r1200b1719],
34	<	JJR	O	<	dep	32	SENT_85	[p6l1462t1696r1552b1719],
35	0.001	CD	NUMBER	0.001	_	0	SENT_85	[p6l1462t1696r1552b1719],

1	Best	NN	O	best	nn	2	SENT_86	[p6l121t1744r178b1767],
2	response	NN	O	response	_	0	SENT_86	[p6l189t1751r312b1775],
3	to	TO	O	to	_	0	SENT_86	[p6l321t1747r347b1767],
4	prior	JJ	O	prior	amod	5	SENT_86	[p6l359t1744r423b1775],
5	chemotherapy	NN	O	chemotherapy	prep_to	2	SENT_86	[p6l432t1742r627b1775],

1	None	NN	O	none	_	0	SENT_87	[p6l171t1265r244b1288],
2	Former	JJ	O	former	amod	1	SENT_87	[p6l171t1217r268b1240],
3	181	CD	NUMBER	181	number	4	SENT_87	[p6l797t1216r842b1240],
4	68	CD	NUMBER	68	dep	1	SENT_87	[p6l812t1264r842b1288],
5	27	CD	NUMBER	27	dep	4	SENT_87	[p6l812t1313r843b1335],

1	Complete	JJ	O	complete	amod	4	SENT_88	[p6l170t1790r300b1823],
2	or	CC	O	or	_	0	SENT_88	[p6l310t1799r338b1815],
3	partial	JJ	O	partial	amod	4	SENT_88	[p6l348t1790r431b1823],
4	response	NN	O	response	dep	12	SENT_88	[p6l444t1799r566b1823],
5	133	CD	NUMBER	133	num	6	SENT_88	[p6l797t1792r841b1815],
6	(	NN	O	(	dep	4	SENT_88	[p6l856t1792r905b1823],
7	41	CD	NUMBER	41	number	8	SENT_88	[p6l856t1792r905b1823],
8	)	CD	NUMBER	)	dep	6	SENT_88	[p6l856t1792r905b1823],
9	59	CD	NUMBER	59	num	10	SENT_88	[p6l1117t1792r1147b1815],
10	(	NN	O	(	dep	12	SENT_88	[p6l1160t1792r1210b1823],
11	47	CD	NUMBER	47	num	12	SENT_88	[p6l1160t1792r1210b1823],
12	)	CD	NUMBER	)	dep	21	SENT_88	[p6l1160t1792r1210b1823],
13	76	CD	NUMBER	76	num	14	SENT_88	[p6l1470t1792r1499b1815],
14	(	NN	O	(	dep	12	SENT_88	[p6l1512t1792r1562b1823],
15	43	CD	NUMBER	43	number	16	SENT_88	[p6l1512t1792r1562b1823],
16	)	CD	NUMBER	)	num	18	SENT_88	[p6l1512t1792r1562b1823],
17	Stable	JJ	O	stable	amod	18	SENT_88	[p6l170t1838r252b1863],
18	disease	NN	O	disease	dep	14	SENT_88	[p6l262t1838r363b1863],
19	137	CD	NUMBER	137	number	20	SENT_88	[p6l797t1840r843b1863],
20	(	CD	NUMBER	(	num	18	SENT_88	[p6l856t1840r863b1871],
21	)	NN	O	)	dep	24	SENT_88	[p6l898t1840r905b1871],
22	52	CD	NUMBER	52	num	21	SENT_88	[p6l1117t1840r1147b1863],
23	(	CD	NUMBER	(	num	24	SENT_88	[p6l1160t1840r1210b1871],
24	42	CD	NUMBER	42	dep	35	SENT_88	[p6l1160t1840r1210b1871],
25	)	NN	O	)	dep	24	SENT_88	[p6l1160t1840r1210b1871],
26	80	CD	NUMBER	80	num	25	SENT_88	[p6l1468t1839r1500b1863],
27	(	CD	NUMBER	(	number	28	SENT_88	[p6l1512t1840r1562b1871],
28	45	CD	NUMBER	45	num	33	SENT_88	[p6l1512t1840r1562b1871],
29	)	NN	O	)	nn	33	SENT_88	[p6l1512t1840r1562b1871],
30	Progression	NN	O	progression	nn	33	SENT_88	[p6l171t1888r331b1919],
31	55	CD	NUMBER	55	number	32	SENT_88	[p6l812t1888r841b1911],
32	(	CD	NUMBER	(	num	33	SENT_88	[p6l856t1888r863b1919],
33	)	NN	O	)	dep	25	SENT_88	[p6l898t1888r905b1919],
34	14	CD	NUMBER	14	num	35	SENT_88	[p6l1118t1888r1147b1910],
35	(	NN	O	(	dep	37	SENT_88	[p6l1160t1888r1210b1919],
36	11	CD	NUMBER	11	num	37	SENT_88	[p6l1160t1888r1210b1919],
37	)	CD	NUMBER	)	dep	43	SENT_88	[p6l1160t1888r1210b1919],
38	21	CD	NUMBER	21	num	39	SENT_88	[p6l1468t1888r1498b1910],
39	(	NN	O	(	dep	37	SENT_88	[p6l1512t1888r1562b1919],
40	12	CD	NUMBER	12	number	41	SENT_88	[p6l1512t1888r1562b1919],
41	)	CD	NUMBER	)	num	42	SENT_88	[p6l1512t1888r1562b1919],
42	P	NN	O	p	dep	39	SENT_88	[p6l172t1936r186b1958],
43	value	NN	O	value	dep	46	SENT_88	[p6l195t1934r266b1959],
44	—	CD	NUMBER	—	num	43	SENT_88	[p6l835t1949r869b1951],
45	0.01	CD	NUMBER	0.01	num	46	SENT_88	[p6l1128t1935r1183b1959],
46	0.003	CD	NUMBER	0.003	_	0	SENT_88	[p6l1471t1935r1543b1959],

1	Time	NNP	O	Time	_	0	SENT_89	[p6l118t1984r187b2007],
2	from	IN	O	from	dep	1	SENT_89	[p6l196t1981r260b2007],
3	diagnosis	NN	O	diagnosis	pobj	2	SENT_89	[p6l272t1982r401b2015],
4	to	TO	O	to	dep	1	SENT_89	[p6l411t1986r438b2007],
5	randomization	NN	O	randomization	pobj	4	SENT_89	[p6l449t1982r648b2007],

1	512	CD	DURATION	512	num	2	SENT_90	[p6l169t2032r218b2054],
2	mo	NN	DURATION	mo	dep	9	SENT_90	[p6l230t2038r272b2055],
3	134	CD	NUMBER	134	num	4	SENT_90	[p6l797t2032r843b2055],
4	(	NN	O	(	dep	2	SENT_90	[p6l856t2032r905b2062],
5	41	CD	NUMBER	41	number	6	SENT_90	[p6l856t2032r905b2062],
6	)	CD	NUMBER	)	dep	4	SENT_90	[p6l856t2032r905b2062],
7	52	CD	NUMBER	52	num	8	SENT_90	[p6l1116t2032r1147b2055],
8	(	NN	O	(	dep	9	SENT_90	[p6l1160t2032r1210b2062],
9	42	CD	NUMBER	42	dep	17	SENT_90	[p6l1160t2032r1210b2062],
10	)	CD	NUMBER	)	number	11	SENT_90	[p6l1160t2032r1210b2062],
11	65	CD	NUMBER	65	num	12	SENT_90	[p6l1469t2032r1498b2055],
12	(	NN	O	(	dep	9	SENT_90	[p6l1512t2032r1562b2062],
13	37	CD	NUMBER	37	number	14	SENT_90	[p6l1512t2032r1562b2062],
14	)	CD	NUMBER	)	npadvmod	15	SENT_90	[p6l1512t2032r1562b2062],
15	>	JJR	O	>	amod	12	SENT_90	[p6l169t2080r218b2102],
16	12	CD	DURATION	12	num	17	SENT_90	[p6l169t2080r218b2102],
17	mo	NN	DURATION	mo	dep	21	SENT_90	[p6l230t2086r272b2103],
18	191	CD	NUMBER	191	number	19	SENT_90	[p6l797t2080r842b2103],
19	(	CD	NUMBER	(	dep	17	SENT_90	[p6l856t2079r905b2110],
20	59	CD	NUMBER	59	dep	19	SENT_90	[p6l856t2079r905b2110],
21	)	NN	O	)	dep	25	SENT_90	[p6l856t2079r905b2110],
22	73	CD	NUMBER	73	num	21	SENT_90	[p6l1117t2079r1145b2102],
23	(	CD	NUMBER	(	num	25	SENT_90	[p6l1160t2079r1210b2110],
24	58	CD	NUMBER	58	num	25	SENT_90	[p6l1160t2079r1210b2110],
25	)	NN	O	)	dep	31	SENT_90	[p6l1160t2079r1210b2110],
26	112	CD	NUMBER	112	num	27	SENT_90	[p6l1453t2080r1499b2102],
27	(	NN	O	(	dep	25	SENT_90	[p6l1512t2079r1562b2110],
28	63	CD	NUMBER	63	number	29	SENT_90	[p6l1512t2079r1562b2110],
29	)	CD	NUMBER	)	num	30	SENT_90	[p6l1512t2079r1562b2110],
30	P	NN	O	p	dep	27	SENT_90	[p6l171t2128r186b2150],
31	value	NN	O	value	dep	34	SENT_90	[p6l195t2125r266b2151],
32	0.01	CD	NUMBER	0.01	num	31	SENT_90	[p6l825t2127r880b2151],
33	—	CD	NUMBER	—	num	34	SENT_90	[p6l1139t2141r1173b2143],
34	0.003	CD	NUMBER	0.003	_	0	SENT_90	[p6l1473t2127r1544b2151],

1	Decrease	NN	O	decrease	dep	11	SENT_91	[p6l121t2175r245b2198],
2	in	IN	O	in	_	0	SENT_91	[p6l256t2176r277b2198],
3	body	NN	O	body	nn	4	SENT_91	[p6l290t2173r354b2206],
4	weight	NN	O	weight	dep	5	SENT_91	[p6l362t2173r453b2206],
5	<	JJR	O	<	prep_in	1	SENT_91	[p6l169t2222r231b2247],
6	5	CD	PERCENT	5	number	7	SENT_91	[p6l169t2222r231b2247],
7	%	NN	PERCENT	%	amod	5	SENT_91	[p6l169t2222r231b2247],
8	21	CD	NUMBER	21	dep	11	SENT_91	[p6l795t2223r825b2246],
9	(	CD	NUMBER	(	num	11	SENT_91	[p6l856t2223r905b2254],
10	65	CD	NUMBER	65	num	11	SENT_91	[p6l856t2223r905b2254],
11	)	NN	O	)	dep	17	SENT_91	[p6l856t2223r905b2254],
12	84	CD	NUMBER	84	number	13	SENT_91	[p6l1116t2223r1147b2246],
13	(	CD	NUMBER	(	dep	11	SENT_91	[p6l1160t2223r1210b2254],
14	67	CD	NUMBER	67	num	15	SENT_91	[p6l1160t2223r1210b2254],
15	)	NN	O	)	dep	13	SENT_91	[p6l1160t2223r1210b2254],
16	116	CD	NUMBER	116	num	17	SENT_91	[p6l1453t2223r1499b2246],
17	(	NN	O	(	dep	24	SENT_91	[p6l1512t2223r1562b2254],
18	66	CD	PERCENT	66	number	19	SENT_91	[p6l1512t2223r1562b2254],
19	)	CD	PERCENT	)	dep	17	SENT_91	[p6l1512t2223r1562b2254],
20	25	CD	PERCENT	25	num	21	SENT_91	[p6l169t2270r231b2295],
21	%	NN	PERCENT	%	dep	19	SENT_91	[p6l169t2270r231b2295],
22	(	CD	NUMBER	(	num	24	SENT_91	[p6l856t2271r905b2302],
23	30	CD	NUMBER	30	num	24	SENT_91	[p6l856t2271r905b2302],
24	)	NN	O	)	dep	33	SENT_91	[p6l856t2271r905b2302],
25	34	CD	NUMBER	34	number	26	SENT_91	[p6l1117t2271r1147b2294],
26	(	CD	NUMBER	(	dep	24	SENT_91	[p6l1160t2271r1210b2302],
27	27	CD	NUMBER	27	num	28	SENT_91	[p6l1160t2271r1210b2302],
28	)	NN	O	)	dep	26	SENT_91	[p6l1160t2271r1210b2302],
29	47	CD	NUMBER	47	num	33	SENT_91	[p6l1468t2271r1499b2294],
30	(	CD	NUMBER	(	num	33	SENT_91	[p6l1512t2271r1562b2302],
31	26	CD	NUMBER	26	num	33	SENT_91	[p6l1512t2271r1562b2302],
32	)	NNP	O	)	nn	33	SENT_91	[p6l1512t2271r1562b2302],
33	Data	NNP	O	Data	_	0	SENT_91	[p6l171t2319r232b2342],
34	missing	VBG	O	miss	rcmod	33	SENT_91	[p6l244t2319r351b2350],
35	(	CD	NUMBER	(	number	36	SENT_91	[p6l856t2319r889b2350],
36	5	CD	NUMBER	5	num	37	SENT_91	[p6l856t2319r889b2350],
37	)	NN	O	)	dobj	34	SENT_91	[p6l856t2319r889b2350],
38	7	CD	NUMBER	7	num	39	SENT_91	[p6l1134t2319r1147b2342],
39	(	NN	O	(	dep	47	SENT_91	[p6l1160t2319r1193b2350],
40	6	CD	NUMBER	6	num	41	SENT_91	[p6l1160t2319r1193b2350],
41	)	NN	O	)	dep	39	SENT_91	[p6l1160t2319r1193b2350],
42	14	CD	NUMBER	14	number	43	SENT_91	[p6l1470t2319r1499b2342],
43	(	CD	NUMBER	(	dep	41	SENT_91	[p6l1512t2319r1545b2350],
44	8	CD	NUMBER	8	num	45	SENT_91	[p6l1512t2319r1545b2350],
45	)	NN	O	)	dep	47	SENT_91	[p6l1512t2319r1545b2350],
46	P	NN	O	p	nn	47	SENT_91	[p6l171t2367r186b2390],
47	value	NN	O	value	dep	37	SENT_91	[p6l195t2365r266b2390],
48	—	CD	NUMBER	—	number	49	SENT_91	[p6l835t2380r869b2383],
49	—	CD	NUMBER	—	dep	47	SENT_91	[p6l1139t2380r1173b2383],
50	0.03	CD	NUMBER	0.03	dep	49	SENT_91	[p6l1471t2367r1526b2390],

1	*	NN	O	*	nn	3	SENT_92	[p6l92t2456r107b2470],
2	P	NN	O	p	nn	3	SENT_92	[p6l119t2456r134b2478],
3	values	NNS	O	value	nsubj	10	SENT_92	[p6l142t2453r227b2479],
4	reﬂect	JJ	O	reﬂect	amod	5	SENT_92	[p6l238t2453r320b2479],
5	significance	NN	O	significance	npadvmod	9	SENT_92	[p6l329t2453r489b2487],
6	in	IN	O	in	_	0	SENT_92	[p6l499t2456r521b2478],
7	a	DT	O	a	det	8	SENT_92	[p6l532t2462r544b2479],
8	subgroup	NN	O	subgroup	prep_in	5	SENT_92	[p6l555t2453r684b2487],
9	as	IN	O	as	advmod	10	SENT_92	[p6l694t2462r721b2479],
10	compared	VBN	O	compare	_	0	SENT_92	[p6l731t2453r867b2486],
11	with	IN	O	with	_	0	SENT_92	[p6l876t2453r932b2479],
12	the	DT	O	the	det	15	SENT_92	[p6l941t2453r984b2479],
13	entire	JJ	O	entire	amod	15	SENT_92	[p6l993t2456r1070b2479],
14	study	NN	O	study	nn	15	SENT_92	[p6l1079t2453r1152b2486],
15	population	NN	O	population	prep_with	10	SENT_92	[p6l1162t2453r1316b2486],
16	.	.	O	.	_	0	SENT_92	[p6l1162t2453r1316b2486],

1	FISH	NN	O	fish	nsubj	5	SENT_93	[p6l1328t2455r1392b2479],
2	and	CC	O	and	_	0	SENT_93	[p6l1404t2453r1452b2479],
3	mutational	JJ	O	mutational	amod	4	SENT_93	[p6l1463t2453r1609b2479],
4	analysis	NN	O	analysis	conj_and	1	SENT_93	[p6l1620t2453r1726b2486],
5	included	VBD	O	include	_	0	SENT_93	[p6l1737t2453r1851b2479],
6	only	RB	O	only	advmod	7	SENT_93	[p6l1861t2453r1917b2486],
7	patients	NNS	O	patient	dobj	5	SENT_93	[p6l1927t2456r2034b2486],
8	whose	WP$	O	whose	dep	12	SENT_93	[p6l116t2491r203b2516],
9	results	NNS	O	result	nsubjpass	12	SENT_93	[p6l215t2491r303b2516],
10	could	MD	O	could	aux	12	SENT_93	[p6l314t2491r387b2516],
11	be	VB	O	be	auxpass	12	SENT_93	[p6l400t2491r430b2516],
12	evaluated	VBN	O	evaluate	dep	7	SENT_93	[p6l439t2491r577b2516],
13	.	.	O	.	_	0	SENT_93	[p6l439t2491r577b2516],

1	Cl	NN	O	cl	nsubj	2	SENT_94	[p6l588t2493r613b2516],
2	denotes	VBZ	O	denote	_	0	SENT_94	[p6l626t2491r733b2516],
3	confidence	NN	O	confidence	nn	4	SENT_94	[p6l744t2491r892b2516],
4	interval	NN	O	interval	dobj	2	SENT_94	[p6l903t2491r1010b2516],
5	.	.	O	.	_	0	SENT_94	[p6l903t2491r1010b2516],

1	1	CD	NUMBER	1	num	2	SENT_95	[p6l93t2530r108b2561],
2	‘	CD	NUMBER	‘	nsubj	9	SENT_95	[p6l93t2530r108b2561],
3	The	DT	O	the	det	5	SENT_95	[p6l116t2528r166b2553],
4	comparison	NN	O	comparison	nn	5	SENT_95	[p6l176t2530r338b2561],
5	group	NN	O	group	dep	2	SENT_95	[p6l350t2537r429b2561],
6	is	VBZ	O	be	cop	9	SENT_95	[p6l440t2530r459b2553],
7	the	DT	O	the	det	9	SENT_95	[p6l469t2528r512b2553],
8	placebo	NN	O	placebo	nn	9	SENT_95	[p6l523t2528r627b2561],
9	group	NN	O	group	_	0	SENT_95	[p6l637t2537r724b2561],
10	.	.	O	.	_	0	SENT_95	[p6l637t2537r724b2561],

1	N	NN	O	n	nn	2	SENT_96	[p6l575t2668r589b2683],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_96	[p6l605t2667r688b2689],
3	MED	VBD	O	med	_	0	SENT_96	[p6l703t2668r756b2683],
4	3532	CD	NUMBER	3532	num	5	SENT_96	[p6l768t2667r832b2689],
5	WWW	NNP	O	WWW	dobj	3	SENT_96	[p6l867t2667r1078b2689],
6	.	.	O	.	_	0	SENT_96	[p6l867t2667r1078b2689],

1	NE	NNS	O	ne	nsubj	2	SENT_97	[p6l867t2667r1078b2689],
2	)	VBP	O	)	_	0	SENT_97	[p6l867t2667r1078b2689],
3	M.ORG	NN	O	m.org	nn	4	SENT_97	[p6l867t2667r1078b2689],
4	JULY14	NN	O	july14	dobj	2	SENT_97	[p6l1112t2667r1219b2689],
5	,	,	O	,	_	0	SENT_97	[p6l1112t2667r1219b2689],
6	2005	CD	DATE	2005	num	7	SENT_97	[p6l1232t2667r1295b2689],
7	135	CD	NUMBER	135	appos	4	SENT_97	[p6l2009t2666r2064b2688],

1	The	DT	O	the	det	5	SENT_98	[p6l751t2764r801b2788],
2	New	NNP	O	New	nn	5	SENT_98	[p6l811t2765r873b2788],
3	England	NNP	O	England	nn	5	SENT_98	[p6l882t2764r993b2795],
4	J	NNP	O	J	nn	5	SENT_98	[p6l1001t2765r1014b2788],
5	oumal	NN	O	oumal	_	0	SENT_98	[p6l1015t2764r1099b2788],
6	of	IN	O	of	_	0	SENT_98	[p6l1109t2764r1137b2788],
7	Medicine	NN	O	medicine	prep_of	5	SENT_98	[p6l1144t2764r1269b2788],

1	Downloaded	VBN	O	download	_	0	SENT_99	[p6l193t2805r363b2828],
2	from	IN	O	from	_	0	SENT_99	[p6l371t2805r436b2828],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_99	[p6l445t2805r563b2835],
4	at	IN	O	at	_	0	SENT_99	[p6l573t2809r596b2828],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_99	[p6l605t2805r787b2828],
6	on	IN	O	on	_	0	SENT_99	[p6l797t2812r829b2828],
7	January	NNP	DATE	January	prep_on	1	SENT_99	[p6l838t2805r941b2835],
8	5	CD	DATE	5	num	7	SENT_99	[p6l951t2805r973b2832],
9	,	,	DATE	,	_	0	SENT_99	[p6l951t2805r973b2832],
10	2014	CD	DATE	2014	num	7	SENT_99	[p6l984t2805r1056b2828],
11	.	.	O	.	_	0	SENT_99	[p6l984t2805r1056b2828],

1	For	IN	O	for	_	0	SENT_100	[p6l1067t2805r1113b2828],
2	personal	JJ	O	personal	amod	3	SENT_100	[p6l1121t2805r1233b2835],
3	use	NN	O	use	pobj	1	SENT_100	[p6l1243t2812r1286b2828],
4	only	RB	O	only	advmod	3	SENT_100	[p6l1296t2805r1361b2835],
5	.	.	O	.	_	0	SENT_100	[p6l1296t2805r1361b2835],

1	No	DT	O	no	det	3	SENT_101	[p6l1371t2805r1411b2828],
2	other	JJ	O	other	amod	3	SENT_101	[p6l1421t2805r1489b2828],
3	uses	NNS	O	use	_	0	SENT_101	[p6l1497t2812r1553b2828],
4	without	IN	O	without	_	0	SENT_101	[p6l1564t2805r1665b2828],
5	permission	NN	O	permission	prep_without	3	SENT_101	[p6l1673t2805r1826b2835],
6	.	.	O	.	_	0	SENT_101	[p6l1673t2805r1826b2835],

1	The	DT	O	the	det	4	SENT_102	[p6l715t2952r752b2973],
2	NEW	NNP	O	NEW	nn	4	SENT_102	[p6l764t2954r845b2973],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_102	[p6l859t2954r1034b2973],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_102	[p6l1048t2954r1214b2980],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_102	[p6l1228t2952r1444b2979],

1	capture	NN	O	capture	nn	2	SENT_103	[p6l11t3191r326b3275],
2	microdissection	NN	O	microdissection	_	0	SENT_103	[p6l363t3174r1058b3253],
3	with	IN	O	with	_	0	SENT_103	[p6l1090t3174r1282b3254],
4	a	DT	O	a	det	11	SENT_103	[p6l1318t3201r1363b3253],
5	PixCell	NNP	O	PixCell	nn	11	SENT_103	[p6l1397t3175r1695b3253],
6	II	NNP	MISC	II	nn	11	SENT_103	[p6l1730t3182r1795b3252],
7	System	NNP	MISC	System	nn	11	SENT_103	[p6l1833t3180r2134b3275],
8	(	NNP	O	(	nn	11	SENT_103	[p6l15t3310r404b3394],
9	Arcturus	NNP	ORGANIZATION	Arcturus	nn	11	SENT_103	[p6l15t3310r404b3394],
10	Bioscience	NNP	ORGANIZATION	Bioscience	nn	11	SENT_103	[p6l424t3303r927b3394],
11	)	NN	O	)	prep_with	2	SENT_103	[p6l424t3303r927b3394],
12	.	.	O	.	_	0	SENT_103	[p6l424t3303r927b3394],

1	After	IN	O	after	_	0	SENT_104	[p6l949t3302r1161b3381],
2	proteinase	NN	O	proteinase	nn	4	SENT_104	[p6l1176t3303r1615b3403],
3	K	NN	O	k	nn	4	SENT_104	[p6l1635t3310r1702b3384],
4	digestion	NN	O	digestion	prep_after	8	SENT_104	[p6l1719t3302r2130b3403],
5	,	,	O	,	_	0	SENT_104	[p6l1719t3302r2130b3403],
6	DNA	NN	O	dna	nsubjpass	8	SENT_104	[p6l9t3437r223b3509],
7	was	VBD	O	be	auxpass	8	SENT_104	[p6l248t3457r412b3510],
8	isolated	VBN	O	isolate	_	0	SENT_104	[p6l446t3431r783b3509],
9	according	VBG	O	accord	_	0	SENT_104	[p6l815t3431r1246b3531],
10	to	TO	O	to	prepc_according_to	8	SENT_104	[p6l1277t3447r1357b3509],
11	the	DT	O	the	det	13	SENT_104	[p6l1392t3431r1522b3509],
12	phenol	NN	O	phenol	nn	13	SENT_104	[p6l1554t3431r2133b3531],
13	—	NN	O	—	pobj	8	SENT_104	[p6l1554t3431r2133b3531],
14	chlo	NN	O	chlo	nn	17	SENT_104	[p6l1554t3431r2133b3531],
15	—	CD	NUMBER	—	num	17	SENT_104	[p6l1554t3431r2133b3531],
16	roform	NN	O	roform	nn	17	SENT_104	[p6l10t3558r315b3637],
17	protocol	NN	O	protocol	dep	13	SENT_104	[p6l343t3559r723b3659],
18	.	.	O	.	_	0	SENT_104	[p6l343t3559r723b3659],

1	Exons	NNS	O	exon	nsubjpass	11	SENT_105	[p6l754t3566r1009b3637],
2	18	CD	NUMBER	18	num	1	SENT_105	[p6l1042t3564r1138b3637],
3	through	IN	O	through	_	0	SENT_105	[p6l1167t3559r1508b3659],
4	21	CD	NUMBER	21	prep_through	1	SENT_105	[p6l1536t3564r1636b3636],
5	of	IN	O	of	_	0	SENT_105	[p6l1665t3558r1765b3637],
6	the	DT	O	the	det	8	SENT_105	[p6l1774t3559r1903b3637],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_105	[p6l1928t3565r2140b3638],
8	gene	NN	O	gene	prep_of	4	SENT_105	[p6l10t3712r209b3787],
9	were	VBD	O	be	auxpass	11	SENT_105	[p6l233t3713r434b3766],
10	sequentially	RB	O	sequentially	advmod	11	SENT_105	[p6l464t3687r970b3787],
11	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_105	[p6l992t3686r1396b3787],
12	by	IN	O	by	_	0	SENT_105	[p6l1425t3687r1521b3787],
13	two	CD	NUMBER	two	num	14	SENT_105	[p6l1545t3703r1697b3766],
14	rounds	NNS	O	round	agent	11	SENT_105	[p6l1726t3687r2023b3766],
15	of	IN	O	of	_	0	SENT_105	[p6l2053t3686r2153b3765],
16	polymerase	NN	O	polymerase	nn	18	SENT_105	[p7l9t21r1170b120],
17	—	NN	O	—	nn	18	SENT_105	[p7l9t21r1170b120],
18	chain	NN	O	chain	prep_of	14	SENT_105	[p7l9t21r1170b120],
19	—	CD	NUMBER	—	num	20	SENT_105	[p7l9t21r1170b120],
20	reaction	NN	O	reaction	dep	18	SENT_105	[p7l9t21r1170b120],
21	(	CD	NUMBER	(	num	24	SENT_105	[p7l1206t26r1448b111],
22	PCR	NN	O	pcr	nn	24	SENT_105	[p7l1206t26r1448b111],
23	)	NN	O	)	nn	24	SENT_105	[p7l1206t26r1448b111],
24	assays	NNS	O	assay	dep	20	SENT_105	[p7l1483t46r1749b120],
25	with	IN	O	with	_	0	SENT_105	[p7l1779t21r1971b100],
26	the	DT	O	the	det	27	SENT_105	[p7l2002t21r2134b98],
27	use	NN	O	use	prep_with	11	SENT_105	[p7l10t175r151b228],
28	of	IN	O	of	_	0	SENT_105	[p7l196t148r298b227],
29	AmpliTaq	NNP	ORGANIZATION	AmpliTaq	nn	34	SENT_105	[p7l317t149r735b249],
30	Gold	NNP	ORGANIZATION	Gold	nn	34	SENT_105	[p7l775t149r984b227],
31	(	NNP	O	(	nn	34	SENT_105	[p7l1029t149r1388b249],
32	Applied	NNP	O	Applied	nn	34	SENT_105	[p7l1029t149r1388b249],
33	Biosystems	NNP	O	Biosystems	nn	34	SENT_105	[p7l1427t149r1934b249],
34	)	NN	O	)	prep_of	27	SENT_105	[p7l1427t149r1934b249],
35	and	CC	O	and	_	0	SENT_105	[p7l1980t149r2135b227],
36	external	JJ	O	external	amod	40	SENT_105	[p7l11t277r346b354],
37	and	CC	O	and	_	0	SENT_105	[p7l373t277r529b354],
38	internal	JJ	O	internal	amod	40	SENT_105	[p7l557t277r885b354],
39	primer	NN	O	primer	nn	40	SENT_105	[p7l911t277r1202b376],
40	sets	NNS	O	set	prep_with	11	SENT_105	[p7l1229t292r1384b354],
41	designed	VBN	O	design	partmod	40	SENT_105	[p7l1416t277r1796b376],
42	by	IN	O	by	_	0	SENT_105	[p7l1825t277r1922b376],
43	Paez	NNP	PERSON	Paez	agent	41	SENT_105	[p7l1944t283r2135b354],
44	et	FW	O	et	nn	45	SENT_105	[p7l11t422r88b484],
45	al.	FW	O	al.	tmod	41	SENT_105	[p7l120t401r301b484],
46	2	CD	NUMBER	2	number	47	SENT_105	[p7l120t401r301b484],
47	°	CD	NUMBER	°	num	50	SENT_105	[p7l120t401r301b484],
48	Puriﬁed	NNP	O	Puriﬁed	nn	50	SENT_105	[p7l337t405r671b485],
49	PCR	NN	O	pcr	nn	50	SENT_105	[p7l706t411r898b489],
50	products	NNS	O	product	nsubjpass	52	SENT_105	[p7l924t406r1296b506],
51	were	VBD	O	be	auxpass	52	SENT_105	[p7l1332t432r1534b485],
52	sequenced	VBN	O	sequence	rcmod	45	SENT_105	[p7l1573t406r2016b506],
53	in	IN	O	in	_	0	SENT_105	[p7l2054t406r2135b483],
54	both	CC	O	both	preconj	55	SENT_105	[p7l11t533r204b612],
55	directions	NNS	O	direction	prep_in	52	SENT_105	[p7l237t534r655b612],
56	with	IN	O	with	_	0	SENT_105	[p7l686t534r876b613],
57	the	DT	O	the	det	58	SENT_105	[p7l909t534r1037b612],
58	use	NN	O	use	prep_with	55	SENT_105	[p7l1071t560r1210b613],
59	of	IN	O	of	_	0	SENT_105	[p7l1244t533r1344b612],
60	the	DT	O	the	det	67	SENT_105	[p7l1359t534r1488b612],
61	BigDye	NNP	O	BigDye	nn	67	SENT_105	[p7l1520t534r1820b634],
62	Terminator	NNP	O	Terminator	nn	67	SENT_105	[p7l1851t534r2134b612, p7l10t678r236b739],
63	Cycle	NNP	O	Cycle	nn	67	SENT_105	[p7l273t662r494b761],
64	Sequencing	NN	O	sequencing	nn	67	SENT_105	[p7l537t662r1030b761],
65	Kit	NN	O	kit	nn	67	SENT_105	[p7l1066t662r1193b742],
66	(	CD	NUMBER	(	num	67	SENT_105	[p7l1233t662r1567b752],
67	version	NN	O	version	prep_of	58	SENT_105	[p7l1233t662r1567b752],
68	3.1	CD	NUMBER	3.1	dep	55	SENT_105	[p7l1608t667r1761b756],
69	,	,	O	,	_	0	SENT_105	[p7l1608t667r1761b756],
70	Applied	NNP	O	Applied	nn	72	SENT_105	[p7l1803t662r2135b761],
71	Biosystems	NNP	O	Biosystems	nn	72	SENT_105	[p7l9t790r515b890],
72	)	NN	O	)	dep	55	SENT_105	[p7l9t790r515b890],
73	and	CC	O	and	_	0	SENT_105	[p7l556t790r712b868],
74	an	DT	O	a	det	77	SENT_105	[p7l747t815r847b868],
75	ABI	NNP	MISC	ABI	nn	77	SENT_105	[p7l879t796r1037b868],
76	Genetic	NNP	MISC	Genetic	nn	77	SENT_105	[p7l1073t790r1398b868],
77	Analyzer	NNP	MISC	Analyzer	conj_and	72	SENT_105	[p7l1429t790r1801b890],
78	(	CD	NUMBER	(	num	77	SENT_105	[p7l1839t790r2135b881],
79	model	NN	O	model	dep	77	SENT_105	[p7l1839t790r2135b881],
80	3100	CD	NUMBER	3100	num	79	SENT_105	[p7l11t923r237b1013],
81	,	,	O	,	_	0	SENT_105	[p7l11t923r237b1013],
82	Applied	NNP	O	Applied	nn	84	SENT_105	[p7l264t918r591b1018],
83	Biosystems	NNP	O	Biosystems	nn	84	SENT_105	[p7l613t918r1139b1018],
84	)	NN	O	)	dep	55	SENT_105	[p7l613t918r1139b1018],
85	.	.	O	.	_	0	SENT_105	[p7l613t918r1139b1018],

1	Sequence	NN	O	sequence	nn	2	SENT_106	[p7l1171t923r1560b1018],
2	data	NNS	O	datum	nsubjpass	4	SENT_106	[p7l1585t918r1762b996],
3	were	VBD	O	be	auxpass	4	SENT_106	[p7l1780t944r1979b997],
4	analyzed	VBN	O	analyze	_	0	SENT_106	[p7l2003t943r2134b996, p7l10t1046r277b1146],
5	by	IN	O	by	_	0	SENT_106	[p7l325t1046r423b1146],
6	means	NNS	O	means	_	0	SENT_106	[p7l465t1071r743b1124],
7	of	IN	O	of	_	0	SENT_106	[p7l793t1045r895b1124],
8	SeqScape	NN	O	seqscape	nn	9	SENT_106	[p7l925t1051r1325b1146],
9	software	NN	O	software	prep_by_means_of	4	SENT_106	[p7l1374t1045r1740b1125],
10	(	CD	NUMBER	(	num	9	SENT_106	[p7l1792t1046r2134b1137],
11	version	NN	O	version	tmod	4	SENT_106	[p7l1792t1046r2134b1137],
12	2.1.1	CD	NUMBER	2.1.1	num	11	SENT_106	[p7l10t1179r244b1269],
13	,	,	O	,	_	0	SENT_106	[p7l10t1179r244b1269],
14	Applied	NNP	ORGANIZATION	Applied	nn	16	SENT_106	[p7l272t1174r598b1274],
15	Biosystems	NNP	ORGANIZATION	Biosystems	nn	16	SENT_106	[p7l623t1174r1149b1274],
16	)	NN	O	)	appos	11	SENT_106	[p7l623t1174r1149b1274],
17	,	,	O	,	_	0	SENT_106	[p7l623t1174r1149b1274],
18	followed	VBN	O	follow	partmod	16	SENT_106	[p7l1180t1173r1542b1253],
19	by	IN	O	by	_	0	SENT_106	[p7l1568t1174r1664b1274],
20	manual	JJ	O	manual	amod	21	SENT_106	[p7l1686t1174r1999b1253],
21	review	NN	O	review	agent	18	SENT_106	[p7l2025t1200r2134b1252, p7l6t1302r210b1380],
22	.	.	O	.	_	0	SENT_106	[p7l2025t1200r2134b1252, p7l6t1302r210b1380],

1	Only	RB	O	only	advmod	3	SENT_107	[p7l251t1302r456b1401],
2	sequence	NN	O	sequence	nn	3	SENT_107	[p7l488t1327r883b1401],
3	variations	NNS	O	variation	nsubjpass	20	SENT_107	[p7l915t1302r1339b1380],
4	that	WDT	O	that	nsubj	6	SENT_107	[p7l1377t1302r1547b1379],
5	were	VBD	O	be	cop	6	SENT_107	[p7l1573t1327r1779b1381],
6	present	JJ	DATE	present	rcmod	3	SENT_107	[p7l1813t1317r2139b1401],
7	in	IN	O	in	prep	6	SENT_107	[p7l10t1430r92b1507],
8	both	CC	O	both	dep	7	SENT_107	[p7l118t1430r314b1508],
9	directions	NNS	O	direction	conj	7	SENT_107	[p7l341t1430r761b1508],
10	in	IN	O	in	_	0	SENT_107	[p7l786t1430r867b1507],
11	more	JJR	O	more	mwe	12	SENT_107	[p7l891t1455r1111b1508],
12	than	IN	O	than	quantmod	13	SENT_107	[p7l1135t1430r1322b1508],
13	15	CD	PERCENT	15	num	14	SENT_107	[p7l1350t1435r1444b1508],
14	percent	NN	PERCENT	percent	prep_in	7	SENT_107	[p7l1469t1446r1790b1530],
15	of	IN	O	of	_	0	SENT_107	[p7l1810t1429r1909b1508],
16	spec	JJ	O	spec	amod	18	SENT_107	[p7l1917t1456r2134b1530],
17	—	NN	O	—	nn	18	SENT_107	[p7l1917t1456r2134b1530],
18	imens	NNS	O	imen	prep_of	14	SENT_107	[p7l10t1558r260b1636],
19	were	VBD	O	be	auxpass	20	SENT_107	[p7l277t1584r475b1637],
20	included	VBN	O	include	_	0	SENT_107	[p7l494t1558r851b1637],
21	in	IN	O	in	_	0	SENT_107	[p7l869t1558r949b1635],
22	the	DT	O	the	det	23	SENT_107	[p7l968t1558r1095b1636],
23	analysis	NN	O	analysis	prep_in	20	SENT_107	[p7l1114t1558r1460b1658],
24	.	.	O	.	_	0	SENT_107	[p7l1114t1558r1460b1658],

1	When	WRB	O	when	advmod	5	SENT_108	[p7l1482t1558r1732b1636],
2	sufficient	JJ	O	sufficient	amod	3	SENT_108	[p7l1753t1557r2140b1637],
3	material	NN	O	material	nsubj	5	SENT_108	[p7l10t1686r352b1764],
4	was	VBD	O	be	cop	5	SENT_108	[p7l371t1712r530b1765],
5	available	JJ	O	available	advcl	12	SENT_108	[p7l555t1686r935b1781],
6	,	,	O	,	_	0	SENT_108	[p7l555t1686r935b1781],
7	a	DT	DURATION	a	det	10	SENT_108	[p7l964t1712r1009b1764],
8	second	JJ	DURATION	second	amod	10	SENT_108	[p7l1033t1686r1324b1764],
9	PCR	NN	O	pcr	nn	10	SENT_108	[p7l1346t1691r1535b1769],
10	assay	NN	O	assay	nsubjpass	12	SENT_108	[p7l1549t1712r1769b1786],
11	was	VBD	O	be	auxpass	12	SENT_108	[p7l1784t1712r1943b1765],
12	performed	VBN	O	perform	_	0	SENT_108	[p7l1968t1712r2134b1786, p7l10t1814r339b1893],
13	.	.	O	.	_	0	SENT_108	[p7l1968t1712r2134b1786, p7l10t1814r339b1893],

1	Fluorescence	NN	O	fluorescence	nsubjpass	10	SENT_109	[p7l138t1943r686b2022],
2	in	FW	O	in	nn	3	SENT_109	[p7l720t1943r801b2020],
3	situ	FW	O	situ	advmod	4	SENT_109	[p7l836t1943r986b2022],
4	hybridization	NN	O	hybridization	rcmod	1	SENT_109	[p7l1020t1943r1578b2043],
5	(	CD	NUMBER	(	num	8	SENT_109	[p7l1616t1948r1884b2034],
6	FISH	NN	O	fish	nn	8	SENT_109	[p7l1616t1948r1884b2034],
7	)	NN	O	)	nn	8	SENT_109	[p7l1616t1948r1884b2034],
8	studies	NNS	O	study	dep	4	SENT_109	[p7l1925t1943r2134b2022, p7l10t2071r121b2149],
9	were	VBD	O	be	auxpass	10	SENT_109	[p7l142t2097r343b2150],
10	performed	VBN	O	perform	_	0	SENT_109	[p7l366t2070r815b2171],
11	with	IN	O	with	_	0	SENT_109	[p7l834t2071r1023b2150],
12	the	DT	O	the	det	13	SENT_109	[p7l1047t2071r1177b2149],
13	use	NN	O	use	prep_with	10	SENT_109	[p7l1201t2097r1340b2150],
14	of	IN	O	of	_	0	SENT_109	[p7l1365t2070r1465b2149],
15	dual	JJ	O	dual	amod	20	SENT_109	[p7l1471t2071r1907b2150],
16	—	NN	O	—	nn	20	SENT_109	[p7l1471t2071r1907b2150],
17	color	NN	O	color	nn	20	SENT_109	[p7l1471t2071r1907b2150],
18	DNA	NN	MISC	dna	nn	20	SENT_109	[p7l1926t2077r2138b2149],
19	FISH	NN	O	fish	nn	20	SENT_109	[p7l9t2204r219b2276],
20	probes	NNS	O	probe	prep_of	13	SENT_109	[p7l240t2199r525b2298],
21	containing	VBG	O	contain	xcomp	10	SENT_109	[p7l549t2199r1005b2298],
22	the	DT	O	the	det	28	SENT_109	[p7l1024t2199r1152b2276],
23	LS1	NN	O	ls1	nn	28	SENT_109	[p7l1172t2204r1307b2276],
24	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_109	[p7l1326t2204r1584b2281],
25	(	CD	NUMBER	(	num	28	SENT_109	[p7l1600t2199r1866b2298],
26	Vysis	NNP	ORGANIZATION	Vysis	nn	28	SENT_109	[p7l1600t2199r1866b2298],
27	)	NN	O	)	nn	28	SENT_109	[p7l1600t2199r1866b2298],
28	probe	NN	O	probe	nsubj	29	SENT_109	[p7l1892t2199r2135b2298],
29	specific	JJ	O	specific	xcomp	21	SENT_109	[p7l12t2326r339b2427],
30	for	IN	O	for	_	0	SENT_109	[p7l384t2326r510b2405],
31	the	DT	O	the	det	34	SENT_109	[p7l553t2327r685b2405],
32	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_109	[p7l728t2333r946b2406],
33	locus	NN	O	locus	nn	34	SENT_109	[p7l983t2327r1209b2406],
34	(	NN	O	(	prep_for	21	SENT_109	[p7l1261t2332r1538b2427],
35	7p12	CD	NUMBER	7p12	num	36	SENT_109	[p7l1261t2332r1538b2427],
36	)	CD	NUMBER	)	dobj	21	SENT_109	[p7l1261t2332r1538b2427],
37	labeled	VBN	O	label	partmod	36	SENT_109	[p7l1588t2327r1899b2405],
38	with	IN	O	with	_	0	SENT_109	[p7l1939t2327r2133b2406],
39	Spectrum	NN	O	spectrum	nn	43	SENT_109	[p7l12t2460r406b2555],
40	Orange	NNP	O	Orange	nn	43	SENT_109	[p7l428t2460r732b2555],
41	(	NNP	O	(	nn	43	SENT_109	[p7l758t2455r1020b2555],
42	Vysis	NNP	ORGANIZATION	Vysis	nn	43	SENT_109	[p7l758t2455r1020b2555],
43	)	NN	O	)	prep_with	37	SENT_109	[p7l758t2455r1020b2555],
44	and	CC	O	and	_	0	SENT_109	[p7l1046t2455r1199b2533],
45	the	DT	O	the	det	49	SENT_109	[p7l1220t2455r1347b2533],
46	CEP7	NN	O	cep7	nn	49	SENT_109	[p7l1368t2461r1567b2533],
47	chromosome	NN	O	chromosome	nn	49	SENT_109	[p7l1585t2455r2135b2533],
48	7	CD	NUMBER	7	num	49	SENT_109	[p7l11t2590r58b2661],
49	centromere	NN	O	centromere	dobj	21	SENT_109	[p7l81t2599r557b2661],
50	(	CD	NUMBER	(	num	52	SENT_109	[p7l584t2588r902b2683],
51	7p11	CD	NUMBER	7p11	num	52	SENT_109	[p7l584t2588r902b2683],
52	.1	NN	NUMBER	.1	dep	36	SENT_109	[p7l584t2588r902b2683],
53	through	IN	O	through	_	0	SENT_109	[p7l924t2583r1263b2683],
54	q11	NN	O	q11	nn	57	SENT_109	[p7l1284t2588r1548b2683],
55	.1	CD	NUMBER	.1	num	57	SENT_109	[p7l1284t2588r1548b2683],
56	)	NN	O	)	nn	57	SENT_109	[p7l1284t2588r1548b2683],
57	probe	NN	O	probe	prep_through	10	SENT_109	[p7l1574t2583r1816b2683],
58	labeled	VBN	O	label	partmod	57	SENT_109	[p7l1837t2583r2135b2661],
59	with	IN	O	with	_	0	SENT_109	[p7l6t2711r192b2790],
60	Spectrum	NNP	O	Spectrum	nn	64	SENT_109	[p7l215t2716r612b2810],
61	Green	NNP	O	Green	nn	64	SENT_109	[p7l633t2716r887b2788],
62	(	NNP	O	(	nn	64	SENT_109	[p7l913t2711r1205b2810],
63	Vysis	NNP	ORGANIZATION	Vysis	nn	64	SENT_109	[p7l913t2711r1205b2810],
64	)	NNP	O	)	prep_with	58	SENT_109	[p7l913t2711r1205b2810],
65	.	.	O	.	_	0	SENT_109	[p7l913t2711r1205b2810],

1	We	PRP	O	we	nsubj	2	SENT_110	[p7l1227t2717r1360b2788],
2	analyzed	VBD	O	analyze	_	0	SENT_110	[p7l1380t2711r1742b2810],
3	33	CD	NUMBER	33	number	5	SENT_110	[p7l1763t2716r1859b2788],
4	to	TO	O	to	dep	5	SENT_110	[p7l1883t2726r1961b2788],
5	100	CD	NUMBER	100	num	10	SENT_110	[p7l1987t2716r2135b2788],
6	nonoverlapping	JJ	O	nonoverlapping	amod	10	SENT_110	[p7l10t2839r685b2939],
7	tumor	NN	O	tumor	nn	10	SENT_110	[p7l706t2839r1147b2918],
8	—	NN	O	—	nn	10	SENT_110	[p7l706t2839r1147b2918],
9	cell	NN	O	cell	nn	10	SENT_110	[p7l706t2839r1147b2918],
10	nuclei	NNS	O	nucleus	dobj	2	SENT_110	[p7l1170t2839r1425b2918],
11	to	TO	O	to	aux	12	SENT_110	[p7l1448t2855r1527b2917],
12	determine	VB	O	determine	xcomp	2	SENT_110	[p7l1553t2839r1982b2917],
13	the	DT	O	the	det	14	SENT_110	[p7l2006t2839r2135b2917],
14	number	NN	O	number	dobj	12	SENT_110	[p7l10t2967r347b3046],
15	of	IN	O	of	_	0	SENT_110	[p7l370t2966r471b3045],
16	red	JJ	O	red	amod	19	SENT_110	[p7l478t2967r611b3045],
17	(	JJ	O	(	amod	19	SENT_110	[p7l642t2973r905b3058],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_110	[p7l642t2973r905b3058],
19	)	NN	O	)	prep_of	14	SENT_110	[p7l642t2973r905b3058],
20	and	CC	O	and	_	0	SENT_110	[p7l936t2967r1091b3045],
21	green	JJ	O	green	amod	25	SENT_110	[p7l1117t2992r1353b3067],
22	(	NN	O	(	nn	25	SENT_110	[p7l1384t2973r1642b3058],
23	CEP7	NN	O	cep7	nn	25	SENT_110	[p7l1384t2973r1642b3058],
24	)	NN	O	)	nn	25	SENT_110	[p7l1384t2973r1642b3058],
25	signals	NNS	O	signal	prep_of	14	SENT_110	[p7l1674t2967r1967b3067],
26	observed	VBN	O	observe	partmod	25	SENT_110	[p7l1996t2967r2133b3045, p7l12t3094r276b3174],
27	as	RB	O	as	_	0	SENT_110	[p7l305t3121r389b3173],
28	well	RB	O	well	_	0	SENT_110	[p7l416t3095r592b3174],
29	as	IN	O	as	_	0	SENT_110	[p7l620t3121r704b3173],
30	the	DT	O	the	det	31	SENT_110	[p7l736t3095r865b3173],
31	pattern	NN	O	pattern	conj_and	14	SENT_110	[p7l894t3111r1197b3195],
32	of	IN	O	of	_	0	SENT_110	[p7l1227t3094r1327b3173],
33	distribution	NN	O	distribution	prep_of	31	SENT_110	[p7l1340t3095r1838b3174],
34	of	IN	O	of	_	0	SENT_110	[p7l1868t3094r1969b3173],
35	signals	NNS	O	signal	prep_of	33	SENT_110	[p7l1981t3095r2134b3195, p7l10t3223r205b3301],
36	.	.	O	.	_	0	SENT_110	[p7l1981t3095r2134b3195, p7l10t3223r205b3301],

1	We	PRP	O	we	nsubj	11	SENT_111	[p7l237t3230r370b3301],
2	also	RB	O	also	advmod	3	SENT_111	[p7l401t3223r568b3301],
3	determined	VBD	O	determine	_	0	SENT_111	[p7l601t3222r1085b3301],
4	the	DT	O	the	det	5	SENT_111	[p7l1117t3223r1245b3301],
5	number	NN	O	number	dobj	3	SENT_111	[p7l1276t3223r1613b3302],
6	of	IN	O	of	_	0	SENT_111	[p7l1641t3222r1742b3301],
7	copies	NNS	O	copy	prep_of	5	SENT_111	[p7l1754t3223r2019b3323],
8	of	IN	O	of	_	0	SENT_111	[p7l2053t3222r2153b3301],
9	EGFR	NN	ORGANIZATION	egfr	prep_of	7	SENT_111	[p7l9t3357r221b3430],
10	and	CC	O	and	_	0	SENT_111	[p7l239t3350r395b3429],
11	classiﬁed	VBD	O	classiﬁed	conj_and	3	SENT_111	[p7l421t3350r812b3429],
12	them	PRP	O	they	dobj	11	SENT_111	[p7l838t3351r1054b3429],
13	according	VBG	O	accord	_	0	SENT_111	[p7l1079t3351r1502b3451],
14	to	TO	O	to	prepc_according_to	11	SENT_111	[p7l1524t3367r1603b3429],
15	the	DT	O	the	det	18	SENT_111	[p7l1630t3351r1760b3429],
16	six	CD	NUMBER	six	num	18	SENT_111	[p7l1786t3351r1902b3429],
17	FISH	NN	O	fish	nn	18	SENT_111	[p7l1922t3356r2134b3429],
18	categories	NNS	O	category	pobj	11	SENT_111	[p7l11t3480r445b3580],
19	deﬁned	VBN	O	deﬁned	partmod	18	SENT_111	[p7l485t3479r806b3558],
20	by	IN	O	by	_	0	SENT_111	[p7l844t3480r942b3580],
21	Cappuzzo	NNP	PERSON	Cappuzzo	agent	19	SENT_111	[p7l973t3485r1404b3580],
22	et	FW	O	et	nn	23	SENT_111	[p7l1442t3496r1520b3558],
23	al.	FW	O	al.	dobj	3	SENT_111	[p7l1551t3475r1735b3558],
24	22	CD	NUMBER	22	num	25	SENT_111	[p7l1551t3475r1735b3558],
25	Samples	NNS	O	sample	nsubjpass	42	SENT_111	[p7l1774t3480r2131b3580],
26	with	IN	O	with	_	0	SENT_111	[p7l6t3608r195b3687],
27	a	DT	O	a	det	29	SENT_111	[p7l216t3634r261b3686],
28	high	JJ	O	high	amod	29	SENT_111	[p7l282t3608r472b3708],
29	number	NN	O	number	prep_with	25	SENT_111	[p7l495t3608r828b3687],
30	of	IN	O	of	_	0	SENT_111	[p7l848t3607r948b3686],
31	copies	NNS	O	copy	prep_of	29	SENT_111	[p7l953t3608r1215b3708],
32	of	IN	O	of	_	0	SENT_111	[p7l1240t3607r1340b3686],
33	EGFR	NN	ORGANIZATION	egfr	prep_of	31	SENT_111	[p7l1341t3614r1552b3687],
34	(	CD	NUMBER	(	num	36	SENT_111	[p7l1573t3608r1793b3708],
35	high	JJ	O	high	amod	36	SENT_111	[p7l1573t3608r1793b3708],
36	degrees	NNS	O	degree	dep	33	SENT_111	[p7l1816t3608r2133b3708],
37	ofpolysomy	NN	O	ofpolysomy	nn	40	SENT_111	[p8l11t20r539b121],
38	or	CC	O	or	_	0	SENT_111	[p8l563t46r654b99],
39	ampliﬁcation	NN	O	ampliﬁcation	conj_or	37	SENT_111	[p8l678t20r1287b121],
40	)	NN	O	)	dep	36	SENT_111	[p8l678t20r1287b121],
41	were	VBD	O	be	auxpass	42	SENT_111	[p8l1317t47r1522b100],
42	considered	VBN	O	consider	rcmod	23	SENT_111	[p8l1552t20r2024b99],
43	to	TO	O	to	aux	47	SENT_111	[p8l2052t37r2133b99],
44	be	VB	O	be	cop	47	SENT_111	[p8l11t149r107b226],
45	FISH	NN	O	fish	nn	47	SENT_111	[p8l134t149r733b248],
46	—	CD	NUMBER	—	num	47	SENT_111	[p8l134t149r733b248],
47	positiVe	NN	O	positive	xcomp	42	SENT_111	[p8l134t149r733b248],
48	.	.	O	.	_	0	SENT_111	[p8l134t149r733b248],

1	STATISTICAL	JJ	O	statistical	amod	4	SENT_112	[p8l11t432r525b481],
2	ANALYSIS	NN	O	analysis	nn	4	SENT_112	[p8l561t432r962b481],
3	Exploratory	NN	O	exploratory	nn	4	SENT_112	[p8l9t533r513b633],
4	analyses	NNS	O	analysis	nsubjpass	6	SENT_112	[p8l550t533r907b633],
5	were	VBD	O	be	auxpass	6	SENT_112	[p8l947t559r1152b612],
6	performed	VBN	O	perform	_	0	SENT_112	[p8l1194t532r1651b633],
7	to	TO	O	to	aux	8	SENT_112	[p8l1695t549r1775b611],
8	characterize	VB	O	characterize	xcomp	6	SENT_112	[p8l1820t533r2132b611, p8l11t661r246b739],
9	the	DT	O	the	det	10	SENT_112	[p8l283t661r414b739],
10	relationships	NNS	O	relationship	dobj	8	SENT_112	[p8l450t660r1000b761],
11	between	IN	O	between	_	0	SENT_112	[p8l1036t661r1385b740],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_112	[p8l1416t666r1676b744],
13	status	NN	O	status	prep_between	10	SENT_112	[p8l1700t677r1945b740],
14	and	CC	O	and	_	0	SENT_112	[p8l1979t661r2135b739],
15	baseline	NN	O	baseline	nn	17	SENT_112	[p8l11t789r356b867],
16	clinical	JJ	O	clinical	amod	17	SENT_112	[p8l381t789r682b867],
17	characteristics	NNS	O	characteristic	prep_between	10	SENT_112	[p8l705t788r1310b867],
18	and	CC	O	and	_	0	SENT_112	[p8l1335t789r1491b867],
19	outcomes	NNS	O	outcome	conj_and	13	SENT_112	[p8l1515t805r1925b868],
20	With	IN	O	with	_	0	SENT_112	[p8l1946t789r2135b868],
21	the	DT	O	the	det	22	SENT_112	[p8l11t917r139b995],
22	use	NN	O	use	prep_with	8	SENT_112	[p8l166t943r305b996],
23	of	IN	O	of	_	0	SENT_112	[p8l332t916r432b995],
24	the	DT	O	the	det	27	SENT_112	[p8l440t917r569b995],
25	chi	NN	O	chus	nn	27	SENT_112	[p8l596t916r1038b1017],
26	—	NN	O	—	nn	27	SENT_112	[p8l596t916r1038b1017],
27	square	NN	O	square	prep_of	22	SENT_112	[p8l596t916r1038b1017],
28	or	CC	O	or	_	0	SENT_112	[p8l1065t942r1155b995],
29	Fisher	NNP	PERSON	Fisher	poss	32	SENT_112	[p8l1176t917r1507b995],
30	’s	POS	O	’s	_	0	SENT_112	[p8l1176t917r1507b995],
31	exact	JJ	O	exact	amod	32	SENT_112	[p8l1535t933r1751b995],
32	test	NN	O	test	conj_or	22	SENT_112	[p8l1772t933r1942b995],
33	.	.	O	.	_	0	SENT_112	[p8l1772t933r1942b995],

1	Cox	NN	O	cox	nn	3	SENT_113	[p8l1973t922r2138b995],
2	regression	NN	O	regression	nn	3	SENT_113	[p8l10t1045r449b1145],
3	models	NNS	O	model	nsubjpass	5	SENT_113	[p8l471t1045r775b1123],
4	were	VBD	O	be	auxpass	5	SENT_113	[p8l797t1071r997b1124],
5	used	VBN	O	use	_	0	SENT_113	[p8l1020t1045r1214b1124],
6	to	TO	O	to	aux	7	SENT_113	[p8l1237t1061r1315b1123],
7	correlate	VB	O	correlate	xcomp	5	SENT_113	[p8l1340t1045r1702b1123],
8	outcomes	NNS	O	outcome	dobj	7	SENT_113	[p8l1726t1061r2131b1124],
9	according	VBG	O	accord	_	0	SENT_113	[p8l10t1172r449b1273],
10	to	TO	O	to	prepc_according_to	7	SENT_113	[p8l485t1189r566b1251],
11	the	DT	O	the	det	12	SENT_113	[p8l607t1173r741b1251],
12	time	NN	O	time	pobj	7	SENT_113	[p8l781t1173r974b1251],
13	to	TO	O	to	_	0	SENT_113	[p8l1015t1189r1095b1251],
14	an	DT	O	a	det	15	SENT_113	[p8l1136t1198r1238b1251],
15	event	NN	O	event	prep_to	12	SENT_113	[p8l1278t1189r1530b1268],
16	,	,	O	,	_	0	SENT_113	[p8l1278t1189r1530b1268],
17	and	CC	O	and	_	0	SENT_113	[p8l1575t1173r1735b1251],
18	logisticregression	NN	O	logisticregression	nn	19	SENT_113	[p8l1773t1173r2131b1273, p8l10t1301r463b1400],
19	models	NNS	O	model	nsubjpass	21	SENT_113	[p8l490t1301r793b1378],
20	were	VBD	O	be	auxpass	21	SENT_113	[p8l818t1326r1018b1379],
21	used	VBN	O	use	conj_and	5	SENT_113	[p8l1045t1301r1237b1379],
22	to	TO	O	to	aux	23	SENT_113	[p8l1264t1316r1343b1378],
23	correlate	VB	O	correlate	xcomp	21	SENT_113	[p8l1372t1301r1731b1378],
24	response	NN	O	response	dobj	23	SENT_113	[p8l1758t1325r2134b1400],
25	to	TO	O	to	_	0	SENT_113	[p8l11t1445r91b1507],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_113	[p8l116t1434r379b1512],
27	status	NN	O	status	prep_to	23	SENT_113	[p8l395t1445r646b1508],
28	and	CC	O	and	_	0	SENT_113	[p8l673t1429r831b1507],
29	other	JJ	O	other	amod	31	SENT_113	[p8l857t1429r1085b1507],
30	baseline	NN	O	baseline	nn	31	SENT_113	[p8l1108t1428r1460b1507],
31	factors	NNS	O	factor	prep_to	23	SENT_113	[p8l1486t1428r1804b1507],
32	.	.	O	.	_	0	SENT_113	[p8l1486t1428r1804b1507],

1	All	DT	O	all	det	4	SENT_114	[p8l1831t1429r1953b1506],
2	731	CD	NUMBER	731	num	4	SENT_114	[p8l1979t1434r2134b1507],
3	randomized	JJ	O	randomized	amod	4	SENT_114	[p8l10t1557r538b1635],
4	patients	NNS	O	patient	nsubjpass	6	SENT_114	[p8l586t1557r934b1657],
5	were	VBD	O	be	auxpass	6	SENT_114	[p8l982t1583r1189b1636],
6	included	VBN	O	include	_	0	SENT_114	[p8l1239t1556r1618b1636],
7	in	IN	O	in	_	0	SENT_114	[p8l1668t1557r1751b1634],
8	survival	NN	O	survival	nn	9	SENT_114	[p8l1802t1557r2134b1636],
9	analyses	NNS	O	analysis	prep_in	6	SENT_114	[p8l10t1685r399b1785],
10	,	,	O	,	_	0	SENT_114	[p8l10t1685r399b1785],
11	and	CC	O	and	_	0	SENT_114	[p8l430t1685r586b1763],
12	all	DT	O	all	det	14	SENT_114	[p8l607t1685r706b1763],
13	427	CD	NUMBER	427	num	14	SENT_114	[p8l726t1690r881b1763],
14	patients	NNS	O	patient	nsubjpass	24	SENT_114	[p8l903t1685r1237b1785],
15	with	IN	O	with	_	0	SENT_114	[p8l1258t1685r1447b1764],
16	measurable	JJ	O	measurable	amod	17	SENT_114	[p8l1469t1685r1956b1764],
17	disease	NN	O	disease	prep_with	14	SENT_114	[p8l1980t1685r2134b1763, p8l11t1839r189b1891],
18	Who	WP	O	who	nsubjpass	20	SENT_114	[p8l215t1813r400b1892],
19	were	VBD	O	be	auxpass	20	SENT_114	[p8l426t1839r631b1892],
20	treated	VBN	O	treat	rcmod	17	SENT_114	[p8l660t1812r956b1891],
21	With	IN	O	with	_	0	SENT_114	[p8l980t1812r1173b1892],
22	erlotinib	NN	O	erlotinib	prep_with	20	SENT_114	[p8l1202t1813r1570b1891],
23	were	VBD	O	be	auxpass	24	SENT_114	[p8l1595t1839r1800b1892],
24	included	VBN	O	include	conj_and	6	SENT_114	[p8l1829t1813r2133b1892, p8l11t1941r108b2019],
25	in	IN	O	in	_	0	SENT_114	[p8l137t1941r219b2018],
26	analyses	NNS	O	analysis	prep_in	24	SENT_114	[p8l249t1941r605b2041],
27	of	IN	O	of	_	0	SENT_114	[p8l638t1940r740b2019],
28	the	DT	O	the	det	29	SENT_114	[p8l752t1941r883b2019],
29	response	NN	O	response	prep_of	26	SENT_114	[p8l914t1966r1325b2041],
30	.	.	O	.	_	0	SENT_114	[p8l914t1966r1325b2041],

1	All	DT	O	all	nsubj	2	SENT_115	[p8l1357t1941r1478b2018],
2	reported	VBD	O	report	_	0	SENT_115	[p8l1508t1941r1874b2041],
3	P	NN	O	p	nn	4	SENT_115	[p8l1904t1947r1955b2018],
4	values	NNS	O	value	nsubj	7	SENT_115	[p8l1979t1941r2133b2020, p8l10t2095r149b2148],
5	are	VBP	O	be	cop	7	SENT_115	[p8l179t2095r307b2147],
6	tWo	CD	NUMBER	two	number	7	SENT_115	[p8l335t2069r774b2148],
7	—	CD	NUMBER	—	ccomp	2	SENT_115	[p8l335t2069r774b2148],
8	sided	VBD	O	side	rcmod	7	SENT_115	[p8l335t2069r774b2148],
9	.	.	O	.	_	0	SENT_115	[p8l335t2069r774b2148],

1	RESULTS	NNS	O	result	_	0	SENT_116	[p8l828t2406r1306b2464],

1	PATIENTS	NNS	O	patient	npadvmod	12	SENT_117	[p8l16t2584r407b2633],
2	Between	IN	O	between	_	0	SENT_117	[p8l9t2691r372b2764],
3	August	NNP	DATE	August	prep_between	12	SENT_117	[p8l402t2692r715b2785],
4	2001	CD	DATE	2001	num	3	SENT_117	[p8l744t2690r953b2763],
5	and	CC	O	and	_	0	SENT_117	[p8l988t2685r1146b2763],
6	January	NNP	DATE	January	conj_and	3	SENT_117	[p8l1171t2692r1503b2785],
7	2003	CD	DATE	2003	num	6	SENT_117	[p8l1533t2690r1768b2780],
8	,	,	O	,	_	0	SENT_117	[p8l1533t2690r1768b2780],
9	731	CD	NUMBER	731	num	6	SENT_117	[p8l1810t2690r1964b2763],
10	patients	NNS	O	patient	nsubjpass	12	SENT_117	[p8l1998t2711r2132b2785, p8l11t2813r246b2891],
11	Were	VBD	O	be	auxpass	12	SENT_117	[p8l277t2839r482b2892],
12	enrolled	VBN	O	enrol	_	0	SENT_117	[p8l515t2812r887b2891],
13	:	:	O	:	_	0	SENT_117	[p8l515t2812r887b2891],
14	488	CD	NUMBER	488	nsubjpass	16	SENT_117	[p8l921t2818r1074b2891],
15	were	VBD	O	be	auxpass	16	SENT_117	[p8l1103t2839r1304b2892],
16	assigned	VBN	O	assign	parataxis	12	SENT_117	[p8l1335t2813r1706b2913],
17	to	TO	O	to	aux	18	SENT_117	[p8l1737t2829r1816b2891],
18	receive	VB	O	receive	ccomp	16	SENT_117	[p8l1849t2813r2134b2891],
19	erlotinib	NN	O	erlotinib	dobj	18	SENT_117	[p8l11t2940r394b3036],
20	,	,	O	,	_	0	SENT_117	[p8l11t2940r394b3036],
21	and	CC	O	and	_	0	SENT_117	[p8l425t2941r581b3019],
22	243	CD	NUMBER	243	advmod	18	SENT_117	[p8l606t2946r757b3019],
23	to	TO	O	to	aux	24	SENT_117	[p8l787t2957r866b3019],
24	receive	VB	O	receive	ccomp	16	SENT_117	[p8l893t2941r1179b3019],
25	placebo	NN	O	placebo	dobj	24	SENT_117	[p8l1203t2941r1555b3041],
26	.	.	O	.	_	0	SENT_117	[p8l1203t2941r1555b3041],

1	Biopsy	NN	O	biopsy	nn	2	SENT_118	[p8l1585t2941r1872b3041],
2	tissue	NN	O	tissue	nsubj	4	SENT_118	[p8l1893t2941r2135b3020],
3	was	VBD	O	be	cop	4	SENT_118	[p8l6t3095r166b3148],
4	available	JJ	O	available	_	0	SENT_118	[p8l203t3068r567b3148],
5	from	IN	O	from	_	0	SENT_118	[p8l602t3068r809b3147],
6	532	CD	NUMBER	532	num	7	SENT_118	[p8l846t3074r996b3147],
7	patients	NNS	O	patient	prep_from	4	SENT_118	[p8l1030t3069r1391b3169],
8	,	,	O	,	_	0	SENT_118	[p8l1030t3069r1391b3169],
9	but	CC	O	but	_	0	SENT_118	[p8l1432t3069r1573b3148],
10	only	RB	O	only	quantmod	11	SENT_118	[p8l1602t3069r1784b3169],
11	472	CD	NUMBER	472	num	12	SENT_118	[p8l1812t3074r1966b3147],
12	patients	NNS	O	patient	nsubj	26	SENT_118	[p8l2001t3095r2134b3169, p8l11t3197r240b3275],
13	(	IN	O	(	_	0	SENT_118	[p8l287t3202r468b3288],
14	313	CD	NUMBER	313	prep_(	12	SENT_118	[p8l287t3202r468b3288],
15	in	IN	O	in	_	0	SENT_118	[p8l511t3197r592b3274],
16	the	DT	O	the	det	18	SENT_118	[p8l633t3197r761b3275],
17	erlotinib	JJ	O	erlotinib	amod	18	SENT_118	[p8l803t3197r1161b3275],
18	group	NN	O	group	prep_in	14	SENT_118	[p8l1202t3222r1454b3297],
19	and	CC	O	and	_	0	SENT_118	[p8l1495t3197r1650b3275],
20	159	CD	NUMBER	159	prep_(	12	SENT_118	[p8l1694t3202r1843b3275],
21	in	IN	O	in	_	0	SENT_118	[p8l1884t3197r1965b3274],
22	the	DT	O	the	det	24	SENT_118	[p8l2006t3197r2135b3275],
23	placebo	NN	O	placebo	nn	24	SENT_118	[p8l9t3324r335b3425],
24	group	NN	O	group	prep_in	20	SENT_118	[p8l364t3332r645b3425],
25	)	CD	NUMBER	)	dep	20	SENT_118	[p8l364t3332r645b3425],
26	consented	VBD	O	consent	conj_but	4	SENT_118	[p8l678t3325r1109b3403],
27	to	TO	O	to	_	0	SENT_118	[p8l1136t3341r1215b3403],
28	tissue	NN	O	tissue	nn	29	SENT_118	[p8l1244t3325r1485b3404],
29	banking	NN	O	banking	prep_to	26	SENT_118	[p8l1513t3325r1884b3425],
30	.	.	O	.	_	0	SENT_118	[p8l1513t3325r1884b3425],

1	A	DT	O	a	det	3	SENT_119	[p8l1913t3332r1979b3402],
2	tissue	NN	O	tissue	nn	3	SENT_119	[p8l2003t3325r2134b3403, p8l12t3479r149b3532],
3	sample	NN	O	sample	nsubj	11	SENT_119	[p8l186t3453r486b3553],
4	adequate	JJ	O	adequate	amod	3	SENT_119	[p8l521t3452r899b3553],
5	for	IN	O	for	_	0	SENT_119	[p8l934t3452r1057b3531],
6	at	IN	O	at	quantmod	8	SENT_119	[p8l1088t3469r1167b3531],
7	least	JJS	O	least	mwe	6	SENT_119	[p8l1195t3453r1392b3531],
8	one	CD	NUMBER	one	num	9	SENT_119	[p8l1423t3478r1575b3531],
9	analysis	NN	O	analysis	prep_for	4	SENT_119	[p8l1609t3453r1939b3553],
10	was	VBD	O	be	cop	11	SENT_119	[p8l1972t3479r2133b3532],
11	available	JJ	O	available	_	0	SENT_119	[p8l10t3581r374b3660],
12	from	IN	O	from	_	0	SENT_119	[p8l417t3580r625b3659],
13	328	CD	NUMBER	328	num	14	SENT_119	[p8l669t3586r820b3659],
14	patients	NNS	O	patient	prep_from	11	SENT_119	[p8l865t3581r1199b3681],
15	(	IN	O	(	quantmod	16	SENT_119	[p8l1250t3586r1432b3672],
16	212	CD	NUMBER	212	num	14	SENT_119	[p8l1250t3586r1432b3672],
17	in	IN	O	in	_	0	SENT_119	[p8l1477t3581r1557b3658],
18	the	DT	O	the	det	20	SENT_119	[p8l1602t3581r1730b3659],
19	erlotinib	JJ	O	erlotinib	amod	20	SENT_119	[p8l1775t3581r2134b3659],
20	group	NN	O	group	prep_in	11	SENT_119	[p8l10t3734r260b3809],
21	and	CC	O	and	_	0	SENT_119	[p8l292t3709r448b3787],
22	116	CD	NUMBER	116	prep_in	11	SENT_119	[p8l482t3714r632b3787],
23	in	IN	O	in	_	0	SENT_119	[p8l663t3709r743b3786],
24	the	DT	O	the	det	26	SENT_119	[p8l775t3709r903b3787],
25	placebo	NN	O	placebo	nn	26	SENT_119	[p8l933t3708r1259b3809],
26	group	NN	O	group	prep_in	22	SENT_119	[p8l1291t3716r1601b3809],
27	)	CD	NUMBER	)	tmod	11	SENT_119	[p8l1291t3716r1601b3809],
28	.	.	O	.	_	0	SENT_119	[p8l1291t3716r1601b3809],

1	The	DT	O	the	det	2	SENT_120	[p8l1634t3709r1795b3787],
2	characteristics	NNS	O	characteristic	_	0	SENT_120	[p8l1827t3709r2133b3787, p9l11t22r336b100],

1	of	IN	O	of	_	0	SENT_121	[p9l368t21r468b100],
2	samples	NNS	O	sample	prep_of	22	SENT_121	[p9l480t22r823b122],
3	that	IN	O	that	nsubj	9	SENT_121	[p9l854t22r1038b117],
4	,	,	O	,	_	0	SENT_121	[p9l854t22r1038b117],
5	after	IN	O	after	_	0	SENT_121	[p9l1072t21r1265b100],
6	pathological	JJ	O	pathological	amod	7	SENT_121	[p9l1290t22r1818b122],
7	review	NN	O	review	prep_after	9	SENT_121	[p9l1846t22r2130b117],
8	,	,	O	,	_	0	SENT_121	[p9l1846t22r2130b117],
9	contained	VBD	O	contain	rcmod	2	SENT_121	[p9l11t150r430b228],
10	sufﬁcient	JJ	O	sufﬁcient	amod	12	SENT_121	[p9l466t149r864b229],
11	tumor	NN	O	tumor	nn	12	SENT_121	[p9l894t166r1157b229],
12	cells	NNS	O	cell	dobj	9	SENT_121	[p9l1189t149r1371b228],
13	to	TO	O	to	aux	14	SENT_121	[p9l1408t166r1487b228],
14	attempt	VB	O	attempt	xcomp	9	SENT_121	[p9l1522t166r1853b250],
15	muta	JJ	O	muta	amod	16	SENT_121	[p9l1882t166r2134b229],
16	—	NN	O	—	dobj	14	SENT_121	[p9l1882t166r2134b229],
17	tional	NN	O	tional	nn	20	SENT_121	[p9l11t278r252b356],
18	and	CC	O	and	_	0	SENT_121	[p9l273t278r428b356],
19	FISH	NN	O	fish	nn	20	SENT_121	[p9l449t283r661b356],
20	analyses	NNS	O	analysis	nsubjpass	22	SENT_121	[p9l683t278r1032b378],
21	are	VBP	O	be	auxpass	22	SENT_121	[p9l1056t304r1182b356],
22	described	VBN	O	describe	_	0	SENT_121	[p9l1205t277r1610b356],
23	in	IN	O	in	_	0	SENT_121	[p9l1632t278r1713b355],
24	Table	NNP	O	Table	prep_in	22	SENT_121	[p9l1732t278r1960b356],
25	1	CD	NUMBER	1	num	24	SENT_121	[p9l1985t283r2029b355],
26	of	IN	O	of	_	0	SENT_121	[p9l2053t277r2153b356],
27	the	DT	O	the	det	30	SENT_121	[p9l11t406r139b484],
28	Supplementary	NNP	O	Supplementary	nn	30	SENT_121	[p9l189t406r832b506],
29	Appendix	NNP	O	Appendix	nn	30	SENT_121	[p9l871t405r1282b506],
30	(	NN	O	(	prep_of	24	SENT_121	[p9l1332t406r1725b497],
31	available	JJ	O	available	amod	30	SENT_121	[p9l1332t406r1725b497],
32	with	IN	O	with	_	0	SENT_121	[p9l1768t406r1957b485],
33	the	DT	O	the	det	35	SENT_121	[p9l2006t406r2135b484],
34	full	JJ	O	full	amod	35	SENT_121	[p9l10t533r149b613],
35	text	NN	O	text	prep_with	31	SENT_121	[p9l175t550r330b612],
36	of	IN	O	of	_	0	SENT_121	[p9l350t533r451b612],
37	this	DT	O	this	det	38	SENT_121	[p9l458t534r610b612],
38	article	NN	O	article	prep_of	35	SENT_121	[p9l637t534r895b612],
39	at	IN	O	at	_	0	SENT_121	[p9l919t550r998b612],
40	wvvw.nejm.org	JJ	O	wvvw.nejm.org	amod	41	SENT_121	[p9l1014t534r1702b634],
41	)	NN	O	)	prep_at	38	SENT_121	[p9l1014t534r1702b634],
42	.	.	O	.	_	0	SENT_121	[p9l1014t534r1702b634],

1	Table	NNP	O	Table	nsubj	3	SENT_122	[p9l136t662r364b740],
2	1	CD	NUMBER	1	num	1	SENT_122	[p9l394t667r438b739],
3	shows	VBZ	O	show	_	0	SENT_122	[p9l469t662r732b741],
4	the	DT	O	the	det	6	SENT_122	[p9l762t662r891b740],
5	baseline	NN	O	baseline	nn	6	SENT_122	[p9l919t662r1264b740],
6	characteristics	NNS	O	characteristic	dobj	3	SENT_122	[p9l1293t661r1897b740],
7	of	IN	O	of	_	0	SENT_122	[p9l1927t661r2028b740],
8	all	DT	O	all	det	9	SENT_122	[p9l2037t662r2135b740],
9	patients	NNS	O	patient	prep_of	6	SENT_122	[p9l9t790r343b890],
10	and	CC	O	and	_	0	SENT_122	[p9l380t790r535b868],
11	those	DT	O	those	prep_of	6	SENT_122	[p9l571t790r798b868],
12	who	WP	O	who	nsubj	13	SENT_122	[p9l829t790r1012b869],
13	underwent	VBD	O	undergo	rcmod	6	SENT_122	[p9l1048t790r1508b869],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_122	[p9l1536t795r1795b873],
15	testing	NN	O	testing	dobj	13	SENT_122	[p9l1820t790r2130b890],
16	.	.	O	.	_	0	SENT_122	[p9l1820t790r2130b890],

1	Although	IN	O	although	mark	3	SENT_123	[p9l7t918r402b1018],
2	there	EX	O	there	expl	3	SENT_123	[p9l424t918r633b996],
3	were	VBD	O	be	advcl	34	SENT_123	[p9l651t944r850b997],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_123	[p9l873t917r1316b1018],
5	differences	NNS	O	difference	nsubj	3	SENT_123	[p9l1333t917r1787b996],
6	in	IN	O	in	_	0	SENT_123	[p9l1810t918r1890b995],
7	some	DT	O	some	det	8	SENT_123	[p9l1913t943r2135b996],
8	characteristics	NNS	O	characteristic	prep_in	5	SENT_123	[p9l11t1046r615b1124],
9	between	IN	O	between	_	0	SENT_123	[p9l668t1046r1017b1125],
10	patients	NNS	O	patient	prep_between	8	SENT_123	[p9l1065t1046r1400b1146],
11	who	WP	O	who	nsubj	12	SENT_123	[p9l1447t1046r1630b1125],
12	underwent	VBD	O	undergo	rcmod	10	SENT_123	[p9l1681t1046r2140b1125],
13	various	JJ	O	various	amod	15	SENT_123	[p9l6t1174r317b1253],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_123	[p9l350t1179r612b1257],
15	tests	NNS	O	test	dobj	12	SENT_123	[p9l633t1190r826b1252],
16	and	CC	O	and	_	0	SENT_123	[p9l859t1174r1016b1252],
17	the	DT	O	the	det	19	SENT_123	[p9l1048t1173r1179b1252],
18	study	NN	O	study	nn	19	SENT_123	[p9l1213t1174r1442b1274],
19	population	NN	O	population	dobj	12	SENT_123	[p9l1468t1174r1942b1274],
20	as	IN	O	as	_	0	SENT_123	[p9l1973t1200r2058b1252],
21	a	DT	O	a	det	22	SENT_123	[p9l2091t1200r2135b1252],
22	whole	JJ	O	whole	prep_as	12	SENT_123	[p9l6t1302r293b1397],
23	,	,	O	,	_	0	SENT_123	[p9l6t1302r293b1397],
24	the	DT	O	the	det	25	SENT_123	[p9l330t1302r461b1380],
25	beneﬁt	NN	O	beneﬁt	appos	22	SENT_123	[p9l493t1301r796b1380],
26	of	IN	O	of	_	0	SENT_123	[p9l823t1301r924b1380],
27	erlotinib	NN	O	erlotinib	prep_of	25	SENT_123	[p9l937t1302r1330b1397],
28	,	,	O	,	_	0	SENT_123	[p9l937t1302r1330b1397],
29	as	IN	O	as	_	0	SENT_123	[p9l1366t1328r1451b1380],
30	compared	VBN	O	compare	prepc_as	34	SENT_123	[p9l1485t1302r1915b1402],
31	with	IN	O	with	pcomp	30	SENT_123	[p9l1941t1302r2134b1381],
32	placebo	NN	O	placebo	pobj	31	SENT_123	[p9l9t1430r367b1530],
33	,	,	O	,	_	0	SENT_123	[p9l9t1430r367b1530],
34	was	VBD	O	be	_	0	SENT_123	[p9l392t1456r553b1509],
35	similar	JJ	O	similar	acomp	34	SENT_123	[p9l580t1430r876b1508],
36	in	IN	O	in	_	0	SENT_123	[p9l896t1430r976b1507],
37	both	CC	O	both	dep	44	SENT_123	[p9l1002t1430r1194b1508],
38	the	DT	O	the	det	44	SENT_123	[p9l1219t1429r1348b1508],
39	entire	JJ	O	entire	amod	44	SENT_123	[p9l1372t1430r1612b1508],
40	study	NN	O	study	nn	44	SENT_123	[p9l1638t1430r1864b1530],
41	group	NN	O	group	nn	44	SENT_123	[p9l1882t1455r2134b1530],
42	(	CD	NUMBER	(	num	44	SENT_123	[p9l15t1558r332b1649],
43	hazard	NN	O	hazard	nn	44	SENT_123	[p9l15t1558r332b1649],
44	ratio	NN	O	ratio	prep_in	35	SENT_123	[p9l374t1558r565b1636],
45	for	IN	O	for	_	0	SENT_123	[p9l608t1557r731b1636],
46	death	NN	O	death	prep_for	44	SENT_123	[p9l771t1558r1026b1653],
47	,	,	O	,	_	0	SENT_123	[p9l771t1558r1026b1653],
48	0.70	CD	NUMBER	0.70	appos	46	SENT_123	[p9l1074t1563r1281b1653],
49	;	:	O	;	_	0	SENT_123	[p9l1074t1563r1281b1653],
50	P	NN	O	p	dep	44	SENT_123	[p9l1326t1563r1705b1649],
51	<	JJR	O	<	dep	35	SENT_123	[p9l1326t1563r1705b1649],
52	0.001	CD	NUMBER	0.001	num	55	SENT_123	[p9l1326t1563r1705b1649],
53	)	NN	O	)	nn	55	SENT_123	[p9l1326t1563r1705b1649],
54	(	CD	NUMBER	(	num	55	SENT_123	[p9l1758t1558r1940b1658],
55	Fig	NN	O	fig	nsubj	34	SENT_123	[p9l1758t1558r1940b1658],
56	.	.	O	.	_	0	SENT_123	[p9l1758t1558r1940b1658],

1	1A	NN	O	1a	nn	2	SENT_124	[p9l1991t1563r2130b1649],
2	)	NN	O	)	_	0	SENT_124	[p9l1991t1563r2130b1649],
3	and	CC	O	and	_	0	SENT_124	[p9l10t1686r164b1764],
4	the	DT	O	the	det	5	SENT_124	[p9l187t1686r314b1764],
5	subgroup	NN	O	subgroup	conj_and	2	SENT_124	[p9l339t1686r735b1786],
6	that	WDT	O	that	nsubj	7	SENT_124	[p9l760t1686r924b1764],
7	underwent	VBD	O	undergo	rcmod	5	SENT_124	[p9l942t1685r1394b1765],
8	at	IN	O	at	quantmod	10	SENT_124	[p9l1411t1702r1489b1764],
9	least	JJS	O	least	mwe	8	SENT_124	[p9l1505t1686r1699b1764],
10	one	CD	NUMBER	one	num	15	SENT_124	[p9l1718t1711r1868b1764],
11	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_124	[p9l1890t1691r2146b1769],
12	analysis	NN	O	analysis	nn	15	SENT_124	[p9l10t1814r340b1914],
13	(	CD	NUMBER	(	num	15	SENT_124	[p9l372t1813r689b1905],
14	hazard	NN	O	hazard	nn	15	SENT_124	[p9l372t1813r689b1905],
15	ratio	NN	O	ratio	dobj	7	SENT_124	[p9l714t1814r930b1909],
16	,	,	O	,	_	0	SENT_124	[p9l714t1814r930b1909],
17	0.76	CD	NUMBER	0.76	appos	15	SENT_124	[p9l962t1819r1170b1909],
18	;	:	O	;	_	0	SENT_124	[p9l962t1819r1170b1909],
19	P	NN	O	p	dep	2	SENT_124	[p9l1197t1819r1539b1905],
20	=	JJ	O	=	advmod	24	SENT_124	[p9l1197t1819r1539b1905],
21	0.03	CD	NUMBER	0.03	dep	20	SENT_124	[p9l1197t1819r1539b1905],
22	)	CD	NUMBER	)	number	23	SENT_124	[p9l1197t1819r1539b1905],
23	(	CD	NUMBER	(	num	24	SENT_124	[p9l1575t1814r1758b1914],
24	Fig	NN	O	fig	rcmod	19	SENT_124	[p9l1575t1814r1758b1914],
25	.	.	O	.	_	0	SENT_124	[p9l1575t1814r1758b1914],

1	1B	NN	O	1b	_	0	SENT_125	[p9l1792t1819r1956b1905],
2	)	NN	O	)	dep	1	SENT_125	[p9l1792t1819r1956b1905],
3	.	.	O	.	_	0	SENT_125	[p9l1792t1819r1956b1905],

1	EXPRESSION	NN	O	expression	nsubj	17	SENT_126	[p9l15t2108r525b2159],
2	or	CC	O	or	_	0	SENT_126	[p9l572t2108r676b2159],
3	EGFR	NN	ORGANIZATION	egfr	nsubj	17	SENT_126	[p9l720t2108r952b2173],
4	,	,	O	,	_	0	SENT_126	[p9l720t2108r952b2173],
5	NUMBER	NN	O	number	nsubj	17	SENT_126	[p9l999t2109r1350b2159],
6	or	CC	O	or	_	0	SENT_126	[p9l1390t2108r1495b2159],
7	copies	NNS	O	copy	nsubj	17	SENT_126	[p9l1534t2108r1832b2159],
8	or	CC	O	or	_	0	SENT_126	[p9l11t2221r116b2271],
9	EGFR	NN	ORGANIZATION	egfr	conj_or	1	SENT_126	[p9l156t2221r392b2286],
10	,	,	O	,	_	0	SENT_126	[p9l156t2221r392b2286],
11	AND	CC	O	and	_	0	SENT_126	[p9l429t2221r606b2270],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_126	[p9l647t2221r855b2271],
13	MUTATIONS	NNS	O	mutation	conj_or	1	SENT_126	[p9l900t2221r1397b2271],
14	Among	IN	O	among	rcmod	13	SENT_126	[p9l7t2320r330b2413],
15	325	CD	NUMBER	325	num	16	SENT_126	[p9l374t2318r526b2391],
16	tumors	NNS	O	tumor	pobj	14	SENT_126	[p9l576t2329r882b2392],
17	subjected	VBN	O	subject	_	0	SENT_126	[p9l932t2313r1335b2413],
18	to	TO	O	to	_	0	SENT_126	[p9l1381t2329r1462b2391],
19	immunohisto	JJ	O	immunohisto	amod	24	SENT_126	[p9l1508t2313r2132b2392],
20	—	NN	O	—	nn	24	SENT_126	[p9l1508t2313r2132b2392],
21	chemical	NN	O	chemical	nn	24	SENT_126	[p9l11t2432r396b2510],
22	analysis	NN	O	analysis	nn	24	SENT_126	[p9l420t2432r750b2532],
23	(	CD	NUMBER	(	num	24	SENT_126	[p9l781t2432r964b2532],
24	Fig	NN	O	fig	prep_to	17	SENT_126	[p9l781t2432r964b2532],
25	.	.	O	.	_	0	SENT_126	[p9l781t2432r964b2532],

1	2	CD	NUMBER	2	_	0	SENT_127	[p9l994t2437r1041b2509],
2	and	CC	O	and	_	0	SENT_127	[p9l1065t2432r1220b2510],
3	Table	NNP	O	Table	conj_and	1	SENT_127	[p9l1241t2432r1469b2510],
4	2	CD	NUMBER	2	number	5	SENT_127	[p9l1493t2437r1599b2527],
5	)	CD	NUMBER	)	dep	3	SENT_127	[p9l1493t2437r1599b2527],
6	,	,	O	,	_	0	SENT_127	[p9l1493t2437r1599b2527],
7	184	CD	NUMBER	184	num	8	SENT_127	[p9l1632t2437r1783b2510],
8	(	NN	O	(	conj_and	1	SENT_127	[p9l1811t2439r1941b2523],
9	57	CD	NUMBER	57	dep	1	SENT_127	[p9l1811t2439r1941b2523],
10	per	IN	O	per	_	0	SENT_127	[p9l1965t2458r2134b2532],
11	—	NN	O	—	prep_per	9	SENT_127	[p9l1965t2458r2134b2532],

1	Figure	NNP	O	Figure	_	0	SENT_128	[p10l84t174r301b256],
2	1	CD	NUMBER	1	number	3	SENT_128	[p10l328t178r359b235],
3	(	CD	NUMBER	(	dep	1	SENT_128	[p10l392t171r627b257],
4	facing	VBG	O	face	partmod	1	SENT_128	[p10l392t171r627b257],
5	page	NN	O	page	nn	6	SENT_128	[p10l653t178r863b257],
6	)	NN	O	)	dobj	4	SENT_128	[p10l653t178r863b257],
7	.	.	O	.	_	0	SENT_128	[p10l653t178r863b257],

1	Kap	NN	O	kap	_	0	SENT_129	[p10l894t172r1382b256],
2	|	CD	NUMBER	|	num	1	SENT_129	[p10l894t172r1382b256],
3	an	DT	O	a	dep	1	SENT_129	[p10l894t172r1382b256],
4	.	.	O	.	_	0	SENT_129	[p10l894t172r1382b256],

1	—	NN	O	—	_	0	SENT_130	[p10l894t172r1382b256],
2	.	.	O	.	_	0	SENT_130	[p10l894t172r1382b256],

1	Meier	NNP	O	Meier	nn	2	SENT_131	[p10l894t172r1382b256],
2	Estimates	NNS	O	estimate	_	0	SENT_131	[p10l1408t173r1748b236],
3	ofSurvival	NN	O	ofsurvival	dep	2	SENT_131	[p10l78t278r468b344],
4	.	.	O	.	_	0	SENT_131	[p10l78t278r468b344],

1	Panel	NN	O	panel	nn	2	SENT_132	[p10l86t409r267b473],
2	A	NN	O	a	nsubj	3	SENT_132	[p10l294t413r344b472],
3	shows	VBZ	O	show	_	0	SENT_132	[p10l369t409r586b473],
4	the	DT	O	the	det	5	SENT_132	[p10l611t409r721b473],
5	results	NNS	O	result	dobj	3	SENT_132	[p10l750t409r979b473],
6	for	IN	O	for	_	0	SENT_132	[p10l1005t407r1102b473],
7	all	DT	O	all	det	10	SENT_132	[p10l1126t409r1197b473],
8	731	CD	NUMBER	731	num	10	SENT_132	[p10l1231t414r1347b472],
9	study	NN	O	study	nn	10	SENT_132	[p10l1378t409r1565b493],
10	patients	NNS	O	patient	prep_for	5	SENT_132	[p10l1593t414r1889b493],
11	.	.	O	.	_	0	SENT_132	[p10l1593t414r1889b493],

1	Panel	NN	O	panel	nn	2	SENT_133	[p10l1924t414r2071b473, p10l79t513r131b578],
2	B	NN	O	b	nsubj	3	SENT_133	[p10l166t519r204b577],
3	shows	VBZ	O	show	_	0	SENT_133	[p10l233t513r450b578],
4	the	DT	O	the	det	5	SENT_133	[p10l475t513r585b578],
5	results	NNS	O	result	dobj	3	SENT_133	[p10l615t513r842b578],
6	for	IN	O	for	_	0	SENT_133	[p10l869t512r966b578],
7	the	DT	O	the	det	9	SENT_133	[p10l988t513r1097b578],
8	328	CD	NUMBER	328	num	9	SENT_133	[p10l1124t517r1245b578],
9	patients	NNS	O	patient	prep_for	5	SENT_133	[p10l1275t520r1552b597],
10	who	WP	O	who	nsubj	11	SENT_133	[p10l1577t513r1722b578],
11	had	VBD	O	have	rcmod	5	SENT_133	[p10l1752t513r1873b578],
12	at	IN	O	at	quantmod	14	SENT_133	[p10l1904t526r1965b578],
13	least	JJS	O	least	mwe	12	SENT_133	[p10l83t618r242b683],
14	one	CD	NUMBER	one	dobj	11	SENT_133	[p10l267t641r393b683],
15	EG	NN	O	eg	nn	17	SENT_133	[p10l425t623r516b683],
16	FR	NN	O	fr	nn	17	SENT_133	[p10l532t624r617b681],
17	analysis	NN	O	analysis	dep	14	SENT_133	[p10l643t618r938b703],
18	.	.	O	.	_	0	SENT_133	[p10l643t618r938b703],

1	Panel	NN	O	panel	nn	2	SENT_134	[p10l972t618r1153b683],
2	C	NN	O	c	nsubj	3	SENT_134	[p10l1184t623r1229b683],
3	shows	VBZ	O	show	_	0	SENT_134	[p10l1256t618r1473b683],
4	the	DT	O	the	det	5	SENT_134	[p10l1499t618r1608b683],
5	results	NNS	O	result	dobj	3	SENT_134	[p10l1638t618r1866b683],
6	for	IN	O	for	_	0	SENT_134	[p10l1892t618r1990b683],
7	patients	NNS	O	patient	prep_for	3	SENT_134	[p10l83t729r360b807],
8	who	WP	O	who	nsubj	11	SENT_134	[p10l384t723r530b787],
9	did	VBD	O	do	aux	11	SENT_134	[p10l557t722r660b787],
10	not	RB	O	not	neg	11	SENT_134	[p10l694t735r805b787],
11	have	VB	O	have	rcmod	7	SENT_134	[p10l832t722r989b787],
12	expression	NN	O	expression	dobj	11	SENT_134	[p10l1015t729r1387b807],
13	of	IN	O	of	_	0	SENT_134	[p10l1416t722r1493b787],
14	EG	NN	O	eg	nn	15	SENT_134	[p10l1512t728r1602b787],
15	FR	NN	O	fr	prep_of	12	SENT_134	[p10l1619t729r1702b786],
16	on	IN	O	on	_	0	SENT_134	[p10l1728t745r1810b787],
17	immunohistochemical	JJ	O	immunohistochemical	amod	18	SENT_134	[p10l1843t729r2071b787, p10l83t828r659b893],
18	analysis	NN	O	analysis	prep_on	15	SENT_134	[p10l689t828r962b913],
19	(	CD	NUMBER	(	num	18	SENT_134	[p10l997t828r1151b912],
20	less	JJR	O	less	mwe	21	SENT_134	[p10l997t828r1151b912],
21	than	IN	O	than	quantmod	22	SENT_134	[p10l1175t828r1328b893],
22	10	CD	PERCENT	10	num	25	SENT_134	[p10l1362t832r1438b893],
23	percent	NN	PERCENT	percent	nn	25	SENT_134	[p10l1465t840r1725b912],
24	oftumor	NN	O	oftumor	nn	25	SENT_134	[p10l1749t827r2055b893],
25	cells	NNS	O	cell	nsubj	26	SENT_134	[p10l80t933r230b997],
26	had	VBD	O	have	rcmod	18	SENT_134	[p10l261t933r382b997],
27	membranous	JJ	O	membranous	amod	29	SENT_134	[p10l415t933r882b997],
28	staining	NN	O	staining	nn	29	SENT_134	[p10l912t938r1240b1018],
29	)	NN	O	)	dobj	26	SENT_134	[p10l912t938r1240b1018],
30	.	.	O	.	_	0	SENT_134	[p10l912t938r1240b1018],

1	Panel	NN	O	panel	nn	2	SENT_135	[p10l1275t933r1455b997],
2	D	NN	O	d	nsubj	3	SENT_135	[p10l1491t939r1539b996],
3	shows	VBZ	O	show	_	0	SENT_135	[p10l1568t933r1785b997],
4	the	DT	O	the	det	5	SENT_135	[p10l1811t933r1920b997],
5	results	NNS	O	result	dobj	3	SENT_135	[p10l1950t956r2033b997, p10l81t1037r242b1102],
6	for	IN	O	for	_	0	SENT_135	[p10l268t1037r366b1102],
7	patients	NNS	O	patient	prep_for	3	SENT_135	[p10l392t1044r668b1121],
8	who	WP	O	who	nsubj	9	SENT_135	[p10l692t1037r837b1102],
9	had	VBD	O	have	rcmod	7	SENT_135	[p10l866t1037r987b1102],
10	expression	NN	O	expression	dobj	9	SENT_135	[p10l1016t1044r1388b1121],
11	of	IN	O	of	_	0	SENT_135	[p10l1417t1037r1494b1102],
12	EG	NN	O	eg	nn	13	SENT_135	[p10l1512t1042r1603b1102],
13	FR	NN	O	fr	prep_of	10	SENT_135	[p10l1620t1043r1703b1101],
14	on	IN	O	on	_	0	SENT_135	[p10l1728t1060r1811b1102],
15	immunohistochemical	JJ	O	immunohistochemical	amod	16	SENT_135	[p10l1843t1044r2071b1102, p10l83t1142r659b1207],
16	analysis	NN	O	analysis	prep_on	9	SENT_135	[p10l690t1142r964b1227],
17	(	CD	PERCENT	(	number	18	SENT_135	[p10l999t1147r1104b1227],
18	10	CD	PERCENT	10	num	19	SENT_135	[p10l999t1147r1104b1227],
19	percent	NN	PERCENT	percent	nsubj	24	SENT_135	[p10l1132t1154r1392b1226],
20	or	CC	O	or	_	0	SENT_135	[p10l1417t1165r1489b1207],
21	more	JJR	O	more	amod	23	SENT_135	[p10l1515t1165r1694b1207],
22	oftumor	NN	O	oftumor	nn	23	SENT_135	[p10l1719t1142r2027b1207],
23	cells	NNS	O	cell	conj_or	19	SENT_135	[p10l80t1247r230b1312],
24	had	VBD	O	have	rcmod	16	SENT_135	[p10l261t1247r382b1312],
25	membranous	JJ	O	membranous	amod	27	SENT_135	[p10l415t1247r882b1312],
26	staining	NN	O	staining	nn	27	SENT_135	[p10l912t1253r1240b1333],
27	)	NN	O	)	dobj	24	SENT_135	[p10l912t1253r1240b1333],
28	.	.	O	.	_	0	SENT_135	[p10l912t1253r1240b1333],

1	Panel	NN	O	panel	nn	2	SENT_136	[p10l1275t1247r1456b1312],
2	E	NN	O	e	nsubj	3	SENT_136	[p10l1491t1253r1525b1311],
3	shows	VBZ	O	show	_	0	SENT_136	[p10l1553t1247r1770b1312],
4	the	DT	O	the	det	5	SENT_136	[p10l1796t1247r1905b1312],
5	results	NNS	O	result	dobj	3	SENT_136	[p10l1935t1270r2018b1312, p10l81t1352r242b1417],
6	for	IN	O	for	_	0	SENT_136	[p10l269t1351r366b1417],
7	patients	NNS	O	patient	prep_for	3	SENT_136	[p10l393t1358r669b1436],
8	who	WP	O	who	nsubj	11	SENT_136	[p10l695t1352r840b1417],
9	did	VBD	O	do	aux	11	SENT_136	[p10l866t1352r971b1417],
10	not	RB	O	not	neg	11	SENT_136	[p10l1004t1365r1116b1417],
11	have	VB	O	have	rcmod	7	SENT_136	[p10l1143t1352r1300b1417],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_136	[p10l1330t1357r1525b1417],
13	amplification	NN	O	amplification	dobj	11	SENT_136	[p10l1550t1351r2007b1436],
14	or	CC	O	or	_	0	SENT_136	[p10l80t1480r151b1521],
15	high	JJ	O	high	amod	16	SENT_136	[p10l177t1456r322b1542],
16	polysomy	NN	O	polysomy	conj_or	13	SENT_136	[p10l355t1457r687b1542],
17	(	CD	NUMBER	(	number	18	SENT_136	[p10l719t1456r885b1542],
18	four	CD	NUMBER	four	dep	13	SENT_136	[p10l719t1456r885b1542],
19	or	CC	O	or	_	0	SENT_136	[p10l909t1480r980b1521],
20	more	JJR	O	more	amod	21	SENT_136	[p10l1007t1480r1186b1521],
21	copies	NNS	O	copy	conj_or	13	SENT_136	[p10l1211t1463r1434b1541],
22	of	IN	O	of	_	0	SENT_136	[p10l1462t1456r1539b1521],
23	EGFR	NN	ORGANIZATION	egfr	prep_of	21	SENT_136	[p10l1557t1462r1752b1521],
24	in	IN	O	in	_	0	SENT_136	[p10l1779t1463r1834b1520],
25	at	IN	O	at	quantmod	27	SENT_136	[p10l1865t1469r1927b1521],
26	least	JJS	O	least	mwe	25	SENT_136	[p10l83t1561r242b1626],
27	40	CD	PERCENT	40	num	29	SENT_136	[p10l265t1566r348b1626],
28	percent	NN	PERCENT	percent	nn	29	SENT_136	[p10l376t1574r636b1645],
29	ofcells	NNS	O	ofcell	prep_in	23	SENT_136	[p10l661t1561r953b1646],
30	)	CD	NUMBER	)	dep	21	SENT_136	[p10l661t1561r953b1646],
31	.	.	O	.	_	0	SENT_136	[p10l661t1561r953b1646],

1	Panel	NN	O	panel	nn	2	SENT_137	[p10l988t1561r1169b1626],
2	F	NN	O	f	nsubj	3	SENT_137	[p10l1204t1567r1237b1625],
3	shows	VBZ	O	show	_	0	SENT_137	[p10l1265t1561r1481b1626],
4	the	DT	O	the	det	5	SENT_137	[p10l1507t1561r1616b1626],
5	results	NNS	O	result	dobj	3	SENT_137	[p10l1646t1561r1874b1626],
6	for	IN	O	for	_	0	SENT_137	[p10l1901t1561r1998b1626],
7	patients	NNS	O	patient	prep_for	3	SENT_137	[p10l83t1672r360b1751],
8	who	WP	O	who	nsubj	9	SENT_137	[p10l385t1667r530b1731],
9	had	VBD	O	have	rcmod	7	SENT_137	[p10l560t1667r681b1731],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_137	[p10l714t1672r909b1731],
11	amplification	NN	O	amplification	dobj	9	SENT_137	[p10l935t1666r1391b1751],
12	or	CC	O	or	_	0	SENT_137	[p10l1421t1689r1493b1731],
13	high	JJ	O	high	amod	14	SENT_137	[p10l1519t1667r1663b1752],
14	polysomy	NN	O	polysomy	dobj	9	SENT_137	[p10l1696t1667r2038b1751],
15	.	.	O	.	_	0	SENT_137	[p10l1696t1667r2038b1751],

1	Panel	NN	O	panel	nn	2	SENT_138	[p10l86t1771r267b1836],
2	G	NN	O	g	nsubj	3	SENT_138	[p10l295t1776r344b1836],
3	shows	VBZ	O	show	_	0	SENT_138	[p10l374t1771r591b1836],
4	the	DT	O	the	det	5	SENT_138	[p10l613t1771r722b1836],
5	results	NNS	O	result	dobj	3	SENT_138	[p10l750t1771r978b1836],
6	for	IN	O	for	_	0	SENT_138	[p10l1002t1770r1099b1836],
7	patients	NNS	O	patient	prep_for	3	SENT_138	[p10l1123t1778r1400b1855],
8	who	WP	O	who	nsubj	9	SENT_138	[p10l1422t1771r1567b1836],
9	had	VBD	O	have	rcmod	7	SENT_138	[p10l1594t1771r1715b1836],
10	wild-type	JJ	O	wild-type	amod	11	SENT_138	[p10l1740t1771r2054b1856],
11	EGFR	NN	ORGANIZATION	egfr	dobj	9	SENT_138	[p10l83t1881r295b1941],
12	.	.	O	.	_	0	SENT_138	[p10l83t1881r295b1941],

1	Panel	NN	O	panel	nn	2	SENT_139	[p10l330t1876r511b1941],
2	H	NN	O	h	nsubj	3	SENT_139	[p10l546t1882r595b1939],
3	shows	VBZ	O	show	_	0	SENT_139	[p10l628t1876r845b1941],
4	the	DT	O	the	det	5	SENT_139	[p10l871t1876r980b1941],
5	results	NNS	O	result	dobj	3	SENT_139	[p10l1010t1876r1238b1941],
6	for	IN	O	for	_	0	SENT_139	[p10l1264t1876r1362b1941],
7	patients	NNS	O	patient	prep_for	3	SENT_139	[p10l1389t1882r1665b1960],
8	who	WP	O	who	nsubj	9	SENT_139	[p10l1690t1876r1836b1941],
9	had	VBD	O	have	rcmod	7	SENT_139	[p10l1865t1876r1986b1941],
10	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_139	[p10l83t1986r278b2046],
11	mutations	NNS	O	mutation	dobj	9	SENT_139	[p10l306t1987r681b2045],
12	.	.	O	.	_	0	SENT_139	[p10l306t1987r681b2045],

1	P	NN	O	p	nn	2	SENT_140	[p10l715t1987r752b2045],
2	values	NNS	O	value	nsubjpass	4	SENT_140	[p10l776t1981r995b2046],
3	were	VBD	O	be	auxpass	4	SENT_140	[p10l1020t2004r1184b2045],
4	calculated	VBN	O	calculate	_	0	SENT_140	[p10l1210t1981r1560b2045],
5	with	IN	O	with	_	0	SENT_140	[p10l1586t1981r1731b2045],
6	the	DT	O	the	det	8	SENT_140	[p10l1758t1981r1868b2045],
7	use	NN	O	use	nn	8	SENT_140	[p10l1897t2004r2013b2045],
8	ofa	NN	O	ofa	prep_with	4	SENT_140	[p10l80t2085r204b2151],
9	stratified	VBN	O	stratify	partmod	8	SENT_140	[p10l233t2085r536b2151],
10	log-rank	JJ	O	log-rank	amod	11	SENT_140	[p10l570t2086r851b2171],
11	test	NN	O	test	dobj	9	SENT_140	[p10l873t2098r1002b2151],
12	in	IN	O	in	_	0	SENT_140	[p10l1030t2092r1086b2150],
13	Panel	NN	O	panel	nn	14	SENT_140	[p10l1121t2086r1302b2151],
14	A	NN	O	a	prep_in	11	SENT_140	[p10l1330t2090r1379b2150],
15	and	CC	O	and	_	0	SENT_140	[p10l1404t2086r1527b2151],
16	the	DT	O	the	det	18	SENT_140	[p10l1555t2086r1664b2151],
17	log-rank	JJ	O	log-rank	amod	18	SENT_140	[p10l1694t2086r1976b2171],
18	test	NN	O	test	dobj	9	SENT_140	[p10l77t2203r207b2255],
19	in	IN	O	in	_	0	SENT_140	[p10l234t2197r290b2254],
20	Panels	NNP	O	Panels	nn	21	SENT_140	[p10l326t2191r547b2255],
21	B	NNP	O	B	prep_in	18	SENT_140	[p10l580t2197r618b2254],
22	through	IN	O	through	_	0	SENT_140	[p10l643t2191r920b2276],
23	H.	NNP	O	H.	prep_through	9	SENT_140	[p10l955t2197r1028b2255],

1	136	CD	NUMBER	136	num	3	SENT_141	[p10l149t2449r205b2472],
2	N	NN	O	n	nn	3	SENT_141	[p10l918t2452r932b2467],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_141	[p10l947t2451r1031b2473],
4	MED	VBD	O	med	_	0	SENT_141	[p10l1046t2452r1099b2467],
5	353:2	CD	NUMBER	353:2	num	7	SENT_141	[p10l1111t2451r1175b2473],
6	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	7	SENT_141	[p10l1210t2451r1421b2473],
7	JULY14	NN	O	july14	dobj	4	SENT_141	[p10l1455t2451r1638b2473],
8	,2005	CD	NUMBER	,2005	tmod	4	SENT_141	[p10l1455t2451r1638b2473],

1	The	DT	O	the	det	4	SENT_142	[p10l935t2484r986b2508],
2	New	NNP	O	New	nn	4	SENT_142	[p10l995t2485r1057b2508],
3	England	NNP	O	England	nn	4	SENT_142	[p10l1066t2484r1177b2515],
4	Journal	NNP	O	Journal	_	0	SENT_142	[p10l1186t2484r1283b2508],
5	of	IN	O	of	_	0	SENT_142	[p10l1293t2484r1322b2508],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_142	[p10l1329t2484r1454b2508],

1	Downloaded	VBN	O	download	_	0	SENT_143	[p10l377t2525r547b2548],
2	from	IN	O	from	_	0	SENT_143	[p10l556t2525r620b2548],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_143	[p10l629t2525r747b2555],
4	at	IN	O	at	_	0	SENT_143	[p10l758t2529r781b2548],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_143	[p10l789t2525r972b2548],
6	on	IN	O	on	_	0	SENT_143	[p10l981t2532r1014b2548],
7	January	NNP	DATE	January	prep_on	1	SENT_143	[p10l1022t2525r1125b2555],
8	5	CD	DATE	5	num	7	SENT_143	[p10l1135t2525r1158b2552],
9	,	,	DATE	,	_	0	SENT_143	[p10l1135t2525r1158b2552],
10	2014	CD	DATE	2014	num	7	SENT_143	[p10l1169t2525r1241b2548],
11	.	.	O	.	_	0	SENT_143	[p10l1169t2525r1241b2548],

1	For	IN	O	for	_	0	SENT_144	[p10l1251t2525r1298b2548],
2	personal	JJ	O	personal	amod	3	SENT_144	[p10l1306t2525r1418b2555],
3	use	NN	O	use	pobj	1	SENT_144	[p10l1427t2532r1471b2548],
4	only	RB	O	only	advmod	3	SENT_144	[p10l1481t2525r1545b2555],
5	.	.	O	.	_	0	SENT_144	[p10l1481t2525r1545b2555],

1	No	DT	O	no	det	3	SENT_145	[p10l1556t2525r1596b2548],
2	other	JJ	O	other	amod	3	SENT_145	[p10l1606t2525r1674b2548],
3	uses	NNS	O	use	_	0	SENT_145	[p10l1682t2532r1738b2548],
4	without	IN	O	without	_	0	SENT_145	[p10l1748t2525r1849b2548],
5	permission	NN	O	permission	prep_without	3	SENT_145	[p10l1858t2525r2010b2555],
6	.	.	O	.	_	0	SENT_145	[p10l1858t2525r2010b2555],

1	ERLOTINIB	JJ	O	erlotinib	amod	2	SENT_146	[p10l593t2610r780b2629],
2	THERAPY	NN	O	therapy	_	0	SENT_146	[p10l793t2610r945b2629],
3	FOR	IN	O	for	_	0	SENT_146	[p10l958t2610r1024b2629],
4	LUNG	NN	O	lung	prep_for	2	SENT_146	[p10l1037t2610r1131b2629],
5	CANCER	NNP	O	CANCER	dep	2	SENT_146	[p10l1145t2610r1281b2629],

1	cent	NN	O	cent	nn	2	SENT_147	[p10l95t2707r173b2739],
2	)	NN	O	)	nsubj	5	SENT_147	[p10l95t2707r173b2739],
3	were	VBD	O	be	cop	5	SENT_147	[p10l184t2714r262b2735],
4	EGFR-positive	JJ	PERCENT	egfr-positive	amod	5	SENT_147	[p10l272t2705r508b2743],
5	(	NN	PERCENT	(	_	0	SENT_147	[p10l520t2706r570b2739],
6	50	CD	PERCENT	50	num	7	SENT_147	[p10l520t2706r570b2739],
7	percent	NN	PERCENT	percent	dep	5	SENT_147	[p10l580t2711r705b2743],
8	of	IN	O	of	_	0	SENT_147	[p10l713t2704r752b2735],
9	adenocar	NN	O	adenocar	prep_of	7	SENT_147	[p10l755t2704r918b2735],
10	-	:	O	-	_	0	SENT_147	[p10l755t2704r918b2735],
11	and	CC	O	and	_	0	SENT_147	[p10l957t2704r1017b2735],
12	Table	NNP	O	Table	conj_and	5	SENT_147	[p10l1028t2704r1118b2735],
13	2	CD	NUMBER	2	number	14	SENT_147	[p10l1130t2706r1172b2739],
14	)	CD	NUMBER	)	dep	12	SENT_147	[p10l1130t2706r1172b2739],
15	.	.	O	.	_	0	SENT_147	[p10l1130t2706r1172b2739],

1	Of	IN	O	of	_	0	SENT_148	[p10l1186t2704r1233b2735],
2	these	DT	O	these	prep_of	6	SENT_148	[p10l1238t2704r1334b2741],
3	,	,	O	,	_	0	SENT_148	[p10l1238t2704r1334b2741],
4	45	CD	PERCENT	45	num	5	SENT_148	[p10l1348t2707r1387b2735],
5	percent	NN	PERCENT	percent	nsubj	6	SENT_148	[p10l1399t2711r1526b2743],
6	had	VBD	O	have	_	0	SENT_148	[p10l1536t2704r1597b2735],
7	high	JJ	O	high	amod	9	SENT_148	[p10l1609t2704r1685b2743],
8	polycinoma	NN	O	polycinoma	nn	9	SENT_148	[p10l1696t2704r1780b2743, p10l95t2754r215b2784],
9	samples	NNS	O	sample	dobj	6	SENT_148	[p10l224t2753r355b2792],
10	and	CC	O	and	_	0	SENT_148	[p10l365t2753r424b2784],
11	63	CD	PERCENT	63	num	12	SENT_148	[p10l434t2755r471b2784],
12	percent	NN	PERCENT	percent	dobj	6	SENT_148	[p10l481t2760r603b2792],
13	of	IN	O	of	_	0	SENT_148	[p10l611t2753r649b2784],
14	samples	NNS	O	sample	prep_of	12	SENT_148	[p10l652t2753r783b2792],
15	of	IN	O	of	_	0	SENT_148	[p10l793t2753r832b2784],
16	other	JJ	O	other	amod	17	SENT_148	[p10l834t2753r919b2784],
17	somy	NN	O	somy	prep_of	14	SENT_148	[p10l958t2763r1047b2792],
18	or	CC	O	or	_	0	SENT_148	[p10l1057t2763r1092b2784],
19	ampliﬁcation	NN	O	ampliﬁcation	prep_of	12	SENT_148	[p10l1103t2753r1327b2792],
20	(	CD	PERCENT	(	number	21	SENT_148	[p10l1341t2755r1392b2788],
21	48	CD	PERCENT	48	num	22	SENT_148	[p10l1341t2755r1392b2788],
22	percent	NN	PERCENT	percent	dep	19	SENT_148	[p10l1404t2760r1531b2792],
23	of	IN	O	of	_	0	SENT_148	[p10l1541t2753r1581b2784],
24	adenocarcitypes	NNS	O	adenocarcitype	prep_of	12	SENT_148	[p10l1585t2753r1780b2784, p10l94t2809r176b2841],
25	of	IN	O	of	_	0	SENT_148	[p10l192t2802r230b2833],
26	tumors	NNS	O	tumor	prep_of	24	SENT_148	[p10l238t2805r378b2837],
27	)	CD	NUMBER	)	tmod	6	SENT_148	[p10l238t2805r378b2837],
28	.	.	O	.	_	0	SENT_148	[p10l238t2805r378b2837],

1	FISH	NN	O	fish	nsubj	20	SENT_149	[p10l395t2804r478b2833],
2	was	VBD	O	be	auxpass	3	SENT_149	[p10l491t2812r554b2833],
3	attempted	VBN	O	attempt	_	0	SENT_149	[p10l570t2802r736b2841],
4	in	IN	O	in	_	0	SENT_149	[p10l751t2803r782b2832],
5	221	CD	NUMBER	221	prep_in	3	SENT_149	[p10l798t2804r857b2832],
6	tu	SYM	O	tu	dep	5	SENT_149	[p10l873t2809r917b2833],
7	-	:	O	-	_	0	SENT_149	[p10l873t2809r917b2833],
8	noma	NN	O	noma	nn	9	SENT_149	[p10l957t2812r1051b2833],
9	samples	NNS	O	sample	dobj	3	SENT_149	[p10l1062t2802r1195b2841],
10	and	CC	O	and	_	0	SENT_149	[p10l1207t2802r1268b2833],
11	41	CD	PERCENT	41	num	12	SENT_149	[p10l1278t2804r1318b2833],
12	percent	NN	PERCENT	percent	dobj	3	SENT_149	[p10l1329t2809r1453b2841],
13	of	IN	O	of	_	0	SENT_149	[p10l1463t2802r1502b2833],
14	samples	NNS	O	sample	prep_of	12	SENT_149	[p10l1506t2802r1639b2841],
15	of	IN	O	of	_	0	SENT_149	[p10l1652t2802r1690b2833],
16	other	JJ	O	other	amod	17	SENT_149	[p10l1695t2802r1782b2833],
17	mors	NNS	O	mor	prep_of	14	SENT_149	[p10l94t2861r178b2882],
18	and	CC	O	and	_	0	SENT_149	[p10l187t2851r247b2882],
19	was	VBD	O	be	cop	20	SENT_149	[p10l254t2861r317b2882],
20	successful	JJ	O	successful	conj_and	3	SENT_149	[p10l327t2851r494b2882],
21	in	IN	O	in	_	0	SENT_149	[p10l502t2852r534b2881],
22	125	CD	PERCENT	125	number	23	SENT_149	[p10l543t2853r601b2882],
23	(	CD	PERCENT	(	prep_in	20	SENT_149	[p10l612t2854r663b2886],
24	57	CD	PERCENT	57	num	25	SENT_149	[p10l612t2854r663b2886],
25	percent	NN	PERCENT	percent	dep	23	SENT_149	[p10l671t2854r805b2890],
26	)	CD	NUMBER	)	number	27	SENT_149	[p10l671t2854r805b2890],
27	(	CD	NUMBER	(	num	28	SENT_149	[p10l817t2852r888b2890],
28	Fig	NN	O	fig	dep	25	SENT_149	[p10l817t2852r888b2890],
29	.	.	O	.	_	0	SENT_149	[p10l817t2852r888b2890],

1	2	CD	NUMBER	2	num	2	SENT_150	[p10l899t2853r918b2881],
2	types	NNS	O	type	_	0	SENT_150	[p10l957t2858r1039b2890],
3	of	IN	O	of	_	0	SENT_150	[p10l1050t2851r1089b2882],
4	tumors	NNS	O	tumor	prep_of	2	SENT_150	[p10l1092t2854r1232b2886],
5	)	CD	NUMBER	)	dep	4	SENT_150	[p10l1092t2854r1232b2886],
6	.	.	O	.	_	0	SENT_150	[p10l1092t2854r1232b2886],

1	A	DT	O	a	predet	3	SENT_151	[p11l112t30r134b55],
2	All	DT	O	all	det	3	SENT_151	[p11l155t32r187b55],
3	Patients	NNS	O	patient	nsubj	4	SENT_151	[p11l199t33r301b56],
4	B	NN	O	b	_	0	SENT_151	[p11l956t30r975b55],
5	Patients	NNS	O	patient	dobj	4	SENT_151	[p11l999t33r1100b56],
6	Who	WP	O	who	nsubj	7	SENT_151	[p11l1109t32r1169b56],
7	Had	VBD	O	have	rcmod	5	SENT_151	[p11l1180t32r1231b56],
8	21	CD	NUMBER	21	num	10	SENT_151	[p11l1241t34r1271b55],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_151	[p11l1284t34r1354b56],
10	Test	NN	O	test	dobj	7	SENT_151	[p11l1362t34r1414b56],

1	100	CD	NUMBER	100	num	3	SENT_152	[p11l319t81r359b102],
2	Hazard	NN	O	hazard	nn	3	SENT_152	[p11l669t89r753b111],
3	ratio	NN	O	ratio	_	0	SENT_152	[p11l765t91r824b115],
4	,	,	O	,	_	0	SENT_152	[p11l765t91r824b115],
5	0.70	CD	NUMBER	0.70	number	6	SENT_152	[p11l834t90r884b111],
6	100	CD	NUMBER	100	num	7	SENT_152	[p11l1160t81r1201b102],
7	P	NN	O	p	appos	3	SENT_152	[p11l1270t90r1351b110],
8	=	JJ	O	=	amod	18	SENT_152	[p11l1270t90r1351b110],
9	0.03	CD	NUMBER	0.03	num	11	SENT_152	[p11l1270t90r1351b110],
10	Hazard	NN	O	hazard	nn	11	SENT_152	[p11l1467t88r1552b110],
11	ratio	NN	O	ratio	tmod	8	SENT_152	[p11l1563t90r1622b113],
12	,	,	O	,	_	0	SENT_152	[p11l1563t90r1622b113],
13	0.76	CD	NUMBER	0.76	num	15	SENT_152	[p11l1632t89r1681b110],
14	30	CD	NUMBER	30	num	15	SENT_152	[p11l332t129r359b150],
15	(	NN	O	(	appos	11	SENT_152	[p11l647t123r708b151],
16	95	CD	PERCENT	95	number	17	SENT_152	[p11l647t123r708b151],
17	%	NN	PERCENT	%	amod	18	SENT_152	[p11l647t123r708b151],
18	CI	NN	O	ci	dep	7	SENT_152	[p11l717t124r747b148],
19	,	,	O	,	_	0	SENT_152	[p11l717t124r747b148],
20	0.58-0	CD	NUMBER	0.58-0	num	21	SENT_152	[p11l758t124r881b151],
21	.85	CD	NUMBER	.85	appos	7	SENT_152	[p11l758t124r881b151],
22	)	CD	NUMBER	)	number	23	SENT_152	[p11l758t124r881b151],
23	30	CD	NUMBER	30	dep	21	SENT_152	[p11l1173t129r1201b150],
24	-	:	O	-	_	0	SENT_152	[p11l1253t137r1271b161],
25	Z	NN	O	z	dep	7	SENT_152	[p11l1253t137r1271b161],
26	‘	CD	PERCENT	‘	num	25	SENT_152	[p11l1253t137r1271b161],
27	(	CD	PERCENT	(	num	30	SENT_152	[p11l1446t122r1506b150],
28	95	CD	PERCENT	95	number	29	SENT_152	[p11l1446t122r1506b150],
29	%	NN	PERCENT	%	amod	30	SENT_152	[p11l1446t122r1506b150],
30	CI	NN	O	ci	dep	25	SENT_152	[p11l1515t123r1545b147],
31	,	,	O	,	_	0	SENT_152	[p11l1515t123r1545b147],
32	0.59-0	CD	NUMBER	0.59-0	num	34	SENT_152	[p11l1556t122r1679b150],
33	.97	CD	NUMBER	.97	num	34	SENT_152	[p11l1556t122r1679b150],
34	)	NN	O	)	dep	7	SENT_152	[p11l1556t122r1679b150],
35	60	CD	NUMBER	60	number	36	SENT_152	[p11l332t177r359b198],
36	60	CD	NUMBER	60	num	38	SENT_152	[p11l1173t177r1201b198],
37	40	CD	NUMBER	40	number	38	SENT_152	[p11l331t226r359b246],
38	40	CD	NUMBER	40	dep	3	SENT_152	[p11l1173t226r1201b246],
39	20	CD	NUMBER	20	number	40	SENT_152	[p11l332t274r359b295],
40	20	CD	NUMBER	20	num	41	SENT_152	[p11l1173t274r1201b295],
41	O	NN	O	o	dep	38	SENT_152	[p11l1187t322r1201b343],

1	l	NN	O	l	_	0	SENT_153	[p11l1315t201r1328b212],
2	e	SYM	O	e	num	1	SENT_153	[p11l1315t201r1328b212],
3	+	CC	O	+	_	0	SENT_153	[p11l1315t201r1328b212],
4	\	CD	NUMBER	\	conj_+	2	SENT_153	[p11l1342t208r1500b241],
5	.	.	O	.	_	0	SENT_153	[p11l1342t208r1500b241],

1	_	NN	O	_	_	0	SENT_154	[p11l1342t208r1500b241],
2	,	,	O	,	_	0	SENT_154	[p11l1342t208r1500b241],
3	_	CD	NUMBER	_	num	5	SENT_154	[p11l1342t208r1500b241],
4	‘	CD	NUMBER	‘	num	5	SENT_154	[p11l1342t208r1500b241],
5	Erlotinib	NN	O	erlotinib	appos	1	SENT_154	[p11l1342t208r1500b241],

1	Survival	NN	O	survival	dep	7	SENT_155	[p11l258t190r281b291],
2	(	CD	PERCENT	(	num	3	SENT_155	[p11l259t137r289b178],
3	%	NN	PERCENT	%	dep	1	SENT_155	[p11l259t137r289b178],
4	)	CD	NUMBER	)	num	5	SENT_155	[p11l259t137r289b178],
5	Survival	NN	O	survival	dep	7	SENT_155	[p11l1099t190r1123b291],
6	(	CD	PERCENT	(	num	7	SENT_155	[p11l1101t137r1130b178],
7	%	NN	PERCENT	%	_	0	SENT_155	[p11l1101t137r1130b178],
8	)	CD	NUMBER	)	dep	7	SENT_155	[p11l1101t137r1130b178],

1	No.	NN	O	no.	_	0	SENT_156	[p11l141t461r185b482],
2	at	IN	O	at	_	0	SENT_156	[p11l195t462r219b482],
3	Risk	NN	O	risk	nn	4	SENT_156	[p11l229t458r281b482],
4	No.	NN	O	no.	prep_at	1	SENT_156	[p11l983t461r1027b482],
5	at	IN	O	at	_	0	SENT_156	[p11l1037t462r1060b482],
6	Risk	NN	O	risk	nn	7	SENT_156	[p11l1071t458r1122b482],
7	Placebo	NN	O	placebo	prep_at	4	SENT_156	[p11l142t495r232b517],
8	243	CD	NUMBER	243	number	9	SENT_156	[p11l346t497r386b517],
9	107	CD	NUMBER	107	num	10	SENT_156	[p11l450t497r490b517],
10	50	CD	NUMBER	50	dep	1	SENT_156	[p11l565t497r592b517],
11	Placebo	NNP	O	Placebo	nn	14	SENT_156	[p11l983t495r1074b517],
12	Erlotinib	NNP	O	Erlotinib	nn	14	SENT_156	[p11l142t529r240b551],
13	488 255 145	CD	NUMBER	488 255 145	num	14	SENT_156	[p11l551t531r590b551],[p11l345t530r387b551],
14	Erlotinib	NNP	O	Erlotinib	dep	10	SENT_156	[p11l983t529r1082b551],

1	C	NN	O	c	_	0	SENT_157	[p11l113t607r134b634],
2	No	DT	O	no	det	4	SENT_157	[p11l158t612r195b633],
3	Expression	NN	O	expression	nn	4	SENT_157	[p11l206t610r343b640],
4	ofEGFR	NN	O	ofegfr	dep	1	SENT_157	[p11l353t610r459b633],
5	D	NN	O	d	nn	7	SENT_157	[p11l956t608r979b633],
6	Expression	NN	O	expression	nn	7	SENT_157	[p11l999t609r1136b639],
7	ofEGFR	NN	O	ofegfr	dep	1	SENT_157	[p11l1147t608r1252b632],

1	100	CD	NUMBER	100	num	2	SENT_158	[p11l319t657r359b678],
2	P	NN	O	p	_	0	SENT_158	[p11l449t667r532b688],
3	=	JJ	O	=	amod	6	SENT_158	[p11l449t667r532b688],
4	0.70	CD	NUMBER	0.70	tmod	3	SENT_158	[p11l449t667r532b688],
5	Hazard	NN	O	hazard	nn	6	SENT_158	[p11l669t666r753b688],
6	ratio	NN	O	ratio	dep	2	SENT_158	[p11l765t668r824b691],
7	,	,	O	,	_	0	SENT_158	[p11l765t668r824b691],
8	0.93	CD	NUMBER	0.93	number	9	SENT_158	[p11l834t667r882b688],
9	100	CD	NUMBER	100	num	11	SENT_158	[p11l1160t657r1201b678],
10	Hazard	NN	O	hazard	nn	11	SENT_158	[p11l1469t666r1554b688],
11	ratio	NN	O	ratio	appos	6	SENT_158	[p11l1565t668r1624b692],
12	,	,	O	,	_	0	SENT_158	[p11l1565t668r1624b692],
13	0.68	CD	NUMBER	0.68	num	18	SENT_158	[p11l1634t667r1683b688],
14	30	CD	NUMBER	30	num	15	SENT_158	[p11l332t706r359b727],
15	(	NN	O	(	amod	18	SENT_158	[p11l647t700r708b728],
16	95	CD	PERCENT	95	num	17	SENT_158	[p11l647t700r708b728],
17	%	NN	PERCENT	%	dep	15	SENT_158	[p11l647t700r708b728],
18	CI	NN	O	ci	appos	6	SENT_158	[p11l717t701r747b725],
19	,	,	O	,	_	0	SENT_158	[p11l717t701r747b725],
20	0.63-1	CD	NUMBER	0.63-1	number	21	SENT_158	[p11l758t700r881b728],
21	.36	CD	NUMBER	.36	num	23	SENT_158	[p11l758t700r881b728],
22	)	CD	NUMBER	)	number	23	SENT_158	[p11l758t700r881b728],
23	30	CD	NUMBER	30	appos	6	SENT_158	[p11l1173t706r1201b727],
24	-	:	O	-	_	0	SENT_158	[p11l1257t712r1273b727],
25	_	CD	NUMBER	_	dep	6	SENT_158	[p11l1257t712r1273b727],
26	,	,	O	,	_	0	SENT_158	[p11l1257t712r1273b727],
27	(	CD	PERCENT	(	num	30	SENT_158	[p11l1448t700r1508b728],
28	95	CD	PERCENT	95	number	29	SENT_158	[p11l1448t700r1508b728],
29	%	NN	PERCENT	%	amod	30	SENT_158	[p11l1448t700r1508b728],
30	CI	NN	O	ci	appos	25	SENT_158	[p11l1517t701r1548b725],
31	,	,	O	,	_	0	SENT_158	[p11l1517t701r1548b725],
32	0.49-0	CD	NUMBER	0.49-0	num	34	SENT_158	[p11l1558t700r1681b728],
33	.95	CD	NUMBER	.95	num	34	SENT_158	[p11l1558t700r1681b728],
34	)	NN	O	)	appos	30	SENT_158	[p11l1558t700r1681b728],
35	60	CD	NUMBER	60	number	36	SENT_158	[p11l332t754r359b775],
36	60	CD	NUMBER	60	num	38	SENT_158	[p11l1173t754r1201b775],
37	40	CD	NUMBER	40	number	38	SENT_158	[p11l331t802r359b823],
38	40	CD	NUMBER	40	dep	34	SENT_158	[p11l1173t802r1201b823],
39	20	CD	NUMBER	20	num	41	SENT_158	[p11l332t851r359b871],
40	20	CD	NUMBER	20	num	41	SENT_158	[p11l1173t851r1201b871],
41	o	NN	O	o	dep	2	SENT_158	[p11l346t899r359b920],

1	Survival	NN	O	survival	dep	7	SENT_159	[p11l258t767r281b868],
2	(	CD	PERCENT	(	num	3	SENT_159	[p11l259t713r289b755],
3	%	NN	PERCENT	%	dep	1	SENT_159	[p11l259t713r289b755],
4	)	CD	NUMBER	)	num	5	SENT_159	[p11l259t713r289b755],
5	Survival	NN	O	survival	dep	7	SENT_159	[p11l1099t766r1123b867],
6	(	CD	PERCENT	(	num	7	SENT_159	[p11l1101t713r1130b755],
7	%	NN	PERCENT	%	_	0	SENT_159	[p11l1101t713r1130b755],
8	)	CD	NUMBER	)	dep	7	SENT_159	[p11l1101t713r1130b755],

1	Months	NNS	DURATION	month	_	0	SENT_160	[p11l1425t980r1522b1003],

1	No.	NN	O	no.	_	0	SENT_161	[p11l141t1037r185b1059],
2	at	IN	O	at	_	0	SENT_161	[p11l195t1039r219b1059],
3	Risk	NN	O	risk	nn	4	SENT_161	[p11l229t1035r281b1059],
4	No.	NN	O	no.	prep_at	1	SENT_161	[p11l983t1037r1027b1059],
5	at	IN	O	at	_	0	SENT_161	[p11l1037t1039r1060b1059],
6	Risk	NN	ORGANIZATION	risk	nn	8	SENT_161	[p11l1071t1035r1122b1059],
7	Placebo	NNP	ORGANIZATION	Placebo	nn	8	SENT_161	[p11l142t1072r232b1094],
8	Placebo	NNP	ORGANIZATION	Placebo	prep_at	4	SENT_161	[p11l983t1072r1074b1094],
9	67	CD	NUMBER	67	num	13	SENT_161	[p11l1202t1074r1229b1094],
10	23	CD	NUMBER	23	num	13	SENT_161	[p11l1305t1074r1330b1094],
11	12	CD	NUMBER	12	num	13	SENT_161	[p11l1408t1074r1433b1094],
12	Erlotinib	NNP	O	Erlotinib	nn	13	SENT_161	[p11l142t1105r240b1127],
13	Erlotinib	NNP	O	Erlotinib	dep	1	SENT_161	[p11l983t1105r1082b1127],
14	117	CD	NUMBER	117	number	15	SENT_161	[p11l1189t1107r1229b1127],
15	71	CD	NUMBER	71	num	16	SENT_161	[p11l1306t1107r1331b1127],
16	43	CD	NUMBER	43	dep	13	SENT_161	[p11l1406t1107r1432b1127],

1	E	NN	O	e	_	0	SENT_162	[p11l116t1183r132b1209],
2	No	DT	MISC	no	det	3	SENT_162	[p11l158t1187r195b1209],
3	Polysomy	NN	MISC	polysomy	dep	1	SENT_162	[p11l206t1185r327b1216],
4	or	CC	MISC	or	_	0	SENT_162	[p11l336t1193r362b1209],
5	Ampliﬁcation	NN	MISC	ampliﬁcation	dep	1	SENT_162	[p11l370t1185r540b1216],
6	of	IN	O	of	_	0	SENT_162	[p11l551t1185r580b1209],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_162	[p11l585t1187r657b1209],
8	F	NN	O	f	prep_of	3	SENT_162	[p11l958t1183r974b1209],
9	High	JJ	O	high	amod	10	SENT_162	[p11l999t1185r1059b1216],
10	Polysomy	NN	O	polysomy	dep	1	SENT_162	[p11l1071t1185r1193b1216],
11	or	CC	O	or	_	0	SENT_162	[p11l1201t1193r1228b1209],
12	Amplification	NN	O	amplification	nn	13	SENT_162	[p11l1235t1185r1406b1216],
13	ofEGFR	NN	O	ofegfr	conj_or	10	SENT_162	[p11l1416t1185r1522b1209],

1	10	CD	NUMBER	10	_	0	SENT_163	[p11l319t1234r359b1255],
2	°	CD	NUMBER	°	rcmod	1	SENT_163	[p11l319t1234r359b1255],
3	Np	NN	ORGANIZATION	np	dep	2	SENT_163	[p11l380t1250r391b1273],
4	e	SYM	O	e	dep	2	SENT_163	[p11l380t1250r391b1273],
5	+	CC	O	+	_	0	SENT_163	[p11l380t1250r391b1273],
6	P	NN	O	p	conj_+	1	SENT_163	[p11l481t1244r563b1265],
7	=	JJ	O	=	dep	6	SENT_163	[p11l481t1244r563b1265],
8	0.59	CD	NUMBER	0.59	iobj	7	SENT_163	[p11l481t1244r563b1265],
9	Hazard	NN	O	hazard	nn	10	SENT_163	[p11l669t1245r753b1267],
10	ratio	NN	O	ratio	dobj	7	SENT_163	[p11l765t1247r824b1271],
11	,	,	O	,	_	0	SENT_163	[p11l765t1247r824b1271],
12	0.85	CD	NUMBER	0.85	number	13	SENT_163	[p11l834t1246r882b1267],
13	100	CD	NUMBER	100	amod	10	SENT_163	[p11l1160t1234r1201b1255],
14	-	:	O	-	_	0	SENT_163	[p11l1226t1252r1232b1255],
15	.	.	O	.	_	0	SENT_163	[p11l1249t1262r1257b1275],

1	__	NN	O	__	nn	2	SENT_164	[p11l1249t1262r1257b1275],
2	P	NN	O	p	dep	21	SENT_164	[p11l1270t1244r1367b1265],
3	=	JJ	O	=	amod	6	SENT_164	[p11l1270t1244r1367b1265],
4	0.008	CD	NUMBER	0.008	tmod	3	SENT_164	[p11l1270t1244r1367b1265],
5	Hazard	NN	O	hazard	nn	6	SENT_164	[p11l1467t1243r1552b1265],
6	ratio	NN	O	ratio	dep	2	SENT_164	[p11l1563t1245r1622b1269],
7	,	,	O	,	_	0	SENT_164	[p11l1563t1245r1622b1269],
8	0.44	CD	NUMBER	0.44	num	14	SENT_164	[p11l1632t1244r1681b1265],
9	so	IN	O	so	amod	14	SENT_164	[p11l332t1282r359b1303],
10	__	CD	PERCENT	__	number	11	SENT_164	[p11l440t1305r446b1312],
11	(	CD	PERCENT	(	dep	9	SENT_164	[p11l647t1279r708b1307],
12	95	CD	PERCENT	95	num	13	SENT_164	[p11l647t1279r708b1307],
13	%	NN	PERCENT	%	dep	11	SENT_164	[p11l647t1279r708b1307],
14	CI	NN	O	ci	appos	6	SENT_164	[p11l717t1280r747b1304],
15	,	,	O	,	_	0	SENT_164	[p11l717t1280r747b1304],
16	0.48-1	CD	NUMBER	0.48-1	number	17	SENT_164	[p11l758t1279r881b1307],
17	.51	CD	NUMBER	.51	num	18	SENT_164	[p11l758t1279r881b1307],
18	)	NN	O	)	appos	6	SENT_164	[p11l758t1279r881b1307],
19	30	CD	NUMBER	30	dep	21	SENT_164	[p11l1173t1282r1201b1303],
20	‘	CD	NUMBER	‘	num	21	SENT_164	[p11l1255t1277r1270b1297],
21	x.	NN	O	x.	dep	35	SENT_164	[p11l1255t1277r1270b1297],
22	(	CD	PERCENT	(	num	25	SENT_164	[p11l1446t1277r1506b1305],
23	95	CD	PERCENT	95	number	24	SENT_164	[p11l1446t1277r1506b1305],
24	%	NN	PERCENT	%	amod	25	SENT_164	[p11l1446t1277r1506b1305],
25	CI	NN	O	ci	dep	21	SENT_164	[p11l1515t1278r1546b1302],
26	,	,	O	,	_	0	SENT_164	[p11l1515t1278r1546b1302],
27	0.23-0	CD	NUMBER	0.23-0	num	29	SENT_164	[p11l1556t1278r1679b1305],
28	.82	CD	NUMBER	.82	num	29	SENT_164	[p11l1556t1278r1679b1305],
29	)	NN	O	)	appos	25	SENT_164	[p11l1556t1278r1679b1305],
30	60	CD	NUMBER	60	number	31	SENT_164	[p11l332t1331r359b1351],
31	60	CD	NUMBER	60	num	33	SENT_164	[p11l1173t1331r1201b1351],
32	40	CD	NUMBER	40	number	33	SENT_164	[p11l331t1379r359b1400],
33	40	CD	NUMBER	40	dep	29	SENT_164	[p11l1173t1379r1201b1400],
34	20	CD	NUMBER	20	num	35	SENT_164	[p11l332t1427r359b1448],
35	20	CD	NUMBER	20	_	0	SENT_164	[p11l1173t1427r1201b1448],

1	I	PRP	O	I	nsubj	4	SENT_165	[p11l1351t1333r1353b1337],
2	'	''	O	'	_	0	SENT_165	[p11l1372t1350r1378b1352],
3	'	''	O	'	_	0	SENT_165	[p11l1401t1374r1404b1378],
4	Erlotinib	NNP	O	Erlotinib	_	0	SENT_165	[p11l1426t1346r1525b1369],

1	Survival	NN	O	survival	dep	7	SENT_166	[p11l258t1343r281b1444],
2	(	CD	PERCENT	(	num	3	SENT_166	[p11l259t1290r289b1331],
3	%	NN	PERCENT	%	dep	1	SENT_166	[p11l259t1290r289b1331],
4	)	CD	NUMBER	)	num	5	SENT_166	[p11l259t1290r289b1331],
5	Survival	NN	O	survival	dep	7	SENT_166	[p11l1099t1343r1123b1444],
6	(	CD	PERCENT	(	num	7	SENT_166	[p11l1101t1290r1130b1331],
7	%	NN	PERCENT	%	_	0	SENT_166	[p11l1101t1290r1130b1331],
8	)	CD	NUMBER	)	dep	7	SENT_166	[p11l1101t1290r1130b1331],

1	No.	NN	O	no.	_	0	SENT_167	[p11l141t1614r185b1635],
2	at	IN	O	at	_	0	SENT_167	[p11l195t1616r219b1635],
3	Risk	NN	O	risk	nn	4	SENT_167	[p11l229t1612r281b1635],
4	No.	NN	O	no.	prep_at	1	SENT_167	[p11l983t1614r1027b1635],
5	at	IN	O	at	_	0	SENT_167	[p11l1037t1616r1060b1635],
6	Risk	NN	O	risk	prep_at	4	SENT_167	[p11l1071t1612r1122b1635],
7	Placebo	NNP	O	Placebo	nn	10	SENT_167	[p11l142t1649r232b1671],
8	Placebo	NNP	O	Placebo	nn	10	SENT_167	[p11l983t1649r1074b1671],
9	Erlotinib	NNP	O	Erlotinib	nn	10	SENT_167	[p11l142t1682r240b1704],
10	Erlotinib	NNP	O	Erlotinib	dep	1	SENT_167	[p11l983t1682r1082b1704],

1	G	NN	O	g	_	0	SENT_168	[p11l111t1760r134b1786],
2	Wild-Type	JJ	O	wild-type	amod	4	SENT_168	[p11l155t1762r282b1793],
3	EGFR	NN	O	egfr	nn	4	SENT_168	[p11l292t1764r364b1786],
4	H	NN	O	h	dep	1	SENT_168	[p11l953t1760r976b1785],
5	Mutant	JJ	O	mutant	amod	6	SENT_168	[p11l999t1764r1092b1786],
6	EGFR	NN	O	egfr	dep	1	SENT_168	[p11l1101t1764r1174b1786],

1	100	CD	NUMBER	100	num	2	SENT_169	[p11l319t1811r359b1831],
2	2	CD	NUMBER	2	_	0	SENT_169	[p11l386t1835r402b1842],
3	V	NN	O	v	prep	2	SENT_169	[p11l413t1849r415b1853],
4	Hazard	NN	O	hazard	nn	5	SENT_169	[p11l669t1823r753b1845],
5	ratio	NN	O	ratio	dep	3	SENT_169	[p11l765t1825r824b1849],
6	,	,	O	,	_	0	SENT_169	[p11l765t1825r824b1849],
7	0.73	CD	NUMBER	0.73	appos	2	SENT_169	[p11l834t1825r882b1845],
8	100	CD	NUMBER	100	num	10	SENT_169	[p11l1160t1811r1201b1831],
9	Hazard	NN	O	hazard	nn	10	SENT_169	[p11l1467t1822r1552b1844],
10	ratio	NN	O	ratio	rcmod	7	SENT_169	[p11l1563t1824r1622b1848],
11	,	,	O	,	_	0	SENT_169	[p11l1563t1824r1622b1848],
12	0.77	CD	NUMBER	0.77	appos	10	SENT_169	[p11l1632t1823r1681b1844],
13	so	IN	O	so	dep	14	SENT_169	[p11l332t1859r359b1880],
14	l	NN	O	l	amod	12	SENT_169	[p11l413t1855r457b1893],
15	e	SYM	O	e	dep	10	SENT_169	[p11l413t1855r457b1893],
16	+	CC	O	+	_	0	SENT_169	[p11l413t1855r457b1893],
17	(	CD	PERCENT	(	num	20	SENT_169	[p11l647t1857r708b1885],
18	95	CD	PERCENT	95	number	19	SENT_169	[p11l647t1857r708b1885],
19	%	NN	PERCENT	%	amod	20	SENT_169	[p11l647t1857r708b1885],
20	CI	NN	O	ci	appos	2	SENT_169	[p11l717t1858r747b1882],
21	,	,	O	,	_	0	SENT_169	[p11l717t1858r747b1882],
22	0.49-1	CD	NUMBER	0.49-1	appos	2	SENT_169	[p11l758t1858r881b1885],
23	.10	CD	NUMBER	.10	num	24	SENT_169	[p11l758t1858r881b1885],
24	)	NN	O	)	rcmod	22	SENT_169	[p11l758t1858r881b1885],
25	80	CD	NUMBER	80	dep	24	SENT_169	[p11l1173t1859r1201b1880],
26	e	SYM	O	e	dep	24	SENT_169	[p11l1257t1864r1286b1893],
27	+	CC	O	+	_	0	SENT_169	[p11l1257t1864r1286b1893],
28	(	CD	PERCENT	(	num	31	SENT_169	[p11l1446t1856r1506b1884],
29	95	CD	PERCENT	95	number	30	SENT_169	[p11l1446t1856r1506b1884],
30	%	NN	PERCENT	%	amod	31	SENT_169	[p11l1446t1856r1506b1884],
31	CI	NN	O	ci	appos	2	SENT_169	[p11l1515t1857r1546b1881],
32	,	,	O	,	_	0	SENT_169	[p11l1515t1857r1546b1881],
33	0.40-1	CD	NUMBER	0.40-1	num	35	SENT_169	[p11l1556t1856r1679b1884],
34	.50	CD	NUMBER	.50	num	35	SENT_169	[p11l1556t1856r1679b1884],
35	)	NN	O	)	appos	2	SENT_169	[p11l1556t1856r1679b1884],
36	so	RB	O	so	advmod	37	SENT_169	[p11l332t1907r359b1928],
37	_	RB	O	_	amod	35	SENT_169	[p11l494t1925r500b1928],
38	,	,	O	,	_	0	SENT_169	[p11l514t1932r520b1939],
39	_	NN	O	_	appos	2	SENT_169	[p11l514t1932r520b1939],
40	so	RB	O	so	advmod	45	SENT_169	[p11l1173t1907r1201b1928],
41	40	CD	NUMBER	40	num	42	SENT_169	[p11l331t1956r359b1976],
42	H	NN	O	h	pobj	40	SENT_169	[p11l542t1945r666b1989],
43	“	CD	NUMBER	“	number	44	SENT_169	[p11l542t1945r666b1989],
44	\	CD	NUMBER	\	num	45	SENT_169	[p11l542t1945r666b1989],
45	__	NN	O	__	rcmod	39	SENT_169	[p11l542t1945r666b1989],
46	.	.	O	.	_	0	SENT_169	[p11l542t1945r666b1989],

1	‘	NN	O	‘	_	0	SENT_170	[p11l542t1945r666b1989],
2	.	.	O	.	_	0	SENT_170	[p11l542t1945r666b1989],

1	.	.	O	.	_	0	SENT_171	[p11l542t1945r666b1989],

1	E	NN	O	e	_	0	SENT_172	[p11l542t1945r666b1989],
2	|	NN	O	|	dep	1	SENT_172	[p11l542t1945r666b1989],
3	'	''	O	'	_	0	SENT_172	[p11l542t1945r666b1989],
4	lotl	JJ	O	lotl	amod	5	SENT_172	[p11l542t1945r666b1989],
5	nib	NN	O	nib	dep	1	SENT_172	[p11l671t1947r706b1969],
6	40	CD	NUMBER	40	number	7	SENT_172	[p11l1173t1956r1201b1976],
7	20	CD	NUMBER	20	num	8	SENT_172	[p11l332t2004r359b2025],
8	20	CD	NUMBER	20	dep	5	SENT_172	[p11l1173t2004r1201b2025],

1	Survival	NN	O	survival	dep	7	SENT_173	[p11l258t1920r281b2021],
2	(	CD	PERCENT	(	num	3	SENT_173	[p11l259t1867r289b1908],
3	%	NN	PERCENT	%	dep	1	SENT_173	[p11l259t1867r289b1908],
4	)	CD	NUMBER	)	num	5	SENT_173	[p11l259t1867r289b1908],
5	Survival	NN	O	survival	dep	7	SENT_173	[p11l1099t1920r1123b2021],
6	(	CD	PERCENT	(	num	7	SENT_173	[p11l1101t1867r1130b1908],
7	%	NN	PERCENT	%	_	0	SENT_173	[p11l1101t1867r1130b1908],
8	)	CD	NUMBER	)	dep	7	SENT_173	[p11l1101t1867r1130b1908],

1	Months	NNS	DURATION	month	_	0	SENT_174	[p11l583t2133r680b2157],

1	No.	NN	O	no.	_	0	SENT_175	[p11l141t2190r185b2212],
2	at	IN	O	at	_	0	SENT_175	[p11l195t2192r219b2212],
3	Risk	NN	O	risk	nn	4	SENT_175	[p11l229t2188r281b2212],
4	No.	NN	O	no.	prep_at	1	SENT_175	[p11l983t2191r1027b2212],
5	at	IN	O	at	_	0	SENT_175	[p11l1037t2192r1060b2212],
6	Risk	NN	O	risk	nn	7	SENT_175	[p11l1071t2188r1122b2212],
7	Placebo	NN	O	placebo	prep_at	4	SENT_175	[p11l142t2225r232b2247],
8	44	CD	NUMBER	44	num	12	SENT_175	[p11l360t2227r388b2247],
9	18	CD	NUMBER	18	num	12	SENT_175	[p11l465t2227r490b2248],
10	11	CD	NUMBER	11	num	12	SENT_175	[p11l566t2227r591b2247],
11	Placebo	NNP	O	Placebo	nn	12	SENT_175	[p11l983t2225r1074b2247],
12	Erlotinib	NNP	O	Erlotinib	dep	1	SENT_175	[p11l142t2259r240b2281],
13	93	CD	NUMBER	93	number	14	SENT_175	[p11l361t2260r386b2281],
14	59	CD	NUMBER	59	dep	12	SENT_175	[p11l464t2260r490b2281],
15	34	CD	NUMBER	34	num	16	SENT_175	[p11l565t2260r592b2281],
16	Erlotinib	NN	O	erlotinib	dep	14	SENT_175	[p11l983t2259r1082b2281],

1	N	NN	O	n	nn	2	SENT_176	[p11l577t2390r591b2405],
2	ENGL	NN	ORGANIZATION	engl	_	0	SENT_176	[p11l607t2389r690b2411],
3	)	CD	NUMBER	)	num	4	SENT_176	[p11l607t2389r690b2411],
4	MED	NN	O	med	dep	2	SENT_176	[p11l705t2390r758b2405],
5	353	CD	NUMBER	353	dep	2	SENT_176	[p11l770t2389r834b2411],
6	;	:	O	;	_	0	SENT_176	[p11l770t2389r834b2411],
7	2	CD	NUMBER	2	dep	2	SENT_176	[p11l770t2389r834b2411],
8	WWW	NNP	O	WWW	dep	7	SENT_176	[p11l869t2389r1080b2411],
9	.	.	O	.	_	0	SENT_176	[p11l869t2389r1080b2411],

1	NE	NNS	O	ne	nsubj	2	SENT_177	[p11l869t2389r1080b2411],
2	)	VBP	O	)	_	0	SENT_177	[p11l869t2389r1080b2411],
3	M.ORG	NNP	O	M.ORG	nn	4	SENT_177	[p11l869t2389r1080b2411],
4	JULY	NNP	DATE	JULY	dobj	2	SENT_177	[p11l1114t2390r1174b2411],
5	14	CD	DATE	14	num	4	SENT_177	[p11l1187t2389r1221b2411],
6	,	,	DATE	,	_	0	SENT_177	[p11l1187t2389r1221b2411],
7	2005	CD	DATE	2005	num	4	SENT_177	[p11l1234t2389r1297b2411],
8	137	CD	NUMBER	137	dep	4	SENT_177	[p11l2011t2388r2067b2410],

1	The	DT	O	the	det	5	SENT_178	[p11l753t2486r804b2510],
2	New	NNP	O	New	nn	5	SENT_178	[p11l813t2487r875b2510],
3	England	NNP	O	England	nn	5	SENT_178	[p11l884t2486r995b2517],
4	J	NNP	O	J	nn	5	SENT_178	[p11l1003t2487r1016b2510],
5	oumal	NN	O	oumal	_	0	SENT_178	[p11l1017t2486r1101b2510],
6	of	IN	O	of	_	0	SENT_178	[p11l1111t2486r1139b2510],
7	Medicine	NN	O	medicine	prep_of	5	SENT_178	[p11l1146t2486r1271b2510],

1	Downloaded	VBN	O	download	_	0	SENT_179	[p11l195t2527r365b2550],
2	from	IN	O	from	_	0	SENT_179	[p11l373t2527r438b2550],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_179	[p11l447t2527r565b2557],
4	at	IN	O	at	_	0	SENT_179	[p11l575t2531r598b2550],
5	UW-Madison	NN	O	uw-madison	prep_at	3	SENT_179	[p11l607t2527r789b2550],
6	on	IN	O	on	_	0	SENT_179	[p11l799t2534r831b2550],
7	J	NN	O	j	prep_on	1	SENT_179	[p11l840t2527r852b2550],
8	anuary	JJ	O	anuary	amod	7	SENT_179	[p11l854t2534r943b2557],
9	5	CD	NUMBER	5	tmod	8	SENT_179	[p11l953t2527r975b2555],
10	,	,	O	,	_	0	SENT_179	[p11l953t2527r975b2555],
11	2014	CD	DATE	2014	dobj	1	SENT_179	[p11l986t2527r1058b2550],
12	.	.	O	.	_	0	SENT_179	[p11l986t2527r1058b2550],

1	For	IN	O	for	_	0	SENT_180	[p11l1069t2527r1115b2550],
2	personal	JJ	O	personal	amod	3	SENT_180	[p11l1123t2527r1236b2557],
3	use	NN	O	use	pobj	1	SENT_180	[p11l1245t2534r1288b2550],
4	only	RB	O	only	advmod	3	SENT_180	[p11l1298t2527r1363b2557],
5	.	.	O	.	_	0	SENT_180	[p11l1298t2527r1363b2557],

1	No	DT	O	no	det	3	SENT_181	[p11l1373t2527r1413b2550],
2	other	JJ	O	other	amod	3	SENT_181	[p11l1423t2527r1491b2550],
3	uses	NNS	O	use	_	0	SENT_181	[p11l1499t2534r1555b2550],
4	without	IN	O	without	_	0	SENT_181	[p11l1566t2527r1667b2550],
5	permission	NN	O	permission	prep_without	3	SENT_181	[p11l1675t2527r1828b2557],
6	.	.	O	.	_	0	SENT_181	[p11l1675t2527r1828b2557],

1	Copyright	NN	O	copyright	_	0	SENT_182	[p11l545t2568r679b2599],
2	©	CD	NUMBER	©	num	6	SENT_182	[p11l689t2568r712b2592],
3	2005	CD	DATE	2005	num	6	SENT_182	[p11l722t2568r786b2592],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_182	[p11l797t2568r988b2592],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_182	[p11l998t2568r1106b2592],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_182	[p11l1116t2568r1221b2599],
7	.	.	O	.	_	0	SENT_182	[p11l1116t2568r1221b2599],

1	All	DT	O	all	det	2	SENT_183	[p11l1232t2568r1273b2592],
2	rights	NNS	O	rights	nsubj	3	SENT_183	[p11l1283t2568r1357b2599],
3	reserved	VBN	O	reserve	_	0	SENT_183	[p11l1367t2568r1486b2592],
4	.	.	O	.	_	0	SENT_183	[p11l1367t2568r1486b2592],

1	The	DT	O	the	det	3	SENT_184	[p11l714t2610r752b2631],
2	NEW	NNP	O	NEW	nn	3	SENT_184	[p11l764t2612r844b2631],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_184	[p11l858t2612r1033b2631],
4	IOURNAL	NNP	O	IOURNAL	nn	5	SENT_184	[p11l1047t2612r1213b2638],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_184	[p11l1227t2610r1443b2637],

1	Figure	NN	O	figure	_	0	SENT_185	[p12l264t1261r348b1293],
2	2	CD	NUMBER	2	dep	1	SENT_185	[p12l357t1263r380b1285],
3	.	.	O	.	_	0	SENT_185	[p12l357t1263r380b1285],

1	Expression	NN	O	expression	nsubj	10	SENT_186	[p12l392t1261r538b1293],
2	of	IN	O	of	_	0	SENT_186	[p12l548t1260r660b1286],
3	'	''	O	'	_	0	SENT_186	[p12l548t1260r660b1286],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_186	[p12l548t1260r660b1286],
5	Protein	NN	O	protein	prep_of	1	SENT_186	[p12l671t1261r766b1286],
6	on	IN	O	on	_	0	SENT_186	[p12l776t1269r809b1286],
7	lmmunohistochemical	JJ	O	lmmunohistochemical	amod	8	SENT_186	[p12l821t1260r1128b1286],
8	Analysis	NN	O	analysis	prep_on	1	SENT_186	[p12l1137t1260r1251b1293],
9	(	CD	NUMBER	(	num	10	SENT_186	[p12l1262t1260r1360b1294],
10	Panels	NNPS	O	Panels	_	0	SENT_186	[p12l1262t1260r1360b1294],
11	A	DT	O	a	dobj	10	SENT_186	[p12l1369t1263r1388b1285],
12	and	CC	O	and	_	0	SENT_186	[p12l1397t1260r1446b1286],
13	B	NN	O	b	dobj	10	SENT_186	[p12l1458t1263r1483b1294],
14	)	NN	O	)	dep	11	SENT_186	[p12l1458t1263r1483b1294],
15	and	CC	O	and	_	0	SENT_186	[p12l1494t1260r1543b1286],
16	Fluorescence	NN	O	fluorescence	dep	11	SENT_186	[p12l1556t1260r1734b1286],
17	in	IN	O	in	_	0	SENT_186	[p12l1744t1261r1767b1285],
18	Situ	NNP	O	Situ	nn	20	SENT_186	[p12l1777t1261r1829b1286],
19	Hybridization	NNP	O	Hybridization	nn	20	SENT_186	[p12l264t1302r446b1335],
20	Analysis	NN	O	analysis	prep_in	10	SENT_186	[p12l455t1302r569b1335],
21	of	IN	O	of	_	0	SENT_186	[p12l578t1302r609b1327],
22	the	DT	O	the	det	23	SENT_186	[p12l612t1302r656b1327],
23	Number	NNP	O	Number	prep_of	20	SENT_186	[p12l667t1302r779b1327],
24	of	IN	O	of	_	0	SENT_186	[p12l787t1302r819b1327],
25	Gene	NNP	O	Gene	nn	29	SENT_186	[p12l822t1304r894b1327],
26	Copies	NNP	O	Copies	nn	29	SENT_186	[p12l903t1303r994b1335],
27	(	NNP	O	(	nn	29	SENT_186	[p12l1006t1302r1103b1335],
28	Panels	NNPS	O	Panels	nn	29	SENT_186	[p12l1006t1302r1103b1335],
29	C	NNP	O	C	prep_of	23	SENT_186	[p12l1113t1304r1132b1327],
30	and	CC	O	and	_	0	SENT_186	[p12l1141t1302r1190b1327],
31	D	NNP	O	D	prep_of	23	SENT_186	[p12l1202t1304r1241b1335],
32	)	CD	NUMBER	)	num	31	SENT_186	[p12l1202t1304r1241b1335],
33	.	.	O	.	_	0	SENT_186	[p12l1202t1304r1241b1335],

1	Incomplete	JJ	O	incomplete	amod	5	SENT_187	[p12l264t1352r416b1385],
2	(	NN	O	(	nn	5	SENT_187	[p12l428t1352r509b1385],
3	Panel	NN	O	panel	nn	5	SENT_187	[p12l428t1352r509b1385],
4	A	NN	O	a	nn	5	SENT_187	[p12l518t1354r546b1385],
5	)	NN	O	)	nsubjpass	16	SENT_187	[p12l518t1354r546b1385],
6	and	CC	O	and	_	0	SENT_187	[p12l558t1352r606b1377],
7	complete	JJ	O	complete	amod	14	SENT_187	[p12l616t1352r742b1385],
8	(	NN	O	(	nn	14	SENT_187	[p12l754t1352r835b1385],
9	Panel	NN	O	panel	nn	14	SENT_187	[p12l754t1352r835b1385],
10	B	NN	O	b	nn	14	SENT_187	[p12l848t1354r872b1385],
11	)	CD	NUMBER	)	num	14	SENT_187	[p12l848t1354r872b1385],
12	membranous	JJ	O	membranous	amod	14	SENT_187	[p12l885t1352r1066b1377],
13	immunohistochemical	JJ	O	immunohistochemical	amod	14	SENT_187	[p12l1077t1352r1383b1377],
14	staining	NN	O	staining	conj_and	5	SENT_187	[p12l1394t1354r1502b1385],
15	are	VBP	O	be	auxpass	16	SENT_187	[p12l1510t1361r1551b1377],
16	scored	VBN	O	score	_	0	SENT_187	[p12l1560t1352r1648b1377],
17	as	IN	O	as	_	0	SENT_187	[p12l1658t1361r1686b1377],
18	'	''	O	'	_	0	SENT_187	[p12l1747t1354r1808b1377],
19	tive	JJ	O	tive	prep_as	16	SENT_187	[p12l1747t1354r1808b1377],
20	.	.	O	.	_	0	SENT_187	[p12l1747t1354r1808b1377],

1	FISH	NN	O	fish	nn	4	SENT_188	[p12l1820t1354r1884b1377],
2	ofdiploid	JJ	O	ofdiploid	amod	4	SENT_188	[p12l262t1393r389b1427],
3	tumor	NN	O	tumor	nn	4	SENT_188	[p12l399t1399r484b1419],
4	cells	NNS	O	cell	nsubj	5	SENT_188	[p12l493t1394r551b1419],
5	shows	VBZ	O	show	_	0	SENT_188	[p12l562t1394r646b1419],
6	one	CD	NUMBER	one	dobj	5	SENT_188	[p12l657t1403r706b1419],
7	or	CC	O	or	_	0	SENT_188	[p12l716t1403r743b1419],
8	two	CD	NUMBER	two	num	12	SENT_188	[p12l751t1399r800b1419],
9	red	JJ	O	red	amod	12	SENT_188	[p12l811t1394r851b1419],
10	(	JJ	O	(	amod	12	SENT_188	[p12l865t1396r960b1427],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_188	[p12l865t1396r960b1427],
12	)	NN	O	)	dobj	5	SENT_188	[p12l865t1396r960b1427],
13	and	CC	O	and	_	0	SENT_188	[p12l973t1394r1021b1419],
14	one	CD	NUMBER	one	conj_and	6	SENT_188	[p12l1032t1403r1081b1419],
15	or	CC	O	or	_	0	SENT_188	[p12l1091t1403r1118b1419],
16	two	CD	NUMBER	two	conj_or	14	SENT_188	[p12l1126t1399r1175b1419],
17	green	JJ	O	green	amod	21	SENT_188	[p12l1185t1403r1259b1427],
18	(	NN	O	(	nn	21	SENT_188	[p12l1273t1396r1363b1427],
19	CEP7	NN	O	cep7	nn	21	SENT_188	[p12l1273t1396r1363b1427],
20	)	NN	O	)	nn	21	SENT_188	[p12l1273t1396r1363b1427],
21	signals	NNS	O	signal	nsubj	25	SENT_188	[p12l1376t1394r1469b1427],
22	in	IN	O	in	_	0	SENT_188	[p12l1480t1396r1502b1419],
23	most	JJS	O	most	amod	24	SENT_188	[p12l1514t1399r1582b1419],
24	cells	NNS	O	cell	prep_in	21	SENT_188	[p12l1592t1394r1650b1419],
25	(	VBP	O	(	rcmod	14	SENT_188	[p12l1663t1396r1689b1427],
26	P	NN	O	p	nn	29	SENT_188	[p12l1663t1396r1689b1427],
27	n	NN	O	n	nn	29	SENT_188	[p12l1708t1403r1721b1419],
28	C	NN	O	c	nn	29	SENT_188	[p12l1756t1396r1793b1427],
29	)	NN	O	)	dobj	25	SENT_188	[p12l1756t1396r1793b1427],
30	,	,	O	,	_	0	SENT_188	[p12l1756t1396r1793b1427],
31	whereas	IN	O	whereas	mark	35	SENT_188	[p12l1803t1394r1893b1419, p12l262t1444r290b1461],
32	cells	NNS	O	cell	nsubj	35	SENT_188	[p12l301t1435r359b1461],
33	with	IN	O	with	_	0	SENT_188	[p12l368t1435r425b1461],
34	ampliﬁcation	NN	O	ampliﬁcation	prep_with	32	SENT_188	[p12l436t1435r613b1468],
35	show	VBP	O	show	advcl	5	SENT_188	[p12l625t1435r696b1461],
36	an	DT	O	a	det	39	SENT_188	[p12l706t1444r736b1461],
37	excess	JJ	O	excess	amod	39	SENT_188	[p12l747t1444r833b1461],
38	ofred	JJ	O	ofred	amod	39	SENT_188	[p12l844t1435r920b1461],
39	signals	NNS	O	signal	nsubj	40	SENT_188	[p12l932t1435r1026b1469],
40	(	VBP	O	(	ccomp	35	SENT_188	[p12l1039t1435r1121b1468],
41	Panel	NN	O	panel	nn	42	SENT_188	[p12l1039t1435r1121b1468],
42	D	NN	O	d	dobj	40	SENT_188	[p12l1135t1438r1173b1468],
43	)	CD	NUMBER	)	num	42	SENT_188	[p12l1135t1438r1173b1468],
44	.	.	O	.	_	0	SENT_188	[p12l1135t1438r1173b1468],

1	Mutational	JJ	O	mutational	amod	2	SENT_189	[p12l136t1712r596b1790],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_189	[p12l619t1712r962b1811],
3	were	VBD	O	be	auxpass	4	SENT_189	[p12l984t1737r1183b1791],
4	attempted	VBN	O	attempt	_	0	SENT_189	[p12l1207t1712r1627b1811],
5	in	IN	O	in	_	0	SENT_189	[p12l1650t1712r1730b1788],
6	197	CD	NUMBER	197	num	7	SENT_189	[p12l1758t1717r1906b1789],
7	samples	NNS	O	sample	prep_in	4	SENT_189	[p12l1932t1737r2134b1789, p12l9t1840r201b1940],
8	,	,	O	,	_	0	SENT_189	[p12l1932t1737r2134b1789, p12l9t1840r201b1940],
9	110	CD	NUMBER	110	nsubj	12	SENT_189	[p12l233t1845r383b1918],
10	of	IN	O	of	_	0	SENT_189	[p12l407t1839r507b1918],
11	which	WDT	O	which	prep_of	9	SENT_189	[p12l507t1840r767b1919],
12	yielded	VBD	O	yield	rcmod	7	SENT_189	[p12l785t1840r1086b1940],
13	sufficient	JJ	O	sufficient	amod	14	SENT_189	[p12l1110t1839r1508b1919],
14	DNA	NN	MISC	dna	dobj	12	SENT_189	[p12l1524t1846r1736b1918],
15	to	TO	O	to	aux	16	SENT_189	[p12l1757t1856r1836b1918],
16	amplify	VB	O	amplify	xcomp	12	SENT_189	[p12l1859t1840r2134b1940, p12l10t1967r86b2068],
17	and	CC	O	and	cc	19	SENT_189	[p12l104t1967r262b2046],
18	sequence	NN	O	sequence	nn	19	SENT_189	[p12l288t1993r684b2068],
19	exons	NNS	O	exon	dobj	16	SENT_189	[p12l709t1993r954b2046],
20	18	CD	NUMBER	18	dep	19	SENT_189	[p12l985t1973r1081b2046],
21	through	IN	O	through	_	0	SENT_189	[p12l1109t1968r1456b2068],
22	21	CD	NUMBER	21	number	23	SENT_189	[p12l1482t1973r1583b2045],
23	(	CD	NUMBER	(	num	24	SENT_189	[p12l1613t1973r1745b2059],
24	59	CD	NUMBER	59	prep_through	16	SENT_189	[p12l1613t1973r1745b2059],
25	required	VBN	O	require	partmod	24	SENT_189	[p12l1771t1968r2134b2068],
26	microdissection	NN	O	microdissection	nn	27	SENT_189	[p12l10t2096r747b2186],
27	)	NN	O	)	dobj	25	SENT_189	[p12l10t2096r747b2186],
28	.	.	O	.	_	0	SENT_189	[p12l10t2096r747b2186],

1	Among	IN	O	among	_	0	SENT_190	[p12l788t2102r1107b2195],
2	these	DT	O	these	det	4	SENT_190	[p12l1142t2096r1361b2173],
3	110	CD	NUMBER	110	num	4	SENT_190	[p12l1403t2101r1553b2173],
4	samples	NNS	O	sample	prep_among	9	SENT_190	[p12l1593t2096r1961b2195],
5	,	,	O	,	_	0	SENT_190	[p12l1593t2096r1961b2195],
6	the	DT	O	the	det	7	SENT_190	[p12l2006t2096r2135b2173],
7	analysis	NN	O	analysis	nsubj	9	SENT_190	[p12l10t2224r340b2324],
8	was	VBD	O	be	cop	9	SENT_190	[p12l369t2250r530b2303],
9	unsuccessful	JJ	O	unsuccessful	_	0	SENT_190	[p12l562t2223r1108b2303],
10	in	IN	O	in	_	0	SENT_190	[p12l1137t2224r1219b2301],
11	3	CD	NUMBER	3	num	12	SENT_190	[p12l1251t2229r1294b2302],
12	samples	NNS	O	sample	prep_in	9	SENT_190	[p12l1330t2224r1672b2324],
13	and	CC	O	and	_	0	SENT_190	[p12l1705t2224r1860b2302],
14	exons	NNS	O	exon	conj_and	12	SENT_190	[p12l1892t2249r2133b2302],
15	19	CD	NUMBER	19	num	14	SENT_190	[p12l14t2357r110b2430],
16	and	CC	O	and	_	0	SENT_190	[p12l139t2352r297b2430],
17	21	CD	NUMBER	21	conj_and	12	SENT_190	[p12l324t2357r427b2429],
18	were	VBD	O	be	auxpass	20	SENT_190	[p12l451t2378r655b2431],
19	successfully	RB	O	successfully	advmod	20	SENT_190	[p12l686t2351r1204b2452],
20	analyzed	VBN	O	analyze	rcmod	14	SENT_190	[p12l1226t2352r1601b2452],
21	in	IN	O	in	_	0	SENT_190	[p12l1629t2352r1711b2429],
22	107	CD	NUMBER	107	num	23	SENT_190	[p12l1742t2357r1894b2430],
23	samples	NNS	O	sample	prep_in	20	SENT_190	[p12l1925t2378r2132b2430, p12l9t2480r206b2580],
24	,	,	O	,	_	0	SENT_190	[p12l1925t2378r2132b2430, p12l9t2480r206b2580],
25	24	CD	NUMBER	24	appos	23	SENT_190	[p12l251t2485r353b2558],
26	of	IN	O	of	_	0	SENT_190	[p12l393t2479r494b2558],
27	which	WDT	O	which	rel	32	SENT_190	[p12l510t2480r775b2559],
28	(	NN	PERCENT	(	nsubj	32	SENT_190	[p12l819t2485r950b2571],
29	22	CD	PERCENT	22	num	31	SENT_190	[p12l819t2485r950b2571],
30	percent	NN	PERCENT	percent	nn	31	SENT_190	[p12l989t2487r1340b2580],
31	)	NN	O	)	dep	28	SENT_190	[p12l989t2487r1340b2580],
32	contained	VBD	O	contain	rcmod	25	SENT_190	[p12l1385t2480r1814b2558],
33	one	CD	NUMBER	one	num	36	SENT_190	[p12l1852t2505r2006b2558],
34	or	CC	O	or	_	0	SENT_190	[p12l2047t2505r2136b2558],
35	more	JJR	O	more	conj_or	33	SENT_190	[p12l10t2632r228b2685],
36	mutations	NNS	O	mutation	dobj	32	SENT_190	[p12l250t2608r694b2686],
37	.	.	O	.	_	0	SENT_190	[p12l250t2608r694b2686],

1	The	DT	O	the	det	3	SENT_191	[p12l717t2608r876b2685],
2	83	CD	NUMBER	83	num	3	SENT_191	[p12l896t2613r992b2685],
3	samples	NNS	O	sample	nsubjpass	12	SENT_191	[p12l1018t2608r1353b2707],
4	without	IN	O	without	_	0	SENT_191	[p12l1371t2608r1698b2686],
5	mutations	NNS	O	mutation	prep_without	3	SENT_191	[p12l1713t2608r2134b2686],
6	in	IN	O	in	_	0	SENT_191	[p12l10t2736r90b2813],
7	exons	NNS	O	exon	prep_in	5	SENT_191	[p12l116t2761r361b2814],
8	19	CD	NUMBER	19	num	7	SENT_191	[p12l392t2741r489b2814],
9	and	CC	O	and	_	0	SENT_191	[p12l514t2736r673b2814],
10	21	CD	NUMBER	21	prep_in	5	SENT_191	[p12l697t2741r800b2813],
11	were	VBD	O	be	auxpass	12	SENT_191	[p12l821t2762r1026b2815],
12	classiﬁed	VBN	O	classiﬁed	_	0	SENT_191	[p12l1052t2735r1453b2814],
13	as	IN	O	as	_	0	SENT_191	[p12l1478t2762r1562b2814],
14	Wild	NNP	O	Wild	nn	15	SENT_191	[p12l1585t2736r1773b2815],
15	type	NN	O	type	prep_as	12	SENT_191	[p12l1798t2752r1997b2836],
16	,	,	O	,	_	0	SENT_191	[p12l1798t2752r1997b2836],
17	although	IN	O	although	mark	34	SENT_191	[p12l2026t2736r2133b2814, p12l11t2864r321b2964],
18	some	DT	O	some	det	19	SENT_191	[p12l347t2889r571b2942],
19	analyses	NNS	O	analysis	nsubj	34	SENT_191	[p12l595t2864r944b2964],
20	of	IN	O	of	_	0	SENT_191	[p12l971t2863r1071b2942],
21	exons	NNS	O	exon	prep_of	19	SENT_191	[p12l1077t2889r1318b2942],
22	18	CD	NUMBER	18	number	23	SENT_191	[p12l1348t2869r1442b2942],
23	(	CD	NUMBER	(	dep	21	SENT_191	[p12l1474t2869r1551b2955],
24	6	CD	NUMBER	6	num	25	SENT_191	[p12l1474t2869r1551b2955],
25	samples	NNS	O	sample	dep	21	SENT_191	[p12l1577t2864r1951b2964],
26	)	CD	NUMBER	)	dep	25	SENT_191	[p12l1577t2864r1951b2964],
27	and	CC	O	and	_	0	SENT_191	[p12l1979t2864r2135b2942],
28	20	CD	NUMBER	20	num	31	SENT_191	[p12l10t2997r112b3070],
29	(	NN	O	(	nn	31	SENT_191	[p12l141t2999r219b3083],
30	7	CD	NUMBER	7	num	31	SENT_191	[p12l141t2999r219b3083],
31	samples	NNS	O	sample	conj_and	21	SENT_191	[p12l245t2992r626b3092],
32	)	CD	NUMBER	)	dep	31	SENT_191	[p12l245t2992r626b3092],
33	had	VBD	O	have	aux	34	SENT_191	[p12l655t2992r813b3070],
34	failed	VBN	O	fail	advcl	12	SENT_191	[p12l835t2991r1098b3070],
35	.	.	O	.	_	0	SENT_191	[p12l835t2991r1098b3070],

1	The	DT	O	the	nsubjpass	26	SENT_192	[p12l1123t2992r1287b3070],
2	remaining	VBG	O	remain	amod	1	SENT_192	[p12l1311t2992r1761b3092],
3	87	CD	NUMBER	87	num	5	SENT_192	[p12l1781t2997r1882b3070],
4	biopsy	NN	O	biopsy	nn	5	SENT_192	[p12l1908t2992r2133b3092, p12l12t3146r97b3220],
5	specimens	NNS	O	specimen	nsubj	10	SENT_192	[p12l125t3120r578b3220],
6	of	IN	O	of	_	0	SENT_192	[p12l611t3119r712b3198],
7	the	DT	O	the	det	9	SENT_192	[p12l725t3120r856b3198],
8	original	JJ	O	original	amod	9	SENT_192	[p12l888t3120r1224b3220],
9	197	CD	NUMBER	197	prep_of	5	SENT_192	[p12l1259t3125r1410b3198],
10	contained	VBD	O	contain	rcmod	1	SENT_192	[p12l1443t3120r1871b3198],
11	small	JJ	O	small	amod	12	SENT_192	[p12l1903t3120r2134b3198],
12	amounts	NNS	O	amount	dobj	10	SENT_192	[p12l10t3263r382b3326],
13	of	IN	O	of	_	0	SENT_192	[p12l414t3246r514b3325],
14	tissue	NN	O	tissue	nn	15	SENT_192	[p12l523t3247r765b3325],
15	(	NN	O	(	prep_of	12	SENT_192	[p12l797t3252r874b3337],
16	1	CD	NUMBER	1	num	15	SENT_192	[p12l797t3252r874b3337],
17	to	TO	O	to	_	0	SENT_192	[p12l903t3263r982b3325],
18	3	CD	NUMBER	3	num	19	SENT_192	[p12l1011t3252r1055b3325],
19	mm	NN	O	mm	prep_to	10	SENT_192	[p12l1086t3273r1255b3323],
20	in	IN	O	in	_	0	SENT_192	[p12l1282t3247r1362b3323],
21	diameter	NN	O	diameter	nn	22	SENT_192	[p12l1390t3247r1822b3341],
22	)	NN	O	)	prep_in	19	SENT_192	[p12l1390t3247r1822b3341],
23	;	:	O	;	_	0	SENT_192	[p12l1390t3247r1822b3341],
24	microdissection	NN	O	microdissection	dep	19	SENT_192	[p12l1853t3247r2134b3325, p12l11t3375r437b3453],
25	was	VBD	O	be	auxpass	26	SENT_192	[p12l461t3401r623b3454],
26	required	VBN	O	require	_	0	SENT_192	[p12l654t3375r1009b3475],
27	for	IN	O	for	_	0	SENT_192	[p12l1037t3374r1160b3453],
28	45	CD	NUMBER	45	prep_for	26	SENT_192	[p12l1184t3380r1311b3470],
29	,	,	O	,	_	0	SENT_192	[p12l1184t3380r1311b3470],
30	since	IN	O	since	mark	39	SENT_192	[p12l1346t3375r1559b3453],
31	only	RB	O	only	quantmod	34	SENT_192	[p12l1589t3375r1770b3475],
32	20	CD	NUMBER	20	number	34	SENT_192	[p12l1794t3380r1895b3453],
33	to	TO	O	to	dep	34	SENT_192	[p12l1925t3391r2004b3453],
34	30	CD	PERCENT	30	num	35	SENT_192	[p12l2034t3380r2134b3453],
35	percent	NN	PERCENT	percent	nsubj	39	SENT_192	[p12l9t3519r329b3603],
36	of	IN	O	of	_	0	SENT_192	[p12l352t3502r453b3581],
37	cells	NNS	O	cell	prep_of	35	SENT_192	[p12l461t3503r644b3581],
38	were	VBD	O	be	cop	39	SENT_192	[p12l669t3529r870b3582],
39	malignant	JJ	O	malignant	advcl	26	SENT_192	[p12l897t3503r1353b3603],
40	.	.	O	.	_	0	SENT_192	[p12l897t3503r1353b3603],

1	These	DT	O	these	det	3	SENT_193	[p12l1383t3503r1633b3581],
2	87	CD	NUMBER	87	num	3	SENT_193	[p12l1661t3508r1761b3581],
3	samples	NNS	O	sample	nsubj	4	SENT_193	[p12l1790t3503r2133b3603],
4	yielded	VBD	O	yield	_	0	SENT_193	[p12l6t3630r307b3731],
5	DNA	NN	O	dna	dobj	4	SENT_193	[p12l338t3637r550b3709],
6	that	WDT	O	that	nsubj	8	SENT_193	[p12l580t3631r747b3709],
7	was	VBD	O	be	cop	8	SENT_193	[p12l771t3657r932b3710],
8	adequate	JJ	O	adequate	rcmod	5	SENT_193	[p12l967t3631r1344b3731],
9	for	IN	O	for	_	0	SENT_193	[p12l1378t3630r1501b3709],
10	analysis	NN	O	analysis	prep_for	8	SENT_193	[p12l1531t3631r1861b3731],
11	of	IN	O	of	_	0	SENT_193	[p12l1897t3630r1997b3709],
12	exons	NNS	O	exon	prep_of	10	SENT_193	[p12l2013t3657r2133b3709, p13l11t46r158b99],

1	19	CD	NUMBER	19	dep	4	SENT_194	[p13l198t26r295b99],
2	and	CC	O	and	_	0	SENT_194	[p13l330t21r488b99],
3	21	CD	NUMBER	21	dep	4	SENT_194	[p13l521t26r623b98],
4	alone	RB	O	alone	_	0	SENT_194	[p13l656t21r914b99],
5	.	.	O	.	_	0	SENT_194	[p13l656t21r914b99],

1	Analysis	NN	O	analysis	nsubjpass	8	SENT_195	[p13l950t21r1308b121],
2	of	IN	O	of	_	0	SENT_195	[p13l1345t20r1446b99],
3	17	CD	NUMBER	17	prep_of	1	SENT_195	[p13l1465t26r1562b99],
4	of	IN	O	of	_	0	SENT_195	[p13l1598t20r1700b99],
5	the	DT	O	the	det	6	SENT_195	[p13l1715t21r1846b99],
6	specimens	NNS	O	specimen	prep_of	3	SENT_195	[p13l1882t21r2133b121, p13l10t174r241b227],
7	Was	VBD	O	be	auxpass	8	SENT_195	[p13l266t175r429b228],
8	considered	VBN	O	consider	_	0	SENT_195	[p13l457t149r920b227],
9	unsuccessful	JJ	O	unsuccessful	acomp	8	SENT_195	[p13l945t148r1490b228],
10	because	IN	O	because	mark	15	SENT_195	[p13l1516t149r1847b228],
11	one	CD	NUMBER	one	nsubj	15	SENT_195	[p13l1874t174r2027b227],
12	of	IN	O	of	_	0	SENT_195	[p13l2053t148r2153b227],
13	these	DT	O	these	det	14	SENT_195	[p13l11t277r229b355],
14	exons	NNS	O	exon	prep_of	11	SENT_195	[p13l259t302r499b355],
15	had	VBD	O	have	advcl	8	SENT_195	[p13l530t276r685b355],
16	no	DT	O	no	det	17	SENT_195	[p13l714t302r819b355],
17	mutations	NNS	O	mutation	dobj	15	SENT_195	[p13l850t277r1280b356],
18	and	CC	O	and	_	0	SENT_195	[p13l1310t277r1466b355],
19	the	DT	O	the	det	20	SENT_195	[p13l1495t277r1624b355],
20	other	JJ	O	other	nsubj	21	SENT_195	[p13l1653t277r1877b355],
21	failed	VBD	O	fail	advcl	8	SENT_195	[p13l1902t276r2135b355],
22	to	TO	O	to	aux	23	SENT_195	[p13l11t421r90b483],
23	yield	VB	O	yield	xcomp	21	SENT_195	[p13l119t405r318b505],
24	a	DT	O	a	det	26	SENT_195	[p13l349t431r394b483],
25	deﬁnitive	JJ	O	deﬁnitive	amod	26	SENT_195	[p13l425t404r815b483],
26	result	NN	O	result	dobj	23	SENT_195	[p13l847t405r1107b484],
27	.	.	O	.	_	0	SENT_195	[p13l847t405r1107b484],

1	Analysis	NN	O	analysis	nsubj	7	SENT_196	[p13l1140t405r1491b505],
2	of	IN	O	of	_	0	SENT_196	[p13l1526t404r1627b483],
3	the	DT	O	the	det	6	SENT_196	[p13l1641t405r1770b483],
4	remaining	VBG	O	remain	amod	6	SENT_196	[p13l1802t405r2134b483, p13l10t533r148b632],
5	70	CD	NUMBER	70	num	6	SENT_196	[p13l168t538r267b610],
6	specimens	NNS	O	specimen	prep_of	1	SENT_196	[p13l291t533r735b632],
7	revealed	VBD	O	reveal	_	0	SENT_196	[p13l759t533r1103b611],
8	17	CD	NUMBER	17	num	9	SENT_196	[p13l1128t538r1224b610],
9	mutations	NNS	O	mutation	dobj	7	SENT_196	[p13l1248t533r1678b611],
10	in	IN	O	in	_	0	SENT_196	[p13l1701t533r1783b609],
11	16	CD	NUMBER	16	num	12	SENT_196	[p13l1808t538r1905b610],
12	samples	NNS	O	sample	prep_in	7	SENT_196	[p13l1930t558r2134b610, p13l9t661r179b760],
13	(	CD	PERCENT	(	number	14	SENT_196	[p13l221t666r350b751],
14	23	CD	PERCENT	23	num	16	SENT_196	[p13l221t666r350b751],
15	percent	NN	PERCENT	percent	nn	16	SENT_196	[p13l388t667r770b760],
16	)	NN	O	)	dep	7	SENT_196	[p13l388t667r770b760],
17	.	.	O	.	_	0	SENT_196	[p13l388t667r770b760],

1	Thus	RB	O	thus	advmod	6	SENT_197	[p13l807t661r1049b755],
2	,	,	O	,	_	0	SENT_197	[p13l807t661r1049b755],
3	mutational	JJ	O	mutational	amod	4	SENT_197	[p13l1090t661r1564b739],
4	analysis	NN	O	analysis	nsubj	6	SENT_197	[p13l1598t661r1935b760],
5	was	VBD	O	be	cop	6	SENT_197	[p13l1968t686r2131b739],
6	successful	JJ	O	successful	_	0	SENT_197	[p13l12t788r450b868],
7	in	IN	O	in	_	0	SENT_197	[p13l476t789r557b866],
8	177	CD	NUMBER	177	prep_in	6	SENT_197	[p13l587t794r737b867],
9	of	IN	O	of	_	0	SENT_197	[p13l766t788r866b867],
10	the	DT	O	the	det	13	SENT_197	[p13l874t789r1004b867],
11	197	CD	NUMBER	197	num	13	SENT_197	[p13l1034t794r1184b867],
12	tumor	NN	O	tumor	nn	13	SENT_197	[p13l1212t805r1475b868],
13	specimens	NNS	O	specimen	prep_of	8	SENT_197	[p13l1500t789r1944b889],
14	that	WDT	O	that	nsubjpass	16	SENT_197	[p13l1973t788r2140b867],
15	were	VBD	O	be	auxpass	16	SENT_197	[p13l6t942r208b996],
16	evaluated	VBN	O	evaluate	rcmod	13	SENT_197	[p13l233t917r627b995],
17	(	RB	O	(	advmod	16	SENT_197	[p13l656t922r786b1007],
18	90	CD	PERCENT	90	num	20	SENT_197	[p13l656t922r786b1007],
19	percent	NN	PERCENT	percent	nn	20	SENT_197	[p13l811t923r1184b1016],
20	)	NN	O	)	dobj	16	SENT_197	[p13l811t923r1184b1016],
21	.	.	O	.	_	0	SENT_197	[p13l811t923r1184b1016],

1	In	IN	O	in	_	0	SENT_198	[p13l138t1052r224b1122],
2	total	NN	O	total	prep_in	7	SENT_198	[p13l247t1045r458b1140],
3	,	,	O	,	_	0	SENT_198	[p13l247t1045r458b1140],
4	45	CD	NUMBER	45	num	5	SENT_198	[p13l484t1050r583b1123],
5	mutations	NNS	O	mutation	nsubjpass	7	SENT_198	[p13l608t1045r1035b1124],
6	Were	VBD	O	be	auxpass	7	SENT_198	[p13l1055t1071r1255b1124],
7	found	VBN	O	find	_	0	SENT_198	[p13l1278t1044r1527b1124],
8	in	IN	O	in	_	0	SENT_198	[p13l1549t1045r1629b1122],
9	40	CD	NUMBER	40	num	10	SENT_198	[p13l1651t1050r1752b1123],
10	patients	NNS	O	patient	prep_in	7	SENT_198	[p13l1774t1045r2131b1145],
11	:	:	O	:	_	0	SENT_198	[p13l1774t1045r2131b1145],
12	3	CD	NUMBER	3	num	13	SENT_198	[p13l11t1178r55b1251],
13	mutations	NNS	O	mutation	dep	10	SENT_198	[p13l86t1173r525b1251],
14	in	IN	O	in	_	0	SENT_198	[p13l555t1173r637b1249],
15	exon	NN	O	exon	prep_in	13	SENT_198	[p13l668t1197r870b1250],
16	18	CD	NUMBER	18	num	15	SENT_198	[p13l903t1178r1026b1267],
17	,	,	O	,	_	0	SENT_198	[p13l903t1178r1026b1267],
18	13	CD	NUMBER	13	num	19	SENT_198	[p13l1064t1178r1159b1251],
19	deletions	NNS	O	deletion	conj_and	10	SENT_198	[p13l1192t1173r1583b1250],
20	and	CC	O	and	_	0	SENT_198	[p13l1613t1173r1771b1251],
21	8	CD	NUMBER	8	num	22	SENT_198	[p13l1801t1178r1846b1250],
22	mutations	NNS	O	mutation	conj_and	10	SENT_198	[p13l1877t1188r2133b1251, p13l11t1301r222b1378],
23	in	IN	O	in	_	0	SENT_198	[p13l256t1301r338b1377],
24	exon	NN	O	exon	prep_in	22	SENT_198	[p13l372t1326r574b1378],
25	19	CD	NUMBER	19	num	24	SENT_198	[p13l611t1306r734b1395],
26	,	,	O	,	_	0	SENT_198	[p13l611t1306r734b1395],
27	5	CD	NUMBER	5	num	28	SENT_198	[p13l775t1307r817b1378],
28	mutations	NNS	O	mutation	conj_and	10	SENT_198	[p13l852t1301r1291b1379],
29	in	IN	O	in	_	0	SENT_198	[p13l1326t1301r1408b1377],
30	exon	NN	O	exon	prep_in	28	SENT_198	[p13l1442t1326r1645b1378],
31	20	CD	NUMBER	20	num	30	SENT_198	[p13l1677t1306r1804b1395],
32	,	,	O	,	_	0	SENT_198	[p13l1677t1306r1804b1395],
33	and	CC	NUMBER	and	_	0	SENT_198	[p13l1842t1301r1999b1378],
34	16	CD	NUMBER	16	num	35	SENT_198	[p13l2035t1306r2133b1378],
35	mutations	NNS	O	mutation	conj_and	10	SENT_198	[p13l10t1429r447b1508],
36	in	IN	O	in	_	0	SENT_198	[p13l469t1429r551b1506],
37	exon	NN	O	exon	prep_in	35	SENT_198	[p13l572t1454r772b1507],
38	21	CD	NUMBER	21	num	37	SENT_198	[p13l793t1434r893b1506],
39	(	CD	NUMBER	(	num	40	SENT_198	[p13l919t1429r1103b1529],
40	Fig	NN	O	fig	dep	35	SENT_198	[p13l919t1429r1103b1529],
41	.	.	O	.	_	0	SENT_198	[p13l919t1429r1103b1529],

1	3	CD	NUMBER	3	_	0	SENT_199	[p13l1130t1434r1174b1507],
2	and	CC	O	and	_	0	SENT_199	[p13l1198t1429r1353b1507],
3	Table	NNP	O	Table	conj_and	1	SENT_199	[p13l1371t1429r1598b1507],
4	2	CD	NUMBER	2	dep	1	SENT_199	[p13l1620t1434r1667b1506],
5	in	IN	O	in	_	0	SENT_199	[p13l1688t1429r1769b1506],
6	the	DT	O	the	det	9	SENT_199	[p13l1790t1429r1920b1507],
7	Supplementary	NNP	O	Supplementary	nn	9	SENT_199	[p13l1943t1434r2132b1529, p13l9t1557r501b1657],
8	Appendix	NNP	O	Appendix	nn	9	SENT_199	[p13l529t1557r1006b1657],
9	)	NN	O	)	prep_in	4	SENT_199	[p13l529t1557r1006b1657],
10	.	.	O	.	_	0	SENT_199	[p13l529t1557r1006b1657],

1	Mutations	NNS	O	mutation	nsubjpass	3	SENT_200	[p13l1044t1557r1486b1636],
2	Were	VBD	O	be	auxpass	3	SENT_200	[p13l1520t1583r1725b1636],
3	found	VBN	O	find	_	0	SENT_200	[p13l1761t1556r2016b1636],
4	in	IN	O	in	_	0	SENT_200	[p13l2051t1557r2134b1634],
5	28	CD	PERCENT	28	num	6	SENT_200	[p13l10t1690r109b1763],
6	percent	NN	PERCENT	percent	prep_in	3	SENT_200	[p13l138t1701r458b1785],
7	of	IN	O	of	_	0	SENT_200	[p13l482t1684r582b1763],
8	adenocarcinoma	NN	O	adenocarcinoma	nn	9	SENT_200	[p13l590t1685r1296b1763],
9	samples	NNS	O	sample	prep_of	6	SENT_200	[p13l1324t1685r1667b1785],
10	examined	VBN	O	examine	partmod	9	SENT_200	[p13l1697t1685r2129b1780],
11	,	,	O	,	_	0	SENT_200	[p13l1697t1685r2129b1780],
12	16	CD	PERCENT	16	num	13	SENT_200	[p13l14t1818r112b1891],
13	percent	NN	PERCENT	percent	prep_in	3	SENT_200	[p13l137t1829r467b1913],
14	of	IN	O	of	_	0	SENT_200	[p13l489t1812r591b1891],
15	tumor	NN	O	tumor	nn	16	SENT_200	[p13l598t1829r868b1892],
16	specimens	NNS	O	specimen	prep_of	13	SENT_200	[p13l892t1813r1348b1913],
17	of	IN	O	of	_	0	SENT_200	[p13l1377t1812r1479b1891],
18	other	JJ	O	other	amod	20	SENT_200	[p13l1487t1813r1717b1891],
19	histologic	JJ	O	histologic	amod	20	SENT_200	[p13l1740t1813r2132b1913, p13l10t1941r80b2019],
20	types	NNS	O	type	prep_of	16	SENT_200	[p13l114t1957r330b2041],
21	(	VBP	O	(	rcmod	20	SENT_200	[p13l372t1946r782b2036],
22	P	NN	O	p	dobj	21	SENT_200	[p13l372t1946r782b2036],
23	=	JJ	O	=	amod	20	SENT_200	[p13l372t1946r782b2036],
24	0.05	CD	NUMBER	0.05	num	25	SENT_200	[p13l372t1946r782b2036],
25	)	NN	O	)	dep	23	SENT_200	[p13l372t1946r782b2036],
26	,	,	O	,	_	0	SENT_200	[p13l372t1946r782b2036],
27	24	CD	PERCENT	24	num	28	SENT_200	[p13l823t1946r925b2019],
28	percent	NN	PERCENT	percent	appos	20	SENT_200	[p13l958t1957r1285b2041],
29	of	IN	O	of	_	0	SENT_200	[p13l1315t1940r1416b2019],
30	specimens	NNS	O	specimen	prep_of	28	SENT_200	[p13l1434t1941r1886b2041],
31	from	IN	O	from	_	0	SENT_200	[p13l1923t1940r2134b2019],
32	Women	NNS	O	woman	prep_from	30	SENT_200	[p13l6t2094r343b2164],
33	,	,	O	,	_	0	SENT_200	[p13l6t2094r343b2164],
34	22	CD	PERCENT	22	num	35	SENT_200	[p13l370t2074r469b2146],
35	percent	NN	PERCENT	percent	appos	20	SENT_200	[p13l490t2085r806b2169],
36	of	IN	O	of	_	0	SENT_200	[p13l823t2068r922b2147],
37	specimens	NNS	O	specimen	prep_of	35	SENT_200	[p13l927t2069r1364b2169],
38	from	IN	O	from	_	0	SENT_200	[p13l1388t2068r1592b2147],
39	men	NNS	O	man	prep_from	37	SENT_200	[p13l1614t2094r1820b2164],
40	,	,	O	,	_	0	SENT_200	[p13l1614t2094r1820b2164],
41	31	CD	PERCENT	31	num	42	SENT_200	[p13l1848t2074r1947b2147],
42	percent	NN	PERCENT	percent	appos	20	SENT_200	[p13l1968t2095r2134b2169, p13l11t2213r195b2275],
43	of	IN	O	of	_	0	SENT_200	[p13l229t2196r331b2275],
44	specimens	NNS	O	specimen	prep_of	42	SENT_200	[p13l352t2197r809b2297],
45	from	IN	O	from	_	0	SENT_200	[p13l849t2196r1061b2275],
46	patients	NNS	O	patient	prep_from	44	SENT_200	[p13l1098t2197r1444b2297],
47	who	WP	O	who	nsubj	50	SENT_200	[p13l1480t2197r1666b2276],
48	had	VBD	O	have	aux	50	SENT_200	[p13l1706t2197r1864b2275],
49	never	RB	O	never	neg	50	SENT_200	[p13l1902t2222r2136b2276],
50	smoked	VBN	O	smoke	rcmod	46	SENT_200	[p13l12t2325r378b2420],
51	,	,	O	,	_	0	SENT_200	[p13l12t2325r378b2420],
52	21	CD	PERCENT	21	num	53	SENT_200	[p13l420t2330r522b2402],
53	percent	NN	PERCENT	percent	conj_and	42	SENT_200	[p13l558t2341r889b2425],
54	of	IN	O	of	_	0	SENT_200	[p13l921t2324r1023b2403],
55	specimens	NNS	O	specimen	prep_of	53	SENT_200	[p13l1043t2325r1499b2425],
56	from	IN	O	from	_	0	SENT_200	[p13l1538t2324r1750b2403],
57	patients	NNS	O	patient	prep_from	55	SENT_200	[p13l1785t2325r2131b2425],
58	who	WP	O	who	nsubj	63	SENT_200	[p13l6t2453r191b2532],
59	were	VBD	O	be	cop	63	SENT_200	[p13l211t2479r415b2532],
60	current	JJ	DATE	current	amod	63	SENT_200	[p13l438t2469r747b2532],
61	or	CC	O	or	_	0	SENT_200	[p13l763t2478r853b2531],
62	former	JJ	O	former	amod	63	SENT_200	[p13l871t2452r1165b2531],
63	smokers	NNS	O	smoker	rcmod	57	SENT_200	[p13l1185t2453r1567b2548],
64	,	,	O	,	_	0	SENT_200	[p13l1185t2453r1567b2548],
65	50	CD	PERCENT	50	num	66	SENT_200	[p13l1596t2458r1694b2531],
66	percent	NN	PERCENT	percent	conj_and	42	SENT_200	[p13l1715t2469r2036b2553],
67	of	IN	O	of	_	0	SENT_200	[p13l2053t2452r2153b2531],
68	specimens	NNS	O	specimen	prep_of	66	SENT_200	[p13l12t2581r464b2681],
69	from	IN	O	from	_	0	SENT_200	[p13l492t2580r703b2659],
70	Asian	JJ	LOCATION	asian	amod	71	SENT_200	[p13l725t2581r968b2659],
71	patients	NNS	O	patient	prep_from	68	SENT_200	[p13l993t2581r1361b2681],
72	,	,	O	,	_	0	SENT_200	[p13l993t2581r1361b2681],
73	and	CC	O	and	_	0	SENT_200	[p13l1392t2581r1550b2659],
74	21	CD	PERCENT	21	num	75	SENT_200	[p13l1576t2586r1677b2658],
75	percent	NN	PERCENT	percent	conj_and	42	SENT_200	[p13l1703t2597r2029b2681],
76	of	IN	O	of	_	0	SENT_200	[p13l2051t2580r2152b2659],
77	specimens	NNS	O	specimen	prep_of	75	SENT_200	[p13l12t2709r468b2809],
78	from	IN	O	from	_	0	SENT_200	[p13l500t2708r712b2787],
79	patients	NNS	O	patient	prep_from	77	SENT_200	[p13l739t2709r1085b2809],
80	in	IN	O	in	_	0	SENT_200	[p13l1115t2709r1198b2786],
81	other	JJ	O	other	amod	82	SENT_200	[p13l1228t2709r1458b2787],
82	racial	JJ	O	racial	prep_in	79	SENT_200	[p13l1484t2709r1720b2787],
83	or	CC	O	or	_	0	SENT_200	[p13l1749t2734r1840b2787],
84	ethnic	JJ	O	ethnic	conj_or	6	SENT_200	[p13l1866t2709r2134b2787],

1	t	NN	O	t	nsubj	5	SENT_201	[p13l149t2884r204b2906],
2	+	CC	O	+	_	0	SENT_201	[p13l149t2884r204b2906],
3	N	NN	O	n	nn	4	SENT_201	[p13l918t2886r932b2901],
4	ENGLJ	NN	O	englj	conj_+	1	SENT_201	[p13l947t2885r1031b2907],
5	MED	VBD	O	med	_	0	SENT_201	[p13l1046t2886r1099b2901],
6	3532	CD	NUMBER	3532	num	7	SENT_201	[p13l1111t2885r1175b2907],
7	WWW	NNP	O	WWW	dobj	5	SENT_201	[p13l1210t2886r1322b2901],
8	.	.	O	.	_	0	SENT_201	[p13l1210t2886r1322b2901],

1	NE	NNS	O	ne	nsubj	2	SENT_202	[p13l1210t2886r1322b2901],
2	M.ORG	VBP	O	m.org	_	0	SENT_202	[p13l1338t2885r1422b2901],
3	JULY14	NN	O	july14	dobj	2	SENT_202	[p13l1455t2885r1562b2907],
4	,	,	O	,	_	0	SENT_202	[p13l1455t2885r1562b2907],
5	2005	CD	DATE	2005	appos	3	SENT_202	[p13l1575t2885r1638b2907],

1	The	DT	O	the	det	5	SENT_203	[p13l935t2918r986b2942],
2	New	NNP	O	New	nn	5	SENT_203	[p13l995t2919r1057b2942],
3	England	NNP	O	England	nn	5	SENT_203	[p13l1066t2918r1177b2949],
4	Journal	NNP	O	Journal	nn	5	SENT_203	[p13l1186t2918r1283b2942],
5	o	NN	O	o	_	0	SENT_203	[p13l1293t2926r1308b2942],
6	edicine	NN	O	edicine	dep	5	SENT_203	[p13l1359t2918r1454b2942],

1	Downloaded	VBN	O	download	_	0	SENT_204	[p13l377t2959r547b2982],
2	from	IN	O	from	_	0	SENT_204	[p13l556t2959r620b2982],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_204	[p13l629t2959r747b2989],
4	at	IN	O	at	_	0	SENT_204	[p13l758t2963r781b2982],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_204	[p13l789t2959r972b2982],
6	on	IN	O	on	_	0	SENT_204	[p13l981t2966r1013b2982],
7	January	NNP	DATE	January	prep_on	1	SENT_204	[p13l1022t2959r1125b2989],
8	5	CD	DATE	5	num	7	SENT_204	[p13l1135t2959r1158b2986],
9	,	,	DATE	,	_	0	SENT_204	[p13l1135t2959r1158b2986],
10	2014	CD	DATE	2014	num	7	SENT_204	[p13l1169t2959r1241b2982],
11	.	.	O	.	_	0	SENT_204	[p13l1169t2959r1241b2982],

1	For	IN	O	for	_	0	SENT_205	[p13l1251t2959r1298b2982],
2	personal	JJ	O	personal	amod	3	SENT_205	[p13l1306t2959r1418b2989],
3	use	NN	O	use	pobj	1	SENT_205	[p13l1427t2966r1471b2982],
4	only	RB	O	only	advmod	3	SENT_205	[p13l1481t2959r1545b2989],
5	.	.	O	.	_	0	SENT_205	[p13l1481t2959r1545b2989],

1	No	DT	O	no	det	3	SENT_206	[p13l1556t2959r1596b2982],
2	other	JJ	O	other	amod	3	SENT_206	[p13l1606t2959r1674b2982],
3	uses	NNS	O	use	_	0	SENT_206	[p13l1682t2966r1738b2982],
4	without	IN	O	without	_	0	SENT_206	[p13l1748t2959r1849b2982],
5	permission	NN	O	permission	prep_without	3	SENT_206	[p13l1858t2959r2010b2989],
6	.	.	O	.	_	0	SENT_206	[p13l1858t2959r2010b2989],

1	ERLOTINIB	JJ	O	erlotinib	amod	2	SENT_207	[p13l736t3106r923b3125],
2	THERAPY	NN	O	therapy	_	0	SENT_207	[p13l936t3106r1089b3125],
3	FOR	IN	O	for	_	0	SENT_207	[p13l1102t3106r1167b3125],
4	LUNG	NN	O	lung	prep_for	2	SENT_207	[p13l1180t3106r1274b3125],
5	CANCER	NNP	O	CANCER	dep	2	SENT_207	[p13l1288t3106r1424b3125],

1	groups	NNS	O	group	_	0	SENT_208	[p13l10t3345r309b3420],
2	(	CD	NUMBER	(	num	3	SENT_208	[p13l342t3325r752b3411],
3	P	NN	O	p	dep	1	SENT_208	[p13l342t3325r752b3411],
4	=	JJ	O	=	amod	6	SENT_208	[p13l342t3325r752b3411],
5	0.03	CD	NUMBER	0.03	tmod	4	SENT_208	[p13l342t3325r752b3411],
6	)	NN	O	)	dep	3	SENT_208	[p13l342t3325r752b3411],
7	.	.	O	.	_	0	SENT_208	[p13l342t3325r752b3411],

1	The	DT	O	the	det	2	SENT_209	[p13l780t3319r943b3398],
2	presence	NN	O	presence	nsubjpass	8	SENT_209	[p13l967t3345r1348b3420],
3	of	IN	O	of	_	0	SENT_209	[p13l1375t3319r1477b3398],
4	a	DT	O	a	det	5	SENT_209	[p13l1483t3346r1527b3398],
5	mutation	NN	O	mutation	prep_of	2	SENT_209	[p13l1551t3320r1948b3399],
6	was	VBD	O	be	auxpass	8	SENT_209	[p13l1969t3346r2132b3399],
7	not	RB	O	not	neg	8	SENT_209	[p13l11t3464r156b3526],
8	correlated	VBN	O	correlate	_	0	SENT_209	[p13l184t3447r606b3526],
9	with	IN	O	with	_	0	SENT_209	[p13l632t3448r821b3527],
10	the	DT	O	the	det	11	SENT_209	[p13l852t3448r981b3526],
11	expression	NN	O	expression	prep_with	8	SENT_209	[p13l1012t3448r1467b3548],
12	of	IN	O	of	_	0	SENT_209	[p13l1497t3447r1598b3526],
13	EGFR	NN	ORGANIZATION	egfr	prep_of	11	SENT_209	[p13l1608t3453r1868b3531],
14	or	CC	O	or	_	0	SENT_209	[p13l1888t3473r1978b3526],
15	the	DT	O	the	det	16	SENT_209	[p13l2006t3448r2135b3526],
16	number	NN	O	number	conj_or	11	SENT_209	[p13l11t3576r347b3655],
17	of	IN	O	of	_	0	SENT_209	[p13l370t3575r470b3654],
18	copies	NNS	O	copy	prep_of	16	SENT_209	[p13l478t3576r743b3676],
19	of	IN	O	of	_	0	SENT_209	[p13l771t3575r871b3654],
20	EGFR	NN	ORGANIZATION	egfr	prep_of	18	SENT_209	[p13l875t3582r1105b3655],
21	.	.	O	.	_	0	SENT_209	[p13l875t3582r1105b3655],

1	RESPONSIVEN	NNP	O	RESPONSIVEN	nn	2	SENT_210	[p14l15t112r596b162],
2	ESS	NNP	ORGANIZATION	ESS	nsubj	7	SENT_210	[p14l620t112r753b161],
3	TO	TO	O	to	aux	7	SENT_210	[p14l790t112r895b161],
4	ERLOTI	NNP	O	ERLOTI	nn	7	SENT_210	[p14l940t112r1220b161],
5	NIB	NNP	O	NIB	nn	7	SENT_210	[p14l1245t112r1383b161],
6	Univariate	NNP	O	Univariate	nn	7	SENT_210	[p14l10t213r441b291],
7	analysis	NN	O	analysis	_	0	SENT_210	[p14l473t212r804b312],
8	of	IN	O	of	_	0	SENT_210	[p14l838t211r939b290],
9	data	NNS	O	datum	prep_of	7	SENT_210	[p14l953t212r1133b290],
10	from	IN	O	from	_	0	SENT_210	[p14l1163t211r1370b290],
11	427	CD	NUMBER	427	num	12	SENT_210	[p14l1400t217r1555b290],
12	patients	NNS	O	patient	prep_from	9	SENT_210	[p14l1586t213r1921b312],
13	who	WP	O	who	nsubjpass	16	SENT_210	[p14l1950t212r2134b291],
14	could	MD	O	could	aux	16	SENT_210	[p14l11t341r248b420],
15	be	VB	O	be	auxpass	16	SENT_210	[p14l273t341r369b419],
16	evaluated	VBN	O	evaluate	dep	7	SENT_210	[p14l395t341r796b420],
17	and	CC	O	and	_	0	SENT_210	[p14l820t341r978b419],
18	who	WP	O	who	nsubj	20	SENT_210	[p14l998t341r1184b420],
19	had	VBD	O	have	aux	20	SENT_210	[p14l1210t341r1367b419],
20	received	VBN	O	receive	dep	7	SENT_210	[p14l1392t341r1740b420],
21	erlotinib	NN	O	erlotinib	dobj	20	SENT_210	[p14l1766t341r2133b419],
22	(	CD	NUMBER	(	num	25	SENT_210	[p14l15t469r275b560],
23	Table	NNP	O	Table	nn	25	SENT_210	[p14l15t469r275b560],
24	3	CD	NUMBER	3	num	25	SENT_210	[p14l314t474r392b560],
25	)	NN	O	)	nsubj	26	SENT_210	[p14l314t474r392b560],
26	showed	VBD	O	show	rcmod	21	SENT_210	[p14l437t469r765b548],
27	that	IN	O	that	complm	34	SENT_210	[p14l804t469r974b547],
28	the	DT	O	the	det	31	SENT_210	[p14l1007t469r1138b547],
29	following	VBG	O	follow	amod	31	SENT_210	[p14l1176t468r1594b570],
30	clinical	JJ	O	clinical	amod	31	SENT_210	[p14l1629t469r1938b547],
31	features	NNS	O	feature	nsubjpass	34	SENT_210	[p14l1975t468r2133b547, p14l11t613r215b676],
32	were	VBD	O	be	auxpass	34	SENT_210	[p14l238t623r438b676],
33	signiﬁcantly	RB	O	signiﬁcantly	advmod	34	SENT_210	[p14l466t596r976b698],
34	associated	VBN	O	associate	ccomp	26	SENT_210	[p14l998t597r1427b675],
35	with	IN	O	with	_	0	SENT_210	[p14l1448t597r1635b676],
36	responsiveness	NN	O	responsiveness	prep_with	34	SENT_210	[p14l1660t598r2135b697, p14l11t751r192b803],
37	to	TO	O	to	_	0	SENT_210	[p14l214t742r292b803],
38	erlotinib	NN	O	erlotinib	prep_to	34	SENT_210	[p14l313t725r690b803],
39	:	:	O	:	_	0	SENT_210	[p14l313t725r690b803],
40	female	JJ	O	female	amod	43	SENT_210	[p14l714t724r992b803],
41	sex	NN	O	sex	nn	43	SENT_210	[p14l1014t751r1145b803],
42	(	NN	O	(	nn	43	SENT_210	[p14l1167t730r1610b821],
43	P	NN	O	p	dep	21	SENT_210	[p14l1167t730r1610b821],
44	=	JJ	O	=	rcmod	43	SENT_210	[p14l1167t730r1610b821],
45	0.007	CD	NUMBER	0.007	iobj	44	SENT_210	[p14l1167t730r1610b821],
46	)	NN	O	)	nn	54	SENT_210	[p14l1167t730r1610b821],
47	,	,	O	,	_	0	SENT_210	[p14l1167t730r1610b821],
48	Asian	JJ	MISC	asian	amod	54	SENT_210	[p14l1631t726r1867b803],
49	origin	NN	O	origin	nn	54	SENT_210	[p14l1887t726r2136b826],
50	(	CD	NUMBER	(	num	54	SENT_210	[p14l15t858r410b949],
51	P	NN	O	p	nn	54	SENT_210	[p14l15t858r410b949],
52	=	JJ	O	=	amod	54	SENT_210	[p14l15t858r410b949],
53	0.02	CD	NUMBER	0.02	num	54	SENT_210	[p14l15t858r410b949],
54	)	NN	O	)	dobj	44	SENT_210	[p14l15t858r410b949],
55	,	,	O	,	_	0	SENT_210	[p14l15t858r410b949],
56	never	RB	O	never	neg	58	SENT_210	[p14l447t879r672b932],
57	having	VBG	O	have	aux	58	SENT_210	[p14l700t853r983b954],
58	smoked	VBN	O	smoke	partmod	20	SENT_210	[p14l1013t853r1344b932],
59	(	CD	NUMBER	(	num	60	SENT_210	[p14l1380t858r1811b948],
60	P	NN	O	p	npadvmod	61	SENT_210	[p14l1380t858r1811b948],
61	<	JJR	O	<	acomp	58	SENT_210	[p14l1380t858r1811b948],
62	0.001	CD	NUMBER	0.001	num	63	SENT_210	[p14l1380t858r1811b948],
63	)	NN	O	)	dep	61	SENT_210	[p14l1380t858r1811b948],
64	,	,	O	,	_	0	SENT_210	[p14l1380t858r1811b948],
65	adenocarcinoma	NN	O	adenocarcinoma	nn	67	SENT_210	[p14l1848t853r2134b931, p14l11t982r463b1059],
66	(	CD	NUMBER	(	num	67	SENT_210	[p14l490t986r936b1077],
67	P	NN	O	p	dep	68	SENT_210	[p14l490t986r936b1077],
68	<	JJR	O	<	appos	63	SENT_210	[p14l490t986r936b1077],
69	0.001	CD	NUMBER	0.001	num	70	SENT_210	[p14l490t986r936b1077],
70	)	NN	O	)	dep	68	SENT_210	[p14l490t986r936b1077],
71	,	,	O	,	_	0	SENT_210	[p14l490t986r936b1077],
72	and	CC	O	and	_	0	SENT_210	[p14l966t981r1124b1059],
73	polysomy	NN	O	polysomy	dep	82	SENT_210	[p14l1147t981r1564b1081],
74	or	CC	O	or	_	0	SENT_210	[p14l1585t1007r1675b1059],
75	ampliﬁcation	NN	O	ampliﬁcation	conj_or	73	SENT_210	[p14l1696t980r2133b1081, p14l11t1111r180b1188],
76	of	IN	O	of	_	0	SENT_210	[p14l216t1109r318b1188],
77	EGFR	NN	ORGANIZATION	egfr	nn	79	SENT_210	[p14l333t1117r549b1190],
78	(	CD	NUMBER	(	num	79	SENT_210	[p14l583t1115r993b1201],
79	P	NN	O	p	prep_of	73	SENT_210	[p14l583t1115r993b1201],
80	=	JJ	O	=	amod	82	SENT_210	[p14l583t1115r993b1201],
81	0.03	CD	NUMBER	0.03	num	82	SENT_210	[p14l583t1115r993b1201],
82	)	NN	O	)	conj_and	7	SENT_210	[p14l583t1115r993b1201],
83	.	.	O	.	_	0	SENT_210	[p14l583t1115r993b1201],

1	Mutational	JJ	O	mutational	amod	2	SENT_211	[p14l1031t1110r1508b1189],
2	status	NN	O	status	nsubj	3	SENT_211	[p14l1545t1127r1796b1189],
3	had	VBD	O	have	_	0	SENT_211	[p14l1833t1110r1991b1188],
4	no	DT	O	no	det	6	SENT_211	[p14l2026t1136r2133b1188],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_211	[p14l12t1237r468b1339],
6	association	NN	O	association	dobj	3	SENT_211	[p14l493t1239r960b1316],
7	with	IN	O	with	_	0	SENT_211	[p14l986t1238r1173b1317],
8	responsiveness	NN	O	responsiveness	prep_with	6	SENT_211	[p14l1203t1239r1856b1338],
9	:	:	O	:	_	0	SENT_211	[p14l1203t1239r1856b1338],
10	7	CD	PERCENT	7	num	11	SENT_211	[p14l1892t1245r1939b1316],
11	percent	NN	PERCENT	percent	nsubj	17	SENT_211	[p14l1968t1264r2135b1338, p14l11t1382r188b1444],
12	of	IN	O	of	_	0	SENT_211	[p14l212t1365r313b1444],
13	those	DT	O	those	prep_of	11	SENT_211	[p14l323t1366r555b1444],
14	with	IN	O	with	_	0	SENT_211	[p14l579t1366r771b1445],
15	wild-type	JJ	O	wild-type	amod	16	SENT_211	[p14l795t1366r1197b1466],
16	EGFR	NN	ORGANIZATION	egfr	prep_with	13	SENT_211	[p14l1224t1373r1440b1445],
17	had	VBD	O	have	parataxis	3	SENT_211	[p14l1461t1366r1619b1444],
18	a	DT	O	a	det	19	SENT_211	[p14l1646t1392r1690b1444],
19	response	NN	O	response	dobj	17	SENT_211	[p14l1717t1392r2129b1466],
20	,	,	O	,	_	0	SENT_211	[p14l1717t1392r2129b1466],
21	as	IN	O	as	_	0	SENT_211	[p14l10t1520r94b1572],
22	compared	VBN	O	compare	prepc_as	17	SENT_211	[p14l123t1494r540b1594],
23	with	IN	O	with	pcomp	22	SENT_211	[p14l562t1494r749b1573],
24	16	CD	PERCENT	16	num	25	SENT_211	[p14l779t1499r876b1572],
25	percent	NN	PERCENT	percent	pobj	23	SENT_211	[p14l902t1511r1218b1594],
26	of	IN	O	of	_	0	SENT_211	[p14l1240t1493r1339b1572],
27	those	DT	O	those	prep_of	25	SENT_211	[p14l1349t1494r1572b1572],
28	with	IN	O	with	_	0	SENT_211	[p14l1595t1494r1782b1573],
29	an	DT	O	a	det	33	SENT_211	[p14l1808t1520r1908b1572],
30	EGFR	NN	ORGANIZATION	egfr	nn	33	SENT_211	[p14l1932t1501r2142b1574],
31	mutation	NN	O	mutation	nn	33	SENT_211	[p14l11t1622r411b1701],
32	(	CD	NUMBER	(	num	33	SENT_211	[p14l454t1627r869b1713],
33	P	NN	O	p	prep_with	27	SENT_211	[p14l454t1627r869b1713],
34	=	JJ	O	=	dep	35	SENT_211	[p14l454t1627r869b1713],
35	O.	NNP	O	O.	dep	33	SENT_211	[p14l454t1627r869b1713],
36	37	CD	NUMBER	37	number	37	SENT_211	[p14l454t1627r869b1713],
37	)	CD	NUMBER	)	num	35	SENT_211	[p14l454t1627r869b1713],
38	.	.	O	.	_	0	SENT_211	[p14l454t1627r869b1713],

1	Multiple	JJ	O	multiple	amod	3	SENT_212	[p14l910t1622r1278b1722],
2	logistic-regression	NN	O	logistic-regression	nn	3	SENT_212	[p14l1314t1622r2134b1723],
3	analyses	NNS	O	analysis	nsubj	4	SENT_212	[p14l10t1750r366b1850],
4	revealed	VBD	O	reveal	_	0	SENT_212	[p14l405t1750r756b1829],
5	that	IN	O	that	complm	74	SENT_212	[p14l793t1750r963b1828],
6	only	RB	O	only	advmod	9	SENT_212	[p14l995t1750r1180b1850],
7	never	RB	O	never	neg	9	SENT_212	[p14l1212t1776r1444b1829],
8	having	VBG	O	have	aux	9	SENT_212	[p14l1478t1750r1768b1851],
9	smoked	VBN	O	smoke	dep	74	SENT_212	[p14l1803t1750r2136b1829],
10	(	CD	NUMBER	(	num	11	SENT_212	[p14l15t1883r445b1972],
11	P	NN	O	p	dep	12	SENT_212	[p14l15t1883r445b1972],
12	<	JJR	O	<	dobj	9	SENT_212	[p14l15t1883r445b1972],
13	0.001	CD	NUMBER	0.001	num	14	SENT_212	[p14l15t1883r445b1972],
14	)	NN	O	)	dep	12	SENT_212	[p14l15t1883r445b1972],
15	,	,	O	,	_	0	SENT_212	[p14l15t1883r445b1972],
16	adenocarcinoma	NN	O	adenocarcinoma	nn	18	SENT_212	[p14l483t1878r1178b1955],
17	(	CD	NUMBER	(	num	18	SENT_212	[p14l1215t1883r1606b1972],
18	P	NN	O	p	dobj	9	SENT_212	[p14l1215t1883r1606b1972],
19	=	JJ	O	=	amod	21	SENT_212	[p14l1215t1883r1606b1972],
20	0.01	CD	NUMBER	0.01	tmod	19	SENT_212	[p14l1215t1883r1606b1972],
21	)	NN	O	)	dep	18	SENT_212	[p14l1215t1883r1606b1972],
22	,	,	O	,	_	0	SENT_212	[p14l1215t1883r1606b1972],
23	and	CC	O	and	_	0	SENT_212	[p14l1645t1878r1799b1955],
24	expression	NN	O	expression	dobj	9	SENT_212	[p14l1833t1903r2134b1977, p14l12t2007r185b2084],
25	of	IN	O	of	_	0	SENT_212	[p14l206t2005r305b2084],
26	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_212	[p14l305t2011r561b2089],
27	(	CD	NUMBER	(	num	28	SENT_212	[p14l575t2011r935b2097],
28	P	NN	O	p	prep_of	24	SENT_212	[p14l575t2011r935b2097],
29	=	JJ	O	=	amod	31	SENT_212	[p14l575t2011r935b2097],
30	0.03	CD	NUMBER	0.03	num	31	SENT_212	[p14l575t2011r935b2097],
31	)	NN	O	)	nsubjpass	48	SENT_212	[p14l575t2011r935b2097],
32	were	VBD	O	be	auxpass	33	SENT_212	[p14l955t2032r1153b2085],
33	associated	VBN	O	associate	ccomp	9	SENT_212	[p14l1173t2006r1599b2084],
34	with	IN	O	with	_	0	SENT_212	[p14l1615t2006r1800b2085],
35	responsiveness	NN	O	responsiveness	prep_with	33	SENT_212	[p14l1820t2031r2135b2106, p14l12t2135r361b2213],
36	in	IN	O	in	_	0	SENT_212	[p14l393t2135r475b2210],
37	patients	NNS	O	patient	prep_in	35	SENT_212	[p14l503t2135r845b2233],
38	with	IN	O	with	_	0	SENT_212	[p14l873t2134r1065b2213],
39	samples	NNS	O	sample	prep_with	33	SENT_212	[p14l1096t2134r1445b2233],
40	that	WDT	O	that	nsubj	41	SENT_212	[p14l1477t2134r1647b2211],
41	underwent	VBD	O	undergo	rcmod	39	SENT_212	[p14l1672t2134r2139b2213],
42	immunohistochemical	JJ	O	immunohistochemical	amod	43	SENT_212	[p14l10t2262r960b2341],
43	analysis	NN	O	analysis	dobj	41	SENT_212	[p14l987t2262r1312b2361],
44	and	CC	O	and	_	0	SENT_212	[p14l1342t2262r1496b2339],
45	that	IN	O	that	complm	48	SENT_212	[p14l1525t2262r1689b2339],
46	never	RB	O	never	neg	48	SENT_212	[p14l1712t2287r1936b2340],
47	having	VBG	O	have	aux	48	SENT_212	[p14l1962t2262r2135b2340, p14l10t2391r147b2491],
48	smoked	VBN	O	smoke	conj_and	33	SENT_212	[p14l177t2390r507b2469],
49	(	CD	NUMBER	(	num	50	SENT_212	[p14l544t2395r972b2485],
50	P	NN	O	p	dep	51	SENT_212	[p14l544t2395r972b2485],
51	<	JJR	O	<	dobj	48	SENT_212	[p14l544t2395r972b2485],
52	0.001	CD	NUMBER	0.001	num	53	SENT_212	[p14l544t2395r972b2485],
53	)	NN	O	)	dep	51	SENT_212	[p14l544t2395r972b2485],
54	,	,	O	,	_	0	SENT_212	[p14l544t2395r972b2485],
55	adenocarcinoma	NN	O	adenocarcinoma	nn	57	SENT_212	[p14l1010t2390r1704b2468],
56	(	CD	NUMBER	(	num	57	SENT_212	[p14l1740t2395r2130b2486],
57	P	NN	O	p	dobj	48	SENT_212	[p14l1740t2395r2130b2486],
58	=	JJ	O	=	amod	60	SENT_212	[p14l1740t2395r2130b2486],
59	0.02	CD	NUMBER	0.02	tmod	58	SENT_212	[p14l1740t2395r2130b2486],
60	)	NN	O	)	dep	57	SENT_212	[p14l1740t2395r2130b2486],
61	,	,	O	,	_	0	SENT_212	[p14l1740t2395r2130b2486],
62	and	CC	O	and	_	0	SENT_212	[p14l10t2518r168b2596],
63	polysomy	NN	O	polysomy	dobj	48	SENT_212	[p14l201t2518r618b2618],
64	or	CC	O	or	_	0	SENT_212	[p14l649t2544r739b2596],
65	ampliﬁcation	NN	O	ampliﬁcation	conj_and	51	SENT_212	[p14l770t2517r1349b2618],
66	of	IN	O	of	_	0	SENT_212	[p14l1384t2517r1486b2596],
67	EGFR	NN	ORGANIZATION	egfr	nn	69	SENT_212	[p14l1500t2525r1716b2597],
68	(	CD	NUMBER	(	num	69	SENT_212	[p14l1748t2523r2129b2609],
69	P	NN	O	p	prep_of	63	SENT_212	[p14l1748t2523r2129b2609],
70	=	JJ	O	=	amod	72	SENT_212	[p14l1748t2523r2129b2609],
71	0.04	CD	NUMBER	0.04	num	72	SENT_212	[p14l1748t2523r2129b2609],
72	)	NN	O	)	nsubjpass	74	SENT_212	[p14l1748t2523r2129b2609],
73	were	VBD	O	be	auxpass	74	SENT_212	[p14l6t2671r211b2725],
74	associated	VBN	O	associate	ccomp	4	SENT_212	[p14l253t2646r699b2723],
75	with	IN	O	with	_	0	SENT_212	[p14l736t2646r929b2725],
76	responsiveness	NN	O	responsiveness	prep_with	74	SENT_212	[p14l971t2647r1623b2745],
77	in	IN	O	in	_	0	SENT_212	[p14l1667t2647r1749b2722],
78	patients	NNS	O	patient	prep_in	76	SENT_212	[p14l1790t2647r2132b2745],
79	with	IN	O	with	_	0	SENT_212	[p14l6t2774r199b2853],
80	samples	NNS	O	sample	prep_with	74	SENT_212	[p14l228t2774r573b2873],
81	subjected	VBN	O	subject	partmod	80	SENT_212	[p14l602t2774r997b2873],
82	to	TO	O	to	_	0	SENT_212	[p14l1022t2790r1100b2851],
83	FISH	NN	O	fish	prep_to	81	SENT_212	[p14l1126t2779r1362b2851],
84	.	.	O	.	_	0	SENT_212	[p14l1126t2779r1362b2851],

1	s	NNS	O	s	nsubj	2	SENT_213	[p14l11t3057r49b3107],
2	u	VBP	O	u	_	0	SENT_213	[p14l65t3058r108b3107],
3	RV	NN	O	rv	dobj	2	SENT_213	[p14l130t3058r223b3107],
4	I	PRP	O	I	nsubj	5	SENT_213	[p14l238t3058r251b3106],
5	VAL	VBP	O	val	rcmod	3	SENT_213	[p14l266t3058r413b3107],
6	Among	IN	O	among	_	0	SENT_213	[p14l7t3164r326b3258],
7	the	DT	O	the	det	8	SENT_213	[p14l357t3157r486b3235],
8	patients	NNS	O	patient	prep_among	45	SENT_213	[p14l518t3158r853b3257],
9	in	IN	O	in	_	0	SENT_213	[p14l887t3158r969b3234],
10	both	CC	O	both	preconj	12	SENT_213	[p14l1003t3157r1196b3235],
11	the	DT	O	the	det	12	SENT_213	[p14l1229t3157r1358b3235],
12	placebo	NN	O	placebo	prep_in	8	SENT_213	[p14l1390t3157r1717b3257],
13	and	CC	O	and	_	0	SENT_213	[p14l1752t3157r1907b3235],
14	erlotinib	NN	O	erlotinib	nn	15	SENT_213	[p14l1941t3157r2134b3235, p14l11t3285r204b3363],
15	groups	NNS	O	group	conj_and	12	SENT_213	[p14l242t3310r535b3386],
16	who	WP	O	who	nsubj	17	SENT_213	[p14l570t3285r753b3364],
17	had	VBD	O	have	rcmod	8	SENT_213	[p14l791t3285r946b3363],
18	at	IN	O	at	quantmod	20	SENT_213	[p14l982t3301r1061b3363],
19	least	JJS	O	least	mwe	18	SENT_213	[p14l1091t3285r1288b3363],
20	one	CD	NUMBER	one	num	22	SENT_213	[p14l1321t3310r1472b3363],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_213	[p14l1508t3290r1767b3368],
22	test	NN	O	test	dobj	17	SENT_213	[p14l1794t3301r1964b3381],
23	,	,	O	,	_	0	SENT_213	[p14l1794t3301r1964b3381],
24	the	DT	O	the	det	25	SENT_213	[p14l2006t3285r2135b3363],
25	status	NN	O	status	nsubjpass	45	SENT_213	[p14l12t3429r262b3492],
26	of	IN	O	of	_	0	SENT_213	[p14l290t3412r392b3491],
27	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_213	[p14l397t3418r659b3496],
28	protein	NN	O	protein	nn	29	SENT_213	[p14l672t3414r986b3513],
29	expression	NN	O	expression	prep_of	25	SENT_213	[p14l1011t3414r1499b3513],
30	,	,	O	,	_	0	SENT_213	[p14l1011t3414r1499b3513],
31	the	DT	O	the	det	32	SENT_213	[p14l1530t3413r1662b3491],
32	number	NN	O	number	prep_of	25	SENT_213	[p14l1687t3413r2028b3492],
33	of	IN	O	of	_	0	SENT_213	[p14l2051t3412r2153b3491],
34	copies	NNS	O	copy	prep_of	32	SENT_213	[p14l11t3542r282b3641],
35	of	IN	O	of	_	0	SENT_213	[p14l325t3540r426b3619],
36	EGFR	NN	ORGANIZATION	egfr	prep_of	34	SENT_213	[p14l443t3548r673b3636],
37	,	,	O	,	_	0	SENT_213	[p14l443t3548r673b3636],
38	and	CC	O	and	_	0	SENT_213	[p14l715t3541r871b3619],
39	EGFR	NN	ORGANIZATION	egfr	nn	41	SENT_213	[p14l906t3548r1118b3621],
40	mutational	JJ	O	mutational	amod	41	SENT_213	[p14l1149t3541r1614b3620],
41	status	NN	O	status	prep_of	25	SENT_213	[p14l1652t3558r1898b3620],
42	were	VBD	O	be	auxpass	45	SENT_213	[p14l1933t3567r2135b3620],
43	not	RB	O	not	neg	45	SENT_213	[p14l11t3686r154b3747],
44	signiﬁcantly	RB	O	signiﬁcantly	advmod	45	SENT_213	[p14l182t3668r703b3770],
45	associated	VBN	O	associate	ccomp	5	SENT_213	[p14l730t3669r1166b3747],
46	with	IN	O	with	_	0	SENT_213	[p14l1193t3669r1382b3748],
47	survival	NN	O	survival	prep_with	45	SENT_213	[p14l1415t3669r1733b3748],
48	in	IN	O	in	_	0	SENT_213	[p14l1763t3670r1845b3746],
49	multivariate	JJ	O	multivariate	prep_in	45	SENT_213	[p14l1876t3669r2133b3748, p15l6t22r291b100],

1	analysis	NN	O	analysis	nsubj	4	SENT_214	[p15l327t21r691b121],
2	,	,	O	,	_	0	SENT_214	[p15l327t21r691b121],
3	nor	CC	O	nor	nsubj	4	SENT_214	[p15l733t47r882b99],
4	were	VBD	O	be	_	0	SENT_214	[p15l911t47r1116b100],
5	there	EX	O	there	expl	7	SENT_214	[p15l1153t21r1369b99],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_214	[p15l1407t20r1869b122],
7	interactions	NNS	O	interaction	xcomp	4	SENT_214	[p15l1899t22r2133b99, p15l10t150r317b227],
8	between	IN	O	between	_	0	SENT_214	[p15l347t149r703b228],
9	treatment	NN	O	treatment	nn	10	SENT_214	[p15l730t165r1153b227],
10	groups	NNS	O	group	prep_between	7	SENT_214	[p15l1175t174r1474b250],
11	With	IN	O	with	dep	7	SENT_214	[p15l1499t149r1691b228],
12	respect	NN	O	respect	pobj	11	SENT_214	[p15l1718t165r2030b249],
13	to	TO	O	to	_	0	SENT_214	[p15l2053t165r2133b227],
14	the	DT	O	the	det	15	SENT_214	[p15l11t277r140b355],
15	status	NN	O	status	prep_to	12	SENT_214	[p15l166t293r407b356],
16	of	IN	O	of	_	0	SENT_214	[p15l434t276r533b355],
17	protein	NN	O	protein	nn	18	SENT_214	[p15l537t278r839b377],
18	expression	NN	O	expression	prep_of	15	SENT_214	[p15l864t278r1309b377],
19	(	CD	NUMBER	(	num	20	SENT_214	[p15l1337t282r1729b373],
20	P	NN	O	p	dep	18	SENT_214	[p15l1337t282r1729b373],
21	=	JJ	O	=	amod	23	SENT_214	[p15l1337t282r1729b373],
22	0.25	CD	NUMBER	0.25	tmod	21	SENT_214	[p15l1337t282r1729b373],
23	)	NN	O	)	dep	20	SENT_214	[p15l1337t282r1729b373],
24	,	,	O	,	_	0	SENT_214	[p15l1337t282r1729b373],
25	the	DT	O	the	det	26	SENT_214	[p15l1758t277r1886b355],
26	number	NN	O	number	prep_of	15	SENT_214	[p15l1909t303r2135b356, p15l11t405r147b483],
27	of	IN	O	of	_	0	SENT_214	[p15l174t404r275b483],
28	copies	NNS	O	copy	prep_of	26	SENT_214	[p15l287t406r552b505],
29	of	IN	O	of	_	0	SENT_214	[p15l585t404r685b483],
30	EGFR	NN	ORGANIZATION	egfr	nn	32	SENT_214	[p15l695t412r907b485],
31	(	CD	NUMBER	(	num	32	SENT_214	[p15l935t410r1335b500],
32	P	NN	O	p	prep_of	28	SENT_214	[p15l935t410r1335b500],
33	=	JJ	O	=	amod	32	SENT_214	[p15l935t410r1335b500],
34	0.10	CD	NUMBER	0.10	num	35	SENT_214	[p15l935t410r1335b500],
35	)	NN	O	)	dep	33	SENT_214	[p15l935t410r1335b500],
36	,	,	O	,	_	0	SENT_214	[p15l935t410r1335b500],
37	or	CC	O	or	_	0	SENT_214	[p15l1371t430r1460b483],
38	mutational	JJ	O	mutational	amod	39	SENT_214	[p15l1487t405r1952b484],
39	status	NN	O	status	conj_or	18	SENT_214	[p15l1983t421r2134b483, p15l11t549r133b612],
40	(	CD	NUMBER	(	num	41	SENT_214	[p15l164t538r563b624],
41	P	NN	O	p	dep	39	SENT_214	[p15l164t538r563b624],
42	=	JJ	O	=	amod	44	SENT_214	[p15l164t538r563b624],
43	0.97	CD	NUMBER	0.97	tmod	42	SENT_214	[p15l164t538r563b624],
44	)	NN	O	)	dep	41	SENT_214	[p15l164t538r563b624],
45	.	.	O	.	_	0	SENT_214	[p15l164t538r563b624],

1	Survival	NN	O	survival	_	0	SENT_215	[p15l595t533r921b612],
2	among	IN	O	among	_	0	SENT_215	[p15l944t558r1243b634],
3	patients	NNS	O	patient	prep_among	1	SENT_215	[p15l1262t534r1597b633],
4	with	IN	O	with	_	0	SENT_215	[p15l1618t533r1807b612],
5	expression	NN	O	expression	prep_with	3	SENT_215	[p15l1832t559r2135b633, p15l12t662r187b739],
6	of	IN	O	of	_	0	SENT_215	[p15l210t660r309b739],
7	EGFRWas	NN	O	egfrwa	prep_of	5	SENT_215	[p15l312t666r735b744],
8	longer	RBR	O	longer	advmod	3	SENT_215	[p15l759t661r1031b762],
9	in	IN	O	in	_	0	SENT_215	[p15l1050t662r1130b738],
10	the	DT	O	the	det	12	SENT_215	[p15l1153t661r1281b739],
11	erlotinib	JJ	O	erlotinib	amod	12	SENT_215	[p15l1304t661r1655b739],
12	group	NN	O	group	prep_in	8	SENT_215	[p15l1679t687r1926b762],
13	than	IN	O	than	dep	3	SENT_215	[p15l1951t661r2136b739],
14	in	IN	O	in	_	0	SENT_215	[p15l10t790r90b866],
15	the	DT	O	the	det	20	SENT_215	[p15l119t789r248b867],
16	placebo	NN	O	placebo	nn	20	SENT_215	[p15l276t789r602b889],
17	group	NN	O	group	nn	20	SENT_215	[p15l632t815r883b890],
18	(	CD	NUMBER	(	num	20	SENT_215	[p15l918t789r1235b880],
19	hazard	NN	O	hazard	nn	20	SENT_215	[p15l918t789r1235b880],
20	ratio	NN	O	ratio	prep_in	3	SENT_215	[p15l1263t790r1455b867],
21	for	IN	O	for	_	0	SENT_215	[p15l1485t788r1608b867],
22	death	NN	O	death	prep_for	20	SENT_215	[p15l1634t789r1889b885],
23	,	,	O	,	_	0	SENT_215	[p15l1634t789r1889b885],
24	0.68	CD	NUMBER	0.68	appos	22	SENT_215	[p15l1923t794r2131b884],
25	;	:	O	;	_	0	SENT_215	[p15l1923t794r2131b884],
26	95	CD	PERCENT	95	num	29	SENT_215	[p15l11t922r107b995],
27	percent	NN	PERCENT	percent	nn	29	SENT_215	[p15l128t934r441b1017],
28	conﬁdence	NN	O	conﬁdence	nn	29	SENT_215	[p15l456t916r907b995],
29	interval	NN	O	interval	dep	1	SENT_215	[p15l925t917r1251b1013],
30	,	,	O	,	_	0	SENT_215	[p15l925t917r1251b1013],
31	0.49	CD	NUMBER	0.49	num	33	SENT_215	[p15l1277t922r1454b995],
32	to	TO	O	to	dep	33	SENT_215	[p15l1475t933r1553b995],
33	0.95	CD	NUMBER	0.95	appos	29	SENT_215	[p15l1573t922r1776b1012],
34	;	:	O	;	_	0	SENT_215	[p15l1573t922r1776b1012],
35	P	NN	O	p	dep	1	SENT_215	[p15l1798t922r2130b1008],
36	=	JJ	O	=	dep	35	SENT_215	[p15l1798t922r2130b1008],
37	0.02	CD	NUMBER	0.02	iobj	36	SENT_215	[p15l1798t922r2130b1008],
38	)	CD	NUMBER	)	number	39	SENT_215	[p15l1798t922r2130b1008],
39	(	CD	NUMBER	(	num	40	SENT_215	[p15l15t1045r277b1136],
40	Table	NNP	O	Table	dobj	36	SENT_215	[p15l15t1045r277b1136],
41	3	CD	NUMBER	3	num	40	SENT_215	[p15l317t1050r360b1124],
42	and	CC	O	and	_	0	SENT_215	[p15l400t1045r559b1123],
43	Fig	NN	O	fig	dep	1	SENT_215	[p15l595t1046r755b1146],
44	.	.	O	.	_	0	SENT_215	[p15l595t1046r755b1146],

1	1D	NN	O	1d	nn	2	SENT_216	[p15l801t1050r981b1140],
2	)	NN	O	)	_	0	SENT_216	[p15l801t1050r981b1140],
3	,	,	O	,	_	0	SENT_216	[p15l801t1050r981b1140],
4	but	CC	O	but	dep	2	SENT_216	[p15l1025t1045r1169b1124],
5	there	EX	O	there	expl	6	SENT_216	[p15l1202t1045r1420b1123],
6	Was	VBD	O	be	dep	2	SENT_216	[p15l1454t1071r1618b1124],
7	no	DT	O	no	det	9	SENT_216	[p15l1657t1070r1765b1123],
8	survival	NN	O	survival	nn	9	SENT_216	[p15l1806t1045r2135b1124],
9	advantage	NN	O	advantage	nsubj	6	SENT_216	[p15l10t1173r433b1274],
10	among	IN	O	among	_	0	SENT_216	[p15l465t1198r762b1274],
11	patients	NNS	O	patient	prep_among	9	SENT_216	[p15l789t1174r1120b1273],
12	With	IN	O	with	_	0	SENT_216	[p15l1149t1173r1336b1252],
13	EGFR	NN	O	egfr	prep_with	17	SENT_216	[p15l1366t1174r1989b1274],
14	—	CD	NUMBER	—	num	16	SENT_216	[p15l1366t1174r1989b1274],
15	negative	JJ	O	negative	amod	16	SENT_216	[p15l1366t1174r1989b1274],
16	tumors	NNS	O	tumor	nsubj	17	SENT_216	[p15l2022t1189r2134b1252, p15l11t1327r223b1379],
17	(	VBP	O	(	rcmod	11	SENT_216	[p15l258t1301r570b1392],
18	hazard	NN	O	hazard	nn	19	SENT_216	[p15l258t1301r570b1392],
19	ratio	NN	O	ratio	dobj	17	SENT_216	[p15l597t1302r809b1397],
20	,	,	O	,	_	0	SENT_216	[p15l597t1302r809b1397],
21	0.93	CD	NUMBER	0.93	appos	19	SENT_216	[p15l842t1306r1046b1396],
22	;	:	O	;	_	0	SENT_216	[p15l842t1306r1046b1396],
23	95	CD	PERCENT	95	num	26	SENT_216	[p15l1078t1306r1174b1379],
24	percent	NN	PERCENT	percent	nn	26	SENT_216	[p15l1203t1317r1518b1401],
25	conﬁdence	NN	O	conﬁdence	nn	26	SENT_216	[p15l1541t1300r1996b1379],
26	interval	NN	O	interval	dep	19	SENT_216	[p15l2022t1302r2135b1378, p15l11t1429r256b1524],
27	,	,	O	,	_	0	SENT_216	[p15l2022t1302r2135b1378, p15l11t1429r256b1524],
28	0.63	CD	NUMBER	0.63	number	30	SENT_216	[p15l287t1434r470b1508],
29	to	TO	O	to	dep	30	SENT_216	[p15l501t1445r581b1507],
30	1.36	CD	NUMBER	1.36	appos	26	SENT_216	[p15l613t1434r818b1524],
31	;	:	O	;	_	0	SENT_216	[p15l613t1434r818b1524],
32	P	NN	O	p	dep	19	SENT_216	[p15l846t1434r1188b1520],
33	=	JJ	O	=	dep	32	SENT_216	[p15l846t1434r1188b1520],
34	0.70	CD	NUMBER	0.70	iobj	33	SENT_216	[p15l846t1434r1188b1520],
35	)	CD	NUMBER	)	number	36	SENT_216	[p15l846t1434r1188b1520],
36	(	CD	NUMBER	(	num	37	SENT_216	[p15l1223t1429r1477b1520],
37	Table	NNP	O	Table	dobj	33	SENT_216	[p15l1223t1429r1477b1520],
38	3	CD	NUMBER	3	num	37	SENT_216	[p15l1503t1434r1547b1508],
39	and	CC	O	and	_	0	SENT_216	[p15l1575t1429r1730b1507],
40	Fig	NN	O	fig	conj_and	19	SENT_216	[p15l1754t1430r1909b1530],
41	.	.	O	.	_	0	SENT_216	[p15l1754t1430r1909b1530],

1	1C	NN	O	1c	_	0	SENT_217	[p15l1943t1434r2111b1520],
2	)	NN	O	)	dep	1	SENT_217	[p15l1943t1434r2111b1520],
3	.	.	O	.	_	0	SENT_217	[p15l1943t1434r2111b1520],

1	Among	IN	O	among	_	0	SENT_218	[p15l136t1564r455b1658],
2	patients	NNS	O	patient	prep_among	11	SENT_218	[p15l473t1558r807b1657],
3	with	IN	O	with	_	0	SENT_218	[p15l826t1557r1015b1636],
4	polysomy	NN	O	polysomy	prep_with	2	SENT_218	[p15l1035t1557r1445b1657],
5	or	CC	O	or	_	0	SENT_218	[p15l1463t1583r1552b1635],
6	ampliﬁcation	NN	O	ampliﬁcation	conj_or	4	SENT_218	[p15l1570t1556r2135b1657],
7	of	IN	O	of	_	0	SENT_218	[p15l11t1684r112b1763],
8	EGFR	NN	ORGANIZATION	egfr	prep_of	4	SENT_218	[p15l125t1692r356b1780],
9	,	,	O	,	_	0	SENT_218	[p15l125t1692r356b1780],
10	survival	NN	O	survival	nsubj	11	SENT_218	[p15l398t1685r724b1764],
11	was	VBD	O	be	_	0	SENT_218	[p15l754t1711r917b1764],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_218	[p15l957t1684r1491b1786],
13	longer	RBR	O	longer	advmod	11	SENT_218	[p15l1521t1685r1802b1786],
14	among	IN	O	among	_	0	SENT_218	[p15l1834t1711r2139b1786],
15	those	DT	O	those	prep_among	13	SENT_218	[p15l11t1813r236b1891],
16	Who	WP	O	who	nsubj	17	SENT_218	[p15l253t1813r435b1892],
17	received	VBD	O	receive	rcmod	15	SENT_218	[p15l458t1813r793b1892],
18	erlotinib	NN	O	erlotinib	dobj	17	SENT_218	[p15l815t1813r1167b1891],
19	than	IN	O	than	dep	17	SENT_218	[p15l1190t1813r1376b1891],
20	among	IN	O	among	_	0	SENT_218	[p15l1397t1838r1693b1914],
21	those	DT	O	those	prep_among	17	SENT_218	[p15l1712t1813r1935b1891],
22	Who	WP	O	who	nsubj	23	SENT_218	[p15l1953t1813r2135b1892],
23	received	VBD	O	receive	rcmod	21	SENT_218	[p15l11t1941r357b2020],
24	placebo	NN	O	placebo	nn	27	SENT_218	[p15l386t1941r720b2041],
25	(	NN	O	(	nn	27	SENT_218	[p15l756t1941r1079b2032],
26	hazard	NN	O	hazard	nn	27	SENT_218	[p15l756t1941r1079b2032],
27	ratio	NN	O	ratio	dobj	23	SENT_218	[p15l1109t1942r1305b2019],
28	for	IN	O	for	_	0	SENT_218	[p15l1336t1940r1462b2019],
29	death	NN	O	death	prep_for	23	SENT_218	[p15l1490t1941r1750b2037],
30	,	,	O	,	_	0	SENT_218	[p15l1490t1941r1750b2037],
31	0.44	CD	NUMBER	0.44	appos	29	SENT_218	[p15l1786t1946r1998b2036],
32	;	:	O	;	_	0	SENT_218	[p15l1786t1946r1998b2036],
33	95	CD	PERCENT	95	num	36	SENT_218	[p15l2033t1946r2131b2019],
34	percent	NN	PERCENT	percent	nn	36	SENT_218	[p15l9t2086r325b2169],
35	conﬁdence	NN	O	conﬁdence	nn	36	SENT_218	[p15l348t2068r802b2147],
36	interval	NN	O	interval	dep	29	SENT_218	[p15l829t2069r1159b2165],
37	,	,	O	,	_	0	SENT_218	[p15l829t2069r1159b2165],
38	0.23	CD	NUMBER	0.23	num	40	SENT_218	[p15l1193t2074r1370b2148],
39	to	TO	O	to	dep	40	SENT_218	[p15l1401t2086r1479b2147],
40	0.82	CD	NUMBER	0.82	appos	36	SENT_218	[p15l1508t2074r1713b2164],
41	;	:	O	;	_	0	SENT_218	[p15l1508t2074r1713b2164],
42	P	NN	O	p	dep	29	SENT_218	[p15l1743t2074r2131b2160],
43	=	JJ	O	=	dep	42	SENT_218	[p15l1743t2074r2131b2160],
44	0.008	CD	NUMBER	0.008	iobj	43	SENT_218	[p15l1743t2074r2131b2160],
45	)	CD	NUMBER	)	number	46	SENT_218	[p15l1743t2074r2131b2160],
46	(	CD	NUMBER	(	num	47	SENT_218	[p15l15t2197r272b2288],
47	Table	NNP	O	Table	dobj	43	SENT_218	[p15l15t2197r272b2288],
48	3	CD	NUMBER	3	num	47	SENT_218	[p15l301t2202r344b2276],
49	and	CC	O	and	_	0	SENT_218	[p15l375t2197r532b2275],
50	Fig	NN	O	fig	prep_for	23	SENT_218	[p15l558t2198r716b2298],
51	.	.	O	.	_	0	SENT_218	[p15l558t2198r716b2298],

1	1F	NN	O	1f	nn	2	SENT_219	[p15l752t2202r911b2293],
2	)	NN	O	)	nsubj	6	SENT_219	[p15l752t2202r911b2293],
3	,	,	O	,	_	0	SENT_219	[p15l752t2202r911b2293],
4	but	CC	O	but	prep	2	SENT_219	[p15l944t2197r1087b2276],
5	there	EX	O	there	dep	4	SENT_219	[p15l1109t2197r1326b2275],
6	Was	VBD	O	be	_	0	SENT_219	[p15l1349t2223r1512b2276],
7	no	DT	O	no	det	9	SENT_219	[p15l1541t2223r1647b2275],
8	signiﬁcant	NN	O	signiﬁcant	nn	9	SENT_219	[p15l1677t2196r2139b2298],
9	difference	NN	O	difference	attr	6	SENT_219	[p15l11t2324r441b2403],
10	in	IN	O	in	_	0	SENT_219	[p15l465t2326r547b2402],
11	the	DT	O	the	det	12	SENT_219	[p15l571t2325r700b2403],
12	length	NN	O	length	prep_in	9	SENT_219	[p15l723t2325r993b2426],
13	of	IN	O	of	_	0	SENT_219	[p15l1017t2324r1118b2403],
14	survival	NN	O	survival	prep_of	12	SENT_219	[p15l1125t2325r1442b2404],
15	between	IN	O	between	_	0	SENT_219	[p15l1466t2325r1816b2404],
16	groups	NNS	O	group	prep_between	14	SENT_219	[p15l1839t2351r2133b2426],

1	Table	NNP	O	Table	_	0	SENT_220	[p16l61t56r197b104],
2	2	CD	NUMBER	2	dep	1	SENT_220	[p16l214t60r258b104],
3	.	.	O	.	_	0	SENT_220	[p16l214t60r258b104],

1	Summary	NN	O	summary	_	0	SENT_221	[p16l277t59r532b119],
2	of	IN	O	of	_	0	SENT_221	[p16l548t55r608b104],
3	the	DT	O	the	det	4	SENT_221	[p16l613t56r698b104],
4	Results	NNS	O	result	prep_of	1	SENT_221	[p16l719t56r906b104],
5	of	IN	O	of	_	0	SENT_221	[p16l925t55r985b104],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_221	[p16l995t59r1140b104],
7	Analyses	NNS	O	analysis	prep_of	4	SENT_221	[p16l1156t56r1388b119],
8	and	CC	O	and	_	0	SENT_221	[p16l1407t56r1501b104],
9	Characteristics	NNS	O	characteristic	prep_of	4	SENT_221	[p16l1521t56r1911b104],
10	of	IN	O	of	_	0	SENT_221	[p16l61t135r122b184],
11	the	DT	O	the	det	12	SENT_221	[p16l127t136r211b185],
12	Patients	NNS	O	patient	prep_of	1	SENT_221	[p16l232t137r440b185],
13	with	IN	O	with	_	0	SENT_221	[p16l457t136r569b185],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_221	[p16l591t140r740b185],
15	Mutations	NNS	O	mutation	prep_with	12	SENT_221	[p16l760t137r1026b185],
16	in	IN	O	in	_	0	SENT_221	[p16l1047t137r1091b184],
17	Tumor	NN	O	tumor	nn	18	SENT_221	[p16l1110t140r1281b185],
18	Specimens	NNS	O	specimen	prep_in	1	SENT_221	[p16l1297t137r1599b198],
19	.	.	O	.	_	0	SENT_221	[p16l1297t137r1599b198],

1	Variable	JJ	O	variable	amod	2	SENT_222	[p16l60t274r269b323],
2	Value	NN	O	value	_	0	SENT_222	[p16l1798t274r1941b323],
3	lmmunohistochemical	JJ	O	lmmunohistochemical	amod	4	SENT_222	[p16l66t402r656b451],
4	analysis	NN	O	analysis	dep	2	SENT_222	[p16l676t402r885b465],
5	of	IN	O	of	_	0	SENT_222	[p16l903t401r963b451],
6	EG	NN	O	eg	nn	8	SENT_222	[p16l974t406r1044b451],
7	FR	NN	O	fr	nn	8	SENT_222	[p16l1054t407r1118b450],
8	protein	NN	O	protein	prep_of	4	SENT_222	[p16l1138t403r1320b465],
9	expression	NN	O	expression	dep	2	SENT_222	[p16l1341t403r1622b465],
10	325	CD	NUMBER	325	num	9	SENT_222	[p16l1746t406r1834b451],

1	—	JJ	O	—	amod	2	SENT_223	[p16l252t504r317b510],
2	no.	NN	O	no.	_	0	SENT_223	[p16l336t491r414b523],
3	of	IN	O	of	_	0	SENT_223	[p16l433t474r493b523],
4	samples	NNS	O	sample	prep_of	2	SENT_223	[p16l499t474r717b537],
5	(	CD	PERCENT	(	num	6	SENT_223	[p16l739t477r824b538],
6	%	NN	PERCENT	%	dep	2	SENT_223	[p16l739t477r824b538],
7	)	CD	NUMBER	)	dep	6	SENT_223	[p16l739t477r824b538],

1	Negative	JJ	O	negative	amod	2	SENT_224	[p16l67t585r295b644],
2	(	NN	O	(	_	0	SENT_224	[p16l320t583r487b643],
3	<	JJR	O	<	amod	7	SENT_224	[p16l320t583r487b643],
4	10	CD	PERCENT	10	num	5	SENT_224	[p16l320t583r487b643],
5	%	NN	PERCENT	%	dep	3	SENT_224	[p16l320t583r487b643],
6	oftumor	NN	O	oftumor	nn	7	SENT_224	[p16l506t580r736b629],
7	cells	NNS	O	cell	dep	2	SENT_224	[p16l753t580r865b629],
8	positive	JJ	O	positive	amod	7	SENT_224	[p16l889t585r1090b643],
9	for	IN	O	for	_	0	SENT_224	[p16l1108t580r1181b629],
10	membranous	JJ	O	membranous	amod	12	SENT_224	[p16l1201t580r1550b629],
11	141	CD	NUMBER	141	num	12	SENT_224	[p16l1749t585r1834b628],
12	(	CD	NUMBER	(	prep_for	8	SENT_224	[p16l1862t584r1958b643],
13	43	CD	NUMBER	43	num	14	SENT_224	[p16l1862t584r1958b643],
14	)	NN	O	)	dep	2	SENT_224	[p16l1862t584r1958b643],

1	staining	VBG	O	stain	_	0	SENT_225	[p16l256t657r482b716],
2	)	CD	NUMBER	)	dobj	1	SENT_225	[p16l256t657r482b716],

1	Positive	JJ	O	positive	amod	2	SENT_226	[p16l67t763r267b807],
2	(	NN	O	(	_	0	SENT_226	[p16l292t761r460b822],
3	210	CD	PERCENT	210	number	4	SENT_226	[p16l292t761r460b822],
4	%	NN	PERCENT	%	amod	6	SENT_226	[p16l292t761r460b822],
5	oftumor	NN	O	oftumor	nn	6	SENT_226	[p16l479t758r708b807],
6	cells	NNS	O	cell	dep	2	SENT_226	[p16l726t758r838b807],
7	positive	JJ	O	positive	amod	6	SENT_226	[p16l861t763r1063b821],
8	for	IN	O	for	_	0	SENT_226	[p16l1081t758r1153b807],
9	membranous	JJ	O	membranous	amod	14	SENT_226	[p16l1173t758r1522b807],
10	184	CD	NUMBER	184	num	11	SENT_226	[p16l1749t761r1837b807],
11	(	NN	O	(	dep	9	SENT_226	[p16l1862t762r1904b822],
12	5	CD	NUMBER	5	number	13	SENT_226	[p16l1862t762r1904b822],
13	7	CD	NUMBER	7	amod	14	SENT_226	[p16l1915t762r1958b822],
14	)	NN	O	)	prep_for	7	SENT_226	[p16l1915t762r1958b822],

1	staining	VBG	O	stain	_	0	SENT_227	[p16l256t835r482b895],
2	)	CD	NUMBER	)	dobj	1	SENT_227	[p16l256t835r482b895],

1	FISH	NN	O	fish	_	0	SENT_228	[p16l66t940r191b985],
2	to	TO	O	to	aux	3	SENT_228	[p16l212t945r263b985],
3	determine	VB	O	determine	dep	1	SENT_228	[p16l281t937r549b985],
4	no.	JJ	O	no.	amod	5	SENT_228	[p16l569t953r646b985],
5	ofcopies	NNS	O	ofcopy	dobj	3	SENT_228	[p16l665t936r899b999],
6	of	IN	O	of	_	0	SENT_228	[p16l917t936r977b985],
7	EGFR	NN	O	egfr	prep_of	5	SENT_228	[p16l987t940r1135b985],
8	125	CD	NUMBER	125	num	7	SENT_228	[p16l1749t941r1834b985],

1	—	JJ	O	—	amod	2	SENT_229	[p16l252t1038r317b1044],
2	no.	NN	O	no.	_	0	SENT_229	[p16l336t1025r414b1057],
3	of	IN	O	of	_	0	SENT_229	[p16l433t1008r493b1057],
4	samples	NNS	O	sample	prep_of	2	SENT_229	[p16l499t1009r717b1071],
5	(	CD	PERCENT	(	num	6	SENT_229	[p16l739t1012r824b1073],
6	%	NN	PERCENT	%	dep	2	SENT_229	[p16l739t1012r824b1073],
7	)	CD	NUMBER	)	dep	6	SENT_229	[p16l739t1012r824b1073],

1	Disomy	NN	O	disomy	_	0	SENT_230	[p16l67t1119r264b1178],
2	(	CD	NUMBER	(	num	5	SENT_230	[p16l288t1119r367b1178],
3	s2	NN	O	s2	nn	5	SENT_230	[p16l288t1119r367b1178],
4	gene	NN	O	gene	nn	5	SENT_230	[p16l388t1132r511b1179],
5	copies	NNS	O	copy	nsubj	11	SENT_230	[p16l531t1120r697b1178],
6	in	IN	O	in	_	0	SENT_230	[p16l720t1120r761b1162],
7	>	JJR	O	>	amod	10	SENT_230	[p16l783t1117r934b1165],
8	90	CD	PERCENT	90	number	9	SENT_230	[p16l783t1117r934b1165],
9	%	NN	PERCENT	%	amod	10	SENT_230	[p16l783t1117r934b1165],
10	ofcells	NNS	O	ofcell	prep_in	5	SENT_230	[p16l953t1114r1151b1178],
11	)	VBP	O	)	rcmod	1	SENT_230	[p16l953t1114r1151b1178],
12	13	CD	NUMBER	13	number	13	SENT_230	[p16l1781t1119r1834b1163],
13	(	CD	NUMBER	(	num	15	SENT_230	[p16l1862t1118r1958b1178],
14	10	CD	NUMBER	10	number	15	SENT_230	[p16l1862t1118r1958b1178],
15	)	CD	NUMBER	)	npadvmod	16	SENT_230	[p16l1862t1118r1958b1178],
16	Low	JJ	O	low	amod	18	SENT_230	[p16l67t1225r169b1269],
17	trisomy	NN	O	trisomy	nn	18	SENT_230	[p16l185t1225r384b1284],
18	(	NN	O	(	dobj	11	SENT_230	[p16l408t1225r449b1284],
19	3	CD	NUMBER	3	num	21	SENT_230	[p16l408t1225r449b1284],
20	gene	NN	O	gene	nn	21	SENT_230	[p16l473t1238r596b1285],
21	copies	NNS	O	copy	nsubj	26	SENT_230	[p16l615t1225r781b1284],
22	in	IN	O	in	_	0	SENT_230	[p16l804t1225r846b1268],
23	10-39	CD	PERCENT	10-39	num	25	SENT_230	[p16l872t1223r1079b1271],
24	%	NN	PERCENT	%	nn	25	SENT_230	[p16l872t1223r1079b1271],
25	ofcells	NNS	O	ofcell	prep_in	21	SENT_230	[p16l1098t1220r1297b1284],
26	)	VBP	O	)	rcmod	18	SENT_230	[p16l1098t1220r1297b1284],
27	23	CD	NUMBER	23	number	28	SENT_230	[p16l1778t1225r1834b1269],
28	(	CD	NUMBER	(	dobj	26	SENT_230	[p16l1863t1224r1958b1284],
29	18	CD	NUMBER	18	num	30	SENT_230	[p16l1863t1224r1958b1284],
30	)	NN	O	)	nsubj	41	SENT_230	[p16l1863t1224r1958b1284],
31	High	JJ	O	high	amod	33	SENT_230	[p16l67t1327r188b1391],
32	trisomy	NN	O	trisomy	nn	33	SENT_230	[p16l208t1331r408b1390],
33	(	NN	O	(	dep	30	SENT_230	[p16l431t1331r473b1390],
34	3	CD	NUMBER	3	num	36	SENT_230	[p16l431t1331r473b1390],
35	gene	NN	O	gene	nn	36	SENT_230	[p16l496t1344r619b1391],
36	copies	NNS	O	copy	dep	30	SENT_230	[p16l639t1331r805b1390],
37	in	IN	O	in	_	0	SENT_230	[p16l828t1331r869b1374],
38	240	CD	PERCENT	240	num	40	SENT_230	[p16l891t1329r1041b1377],
39	%	NN	PERCENT	%	nn	40	SENT_230	[p16l891t1329r1041b1377],
40	ofcells	NNS	O	ofcell	prep_in	36	SENT_230	[p16l1061t1326r1259b1390],
41	)	VBP	O	)	rcmod	28	SENT_230	[p16l1061t1326r1259b1390],
42	3	CD	NUMBER	3	num	43	SENT_230	[p16l1810t1331r1834b1375],
43	(	NN	O	(	dobj	41	SENT_230	[p16l1862t1331r1926b1390],
44	2	CD	NUMBER	2	number	45	SENT_230	[p16l1862t1331r1926b1390],
45	)	CD	NUMBER	)	num	48	SENT_230	[p16l1862t1331r1926b1390],
46	Low	JJ	O	low	amod	48	SENT_230	[p16l67t1437r169b1481],
47	polysomy	NN	O	polysomy	nn	48	SENT_230	[p16l189t1433r437b1496],
48	(	NN	O	(	dep	43	SENT_230	[p16l461t1437r541b1496],
49	24	CD	NUMBER	24	num	51	SENT_230	[p16l461t1437r541b1496],
50	gene	NN	O	gene	nn	51	SENT_230	[p16l561t1450r684b1496],
51	copies	NNS	O	copy	nsubj	56	SENT_230	[p16l703t1437r870b1496],
52	in	IN	O	in	_	0	SENT_230	[p16l893t1437r934b1480],
53	11-39	CD	PERCENT	11-39	num	55	SENT_230	[p16l960t1435r1167b1483],
54	%	NN	PERCENT	%	nn	55	SENT_230	[p16l960t1435r1167b1483],
55	ofcells	NNS	O	ofcell	prep_in	51	SENT_230	[p16l1187t1432r1385b1496],
56	)	VBP	O	)	rcmod	43	SENT_230	[p16l1187t1432r1385b1496],
57	30	CD	NUMBER	30	num	58	SENT_230	[p16l1778t1436r1838b1481],
58	(	CD	NUMBER	(	dobj	56	SENT_230	[p16l1862t1437r1958b1496],
59	24	CD	NUMBER	24	num	60	SENT_230	[p16l1862t1437r1958b1496],
60	)	NN	O	)	dep	66	SENT_230	[p16l1862t1437r1958b1496],
61	High	JJ	O	high	amod	62	SENT_230	[p16l67t1539r188b1602],
62	polysomy	NN	O	polysomy	dep	60	SENT_230	[p16l213t1539r461b1602],
63	(	NN	O	(	dep	66	SENT_230	[p16l484t1543r564b1602],
64	24	CD	NUMBER	24	num	63	SENT_230	[p16l484t1543r564b1602],
65	gene	NN	O	gene	nn	66	SENT_230	[p16l585t1556r707b1602],
66	copies	NNS	O	copy	dep	70	SENT_230	[p16l727t1543r893b1602],
67	in	IN	O	in	_	0	SENT_230	[p16l916t1543r958b1586],
68	240	CD	PERCENT	240	num	69	SENT_230	[p16l980t1541r1130b1589],
69	%	NN	PERCENT	%	prep_in	66	SENT_230	[p16l980t1541r1130b1589],
70	ofcells	NNS	O	ofcell	dep	1	SENT_230	[p16l1149t1538r1348b1602],
71	)	VBP	O	)	rcmod	70	SENT_230	[p16l1149t1538r1348b1602],
72	42	CD	NUMBER	42	dobj	71	SENT_230	[p16l1776t1543r1836b1586],
73	(	CD	NUMBER	(	number	74	SENT_230	[p16l1862t1543r1958b1602],
74	34	CD	NUMBER	34	num	78	SENT_230	[p16l1862t1543r1958b1602],
75	)	NN	O	)	nn	78	SENT_230	[p16l1862t1543r1958b1602],
76	Ampliﬁcation	NN	O	ampliﬁcation	nn	78	SENT_230	[p16l61t1644r412b1708],
77	(	NN	O	(	nn	78	SENT_230	[p16l440t1645r952b1708],
78	genezchromosome	NN	O	genezchromosome	dep	72	SENT_230	[p16l440t1645r952b1708],
79	22	CD	NUMBER	22	num	83	SENT_230	[p16l971t1649r1033b1692],
80	or	CC	O	or	_	0	SENT_230	[p16l1054t1662r1107b1693],
81	215	CD	NUMBER	215	num	83	SENT_230	[p16l1124t1649r1216b1693],
82	gene	NN	O	gene	nn	83	SENT_230	[p16l1239t1662r1362b1708],
83	copies	NNS	O	copy	dep	78	SENT_230	[p16l1381t1649r1548b1707],
84	14	CD	NUMBER	14	num	85	SENT_230	[p16l1781t1649r1837b1692],
85	(	CD	NUMBER	(	dep	71	SENT_230	[p16l1863t1648r1958b1708],
86	11	CD	NUMBER	11	num	87	SENT_230	[p16l1863t1648r1958b1708],
87	)	NN	O	)	dep	85	SENT_230	[p16l1863t1648r1958b1708],

1	per	IN	O	per	mark	7	SENT_231	[p16l258t1734r340b1780],
2	cell	NN	O	cell	nsubj	7	SENT_231	[p16l357t1717r439b1765],
3	in	IN	O	in	_	0	SENT_231	[p16l463t1721r504b1764],
4	210	CD	PERCENT	210	number	5	SENT_231	[p16l527t1719r677b1767],
5	%	NN	PERCENT	%	amod	6	SENT_231	[p16l527t1719r677b1767],
6	Ofcells	NNS	O	ofcell	prep_in	2	SENT_231	[p16l696t1716r894b1780],
7	)	VBP	O	)	_	0	SENT_231	[p16l696t1716r894b1780],

1	Sequencing	NN	O	sequencing	nsubj	6	SENT_232	[p16l62t1824r369b1886],
2	to	TO	O	to	aux	3	SENT_232	[p16l384t1831r436b1871],
3	identify	VB	O	identify	infmod	1	SENT_232	[p16l456t1822r649b1886],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_232	[p16l668t1827r816b1871],
5	mutations	NNS	O	mutation	dobj	3	SENT_232	[p16l835t1824r1133b1871],
6	*	VBP	O	*	_	0	SENT_232	[p16l835t1824r1133b1871],
7	177	CD	NUMBER	177	num	9	SENT_232	[p16l1749t1827r1837b1871],
8	Wild	NNP	O	Wild	nn	9	SENT_232	[p16l61t1929r175b1977],
9	type	NN	O	type	nsubj	10	SENT_232	[p16l190t1938r296b1992],
10	(	CD	NUMBER	(	xcomp	6	SENT_232	[p16l317t1933r397b1992],
11	no	DT	O	no	det	12	SENT_232	[p16l317t1933r397b1992],
12	deletions	NNS	O	deletion	dep	10	SENT_232	[p16l413t1929r645b1977],
13	or	CC	O	or	_	0	SENT_232	[p16l661t1946r714b1977],
14	mutations	NNS	O	mutation	dep	10	SENT_232	[p16l729t1933r989b1977],
15	detected	VBN	O	detect	partmod	10	SENT_232	[p16l1005t1929r1221b1977],
16	in	IN	O	in	_	0	SENT_232	[p16l1241t1933r1281b1976],
17	exons	NNS	O	exon	prep_in	15	SENT_232	[p16l1299t1946r1444b1977],
18	18-21	CD	NUMBER	18-21	num	19	SENT_232	[p16l1464t1932r1630b1992],
19	)	NN	O	)	dep	17	SENT_232	[p16l1464t1932r1630b1992],
20	137	CD	NUMBER	137	num	21	SENT_232	[p16l1749t1933r1837b1977],
21	(	NN	O	(	dep	19	SENT_232	[p16l1862t1933r1958b1992],
22	77	CD	NUMBER	77	num	23	SENT_232	[p16l1862t1933r1958b1992],
23	)	NN	O	)	dep	19	SENT_232	[p16l1862t1933r1958b1992],

1	—	JJ	O	—	amod	2	SENT_233	[p16l252t2031r317b2035],
2	no.	NN	O	no.	_	0	SENT_233	[p16l336t2018r411b2049],
3	(	CD	PERCENT	(	num	4	SENT_233	[p16l436t2003r521b2064],
4	%	NN	PERCENT	%	dep	2	SENT_233	[p16l436t2003r521b2064],
5	)	CD	NUMBER	)	dep	2	SENT_233	[p16l436t2003r521b2064],

1	Mutations	NNS	O	mutation	dep	14	SENT_234	[p16l67t2111r332b2155],
2	—	CD	NUMBER	—	num	3	SENT_234	[p16l350t2137r415b2141],
3	no.	NN	O	no.	dep	1	SENT_234	[p16l435t2124r511b2155],
4	(	CD	PERCENT	(	num	5	SENT_234	[p16l538t2109r624b2170],
5	%	NN	PERCENT	%	dep	3	SENT_234	[p16l538t2109r624b2170],
6	)	CD	NUMBER	)	number	7	SENT_234	[p16l538t2109r624b2170],
7	40	CD	NUMBER	40	num	5	SENT_234	[p16l1776t2110r1838b2155],
8	(	NN	O	(	dep	14	SENT_234	[p16l1862t2111r1958b2170],
9	23	CD	NUMBER	23	number	10	SENT_234	[p16l1862t2111r1958b2170],
10	)	CD	NUMBER	)	num	14	SENT_234	[p16l1862t2111r1958b2170],
11	Type	NN	O	type	nn	14	SENT_234	[p16l60t2217r179b2276],
12	ofmutation	NN	O	ofmutation	nn	14	SENT_234	[p16l198t2212r502b2261],
13	—	CD	NUMBER	—	num	14	SENT_234	[p16l522t2243r587b2247],
14	no.	NN	O	no.	dep	18	SENT_234	[p16l607t2230r682b2261],
15	of	IN	O	of	_	0	SENT_234	[p16l704t2212r761b2261],
16	mutations	NNS	O	mutation	prep_of	14	SENT_234	[p16l774t2217r1039b2261],
17	(	CD	PERCENT	(	num	18	SENT_234	[p16l1065t2215r1151b2276],
18	%	NN	PERCENT	%	dep	20	SENT_234	[p16l1065t2215r1151b2276],
19	)	CD	NUMBER	)	num	20	SENT_234	[p16l1065t2215r1151b2276],
20	45	CD	NUMBER	45	_	0	SENT_234	[p16l1776t2217r1834b2261],

1	Exon	NN	O	exon	_	0	SENT_235	[p16l163t2323r281b2367],
2	19	CD	NUMBER	19	num	1	SENT_235	[p16l307t2323r363b2367],
3	deletion	NN	O	deletion	num	10	SENT_235	[p16l383t2319r590b2367],
4	13	CD	NUMBER	13	number	3	SENT_235	[p16l1781t2323r1834b2367],
5	(	CD	NUMBER	(	number	3	SENT_235	[p16l1862t2323r1958b2382],
6	29	CD	NUMBER	29	number	3	SENT_235	[p16l1862t2323r1958b2382],
7	)	NN	O	)	nn	10	SENT_235	[p16l1862t2323r1958b2382],
8	Exon	NN	O	exon	nn	10	SENT_235	[p16l163t2429r281b2473],
9	21	CD	NUMBER	21	num	10	SENT_235	[p16l304t2429r360b2472],
10	L858R	NN	O	l858r	dep	1	SENT_235	[p16l387t2428r544b2473],
11	8	CD	NUMBER	8	num	12	SENT_235	[p16l1810t2428r1836b2473],
12	(	NN	O	(	dep	1	SENT_235	[p16l1862t2428r1958b2488],
13	18	CD	NUMBER	18	number	14	SENT_235	[p16l1862t2428r1958b2488],
14	)	CD	NUMBER	)	num	20	SENT_235	[p16l1862t2428r1958b2488],
15	Other	JJ	O	other	amod	20	SENT_235	[p16l159t2531r312b2579],
16	variant	JJ	O	variant	amod	20	SENT_235	[p16l328t2535r508b2579],
17	24	CD	NUMBER	24	amod	20	SENT_235	[p16l1778t2535r1837b2578],
18	(	CD	NUMBER	(	number	19	SENT_235	[p16l1862t2535r1958b2594],
19	53	CD	NUMBER	53	num	20	SENT_235	[p16l1862t2535r1958b2594],
20	)	NN	O	)	dep	12	SENT_235	[p16l1862t2535r1958b2594],

1	Characteristics	NNS	O	characteristic	dep	11	SENT_236	[p16l62t2637r452b2685],
2	of	IN	O	of	_	0	SENT_236	[p16l471t2636r530b2685],
3	the	DT	O	the	det	4	SENT_236	[p16l536t2637r620b2685],
4	patients	NNS	O	patient	prep_of	1	SENT_236	[p16l639t2638r848b2699],
5	with	IN	O	with	_	0	SENT_236	[p16l865t2637r977b2685],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_236	[p16l1000t2640r1148b2685],
7	mutations	NNS	O	mutation	prep_with	4	SENT_236	[p16l1167t2638r1432b2685],
8	Geographic	JJ	MISC	geographic	amod	9	SENT_236	[p16l63t2742r368b2806],
9	region	NN	O	region	dep	11	SENT_236	[p16l388t2747r548b2806],
10	—	JJ	O	—	amod	11	SENT_236	[p16l567t2772r632b2777],
11	no.	NN	O	no.	dep	16	SENT_236	[p16l652t2760r728b2791],
12	of	IN	O	of	_	0	SENT_236	[p16l749t2742r807b2791],
13	patients/total	JJ	O	patients/total	amod	14	SENT_236	[p16l820t2742r1170b2806],
14	no.	NN	O	no.	prep_of	11	SENT_236	[p16l1195t2760r1271b2791],
15	(	CD	PERCENT	(	num	16	SENT_236	[p16l1298t2745r1384b2806],
16	%	NN	PERCENT	%	dep	17	SENT_236	[p16l1298t2745r1384b2806],
17	)	CD	NUMBER	)	_	0	SENT_236	[p16l1298t2745r1384b2806],

1	North	NNP	LOCATION	North	nn	2	SENT_237	[p16l163t2848r311b2897],
2	America	NNP	LOCATION	America	dep	11	SENT_237	[p16l331t2852r546b2897],
3	12/56	CD	NUMBER	12/56	num	8	SENT_237	[p16l1688t2852r1834b2912],
4	(	CD	NUMBER	(	num	8	SENT_237	[p16l1859t2852r1955b2912],
5	21	CD	NUMBER	21	num	8	SENT_237	[p16l1859t2852r1955b2912],
6	)	CD	NUMBER	)	num	8	SENT_237	[p16l1859t2852r1955b2912],
7	South	NNP	LOCATION	South	nn	8	SENT_237	[p16l160t2954r309b3003],
8	America	NNP	LOCATION	America	dep	2	SENT_237	[p16l329t2957r545b3003],
9	18/78	CD	NUMBER	18/78	dep	11	SENT_237	[p16l1688t2957r1833b3017],
10	(	CD	NUMBER	(	number	11	SENT_237	[p16l1859t2958r1955b3017],
11	23	CD	NUMBER	23	dep	27	SENT_237	[p16l1859t2958r1955b3017],
12	)	NNP	O	)	nn	13	SENT_237	[p16l1859t2958r1955b3017],
13	Australia	NNP	LOCATION	Australia	dep	11	SENT_237	[p16l157t3060r389b3109],
14	or	CC	O	or	_	0	SENT_237	[p16l409t3077r463b3109],
15	New	NNP	LOCATION	New	nn	16	SENT_237	[p16l485t3065r599b3109],
16	Zealand	NNP	LOCATION	Zealand	dep	27	SENT_237	[p16l617t3060r824b3109],
17	1/9	CD	NUMBER	1/9	number	18	SENT_237	[p16l1752t3064r1833b3123],
18	(	CD	NUMBER	(	num	20	SENT_237	[p16l1859t3064r1955b3123],
19	11	CD	NUMBER	11	number	20	SENT_237	[p16l1859t3064r1955b3123],
20	)	CD	NUMBER	)	dep	16	SENT_237	[p16l1859t3064r1955b3123],
21	Asia	NNP	LOCATION	Asia	nn	27	SENT_237	[p16l157t3169r267b3215],
22	5/14	CD	NUMBER	5/14	num	27	SENT_237	[p16l1717t3171r1834b3229],
23	(	CD	NUMBER	(	num	27	SENT_237	[p16l1859t3170r1955b3229],
24	36	CD	NUMBER	36	num	27	SENT_237	[p16l1859t3170r1955b3229],
25	)	CD	NUMBER	)	num	27	SENT_237	[p16l1859t3170r1955b3229],
26	Continental	NNP	ORGANIZATION	Continental	nn	27	SENT_237	[p16l159t3272r460b3321],
27	Europe	NNP	ORGANIZATION	Europe	_	0	SENT_237	[p16l486t3277r668b3335],
28	4/20	CD	NUMBER	4/20	number	29	SENT_237	[p16l1715t3275r1835b3335],
29	(	CD	NUMBER	(	dep	27	SENT_237	[p16l1859t3275r1955b3335],
30	20	CD	NUMBER	20	num	31	SENT_237	[p16l1859t3275r1955b3335],
31	)	NN	O	)	dep	29	SENT_237	[p16l1859t3275r1955b3335],

1	Race	NN	O	race	nn	4	SENT_238	[p16l67t3383r185b3427],
2	or	CC	O	or	_	0	SENT_238	[p16l204t3395r258b3427],
3	ethnic	JJ	O	ethnic	nn	4	SENT_238	[p16l275t3378r436b3427],
4	group	NN	O	group	_	0	SENT_238	[p16l454t3395r607b3442],
5	—	CD	NUMBER	—	num	6	SENT_238	[p16l624t3408r689b3412],
6	no.	NN	O	no.	dep	4	SENT_238	[p16l709t3395r784b3427],
7	of	IN	O	of	_	0	SENT_238	[p16l806t3377r863b3427],
8	patients/total	JJ	O	patients/total	amod	9	SENT_238	[p16l876t3378r1227b3441],
9	no.	NN	O	no.	prep_of	6	SENT_238	[p16l1252t3395r1328b3427],
10	(	CD	PERCENT	(	num	11	SENT_238	[p16l1355t3380r1440b3441],
11	%	NN	PERCENT	%	dep	6	SENT_238	[p16l1355t3380r1440b3441],
12	)	CD	NUMBER	)	dep	4	SENT_238	[p16l1355t3380r1440b3441],

1	Asian	JJ	MISC	asian	amod	3	SENT_239	[p16l157t3487r300b3532],
2	6/12	CD	NUMBER	6/12	number	3	SENT_239	[p16l1717t3488r1833b3547],
3	(	CD	NUMBER	(	_	0	SENT_239	[p16l1859t3487r1955b3547],
4	50	CD	NUMBER	50	number	5	SENT_239	[p16l1859t3487r1955b3547],
5	)	CD	NUMBER	)	num	6	SENT_239	[p16l1859t3487r1955b3547],
6	Other	JJ	O	other	dep	3	SENT_239	[p16l159t3590r311b3638],
7	34/165	CD	NUMBER	34/165	number	8	SENT_239	[p16l1653t3594r1831b3653],
8	(	CD	NUMBER	(	dep	3	SENT_239	[p16l1859t3594r1955b3653],
9	21	CD	NUMBER	21	num	10	SENT_239	[p16l1859t3594r1955b3653],
10	)	NN	O	)	dep	8	SENT_239	[p16l1859t3594r1955b3653],

1	7	CD	NUMBER	7	nsubjpass	8	SENT_240	[p17l10t35r38b63],
2	"	``	O	"	punct	6	SENT_240	[p17l10t35r38b63],
3	A	NN	O	a	nn	6	SENT_240	[p17l57t34r94b78],
4	total	JJ	O	total	amod	6	SENT_240	[p17l110t30r224b79],
5	of45	NN	O	of45	nn	6	SENT_240	[p17l247t30r370b79],
6	mutations	NNS	O	mutation	nsubjpass	8	SENT_240	[p17l396t35r660b79],
7	were	VBD	O	be	auxpass	8	SENT_240	[p17l679t48r801b79],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_240	[p17l823t30r1063b79],
9	in	IN	O	in	_	0	SENT_240	[p17l1088t35r1129b78],
10	40	CD	NUMBER	40	num	11	SENT_240	[p17l1150t34r1212b79],
11	patients	NNS	O	patient	prep_in	8	SENT_240	[p17l1233t35r1455b93],
12	.	.	O	.	_	0	SENT_240	[p17l1233t35r1455b93],

1	among	IN	O	among	_	0	SENT_241	[p17l10t315r234b371],
2	patients	NNS	O	patient	prep_among	6	SENT_241	[p17l258t297r508b371],
3	with	IN	O	with	_	0	SENT_241	[p17l535t297r677b355],
4	FISH-negative	JJ	O	fish-negative	amod	5	SENT_241	[p17l704t297r1151b371],
5	tumors	NNS	O	tumor	prep_with	2	SENT_241	[p17l1180t309r1405b355],
6	(	VBP	O	(	_	0	SENT_241	[p17l1438t297r1595b364, p17l10t392r111b450],
7	hazard	NN	O	hazard	nn	8	SENT_241	[p17l1438t297r1595b364, p17l10t392r111b450],
8	ratio	NN	O	ratio	dobj	6	SENT_241	[p17l127t392r289b462],
9	,	,	O	,	_	0	SENT_241	[p17l127t392r289b462],
10	0.85	CD	NUMBER	0.85	amod	8	SENT_241	[p17l309t396r465b462],
11	;	:	O	;	_	0	SENT_241	[p17l309t396r465b462],
12	95	CD	PERCENT	95	num	15	SENT_241	[p17l484t396r557b450],
13	percent	NN	PERCENT	percent	nn	15	SENT_241	[p17l575t404r814b466],
14	conﬁdence	NN	O	conﬁdence	nn	15	SENT_241	[p17l827t391r1172b450],
15	interval	NN	O	interval	nsubj	6	SENT_241	[p17l1188t392r1439b462],
16	,	,	O	,	_	0	SENT_241	[p17l1188t392r1439b462],
17	0.48	CD	NUMBER	0.48	number	19	SENT_241	[p17l1460t396r1595b450],
18	to	TO	O	to	dep	19	SENT_241	[p17l11t499r71b545],
19	1.51	CD	NUMBER	1.51	appos	15	SENT_241	[p17l92t491r248b557],
20	;	:	O	;	_	0	SENT_241	[p17l92t491r248b557],
21	P	NN	O	p	dep	19	SENT_241	[p17l268t491r530b554],
22	=	JJ	O	=	dep	21	SENT_241	[p17l268t491r530b554],
23	0.59	CD	NUMBER	0.59	iobj	22	SENT_241	[p17l268t491r530b554],
24	)	CD	NUMBER	)	number	25	SENT_241	[p17l268t491r530b554],
25	(	CD	NUMBER	(	num	26	SENT_241	[p17l556t487r749b554],
26	Table	NNP	O	Table	dobj	22	SENT_241	[p17l556t487r749b554],
27	3	CD	NUMBER	3	num	26	SENT_241	[p17l768t491r801b545],
28	and	CC	O	and	_	0	SENT_241	[p17l821t487r939b545],
29	Fig	NN	O	fig	conj_and	21	SENT_241	[p17l955t487r1073b561],
30	.	.	O	.	_	0	SENT_241	[p17l955t487r1073b561],

1	1E	NN	O	1e	_	0	SENT_242	[p17l1098t491r1220b554],
2	)	NN	O	)	dep	1	SENT_242	[p17l1098t491r1220b554],
3	.	.	O	.	_	0	SENT_242	[p17l1098t491r1220b554],

1	Mutational	JJ	O	mutational	amod	2	SENT_243	[p17l1240t487r1596b545],
2	status	NN	O	status	nsubj	3	SENT_243	[p17l12t593r194b640],
3	had	VBD	O	have	_	0	SENT_243	[p17l214t582r329b640],
4	no	DT	O	no	det	6	SENT_243	[p17l347t600r425b640],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_243	[p17l445t581r776b656],
6	effect	NN	O	effect	dobj	3	SENT_243	[p17l791t581r962b640],
7	on	IN	O	on	_	0	SENT_243	[p17l977t600r1056b640],
8	survival	NN	O	survival	prep_on	6	SENT_243	[p17l1075t582r1324b640],
9	.	.	O	.	_	0	SENT_243	[p17l1075t582r1324b640],

1	The	DT	O	the	det	2	SENT_244	[p17l1344t582r1463b640],
2	risk	NN	O	risk	nsubj	7	SENT_244	[p17l1482t581r1600b641],
3	of	IN	O	of	_	0	SENT_244	[p17l11t676r85b735],
4	death	NN	O	death	prep_of	2	SENT_244	[p17l89t677r259b735],
5	did	VBD	O	do	aux	7	SENT_244	[p17l277t677r376b735],
6	not	RB	O	not	neg	7	SENT_244	[p17l394t689r501b735],
7	differ	VB	O	differ	dep	14	SENT_244	[p17l515t676r687b735],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_244	[p17l704t676r1093b751],
9	among	IN	O	among	_	0	SENT_244	[p17l1107t695r1331b751],
10	patients	NNS	O	patient	prep_among	7	SENT_244	[p17l1345t677r1595b751],
11	With	IN	O	with	_	0	SENT_244	[p17l7t772r149b830],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_244	[p17l167t776r325b831],
13	mutations	NNS	O	mutation	prep_with	10	SENT_244	[p17l340t772r661b830],
14	(	VBP	O	(	_	0	SENT_244	[p17l686t777r848b839],
15	even	RB	O	even	advmod	16	SENT_244	[p17l686t777r848b839],
16	Asian	JJ	LOCATION	asian	amod	17	SENT_244	[p17l865t772r1043b830],
17	patients	NNS	O	patient	dobj	14	SENT_244	[p17l1061t772r1334b846],
18	)	IN	O	)	_	0	SENT_244	[p17l1061t772r1334b846],
19	who	WP	O	who	nsubj	20	SENT_244	[p17l1355t772r1492b831],
20	received	VBD	O	receive	dep	40	SENT_244	[p17l1512t791r1595b830, p17l11t867r203b926],
21	erlotinib	NN	O	erlotinib	dobj	20	SENT_244	[p17l235t866r521b937],
22	,	,	O	,	_	0	SENT_244	[p17l235t866r521b937],
23	as	IN	O	as	prep	20	SENT_244	[p17l556t886r619b925],
24	compared	VBN	O	compare	_	0	SENT_244	[p17l652t867r968b941],
25	with	IN	O	with	prepc_compared_with	20	SENT_244	[p17l996t866r1137b926],
26	such	JJ	O	such	amod	27	SENT_244	[p17l1170t867r1315b925],
27	patients	NNS	O	patient	pobj	20	SENT_244	[p17l1345t867r1595b941],
28	Who	WP	O	who	nsubj	29	SENT_244	[p17l7t962r144b1020],
29	received	VBD	O	receive	rcmod	27	SENT_244	[p17l163t962r418b1021],
30	placebo	NN	O	placebo	nn	33	SENT_244	[p17l434t962r678b1036],
31	(	NN	O	(	nn	33	SENT_244	[p17l701t961r938b1029],
32	hazard	NN	O	hazard	nn	33	SENT_244	[p17l701t961r938b1029],
33	ratio	NN	O	ratio	dobj	29	SENT_244	[p17l956t962r1098b1020],
34	for	IN	O	for	_	0	SENT_244	[p17l1118t961r1209b1020],
35	death	NN	O	death	prep_for	29	SENT_244	[p17l1226t962r1416b1032],
36	,	,	O	,	_	0	SENT_244	[p17l1226t962r1416b1032],
37	0.77	CD	NUMBER	0.77	appos	35	SENT_244	[p17l1438t966r1594b1032],
38	;	:	O	;	_	0	SENT_244	[p17l1438t966r1594b1032],
39	95	CD	PERCENT	95	num	40	SENT_244	[p17l11t1061r82b1115],
40	percent	NN	PERCENT	percent	prep_)	14	SENT_244	[p17l98t1069r332b1131],
41	conﬁdence	NN	O	conﬁdence	nn	42	SENT_244	[p17l343t1056r679b1115],
42	interval	NN	O	interval	nsubj	14	SENT_244	[p17l693t1057r937b1127],
43	,	,	O	,	_	0	SENT_244	[p17l693t1057r937b1127],
44	0.40	CD	NUMBER	0.40	number	46	SENT_244	[p17l956t1061r1089b1115],
45	to	TO	O	to	dep	46	SENT_244	[p17l1104t1069r1162b1115],
46	1.50	CD	NUMBER	1.50	appos	42	SENT_244	[p17l1180t1061r1329b1127],
47	;	:	O	;	_	0	SENT_244	[p17l1180t1061r1329b1127],
48	P	NN	O	p	dep	46	SENT_244	[p17l1345t1061r1594b1124],
49	=	JJ	O	=	advmod	53	SENT_244	[p17l1345t1061r1594b1124],
50	0.54	CD	NUMBER	0.54	dep	49	SENT_244	[p17l1345t1061r1594b1124],
51	)	CD	NUMBER	)	number	52	SENT_244	[p17l1345t1061r1594b1124],
52	(	CD	NUMBER	(	num	53	SENT_244	[p17l14t1152r151b1226],
53	Fig	NN	O	fig	rcmod	48	SENT_244	[p17l14t1152r151b1226],
54	.	.	O	.	_	0	SENT_244	[p17l14t1152r151b1226],

1	1H	NN	O	1h	nn	2	SENT_245	[p17l184t1156r318b1222],
2	)	NN	O	)	_	0	SENT_245	[p17l184t1156r318b1222],
3	,	,	O	,	_	0	SENT_245	[p17l184t1156r318b1222],
4	or	CC	O	or	_	0	SENT_245	[p17l349t1170r416b1210],
5	among	IN	O	among	_	0	SENT_245	[p17l439t1170r663b1226],
6	patients	NNS	O	patient	prep_among	7	SENT_245	[p17l686t1152r935b1226],
7	with	IN	O	with	conj_or	2	SENT_245	[p17l960t1152r1101b1210],
8	Wild	NNP	O	Wild	pobj	7	SENT_245	[p17l1124t1152r1418b1226],
9	—	CD	NUMBER	—	num	8	SENT_245	[p17l1124t1152r1418b1226],
10	type	NN	O	type	nn	11	SENT_245	[p17l1124t1152r1418b1226],
11	EGFR	NN	ORGANIZATION	egfr	dep	2	SENT_245	[p17l1442t1156r1601b1211],

1	N	NN	O	n	nn	2	SENT_246	[p17l526t1303r540b1318],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_246	[p17l556t1302r639b1324],
3	MED	VBD	O	med	_	0	SENT_246	[p17l654t1303r707b1318],
4	353:2	CD	NUMBER	353:2	dobj	3	SENT_246	[p17l719t1302r783b1324],
5	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	6	SENT_246	[p17l818t1302r1029b1324],
6	JULY	NNP	DATE	JULY	dep	3	SENT_246	[p17l1063t1303r1123b1324],
7	14	CD	DATE	14	num	6	SENT_246	[p17l1136t1302r1170b1324],
8	,	,	DATE	,	_	0	SENT_246	[p17l1136t1302r1170b1324],
9	2005	CD	DATE	2005	num	6	SENT_246	[p17l1183t1302r1246b1324],
10	The	DT	O	the	det	13	SENT_246	[p17l702t1335r752b1359],
11	New	NNP	O	New	nn	13	SENT_246	[p17l762t1336r824b1359],
12	England	NNP	O	England	nn	13	SENT_246	[p17l833t1335r944b1366],
13	Journal	NNP	O	Journal	dep	6	SENT_246	[p17l952t1335r1050b1359],
14	of	IN	O	of	_	0	SENT_246	[p17l1060t1335r1088b1359],
15	Medicine	NNP	O	Medicine	prep_of	13	SENT_246	[p17l1095t1335r1220b1359],

1	Downloaded	VBN	O	download	_	0	SENT_247	[p17l144t1376r314b1399],
2	from	IN	O	from	_	0	SENT_247	[p17l322t1376r387b1399],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_247	[p17l396t1376r514b1406],
4	at	IN	O	at	_	0	SENT_247	[p17l524t1380r547b1399],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_247	[p17l556t1376r738b1399],
6	on	IN	O	on	_	0	SENT_247	[p17l748t1383r780b1399],
7	January	NNP	DATE	January	prep_on	1	SENT_247	[p17l789t1376r892b1406],
8	5	CD	DATE	5	num	7	SENT_247	[p17l902t1376r924b1403],
9	,	,	DATE	,	_	0	SENT_247	[p17l902t1376r924b1403],
10	2014	CD	DATE	2014	num	7	SENT_247	[p17l935t1376r1007b1399],
11	.	.	O	.	_	0	SENT_247	[p17l935t1376r1007b1399],

1	For	IN	O	for	_	0	SENT_248	[p17l1018t1376r1064b1399],
2	personal	JJ	O	personal	amod	3	SENT_248	[p17l1072t1376r1184b1406],
3	use	NN	O	use	pobj	1	SENT_248	[p17l1194t1383r1237b1399],
4	only	RB	O	only	advmod	3	SENT_248	[p17l1247t1376r1312b1406],
5	.	.	O	.	_	0	SENT_248	[p17l1247t1376r1312b1406],

1	No	DT	O	no	det	3	SENT_249	[p17l1322t1376r1362b1399],
2	other	JJ	O	other	amod	3	SENT_249	[p17l1372t1376r1440b1399],
3	uses	NNS	O	use	_	0	SENT_249	[p17l1448t1383r1504b1399],
4	without	IN	O	without	_	0	SENT_249	[p17l1515t1376r1616b1399],
5	permission	NN	O	permission	prep_without	3	SENT_249	[p17l1624t1376r1777b1406],
6	.	.	O	.	_	0	SENT_249	[p17l1624t1376r1777b1406],

1	The	DT	O	the	det	3	SENT_250	[p17l855t1459r892b1480],
2	NEW	NNP	O	NEW	nn	3	SENT_250	[p17l904t1461r985b1480],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_250	[p17l999t1461r1174b1480],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_250	[p17l1188t1461r1353b1487],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_250	[p17l1367t1459r1584b1486],

1	o	NN	O	o	nn	5	SENT_251	[p18l1361t114r1378b131],
2	Point	NN	O	point	nn	5	SENT_251	[p18l1393t112r1454b132],
3	mutation	NN	O	mutation	nn	5	SENT_251	[p18l1464t112r1570b132],
4	V	NN	O	v	nn	5	SENT_251	[p18l1361t166r1377b182],
5	Deletion	NN	O	deletion	_	0	SENT_251	[p18l1393t164r1491b186],
6	or	CC	O	or	_	0	SENT_251	[p18l1501t172r1526b186],
7	insertion	NN	O	insertion	nn	8	SENT_251	[p18l1535t166r1638b186],
8	o	NN	O	o	conj_or	5	SENT_251	[p18l1088t305r1108b328],
9	0300	CD	DATE	0300	num	10	SENT_251	[p18l1229t287r1387b328],
10	o	NN	O	o	dep	5	SENT_251	[p18l1500t305r1520b328],
11	Joan	NNP	PERSON	Joan	dep	5	SENT_251	[p18l1636t286r1831b328],

1	L858R	NN	O	l858r	_	0	SENT_252	[p18l1763t575r1835b596],
2	(	CD	NUMBER	(	number	3	SENT_252	[p18l1846t575r1867b603],
3	8	CD	NUMBER	8	num	4	SENT_252	[p18l1846t575r1867b603],
4	samples	NNS	O	sample	dep	1	SENT_252	[p18l1877t574r1984b603],
5	)	IN	O	)	amod	4	SENT_252	[p18l1877t574r1984b603],

1	de	IN	O	de	dep	9	SENT_253	[p18l615t625r785b649],
2	|	CD	NUMBER	|	num	3	SENT_253	[p18l615t625r785b649],
3	E746J	NN	O	e746j	dep	1	SENT_253	[p18l615t625r785b649],
4	\	CD	NUMBER	\	num	5	SENT_253	[p18l615t625r785b649],
5	75O	NNP	O	75O	dep	3	SENT_253	[p18l615t625r785b649],
6	(	CD	NUMBER	(	num	5	SENT_253	[p18l796t627r817b654],
7	4	CD	NUMBER	4	num	8	SENT_253	[p18l796t627r817b654],
8	samples	NNS	O	sample	dep	9	SENT_253	[p18l826t626r933b655],
9	)	CD	NUMBER	)	dep	12	SENT_253	[p18l826t626r933b655],
10	de	IN	O	de	_	0	SENT_253	[p18l599t670r784b694],
11	|	CD	NUMBER	|	prep_de	9	SENT_253	[p18l599t670r784b694],
12	E746_S752V	NN	O	e746_s752v	_	0	SENT_253	[p18l599t670r784b694],
13	(	CD	NUMBER	(	number	14	SENT_253	[p18l795t672r816b699],
14	6	CD	NUMBER	6	num	15	SENT_253	[p18l795t672r816b699],
15	samples	NNS	O	sample	nsubj	16	SENT_253	[p18l826t671r933b700],
16	)	VBP	O	)	rcmod	12	SENT_253	[p18l826t671r933b700],
17	delE746_P753insLS	NN	O	dele746_p753insls	nn	19	SENT_253	[p18l700t716r934b739],
18	delL747_A750insP	NN	O	dell747_a750insp	nn	19	SENT_253	[p18l713t761r934b784],
19	del747_T75linsP	NN	O	del747_t75linsp	dobj	16	SENT_253	[p18l729t806r934b829],

1	2235_2249de	JJ	O	2235_2249de	amod	4	SENT_254	[p18l785t931r949b954],
2	|	NN	O	|	nn	4	SENT_254	[p18l785t931r949b954],
3	(	NN	O	(	nn	4	SENT_254	[p18l962t931r1148b960],
4	delE746_A750	NN	O	dele746_a750	dep	10	SENT_254	[p18l962t931r1148b960],
5	)	CD	NUMBER	)	num	6	SENT_254	[p18l962t931r1148b960],
6	2573T	NN	O	2573t	dep	4	SENT_254	[p18l1503t935r1614b955],
7	>	JJR	O	>	amod	8	SENT_254	[p18l1503t935r1614b955],
8	G	NN	O	g	dep	10	SENT_254	[p18l1503t935r1614b955],
9	(	CD	NUMBER	(	num	10	SENT_254	[p18l1627t934r1716b962],
10	L858R	NN	O	l858r	dep	17	SENT_254	[p18l1627t934r1716b962],
11	)	NN	O	)	dep	10	SENT_254	[p18l1627t934r1716b962],
12	i	FW	O	i	nn	11	SENT_254	[p18l1526t1005r1531b1027],
13	ll	FW	O	ll	nn	11	SENT_254	[p18l1601t962r1640b1032],
14	‘	FW	O	‘	nn	11	SENT_254	[p18l1601t962r1640b1032],
15	i	FW	O	i	nn	11	SENT_254	[p18l1698t1003r1704b1034],
16	‘	FW	O	‘	dep	11	SENT_254	[p18l1594t1021r1642b1059],
17	ll	NN	O	ll	dep	37	SENT_254	[p18l1594t1021r1642b1059],
18	I	PRP	O	I	dep	17	SENT_254	[p18l1704t1019r1706b1041],
19	1	CD	NUMBER	1	dep	18	SENT_254	[p18l1570t1054r1578b1080],
20	'	''	O	'	_	0	SENT_254	[p18l1570t1054r1578b1080],
21	:	:	O	:	_	0	SENT_254	[p18l1570t1054r1578b1080],
22	l	NN	O	l	dep	18	SENT_254	[p18l1598t1058r1599b1076],
23	[	NN	O	[	dep	22	SENT_254	[p18l1642t1056r1646b1087],
24	'	''	O	'	_	0	SENT_254	[p18l1736t1060r1740b1061],
25	‘	CD	NUMBER	‘	num	26	SENT_254	[p18l1546t1070r1555b1107],
26	il	NN	O	il	dep	23	SENT_254	[p18l1546t1070r1555b1107],
27	l	NN	O	l	tmod	23	SENT_254	[p18l1568t1082r1569b1100],
28	l	NN	O	l	tmod	23	SENT_254	[p18l1578t1084r1579b1110],
29	l	NN	O	l	tmod	23	SENT_254	[p18l1590t1076r1591b1102],
30	)	CD	NUMBER	)	number	31	SENT_254	[p18l1600t1091r1601b1118],
31	,1	CD	NUMBER	,1	num	36	SENT_254	[p18l1612t1088r1620b1106],
32	w	NN	O	w	nn	36	SENT_254	[p18l1628t1070r1632b1124],
33	M	NN	O	m	nn	36	SENT_254	[p18l1628t1070r1632b1124],
34	*	CD	NUMBER	*	num	36	SENT_254	[p18l1628t1070r1632b1124],
35	llnl	NN	O	llnl	nn	36	SENT_254	[p18l1644t1074r1664b1113],
36	lalll	NN	O	lalll	dep	18	SENT_254	[p18l1676t1072r1696b1116],
37	M	NN	O	m	dep	39	SENT_254	[p18l1706t1057r1720b1127],
38	*	CD	NUMBER	*	num	37	SENT_254	[p18l1706t1057r1720b1127],
39	ll	NN	O	ll	dep	45	SENT_254	[p18l1522t1063r1535b1100],
40	1	CD	NUMBER	1	number	41	SENT_254	[p18l1490t1111r1491b1114],
41	‘	CD	NUMBER	‘	dep	39	SENT_254	[p18l1534t1105r1567b1129],
42	ll	NN	O	ll	nn	44	SENT_254	[p18l1534t1105r1567b1129],
43	y	NN	O	y	nn	44	SENT_254	[p18l1602t1112r1622b1127],
44	M	NN	O	m	dep	41	SENT_254	[p18l1602t1112r1622b1127],
45	*	CD	NUMBER	*	_	0	SENT_254	[p18l1602t1112r1622b1127],
46	I	PRP	O	I	nsubj	47	SENT_254	[p18l1652t1106r1654b1127],
47	ll	VBP	O	ll	rcmod	45	SENT_254	[p18l1514t1097r1628b1167],
48	‘	SYM	O	‘	dep	50	SENT_254	[p18l1514t1097r1628b1167],
49	-	:	O	-	_	0	SENT_254	[p18l1514t1097r1628b1167],
50	‘	NN	O	‘	ccomp	47	SENT_254	[p18l1514t1097r1628b1167],
51	llli5	NN	O	llli5	nn	53	SENT_254	[p18l1514t1097r1628b1167],
52	'	''	O	'	_	0	SENT_254	[p18l1514t1097r1628b1167],
53	llll	NN	O	llll	nsubj	60	SENT_254	[p18l1646t1114r1716b1167],
54	'	''	O	'	_	0	SENT_254	[p18l1646t1114r1716b1167],
55	l	NN	O	l	dep	53	SENT_254	[p18l1514t1144r1519b1211],
56	ll	NN	O	ll	dep	53	SENT_254	[p18l1582t1162r1630b1214],
57	’	CD	NUMBER	’	num	59	SENT_254	[p18l1582t1162r1630b1214],
58	:	:	O	:	_	0	SENT_254	[p18l1582t1162r1630b1214],
59	1	CD	MONEY	1	dep	53	SENT_254	[p18l1664t1160r1674b1215],
60	#	#	MONEY	#	ccomp	50	SENT_254	[p18l1706t1156r1718b1215],
61	M	NN	O	m	prep	50	SENT_254	[p18l1706t1156r1718b1215],
62	*	NN	O	*	dep	61	SENT_254	[p18l1706t1156r1718b1215],

1	Lt	NN	O	lt	_	0	SENT_255	[p18l1587t1211r1604b1219],

1	2198C	CD	NUMBER	2198c	num	3	SENT_256	[p18l1114t1297r1223b1318],
2	>	JJR	O	>	amod	3	SENT_256	[p18l1114t1297r1223b1318],
3	T	NN	O	t	_	0	SENT_256	[p18l1114t1297r1223b1318],
4	(	CD	NUMBER	(	num	6	SENT_256	[p18l1234t1297r1323b1324],
5	P733L	NN	O	p733l	nn	6	SENT_256	[p18l1234t1297r1323b1324],
6	)	NN	O	)	dep	3	SENT_256	[p18l1234t1297r1323b1324],

1	Figure	NNP	O	Figure	_	0	SENT_257	[p18l404t2084r488b2116],
2	3	CD	NUMBER	3	dep	1	SENT_257	[p18l498t2086r520b2108],
3	.	.	O	.	_	0	SENT_257	[p18l498t2086r520b2108],

1	Mutations	NNS	O	mutation	_	0	SENT_258	[p18l532t2084r671b2109],
2	in	IN	O	in	_	0	SENT_258	[p18l681t2084r704b2108],
3	the	DT	O	the	det	5	SENT_258	[p18l713t2083r757b2109],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_258	[p18l767t2085r845b2109],
5	Gene	NN	O	gene	prep_in	1	SENT_258	[p18l853t2085r932b2109],
6	.	.	O	.	_	0	SENT_258	[p18l853t2085r932b2109],

1	Panel	NN	O	panel	nn	2	SENT_259	[p18l405t2133r475b2159],
2	A	NN	O	a	nsubj	3	SENT_259	[p18l485t2135r505b2158],
3	shows	VBZ	O	show	_	0	SENT_259	[p18l514t2133r598b2159],
4	the	DT	O	the	det	7	SENT_259	[p18l607t2133r650b2159],
5	distribution	NN	O	distribution	nn	7	SENT_259	[p18l660t2133r817b2159],
6	of45	NN	O	of45	nn	7	SENT_259	[p18l828t2133r892b2159],
7	mutations	NNS	O	mutation	dobj	3	SENT_259	[p18l905t2136r1042b2159],
8	in	IN	O	in	_	0	SENT_259	[p18l1054t2136r1075b2158],
9	exons	NNS	O	exon	prep_in	3	SENT_259	[p18l1086t2142r1163b2159],
10	18	CD	NUMBER	18	num	9	SENT_259	[p18l1176t2135r1204b2159],
11	through	IN	O	through	_	0	SENT_259	[p18l1213t2133r1321b2167],
12	21	CD	NUMBER	21	num	15	SENT_259	[p18l1332t2136r1361b2158],
13	ofthe	NN	O	ofthe	nn	15	SENT_259	[p18l1372t2133r1449b2159],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_259	[p18l1460t2135r1536b2159],
15	gene	NN	O	gene	prep_through	9	SENT_259	[p18l1545t2142r1616b2167],
16	.	.	O	.	_	0	SENT_259	[p18l1545t2142r1616b2167],

1	Panel	NN	O	panel	nn	2	SENT_260	[p18l1629t2133r1700b2159],
2	B	NN	O	b	nsubj	3	SENT_260	[p18l1713t2136r1728b2158],
3	shows	VBZ	O	show	_	0	SENT_260	[p18l1738t2133r1823b2159],
4	representative	JJ	O	representative	amod	5	SENT_260	[p18l1834t2136r2027b2166],
5	sequencing	NN	O	sequencing	nsubj	6	SENT_260	[p18l403t2177r559b2208],
6	results	VBZ	O	result	ccomp	3	SENT_260	[p18l569t2175r658b2200],
7	oftypical	JJ	O	oftypical	amod	8	SENT_260	[p18l669t2175r789b2208],
8	mutations	NNS	O	mutation	nsubj	9	SENT_260	[p18l802t2177r939b2200],
9	(	VBP	O	(	ccomp	6	SENT_260	[p18l953t2175r1156b2208],
10	de	IN	O	de	amod	12	SENT_260	[p18l953t2175r1156b2208],
11	|	CD	NUMBER	|	num	12	SENT_260	[p18l953t2175r1156b2208],
12	E746J750	NN	O	e746j750	dobj	9	SENT_260	[p18l953t2175r1156b2208],
13	and	CC	O	and	_	0	SENT_260	[p18l1166t2175r1214b2200],
14	2573T	NN	O	2573t	dobj	9	SENT_260	[p18l1225t2177r1359b2208],
15	>	JJR	O	>	amod	17	SENT_260	[p18l1225t2177r1359b2208],
16	G	NN	O	g	nn	17	SENT_260	[p18l1225t2177r1359b2208],
17	)	NNS	O	)	dep	14	SENT_260	[p18l1225t2177r1359b2208],
18	and	CC	O	and	_	0	SENT_260	[p18l1372t2175r1420b2200],
19	novel	JJ	O	novel	amod	21	SENT_260	[p18l1433t2175r1502b2200],
20	variant	JJ	O	variant	amod	21	SENT_260	[p18l1513t2177r1607b2200],
21	mutations	NNS	O	mutation	conj_and	17	SENT_260	[p18l1617t2177r1763b2200],
22	.	.	O	.	_	0	SENT_260	[p18l1617t2177r1763b2200],

1	For	IN	O	for	_	0	SENT_261	[p18l1776t2177r1818b2200],
2	the	DT	O	the	det	3	SENT_261	[p18l1826t2175r1868b2200],
3	specimen	NN	O	specimen	prep_for	12	SENT_261	[p18l1879t2177r2008b2208],
4	with	IN	O	with	_	0	SENT_261	[p18l401t2217r458b2242],
5	the	DT	O	the	det	7	SENT_261	[p18l468t2217r510b2242],
6	V851A	NN	O	v851a	nn	7	SENT_261	[p18l519t2218r608b2242],
7	mutation	NN	O	mutation	prep_with	3	SENT_261	[p18l619t2219r749b2246],
8	,	,	O	,	_	0	SENT_261	[p18l619t2219r749b2246],
9	the	DT	O	the	det	11	SENT_261	[p18l759t2217r802b2242],
10	minor	JJ	O	minor	amod	11	SENT_261	[p18l813t2219r894b2242],
11	peak	NN	O	peak	nsubj	12	SENT_261	[p18l905t2217r967b2250],
12	represents	VBZ	O	represent	_	0	SENT_261	[p18l977t2222r1119b2250],
13	the	DT	O	the	det	16	SENT_261	[p18l1128t2217r1171b2242],
14	wild-type	JJ	O	wild-type	amod	16	SENT_261	[p18l1180t2217r1302b2250],
15	T	NN	O	t	nn	16	SENT_261	[p18l1311t2219r1329b2242],
16	nucleotide	NN	O	nucleotide	dobj	12	SENT_261	[p18l1339t2217r1487b2242],
17	.	.	O	.	_	0	SENT_261	[p18l1339t2217r1487b2242],

1	All	DT	O	all	det	2	SENT_262	[p18l1497t2217r1530b2242],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_262	[p18l1543t2219r1681b2242],
3	were	VBD	O	be	auxpass	4	SENT_262	[p18l1690t2226r1754b2242],
4	confirmed	VBN	O	confirm	_	0	SENT_262	[p18l1764t2216r1902b2242],
5	bidirectionally	RB	O	bidirectionally	advmod	4	SENT_262	[p18l1914t2217r2013b2242, p18l402t2258r501b2291],
6	with	IN	O	with	prep	4	SENT_262	[p18l509t2258r565b2284],
7	forward	RB	O	forward	pcomp	6	SENT_262	[p18l576t2258r679b2284],
8	and	CC	O	and	_	0	SENT_262	[p18l690t2258r738b2284],
9	reverse	VB	O	reverse	conj_and	4	SENT_262	[p18l751t2267r847b2284],
10	sequencing	NN	O	sequencing	dobj	9	SENT_262	[p18l857t2261r1019b2292],
11	.	.	O	.	_	0	SENT_262	[p18l857t2261r1019b2292],

1	who	WP	O	who	nsubj	2	SENT_263	[p18l376t2398r448b2429],
2	received	VBD	O	receive	dep	32	SENT_263	[p18l458t2398r591b2429],
3	erlotinib	NN	O	erlotinib	dobj	2	SENT_263	[p18l602t2398r750b2435],
4	,	,	O	,	_	0	SENT_263	[p18l602t2398r750b2435],
5	as	IN	O	as	mark	21	SENT_263	[p18l763t2408r795b2429],
6	compared	VBN	O	compare	_	0	SENT_263	[p18l807t2398r971b2437],
7	with	IN	O	with	prepc_compared_with	21	SENT_263	[p18l980t2398r1053b2429],
8	such	JJ	O	such	amod	10	SENT_263	[p18l1064t2398r1140b2429],
9	pa	NN	O	pa	nn	10	SENT_263	[p18l1149t2408r1201b2437],
10	—	NN	O	—	pobj	21	SENT_263	[p18l1149t2408r1201b2437],
11	Twenty	CD	NUMBER	twenty	num	14	SENT_263	[p18l1289t2401r1479b2437],
12	—	CD	NUMBER	—	num	14	SENT_263	[p18l1289t2401r1479b2437],
13	one	CD	NUMBER	one	num	14	SENT_263	[p18l1289t2401r1479b2437],
14	mutations	NNS	O	mutation	dep	10	SENT_263	[p18l1488t2399r1653b2429],
15	(	RB	O	(	advmod	10	SENT_263	[p18l1665t2399r1707b2434],
16	in	IN	O	in	_	0	SENT_263	[p18l1665t2399r1707b2434],
17	20	CD	NUMBER	20	num	18	SENT_263	[p18l1716t2400r1755b2429],
18	patients	NNS	O	patient	prep_in	10	SENT_263	[p18l1763t2399r1904b2437],
19	)	CD	NUMBER	)	nsubj	21	SENT_263	[p18l1763t2399r1904b2437],
20	were	VBD	O	be	cop	21	SENT_263	[p18l1913t2408r1990b2429],
21	pretients	NNS	O	pretient	dep	32	SENT_263	[p18l1999t2408r2064b2437, p18l378t2448r467b2478],
22	who	WP	O	who	nsubj	23	SENT_263	[p18l475t2447r546b2478],
23	received	VBD	O	receive	rcmod	21	SENT_263	[p18l554t2447r687b2478],
24	placebo	NN	O	placebo	nn	27	SENT_263	[p18l694t2447r821b2486],
25	(	NN	O	(	nn	27	SENT_263	[p18l831t2447r955b2482],
26	hazard	NN	O	hazard	nn	27	SENT_263	[p18l831t2447r955b2482],
27	ratio	NN	O	ratio	dobj	23	SENT_263	[p18l962t2448r1037b2478],
28	for	IN	O	for	_	0	SENT_263	[p18l1045t2447r1093b2478],
29	death	NN	O	death	prep_for	23	SENT_263	[p18l1100t2447r1199b2484],
30	,	,	O	,	_	0	SENT_263	[p18l1100t2447r1199b2484],
31	viously	RB	O	viously	advmod	32	SENT_263	[p18l1239t2447r1353b2486],
32	described	VBN	O	describe	_	0	SENT_263	[p18l1360t2447r1518b2478],
33	deletions	NNS	O	deletion	dobj	32	SENT_263	[p18l1526t2447r1674b2478],
34	in	IN	O	in	_	0	SENT_263	[p18l1683t2448r1715b2477],
35	exon	NN	O	exon	prep_in	33	SENT_263	[p18l1724t2457r1801b2478],
36	19	CD	NUMBER	19	num	35	SENT_263	[p18l1811t2449r1848b2478],
37	or	CC	O	or	_	0	SENT_263	[p18l1857t2457r1892b2478],
38	the	DT	O	the	det	39	SENT_263	[p18l1900t2447r1950b2478],
39	L858R	NN	O	l858r	conj_or	33	SENT_263	[p18l1958t2449r2068b2480],
40	0.73	CD	NUMBER	0.73	dep	39	SENT_263	[p18l378t2498r459b2533],
41	;	:	O	;	_	0	SENT_263	[p18l378t2498r459b2533],
42	95	CD	PERCENT	95	num	45	SENT_263	[p18l472t2498r510b2527],
43	percent	NN	PERCENT	percent	nn	45	SENT_263	[p18l523t2503r647b2535],
44	conﬁdence	NN	O	conﬁdence	nn	45	SENT_263	[p18l657t2496r837b2527],
45	interval	NN	O	interval	dep	39	SENT_263	[p18l848t2496r979b2533],
46	,	,	O	,	_	0	SENT_263	[p18l848t2496r979b2533],
47	0.49	CD	NUMBER	0.49	number	49	SENT_263	[p18l993t2498r1064b2527],
48	to	TO	O	to	dep	49	SENT_263	[p18l1076t2503r1107b2527],
49	1.10	CD	NUMBER	1.10	appos	45	SENT_263	[p18l1120t2498r1200b2533],
50	;	:	O	;	_	0	SENT_263	[p18l1120t2498r1200b2533],
51	mutation	NN	O	mutation	dep	39	SENT_263	[p18l1241t2497r1392b2527],
52	in	IN	O	in	_	0	SENT_263	[p18l1402t2497r1434b2526],
53	exon	NN	O	exon	prep_in	51	SENT_263	[p18l1445t2506r1522b2527],
54	21	CD	NUMBER	21	num	53	SENT_263	[p18l1533t2498r1581b2527],
55	.	.	O	.	_	0	SENT_263	[p18l1533t2498r1581b2527],

1	There	EX	O	there	expl	2	SENT_264	[p18l1593t2496r1688b2527],
2	was	VBD	O	be	_	0	SENT_264	[p18l1697t2506r1759b2527],
3	no	DT	O	no	det	5	SENT_264	[p18l1771t2506r1812b2527],
4	significant	JJ	O	significant	amod	5	SENT_264	[p18l1824t2496r1999b2535],
5	difP	NN	O	difp	nsubj	2	SENT_264	[p18l2008t2496r2064b2527, p18l377t2547r510b2581],
6	=	JJ	O	=	dep	5	SENT_264	[p18l2008t2496r2064b2527, p18l377t2547r510b2581],
7	0.13	CD	NUMBER	0.13	iobj	6	SENT_264	[p18l2008t2496r2064b2527, p18l377t2547r510b2581],
8	)	CD	NUMBER	)	number	9	SENT_264	[p18l2008t2496r2064b2527, p18l377t2547r510b2581],
9	(	CD	NUMBER	(	num	10	SENT_264	[p18l524t2546r595b2584],
10	Fig	NN	O	fig	dobj	6	SENT_264	[p18l524t2546r595b2584],
11	.	.	O	.	_	0	SENT_264	[p18l524t2546r595b2584],

1	1G	NN	O	1g	_	0	SENT_265	[p18l608t2547r677b2581],
2	)	NN	O	)	dep	1	SENT_265	[p18l608t2547r677b2581],
3	.	.	O	.	_	0	SENT_265	[p18l608t2547r677b2581],

1	ference	NN	O	ference	_	0	SENT_266	[p18l1241t2545r1362b2576],
2	in	IN	O	in	dep	1	SENT_266	[p18l1371t2546r1403b2575],
3	survival	NN	O	survival	pobj	2	SENT_266	[p18l1413t2545r1539b2576],
4	associated	VBN	O	associate	partmod	3	SENT_266	[p18l1548t2545r1721b2576],
5	with	IN	O	with	_	0	SENT_266	[p18l1729t2545r1803b2576],
6	erlotinib	NN	O	erlotinib	nn	7	SENT_266	[p18l1813t2545r1955b2576],
7	thera140	NN	O	thera140	prep_with	4	SENT_266	[p18l1965t2545r2063b2576, p18l92t2659r148b2680],

1	N	NN	O	n	nn	3	SENT_267	[p18l861t2661r875b2676],
2	ENGLJ	NN	O	englj	nn	3	SENT_267	[p18l890t2660r974b2682],
3	MED	NN	O	med	nsubj	9	SENT_267	[p18l989t2661r1042b2676],
4	353	CD	NUMBER	353	num	6	SENT_267	[p18l1054t2660r1118b2682],
5	;	:	O	;	_	0	SENT_267	[p18l1054t2660r1118b2682],
6	2	CD	NUMBER	2	dep	3	SENT_267	[p18l1054t2660r1118b2682],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_267	[p18l1153t2660r1364b2682],
8	JULY	NNP	DATE	JULY	dep	3	SENT_267	[p18l1397t2661r1458b2682],
9	‘	VBD	O	‘	_	0	SENT_267	[p18l1470t2660r1504b2682],
10	I4	NN	O	i4	dobj	9	SENT_267	[p18l1470t2660r1504b2682],
11	,	,	O	,	_	0	SENT_267	[p18l1470t2660r1504b2682],
12	2005	CD	DATE	2005	appos	10	SENT_267	[p18l1517t2660r1581b2682],

1	The	DT	O	the	det	4	SENT_268	[p18l878t2757r929b2781],
2	New	NNP	O	New	nn	4	SENT_268	[p18l938t2758r1000b2781],
3	England	NNP	O	England	nn	4	SENT_268	[p18l1009t2757r1120b2788],
4	Journal	NNP	O	Journal	_	0	SENT_268	[p18l1129t2757r1226b2781],
5	of	IN	O	of	_	0	SENT_268	[p18l1236t2757r1265b2781],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_268	[p18l1271t2757r1396b2781],

1	Downloaded	VBN	O	download	_	0	SENT_269	[p18l320t2798r490b2821],
2	from	IN	O	from	_	0	SENT_269	[p18l499t2798r563b2821],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_269	[p18l572t2798r690b2828],
4	at	IN	O	at	_	0	SENT_269	[p18l700t2802r724b2821],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_269	[p18l732t2798r915b2821],
6	on	IN	O	on	_	0	SENT_269	[p18l924t2805r956b2821],
7	January	NNP	DATE	January	prep_on	1	SENT_269	[p18l965t2798r1068b2828],
8	5	CD	DATE	5	num	7	SENT_269	[p18l1078t2798r1100b2826],
9	,	,	DATE	,	_	0	SENT_269	[p18l1078t2798r1100b2826],
10	2014	CD	DATE	2014	num	7	SENT_269	[p18l1111t2798r1183b2821],
11	.	.	O	.	_	0	SENT_269	[p18l1111t2798r1183b2821],

1	For	IN	O	for	_	0	SENT_270	[p18l1194t2798r1240b2821],
2	personal	JJ	O	personal	amod	3	SENT_270	[p18l1248t2798r1361b2828],
3	use	NN	O	use	pobj	1	SENT_270	[p18l1370t2805r1413b2821],
4	only	RB	O	only	advmod	3	SENT_270	[p18l1423t2798r1488b2828],
5	.	.	O	.	_	0	SENT_270	[p18l1423t2798r1488b2828],

1	N	NN	O	n	nn	2	SENT_271	[p18l1498t2798r1522b2821],
2	o	NN	O	o	_	0	SENT_271	[p18l1523t2805r1538b2821],
3	other	JJ	O	other	amod	4	SENT_271	[p18l1548t2798r1616b2821],
4	uses	NNS	O	use	dep	2	SENT_271	[p18l1625t2805r1680b2821],
5	without	IN	O	without	_	0	SENT_271	[p18l1691t2798r1792b2821],
6	permission	NN	O	permission	prep_without	4	SENT_271	[p18l1800t2798r1953b2828],
7	.	.	O	.	_	0	SENT_271	[p18l1800t2798r1953b2828],

1	ERLOTINIB	JJ	O	erlotinib	amod	2	SENT_272	[p18l736t2883r923b2902],
2	THERAPY	NN	O	therapy	_	0	SENT_272	[p18l936t2883r1088b2902],
3	FOR	IN	O	for	_	0	SENT_272	[p18l1101t2883r1167b2902],
4	LUNG	NN	O	lung	prep_for	2	SENT_272	[p18l1180t2883r1274b2902],
5	CANCER	NNP	O	CANCER	dep	2	SENT_272	[p18l1287t2883r1423b2902],

1	Table	NNP	O	Table	_	0	SENT_273	[p19l263t34r334b59],
2	3	CD	NUMBER	3	dep	1	SENT_273	[p19l343t36r366b59],
3	.	.	O	.	_	0	SENT_273	[p19l343t36r366b59],

1	Analysis	NN	O	analysis	_	0	SENT_274	[p19l375t34r488b67],
2	of	IN	O	of	_	0	SENT_274	[p19l498t33r529b59],
3	Responses	NNS	O	response	prep_of	1	SENT_274	[p19l534t36r679b66],
4	and	CC	O	and	_	0	SENT_274	[p19l689t34r738b59],
5	Survival	NN	O	survival	prep_of	1	SENT_274	[p19l748t34r882b59],
6	.	.	O	.	_	0	SENT_274	[p19l748t34r882b59],

1	‘	SYM	O	‘	dep	3	SENT_275	[p19l748t34r882b59],
2	-	:	O	-	_	0	SENT_275	[p19l748t34r882b59],
3	“	NN	O	“	_	0	SENT_275	[p19l748t34r882b59],

1	No.	NN	O	no.	_	0	SENT_276	[p19l738t110r785b133],
2	of	IN	O	of	_	0	SENT_276	[p19l794t107r826b133],
3	No.	NN	O	no.	prep_of	1	SENT_276	[p19l877t110r924b133],
4	.	.	O	.	_	0	SENT_276	[p19l877t110r924b133],

1	Who	WP	O	who	nsubj	3	SENT_277	[p19l933t107r996b133],
2	Could	MD	O	could	aux	3	SENT_277	[p19l1005t107r1083b133],
3	No.	NN	O	no.	_	0	SENT_277	[p19l1190t110r1237b133],
4	of	IN	O	of	_	0	SENT_277	[p19l1246t107r1278b133],
5	Hazard	NNP	O	Hazard	nn	6	SENT_277	[p19l1524t107r1620b133],
6	Ratio	NNP	O	Ratio	prep_of	3	SENT_277	[p19l1632t108r1700b133],
7	for	IN	O	for	prep	3	SENT_277	[p19l1708t107r1747b133],

1	Factor	NN	O	factor	nn	2	SENT_278	[p19l266t147r348b170],
2	Patients	NNS	O	patient	_	0	SENT_278	[p19l724t145r832b170],
3	Be	VB	O	be	auxpass	4	SENT_278	[p19l894t147r926b170],
4	Evaluated	VBN	O	evaluate	dep	2	SENT_278	[p19l937t145r1067b170],
5	Responses	NNS	O	response	dobj	4	SENT_278	[p19l1130t147r1275b177],
6	(	CD	PERCENT	(	num	7	SENT_278	[p19l1286t146r1330b178],
7	%	NN	PERCENT	%	dep	5	SENT_278	[p19l1286t146r1330b178],
8	)	CD	NUMBER	)	num	14	SENT_278	[p19l1286t146r1330b178],
9	PValue	NNP	O	PValue	nn	14	SENT_278	[p19l1378t145r1476b170],
10	Death	NNP	O	Death	nn	14	SENT_278	[p19l1521t145r1600b170],
11	(	CD	PERCENT	(	num	14	SENT_278	[p19l1612t146r1681b178],
12	95	CD	PERCENT	95	num	14	SENT_278	[p19l1612t146r1681b178],
13	%	NN	PERCENT	%	nn	14	SENT_278	[p19l1612t146r1681b178],
14	Cl	NN	O	cl	dep	22	SENT_278	[p19l1690t147r1748b178],
15	)	NN	O	)	nn	17	SENT_278	[p19l1690t147r1748b178],
16	'	''	O	'	_	0	SENT_278	[p19l1690t147r1748b178],
17	j'	NN	O	j'	dep	14	SENT_278	[p19l1690t147r1748b178],
18	P	NN	O	p	nn	19	SENT_278	[p19l1795t147r1810b170],
19	Value	NN	ORGANIZATION	value	dep	22	SENT_278	[p19l1818t145r1892b170],
20	Entire	JJ	ORGANIZATION	entire	amod	22	SENT_278	[p19l266t216r344b239],
21	study	NN	O	study	nn	22	SENT_278	[p19l354t213r427b246],
22	group	NN	O	group	dep	28	SENT_278	[p19l436t222r516b247],
23	731	CD	NUMBER	731	number	24	SENT_278	[p19l755t216r800b239],
24	427	CD	NUMBER	427	dep	22	SENT_278	[p19l955t216r1004b238],
25	38	CD	NUMBER	38	num	26	SENT_278	[p19l1182t215r1212b239],
26	(	CD	NUMBER	(	dep	24	SENT_278	[p19l1226t216r1259b246],
27	9	CD	NUMBER	9	num	28	SENT_278	[p19l1226t216r1259b246],
28	)	NN	O	)	dep	37	SENT_278	[p19l1226t216r1259b246],
29	—	CD	NUMBER	—	number	30	SENT_278	[p19l1409t229r1442b231],
30	0.70	CD	NUMBER	0.70	num	31	SENT_278	[p19l1523t215r1580b239],
31	(	NN	O	(	dep	28	SENT_278	[p19l1592t215r1742b246],
32	0.58	CD	NUMBER	0.58	number	33	SENT_278	[p19l1592t215r1742b246],
33	—	CD	NUMBER	—	dep	36	SENT_278	[p19l1592t215r1742b246],
34	0.85	CD	NUMBER	0.85	num	35	SENT_278	[p19l1592t215r1742b246],
35	)	NN	O	)	npadvmod	36	SENT_278	[p19l1592t215r1742b246],
36	<	JJR	O	<	amod	31	SENT_278	[p19l1797t215r1887b239],
37	0.001	CD	NUMBER	0.001	dep	38	SENT_278	[p19l1797t215r1887b239],
38	Sex	NN	O	sex	dep	5	SENT_278	[p19l315t272r360b296],
39	0.007	CD	NUMBER	0.007	num	38	SENT_278	[p19l1398t272r1471b296],

1	Male	JJ	O	male	dep	9	SENT_279	[p19l366t328r431b353],
2	475	CD	NUMBER	475	number	3	SENT_279	[p19l753t330r800b353],
3	281	CD	NUMBER	281	dep	1	SENT_279	[p19l956t329r1002b353],
4	17	CD	NUMBER	17	num	5	SENT_279	[p19l1184t330r1213b352],
5	(	NN	O	(	dep	3	SENT_279	[p19l1226t330r1259b361],
6	6	CD	NUMBER	6	num	7	SENT_279	[p19l1226t330r1259b361],
7	)	NN	O	)	dep	9	SENT_279	[p19l1226t330r1259b361],
8	0.76	CD	NUMBER	0.76	num	9	SENT_279	[p19l1523t329r1579b353],
9	(	CD	NUMBER	(	dep	19	SENT_279	[p19l1592t329r1742b361],
10	0.62	CD	NUMBER	0.62	num	11	SENT_279	[p19l1592t329r1742b361],
11	—	NN	O	—	dep	9	SENT_279	[p19l1592t329r1742b361],
12	0.94	CD	NUMBER	0.94	number	13	SENT_279	[p19l1592t329r1742b361],
13	)	CD	NUMBER	)	num	14	SENT_279	[p19l1592t329r1742b361],
14	0.01	CD	NUMBER	0.01	dep	11	SENT_279	[p19l1814t329r1869b353],
15	Female	JJ	O	female	amod	14	SENT_279	[p19l366t385r462b410],
16	21	CD	NUMBER	21	number	17	SENT_279	[p19l1182t387r1211b409],
17	(	CD	NUMBER	(	dep	15	SENT_279	[p19l1226t387r1275b418],
18	14	CD	NUMBER	14	num	19	SENT_279	[p19l1226t387r1275b418],
19	)	NN	O	)	dep	23	SENT_279	[p19l1226t387r1275b418],
20	0.80	CD	NUMBER	0.80	number	21	SENT_279	[p19l1523t386r1580b410],
21	(	CD	NUMBER	(	dep	19	SENT_279	[p19l1592t386r1742b418],
22	0.59	CD	NUMBER	0.59	dep	21	SENT_279	[p19l1592t386r1742b418],
23	—	NN	O	—	dep	26	SENT_279	[p19l1592t386r1742b418],
24	1.07	CD	NUMBER	1.07	num	23	SENT_279	[p19l1592t386r1742b418],
25	)	CD	NUMBER	)	num	26	SENT_279	[p19l1592t386r1742b418],
26	0.13	CD	NUMBER	0.13	_	0	SENT_279	[p19l1814t386r1869b410],

1	Histopathological	JJ	O	histopathological	amod	3	SENT_280	[p19l316t442r557b475],
2	subtype	NN	O	subtype	nn	3	SENT_280	[p19l569t442r674b475],
3	Adenocarcinoma	NN	O	adenocarcinoma	dep	10	SENT_280	[p19l363t499r596b524],
4	29	CD	NUMBER	29	number	5	SENT_280	[p19l1182t501r1212b524],
5	(	CD	NUMBER	(	dep	3	SENT_280	[p19l1226t501r1275b532],
6	14	CD	NUMBER	14	dep	5	SENT_280	[p19l1226t501r1275b532],
7	)	NN	O	)	dep	10	SENT_280	[p19l1226t501r1275b532],
8	0.72	CD	NUMBER	0.72	num	7	SENT_280	[p19l1523t500r1579b524],
9	(	CD	NUMBER	(	num	10	SENT_280	[p19l1592t500r1742b532],
10	0.56	CD	NUMBER	0.56	dep	17	SENT_280	[p19l1592t500r1742b532],
11	—	NN	O	—	dep	10	SENT_280	[p19l1592t500r1742b532],
12	0.92	CD	NUMBER	0.92	num	11	SENT_280	[p19l1592t500r1742b532],
13	)	CD	NUMBER	)	number	14	SENT_280	[p19l1592t500r1742b532],
14	0.008	CD	NUMBER	0.008	num	15	SENT_280	[p19l1814t500r1887b524],
15	Other	JJ	O	other	dep	11	SENT_280	[p19l365t556r444b581],
16	9	CD	NUMBER	9	num	17	SENT_280	[p19l1199t558r1212b581],
17	(	NN	O	(	dep	21	SENT_280	[p19l1226t558r1259b589],
18	4	CD	NUMBER	4	number	19	SENT_280	[p19l1226t558r1259b589],
19	)	CD	NUMBER	)	dep	17	SENT_280	[p19l1226t558r1259b589],
20	0.81	CD	NUMBER	0.81	dep	19	SENT_280	[p19l1523t558r1578b581],
21	(	NN	O	(	dep	24	SENT_280	[p19l1592t558r1742b589],
22	0.64-1	CD	NUMBER	0.64-1	num	21	SENT_280	[p19l1592t558r1742b589],
23	.02	CD	NUMBER	.02	num	24	SENT_280	[p19l1592t558r1742b589],
24	)	NN	O	)	dep	25	SENT_280	[p19l1592t558r1742b589],
25	0.07	CD	NUMBER	0.07	_	0	SENT_280	[p19l1814t558r1870b581],

1	Smoking	NN	MISC	smoking	nn	2	SENT_281	[p19l315t613r435b646],
2	history	NN	O	history	_	0	SENT_281	[p19l445t613r537b646],

1	Current	JJ	DATE	current	dep	7	SENT_282	[p19l365t672r467b695],
2	or	CC	O	or	_	0	SENT_282	[p19l477t679r505b695],
3	former	JJ	O	former	amod	4	SENT_282	[p19l513t670r606b695],
4	12	CD	NUMBER	12	conj_or	1	SENT_282	[p19l1184t672r1212b695],
5	(	CD	NUMBER	(	dep	7	SENT_282	[p19l1226t672r1259b703],
6	4	CD	NUMBER	4	num	7	SENT_282	[p19l1226t672r1259b703],
7	)	NN	O	)	dep	12	SENT_282	[p19l1226t672r1259b703],
8	0.87	CD	NUMBER	0.87	number	9	SENT_282	[p19l1523t672r1579b695],
9	(	CD	NUMBER	(	dep	7	SENT_282	[p19l1592t672r1742b703],
10	0.71	CD	NUMBER	0.71	num	11	SENT_282	[p19l1592t672r1742b703],
11	—	CD	NUMBER	—	dep	9	SENT_282	[p19l1592t672r1742b703],
12	l.	NN	O	l.	dep	16	SENT_282	[p19l1592t672r1742b703],
13	05	CD	NUMBER	05	num	12	SENT_282	[p19l1592t672r1742b703],
14	)	CD	NUMBER	)	num	16	SENT_282	[p19l1592t672r1742b703],
15	0.14	CD	NUMBER	0.14	num	16	SENT_282	[p19l1814t672r1870b695],
16	None	NN	O	none	dep	27	SENT_282	[p19l366t729r439b752],
17	0.42	CD	NUMBER	0.42	number	18	SENT_282	[p19l1523t729r1579b752],
18	(	CD	NUMBER	(	num	19	SENT_282	[p19l1592t729r1742b760],
19	0.28	CD	NUMBER	0.28	dep	16	SENT_282	[p19l1592t729r1742b760],
20	—	CD	NUMBER	—	number	21	SENT_282	[p19l1592t729r1742b760],
21	0.64	CD	NUMBER	0.64	num	22	SENT_282	[p19l1592t729r1742b760],
22	)	NN	O	)	npadvmod	23	SENT_282	[p19l1592t729r1742b760],
23	<	JJR	O	<	amod	19	SENT_282	[p19l1797t729r1887b752],
24	0.001	CD	NUMBER	0.001	npadvmod	25	SENT_282	[p19l1797t729r1887b752],
25	Unknown	JJ	O	unknown	amod	19	SENT_282	[p19l366t784r494b810],
26	3	CD	NUMBER	3	num	27	SENT_282	[p19l1199t786r1211b809],
27	(	CD	NUMBER	(	dep	33	SENT_282	[p19l1226t786r1275b817],
28	13	CD	NUMBER	13	num	29	SENT_282	[p19l1226t786r1275b817],
29	)	NN	O	)	dep	27	SENT_282	[p19l1226t786r1275b817],
30	1.09	CD	NUMBER	1.09	number	31	SENT_282	[p19l1525t786r1579b810],
31	(	CD	NUMBER	(	num	32	SENT_282	[p19l1592t786r1742b817],
32	0.54	CD	NUMBER	0.54	dep	29	SENT_282	[p19l1592t786r1742b817],
33	—	NN	O	—	dep	36	SENT_282	[p19l1592t786r1742b817],
34	2.22	CD	NUMBER	2.22	num	33	SENT_282	[p19l1592t786r1742b817],
35	)	CD	NUMBER	)	num	36	SENT_282	[p19l1592t786r1742b817],
36	0.80	CD	NUMBER	0.80	_	0	SENT_282	[p19l1814t786r1871b810],

1	Race	NN	O	race	nn	4	SENT_283	[p19l316t844r378b867],
2	or	CC	O	or	_	0	SENT_283	[p19l388t850r416b867],
3	ethnic	JJ	O	ethnic	nn	4	SENT_283	[p19l425t841r508b867],
4	group	NN	O	group	_	0	SENT_283	[p19l518t850r597b875],
5	Asian	JJ	O	asian	dep	4	SENT_283	[p19l363t900r438b924],
6	Other	JJ	O	other	dep	4	SENT_283	[p19l365t955r444b981],

1	Results	NNS	O	result	_	0	SENT_284	[p19l266t1013r363b1038],
2	of	IN	O	of	_	0	SENT_284	[p19l373t1012r403b1038],
3	EGFR	NN	O	egfr	nn	5	SENT_284	[p19l410t1015r484b1038],
4	IHC	NN	O	ihc	nn	5	SENT_284	[p19l497t1014r548b1038],
5	analysis	NN	O	analysis	prep_of	1	SENT_284	[p19l558t1013r664b1046],

1	Positiveji	NNP	O	Positiveji	_	0	SENT_285	[p19l316t1072r439b1103],
2	Negative	JJ	O	negative	amod	4	SENT_285	[p19l316t1129r435b1160],
3	FISH	NN	O	fish	nn	4	SENT_285	[p19l266t1186r331b1209],
4	status	NN	O	status	dep	1	SENT_285	[p19l344t1189r424b1209],

1	Not	RB	O	not	dep	2	SENT_286	[p19l316t1243r366b1266],
2	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_286	[p19l376t1241r501b1274],
3	Ampliﬁedfl	NNP	O	Ampliﬁedfl	nn	5	SENT_286	[p19l313t1298r458b1331],
4	Mutational	JJ	O	mutational	amod	5	SENT_286	[p19l266t1355r412b1380],
5	status	NN	O	status	nsubj	8	SENT_286	[p19l424t1360r505b1380],
6	Wild	NNP	O	Wild	nn	8	SENT_286	[p19l313t1412r374b1437],
7	type	NN	O	type	nn	8	SENT_286	[p19l384t1417r440b1445],
8	Mutation	NN	O	mutation	xcomp	2	SENT_286	[p19l316t1472r439b1494],

1	0.68	CD	NUMBER	0.68	num	3	SENT_287	[p19l1523t1071r1579b1095],
2	(	CD	NUMBER	(	num	3	SENT_287	[p19l1592t1071r1742b1103],
3	o.	NN	O	o.	dep	9	SENT_287	[p19l1592t1071r1742b1103],
4	49	CD	NUMBER	49	num	5	SENT_287	[p19l1592t1071r1742b1103],
5	—	CD	NUMBER	—	dep	3	SENT_287	[p19l1592t1071r1742b1103],
6	o.	NN	O	o.	dep	9	SENT_287	[p19l1592t1071r1742b1103],
7	95	CD	NUMBER	95	num	6	SENT_287	[p19l1592t1071r1742b1103],
8	)	CD	NUMBER	)	num	9	SENT_287	[p19l1592t1071r1742b1103],
9	0.93	CD	NUMBER	0.93	dep	14	SENT_287	[p19l1523t1128r1578b1152],
10	(	CD	NUMBER	(	number	11	SENT_287	[p19l1592t1128r1742b1160],
11	0.63	CD	NUMBER	0.63	dep	9	SENT_287	[p19l1592t1128r1742b1160],
12	—	NN	O	—	dep	11	SENT_287	[p19l1592t1128r1742b1160],
13	1.36	CD	NUMBER	1.36	num	14	SENT_287	[p19l1592t1128r1742b1160],
14	)	NN	O	)	_	0	SENT_287	[p19l1592t1128r1742b1160],

1	0.85	CD	NUMBER	0.85	number	2	SENT_288	[p19l1523t1243r1578b1266],
2	(	CD	NUMBER	(	num	4	SENT_288	[p19l1592t1243r1742b1274],
3	o.	NN	O	o.	nn	4	SENT_288	[p19l1592t1243r1742b1274],
4	4s	NNS	O	4	nsubj	5	SENT_288	[p19l1592t1243r1742b1274],
5	—	VBP	O	—	_	0	SENT_288	[p19l1592t1243r1742b1274],
6	1.51	CD	NUMBER	1.51	number	7	SENT_288	[p19l1592t1243r1742b1274],
7	)	CD	NUMBER	)	dobj	5	SENT_288	[p19l1592t1243r1742b1274],
8	0.44	CD	NUMBER	0.44	num	9	SENT_288	[p19l1523t1300r1579b1323],
9	(	NN	O	(	dep	7	SENT_288	[p19l1592t1300r1742b1331],
10	0.23	CD	NUMBER	0.23	num	11	SENT_288	[p19l1592t1300r1742b1331],
11	—	CD	NUMBER	—	dep	5	SENT_288	[p19l1592t1300r1742b1331],
12	0.82	CD	NUMBER	0.82	num	13	SENT_288	[p19l1592t1300r1742b1331],
13	)	NN	O	)	dep	11	SENT_288	[p19l1592t1300r1742b1331],

1	0.73	CD	NUMBER	0.73	num	3	SENT_289	[p19l1523t1414r1578b1437],
2	(	CD	NUMBER	(	num	3	SENT_289	[p19l1592t1414r1742b1445],
3	o.	NN	O	o.	_	0	SENT_289	[p19l1592t1414r1742b1445],
4	49	CD	NUMBER	49	num	5	SENT_289	[p19l1592t1414r1742b1445],
5	—	NN	O	—	dep	3	SENT_289	[p19l1592t1414r1742b1445],
6	1.1	CD	NUMBER	1.1	num	7	SENT_289	[p19l1592t1414r1742b1445],
7	o	NN	O	o	dep	5	SENT_289	[p19l1592t1414r1742b1445],
8	)	CD	NUMBER	)	number	9	SENT_289	[p19l1592t1414r1742b1445],
9	0.77	CD	NUMBER	0.77	dep	3	SENT_289	[p19l1523t1471r1579b1494],
10	(	CD	NUMBER	(	num	11	SENT_289	[p19l1592t1471r1742b1502],
11	o.	NN	O	o.	dep	9	SENT_289	[p19l1592t1471r1742b1502],
12	4o	NN	O	4o	nn	13	SENT_289	[p19l1592t1471r1742b1502],
13	—	NN	O	—	dep	3	SENT_289	[p19l1592t1471r1742b1502],
14	1	CD	NUMBER	1	dep	13	SENT_289	[p19l1592t1471r1742b1502],
15	.	.	O	.	_	0	SENT_289	[p19l1592t1471r1742b1502],

1	so	RB	O	so	_	0	SENT_290	[p19l1592t1471r1742b1502],
2	)	IN	O	)	dep	1	SENT_290	[p19l1592t1471r1742b1502],

1	*	NN	O	*	nn	2	SENT_291	[p19l237t1565r252b1579],
2	Response	NN	O	response	nsubjpass	4	SENT_291	[p19l264t1565r395b1595],
3	was	VBD	O	be	auxpass	4	SENT_291	[p19l403t1571r454b1588],
4	assessed	VBN	O	assess	_	0	SENT_291	[p19l465t1562r586b1588],
5	ac	NN	O	ac	nn	6	SENT_291	[p19l597t1571r626b1588],
6	ing	NN	O	ing	dobj	4	SENT_291	[p19l690t1565r731b1596],
7	e	SYM	O	e	dep	13	SENT_291	[p19l804t1571r817b1588],
8	Response	NN	O	response	nn	9	SENT_291	[p19l829t1565r959b1595],
9	Criteria	NNS	O	criterion	nsubj	13	SENT_291	[p19l969t1564r1065b1588],
10	i	FW	O	i	nn	12	SENT_291	[p19l1077t1565r1080b1587],
11	olid	FW	O	olid	nn	12	SENT_291	[p19l1127t1562r1175b1588],
12	Tumors	NNS	O	tumor	dep	9	SENT_291	[p19l1185t1565r1288b1588],
13	(	VBP	O	(	dep	6	SENT_291	[p19l1302t1564r1413b1595],
14	RECIST	NN	O	recist	nn	15	SENT_291	[p19l1302t1564r1413b1595],
15	criteria	NNS	O	criterion	nsubj	16	SENT_291	[p19l1422t1564r1554b1595],
16	)	VBP	O	)	ccomp	13	SENT_291	[p19l1422t1564r1554b1595],
17	34	CD	NUMBER	34	dobj	16	SENT_291	[p19l1422t1564r1554b1595],
18	in	IN	O	in	_	0	SENT_291	[p19l1564t1565r1586b1587],
19	patients	NNS	O	patient	prep_in	16	SENT_291	[p19l1599t1565r1706b1595],
20	who	WP	O	who	nsubj	21	SENT_291	[p19l1715t1562r1772b1588],
21	had	VBD	O	have	rcmod	19	SENT_291	[p19l1783t1562r1829b1588],
22	one	CD	NUMBER	one	num	25	SENT_291	[p19l1841t1571r1890b1588],
23	or	CC	O	or	_	0	SENT_291	[p19l262t1609r290b1625],
24	more	JJR	O	more	num	25	SENT_291	[p19l300t1609r370b1625],
25	lesions	NNS	O	lesion	dobj	21	SENT_291	[p19l381t1600r474b1625],
26	that	WDT	O	that	dep	28	SENT_291	[p19l484t1600r537b1625],
27	c	NN	O	c	nn	28	SENT_291	[p19l547t1609r560b1625],
28	valu	NN	O	valu	rcmod	25	SENT_291	[p19l687t1600r741b1625],
29	and	CC	O	and	_	0	SENT_291	[p19l813t1600r861b1625],
30	at	IN	O	at	advmod	28	SENT_291	[p19l872t1605r896b1625],
31	least	JJS	O	least	pobj	30	SENT_291	[p19l907t1600r969b1625],
32	one	CD	NUMBER	one	rcmod	25	SENT_291	[p19l978t1609r1028b1625],
33	to	TO	O	to	prep	21	SENT_291	[p19l1037t1600r1062b1625],
34	-	:	O	-	_	0	SENT_291	[p19l1121t1609r1164b1633],
35	up	RP	O	up	prep	6	SENT_291	[p19l1121t1609r1164b1633],
36	radiologic	JJ	O	radiologic	amod	37	SENT_291	[p19l1175t1600r1309b1633],
37	examination	NN	O	examination	dep	35	SENT_291	[p19l1318t1602r1493b1625],
38	.	.	O	.	_	0	SENT_291	[p19l1318t1602r1493b1625],

1	Cl	NN	O	cl	nsubj	2	SENT_292	[p19l1504t1602r1530b1625],
2	denotes	VBZ	O	denote	_	0	SENT_292	[p19l1542t1600r1649b1625],
3	conﬁdence	NN	O	conﬁdence	nn	4	SENT_292	[p19l1660t1600r1809b1625],
4	interval	NN	O	interval	dobj	2	SENT_292	[p19l1820t1602r1889b1625, p19l262t1637r306b1667],
5	,	,	O	,	_	0	SENT_292	[p19l1820t1602r1889b1625, p19l262t1637r306b1667],
6	and	CC	O	and	_	0	SENT_292	[p19l318t1637r365b1662],
7	IHC	NNP	ORGANIZATION	IHC	nn	8	SENT_292	[p19l379t1639r431b1662],
8	immuno	NNP	O	immuno	nsubj	10	SENT_292	[p19l442t1639r557b1662],
9	is	VBZ	O	be	cop	10	SENT_292	[p19l578t1639r597b1662],
10	ochemical	JJ	O	ochemical	conj_and	2	SENT_292	[p19l611t1637r757b1662],
11	.	.	O	.	_	0	SENT_292	[p19l611t1637r757b1662],

1	1	CD	NUMBER	1	dep	9	SENT_293	[p19l238t1677r253b1708],
2	'	''	O	'	_	0	SENT_293	[p19l238t1677r253b1708],
3	The	DT	O	the	det	5	SENT_293	[p19l261t1675r311b1700],
4	comparison	NN	O	comparison	nn	5	SENT_293	[p19l321t1677r483b1708],
5	group	NN	O	group	nsubj	9	SENT_293	[p19l495t1684r574b1708],
6	is	VBZ	O	be	cop	9	SENT_293	[p19l585t1677r604b1700],
7	the	DT	O	the	det	9	SENT_293	[p19l614t1675r657b1700],
8	placebo	NN	O	placebo	nn	9	SENT_293	[p19l668t1675r772b1708],
9	group	NN	O	group	_	0	SENT_293	[p19l782t1684r869b1708],
10	.	.	O	.	_	0	SENT_293	[p19l782t1684r869b1708],

1	1	CD	NUMBER	1	num	3	SENT_294	[p19l238t1754r253b1784],
2	sitive	JJ	O	sitive	amod	3	SENT_294	[p19l326t1754r396b1777],
3	result	NN	O	result	nsubj	5	SENT_294	[p19l407t1751r482b1777],
4	was	VBD	O	be	cop	5	SENT_294	[p19l490t1760r541b1777],
5	one	CD	NUMBER	one	_	0	SENT_294	[p19l552t1760r602b1777],
6	in	IN	O	in	_	0	SENT_294	[p19l613t1754r634b1776],
7	which	WDT	O	which	rel	13	SENT_294	[p19l645t1751r723b1777],
8	10	CD	PERCENT	10	num	9	SENT_294	[p19l736t1753r766b1777],
9	percent	NN	PERCENT	percent	nsubj	13	SENT_294	[p19l777t1756r878b1784],
10	or	CC	O	or	_	0	SENT_294	[p19l887t1760r915b1777],
11	mor	NN	O	mor	nn	12	SENT_294	[p19l925t1760r980b1777],
12	cells	NNS	O	cell	nsubj	13	SENT_294	[p19l1039t1751r1098b1777],
13	had	VBD	O	have	rcmod	5	SENT_294	[p19l1110t1751r1157b1777],
14	membranous	JJ	O	membranous	amod	15	SENT_294	[p19l1169t1751r1350b1777],
15	staining	NN	O	staining	dobj	13	SENT_294	[p19l1362t1754r1477b1785],
16	.	.	O	.	_	0	SENT_294	[p19l1362t1754r1477b1785],

1	§	NN	O	§	nn	2	SENT_295	[p19l237t1789r248b1822],
2	ults	NNS	O	ult	nsubj	3	SENT_295	[p19l314t1789r360b1814],
3	include	VBP	O	include	_	0	SENT_295	[p19l372t1789r470b1814],
4	findings	NNS	O	finding	nsubj	6	SENT_295	[p19l479t1789r589b1822],
5	ofhigh	JJ	O	ofhigh	amod	6	SENT_295	[p19l599t1789r692b1822],
6	polysomy	NN	O	polysomy	xcomp	3	SENT_295	[p19l704t1789r833b1822],
7	and	CC	O	and	_	0	SENT_295	[p19l843t1789r891b1814],
8	ampl	NN	O	ampl	nn	10	SENT_295	[p19l903t1789r977b1822],
9	'	''	O	'	_	0	SENT_295	[p19l903t1789r977b1822],
10	ion	NN	O	ion	xcomp	3	SENT_295	[p19l1040t1791r1088b1818],
11	,	,	O	,	_	0	SENT_295	[p19l1040t1791r1088b1818],
12	as	IN	O	as	mark	13	SENT_295	[p19l1100t1798r1127b1814],
13	deﬁned	VBN	O	deﬁned	advcl	3	SENT_295	[p19l1138t1789r1237b1814],
14	in	IN	O	in	_	0	SENT_295	[p19l1250t1791r1271b1814],
15	Table	NNP	O	Table	prep_in	13	SENT_295	[p19l1282t1789r1352b1814],
16	2	CD	NUMBER	2	num	15	SENT_295	[p19l1362t1791r1384b1814],
17	.	.	O	.	_	0	SENT_295	[p19l1362t1791r1384b1814],

1	py	NN	O	py	_	0	SENT_296	[p19l9t2072r121b2146],
2	,	,	O	,	_	0	SENT_296	[p19l9t2072r121b2146],
3	as	IN	O	as	_	0	SENT_296	[p19l150t2072r233b2124],
4	compared	VBN	O	compare	prepc_as	1	SENT_296	[p19l261t2046r677b2146],
5	With	IN	O	with	pcomp	4	SENT_296	[p19l697t2046r885b2125],
6	placebo	NN	O	placebo	pobj	5	SENT_296	[p19l908t2046r1253b2146],
7	,	,	O	,	_	0	SENT_296	[p19l908t2046r1253b2146],
8	among	IN	O	among	_	0	SENT_296	[p19l1283t2071r1579b2147],
9	patients	NNS	O	patient	prep_among	6	SENT_296	[p19l1598t2047r1927b2146],
10	with	IN	O	with	_	0	SENT_296	[p19l1949t2046r2136b2125],
11	the	DT	O	the	det	13	SENT_296	[p19l11t2175r138b2253],
12	classic	JJ	O	classic	amod	13	SENT_296	[p19l167t2175r441b2253],
13	exon	NN	O	exon	prep_with	9	SENT_296	[p19l469t2200r668b2253],
14	19	CD	NUMBER	19	num	15	SENT_296	[p19l699t2180r795b2253],
15	deletions	NNS	O	deletion	dep	6	SENT_296	[p19l824t2175r1206b2253],
16	or	CC	O	or	_	0	SENT_296	[p19l1236t2200r1325b2253],
17	the	DT	O	the	det	20	SENT_296	[p19l1350t2175r1479b2253],
18	exon	NN	O	exon	nn	20	SENT_296	[p19l1507t2200r1707b2253],
19	21	CD	NUMBER	21	num	20	SENT_296	[p19l1734t2180r1834b2252],
20	L858R	NN	O	l858r	dep	6	SENT_296	[p19l1861t2180r2145b2258],

1	mutation	NN	O	mutation	nn	4	SENT_297	[p19l11t2304r400b2382],
2	(	NN	O	(	nn	4	SENT_297	[p19l435t2303r752b2394],
3	hazard	NN	O	hazard	nn	4	SENT_297	[p19l435t2303r752b2394],
4	ratio	NN	O	ratio	nsubj	29	SENT_297	[p19l782t2304r974b2381],
5	for	IN	O	for	_	0	SENT_297	[p19l1006t2302r1128b2381],
6	death	NN	O	death	prep_for	4	SENT_297	[p19l1157t2303r1411b2399],
7	,	,	O	,	_	0	SENT_297	[p19l1157t2303r1411b2399],
8	0.65	CD	NUMBER	0.65	appos	6	SENT_297	[p19l1447t2308r1655b2398],
9	;	:	O	;	_	0	SENT_297	[p19l1447t2308r1655b2398],
10	95	CD	PERCENT	95	num	13	SENT_297	[p19l1690t2308r1787b2381],
11	percent	NN	PERCENT	percent	nn	13	SENT_297	[p19l1820t2320r2140b2403],
12	conﬁdence	NN	O	conﬁdence	nn	13	SENT_297	[p19l11t2429r465b2508],
13	interval	NN	O	interval	dep	6	SENT_297	[p19l486t2430r816b2524],
14	,	,	O	,	_	0	SENT_297	[p19l486t2430r816b2524],
15	0.24	CD	NUMBER	0.24	num	17	SENT_297	[p19l843t2435r1024b2508],
16	to	TO	O	to	dep	17	SENT_297	[p19l1046t2447r1123b2508],
17	1.75	CD	NUMBER	1.75	appos	13	SENT_297	[p19l1149t2435r1351b2524],
18	;	:	O	;	_	0	SENT_297	[p19l1149t2435r1351b2524],
19	P	NN	O	p	dep	6	SENT_297	[p19l1375t2435r1710b2520],
20	=	JJ	O	=	amod	22	SENT_297	[p19l1375t2435r1710b2520],
21	0.39	CD	NUMBER	0.39	tmod	20	SENT_297	[p19l1375t2435r1710b2520],
22	)	NN	O	)	dep	19	SENT_297	[p19l1375t2435r1710b2520],
23	and	CC	O	and	_	0	SENT_297	[p19l1736t2430r1891b2508],
24	those	DT	O	those	prep_for	4	SENT_297	[p19l1912t2430r2136b2508],
25	With	IN	O	with	_	0	SENT_297	[p19l6t2558r196b2637],
26	only	RB	O	only	advmod	28	SENT_297	[p19l232t2558r413b2657],
27	novel	JJ	O	novel	amod	28	SENT_297	[p19l444t2558r668b2637],
28	mutations	NNS	O	mutation	prep_with	24	SENT_297	[p19l704t2559r1134b2637],
29	(	VBP	O	(	_	0	SENT_297	[p19l1176t2558r1494b2648],
30	hazard	NN	O	hazard	nn	31	SENT_297	[p19l1176t2558r1494b2648],
31	ratio	NN	O	ratio	dobj	29	SENT_297	[p19l1528t2559r1745b2652],
32	,	,	O	,	_	0	SENT_297	[p19l1528t2559r1745b2652],
33	0.67	CD	NUMBER	0.67	appos	31	SENT_297	[p19l1786t2563r1994b2652],
34	;	:	O	;	_	0	SENT_297	[p19l1786t2563r1994b2652],
35	95	CD	PERCENT	95	num	38	SENT_297	[p19l2034t2563r2132b2635],
36	percent	NN	PERCENT	percent	nn	38	SENT_297	[p19l9t2703r330b2786],
37	conﬁdence	NN	O	conﬁdence	nn	38	SENT_297	[p19l356t2685r818b2764],
38	interval	NN	O	interval	dep	31	SENT_297	[p19l848t2686r1185b2781],
39	,	,	O	,	_	0	SENT_297	[p19l848t2686r1185b2781],
40	0.26	CD	NUMBER	0.26	number	42	SENT_297	[p19l1221t2691r1403b2764],
41	to	TO	O	to	dep	42	SENT_297	[p19l1435t2703r1514b2764],
42	1.75	CD	NUMBER	1.75	appos	38	SENT_297	[p19l1549t2691r1754b2781],
43	;	:	O	;	_	0	SENT_297	[p19l1549t2691r1754b2781],
44	P	NN	O	p	dep	31	SENT_297	[p19l1787t2691r2130b2777],
45	=	JJ	O	=	advmod	49	SENT_297	[p19l1787t2691r2130b2777],
46	0.41	CD	NUMBER	0.41	dep	45	SENT_297	[p19l1787t2691r2130b2777],
47	)	CD	NUMBER	)	number	48	SENT_297	[p19l1787t2691r2130b2777],
48	(	CD	NUMBER	(	num	49	SENT_297	[p19l15t2815r198b2915],
49	Fig	NN	O	fig	rcmod	44	SENT_297	[p19l15t2815r198b2915],
50	.	.	O	.	_	0	SENT_297	[p19l15t2815r198b2915],

1	1	CD	NUMBER	1	_	0	SENT_298	[p19l233t2819r277b2891],
2	of	IN	O	of	_	0	SENT_298	[p19l303t2813r404b2892],
3	the	DT	O	the	det	6	SENT_298	[p19l411t2814r540b2892],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_298	[p19l567t2814r1210b2914],
5	Appendix	NNP	O	Appendix	nn	6	SENT_298	[p19l1226t2814r1693b2914],
6	)	NN	O	)	prep_of	1	SENT_298	[p19l1226t2814r1693b2914],
7	.	.	O	.	_	0	SENT_298	[p19l1226t2814r1693b2914],

1	In	IN	O	in	_	0	SENT_299	[p19l138t2949r225b3019],
2	multivariate	JJ	O	multivariate	amod	5	SENT_299	[p19l261t2942r776b3021],
3	Cox	NN	O	cox	nn	5	SENT_299	[p19l813t2947r980b3020],
4	regression	NN	O	regression	nn	5	SENT_299	[p19l1013t2943r1466b3043],
5	analysis	NN	O	analysis	prep_in	16	SENT_299	[p19l1501t2942r1866b3042],
6	,	,	O	,	_	0	SENT_299	[p19l1501t2942r1866b3042],
7	treatment	NN	O	treatment	nsubj	16	SENT_299	[p19l1909t2958r2135b3020, p19l11t3086r234b3147],
8	with	IN	O	with	_	0	SENT_299	[p19l266t3070r459b3149],
9	erlotinib	NN	O	erlotinib	prep_with	7	SENT_299	[p19l501t3070r894b3164],
10	,	,	O	,	_	0	SENT_299	[p19l501t3070r894b3164],
11	as	IN	O	as	mark	7	SENT_299	[p19l940t3096r1025b3147],
12	compared	VBN	O	compare	_	0	SENT_299	[p19l1069t3070r1500b3169],
13	with	IN	O	with	_	0	SENT_299	[p19l1537t3070r1730b3148],
14	placebo	NN	O	placebo	prep_compared_with	7	SENT_299	[p19l1769t3070r2128b3169],
15	,	,	O	,	_	0	SENT_299	[p19l1769t3070r2128b3169],
16	remained	VBD	O	remain	_	0	SENT_299	[p19l11t3198r411b3276],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_299	[p19l442t3197r963b3299],
18	associated	VBN	O	associate	dep	16	SENT_299	[p19l988t3198r1424b3276],
19	with	IN	O	with	prt	18	SENT_299	[p19l1449t3198r1638b3277],
20	longer	JJR	O	longer	amod	26	SENT_299	[p19l1666t3198r1943b3299],
21	survival	NN	O	survival	nn	26	SENT_299	[p19l1971t3224r2134b3277, p19l6t3326r199b3405],
22	(	CD	NUMBER	(	num	26	SENT_299	[p19l249t3331r720b3417],
23	P	NN	O	p	nn	26	SENT_299	[p19l249t3331r720b3417],
24	=	JJ	O	=	amod	26	SENT_299	[p19l249t3331r720b3417],
25	0.001	CD	NUMBER	0.001	num	26	SENT_299	[p19l249t3331r720b3417],
26	)	NN	O	)	dobj	18	SENT_299	[p19l249t3331r720b3417],
27	.	.	O	.	_	0	SENT_299	[p19l249t3331r720b3417],

1	In	IN	O	in	dep	7	SENT_300	[p19l768t3333r858b3403],
2	the	DT	O	the	det	4	SENT_300	[p19l904t3326r1036b3404],
3	entire	JJ	O	entire	amod	4	SENT_300	[p19l1082t3327r1330b3404],
4	group	NN	O	group	pobj	1	SENT_300	[p19l1376t3351r1660b3427],
5	,	,	O	,	_	0	SENT_300	[p19l1376t3351r1660b3427],
6	Asian	JJ	MISC	asian	amod	7	SENT_300	[p19l1707t3327r1952b3404],
7	patients	NNS	O	patient	_	0	SENT_300	[p19l1996t3352r2132b3426, p19l11t3455r246b3531],
8	(	IN	O	(	_	0	SENT_300	[p19l288t3459r699b3549],
9	P	NN	O	p	prep_(	7	SENT_300	[p19l288t3459r699b3549],
10	=	JJ	O	=	amod	9	SENT_300	[p19l288t3459r699b3549],
11	0.01	CD	NUMBER	0.01	num	12	SENT_300	[p19l288t3459r699b3549],
12	)	NN	O	)	tmod	10	SENT_300	[p19l288t3459r699b3549],
13	,	,	O	,	_	0	SENT_300	[p19l288t3459r699b3549],
14	patients	NNS	O	patient	appos	12	SENT_300	[p19l739t3455r1081b3553],
15	who	WP	O	who	nsubj	18	SENT_300	[p19l1114t3454r1300b3533],
16	had	VBD	O	have	aux	18	SENT_300	[p19l1336t3454r1494b3531],
17	never	RB	O	never	neg	18	SENT_300	[p19l1529t3479r1761b3533],
18	smoked	VBN	O	smoke	rcmod	7	SENT_300	[p19l1795t3454r2135b3533],
19	(	CD	NUMBER	(	num	20	SENT_300	[p19l15t3587r462b3678],
20	P	NN	O	p	npadvmod	21	SENT_300	[p19l15t3587r462b3678],
21	<	JJR	O	<	acomp	18	SENT_300	[p19l15t3587r462b3678],
22	0.001	CD	NUMBER	0.001	num	23	SENT_300	[p19l15t3587r462b3678],
23	)	NN	O	)	dep	21	SENT_300	[p19l15t3587r462b3678],
24	,	,	O	,	_	0	SENT_300	[p19l15t3587r462b3678],
25	patients	NNS	O	patient	appos	23	SENT_300	[p19l494t3583r833b3682],
26	who	WP	O	who	nsubj	27	SENT_300	[p19l856t3582r1039b3661],
27	lost	VBD	O	lose	rcmod	25	SENT_300	[p19l1065t3582r1223b3660],
28	less	JJR	O	less	mwe	29	SENT_300	[p19l1243t3582r1397b3660],
29	than	IN	O	than	quantmod	30	SENT_300	[p19l1425t3582r1614b3660],
30	5	CD	PERCENT	5	num	31	SENT_300	[p19l1641t3589r1683b3660],
31	percent	NN	PERCENT	percent	dobj	27	SENT_300	[p19l1711t3599r2032b3682],
32	of	IN	O	of	_	0	SENT_300	[p19l2053t3581r2154b3660],
33	their	PRP$	O	they	poss	34	SENT_300	[p19l11t3710r209b3788],
34	body	NN	O	body	prep_of	31	SENT_300	[p19l232t3710r438b3810],
35	Weight	NNP	O	Weight	dep	34	SENT_300	[p19l455t3710r749b3811],
36	(	CD	NUMBER	(	num	37	SENT_300	[p19l773t3715r1173b3806],
37	P	NN	O	p	dep	40	SENT_300	[p19l773t3715r1173b3806],
38	=	JJ	O	=	amod	40	SENT_300	[p19l773t3715r1173b3806],
39	0.03	CD	NUMBER	0.03	num	40	SENT_300	[p19l773t3715r1173b3806],
40	)	NN	O	)	dep	35	SENT_300	[p19l773t3715r1173b3806],
41	,	,	O	,	_	0	SENT_300	[p19l773t3715r1173b3806],
42	patients	NNS	O	patient	dep	40	SENT_300	[p19l1202t3711r1537b3810],
43	With	IN	O	with	dep	42	SENT_300	[p19l1559t3710r1749b3789],
44	a	DT	O	a	det	45	SENT_300	[p19l1773t3736r1818b3788],
45	performance	NN	O	performance	pobj	43	SENT_300	[p19l1840t3709r2134b3810, p20l11t48r290b100],

1	status	NN	O	status	nsubj	51	SENT_301	[p20l316t38r563b101],
2	of	IN	O	of	_	0	SENT_301	[p20l590t21r691b100],
3	O	NN	O	o	prep_of	1	SENT_301	[p20l697t27r744b100],
4	or	CC	O	or	_	0	SENT_301	[p20l770t48r860b100],
5	1	CD	NUMBER	1	number	6	SENT_301	[p20l884t27r929b99],
6	(	CD	NUMBER	(	num	7	SENT_301	[p20l958t27r1398b117],
7	P	NN	O	p	npadvmod	8	SENT_301	[p20l958t27r1398b117],
8	<	JJR	O	<	amod	10	SENT_301	[p20l958t27r1398b117],
9	0.001	CD	NUMBER	0.001	num	10	SENT_301	[p20l958t27r1398b117],
10	)	NN	O	)	conj_or	3	SENT_301	[p20l958t27r1398b117],
11	,	,	O	,	_	0	SENT_301	[p20l958t27r1398b117],
12	patients	NNS	O	patient	appos	10	SENT_301	[p20l1426t23r1763b122],
13	who	WP	O	who	nsubj	17	SENT_301	[p20l1785t22r1970b101],
14	had	VBD	O	have	aux	17	SENT_301	[p20l1994t22r2151b100],
15	not	RB	O	not	neg	17	SENT_301	[p20l11t167r157b229],
16	previously	RB	DATE	previously	advmod	17	SENT_301	[p20l201t151r648b251],
17	received	VBN	O	receive	rcmod	1	SENT_301	[p20l694t151r1046b230],
18	cisplatin	NN	O	cisplatin	nn	20	SENT_301	[p20l1097t151r1467b251],
19	(	CD	NUMBER	(	num	20	SENT_301	[p20l1522t156r1935b247],
20	P	NN	O	p	dobj	17	SENT_301	[p20l1522t156r1935b247],
21	=	JJ	O	=	amod	1	SENT_301	[p20l1522t156r1935b247],
22	0.04	CD	NUMBER	0.04	num	23	SENT_301	[p20l1522t156r1935b247],
23	)	NN	O	)	dep	21	SENT_301	[p20l1522t156r1935b247],
24	,	,	O	,	_	0	SENT_301	[p20l1522t156r1935b247],
25	and	CC	O	and	_	0	SENT_301	[p20l1991t151r2149b229],
26	patients	NNS	O	patient	conj_and	1	SENT_301	[p20l9t281r354b380],
27	who	WP	O	who	nsubj	28	SENT_301	[p20l388t280r574b359],
28	enrolled	VBD	O	enrol	rcmod	26	SENT_301	[p20l613t280r969b358],
29	in	IN	O	in	_	0	SENT_301	[p20l1004t280r1087b357],
30	the	DT	O	the	det	31	SENT_301	[p20l1124t280r1256b358],
31	study	NN	O	study	prep_in	28	SENT_301	[p20l1294t280r1525b380],
32	more	RBR	DURATION	more	advmod	33	SENT_301	[p20l1557t306r1781b358],
33	than	IN	DURATION	than	quantmod	34	SENT_301	[p20l1819t280r2010b358],
34	12	CD	DURATION	12	num	35	SENT_301	[p20l2050t285r2148b357],
35	months	NNS	NUMBER	month	tmod	31	SENT_301	[p20l11t408r341b487],
36	after	IN	O	after	_	0	SENT_301	[p20l379t407r574b487],
37	receiving	VBG	O	receive	prepc_after	28	SENT_301	[p20l606t409r991b510],
38	a	DT	O	a	det	39	SENT_301	[p20l1022t434r1067b487],
39	diagnosis	NN	O	diagnosis	nsubj	48	SENT_301	[p20l1101t408r1507b510],
40	of	IN	O	of	_	0	SENT_301	[p20l1545t407r1646b487],
41	non	JJ	O	non	amod	45	SENT_301	[p20l1663t408r2149b487, p20l11t537r154b615],
42	—	NN	O	—	nn	45	SENT_301	[p20l1663t408r2149b487, p20l11t537r154b615],
43	smallcell	NN	O	smallcell	nn	45	SENT_301	[p20l1663t408r2149b487, p20l11t537r154b615],
44	lung	NN	O	lung	nn	45	SENT_301	[p20l177t537r372b638],
45	cancer	NN	O	cancer	prep_of	39	SENT_301	[p20l395t563r673b615],
46	(	CD	NUMBER	(	num	47	SENT_301	[p20l700t542r1111b628],
47	P	NN	O	p	npadvmod	48	SENT_301	[p20l700t542r1111b628],
48	<	JJR	O	<	xcomp	37	SENT_301	[p20l700t542r1111b628],
49	0.001	CD	NUMBER	0.001	num	50	SENT_301	[p20l700t542r1111b628],
50	)	NN	O	)	dep	1	SENT_301	[p20l700t542r1111b628],
51	survived	VBD	O	survive	_	0	SENT_301	[p20l1143t537r1489b616],
52	longest	JJS	O	longest	advmod	51	SENT_301	[p20l1513t537r1850b638],
53	.	.	O	.	_	0	SENT_301	[p20l1513t537r1850b638],

1	DISCUSSION	NN	O	discussion	_	0	SENT_302	[p20l722t851r1425b911],

1	Phase	NN	O	phase	nsubj	5	SENT_303	[p20l9t1046r254b1124],
2	2	CD	NUMBER	2	num	3	SENT_303	[p20l277t1051r324b1123],
3	studies	NNS	O	study	dep	1	SENT_303	[p20l349t1046r644b1125],
4	have	VBP	O	have	aux	5	SENT_303	[p20l667t1046r857b1125],
5	shown	VBN	O	show	_	0	SENT_303	[p20l881t1046r1163b1125],
6	that	IN	O	that	complm	8	SENT_303	[p20l1185t1046r1352b1124],
7	female	JJ	O	female	amod	8	SENT_303	[p20l1369t1045r1653b1124],
8	sex	NN	O	sex	dep	5	SENT_303	[p20l1677t1072r1831b1142],
9	,	,	O	,	_	0	SENT_303	[p20l1677t1072r1831b1142],
10	adenocarcinoma	NN	O	adenocarcinoma	appos	8	SENT_303	[p20l1858t1046r2149b1124, p20l11t1175r481b1269],
11	,	,	O	,	_	0	SENT_303	[p20l1858t1046r2149b1124, p20l11t1175r481b1269],
12	Asian	JJ	MISC	asian	amod	13	SENT_303	[p20l506t1175r747b1252],
13	origin	NN	O	origin	appos	8	SENT_303	[p20l770t1175r1050b1275],
14	,	,	O	,	_	0	SENT_303	[p20l770t1175r1050b1275],
15	and	CC	O	and	_	0	SENT_303	[p20l1077t1174r1234b1252],
16	never	RB	O	never	neg	20	SENT_303	[p20l1257t1200r1486b1253],
17	having	VBG	O	have	aux	18	SENT_303	[p20l1506t1174r1793b1275],
18	smoked	VBN	O	smoke	csubjpass	20	SENT_303	[p20l1815t1174r2151b1253],
19	are	VBP	O	be	auxpass	20	SENT_303	[p20l10t1328r136b1380],
20	associated	VBN	O	associate	conj_and	5	SENT_303	[p20l171t1302r610b1380],
21	with	IN	O	with	_	0	SENT_303	[p20l640t1302r831b1381],
22	responsiveness	NN	O	responsiveness	prep_with	20	SENT_303	[p20l865t1303r1508b1402],
23	of	IN	O	of	_	0	SENT_303	[p20l1546t1301r1646b1380],
24	non	JJ	O	non	amod	28	SENT_303	[p20l1663t1302r2149b1380, p20l11t1430r154b1509],
25	—	NN	O	—	nn	28	SENT_303	[p20l1663t1302r2149b1380, p20l11t1430r154b1509],
26	smallcell	NN	O	smallcell	nn	28	SENT_303	[p20l1663t1302r2149b1380, p20l11t1430r154b1509],
27	lung	NN	O	lung	nn	28	SENT_303	[p20l186t1431r382b1532],
28	cancer	NN	O	cancer	prep_of	22	SENT_303	[p20l414t1456r691b1509],
29	to	TO	O	to	_	0	SENT_303	[p20l723t1447r803b1509],
30	erlotinib	NN	O	erlotinib	prep_to	28	SENT_303	[p20l839t1431r1200b1509],
31	or	CC	O	or	_	0	SENT_303	[p20l1237t1456r1327b1509],
32	geﬁtinib	NN	O	geﬁtinib	prep_to	28	SENT_303	[p20l1358t1424r2149b1532],
33	.16	CD	NUMBER	.16	num	32	SENT_303	[p20l1358t1424r2149b1532],
34	'	''	DATE	'	_	0	SENT_303	[p20l1358t1424r2149b1532],
35	18	CD	DATE	18	number	36	SENT_303	[p20l1358t1424r2149b1532],
36	’	CD	NUMBER	’	dep	28	SENT_303	[p20l1358t1424r2149b1532],
37	35	CD	NUMBER	35	num	38	SENT_303	[p20l1358t1424r2149b1532],
38	‘	NN	O	‘	dep	36	SENT_303	[p20l1358t1424r2149b1532],
39	37	CD	NUMBER	37	tmod	20	SENT_303	[p20l1358t1424r2149b1532],
40	We	PRP	O	we	nsubj	41	SENT_303	[p20l7t1567r141b1638],
41	conﬁrmed	VBD	O	conﬁrmed	rcmod	39	SENT_303	[p20l167t1559r609b1638],
42	these	DT	O	these	det	43	SENT_303	[p20l635t1560r855b1638],
43	associations	NNS	O	association	dobj	41	SENT_303	[p20l879t1561r1425b1638],
44	.	.	O	.	_	0	SENT_303	[p20l879t1561r1425b1638],

1	The	DT	O	the	det	2	SENT_304	[p20l137t1688r300b1766],
2	expression	NN	O	expression	_	0	SENT_304	[p20l341t1689r799b1788],
3	of	IN	O	of	_	0	SENT_304	[p20l840t1687r941b1766],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_304	[p20l961t1693r1222b1771],
5	protein	NN	O	protein	prep_of	2	SENT_304	[p20l1251t1689r1560b1788],
6	on	IN	O	on	_	0	SENT_304	[p20l1602t1714r1709b1766],
7	immunoN	NN	O	immunon	prep_on	2	SENT_304	[p20l1748t1689r2149b1767, p20l526t1865r540b1880],

1	ENGLJ	NNP	MISC	ENGLJ	nn	2	SENT_305	[p20l555t1864r639b1886],
2	MED	NNP	MISC	MED	_	0	SENT_305	[p20l654t1865r707b1880],
3	353	CD	NUMBER	353	num	2	SENT_305	[p20l719t1864r783b1886],
4	;	:	O	;	_	0	SENT_305	[p20l719t1864r783b1886],
5	2	CD	NUMBER	2	num	7	SENT_305	[p20l719t1864r783b1886],
6	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	7	SENT_305	[p20l818t1864r1029b1886],
7	ULY14	NN	O	uly14	dep	2	SENT_305	[p20l1078t1865r1169b1886],
8	,	,	O	,	_	0	SENT_305	[p20l1078t1865r1169b1886],
9	2005	CD	DATE	2005	num	10	SENT_305	[p20l1183t1864r1246b1886],
10	141	CD	NUMBER	141	appos	7	SENT_305	[p20l1960t1863r2016b1884],

1	The	DT	O	the	det	5	SENT_306	[p20l701t1897r752b1921],
2	New	NNP	O	New	nn	5	SENT_306	[p20l761t1898r823b1921],
3	England	NNP	O	England	nn	5	SENT_306	[p20l833t1897r943b1928],
4	Joumal	NNP	PERSON	Joumal	nn	5	SENT_306	[p20l952t1897r1049b1921],
5	o	NN	O	o	_	0	SENT_306	[p20l1059t1905r1074b1921],
6	edicine	NN	O	edicine	dep	5	SENT_306	[p20l1125t1897r1220b1921],

1	Downloaded	VBN	O	download	_	0	SENT_307	[p20l144t1938r313b1961],
2	from	IN	O	from	_	0	SENT_307	[p20l322t1938r387b1961],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_307	[p20l396t1938r514b1968],
4	at	IN	O	at	_	0	SENT_307	[p20l524t1942r547b1961],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_307	[p20l556t1938r738b1961],
6	on	IN	O	on	_	0	SENT_307	[p20l748t1945r780b1961],
7	January	NNP	DATE	January	prep_on	1	SENT_307	[p20l789t1938r891b1968],
8	5	CD	DATE	5	num	7	SENT_307	[p20l901t1938r924b1965],
9	,	,	DATE	,	_	0	SENT_307	[p20l901t1938r924b1965],
10	2014	CD	DATE	2014	num	7	SENT_307	[p20l935t1938r1007b1961],
11	.	.	O	.	_	0	SENT_307	[p20l935t1938r1007b1961],

1	For	IN	O	for	_	0	SENT_308	[p20l1017t1938r1064b1961],
2	personal	JJ	O	personal	amod	3	SENT_308	[p20l1072t1938r1184b1968],
3	use	NN	O	use	pobj	1	SENT_308	[p20l1193t1945r1237b1961],
4	only	RB	O	only	advmod	3	SENT_308	[p20l1247t1938r1311b1968],
5	.	.	O	.	_	0	SENT_308	[p20l1247t1938r1311b1968],

1	No	DT	O	no	det	3	SENT_309	[p20l1322t1938r1362b1961],
2	other	JJ	O	other	amod	3	SENT_309	[p20l1372t1938r1440b1961],
3	uses	NNS	O	use	_	0	SENT_309	[p20l1448t1945r1504b1961],
4	without	IN	O	without	_	0	SENT_309	[p20l1514t1938r1615b1961],
5	permission	NN	O	permission	prep_without	3	SENT_309	[p20l1624t1938r1776b1968],
6	.	.	O	.	_	0	SENT_309	[p20l1624t1938r1776b1968],

1	The	DT	O	the	det	4	SENT_310	[p20l715t2085r752b2106],
2	NEW	NNP	O	NEW	nn	4	SENT_310	[p20l764t2087r845b2106],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_310	[p20l859t2087r1034b2106],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_310	[p20l1048t2087r1214b2113],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_310	[p20l1228t2085r1444b2112],

1	histochemistry	NN	O	histochemistry	nsubj	7	SENT_311	[p20l10t2307r642b2408],
2	has	VBZ	O	have	aux	7	SENT_311	[p20l665t2307r807b2386],
3	not	RB	O	not	neg	7	SENT_311	[p20l837t2324r980b2386],
4	been	VBN	O	be	cop	7	SENT_311	[p20l1003t2308r1203b2386],
5	a	DT	O	a	det	7	SENT_311	[p20l1230t2334r1274b2386],
6	reliable	JJ	O	reliable	amod	7	SENT_311	[p20l1300t2307r1611b2386],
7	predictor	NN	O	predictor	_	0	SENT_311	[p20l1638t2307r2027b2408],
8	of	IN	O	of	_	0	SENT_311	[p20l2053t2307r2153b2386],
9	responsiveness	NN	O	responsiveness	prep_of	7	SENT_311	[p20l10t2436r660b2536],
10	in	IN	O	in	_	0	SENT_311	[p20l703t2436r785b2513],
11	most	JJS	O	most	amod	12	SENT_311	[p20l826t2452r1046b2514],
12	studies	NNS	O	study	prep_in	9	SENT_311	[p20l1084t2435r1384b2515],
13	of	IN	O	of	_	0	SENT_311	[p20l1428t2435r1530b2514],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_311	[p20l1551t2441r1814b2519],
15	inhibitors	NNS	O	inhibitor	prep_of	12	SENT_311	[p20l1843t2436r2133b2514, p20l11t2558r496b2642],
16	.18	CD	NUMBER	.18	number	17	SENT_311	[p20l1843t2436r2133b2514, p20l11t2558r496b2642],
17	’	CD	NUMBER	’	num	19	SENT_311	[p20l1843t2436r2133b2514, p20l11t2558r496b2642],
18	37	CD	NUMBER	37	number	19	SENT_311	[p20l1843t2436r2133b2514, p20l11t2558r496b2642],
19	’38	CD	NUMBER	’38	npadvmod	7	SENT_311	[p20l1843t2436r2133b2514, p20l11t2558r496b2642],
20	In	IN	O	in	_	0	SENT_311	[p20l527t2571r614b2641],
21	our	PRP$	O	we	poss	22	SENT_311	[p20l646t2589r791b2643],
22	trial	NN	O	trial	prep_in	7	SENT_311	[p20l820t2564r1009b2659],
23	,	,	O	,	_	0	SENT_311	[p20l820t2564r1009b2659],
24	57	CD	PERCENT	57	num	25	SENT_311	[p20l1048t2571r1146b2642],
25	percent	NN	PERCENT	percent	nsubj	32	SENT_311	[p20l1177t2580r1498b2664],
26	of	IN	O	of	_	0	SENT_311	[p20l1525t2563r1625b2642],
27	the	DT	O	the	det	28	SENT_311	[p20l1638t2564r1767b2642],
28	patients	NNS	O	patient	prep_of	25	SENT_311	[p20l1798t2565r2133b2664],
29	who	WP	O	who	nsubjpass	31	SENT_311	[p20l6t2692r189b2771],
30	were	VBD	O	be	auxpass	31	SENT_311	[p20l212t2718r414b2771],
31	tested	VBN	O	test	rcmod	28	SENT_311	[p20l442t2691r690b2770],
32	had	VBD	O	have	ccomp	7	SENT_311	[p20l716t2691r871b2770],
33	tumors	NNS	O	tumor	dobj	32	SENT_311	[p20l898t2708r1199b2771],
34	that	WDT	O	that	nsubj	35	SENT_311	[p20l1228t2692r1395b2770],
35	expressed	VBD	O	express	rcmod	33	SENT_311	[p20l1417t2691r1832b2792],
36	EGFR	NN	ORGANIZATION	egfr	dobj	35	SENT_311	[p20l1857t2697r2129b2787],
37	,	,	O	,	_	0	SENT_311	[p20l1857t2697r2129b2787],
38	and	CC	O	and	_	0	SENT_311	[p20l10t2820r166b2898],
39	on	IN	O	on	_	0	SENT_311	[p20l202t2845r309b2898],
40	multivariate	JJ	O	multivariate	amod	41	SENT_311	[p20l345t2820r866b2899],
41	analysis	NN	O	analysis	prep_on	47	SENT_311	[p20l900t2819r1269b2920],
42	,	,	O	,	_	0	SENT_311	[p20l900t2819r1269b2920],
43	their	PRP$	O	they	poss	45	SENT_311	[p20l1310t2820r1514b2898],
44	response	NN	O	response	nn	45	SENT_311	[p20l1546t2845r1936b2920],
45	rate	NN	O	rate	nsubj	47	SENT_311	[p20l1972t2836r2133b2898],
46	was	VBD	O	be	cop	47	SENT_311	[p20l6t2974r169b3027],
47	higher	JJR	O	higher	conj_and	7	SENT_311	[p20l203t2947r486b3048],
48	than	IN	O	than	mark	55	SENT_311	[p20l515t2947r703b3026],
49	that	DT	O	that	nsubj	55	SENT_311	[p20l734t2948r900b3026],
50	of	IN	O	of	_	0	SENT_311	[p20l927t2947r1027b3026],
51	patients	NNS	O	patient	prep_of	49	SENT_311	[p20l1037t2948r1372b3048],
52	with	IN	O	with	_	0	SENT_311	[p20l1400t2948r1589b3027],
53	EGFRnegative	JJ	O	egfrnegative	amod	54	SENT_311	[p20l1618t2953r2134b3048, p20l11t3076r153b3155],
54	tumors	NNS	O	tumor	prep_with	51	SENT_311	[p20l182t3092r483b3155],
55	(	VBP	O	(	ccomp	47	SENT_311	[p20l518t3081r649b3167],
56	11	CD	PERCENT	11	num	57	SENT_311	[p20l518t3081r649b3167],
57	percent	NN	PERCENT	percent	dobj	55	SENT_311	[p20l677t3092r997b3176],
58	vs.	CC	PERCENT	vs.	prep	57	SENT_311	[p20l1016t3102r1126b3155],
59	4	CD	PERCENT	4	num	61	SENT_311	[p20l1158t3081r1208b3154],
60	percent	NN	PERCENT	percent	nn	61	SENT_311	[p20l1235t3083r1609b3176],
61	)	NN	O	)	dep	58	SENT_311	[p20l1235t3083r1609b3176],
62	.	.	O	.	_	0	SENT_311	[p20l1235t3083r1609b3176],

1	The	DT	O	the	det	2	SENT_312	[p20l1639t3075r1801b3154],
2	expression	NN	O	expression	nsubjpass	7	SENT_312	[p20l1830t3102r2134b3176, p20l12t3204r188b3282],
3	of	IN	O	of	_	0	SENT_312	[p20l217t3203r317b3282],
4	EGFR	NN	ORGANIZATION	egfr	prep_of	2	SENT_312	[p20l326t3209r584b3287],
5	is	VBZ	O	be	auxpass	7	SENT_312	[p20l601t3204r666b3282],
6	often	RB	O	often	advmod	7	SENT_312	[p20l696t3203r913b3282],
7	associated	VBN	O	associate	_	0	SENT_312	[p20l940t3204r1376b3282],
8	with	IN	O	with	_	0	SENT_312	[p20l1399t3204r1589b3283],
9	polysomy	NN	O	polysomy	prep_with	7	SENT_312	[p20l1615t3204r2025b3304],
10	or	CC	O	or	_	0	SENT_312	[p20l2049t3229r2138b3282],
11	ampliﬁcation	NN	O	ampliﬁcation	conj_or	9	SENT_312	[p20l10t3331r561b3432],
12	of	IN	O	of	_	0	SENT_312	[p20l584t3331r683b3410],
13	EGFR	NN	ORGANIZATION	egfr	prep_of	9	SENT_312	[p20l685t3339r909b3411],
14	.	.	O	.	_	0	SENT_312	[p20l685t3339r909b3411],

1	12	CD	NUMBER	12	_	0	SENT_313	[p20l920t3326r993b3370],
2	We	PRP	O	we	nsubj	3	SENT_313	[p20l1013t3339r1144b3410],
3	found	VBD	O	find	rcmod	1	SENT_313	[p20l1167t3331r1413b3411],
4	that	IN	O	that	complm	10	SENT_313	[p20l1435t3332r1598b3410],
5	the	DT	O	the	det	7	SENT_313	[p20l1616t3332r1743b3410],
6	response	NN	O	response	nn	7	SENT_313	[p20l1765t3357r2135b3432],
7	rate	NN	O	rate	nsubj	10	SENT_313	[p20l10t3476r170b3538],
8	was	VBD	O	be	cop	10	SENT_313	[p20l193t3486r356b3539],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_313	[p20l386t3459r920b3560],
10	higher	JJR	O	higher	ccomp	3	SENT_313	[p20l942t3459r1226b3560],
11	among	IN	O	among	_	0	SENT_313	[p20l1249t3485r1553b3560],
12	patients	NNS	O	patient	prep_among	10	SENT_313	[p20l1575t3460r1917b3560],
13	with	IN	O	with	_	0	SENT_313	[p20l1941t3460r2134b3539],
14	tumors	NNS	O	tumor	prep_with	12	SENT_313	[p20l11t3604r320b3667],
15	with	IN	O	with	_	0	SENT_313	[p20l359t3587r553b3667],
16	high	JJ	O	high	amod	17	SENT_313	[p20l595t3588r793b3688],
17	polysomy	NN	O	polysomy	prep_with	14	SENT_313	[p20l833t3588r1254b3688],
18	or	CC	O	or	_	0	SENT_313	[p20l1293t3613r1384b3666],
19	ampliﬁcation	NN	O	ampliﬁcation	prep_with	14	SENT_313	[p20l1421t3587r2006b3688],
20	of	IN	O	of	prep	10	SENT_313	[p20l2050t3587r2152b3666],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_314	[p21l9t27r224b100],
2	than	IN	O	than	dep	1	SENT_314	[p21l247t21r436b99],
3	among	IN	O	among	_	0	SENT_314	[p21l461t46r761b121],
4	those	DT	O	those	prep_among	2	SENT_314	[p21l784t21r1011b99],
5	without	IN	O	without	_	0	SENT_314	[p21l1033t21r1369b100],
6	this	DT	O	this	det	10	SENT_314	[p21l1390t21r1543b99],
7	characteristic	JJ	O	characteristic	amod	10	SENT_314	[p21l1572t21r2135b99],
8	(	CD	PERCENT	(	number	9	SENT_314	[p21l15t155r145b241],
9	20	CD	PERCENT	20	num	10	SENT_314	[p21l15t155r145b241],
10	percent	NN	PERCENT	percent	prep_without	4	SENT_314	[p21l171t166r491b250],
11	vs.	CC	O	vs.	prep	10	SENT_314	[p21l508t176r618b229],
12	2	CD	PERCENT	2	num	14	SENT_314	[p21l650t155r696b227],
13	percent	NN	PERCENT	percent	nn	14	SENT_314	[p21l722t156r1096b250],
14	)	NN	O	)	dep	11	SENT_314	[p21l722t156r1096b250],
15	.	.	O	.	_	0	SENT_314	[p21l722t156r1096b250],

1	Cappuzzo	NNP	PERSON	Cappuzzo	nsubj	5	SENT_315	[p21l1128t155r1551b250],
2	et	FW	O	et	nn	3	SENT_315	[p21l1580t166r1656b228],
3	al.	FW	O	al.	dep	1	SENT_315	[p21l1677t145r1857b228],
4	22	CD	NUMBER	22	dep	1	SENT_315	[p21l1677t145r1857b228],
5	found	VBD	O	find	_	0	SENT_315	[p21l1883t149r2135b229],
6	that	IN	O	that	complm	17	SENT_315	[p21l11t278r179b356],
7	an	DT	O	a	det	9	SENT_315	[p21l203t303r304b356],
8	increased	VBN	O	increase	amod	9	SENT_315	[p21l332t277r742b356],
9	number	NN	O	number	nsubj	17	SENT_315	[p21l771t278r1113b357],
10	of	IN	O	of	_	0	SENT_315	[p21l1139t277r1241b356],
11	copies	NNS	O	copy	prep_of	9	SENT_315	[p21l1252t278r1522b378],
12	of	IN	O	of	_	0	SENT_315	[p21l1554t277r1655b356],
13	EGFR	NN	ORGANIZATION	egfr	prep_of	11	SENT_315	[p21l1663t284r1879b357],
14	was	VBD	O	be	cop	17	SENT_315	[p21l1897t304r2060b357],
15	a	DT	O	a	det	17	SENT_315	[p21l2091t304r2135b356],
16	stronger	JJR	O	stronger	amod	17	SENT_315	[p21l12t422r368b506],
17	predictor	NN	O	predictor	ccomp	5	SENT_315	[p21l385t406r771b506],
18	of	IN	O	of	_	0	SENT_315	[p21l792t405r891b484],
19	response	NN	O	response	prep_of	17	SENT_315	[p21l895t431r1271b506],
20	than	IN	O	than	mark	23	SENT_315	[p21l1294t405r1480b484],
21	was	VBD	O	be	cop	23	SENT_315	[p21l1497t432r1658b485],
22	the	DT	O	the	det	23	SENT_315	[p21l1683t406r1811b484],
23	expression	NN	O	expression	advcl	17	SENT_315	[p21l1834t432r2134b506, p21l12t534r188b612],
24	of	IN	O	of	_	0	SENT_315	[p21l213t533r313b612],
25	EGFR	NN	ORGANIZATION	egfr	prep_of	23	SENT_315	[p21l317t539r588b617],
26	.	.	O	.	_	0	SENT_315	[p21l317t539r588b617],

1	Several	JJ	O	several	amod	2	SENT_316	[p21l141t662r430b741],
2	groups	NNS	O	group	nsubj	4	SENT_316	[p21l450t687r739b762],
3	have	VBP	O	have	aux	4	SENT_316	[p21l762t662r948b741],
4	found	VBN	O	find	_	0	SENT_316	[p21l970t661r1216b741],
5	mutations	NNS	O	mutation	dobj	4	SENT_316	[p21l1237t662r1661b741],
6	in	IN	O	in	_	0	SENT_316	[p21l1683t662r1764b739],
7	the	DT	O	the	det	11	SENT_316	[p21l1785t662r1913b740],
8	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_316	[p21l1931t668r2142b741],
9	tyrosine	NN	O	tyrosine	nn	11	SENT_316	[p21l11t790r342b890],
10	kinase	NN	O	kinase	nn	11	SENT_316	[p21l367t790r637b869],
11	domain	NN	O	domain	prep_in	5	SENT_316	[p21l664t790r988b868],
12	(	CD	NUMBER	(	num	13	SENT_316	[p21l1018t797r1289b881],
13	exons	NNS	O	exon	dep	11	SENT_316	[p21l1018t797r1289b881],
14	18	CD	NUMBER	18	dep	13	SENT_316	[p21l1321t795r1416b868],
15	through	IN	O	through	_	0	SENT_316	[p21l1444t789r1786b890],
16	21	CD	NUMBER	21	num	17	SENT_316	[p21l1811t795r1942b881],
17	)	NN	O	)	prep_through	4	SENT_316	[p21l1811t795r1942b881],
18	that	WDT	O	that	nsubj	19	SENT_316	[p21l1973t789r2140b868],
19	sensitize	VBP	O	sensitize	rcmod	17	SENT_316	[p21l12t918r385b996],
20	tumor	NN	O	tumor	nn	21	SENT_316	[p21l419t934r685b997],
21	cells	NNS	O	cell	dobj	19	SENT_316	[p21l716t917r902b996],
22	to	TO	O	to	_	0	SENT_316	[p21l937t934r1018b996],
23	the	DT	O	the	det	24	SENT_316	[p21l1052t918r1183b996],
24	effects	NNS	O	effect	prep_to	19	SENT_316	[p21l1217t917r1493b996],
25	of	IN	O	of	_	0	SENT_316	[p21l1529t917r1630b996],
26	erlotinib	NN	O	erlotinib	prep_of	24	SENT_316	[p21l1645t917r2012b996],
27	or	CC	O	or	_	0	SENT_316	[p21l2047t943r2137b996],
28	geﬁtinib	NN	O	geﬁtinib	conj_or	26	SENT_316	[p21l10t1045r371b1146],
29	and	CC	O	and	_	0	SENT_316	[p21l401t1045r556b1124],
30	appear	VBP	O	appear	conj_and	19	SENT_316	[p21l584t1072r872b1146],
31	to	TO	O	to	aux	33	SENT_316	[p21l899t1062r977b1124],
32	be	VB	O	be	auxpass	33	SENT_316	[p21l1007t1046r1103b1124],
33	associated	VBN	O	associate	xcomp	30	SENT_316	[p21l1131t1046r1568b1124],
34	with	IN	O	with	_	0	SENT_316	[p21l1592t1046r1781b1125],
35	responsiveness	NN	O	responsiveness	prep_with	33	SENT_316	[p21l1810t1071r2133b1146, p21l12t1175r361b1253],
36	to	TO	O	to	_	0	SENT_316	[p21l399t1190r479b1252],
37	these	DT	O	these	det	39	SENT_316	[p21l517t1174r739b1252],
38	drugs	NNS	O	drug	nn	39	SENT_316	[p21l776t1168r1243b1274],
39	.19	NN	NUMBER	.19	prep_to	33	SENT_316	[p21l776t1168r1243b1274],
40	'	''	O	'	_	0	SENT_316	[p21l776t1168r1243b1274],
41	3	CD	NUMBER	3	number	42	SENT_316	[p21l776t1168r1243b1274],
42	°	CD	NUMBER	°	dobj	19	SENT_316	[p21l776t1168r1243b1274],
43	The	DT	O	the	det	45	SENT_316	[p21l1275t1174r1439b1252],
44	reported	VBN	O	report	amod	45	SENT_316	[p21l1475t1174r1841b1274],
45	mutations	NNS	O	mutation	nsubj	46	SENT_316	[p21l1877t1190r2132b1253, p21l11t1301r222b1379],
46	are	VBP	O	be	conj_or	46	SENT_316	[p21l248t1327r376b1378],
47	in	IN	O	in	_	0	SENT_316	[p21l400t1300r766b1378],
48	—	NN	O	—	nn	50	SENT_316	[p21l400t1300r766b1378],
49	frame	NN	O	frame	nn	50	SENT_316	[p21l400t1300r766b1378],
50	deletions	NNS	O	deletion	prep_with	46	SENT_316	[p21l790t1300r1197b1395],
51	,	,	O	,	_	0	SENT_316	[p21l790t1300r1197b1395],
52	with	IN	O	with	_	0	SENT_316	[p21l1222t1301r1411b1380],
53	or	CC	O	or	_	0	SENT_316	[p21l1435t1326r1525b1379],
54	without	IN	O	without	_	0	SENT_316	[p21l1540t1301r1875b1379],
55	insertions	NNS	O	insertion	prep_without	46	SENT_316	[p21l1892t1301r2134b1378, p21l11t1429r221b1507],
56	in	IN	O	in	_	0	SENT_316	[p21l257t1429r339b1506],
57	exon	NN	O	exon	prep_in	55	SENT_316	[p21l374t1454r577b1507],
58	19	CD	NUMBER	19	num	57	SENT_316	[p21l615t1434r738b1524],
59	,	,	O	,	_	0	SENT_316	[p21l615t1434r738b1524],
60	and	CC	O	and	_	0	SENT_316	[p21l777t1428r935b1507],
61	missense	NN	O	missense	nn	63	SENT_316	[p21l970t1429r1367b1507],
62	point	NN	O	point	nn	63	SENT_316	[p21l1400t1429r1633b1529],
63	mutations	NNS	O	mutation	conj_and	55	SENT_316	[p21l1662t1429r2129b1524],
64	,	,	O	,	_	0	SENT_316	[p21l1662t1429r2129b1524],
65	mainly	RB	O	mainly	advmod	63	SENT_316	[p21l10t1556r295b1657],
66	in	IN	O	in	_	0	SENT_316	[p21l313t1557r393b1634],
67	exon	NN	O	exon	prep_in	46	SENT_316	[p21l417t1582r614b1635],
68	21	CD	NUMBER	21	num	67	SENT_316	[p21l637t1562r760b1635],
69	.	.	O	.	_	0	SENT_316	[p21l637t1562r760b1635],

1	The	DT	O	the	det	2	SENT_317	[p21l784t1557r944b1635],
2	prevalence	NN	O	prevalence	nsubj	5	SENT_317	[p21l966t1557r1406b1657],
3	of	IN	O	of	_	0	SENT_317	[p21l1429t1556r1529b1635],
4	mutations	NNS	O	mutation	prep_of	2	SENT_317	[p21l1533t1557r1957b1636],
5	varies	VBZ	O	vary	_	0	SENT_317	[p21l1977t1583r2134b1636, p21l10t1685r143b1780],
6	,	,	O	,	_	0	SENT_317	[p21l1977t1583r2134b1636, p21l10t1685r143b1780],
7	ranging	VBG	O	range	xcomp	5	SENT_317	[p21l180t1685r514b1785],
8	from	IN	O	from	_	0	SENT_317	[p21l544t1684r751b1763],
9	20	CD	NUMBER	20	number	11	SENT_317	[p21l784t1690r884b1763],
10	to	TO	O	to	dep	11	SENT_317	[p21l918t1701r997b1763],
11	40	CD	PERCENT	40	num	12	SENT_317	[p21l1030t1690r1132b1763],
12	percent	NN	PERCENT	percent	dep	25	SENT_317	[p21l1164t1701r1485b1785],
13	in	IN	O	in	_	0	SENT_317	[p21l1512t1685r1593b1762],
14	Asian	JJ	LOCATION	asian	amod	15	SENT_317	[p21l1623t1685r1862b1763],
15	countries	NNS	O	country	prep_in	12	SENT_317	[p21l1895t1710r2134b1764, p21l11t1813r186b1890],
16	(	IN	O	(	_	0	SENT_317	[p21l218t1813r566b1907],
17	Taiwan	NNP	LOCATION	Taiwan	prep_(	15	SENT_317	[p21l218t1813r566b1907],
18	,	,	O	,	_	0	SENT_317	[p21l218t1813r566b1907],
19	Korea	NNP	LOCATION	Korea	prep_(	15	SENT_317	[p21l597t1819r864b1907],
20	,	,	O	,	_	0	SENT_317	[p21l597t1819r864b1907],
21	and	CC	O	and	_	0	SENT_317	[p21l895t1812r1048b1890],
22	Japan	NNP	LOCATION	Japan	prep_(	15	SENT_317	[p21l1064t1805r1725b1912],
23	)	CD	NUMBER	)	dep	25	SENT_317	[p21l1064t1805r1725b1912],
24	23	CD	NUMBER	23	num	25	SENT_317	[p21l1064t1805r1725b1912],
25	’	NN	O	’	dep	30	SENT_317	[p21l1064t1805r1725b1912],
26	24	CD	NUMBER	24	number	27	SENT_317	[p21l1064t1805r1725b1912],
27	’	CD	NUMBER	’	dep	25	SENT_317	[p21l1064t1805r1725b1912],
28	26	CD	NUMBER	26	num	29	SENT_317	[p21l1064t1805r1725b1912],
29	‘	NN	O	‘	dep	27	SENT_317	[p21l1064t1805r1725b1912],
30	28	CD	NUMBER	28	prep_from	7	SENT_317	[p21l1064t1805r1725b1912],
31	and	CC	O	and	_	0	SENT_317	[p21l1751t1812r1905b1890],
32	from	IN	O	from	_	0	SENT_317	[p21l1931t1811r2135b1890],
33	5	CD	NUMBER	5	number	35	SENT_317	[p21l12t1949r55b2020],
34	to	TO	O	to	dep	35	SENT_317	[p21l90t1958r169b2020],
35	19	CD	PERCENT	19	num	36	SENT_317	[p21l204t1947r302b2020],
36	percent	NN	PERCENT	percent	conj_and	30	SENT_317	[p21l332t1958r659b2042],
37	in	IN	O	in	_	0	SENT_317	[p21l684t1942r766b2019],
38	Italy	NNP	LOCATION	Italy	prep_in	36	SENT_317	[p21l795t1937r1189b2042],
39	.22	CD	NUMBER	.22	num	38	SENT_317	[p21l795t1937r1189b2042],
40	’25	CD	NUMBER	’25	dobj	7	SENT_317	[p21l795t1937r1189b2042],
41	We	PRP	O	we	nsubj	42	SENT_317	[p21l1219t1949r1353b2020],
42	identiﬁed	VBD	O	identiﬁed	rcmod	40	SENT_317	[p21l1383t1941r1797b2020],
43	45	CD	NUMBER	45	num	44	SENT_317	[p21l1825t1947r1926b2020],
44	mutations	NNS	O	mutation	nsubj	45	SENT_317	[p21l1959t1968r2132b2021, p21l11t2070r304b2148],
45	(	VBP	O	(	ccomp	42	SENT_317	[p21l335t2075r462b2161],
46	13	CD	NUMBER	13	num	47	SENT_317	[p21l335t2075r462b2161],
47	deletions	NNS	O	deletion	nsubj	52	SENT_317	[p21l489t2069r871b2148],
48	and	CC	O	and	_	0	SENT_317	[p21l895t2069r1050b2148],
49	32	CD	NUMBER	32	num	51	SENT_317	[p21l1073t2075r1173b2148],
50	point	NN	O	point	nn	51	SENT_317	[p21l1195t2070r1424b2170],
51	mutations	NNS	O	mutation	nsubj	52	SENT_317	[p21l1441t2070r1903b2161],
52	)	VBP	O	)	ccomp	45	SENT_317	[p21l1441t2070r1903b2161],
53	in	IN	O	in	_	0	SENT_317	[p21l1930t2070r2011b2147],
54	40	CD	NUMBER	40	num	55	SENT_317	[p21l2033t2075r2134b2148],
55	patients	NNS	O	patient	prep_in	52	SENT_317	[p21l9t2198r369b2298],
56	.	.	O	.	_	0	SENT_317	[p21l9t2198r369b2298],

1	The	DT	O	the	det	4	SENT_318	[p21l408t2198r570b2276],
2	23	CD	PERCENT	23	num	4	SENT_318	[p21l608t2203r706b2276],
3	percent	NN	PERCENT	percent	nn	4	SENT_318	[p21l745t2214r1066b2298],
4	prevalence	NN	O	prevalence	nsubj	17	SENT_318	[p21l1096t2198r1544b2298],
5	of	IN	O	of	_	0	SENT_318	[p21l1583t2197r1683b2276],
6	mutations	NNS	O	mutation	prep_of	4	SENT_318	[p21l1702t2198r2133b2277],
7	in	IN	O	in	_	0	SENT_318	[p21l10t2326r91b2403],
8	our	PRP$	O	we	poss	9	SENT_318	[p21l120t2351r264b2405],
9	population	NN	O	population	prep_in	6	SENT_318	[p21l288t2325r752b2426],
10	(	CD	NUMBER	(	number	11	SENT_318	[p21l785t2331r916b2417],
11	40	CD	NUMBER	40	npadvmod	9	SENT_318	[p21l785t2331r916b2417],
12	of	IN	O	of	_	0	SENT_318	[p21l946t2325r1046b2404],
13	177	CD	NUMBER	177	num	14	SENT_318	[p21l1060t2331r1209b2404],
14	patients	NNS	O	patient	prep_of	9	SENT_318	[p21l1237t2326r1603b2426],
15	)	CD	NUMBER	)	dep	14	SENT_318	[p21l1237t2326r1603b2426],
16	is	VBZ	O	be	cop	17	SENT_318	[p21l1637t2326r1701b2404],
17	similar	JJ	O	similar	_	0	SENT_318	[p21l1734t2326r2029b2404],
18	to	TO	O	to	_	0	SENT_318	[p21l2055t2342r2134b2404],
19	that	DT	O	that	prep_to	17	SENT_318	[p21l11t2454r179b2532],
20	reported	VBN	O	report	partmod	19	SENT_318	[p21l207t2454r574b2554],
21	by	IN	O	by	_	0	SENT_318	[p21l607t2454r706b2554],
22	Shigematsu	NNP	PERSON	Shigematsu	agent	20	SENT_318	[p21l736t2453r1241b2554],
23	et	FW	O	et	nn	24	SENT_318	[p21l1274t2470r1352b2532],
24	al.	FW	O	al.	tmod	20	SENT_318	[p21l1380t2454r1506b2549],
25	,	,	O	,	_	0	SENT_318	[p21l1380t2454r1506b2549],
26	who	WP	O	who	nsubj	39	SENT_318	[p21l1540t2454r1725b2533],
27	analyzed	VBD	O	analyze	rcmod	24	SENT_318	[p21l1759t2453r2134b2554],
28	617	CD	NUMBER	617	num	29	SENT_318	[p21l11t2587r165b2660],
29	tumors	NNS	O	tumor	dobj	27	SENT_318	[p21l198t2598r500b2661],
30	from	IN	O	from	_	0	SENT_318	[p21l533t2581r740b2660],
31	patients	NNS	O	patient	prep_from	27	SENT_318	[p21l769t2582r1103b2682],
32	from	IN	O	from	_	0	SENT_318	[p21l1136t2581r1343b2660],
33	various	JJ	O	various	amod	34	SENT_318	[p21l1368t2582r1673b2661],
34	regions	NNS	O	region	prep_from	27	SENT_318	[p21l1706t2582r2020b2682],
35	of	IN	O	of	_	0	SENT_318	[p21l2053t2581r2153b2660],
36	the	DT	O	the	det	37	SENT_318	[p21l11t2710r139b2788],
37	world	NN	O	world	prep_of	34	SENT_318	[p21l157t2710r405b2789],
38	and	CC	O	and	_	0	SENT_318	[p21l425t2709r582b2788],
39	found	VBD	O	find	rcmod	24	SENT_318	[p21l603t2709r854b2789],
40	the	DT	O	the	det	42	SENT_318	[p21l875t2709r1005b2788],
41	highest	JJS	O	highest	amod	42	SENT_318	[p21l1026t2710r1344b2810],
42	rates	NNS	O	rate	dobj	39	SENT_318	[p21l1361t2726r1558b2788],
43	among	IN	O	among	_	0	SENT_318	[p21l1582t2735r1881b2810],
44	Asian	JJ	MISC	asian	amod	45	SENT_318	[p21l1896t2710r2135b2788],
45	patients	NNS	O	patient	prep_among	39	SENT_318	[p21l9t2834r455b2939],
46	.	.	O	.	_	0	SENT_318	[p21l9t2834r455b2939],

1	”	NN	O	”	nsubj	16	SENT_319	[p21l9t2834r455b2939],
2	The	DT	O	the	det	5	SENT_319	[p21l489t2839r651b2917],
3	most	RBS	O	most	advmod	5	SENT_319	[p21l687t2855r904b2917],
4	common	JJ	O	common	amod	5	SENT_319	[p21l936t2864r1317b2917],
5	mutations	NNS	O	mutation	nsubj	11	SENT_319	[p21l1353t2839r1784b2918],
6	in	IN	O	in	_	0	SENT_319	[p21l1822t2839r1903b2916],
7	their	PRP$	O	they	poss	8	SENT_319	[p21l1940t2839r2138b2917],
8	study	NN	O	study	prep_in	5	SENT_319	[p21l12t2967r237b3067],
9	were	VBD	O	be	cop	11	SENT_319	[p21l253t2993r455b3046],
10	short	JJ	O	short	amod	11	SENT_319	[p21l482t2967r704b3045],
11	deletions	NNS	O	deletion	rcmod	1	SENT_319	[p21l725t2966r1107b3045],
12	in	IN	O	in	_	0	SENT_319	[p21l1132t2967r1214b3044],
13	exon	NN	O	exon	prep_in	11	SENT_319	[p21l1239t2992r1439b3045],
14	19	CD	NUMBER	19	num	13	SENT_319	[p21l1467t2972r1588b3062],
15	,	,	O	,	_	0	SENT_319	[p21l1467t2972r1588b3062],
16	correspond	VBP	O	correspond	_	0	SENT_319	[p21l1619t2967r2134b3067],
17	—	NN	O	—	nn	18	SENT_319	[p21l1619t2967r2134b3067],
18	ing	NN	O	ing	dobj	16	SENT_319	[p21l10t3095r148b3195],
19	to	TO	O	to	_	0	SENT_319	[p21l169t3111r248b3173],
20	the	DT	O	the	det	21	SENT_319	[p21l273t3095r402b3173],
21	region	NN	O	region	prep_to	16	SENT_319	[p21l425t3095r698b3195],
22	between	IN	O	between	_	0	SENT_319	[p21l722t3094r1072b3174],
23	amino	NN	O	amino	prep_between	21	SENT_319	[p21l1095t3095r1363b3173],
24	acids	NNS	O	acid	dep	16	SENT_319	[p21l1387t3095r1600b3173],
25	746	CD	NUMBER	746	num	24	SENT_319	[p21l1626t3100r1778b3173],
26	and	CC	O	and	_	0	SENT_319	[p21l1802t3094r1957b3173],
27	753	CD	NUMBER	753	dep	16	SENT_319	[p21l1982t3100r2131b3173],
28	in	IN	O	in	_	0	SENT_319	[p21l10t3223r92b3300],
29	EGFR	NN	ORGANIZATION	egfr	prep_in	24	SENT_319	[p21l127t3229r362b3318],
30	,	,	O	,	_	0	SENT_319	[p21l127t3229r362b3318],
31	and	CC	O	and	_	0	SENT_319	[p21l404t3223r562b3301],
32	the	DT	O	the	det	36	SENT_319	[p21l600t3223r731b3301],
33	exon	NN	O	exon	nn	36	SENT_319	[p21l770t3248r973b3301],
34	21	CD	NUMBER	21	num	36	SENT_319	[p21l1010t3228r1112b3300],
35	L858R	NN	O	l858r	nn	36	SENT_319	[p21l1149t3228r1437b3306],
36	mutation	NN	O	mutation	conj_and	24	SENT_319	[p21l1465t3223r1886b3302],
37	.	.	O	.	_	0	SENT_319	[p21l1465t3223r1886b3302],

1	They	PRP	O	they	nsubj	3	SENT_320	[p21l1926t3223r2138b3323],
2	also	RB	O	also	advmod	3	SENT_320	[p21l10t3350r180b3429],
3	identiﬁed	VBD	O	identiﬁed	_	0	SENT_320	[p21l204t3350r618b3429],
4	point	NN	O	point	nn	5	SENT_320	[p21l639t3351r873b3451],
5	mutations	NNS	O	mutation	dobj	3	SENT_320	[p21l891t3351r1330b3430],
6	that	WDT	O	that	nsubjpass	11	SENT_320	[p21l1357t3351r1526b3429],
7	had	VBD	O	have	aux	11	SENT_320	[p21l1545t3350r1702b3429],
8	not	RB	O	not	neg	11	SENT_320	[p21l1726t3367r1871b3429],
9	previously	RB	DATE	previously	advmod	11	SENT_320	[p21l1888t3351r2133b3451, p21l11t3479r236b3580],
10	been	VBN	O	be	auxpass	11	SENT_320	[p21l273t3480r475b3558],
11	reported	VBN	O	report	rcmod	5	SENT_320	[p21l516t3480r907b3580],
12	.	.	O	.	_	0	SENT_320	[p21l516t3480r907b3580],

1	Huang	NNP	PERSON	Huang	nsubj	5	SENT_321	[p21l953t3487r1247b3580],
2	et	FW	O	et	nn	3	SENT_321	[p21l1286t3496r1364b3558],
3	al.	FW	O	al.	dep	1	SENT_321	[p21l1398t3475r1584b3558],
4	24	CD	NUMBER	24	dep	1	SENT_321	[p21l1398t3475r1584b3558],
5	reported	VBD	O	report	_	0	SENT_321	[p21l1624t3480r1991b3580],
6	10	CD	NUMBER	10	num	8	SENT_321	[p21l2034t3485r2133b3558],
7	new	JJ	O	new	amod	8	SENT_321	[p21l10t3633r188b3687],
8	mutations	NNS	O	mutation	dobj	5	SENT_321	[p21l214t3608r653b3687],
9	among	IN	O	among	_	0	SENT_321	[p21l685t3633r988b3708],
10	117	CD	NUMBER	117	num	11	SENT_321	[p21l1019t3613r1170b3686],
11	tumors	NNS	O	tumor	prep_among	5	SENT_321	[p21l1202t3624r1536b3703],
12	;	:	O	;	_	0	SENT_321	[p21l1202t3624r1536b3703],
13	5	CD	NUMBER	5	nsubjpass	15	SENT_321	[p21l1572t3615r1615b3686],
14	were	VBD	O	be	auxpass	15	SENT_321	[p21l1644t3634r1849b3687],
15	found	VBN	O	find	parataxis	5	SENT_321	[p21l1879t3607r2134b3687],
16	in	IN	O	in	_	0	SENT_321	[p22l10t21r92b98],
17	16	CD	NUMBER	16	num	18	SENT_321	[p22l121t26r218b99],
18	tumors	NNS	O	tumor	prep_in	15	SENT_321	[p22l245t37r552b100],
19	that	WDT	O	that	nsubjpass	22	SENT_321	[p22l580t21r749b99],
20	had	VBD	O	have	aux	22	SENT_321	[p22l770t21r927b99],
21	been	VBN	O	be	auxpass	22	SENT_321	[p22l953t21r1156b99],
22	embedded	VBN	O	embed	rcmod	18	SENT_321	[p22l1181t20r1630b99],
23	in	IN	O	in	_	0	SENT_321	[p22l1655t21r1737b98],
24	parafﬁn	NN	O	parafﬁn	prep_in	22	SENT_321	[p22l1761t20r2128b121],
25	.	.	O	.	_	0	SENT_321	[p22l1761t20r2128b121],

1	Among	IN	O	among	_	0	SENT_322	[p22l7t156r333b249],
2	the	DT	O	the	det	4	SENT_322	[p22l372t148r504b227],
3	approximately	RB	O	approximately	quantmod	4	SENT_322	[p22l545t149r1173b249],
4	2400	CD	DATE	2400	prep_among	62	SENT_322	[p22l1210t154r1422b227],
5	reported	VBD	O	report	rcmod	4	SENT_322	[p22l1464t149r1834b249],
6	analyses	NNS	O	analysis	nsubj	25	SENT_322	[p22l1875t148r2134b249, p22l12t303r134b355],
7	for	IN	O	for	_	0	SENT_322	[p22l168t276r289b355],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_322	[p22l316t284r526b356],
9	mutations	NNS	O	mutation	prep_for	6	SENT_322	[p22l550t271r1189b372],
10	,19	CD	NUMBER	,19	nsubjpass	18	SENT_322	[p22l550t271r1189b372],
11	‘	CD	NUMBER	‘	num	12	SENT_322	[p22l550t271r1189b372],
12	28	CD	NUMBER	28	npadvmod	13	SENT_322	[p22l550t271r1189b372],
13	only	RB	O	only	advmod	10	SENT_322	[p22l1223t277r1402b377],
14	about	IN	O	about	_	0	SENT_322	[p22l1428t277r1668b356],
15	10	CD	PERCENT	10	num	16	SENT_322	[p22l1698t282r1794b355],
16	percent	NN	PERCENT	percent	prep_about	10	SENT_322	[p22l1825t293r2140b377],
17	were	VBD	O	be	auxpass	18	SENT_322	[p22l6t431r209b484],
18	performed	VBN	O	perform	rcmod	9	SENT_322	[p22l232t404r687b505],
19	in	IN	O	in	_	0	SENT_322	[p22l707t405r788b482],
20	formalin	NN	O	formalin	nn	24	SENT_322	[p22l810t404r1421b483],
21	—	CD	NUMBER	—	num	24	SENT_322	[p22l810t404r1421b483],
22	ﬁxed	JJ	O	ﬁxed	amod	24	SENT_322	[p22l810t404r1421b483],
23	parafﬁn	NN	O	parafﬁn	nn	24	SENT_322	[p22l1441t404r2134b505],
24	—	NN	O	—	prep_in	18	SENT_322	[p22l1441t404r2134b505],
25	embed	VBD	O	embed	ccomp	5	SENT_322	[p22l1441t404r2134b505],
26	—	CD	NUMBER	—	nsubj	27	SENT_322	[p22l1441t404r2134b505],
27	ded	VBD	O	ded	ccomp	25	SENT_322	[p22l11t533r162b611],
28	specimens	NNS	O	specimen	dobj	27	SENT_322	[p22l199t533r669b633],
29	,	,	O	,	_	0	SENT_322	[p22l199t533r669b633],
30	and	CC	O	and	_	0	SENT_322	[p22l710t533r866b611],
31	few	JJ	O	few	prep_among	62	SENT_322	[p22l901t532r1053b612],
32	routinely	RB	O	routinely	advmod	33	SENT_322	[p22l1085t533r1464b633],
33	used	VBN	O	use	partmod	31	SENT_322	[p22l1496t533r1691b612],
34	microdis	NN	O	microdi	nn	36	SENT_322	[p22l1727t533r2134b611],
35	—	NN	O	—	nn	36	SENT_322	[p22l1727t533r2134b611],
36	section	NN	O	section	dobj	33	SENT_322	[p22l12t661r320b739],
37	to	TO	O	to	aux	38	SENT_322	[p22l353t677r433b739],
38	increase	VB	O	increase	xcomp	33	SENT_322	[p22l467t661r828b739],
39	the	DT	O	the	det	40	SENT_322	[p22l861t660r995b739],
40	number	NN	O	number	dobj	38	SENT_322	[p22l1028t660r1375b740],
41	of	IN	O	of	_	0	SENT_322	[p22l1406t660r1508b739],
42	tumor	NN	O	tumor	nn	43	SENT_322	[p22l1522t677r1794b740],
43	cells	NNS	O	cell	prep_of	40	SENT_322	[p22l1824t660r2015b739],
44	in	IN	O	in	_	0	SENT_322	[p22l2050t661r2133b738],
45	a	DT	O	a	det	47	SENT_322	[p22l10t816r54b868],
46	given	VBN	O	give	amod	47	SENT_322	[p22l84t790r316b890],
47	sample	NN	O	sample	prep_in	38	SENT_322	[p22l349t785r863b890],
48	.22	CD	NUMBER	.22	number	49	SENT_322	[p22l349t785r863b890],
49	’24	CD	NUMBER	’24	num	52	SENT_322	[p22l349t785r863b890],
50	The	DT	O	the	det	52	SENT_322	[p22l885t789r1045b868],
51	routine	JJ	O	routine	amod	52	SENT_322	[p22l1070t790r1369b869],
52	application	NN	O	application	dep	31	SENT_322	[p22l1394t789r1860b890],
53	of	IN	O	of	_	0	SENT_322	[p22l1886t789r1985b868],
54	microdissection	NN	O	microdissection	prep_of	52	SENT_322	[p22l1993t790r2134b867, p22l11t918r587b996],
55	to	TO	O	to	aux	56	SENT_322	[p22l628t934r708b996],
56	enrich	VB	O	enrich	infmod	52	SENT_322	[p22l750t918r1021b996],
57	tumor	NN	O	tumor	dobj	56	SENT_322	[p22l1061t917r1513b997],
58	—	JJ	O	—	amod	60	SENT_322	[p22l1061t917r1513b997],
59	cell	NN	O	cell	nn	60	SENT_322	[p22l1061t917r1513b997],
60	DNA	NN	O	dna	nsubj	62	SENT_322	[p22l1551t924r1765b996],
61	may	MD	O	may	aux	62	SENT_322	[p22l1802t944r1981b1018],
62	increase	VB	O	increase	_	0	SENT_322	[p22l2016t918r2133b995, p22l11t1072r275b1124],
63	the	DT	O	the	det	64	SENT_322	[p22l301t1045r430b1124],
64	rate	NN	O	rate	dobj	62	SENT_322	[p22l453t1062r609b1124],
65	of	IN	O	of	_	0	SENT_322	[p22l633t1045r734b1124],
66	detection	NN	O	detection	prep_of	64	SENT_322	[p22l739t1045r1128b1124],
67	of	IN	O	of	_	0	SENT_322	[p22l1152t1045r1252b1124],
68	new	JJ	O	new	amod	69	SENT_322	[p22l1256t1071r1432b1125],
69	mutations	NNS	O	mutation	prep_of	66	SENT_322	[p22l1451t1046r1907b1125],
70	.	.	O	.	_	0	SENT_322	[p22l1451t1046r1907b1125],

1	Multiple	JJ	O	multiple	_	0	SENT_323	[p22l1932t1046r2134b1125, p22l11t1174r194b1274],

1	(	RB	O	(	amod	6	SENT_324	[p22l227t1181r409b1265],
2	two	CD	NUMBER	two	tmod	1	SENT_324	[p22l227t1181r409b1265],
3	or	CC	O	or	_	0	SENT_324	[p22l439t1199r528b1252],
4	three	CD	NUMBER	three	tmod	1	SENT_324	[p22l553t1174r795b1265],
5	)	NN	O	)	nn	6	SENT_324	[p22l553t1174r795b1265],
6	mutations	NNS	O	mutation	nsubjpass	9	SENT_324	[p22l828t1174r1259b1253],
7	have	VBP	O	have	aux	9	SENT_324	[p22l1288t1174r1476b1253],
8	been	VBN	O	be	auxpass	9	SENT_324	[p22l1505t1174r1704b1252],
9	identiﬁed	VBN	O	identiﬁed	_	0	SENT_324	[p22l1731t1173r2135b1252],
10	in	IN	O	in	_	0	SENT_324	[p22l10t1303r91b1379],
11	individual	JJ	O	individual	amod	12	SENT_324	[p22l115t1302r535b1381],
12	tumors	NNS	O	tumor	prep_in	9	SENT_324	[p22l561t1296r1389b1381],
13	.21	CD	NUMBER	.21	number	14	SENT_324	[p22l561t1296r1389b1381],
14	’	CD	NUMBER	’	dep	12	SENT_324	[p22l561t1296r1389b1381],
15	23	CD	NUMBER	23	num	16	SENT_324	[p22l561t1296r1389b1381],
16	’	NN	O	’	dep	14	SENT_324	[p22l561t1296r1389b1381],
17	24	CD	NUMBER	24	number	18	SENT_324	[p22l561t1296r1389b1381],
18	’	CD	NUMBER	’	num	20	SENT_324	[p22l561t1296r1389b1381],
19	27	CD	NUMBER	27	number	20	SENT_324	[p22l561t1296r1389b1381],
20	’29	CD	NUMBER	’29	dep	14	SENT_324	[p22l561t1296r1389b1381],

1	In	IN	O	in	_	0	SENT_325	[p22l138t1437r225b1507],
2	our	PRP$	O	we	poss	3	SENT_325	[p22l270t1455r417b1509],
3	study	NN	O	study	prep_in	9	SENT_325	[p22l461t1429r703b1530],
4	,	,	O	,	_	0	SENT_325	[p22l461t1429r703b1530],
5	21	CD	NUMBER	21	num	6	SENT_325	[p22l754t1435r855b1507],
6	mutations	NNS	O	mutation	nsubj	9	SENT_325	[p22l901t1430r1340b1509],
7	were	VBD	O	be	cop	9	SENT_325	[p22l1383t1456r1588b1509],
8	either	RB	O	either	advmod	9	SENT_325	[p22l1634t1430r1883b1508],
9	deletions	NNS	O	deletion	_	0	SENT_325	[p22l1926t1429r2132b1508, p22l12t1558r223b1636],
10	in	IN	O	in	_	0	SENT_325	[p22l260t1558r343b1635],
11	exon	NN	O	exon	prep_in	9	SENT_325	[p22l379t1583r581b1636],
12	19	CD	NUMBER	19	num	11	SENT_325	[p22l621t1563r719b1636],
13	or	CC	O	or	_	0	SENT_325	[p22l756t1583r847b1636],
14	the	DT	O	the	det	18	SENT_325	[p22l880t1557r1011b1636],
15	exon	NN	O	exon	nn	18	SENT_325	[p22l1048t1583r1251b1636],
16	21	CD	NUMBER	21	num	18	SENT_325	[p22l1286t1563r1388b1635],
17	L858R	NN	O	l858r	nn	18	SENT_325	[p22l1423t1563r1712b1641],
18	mutation	NN	O	mutation	prep_in	9	SENT_325	[p22l1738t1558r2134b1637],
19	and	CC	O	and	_	0	SENT_325	[p22l11t1686r168b1764],
20	24	CD	NUMBER	24	nsubj	23	SENT_325	[p22l198t1691r300b1764],
21	were	VBD	O	be	cop	23	SENT_325	[p22l326t1712r531b1765],
22	novel	JJ	O	novel	amod	23	SENT_325	[p22l560t1686r788b1765],
23	mutations	NNS	O	mutation	conj_and	9	SENT_325	[p22l815t1686r1271b1765],
24	.	.	O	.	_	0	SENT_325	[p22l815t1686r1271b1765],

1	In	IN	O	in	_	0	SENT_326	[p22l1303t1693r1390b1763],
2	keeping	VBG	O	keep	prepc_in	14	SENT_326	[p22l1417t1685r1756b1786],
3	with	IN	O	with	_	0	SENT_326	[p22l1777t1686r1965b1765],
4	our	PRP$	O	we	poss	5	SENT_326	[p22l1994t1711r2138b1765],
5	results	NNS	O	result	prep_with	2	SENT_326	[p22l11t1813r310b1909],
6	,	,	O	,	_	0	SENT_326	[p22l11t1813r310b1909],
7	increasing	VBG	O	increase	amod	8	SENT_326	[p22l341t1814r779b1914],
8	numbers	NNS	O	number	nsubjpass	14	SENT_326	[p22l801t1813r1173b1893],
9	of	IN	O	of	_	0	SENT_326	[p22l1202t1813r1302b1892],
10	novel	JJ	O	novel	amod	11	SENT_326	[p22l1310t1814r1532b1893],
11	mutations	NNS	O	mutation	prep_of	8	SENT_326	[p22l1557t1814r1983b1893],
12	are	VBP	O	be	aux	14	SENT_326	[p22l2011t1840r2135b1892],
13	being	VBG	O	be	auxpass	14	SENT_326	[p22l12t1942r253b2042],
14	reported	VBN	O	report	_	0	SENT_326	[p22l279t1941r646b2042],
15	in	IN	O	in	_	0	SENT_326	[p22l674t1942r756b2019],
16	lung	NN	O	lung	nn	17	SENT_326	[p22l785t1942r982b2042],
17	cancers	NNS	O	cancer	prep_in	14	SENT_326	[p22l1009t1967r1329b2020],
18	and	CC	O	and	_	0	SENT_326	[p22l1360t1942r1518b2020],
19	other	JJ	O	other	amod	20	SENT_326	[p22l1547t1942r1776b2020],
20	types	NNS	O	type	prep_in	14	SENT_326	[p22l1802t1958r2019b2042],
21	of	IN	O	of	_	0	SENT_326	[p22l2051t1941r2152b2020],
22	tumors	NNS	O	tumor	prep_of	20	SENT_326	[p22l12t2064r753b2147],
23	.23	CD	NUMBER	.23	number	24	SENT_326	[p22l12t2064r753b2147],
24	’	CD	NUMBER	’	dep	22	SENT_326	[p22l12t2064r753b2147],
25	24	CD	NUMBER	24	num	26	SENT_326	[p22l12t2064r753b2147],
26	’	NN	O	’	dep	24	SENT_326	[p22l12t2064r753b2147],
27	39	CD	NUMBER	39	num	28	SENT_326	[p22l12t2064r753b2147],
28	’	NN	O	’	dep	37	SENT_326	[p22l12t2064r753b2147],
29	4	CD	NUMBER	4	number	30	SENT_326	[p22l12t2064r753b2147],
30	°	CD	NUMBER	°	num	28	SENT_326	[p22l12t2064r753b2147],
31	Among	IN	O	among	_	0	SENT_326	[p22l782t2075r1106b2168],
32	the	DT	O	the	det	35	SENT_326	[p22l1135t2069r1266b2146],
33	24	CD	NUMBER	24	num	35	SENT_326	[p22l1298t2074r1400b2146],
34	novel	JJ	O	novel	amod	35	SENT_326	[p22l1433t2069r1661b2147],
35	mutations	NNS	O	mutation	prep_among	28	SENT_326	[p22l1693t2069r2132b2147],
36	we	PRP	O	we	nsubj	37	SENT_326	[p22l7t2223r127b2276],
37	identiﬁed	VBD	O	identiﬁed	rcmod	20	SENT_326	[p22l177t2196r621b2292],
38	,	,	O	,	_	0	SENT_326	[p22l177t2196r621b2292],
39	1	CD	NUMBER	1	nsubj	40	SENT_326	[p22l680t2202r724b2274],
40	involves	VBZ	O	involve	parataxis	37	SENT_326	[p22l776t2197r1123b2276],
41	a	DT	O	a	det	44	SENT_326	[p22l1175t2223r1220b2275],
42	previously	RB	DATE	previously	advmod	43	SENT_326	[p22l1268t2197r1716b2297],
43	reported	VBN	O	report	amod	44	SENT_326	[p22l1763t2196r2133b2297],
44	codon	NN	O	codon	dobj	40	SENT_326	[p22l12t2325r282b2403],
45	(	CD	NUMBER	(	num	47	SENT_326	[p22l327t2330r607b2416],
46	V851	NN	O	v851	nn	47	SENT_326	[p22l327t2330r607b2416],
47	)	NN	O	)	dobj	37	SENT_326	[p22l327t2330r607b2416],
48	but	CC	O	but	prep	47	SENT_326	[p22l652t2325r794b2404],
49	a	DT	O	a	det	57	SENT_326	[p22l826t2351r871b2403],
50	change	NN	O	change	dep	57	SENT_326	[p22l908t2324r1214b2425],
51	in	IN	O	in	_	0	SENT_326	[p22l1252t2325r1334b2402],
52	a	DT	O	a	det	54	SENT_326	[p22l1371t2351r1416b2403],
53	different	JJ	O	different	amod	54	SENT_326	[p22l1453t2324r1828b2403],
54	amino	NN	O	amino	prep_in	50	SENT_326	[p22l1860t2325r2133b2403],
55	acid	NN	O	acid	nn	57	SENT_326	[p22l11t2453r185b2531],
56	(	CD	NUMBER	(	num	57	SENT_326	[p22l215t2458r531b2543],
57	V851A	NN	O	v851a	dep	48	SENT_326	[p22l215t2458r531b2543],
58	rather	RB	O	rather	_	0	SENT_326	[p22l554t2453r812b2530],
59	than	IN	O	than	_	0	SENT_326	[p22l833t2453r1021b2530],
60	V851I	NN	O	v851us	dobj	37	SENT_326	[p22l1040t2448r1436b2547],
61	)	CD	NUMBER	)	number	62	SENT_326	[p22l1040t2448r1436b2547],
62	,22	CD	NUMBER	,22	dep	60	SENT_326	[p22l1040t2448r1436b2547],
63	and	CC	O	and	_	0	SENT_326	[p22l1459t2453r1614b2530],
64	several	JJ	O	several	nsubjpass	68	SENT_326	[p22l1639t2452r1924b2532],
65	have	VBP	O	have	aux	68	SENT_326	[p22l1947t2452r2134b2532],
66	also	RB	O	also	advmod	68	SENT_326	[p22l11t2580r177b2659],
67	been	VBN	O	be	auxpass	68	SENT_326	[p22l201t2581r400b2659],
68	identiﬁed	VBN	O	identiﬁed	conj_and	37	SENT_326	[p22l421t2580r824b2659],
69	recently	RB	DATE	recently	advmod	68	SENT_326	[p22l845t2580r1178b2681],
70	by	IN	O	by	_	0	SENT_326	[p22l1195t2580r1292b2681],
71	other	JJ	O	other	amod	73	SENT_326	[p22l1310t2581r1533b2659],
72	groups39	NN	O	groups39	nn	73	SENT_326	[p22l1551t2587r1927b2681],
73	(	NN	O	(	agent	68	SENT_326	[p22l1950t2581r2135b2672],
74	and	CC	O	and	_	0	SENT_326	[p22l1950t2581r2135b2672],
75	unpublished	JJ	O	unpublished	amod	77	SENT_326	[p22l11t2708r553b2809],
76	data	NNS	O	datum	nn	77	SENT_326	[p22l577t2709r817b2800],
77	)	NN	O	)	conj_and	73	SENT_326	[p22l577t2709r817b2800],
78	.	.	O	.	_	0	SENT_326	[p22l577t2709r817b2800],

1	In	IN	O	in	_	0	SENT_327	[p22l845t2716r933b2786],
2	21	CD	NUMBER	21	prep_in	13	SENT_327	[p22l956t2714r1058b2786],
3	of	IN	O	of	_	0	SENT_327	[p22l1084t2708r1185b2787],
4	our	PRP$	O	we	poss	5	SENT_327	[p22l1191t2734r1337b2788],
5	patients	NNS	O	patient	prep_of	2	SENT_327	[p22l1356t2709r1698b2809],
6	With	IN	O	with	_	0	SENT_327	[p22l1720t2709r1911b2788],
7	such	JJ	O	such	amod	8	SENT_327	[p22l1936t2709r2134b2788],
8	mutations	NNS	O	mutation	prep_with	13	SENT_327	[p22l11t2836r460b2930],
9	,	,	O	,	_	0	SENT_327	[p22l11t2836r460b2930],
10	sufﬁcient	JJ	O	sufﬁcient	amod	11	SENT_327	[p22l493t2835r884b2914],
11	DNA	NN	O	dna	nsubj	13	SENT_327	[p22l903t2842r1114b2914],
12	was	VBD	O	be	cop	13	SENT_327	[p22l1133t2862r1292b2915],
13	available	JJ	O	available	_	0	SENT_327	[p22l1320t2835r1678b2915],
14	for	IN	O	for	_	0	SENT_327	[p22l1704t2835r1826b2914],
15	reanalysis	NN	O	reanalysis	prep_for	13	SENT_327	[p22l1849t2835r2134b2913, p22l7t2964r189b3064],
16	,	,	O	,	_	0	SENT_327	[p22l1849t2835r2134b2913, p22l7t2964r189b3064],
17	and	CC	O	and	_	0	SENT_327	[p22l225t2963r384b3042],
18	thus	RB	O	thus	advmod	21	SENT_327	[p22l414t2963r625b3059],
19	,	,	O	,	_	0	SENT_327	[p22l414t2963r625b3059],
20	We	PRP	O	we	nsubj	21	SENT_327	[p22l657t2990r777b3043],
21	used	VBD	O	use	conj_and	13	SENT_327	[p22l808t2964r1008b3043],
22	independent	JJ	O	independent	amod	23	SENT_327	[p22l1037t2963r1591b3064],
23	PCR	NN	O	pcr	dobj	21	SENT_327	[p22l1615t2969r1809b3047],
24	to	TO	O	to	aux	25	SENT_327	[p22l1830t2980r1911b3042],
25	conﬁrm	VB	O	conﬁrm	xcomp	21	SENT_327	[p22l1943t2989r2133b3042, p22l11t3091r193b3169],
26	the	DT	O	the	det	28	SENT_327	[p22l218t3092r345b3170],
27	novel	JJ	O	novel	amod	28	SENT_327	[p22l371t3092r593b3171],
28	sequence	NN	O	sequence	dobj	25	SENT_327	[p22l619t3117r1003b3192],
29	in	IN	O	in	_	0	SENT_327	[p22l1027t3092r1108b3169],
30	one	CD	NUMBER	one	num	31	SENT_327	[p22l1134t3117r1285b3170],
31	specimen	NN	O	specimen	prep_in	25	SENT_327	[p22l1312t3092r1711b3192],
32	(	CD	NUMBER	(	num	34	SENT_327	[p22l1740t3097r2129b3183],
33	D761N	NN	O	d761n	nn	34	SENT_327	[p22l1740t3097r2129b3183],
34	)	NN	O	)	dep	31	SENT_327	[p22l1740t3097r2129b3183],
35	.	.	O	.	_	0	SENT_327	[p22l1740t3097r2129b3183],

1	N	NN	O	n	nn	3	SENT_328	[p22l9t3227r84b3298],
2	o	NN	O	o	nn	3	SENT_328	[p22l89t3245r136b3298],
3	information	NN	O	information	nsubj	12	SENT_328	[p22l169t3219r691b3298],
4	on	IN	O	on	_	0	SENT_328	[p22l724t3245r831b3298],
5	the	DT	O	the	det	7	SENT_328	[p22l863t3219r995b3298],
6	functional	JJ	O	functional	amod	7	SENT_328	[p22l1026t3219r1468b3299],
7	signiﬁcance	NN	O	signiﬁcance	prep_on	3	SENT_328	[p22l1501t3219r2018b3320],
8	of	IN	O	of	_	0	SENT_328	[p22l2051t3219r2152b3298],
9	these	DT	O	these	det	10	SENT_328	[p22l12t3346r234b3424],
10	mutations	NNS	O	mutation	prep_of	7	SENT_328	[p22l279t3347r718b3425],
11	is	VBZ	O	be	cop	12	SENT_328	[p22l764t3347r830b3424],
12	available	JJ	O	available	_	0	SENT_328	[p22l876t3347r1273b3441],
13	,	,	O	,	_	0	SENT_328	[p22l876t3347r1273b3441],
14	and	CC	O	and	_	0	SENT_328	[p22l1322t3347r1480b3425],
15	none	NN	O	none	nsubjpass	21	SENT_328	[p22l1524t3372r1738b3425],
16	of	IN	O	of	_	0	SENT_328	[p22l1783t3346r1885b3425],
17	these	DT	O	these	det	18	SENT_328	[p22l1911t3347r2134b3424],
18	mutations	NNS	O	mutation	prep_of	15	SENT_328	[p22l11t3475r450b3554],
19	have	VBP	O	have	aux	21	SENT_328	[p22l476t3475r668b3554],
20	been	VBN	O	be	auxpass	21	SENT_328	[p22l693t3475r896b3553],
21	reported	VBN	O	report	conj_and	12	SENT_328	[p22l920t3475r1286b3575],
22	as	IN	O	as	_	0	SENT_328	[p22l1309t3501r1394b3553],
23	polymorphisms	NNS	O	polymorphism	prep_as	21	SENT_328	[p22l1419t3475r2129b3575],
24	.	.	O	.	_	0	SENT_328	[p22l1419t3475r2129b3575],

1	A	DT	O	a	det	4	SENT_329	[p22l8t3610r74b3680],
2	more	RBR	O	more	advmod	3	SENT_329	[p22l100t3628r322b3681],
3	important	JJ	O	important	amod	4	SENT_329	[p22l351t3603r793b3703],
4	point	NN	O	point	nsubj	5	SENT_329	[p22l815t3603r1048b3703],
5	is	VBZ	O	be	_	0	SENT_329	[p22l1071t3603r1137b3681],
6	that	IN	O	that	complm	13	SENT_329	[p22l1168t3603r1338b3681],
7	no	DT	O	no	det	9	SENT_329	[p22l1361t3628r1468b3681],
8	signiﬁcant	NN	O	signiﬁcant	nn	9	SENT_329	[p22l1500t3602r1961b3703],
9	difference	NN	O	difference	nsubjpass	13	SENT_329	[p22l1986t3602r2133b3681, p22l11t3730r327b3809],
10	in	IN	O	in	_	0	SENT_329	[p22l363t3731r446b3808],
11	survival	NN	O	survival	prep_in	9	SENT_329	[p22l484t3731r813b3810],
12	Was	VBD	O	be	auxpass	13	SENT_329	[p22l844t3757r1008b3810],
13	associated	VBN	O	associate	ccomp	5	SENT_329	[p22l1047t3731r1498b3809],
14	with	IN	O	with	_	0	SENT_329	[p22l1530t3731r1724b3810],
15	erlotinib	NN	O	erlotinib	nn	16	SENT_329	[p22l1761t3730r2132b3809],
16	therapy	NN	O	therapy	prep_with	13	SENT_329	[p23l12t44r336b144],
17	,	,	O	,	_	0	SENT_329	[p23l12t44r336b144],
18	as	IN	O	as	_	0	SENT_329	[p23l364t70r448b122],
19	compared	VBN	O	compare	prepc_as	13	SENT_329	[p23l474t44r891b144],
20	with	IN	O	with	pcomp	19	SENT_329	[p23l909t44r1096b123],
21	placebo	NN	O	placebo	pobj	20	SENT_329	[p23l1117t43r1463b144],
22	,	,	O	,	_	0	SENT_329	[p23l1117t43r1463b144],
23	among	IN	O	among	_	0	SENT_329	[p23l1491t69r1787b144],
24	patients	NNS	O	patient	prep_among	13	SENT_329	[p23l1805t44r2134b144],
25	with	IN	O	with	_	0	SENT_329	[p23l7t172r201b251],
26	the	DT	O	the	det	28	SENT_329	[p23l232t172r364b250],
27	classic	JJ	O	classic	amod	28	SENT_329	[p23l397t172r680b250],
28	exon	NN	O	exon	prep_with	24	SENT_329	[p23l712t197r916b250],
29	19	CD	NUMBER	19	num	30	SENT_329	[p23l951t177r1049b250],
30	deletions	NNS	O	deletion	dep	28	SENT_329	[p23l1084t172r1477b250],
31	or	CC	O	or	_	0	SENT_329	[p23l1512t197r1603b250],
32	the	DT	O	the	det	33	SENT_329	[p23l1632t171r1764b250],
33	exon	NN	O	exon	conj_or	28	SENT_329	[p23l1796t197r2000b250],
34	21	CD	NUMBER	21	dep	33	SENT_329	[p23l2031t177r2133b249],

1	L858R	NN	O	l858r	nn	5	SENT_330	[p23l10t304r299b382],
2	mutation	NN	O	mutation	nn	5	SENT_330	[p23l319t299r716b377],
3	(	NN	O	(	nn	5	SENT_330	[p23l751t299r1075b389],
4	hazard	NN	O	hazard	nn	5	SENT_330	[p23l751t299r1075b389],
5	ratio	NN	O	ratio	nsubj	31	SENT_330	[p23l1106t299r1302b377],
6	for	IN	O	for	_	0	SENT_330	[p23l1334t298r1459b377],
7	death	NN	O	death	prep_for	5	SENT_330	[p23l1488t298r1748b393],
8	,	,	O	,	_	0	SENT_330	[p23l1488t298r1748b393],
9	0.65	CD	NUMBER	0.65	appos	7	SENT_330	[p23l1785t304r1997b393],
10	;	:	O	;	_	0	SENT_330	[p23l1785t304r1997b393],
11	95	CD	PERCENT	95	num	14	SENT_330	[p23l2032t304r2130b377],
12	percent	NN	PERCENT	percent	nn	14	SENT_330	[p23l10t443r337b527],
13	conﬁdence	NN	O	conﬁdence	nn	14	SENT_330	[p23l356t426r827b505],
14	interval	NN	O	interval	dep	7	SENT_330	[p23l850t426r1195b522],
15	,	,	O	,	_	0	SENT_330	[p23l850t426r1195b522],
16	0.24	CD	NUMBER	0.24	num	18	SENT_330	[p23l1225t432r1411b505],
17	to	TO	O	to	dep	18	SENT_330	[p23l1435t443r1515b505],
18	1.75	CD	NUMBER	1.75	appos	14	SENT_330	[p23l1543t432r1752b522],
19	;	:	O	;	_	0	SENT_330	[p23l1543t432r1752b522],
20	P	NN	O	p	dep	7	SENT_330	[p23l1778t432r2129b518],
21	=	JJ	O	=	amod	20	SENT_330	[p23l1778t432r2129b518],
22	O.	NNP	O	O.	nn	24	SENT_330	[p23l1778t432r2129b518],
23	39	CD	NUMBER	39	num	24	SENT_330	[p23l1778t432r2129b518],
24	)	NN	O	)	dep	20	SENT_330	[p23l1778t432r2129b518],
25	and	CC	O	and	_	0	SENT_330	[p23l11t555r170b633],
26	those	DT	O	those	prep_for	5	SENT_330	[p23l203t554r437b633],
27	with	IN	O	with	_	0	SENT_330	[p23l466t555r660b634],
28	only	RB	O	only	advmod	30	SENT_330	[p23l694t555r880b655],
29	novel	JJ	O	novel	amod	30	SENT_330	[p23l910t555r1140b634],
30	mutations	NNS	O	mutation	prep_with	26	SENT_330	[p23l1173t555r1616b634],
31	(	VBP	O	(	_	0	SENT_330	[p23l1657t554r1983b646],
32	hazard	NN	O	hazard	nn	33	SENT_330	[p23l1657t554r1983b646],
33	ratio	NN	O	ratio	dobj	31	SENT_330	[p23l2017t581r2132b633, p23l12t683r148b778],
34	,	,	O	,	_	0	SENT_330	[p23l2017t581r2132b633, p23l12t683r148b778],
35	0.67	CD	NUMBER	0.67	appos	33	SENT_330	[p23l187t688r401b778],
36	;	:	O	;	_	0	SENT_330	[p23l187t688r401b778],
37	95	CD	PERCENT	95	num	40	SENT_330	[p23l439t688r538b761],
38	percent	NN	PERCENT	percent	nn	40	SENT_330	[p23l573t699r904b783],
39	conﬁdence	NN	O	conﬁdence	nn	40	SENT_330	[p23l932t682r1408b761],
40	interval	NN	O	interval	dep	33	SENT_330	[p23l1441t683r1791b778],
41	,	,	O	,	_	0	SENT_330	[p23l1441t683r1791b778],
42	0.26	CD	NUMBER	0.26	number	44	SENT_330	[p23l1830t688r2017b761],
43	to	TO	O	to	dep	44	SENT_330	[p23l2051t699r2132b761],
44	1.75	CD	NUMBER	1.75	appos	40	SENT_330	[p23l15t816r225b906],
45	;	:	O	;	_	0	SENT_330	[p23l15t816r225b906],
46	P	NN	O	p	dep	33	SENT_330	[p23l266t816r621b902],
47	=	JJ	O	=	advmod	51	SENT_330	[p23l266t816r621b902],
48	0.41	CD	NUMBER	0.41	dep	47	SENT_330	[p23l266t816r621b902],
49	)	CD	NUMBER	)	number	50	SENT_330	[p23l266t816r621b902],
50	(	CD	NUMBER	(	num	51	SENT_330	[p23l670t811r860b911],
51	Fig	NN	O	fig	rcmod	46	SENT_330	[p23l670t811r860b911],
52	.	.	O	.	_	0	SENT_330	[p23l670t811r860b911],

1	1	CD	NUMBER	1	_	0	SENT_331	[p23l907t816r951b888],
2	of	IN	O	of	_	0	SENT_331	[p23l990t810r1092b889],
3	the	DT	O	the	det	6	SENT_331	[p23l1112t811r1244b889],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_331	[p23l1285t811r1947b911],
5	Appendix	NNP	O	Appendix	nn	6	SENT_331	[p23l1976t818r2132b911, p23l10t939r362b1039],
6	)	NN	O	)	prep_of	1	SENT_331	[p23l1976t818r2132b911, p23l10t939r362b1039],
7	.	.	O	.	_	0	SENT_331	[p23l1976t818r2132b911, p23l10t939r362b1039],

1	The	DT	O	the	det	3	SENT_332	[p23l137t1066r298b1145],
2	clinical	JJ	O	clinical	amod	3	SENT_332	[p23l330t1066r630b1145],
3	characteristics	NNS	O	characteristic	nsubj	10	SENT_332	[p23l662t1067r1266b1145],
4	of	IN	O	of	_	0	SENT_332	[p23l1299t1066r1400b1145],
5	our	PRP$	O	we	poss	6	SENT_332	[p23l1413t1092r1557b1146],
6	patients	NNS	O	patient	prep_of	3	SENT_332	[p23l1583t1067r1917b1167],
7	with	IN	O	with	_	0	SENT_332	[p23l1946t1067r2135b1146],
8	mutations	NNS	O	mutation	prep_with	6	SENT_332	[p23l11t1195r442b1274],
9	were	VBD	O	be	cop	10	SENT_332	[p23l464t1221r666b1274],
10	similar	JJ	O	similar	_	0	SENT_332	[p23l692t1194r987b1273],
11	to	TO	O	to	_	0	SENT_332	[p23l1009t1211r1088b1273],
12	those	DT	O	those	prep_to	10	SENT_332	[p23l1115t1195r1342b1273],
13	of	IN	O	of	_	0	SENT_332	[p23l1368t1194r1468b1273],
14	patients	NNS	O	patient	prep_of	12	SENT_332	[p23l1473t1195r1808b1295],
15	in	IN	O	in	_	0	SENT_332	[p23l1833t1195r1915b1272],
16	published	VBN	O	publish	amod	17	SENT_332	[p23l1938t1195r2134b1295, p23l10t1322r264b1401],
17	studies	NNS	O	study	prep_in	10	SENT_332	[p23l292t1323r611b1418],
18	,	,	O	,	_	0	SENT_332	[p23l292t1323r611b1418],
19	with	IN	O	with	_	0	SENT_332	[p23l639t1322r828b1402],
20	a	DT	O	a	det	21	SENT_332	[p23l853t1349r897b1401],
21	preponderance	NN	O	preponderance	prep_with	10	SENT_332	[p23l921t1323r1559b1423],
22	of	IN	O	of	_	0	SENT_332	[p23l1586t1322r1686b1401],
23	female	JJ	O	female	amod	24	SENT_332	[p23l1694t1322r1976b1401],
24	patients	NNS	O	patient	prep_of	21	SENT_332	[p23l2001t1349r2134b1423, p23l12t1451r267b1546],
25	,	,	O	,	_	0	SENT_332	[p23l2001t1349r2134b1423, p23l12t1451r267b1546],
26	patients	NNS	O	patient	prep_with	10	SENT_332	[p23l315t1451r649b1551],
27	with	IN	O	with	_	0	SENT_332	[p23l690t1451r879b1530],
28	adenocarcinoma	NN	O	adenocarcinoma	prep_with	26	SENT_332	[p23l923t1450r1650b1546],
29	,	,	O	,	_	0	SENT_332	[p23l923t1450r1650b1546],
30	nonsmoking	JJ	O	nonsmoking	amod	31	SENT_332	[p23l1699t1451r2134b1530, p23l11t1580r150b1679],
31	patients	NNS	O	patient	appos	28	SENT_332	[p23l178t1580r546b1679],
32	,	,	O	,	_	0	SENT_332	[p23l178t1580r546b1679],
33	and	CC	O	and	_	0	SENT_332	[p23l584t1579r742b1657],
34	Asian	JJ	MISC	asian	amod	35	SENT_332	[p23l770t1580r1013b1657],
35	patients	NNS	O	patient	prep_with	10	SENT_332	[p23l1044t1573r1611b1679],
36	,19	CD	NUMBER	,19	number	37	SENT_332	[p23l1044t1573r1611b1679],
37	'28	CD	NUMBER	'28	dep	35	SENT_332	[p23l1044t1573r1611b1679],
38	but	CC	O	but	_	0	SENT_332	[p23l1645t1579r1787b1658],
39	We	PRP	O	we	nsubj	41	SENT_332	[p23l1810t1605r1930b1658],
40	also	RB	O	also	advmod	41	SENT_332	[p23l1962t1579r2133b1657],
41	identiﬁed	VBD	O	identiﬁed	conj_but	10	SENT_332	[p23l11t1706r411b1785],
42	mutations	NNS	O	mutation	dobj	41	SENT_332	[p23l430t1707r854b1786],
43	in	IN	O	in	_	0	SENT_332	[p23l876t1707r956b1784],
44	other	JJ	O	other	amod	45	SENT_332	[p23l977t1706r1198b1785],
45	subgroups	NNS	O	subgroup	prep_in	41	SENT_332	[p23l1216t1707r1654b1807],
46	of	IN	O	of	_	0	SENT_332	[p23l1677t1706r1777b1785],
47	patients	NNS	O	patient	prep_of	45	SENT_332	[p23l1778t1707r2130b1807],
48	.	.	O	.	_	0	SENT_332	[p23l1778t1707r2130b1807],

1	As	IN	O	as	prep	21	SENT_333	[p23l8t1842r111b1913],
2	in	IN	O	in	pcomp	1	SENT_333	[p23l137t1835r220b1912],
3	other	JJ	O	other	amod	4	SENT_333	[p23l245t1835r473b1913],
4	reports	NNS	O	report	pobj	2	SENT_333	[p23l494t1851r826b1935],
5	,	,	O	,	_	0	SENT_333	[p23l494t1851r826b1935],
6	in	IN	O	in	_	0	SENT_333	[p23l857t1835r938b1912],
7	our	PRP$	O	we	poss	8	SENT_333	[p23l964t1860r1110b1914],
8	study	NN	O	study	prep_in	21	SENT_333	[p23l1133t1834r1376b1935],
9	,	,	O	,	_	0	SENT_333	[p23l1133t1834r1376b1935],
10	the	DT	O	the	det	12	SENT_333	[p23l1406t1834r1538b1913],
11	response	NN	O	response	nn	12	SENT_333	[p23l1562t1860r1949b1935],
12	rate	NN	O	rate	nsubj	21	SENT_333	[p23l1974t1851r2134b1913],
13	among	IN	O	among	_	0	SENT_333	[p23l11t1988r317b2063],
14	patients	NNS	O	patient	prep_among	12	SENT_333	[p23l355t1963r701b2063],
15	with	IN	O	with	_	0	SENT_333	[p23l742t1963r936b2042],
16	mutations	NNS	O	mutation	prep_with	14	SENT_333	[p23l978t1963r1422b2042],
17	was	VBD	O	be	cop	21	SENT_333	[p23l1463t1989r1627b2042],
18	more	RBR	O	more	advmod	19	SENT_333	[p23l1672t1988r1897b2041],
19	than	IN	O	than	advmod	21	SENT_333	[p23l1941t1963r2134b2041],
20	twice	RB	O	twice	advmod	19	SENT_333	[p23l12t2091r234b2170],
21	that	DT	O	that	_	0	SENT_333	[p23l257t2091r427b2169],
22	among	IN	O	among	_	0	SENT_333	[p23l445t2116r749b2191],
23	patients	NNS	O	patient	prep_among	21	SENT_333	[p23l767t2091r1109b2191],
24	with	IN	O	with	_	0	SENT_333	[p23l1130t2091r1323b2170],
25	wild	JJ	O	wild	amod	28	SENT_333	[p23l1341t2090r1743b2191],
26	—	NN	O	—	nn	28	SENT_333	[p23l1341t2090r1743b2191],
27	type	NN	O	type	nn	28	SENT_333	[p23l1341t2090r1743b2191],
28	EGFR	NN	ORGANIZATION	egfr	prep_with	23	SENT_333	[p23l1765t2097r1999b2186],
29	,	,	O	,	_	0	SENT_333	[p23l1765t2097r1999b2186],
30	although	IN	O	although	mark	35	SENT_333	[p23l2027t2091r2132b2169, p23l12t2218r322b2319],
31	the	DT	O	the	det	32	SENT_333	[p23l348t2219r479b2297],
32	difference	NN	O	difference	nsubj	35	SENT_333	[p23l506t2218r927b2297],
33	Was	VBD	O	be	cop	35	SENT_333	[p23l946t2245r1107b2298],
34	not	RB	O	not	neg	35	SENT_333	[p23l1134t2235r1277b2297],
35	signiﬁcant	JJ	O	signiﬁcant	advcl	21	SENT_333	[p23l1298t2218r1767b2319],
36	,	,	O	,	_	0	SENT_333	[p23l1298t2218r1767b2319],
37	perhaps	RB	O	perhaps	advmod	35	SENT_333	[p23l1796t2218r2133b2319],
38	because	IN	O	because	mark	44	SENT_333	[p23l12t2346r350b2426],
39	the	DT	O	the	det	40	SENT_333	[p23l381t2347r513b2425],
40	number	NN	O	number	nsubj	44	SENT_333	[p23l543t2347r885b2426],
41	of	IN	O	of	_	0	SENT_333	[p23l914t2346r1015b2425],
42	responses	NNS	O	response	prep_of	40	SENT_333	[p23l1027t2372r1456b2447],
43	Was	VBD	O	be	cop	44	SENT_333	[p23l1485t2373r1648b2426],
44	small	JJ	O	small	advcl	35	SENT_333	[p23l1682t2346r1938b2425],
45	.	.	O	.	_	0	SENT_333	[p23l1682t2346r1938b2425],

1	The	DT	O	the	det	2	SENT_334	[p23l1970t2346r2134b2425],
2	presence	NN	O	presence	nsubj	9	SENT_334	[p23l10t2500r391b2575],
3	of	IN	O	of	_	0	SENT_334	[p23l424t2474r526b2553],
4	a	DT	O	a	det	5	SENT_334	[p23l539t2501r583b2553],
5	mutation	NN	O	mutation	prep_of	2	SENT_334	[p23l614t2475r1011b2554],
6	was	VBD	O	be	cop	9	SENT_334	[p23l1039t2501r1202b2554],
7	not	RB	O	not	neg	9	SENT_334	[p23l1236t2491r1382b2553],
8	more	RBR	O	more	advmod	9	SENT_334	[p23l1409t2500r1631b2553],
9	likely	JJ	O	likely	_	0	SENT_334	[p23l1663t2474r1894b2575],
10	to	TO	O	to	aux	12	SENT_334	[p23l1923t2491r2003b2553],
11	be	VB	O	be	auxpass	12	SENT_334	[p23l2037t2474r2134b2553],
12	associated	VBN	O	associate	xcomp	9	SENT_334	[p23l11t2602r438b2681],
13	with	IN	O	with	_	0	SENT_334	[p23l453t2603r638b2682],
14	responsiveness	NN	O	responsiveness	prep_with	12	SENT_334	[p23l658t2603r1279b2703],
15	than	IN	O	than	mark	19	SENT_334	[p23l1302t2602r1485b2681],
16	were	VBD	O	be	cop	19	SENT_334	[p23l1500t2629r1698b2682],
17	other	JJ	O	other	amod	19	SENT_334	[p23l1718t2603r1938b2681],
18	clinical	JJ	O	clinical	amod	19	SENT_334	[p23l1955t2603r2135b2681, p23l11t2732r151b2810],
19	characteristics	NNS	O	characteristic	ccomp	9	SENT_334	[p23l175t2731r804b2810],
20	.	.	O	.	_	0	SENT_334	[p23l175t2731r804b2810],

1	A	DT	O	a	det	4	SENT_335	[p23l137t2867r203b2937],
2	meta	NN	O	meta	nn	4	SENT_335	[p23l224t2854r879b2960],
3	—	NN	O	—	nn	4	SENT_335	[p23l224t2854r879b2960],
4	analysis14	NN	O	analysis14	nsubj	6	SENT_335	[p23l224t2854r879b2960],
5	has	VBZ	O	have	aux	6	SENT_335	[p23l903t2860r1043b2938],
6	suggested	VBN	O	suggest	_	0	SENT_335	[p23l1072t2860r1489b2960],
7	that	IN	O	that	complm	37	SENT_335	[p23l1515t2860r1680b2938],
8	in	IN	O	in	_	0	SENT_335	[p23l1699t2860r1779b2937],
9	patients	NNS	O	patient	prep_in	37	SENT_335	[p23l1802t2861r2133b2960],
10	with	IN	O	with	_	0	SENT_335	[p23l7t2988r193b3067],
11	non	JJ	O	non	amod	17	SENT_335	[p23l216t2988r837b3066],
12	—	JJ	O	—	amod	17	SENT_335	[p23l216t2988r837b3066],
13	small	JJ	O	small	amod	17	SENT_335	[p23l216t2988r837b3066],
14	—	NN	O	—	nn	17	SENT_335	[p23l216t2988r837b3066],
15	cell	NN	O	cell	nn	17	SENT_335	[p23l216t2988r837b3066],
16	lung	NN	O	lung	nn	17	SENT_335	[p23l858t2987r1049b3088],
17	cancer	NN	O	cancer	prep_with	9	SENT_335	[p23l1070t3013r1341b3066],
18	who	WP	O	who	nsubj	21	SENT_335	[p23l1356t2988r1537b3067],
19	are	VBP	O	be	aux	21	SENT_335	[p23l1561t3014r1685b3066],
20	not	RB	O	not	neg	21	SENT_335	[p23l1708t3004r1849b3066],
21	receiv	VB	O	receiv	rcmod	9	SENT_335	[p23l1867t2988r2134b3067],
22	—	NN	O	—	dobj	21	SENT_335	[p23l1867t2988r2134b3067],
23	ing	JJ	O	ing	amod	27	SENT_335	[p23l11t3116r148b3216],
24	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_335	[p23l180t3115r851b3199],
25	—	NN	O	—	nn	27	SENT_335	[p23l180t3115r851b3199],
26	inhibitor	NN	O	inhibitor	nn	27	SENT_335	[p23l180t3115r851b3199],
27	therapy	NN	O	therapy	dep	22	SENT_335	[p23l885t3116r1221b3216],
28	,	,	O	,	_	0	SENT_335	[p23l885t3116r1221b3216],
29	expression	NN	O	expression	nsubj	37	SENT_335	[p23l1263t3116r1727b3216],
30	of	IN	O	of	_	0	SENT_335	[p23l1764t3115r1866b3194],
31	EGFR	NN	ORGANIZATION	egfr	prep_of	29	SENT_335	[p23l1882t3121r2145b3199],
32	is	VBZ	O	be	cop	37	SENT_335	[p23l11t3244r77b3322],
33	not	RB	O	not	neg	37	SENT_335	[p23l109t3260r254b3322],
34	a	DT	O	a	det	37	SENT_335	[p23l278t3270r322b3322],
35	strong	JJ	O	strong	amod	37	SENT_335	[p23l352t3260r633b3344],
36	prognostic	JJ	O	prognostic	amod	37	SENT_335	[p23l657t3244r1125b3344],
37	factor	NN	O	factor	ccomp	6	SENT_335	[p23l1155t3243r1406b3322],
38	for	IN	O	for	_	0	SENT_335	[p23l1433t3243r1558b3322],
39	survival	NN	O	survival	prep_for	37	SENT_335	[p23l1586t3243r1936b3323],
40	.	.	O	.	_	0	SENT_335	[p23l1586t3243r1936b3323],

1	Our	PRP$	O	we	poss	2	SENT_336	[p23l1971t3249r2137b3323],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_336	[p23l11t3371r368b3472],
3	were	VBD	O	be	cop	4	SENT_336	[p23l391t3398r597b3451],
4	similar	JJ	O	similar	_	0	SENT_336	[p23l624t3372r942b3467],
5	,	,	O	,	_	0	SENT_336	[p23l624t3372r942b3467],
6	but	CC	O	but	_	0	SENT_336	[p23l974t3372r1117b3451],
7	Whether	IN	O	whether	complm	13	SENT_336	[p23l1133t3371r1491b3451],
8	the	DT	O	the	det	9	SENT_336	[p23l1513t3371r1644b3450],
9	expression	NN	O	expression	nsubjpass	13	SENT_336	[p23l1671t3372r2134b3472],
10	of	IN	O	of	_	0	SENT_336	[p23l12t3499r113b3578],
11	EGFR	NN	ORGANIZATION	egfr	prep_of	9	SENT_336	[p23l122t3505r384b3583],
12	is	VBZ	O	be	auxpass	13	SENT_336	[p23l400t3500r465b3578],
13	associated	VBN	O	associate	conj_or	13	SENT_336	[p23l493t3500r929b3578],
14	With	IN	O	with	_	0	SENT_336	[p23l951t3500r1141b3579],
15	responsiveness	NN	O	responsiveness	prep_with	13	SENT_336	[p23l1167t3500r1805b3600],
16	to	TO	O	to	aux	17	SENT_336	[p23l1833t3516r1912b3578],
17	erlo	VB	O	erlo	infmod	15	SENT_336	[p23l1941t3500r2134b3578],
18	—	NN	O	—	nn	19	SENT_336	[p23l1941t3500r2134b3578],
19	tinib	NN	O	tinib	dobj	17	SENT_336	[p23l12t3628r206b3706],
20	or	CC	O	or	_	0	SENT_336	[p23l238t3653r328b3706],
21	to	TO	O	to	_	0	SENT_336	[p23l356t3644r437b3706],
22	a	DT	O	a	det	24	SENT_336	[p23l467t3654r512b3706],
23	differential	JJ	O	differential	amod	24	SENT_336	[p23l542t3627r1018b3706],
24	effect	NN	O	effect	prep_to	13	SENT_336	[p23l1049t3627r1288b3706],
25	of	IN	O	of	_	0	SENT_336	[p23l1315t3627r1416b3706],
26	erlotinib	NN	O	erlotinib	prep_of	24	SENT_336	[p23l1428t3627r1795b3706],
27	on	IN	O	on	_	0	SENT_336	[p23l1828t3653r1936b3706],
28	survival	NN	O	survival	prep_on	26	SENT_336	[p23l1967t3654r2133b3707, p24l7t32r199b111],

1	requires	VBZ	O	require	_	0	SENT_337	[p24l226t32r573b132],
2	further	RB	O	further	advmod	1	SENT_337	[p24l600t31r896b111],
3	exploration	NN	O	exploration	dobj	1	SENT_337	[p24l919t32r1423b132],
4	.	.	O	.	_	0	SENT_337	[p24l919t32r1423b132],

1	Cappuzzo	NNP	PERSON	Cappuzzo	nsubj	5	SENT_338	[p24l140t164r568b258],
2	et	FW	O	et	nn	3	SENT_338	[p24l603t175r681b236],
3	al.	FW	O	al.	dep	1	SENT_338	[p24l708t154r893b236],
4	22	CD	NUMBER	22	dep	1	SENT_338	[p24l708t154r893b236],
5	reported	VBD	O	report	_	0	SENT_338	[p24l926t158r1292b258],
6	that	IN	O	that	complm	16	SENT_338	[p24l1325t159r1495b236],
7	only	RB	O	only	advmod	9	SENT_338	[p24l1524t159r1708b258],
8	the	DT	O	the	det	9	SENT_338	[p24l1737t159r1868b236],
9	number	NN	O	number	nsubj	16	SENT_338	[p24l1902t184r2133b237, p24l12t286r151b365],
10	of	IN	O	of	_	0	SENT_338	[p24l181t286r283b365],
11	copies	NNS	O	copy	prep_of	9	SENT_338	[p24l297t287r570b387],
12	of	IN	O	of	_	0	SENT_338	[p24l604t286r706b365],
13	EGFR	NN	ORGANIZATION	egfr	prep_of	11	SENT_338	[p24l718t293r935b366],
14	was	VBD	O	be	cop	16	SENT_338	[p24l956t313r1120b366],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_338	[p24l1156t286r1697b387],
16	related	JJ	O	related	ccomp	5	SENT_338	[p24l1724t287r2019b365],
17	to	TO	O	to	_	0	SENT_338	[p24l2051t303r2132b365],
18	survival	NN	O	survival	prep_to	16	SENT_338	[p24l13t415r340b494],
19	in	IN	O	in	_	0	SENT_338	[p24l369t415r452b492],
20	a	DT	O	a	det	22	SENT_338	[p24l481t441r526b493],
21	multivariate	JJ	O	multivariate	amod	22	SENT_338	[p24l554t415r1068b494],
22	analysis	NN	O	analysis	prep_in	16	SENT_338	[p24l1097t414r1435b515],
23	of	IN	O	of	_	0	SENT_338	[p24l1467t414r1569b493],
24	patients	NNS	O	patient	prep_of	22	SENT_338	[p24l1578t415r1920b515],
25	who	WP	O	who	nsubjpass	27	SENT_338	[p24l1947t414r2133b494],
26	were	VBD	O	be	auxpass	27	SENT_338	[p24l7t569r212b622],
27	treated	VBN	O	treat	rcmod	24	SENT_338	[p24l238t543r533b621],
28	with	IN	O	with	_	0	SENT_338	[p24l554t543r747b622],
29	geﬁtinib	NN	O	geﬁtinib	prep_with	27	SENT_338	[p24l772t542r1161b643],
30	.	.	O	.	_	0	SENT_338	[p24l772t542r1161b643],

1	In	IN	O	in	_	0	SENT_339	[p24l1191t550r1279b620],
2	our	PRP$	O	we	poss	3	SENT_339	[p24l1306t568r1452b622],
3	study	NN	O	study	pobj	1	SENT_339	[p24l1476t542r1719b643],
4	,	,	O	,	_	0	SENT_339	[p24l1476t542r1719b643],
5	however	RB	O	however	advmod	3	SENT_339	[p24l1750t543r2129b638],
6	,	,	O	,	_	0	SENT_339	[p24l1750t543r2129b638],

1	142	CD	NUMBER	142	num	3	SENT_340	[p24l149t718r205b739],
2	N	NN	O	n	nn	3	SENT_340	[p24l918t720r932b735],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_340	[p24l947t719r1031b741],
4	MED	VBD	O	med	_	0	SENT_340	[p24l1046t720r1099b735],
5	35	CD	NUMBER	35	number	6	SENT_340	[p24l1111t719r1136b741],
6	:2	CD	NUMBER	:2	dobj	4	SENT_340	[p24l1155t719r1175b739],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_340	[p24l1210t719r1421b741],
8	JULY	NNP	DATE	JULY	dep	6	SENT_340	[p24l1455t720r1515b741],
9	14	CD	DATE	14	num	8	SENT_340	[p24l1527t719r1562b741],
10	,	,	DATE	,	_	0	SENT_340	[p24l1527t719r1562b741],
11	2005	CD	DATE	2005	num	8	SENT_340	[p24l1575t719r1638b741],

1	The	DT	O	the	det	4	SENT_341	[p24l935t752r986b776],
2	New	NNP	O	New	nn	4	SENT_341	[p24l995t753r1057b776],
3	Englan	NNP	O	Englan	nn	4	SENT_341	[p24l1066t752r1160b783],
4	oumal	NN	O	oumal	_	0	SENT_341	[p24l1200t752r1283b776],
5	of	IN	O	of	_	0	SENT_341	[p24l1293t752r1322b776],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_341	[p24l1329t752r1454b776],

1	Downloaded	VBN	O	download	_	0	SENT_342	[p24l377t793r547b816],
2	from	IN	O	from	_	0	SENT_342	[p24l556t793r620b816],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_342	[p24l629t793r747b823],
4	at	IN	O	at	_	0	SENT_342	[p24l758t797r781b816],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_342	[p24l789t793r972b816],
6	on	IN	O	on	_	0	SENT_342	[p24l981t800r1014b816],
7	January	NNP	DATE	January	prep_on	1	SENT_342	[p24l1022t793r1125b823],
8	5	CD	DATE	5	num	7	SENT_342	[p24l1135t793r1158b820],
9	,	,	DATE	,	_	0	SENT_342	[p24l1135t793r1158b820],
10	2014	CD	DATE	2014	num	7	SENT_342	[p24l1168t793r1241b816],
11	.	.	O	.	_	0	SENT_342	[p24l1168t793r1241b816],

1	For	IN	O	for	_	0	SENT_343	[p24l1251t793r1298b816],
2	personal	JJ	O	personal	amod	3	SENT_343	[p24l1306t793r1418b823],
3	use	NN	O	use	pobj	1	SENT_343	[p24l1427t800r1471b816],
4	only	RB	O	only	advmod	3	SENT_343	[p24l1481t793r1545b823],
5	.	.	O	.	_	0	SENT_343	[p24l1481t793r1545b823],

1	No	DT	O	no	det	3	SENT_344	[p24l1556t793r1596b816],
2	other	JJ	O	other	amod	3	SENT_344	[p24l1606t793r1674b816],
3	uses	NNS	O	use	_	0	SENT_344	[p24l1682t800r1738b816],
4	without	IN	O	without	_	0	SENT_344	[p24l1748t793r1849b816],
5	permission	NN	O	permission	prep_without	3	SENT_344	[p24l1858t793r2010b823],
6	.	.	O	.	_	0	SENT_344	[p24l1858t793r2010b823],

1	ERLOTINIB	JJ	O	erlotinib	amod	2	SENT_345	[p24l736t940r923b959],
2	THERAPY	NN	O	therapy	_	0	SENT_345	[p24l936t940r1089b959],
3	FOR	IN	O	for	_	0	SENT_345	[p24l1102t940r1167b959],
4	LUNG	NN	O	lung	prep_for	2	SENT_345	[p24l1180t940r1274b959],
5	CANCER	NNP	O	CANCER	dep	2	SENT_345	[p24l1288t940r1424b959],

1	the	DT	O	the	det	2	SENT_346	[p24l12t1154r143b1233],
2	number	NN	O	number	nsubj	12	SENT_346	[p24l169t1155r508b1234],
3	of	IN	O	of	_	0	SENT_346	[p24l532t1154r632b1233],
4	copies	NNS	O	copy	prep_of	2	SENT_346	[p24l641t1155r907b1255],
5	of	IN	O	of	_	0	SENT_346	[p24l937t1154r1038b1233],
6	EGFR	NN	ORGANIZATION	egfr	prep_of	4	SENT_346	[p24l1043t1161r1257b1234],
7	was	VBD	O	be	cop	12	SENT_346	[p24l1272t1181r1434b1234],
8	not	RB	O	not	neg	12	SENT_346	[p24l1463t1171r1607b1233],
9	a	DT	O	a	det	12	SENT_346	[p24l1628t1181r1672b1233],
10	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_346	[p24l1698t1154r2152b1255],
11	prognostic	JJ	O	prognostic	amod	12	SENT_346	[p24l10t1283r479b1383],
12	factor	NN	O	factor	_	0	SENT_346	[p24l506t1282r758b1361],
13	in	IN	O	in	_	0	SENT_346	[p24l781t1283r862b1360],
14	multivariate	JJ	O	multivariate	amod	15	SENT_346	[p24l887t1283r1393b1362],
15	analysis	NN	O	analysis	prep_in	12	SENT_346	[p24l1418t1283r1776b1383],
16	.	.	O	.	_	0	SENT_346	[p24l1418t1283r1776b1383],

1	The	DT	O	the	det	2	SENT_347	[p24l138t1411r303b1489],
2	view	NN	O	view	nsubjpass	26	SENT_347	[p24l337t1411r536b1490],
3	that	IN	O	that	complm	12	SENT_347	[p24l570t1410r742b1489],
4	patients	NNS	O	patient	nsubj	22	SENT_347	[p24l774t1411r1121b1511],
5	with	IN	O	with	_	0	SENT_347	[p24l1157t1410r1352b1490],
6	wild	JJ	O	wild	amod	9	SENT_347	[p24l1385t1410r1794b1511],
7	—	NN	O	—	nn	9	SENT_347	[p24l1385t1410r1794b1511],
8	type	NN	O	type	nn	9	SENT_347	[p24l1385t1410r1794b1511],
9	tumors	NNS	O	tumor	prep_with	4	SENT_347	[p24l1833t1427r2143b1490],
10	would	MD	O	would	aux	12	SENT_347	[p24l7t1539r281b1618],
11	not	RB	O	not	neg	12	SENT_347	[p24l320t1555r468b1617],
12	beneﬁt	VB	O	beneﬁt	dep	2	SENT_347	[p24l503t1538r802b1617],
13	from	IN	O	from	_	0	SENT_347	[p24l833t1538r1042b1617],
14	treatment	NN	O	treatment	prep_from	12	SENT_347	[p24l1078t1555r1495b1617],
15	with	IN	O	with	_	0	SENT_347	[p24l1521t1539r1711b1618],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_347	[p24l1746t1544r2006b1622],
17	inhibitors	NNS	O	inhibitor	prep_with	12	SENT_347	[p24l2031t1539r2145b1616, p24l12t1666r341b1745],
18	and	CC	O	and	_	0	SENT_347	[p24l379t1666r535b1745],
19	thus	RB	O	thus	advmod	22	SENT_347	[p24l571t1667r752b1746],
20	should	MD	O	should	aux	22	SENT_347	[p24l791t1667r1081b1746],
21	not	RB	O	not	neg	22	SENT_347	[p24l1116t1683r1261b1745],
22	receive	VB	O	receive	dep	2	SENT_347	[p24l1291t1667r1579b1746],
23	these	DT	O	these	det	24	SENT_347	[p24l1615t1667r1834b1745],
24	agents	NNS	O	agent	dobj	22	SENT_347	[p24l1870t1683r2144b1767],
25	was	VBD	O	be	auxpass	26	SENT_347	[p24l7t1821r169b1874],
26	reinforced	VBN	O	reinforce	_	0	SENT_347	[p24l207t1794r645b1873],
27	by	IN	O	by	_	0	SENT_347	[p24l681t1795r778b1895],
28	reports	NNS	O	report	agent	26	SENT_347	[p24l810t1811r1110b1895],
29	that	IN	O	that	complm	38	SENT_347	[p24l1148t1795r1316b1873],
30	patients	NNS	O	patient	dep	38	SENT_347	[p24l1345t1795r1681b1895],
31	with	IN	O	with	_	0	SENT_347	[p24l1716t1794r1906b1874],
32	EGFR	NN	ORGANIZATION	egfr	nn	33	SENT_347	[p24l1939t1801r2153b1874],
33	mutations	NNS	O	mutation	prep_with	30	SENT_347	[p24l12t1923r444b2002],
34	in	IN	O	in	_	0	SENT_347	[p24l470t1923r551b2000],
35	their	PRP$	O	they	poss	37	SENT_347	[p24l575t1923r774b2001],
36	tumor	NN	O	tumor	nn	37	SENT_347	[p24l795t1939r1059b2002],
37	cells	NNS	O	cell	prep_in	30	SENT_347	[p24l1080t1922r1264b2001],
38	survived	VBD	O	survive	dep	28	SENT_347	[p24l1291t1922r1637b2002],
39	longer	JJR	O	longer	advmod	38	SENT_347	[p24l1659t1923r1937b2023],
40	than	IN	O	than	_	0	SENT_347	[p24l1958t1922r2147b2001],
41	patients	NNS	O	patient	prep_than	39	SENT_347	[p24l11t2052r347b2152],
42	without	IN	O	without	_	0	SENT_347	[p24l376t2051r713b2131],
43	such	JJ	O	such	amod	44	SENT_347	[p24l741t2051r936b2131],
44	mutations	NNS	O	mutation	prep_without	41	SENT_347	[p24l968t2044r1721b2131],
45	.26	CD	NUMBER	.26	num	46	SENT_347	[p24l968t2044r1721b2131],
46	’	CD	NUMBER	’	dobj	38	SENT_347	[p24l968t2044r1721b2131],
47	28	CD	NUMBER	28	num	50	SENT_347	[p24l968t2044r1721b2131],
48	’	NN	O	’	nn	50	SENT_347	[p24l968t2044r1721b2131],
49	3	CD	NUMBER	3	num	50	SENT_347	[p24l968t2044r1721b2131],
50	°	NN	O	°	nsubj	38	SENT_347	[p24l968t2044r1721b2131],
51	However	RB	O	however	advmod	26	SENT_347	[p24l1747t2058r2140b2147],
52	,	,	O	,	_	0	SENT_347	[p24l1747t2058r2140b2147],
53	none	NN	O	none	nsubj	57	SENT_347	[p24l12t2205r226b2258],
54	of	IN	O	of	_	0	SENT_347	[p24l260t2179r362b2258],
55	these	DT	O	these	det	56	SENT_347	[p24l376t2180r600b2258],
56	studies	NNS	O	study	prep_of	53	SENT_347	[p24l634t2180r936b2259],
57	included	VBD	O	include	ccomp	26	SENT_347	[p24l969t2179r1344b2259],
58	an	DT	O	a	det	61	SENT_347	[p24l1376t2205r1478b2258],
59	untreated	JJ	O	untreated	amod	61	SENT_347	[p24l1511t2180r1923b2259],
60	control	NN	O	control	nn	61	SENT_347	[p24l1956t2205r2144b2258, p24l12t2308r162b2386],
61	group	NN	O	group	dobj	57	SENT_347	[p24l187t2333r470b2408],
62	,	,	O	,	_	0	SENT_347	[p24l187t2333r470b2408],
63	and	CC	O	and	_	0	SENT_347	[p24l499t2307r654b2386],
64	thus	RB	O	thus	advmod	68	SENT_347	[p24l676t2308r879b2403],
65	,	,	O	,	_	0	SENT_347	[p24l676t2308r879b2403],
66	they	PRP	O	they	nsubj	68	SENT_347	[p24l907t2308r1082b2408],
67	were	VBD	O	be	cop	68	SENT_347	[p24l1095t2334r1295b2387],
68	unable	JJ	O	unable	conj_and	26	SENT_347	[p24l1318t2307r1598b2387],
69	to	TO	O	to	aux	70	SENT_347	[p24l1621t2324r1699b2386],
70	determine	VB	O	determine	xcomp	68	SENT_347	[p24l1724t2307r2147b2386],
71	whether	IN	O	whether	complm	75	SENT_347	[p24l7t2435r356b2515],
72	this	DT	O	this	det	73	SENT_347	[p24l377t2436r530b2514],
73	ﬁnding	NN	O	ﬁnding	nsubj	75	SENT_347	[p24l557t2435r870b2536],
74	was	VBD	O	be	cop	75	SENT_347	[p24l887t2462r1048b2515],
75	due	JJ	O	due	ccomp	70	SENT_347	[p24l1076t2436r1227b2515],
76	to	TO	O	to	_	0	SENT_347	[p24l1252t2452r1331b2514],
77	a	DT	O	a	det	79	SENT_347	[p24l1357t2462r1401b2514],
78	differential	JJ	O	differential	amod	79	SENT_347	[p24l1425t2435r1892b2514],
79	effect	NN	O	effect	prep_to	75	SENT_347	[p24l1917t2435r2152b2514],
80	of	IN	O	of	_	0	SENT_347	[p24l12t2563r114b2642],
81	treatment	NN	O	treatment	prep_of	79	SENT_347	[p24l128t2580r550b2642],
82	on	IN	O	on	_	0	SENT_347	[p24l580t2589r689b2642],
83	tumors	NNS	O	tumor	prep_on	75	SENT_347	[p24l724t2580r1033b2643],
84	with	IN	O	with	_	0	SENT_347	[p24l1065t2563r1258b2643],
85	mutations	NNS	O	mutation	prep_with	83	SENT_347	[p24l1293t2564r1735b2643],
86	or	CC	O	or	_	0	SENT_347	[p24l1773t2589r1864b2642],
87	to	TO	O	to	_	0	SENT_347	[p24l1896t2580r1977b2642],
88	the	DT	O	the	det	90	SENT_347	[p24l2014t2564r2145b2642],
89	indolent	JJ	O	indolent	amod	90	SENT_347	[p24l11t2691r383b2770],
90	behavior	NN	O	behavior	prep_to	75	SENT_347	[p24l411t2691r790b2771],
91	of	IN	O	of	_	0	SENT_347	[p24l821t2691r924b2770],
92	tumors	NNS	O	tumor	prep_of	90	SENT_347	[p24l939t2708r1249b2771],
93	with	IN	O	with	_	0	SENT_347	[p24l1280t2692r1475b2771],
94	mutations	NNS	O	mutation	prep_with	92	SENT_347	[p24l1508t2692r1982b2771],
95	.	.	O	.	_	0	SENT_347	[p24l1508t2692r1982b2771],

1	Although	IN	O	although	mark	3	SENT_348	[p24l2017t2692r2144b2769, p24l12t2819r316b2920],
2	there	EX	O	there	expl	3	SENT_348	[p24l347t2820r557b2898],
3	was	VBD	O	be	advcl	36	SENT_348	[p24l583t2846r742b2899],
4	a	DT	O	a	det	6	SENT_348	[p24l774t2846r819b2898],
5	higher	JJR	O	higher	amod	6	SENT_348	[p24l847t2820r1123b2920],
6	rate	NN	O	rate	nsubj	3	SENT_348	[p24l1150t2836r1305b2898],
7	of	IN	O	of	_	0	SENT_348	[p24l1336t2819r1436b2898],
8	response	NN	O	response	prep_of	6	SENT_348	[p24l1447t2845r1822b2920],
9	among	IN	O	among	_	0	SENT_348	[p24l1852t2845r2149b2920],
10	the	DT	O	the	det	12	SENT_348	[p24l12t2947r144b3026],
11	small	JJ	O	small	amod	12	SENT_348	[p24l175t2947r408b3026],
12	number	NN	O	number	prep_among	8	SENT_348	[p24l436t2948r780b3027],
13	of	IN	O	of	_	0	SENT_348	[p24l806t2947r908b3026],
14	patients	NNS	O	patient	prep_of	12	SENT_348	[p24l917t2948r1255b3048],
15	with	IN	O	with	_	0	SENT_348	[p24l1279t2948r1470b3027],
16	mutations	NNS	O	mutation	prep_with	14	SENT_348	[p24l1496t2948r1929b3027],
17	than	IN	O	than	dep	3	SENT_348	[p24l1958t2947r2147b3026],
18	among	IN	O	among	_	0	SENT_348	[p24l11t3101r312b3176],
19	those	DT	O	those	prep_among	3	SENT_348	[p24l338t3076r566b3154],
20	with	IN	O	with	_	0	SENT_348	[p24l590t3076r780b3155],
21	wild	JJ	O	wild	amod	24	SENT_348	[p24l804t3075r1200b3176],
22	—	NN	O	—	nn	24	SENT_348	[p24l804t3075r1200b3176],
23	type	NN	O	type	nn	24	SENT_348	[p24l804t3075r1200b3176],
24	EGFR	NN	ORGANIZATION	egfr	prep_with	19	SENT_348	[p24l1226t3082r1440b3155],
25	in	IN	O	in	_	0	SENT_348	[p24l1462t3076r1543b3153],
26	our	PRP$	O	we	poss	27	SENT_348	[p24l1572t3101r1717b3155],
27	study	NN	O	study	prep_in	24	SENT_348	[p24l1744t3076r1982b3176],
28	,	,	O	,	_	0	SENT_348	[p24l1744t3076r1982b3176],
29	the	DT	O	the	det	30	SENT_348	[p24l2017t3076r2146b3154],
30	presence	NN	O	presence	nsubjpass	36	SENT_348	[p24l11t3229r392b3304],
31	of	IN	O	of	_	0	SENT_348	[p24l435t3203r536b3282],
32	a	DT	O	a	det	33	SENT_348	[p24l558t3230r603b3282],
33	mutation	NN	O	mutation	prep_of	30	SENT_348	[p24l642t3204r1042b3283],
34	was	VBD	O	be	auxpass	36	SENT_348	[p24l1078t3230r1242b3283],
35	not	RB	O	not	neg	36	SENT_348	[p24l1285t3220r1432b3282],
36	associated	VBN	O	associate	_	0	SENT_348	[p24l1467t3204r1916b3282],
37	with	IN	O	with	_	0	SENT_348	[p24l1952t3204r2146b3283],
38	the	DT	O	the	det	40	SENT_348	[p24l12t3331r144b3410],
39	survival	NN	O	survival	nn	40	SENT_348	[p24l169t3332r495b3411],
40	beneﬁt	NN	O	beneﬁt	prep_with	36	SENT_348	[p24l517t3331r815b3410],
41	of	IN	O	of	_	0	SENT_348	[p24l831t3331r933b3410],
42	erlotinib	NN	O	erlotinib	nn	43	SENT_348	[p24l935t3332r1296b3410],
43	therapy	NN	O	therapy	prep_of	40	SENT_348	[p24l1319t3332r1649b3432],
44	.	.	O	.	_	0	SENT_348	[p24l1319t3332r1649b3432],

1	The	DT	O	the	det	2	SENT_349	[p24l1672t3331r1834b3410],
2	beneﬁt	NN	O	beneﬁt	_	0	SENT_349	[p24l1856t3331r2153b3410],
3	from	IN	O	from	_	0	SENT_349	[p24l12t3459r217b3538],
4	erlotinib	NN	O	erlotinib	prep_from	2	SENT_349	[p24l253t3459r631b3555],
5	,	,	O	,	_	0	SENT_349	[p24l253t3459r631b3555],
6	as	IN	O	as	_	0	SENT_349	[p24l671t3486r755b3538],
7	compared	VBN	O	compare	conj_as	2	SENT_349	[p24l794t3459r1212b3560],
8	with	IN	O	with	_	0	SENT_349	[p24l1243t3460r1431b3539],
9	placebo	NN	O	placebo	prep_with	7	SENT_349	[p24l1465t3460r1812b3560],
10	,	,	O	,	_	0	SENT_349	[p24l1465t3460r1812b3560],
11	among	IN	O	among	_	0	SENT_349	[p24l1853t3485r2151b3560],
12	patients	NNS	O	patient	prep_among	7	SENT_349	[p24l11t3588r342b3688],
13	with	IN	O	with	_	0	SENT_349	[p24l361t3587r548b3667],
14	wild	JJ	O	wild	amod	20	SENT_349	[p24l564t3587r954b3688],
15	—	NN	O	—	nn	20	SENT_349	[p24l564t3587r954b3688],
16	type	NN	O	type	nn	20	SENT_349	[p24l564t3587r954b3688],
17	EGFR	NN	ORGANIZATION	egfr	nn	20	SENT_349	[p24l973t3594r1183b3667],
18	(	CD	NUMBER	(	num	20	SENT_349	[p24l1203t3588r1517b3679],
19	hazard	NN	O	hazard	nn	20	SENT_349	[p24l1203t3588r1517b3679],
20	ratio	NN	O	ratio	prep_with	12	SENT_349	[p24l1537t3588r1727b3666],
21	for	IN	O	for	_	0	SENT_349	[p24l1749t3587r1871b3666],
22	death	NN	O	death	prep_for	20	SENT_349	[p24l1890t3588r2142b3683],
23	,	,	O	,	_	0	SENT_349	[p24l1890t3588r2142b3683],

1	REFERENCES	NNS	O	reference	_	0	SENT_350	[p25l15t129r487b170],

1	1	LS	NUMBER	1	_	0	SENT_351	[p25l9t228r45b267],
2	.	.	O	.	_	0	SENT_351	[p25l9t228r45b267],

1	Salomon	NNP	ORGANIZATION	Salomon	nn	2	SENT_352	[p25l104t223r315b267],
2	D	NNP	ORGANIZATION	D	_	0	SENT_352	[p25l330t227r380b276],
3	,	,	O	,	_	0	SENT_352	[p25l330t227r380b276],
4	Gullick	NNP	PERSON	Gullick	nn	8	SENT_352	[p25l399t223r575b268],
5	W.	NNP	O	W.	nn	8	SENT_352	[p25l587t227r645b267],
6	The	NNP	O	The	nn	8	SENT_352	[p25l663t223r753b267],
7	erbB	NN	O	erbb	nn	8	SENT_352	[p25l770t223r878b267],
8	family	NN	O	family	appos	2	SENT_352	[p25l895t222r1044b279],
9	of	IN	O	of	_	0	SENT_352	[p25l7t293r64b338],
10	receptors	NNS	O	receptor	prep_of	8	SENT_352	[p25l70t303r289b350],
11	and	CC	O	and	_	0	SENT_352	[p25l307t294r394b338],
12	their	PRP$	O	they	poss	13	SENT_352	[p25l411t294r522b338],
13	ligands	NNS	O	ligand	prep_of	8	SENT_352	[p25l537t294r725b350],
14	:	:	O	:	_	0	SENT_352	[p25l537t294r725b350],
15	multiple	JJ	O	multiple	amod	16	SENT_352	[p25l744t294r942b350],
16	targets	NNS	O	target	dep	2	SENT_352	[p25l960t303r1041b338, p25l7t374r101b421],
17	for	IN	O	for	_	0	SENT_352	[p25l116t364r186b409],
18	therapy	NN	O	therapy	prep_for	16	SENT_352	[p25l198t365r382b421],
19	.	.	O	.	_	0	SENT_352	[p25l198t365r382b421],

1	Signal	NN	O	signal	_	0	SENT_353	[p25l400t365r546b421],
2	2001	CD	DATE	2001	num	1	SENT_353	[p25l560t368r860b418],
3	;	:	O	;	_	0	SENT_353	[p25l560t368r860b418],
4	2:4	CD	NUMBER	2:4	number	5	SENT_353	[p25l560t368r860b418],
5	—	CD	NUMBER	—	dep	1	SENT_353	[p25l560t368r860b418],
6	11	CD	NUMBER	11	dep	5	SENT_353	[p25l560t368r860b418],
7	.	.	O	.	_	0	SENT_353	[p25l560t368r860b418],

1	2	LS	NUMBER	2	_	0	SENT_354	[p25l6t441r45b480],
2	.	.	O	.	_	0	SENT_354	[p25l6t441r45b480],

1	Schlessinger	NNP	PERSON	Schlessinger	nn	2	SENT_355	[p25l104t436r405b492],
2	J.	NNP	PERSON	J.	_	0	SENT_355	[p25l422t440r455b487],
3	Ligand-induced	JJ	PERSON	ligand-induced	amod	6	SENT_355	[p25l481t436r869b492],
4	,	,	O	,	_	0	SENT_355	[p25l481t436r869b492],
5	receptor-mediated	JJ	O	receptor-mediated	amod	6	SENT_355	[p25l896t450r1042b492, p25l7t507r315b550],
6	dimerization	NN	O	dimerization	dep	2	SENT_355	[p25l330t507r635b550],
7	and	CC	O	and	_	0	SENT_355	[p25l649t507r737b550],
8	activation	NN	O	activation	dep	2	SENT_355	[p25l752t507r981b551],
9	of	IN	O	of	_	0	SENT_355	[p25l996t506r1053b550],
10	EGF	NN	ORGANIZATION	egf	nn	11	SENT_355	[p25l6t581r108b622],
11	receptor	NN	O	receptor	prep_of	6	SENT_355	[p25l123t587r329b634],
12	.	.	O	.	_	0	SENT_355	[p25l123t587r329b634],

1	Cell	NN	O	cell	_	0	SENT_356	[p25l346t578r437b622],
2	2002	CD	DATE	2002	num	1	SENT_356	[p25l451t581r870b631],
3	;	:	O	;	_	0	SENT_356	[p25l451t581r870b631],
4	110:669	CD	NUMBER	110:669	number	5	SENT_356	[p25l451t581r870b631],
5	-72	CD	NUMBER	-72	dep	1	SENT_356	[p25l451t581r870b631],
6	.	.	O	.	_	0	SENT_356	[p25l451t581r870b631],

1	3	LS	NUMBER	3	_	0	SENT_357	[p25l7t654r45b693],
2	.	.	O	.	_	0	SENT_357	[p25l7t654r45b693],

1	Arteaga	NNP	O	Arteaga	_	0	SENT_358	[p25l101t653r292b705],
2	CL	NN	O	cl	dep	1	SENT_358	[p25l328t652r407b693],
3	.	.	O	.	_	0	SENT_358	[p25l328t652r407b693],

1	Overview	NN	O	overview	_	0	SENT_359	[p25l447t649r674b694],
2	of	IN	O	of	_	0	SENT_359	[p25l708t648r766b693],
3	epidermal	JJ	O	epidermal	amod	7	SENT_359	[p25l793t649r1041b705],
4	growth	NN	O	growth	nn	7	SENT_359	[p25l7t720r171b776],
5	factor	NN	O	factor	nn	7	SENT_359	[p25l181t719r319b764],
6	receptor	NN	O	receptor	nn	7	SENT_359	[p25l331t729r528b776],
7	biology	NN	O	biology	prep_of	1	SENT_359	[p25l539t720r716b776],
8	and	CC	O	and	_	0	SENT_359	[p25l725t720r813b764],
9	its	PRP$	O	its	poss	10	SENT_359	[p25l824t720r878b764],
10	role	NN	O	role	prep_of	1	SENT_359	[p25l892t720r982b764],
11	as	IN	O	as	_	0	SENT_359	[p25l994t734r1041b764],
12	a	DT	O	a	det	14	SENT_359	[p25l7t805r31b835],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_359	[p25l58t791r331b847],
14	target	NN	O	target	prep_as	1	SENT_359	[p25l357t800r500b847],
15	in	IN	O	in	_	0	SENT_359	[p25l523t791r570b834],
16	human	JJ	O	human	amod	17	SENT_359	[p25l597t791r767b835],
17	neoplasia	NN	O	neoplasium	prep_in	14	SENT_359	[p25l794t791r1038b847],
18	.	.	O	.	_	0	SENT_359	[p25l794t791r1038b847],

1	Semin	NNP	O	Semin	nn	2	SENT_360	[p25l8t862r159b906],
2	Oncol	NNP	O	Oncol	_	0	SENT_360	[p25l174t862r317b906],
3	2002	CD	DATE	2002	num	5	SENT_360	[p25l331t862r678b918],
4	;	:	O	;	_	0	SENT_360	[p25l331t862r678b918],
5	29	CD	NUMBER	29	dep	2	SENT_360	[p25l331t862r678b918],
6	:	:	O	:	_	0	SENT_360	[p25l331t862r678b918],
7	Suppl	NNP	O	Suppl	dep	2	SENT_360	[p25l331t862r678b918],
8	14:3	CD	NUMBER	14:3	num	7	SENT_360	[p25l694t865r857b906],
9	-9	CD	NUMBER	-9	dep	7	SENT_360	[p25l694t865r857b906],
10	.	.	O	.	_	0	SENT_360	[p25l694t865r857b906],

1	4	LS	NUMBER	4	_	0	SENT_361	[p25l6t938r45b977],
2	.	.	O	.	_	0	SENT_361	[p25l6t938r45b977],

1	Herbst	NNP	ORGANIZATION	Herbst	nn	2	SENT_362	[p25l103t933r271b977],
2	RS	NN	ORGANIZATION	r	_	0	SENT_362	[p25l291t936r370b986],
3	,	,	O	,	_	0	SENT_362	[p25l291t936r370b986],
4	Bunn	NNP	PERSON	Bunn	nn	6	SENT_362	[p25l396t937r526b977],
5	PA	NN	O	pa	nn	6	SENT_362	[p25l549t937r613b976],
6	Jr.	NNP	O	Jr.	appos	2	SENT_362	[p25l629t937r683b984],
7	.	.	O	.	_	0	SENT_362	[p25l629t937r683b984],

1	Targeting	NN	O	targeting	_	0	SENT_363	[p25l707t933r945b989],
2	the	DT	O	the	det	6	SENT_363	[p25l966t933r1041b977],
3	epidermal	JJ	O	epidermal	amod	6	SENT_363	[p25l7t1004r251b1060],
4	growth	NN	O	growth	nn	6	SENT_363	[p25l274t1004r448b1060],
5	factor	NN	O	factor	nn	6	SENT_363	[p25l471t1003r613b1048],
6	receptor	NN	O	receptor	dep	1	SENT_363	[p25l635t1013r836b1060],
7	in	IN	O	in	_	0	SENT_363	[p25l858t1004r904b1047],
8	nonsmall	JJ	O	nonsmall	amod	11	SENT_363	[p25l928t1018r1041b1048, p25l8t1075r135b1119],
9	cell	NN	O	cell	nn	11	SENT_363	[p25l148t1075r225b1119],
10	lung	NN	O	lung	nn	11	SENT_363	[p25l237t1075r345b1131],
11	cancer	NN	O	cancer	prep_in	6	SENT_363	[p25l356t1089r517b1119],
12	.	.	O	.	_	0	SENT_363	[p25l356t1089r517b1119],

1	Clin	NNP	O	Clin	nn	3	SENT_364	[p25l532t1075r628b1119],
2	Cancer	NNP	O	Cancer	nn	3	SENT_364	[p25l641t1078r805b1119],
3	Res	NNP	O	Res	_	0	SENT_364	[p25l815t1079r898b1122],
4	2003	CD	DATE	2003	num	3	SENT_364	[p25l912t1078r1040b1128],
5	;	:	O	;	_	0	SENT_364	[p25l912t1078r1040b1128],
6	9:5813	CD	NUMBER	9:5813	number	7	SENT_364	[p25l7t1149r259b1190],
7	-24	CD	NUMBER	-24	dep	3	SENT_364	[p25l7t1149r259b1190],
8	.	.	O	.	_	0	SENT_364	[p25l7t1149r259b1190],

1	5	CD	NUMBER	5	_	0	SENT_365	[p25l8t1222r45b1261],
2	.	.	O	.	_	0	SENT_365	[p25l8t1222r45b1261],

1	Nicholson	NNP	PERSON	Nicholson	nn	2	SENT_366	[p25l102t1217r350b1261],
2	R1	NNP	O	R1	_	0	SENT_366	[p25l378t1221r445b1270],
3	,	,	O	,	_	0	SENT_366	[p25l378t1221r445b1270],
4	Gee	NNP	O	Gee	nn	5	SENT_366	[p25l477t1220r568b1261],
5	JMVV	NNP	O	JMVV	appos	2	SENT_366	[p25l592t1221r720b1270],
6	,	,	O	,	_	0	SENT_366	[p25l592t1221r720b1270],
7	Harper	NNP	PERSON	Harper	nn	8	SENT_366	[p25l751t1221r920b1273],
8	ME	NNP	O	ME	appos	5	SENT_366	[p25l946t1221r1039b1261],
9	.	.	O	.	_	0	SENT_366	[p25l946t1221r1039b1261],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_367	[p25l6t1291r152b1335],
2	and	CC	O	and	_	0	SENT_367	[p25l169t1288r257b1332],
3	cancer	NN	O	cancer	conj_and	1	SENT_367	[p25l281t1302r435b1332],
4	prognosis	NN	O	prognosis	dep	1	SENT_367	[p25l456t1288r708b1344],
5	.	.	O	.	_	0	SENT_367	[p25l456t1288r708b1344],

1	EurJ	NN	O	eurj	nn	2	SENT_368	[p25l734t1292r855b1339],
2	Cancer	NN	O	cancer	_	0	SENT_368	[p25l878t1291r1044b1332],
3	2001	CD	DATE	2001	num	5	SENT_368	[p25l7t1359r354b1415],
4	;	:	O	;	_	0	SENT_368	[p25l7t1359r354b1415],
5	37	CD	NUMBER	37	dep	2	SENT_368	[p25l7t1359r354b1415],
6	:	:	O	:	_	0	SENT_368	[p25l7t1359r354b1415],
7	Suppl	NNP	O	Suppl	dep	2	SENT_368	[p25l7t1359r354b1415],
8	4	CD	NUMBER	4	num	7	SENT_368	[p25l367t1362r592b1403],
9	:	:	O	:	_	0	SENT_368	[p25l367t1362r592b1403],
10	S9-S15	NN	O	s9-s15	dep	7	SENT_368	[p25l367t1362r592b1403],
11	.	.	O	.	_	0	SENT_368	[p25l367t1362r592b1403],

1	6	CD	NUMBER	6	_	0	SENT_369	[p25l7t1435r45b1474],
2	.	.	O	.	_	0	SENT_369	[p25l7t1435r45b1474],

1	Veale	NNP	ORGANIZATION	Veale	nn	2	SENT_370	[p25l101t1430r225b1474],
2	D	NNP	ORGANIZATION	D	_	0	SENT_370	[p25l251t1434r300b1483],
3	,	,	O	,	_	0	SENT_370	[p25l251t1434r300b1483],
4	Kerr	NNP	PERSON	Kerr	nn	5	SENT_370	[p25l329t1434r434b1475],
5	N	NNP	O	N	appos	2	SENT_370	[p25l458t1434r510b1483],
6	,	,	O	,	_	0	SENT_370	[p25l458t1434r510b1483],
7	Gibson	NNP	PERSON	Gibson	nn	8	SENT_370	[p25l539t1430r713b1474],
8	GJ	NNP	O	GJ	appos	2	SENT_370	[p25l739t1433r810b1483],
9	,	,	O	,	_	0	SENT_370	[p25l739t1433r810b1483],
10	Kelly	NNP	PERSON	Kelly	nn	11	SENT_370	[p25l839t1430r958b1486],
11	PJ	NNP	PERSON	PJ	appos	2	SENT_370	[p25l981t1434r1039b1483],
12	,	,	O	,	_	0	SENT_370	[p25l981t1434r1039b1483],
13	Harris	NNP	PERSON	Harris	nn	14	SENT_370	[p25l7t1501r155b1545],
14	AL.	NNP	O	AL.	appos	2	SENT_370	[p25l175t1505r253b1545],
15	.	.	O	.	_	0	SENT_370	[p25l175t1505r253b1545],

1	The	DT	O	the	det	2	SENT_371	[p25l276t1501r367b1545],
2	relationship	NN	O	relationship	_	0	SENT_371	[p25l388t1501r673b1557],
3	of	IN	O	of	_	0	SENT_371	[p25l696t1500r752b1545],
4	quantitative	JJ	O	quantitative	amod	9	SENT_371	[p25l763t1501r1042b1557],
5	epidermal	JJ	O	epidermal	amod	9	SENT_371	[p25l7t1572r244b1628],
6	growth	NN	O	growth	nn	9	SENT_371	[p25l256t1572r425b1628],
7	factor	NN	O	factor	nn	9	SENT_371	[p25l437t1571r574b1616],
8	receptor	NN	O	receptor	nn	9	SENT_371	[p25l585t1581r780b1628],
9	expression	NN	O	expression	prep_of	2	SENT_371	[p25l791t1572r1043b1628],
10	in	IN	O	in	_	0	SENT_371	[p25l7t1643r52b1686],
11	non-small	JJ	O	non-small	amod	14	SENT_371	[p25l73t1643r316b1687],
12	cell	NN	O	cell	nn	14	SENT_371	[p25l337t1643r416b1687],
13	lung	NN	O	lung	nn	14	SENT_371	[p25l436t1643r545b1699],
14	cancer	NN	O	cancer	prep_in	2	SENT_371	[p25l564t1657r719b1687],
15	to	TO	O	to	_	0	SENT_371	[p25l738t1652r783b1687],
16	long	JJ	O	long	amod	18	SENT_371	[p25l804t1643r913b1699],
17	term	NN	O	term	nn	18	SENT_371	[p25l932t1652r1042b1687],
18	survival	NN	O	survival	prep_to	2	SENT_371	[p25l8t1714r199b1758],
19	.	.	O	.	_	0	SENT_371	[p25l8t1714r199b1758],

1	BrJ	NN	O	brj	nn	2	SENT_372	[p25l215t1718r298b1765],
2	Cancer	NN	O	cancer	_	0	SENT_372	[p25l311t1717r477b1758],
3	1993	CD	DATE	1993	dep	2	SENT_372	[p25l491t1717r849b1767],
4	;	:	O	;	_	0	SENT_372	[p25l491t1717r849b1767],
5	68:162	CD	NUMBER	68:162	num	6	SENT_372	[p25l491t1717r849b1767],
6	-5	CD	NUMBER	-5	dep	2	SENT_372	[p25l491t1717r849b1767],
7	.	.	O	.	_	0	SENT_372	[p25l491t1717r849b1767],

1	7	CD	NUMBER	7	_	0	SENT_373	[p25l8t1790r45b1829],
2	.	.	O	.	_	0	SENT_373	[p25l8t1790r45b1829],

1	Rusch	NNP	PERSON	Rusch	nn	2	SENT_374	[p25l102t1785r248b1832],
2	V	NNP	O	V	nsubj	43	SENT_374	[p25l257t1789r296b1838],
3	,	,	O	,	_	0	SENT_374	[p25l257t1789r296b1838],
4	Klimstra	NNP	ORGANIZATION	Klimstra	nn	5	SENT_374	[p25l310t1785r510b1830],
5	D	NNP	ORGANIZATION	D	conj_and	2	SENT_374	[p25l520t1789r569b1838],
6	,	,	O	,	_	0	SENT_374	[p25l520t1789r569b1838],
7	Venkatraman	NNP	PERSON	Venkatraman	nn	8	SENT_374	[p25l581t1785r891b1830],
8	E	NNP	O	E	conj_and	2	SENT_374	[p25l901t1789r944b1838],
9	,	,	O	,	_	0	SENT_374	[p25l901t1789r944b1838],
10	Pisters	NNP	ORGANIZATION	Pisters	nn	11	SENT_374	[p25l957t1785r1042b1829, p25l7t1865r90b1900],
11	PW	NNP	ORGANIZATION	PW	conj_and	2	SENT_374	[p25l108t1860r195b1909],
12	,	,	O	,	_	0	SENT_374	[p25l108t1860r195b1909],
13	Langenfeld	NNP	PERSON	Langenfeld	nn	14	SENT_374	[p25l216t1855r483b1912],
14	J	NNP	PERSON	J	conj_and	2	SENT_374	[p25l497t1860r530b1909],
15	,	,	O	,	_	0	SENT_374	[p25l497t1860r530b1909],
16	Dmitrovsky	NNP	PERSON	Dmitrovsky	nn	18	SENT_374	[p25l553t1856r830b1912],
17	E.	NNP	O	E.	nn	18	SENT_374	[p25l846t1860r890b1900],
18	Overexpression	NN	O	overexpression	nsubj	33	SENT_374	[p25l914t1859r1042b1900, p25l7t1927r262b1983],
19	of	IN	O	of	_	0	SENT_374	[p25l285t1926r342b1971],
20	the	DT	O	the	det	24	SENT_374	[p25l355t1927r427b1971],
21	epidermal	JJ	O	epidermal	amod	24	SENT_374	[p25l451t1927r690b1983],
22	growth	NN	O	growth	nn	24	SENT_374	[p25l712t1927r883b1983],
23	factor	NN	O	factor	nn	24	SENT_374	[p25l906t1926r1044b1971],
24	receptor	NN	O	receptor	prep_of	18	SENT_374	[p25l7t2007r204b2054],
25	and	CC	O	and	_	0	SENT_374	[p25l215t1998r302b2042],
26	its	PRP$	O	its	poss	27	SENT_374	[p25l315t1998r368b2042],
27	ligand	NN	O	ligand	nsubj	33	SENT_374	[p25l382t1998r531b2054],
28	transforming	VBG	O	transform	partmod	2	SENT_374	[p25l544t1997r862b2054],
29	growth	NN	O	growth	nn	30	SENT_374	[p25l872t1998r1042b2054],
30	factor	NN	O	factor	nsubj	31	SENT_374	[p25l7t2068r145b2113],
31	alpha	NN	O	alpha	xcomp	28	SENT_374	[p25l166t2069r297b2125],
32	is	VBZ	O	be	cop	33	SENT_374	[p25l319t2069r355b2113],
33	frequent	JJ	O	frequent	_	0	SENT_374	[p25l379t2068r582b2125],
34	in	IN	O	in	_	0	SENT_374	[p25l602t2069r647b2112],
35	resectable	JJ	O	resectable	amod	39	SENT_374	[p25l670t2069r907b2113],
36	nonsmall	JJ	O	nonsmall	amod	39	SENT_374	[p25l930t2083r1041b2113, p25l8t2140r135b2184],
37	cell	NN	O	cell	nn	39	SENT_374	[p25l155t2140r235b2184],
38	lung	NN	O	lung	nn	39	SENT_374	[p25l254t2140r363b2196],
39	cancer	NN	O	cancer	prep_in	33	SENT_374	[p25l381t2154r536b2184],
40	but	CC	O	but	_	0	SENT_374	[p25l555t2140r634b2184],
41	does	VBZ	O	do	aux	43	SENT_374	[p25l651t2140r759b2184],
42	not	RB	O	not	neg	43	SENT_374	[p25l780t2149r860b2184],
43	predict	VB	O	predict	conj_but	33	SENT_374	[p25l876t2140r1045b2196],
44	tumor	NN	O	tumor	nn	45	SENT_374	[p25l7t2220r155b2255],
45	progression	NN	O	progression	dobj	43	SENT_374	[p25l165t2211r464b2267],
46	.	.	O	.	_	0	SENT_374	[p25l165t2211r464b2267],

1	Clin	NNP	O	Clin	nn	3	SENT_375	[p25l480t2211r577b2255],
2	Cancer	NNP	O	Cancer	nn	3	SENT_375	[p25l590t2214r756b2255],
3	Res	NNP	O	Res	_	0	SENT_375	[p25l766t2215r850b2258],
4	1997	CD	DATE	1997	num	3	SENT_375	[p25l866t2214r1040b2264],
5	;	:	O	;	_	0	SENT_375	[p25l866t2214r1040b2264],
6	3	CD	NUMBER	3	num	8	SENT_375	[p25l866t2214r1040b2264],
7	:	:	O	:	_	0	SENT_375	[p25l866t2214r1040b2264],
8	515-22	CD	NUMBER	515-22	dep	3	SENT_375	[p25l8t2285r185b2326],
9	.	.	O	.	_	0	SENT_375	[p25l8t2285r185b2326],

1	8	CD	NUMBER	8	_	0	SENT_376	[p25l6t2357r45b2397],
2	.	.	O	.	_	0	SENT_376	[p25l6t2357r45b2397],

1	Fontanini	NNP	O	Fontanini	nn	2	SENT_377	[p25l102t2353r335b2397],
2	G	NNP	O	G	_	0	SENT_377	[p25l347t2356r401b2406],
3	,	,	O	,	_	0	SENT_377	[p25l347t2356r401b2406],
4	De	NNP	PERSON	De	nn	6	SENT_377	[p25l416t2357r480b2397],
5	Laurentiis	NNP	PERSON	Laurentiis	nn	6	SENT_377	[p25l492t2353r728b2397],
6	M	NN	PERSON	m	appos	2	SENT_377	[p25l741t2357r802b2406],
7	,	,	O	,	_	0	SENT_377	[p25l741t2357r802b2406],
8	Vignati	NNP	PERSON	Vignati	nn	9	SENT_377	[p25l815t2353r987b2409],
9	S	NNP	O	S	appos	2	SENT_377	[p25l1001t2356r1039b2406],
10	,	,	O	,	_	0	SENT_377	[p25l1001t2356r1039b2406],
11	et	FW	O	et	nn	12	SENT_377	[p25l7t2433r50b2468],
12	al.	FW	O	al.	appos	2	SENT_377	[p25l69t2424r121b2468],
13	.	.	O	.	_	0	SENT_377	[p25l69t2424r121b2468],

1	Evaluation	NN	O	evaluation	nn	20	SENT_378	[p25l145t2424r398b2468],
2	of	IN	O	of	_	0	SENT_378	[p25l421t2423r478b2468],
3	epidermal	JJ	O	epidermal	amod	7	SENT_378	[p25l491t2424r735b2480],
4	growth	NN	O	growth	nn	7	SENT_378	[p25l757t2424r930b2480],
5	factor-related	JJ	O	factor-related	amod	7	SENT_378	[p25l953t2423r1041b2468, p25l7t2495r262b2539],
6	growth	NN	O	growth	nn	7	SENT_378	[p25l297t2495r470b2551],
7	factors	NNS	O	factor	prep_of	1	SENT_378	[p25l506t2494r666b2539],
8	and	CC	O	and	_	0	SENT_378	[p25l701t2495r789b2539],
9	receptors	NNS	O	receptor	prep_of	1	SENT_378	[p25l822t2504r1041b2551],
10	and	CC	O	and	_	0	SENT_378	[p25l7t2566r93b2610],
11	of	IN	O	of	conj_and	1	SENT_378	[p25l105t2565r161b2610],
12	neoangiogenesis	NN	O	neoangiogenesis	pobj	11	SENT_378	[p25l163t2566r555b2622],
13	in	IN	O	in	_	0	SENT_378	[p25l567t2566r612b2609],
14	completely	RB	O	completely	advmod	15	SENT_378	[p25l624t2566r880b2622],
15	resected	JJ	O	resected	amod	17	SENT_378	[p25l889t2575r1042b2610, p25l7t2637r61b2681],
16	stage	NN	O	stage	nn	17	SENT_378	[p25l83t2646r204b2693],
17	I-IIIA	NN	O	i-iium	prep_in	12	SENT_378	[p25l226t2641r355b2680],
18	non-small-cell	JJ	O	non-small-cell	amod	20	SENT_378	[p25l376t2637r721b2681],
19	lung	NN	O	lung	nn	20	SENT_378	[p25l743t2637r852b2693],
20	cancer	NN	O	cancer	_	0	SENT_378	[p25l873t2651r1040b2681],
21	:	:	O	:	_	0	SENT_378	[p25l873t2651r1040b2681],
22	amphiregulin	NN	O	amphiregulin	nn	25	SENT_378	[p25l7t2708r330b2764],
23	and	CC	O	and	_	0	SENT_378	[p25l346t2708r433b2752],
24	microvessel	NN	O	microvessel	nn	25	SENT_378	[p25l449t2708r727b2752],
25	count	NN	O	count	dep	20	SENT_378	[p25l743t2717r879b2752],
26	are	VBP	O	be	cop	29	SENT_378	[p25l892t2722r962b2752],
27	independent	JJ	O	independent	amod	29	SENT_378	[p25l977t2708r1042b2751, p25l7t2779r260b2835],
28	prognostic	JJ	O	prognostic	amod	29	SENT_378	[p25l269t2779r526b2835],
29	indicators	NNS	O	indicator	rcmod	25	SENT_378	[p25l538t2779r774b2823],
30	of	IN	O	of	_	0	SENT_378	[p25l788t2778r845b2823],
31	survival	NN	O	survival	prep_of	29	SENT_378	[p25l848t2779r1039b2824],
32	.	.	O	.	_	0	SENT_378	[p25l848t2779r1039b2824],

1	Clin	NNP	O	Clin	nn	3	SENT_379	[p25l7t2850r104b2894],
2	Cancer	NNP	O	Cancer	nn	3	SENT_379	[p25l118t2853r284b2894],
3	Res	NNP	O	Res	_	0	SENT_379	[p25l296t2854r380b2897],
4	1998	CD	DATE	1998	num	3	SENT_379	[p25l397t2853r725b2903],
5	;	:	O	;	_	0	SENT_379	[p25l397t2853r725b2903],
6	4:241	CD	NUMBER	4:241	number	7	SENT_379	[p25l397t2853r725b2903],
7	-9	CD	NUMBER	-9	dep	3	SENT_379	[p25l397t2853r725b2903],
8	.	.	O	.	_	0	SENT_379	[p25l397t2853r725b2903],

1	9	CD	NUMBER	9	_	0	SENT_380	[p25l7t2926r45b2965],
2	.	.	O	.	_	0	SENT_380	[p25l7t2926r45b2965],

1	Hsieh	NNP	ORGANIZATION	Hsieh	nn	2	SENT_381	[p25l103t2921r245b2965],
2	ET	NNP	ORGANIZATION	ET	_	0	SENT_381	[p25l261t2924r335b2974],
3	,	,	O	,	_	0	SENT_381	[p25l261t2924r335b2974],
4	Shepherd	NNP	ORGANIZATION	Shepherd	nn	5	SENT_381	[p25l357t2921r586b2977],
5	FA	NNP	ORGANIZATION	FA	appos	2	SENT_381	[p25l602t2925r677b2974],
6	,	,	O	,	_	0	SENT_381	[p25l602t2925r677b2974],
7	Tsao	NNP	PERSON	Tsao	nn	8	SENT_381	[p25l695t2924r808b2965],
8	M-S	NNP	O	M-S	appos	5	SENT_381	[p25l824t2924r936b2965],
9	.	.	O	.	_	0	SENT_381	[p25l824t2924r936b2965],

1	Coexpression	NN	O	coexpression	nsubj	12	SENT_382	[p25l956t2924r1041b2965, p25l1117t223r1377b279],
2	of	IN	O	of	_	0	SENT_382	[p25l1420t222r1477b267],
3	epidermal	JJ	O	epidermal	amod	6	SENT_382	[p25l1510t223r1754b279],
4	growth	NN	O	growth	nn	6	SENT_382	[p25l1796t223r1969b279],
5	factor	NN	O	factor	nn	6	SENT_382	[p25l2012t222r2153b267],
6	receptor	NN	O	receptor	prep_of	1	SENT_382	[p25l1117t303r1318b350],
7	and	CC	O	and	_	0	SENT_382	[p25l1330t294r1419b338],
8	transforming	VBG	O	transform	amod	10	SENT_382	[p25l1432t293r1757b350],
9	growth	NN	O	growth	nn	10	SENT_382	[p25l1768t294r1942b350],
10	factor-a	NN	O	factor-a	prep_of	1	SENT_382	[p25l1955t293r2149b338],
11	is	VBZ	O	be	cop	12	SENT_382	[p25l1116t365r1153b409],
12	independent	JJ	O	independent	_	0	SENT_382	[p25l1168t365r1476b421],
13	of	IN	O	of	_	0	SENT_382	[p25l1487t364r1544b409],
14	ras	NN	O	ra	nn	15	SENT_382	[p25l1548t379r1617b409],
15	mutations	NNS	O	mutation	prep_of	12	SENT_382	[p25l1632t365r1878b409],
16	in	IN	O	in	_	0	SENT_382	[p25l1893t365r1939b408],
17	lung	NN	O	lung	nn	18	SENT_382	[p25l1953t365r2064b421],
18	adenocarcinoma	NN	O	adenocarcinoma	prep_in	15	SENT_382	[p25l2075t365r2150b409, p25l1117t436r1475b480],
19	.	.	O	.	_	0	SENT_382	[p25l2075t365r2150b409, p25l1117t436r1475b480],

1	Lung	NN	O	lung	nn	2	SENT_383	[p25l1497t440r1622b492],
2	Cancer	NN	O	cancer	_	0	SENT_383	[p25l1640t439r1810b480],
3	2000	CD	DATE	2000	num	5	SENT_383	[p25l1828t439r2151b489, p25l1117t511r1157b550],
4	;	:	O	;	_	0	SENT_383	[p25l1828t439r2151b489, p25l1117t511r1157b550],
5	29:1517	CD	NUMBER	29:1517	dep	2	SENT_383	[p25l1828t439r2151b489, p25l1117t511r1157b550],
6	.	.	O	.	_	0	SENT_383	[p25l1828t439r2151b489, p25l1117t511r1157b550],

1	10	CD	NUMBER	10	_	0	SENT_384	[p25l1118t582r1183b622],
2	.	.	O	.	_	0	SENT_384	[p25l1118t582r1183b622],

1	BrabenderJ	NNP	O	BrabenderJ	_	0	SENT_385	[p25l1212t578r1500b631],
2	,	,	O	,	_	0	SENT_385	[p25l1212t578r1500b631],
3	Danenberg	NNP	PERSON	Danenberg	nn	4	SENT_385	[p25l1515t578r1781b634],
4	KD	NN	O	kd	appos	1	SENT_385	[p25l1791t582r1878b631],
5	,	,	O	,	_	0	SENT_385	[p25l1791t582r1878b631],
6	Metzger	NNP	PERSON	Metzger	nn	7	SENT_385	[p25l1893t582r2090b634],
7	R	NNP	PERSON	R	appos	1	SENT_385	[p25l2101t582r2148b631],
8	,	,	O	,	_	0	SENT_385	[p25l2101t582r2148b631],
9	et	FW	O	et	nn	10	SENT_385	[p25l1117t658r1160b693],
10	al.	FW	O	al.	appos	1	SENT_385	[p25l1174t649r1227b693],
11	.	.	O	.	_	0	SENT_385	[p25l1174t649r1227b693],

1	Epidermal	JJ	O	epidermal	amod	3	SENT_386	[p25l1247t649r1493b705],
2	growth	NN	O	growth	nn	3	SENT_386	[p25l1510t649r1681b705],
3	factor	NN	O	factor	nsubjpass	17	SENT_386	[p25l1698t648r1836b693],
4	receptor	NN	O	receptor	dep	3	SENT_386	[p25l1852t658r2049b705],
5	and	CC	O	and	_	0	SENT_386	[p25l2065t649r2152b693],
6	HER2	NN	O	her2	dep	3	SENT_386	[p25l1116t723r1365b767],
7	—	CD	NUMBER	—	num	10	SENT_386	[p25l1116t723r1365b767],
8	neu	NN	O	neu	nn	10	SENT_386	[p25l1116t723r1365b767],
9	mRNA	NN	O	mrna	nn	10	SENT_386	[p25l1385t724r1549b767],
10	expression	NN	O	expression	dep	3	SENT_386	[p25l1568t720r1823b776],
11	in	IN	O	in	_	0	SENT_386	[p25l1843t720r1889b763],
12	non-small	JJ	O	non-small	amod	15	SENT_386	[p25l1909t720r2152b764],
13	cell	NN	O	cell	nn	15	SENT_386	[p25l1117t791r1197b835],
14	lung	NN	O	lung	nn	15	SENT_386	[p25l1216t791r1325b847],
15	cancer	NN	O	cancer	prep_in	10	SENT_386	[p25l1344t805r1499b835],
16	is	VBZ	O	be	auxpass	17	SENT_386	[p25l1517t791r1553b835],
17	correlated	VBN	O	correlate	_	0	SENT_386	[p25l1575t791r1812b835],
18	with	IN	O	with	_	0	SENT_386	[p25l1830t791r1936b835],
19	survival	NN	O	survival	prep_with	17	SENT_386	[p25l1958t791r2149b836],
20	.	.	O	.	_	0	SENT_386	[p25l1958t791r2149b836],

1	Clin	NNP	O	Clin	nn	3	SENT_387	[p25l1116t862r1214b906],
2	Cancer	NNP	O	Cancer	nn	3	SENT_387	[p25l1228t865r1394b906],
3	Res	NNP	O	Res	_	0	SENT_387	[p25l1406t866r1489b909],
4	2001	CD	DATE	2001	num	3	SENT_387	[p25l1505t865r1865b915],
5	;	:	O	;	_	0	SENT_387	[p25l1505t865r1865b915],
6	7:1850	CD	NUMBER	7:1850	number	7	SENT_387	[p25l1505t865r1865b915],
7	—	CD	NUMBER	—	dep	3	SENT_387	[p25l1505t865r1865b915],
8	5	CD	NUMBER	5	dep	7	SENT_387	[p25l1505t865r1865b915],
9	.	.	O	.	_	0	SENT_387	[p25l1505t865r1865b915],

1	11	CD	NUMBER	11	_	0	SENT_388	[p25l1118t938r1183b977],
2	.	.	O	.	_	0	SENT_388	[p25l1118t938r1183b977],

1	Selvaggi	NNP	PERSON	Selvaggi	nn	2	SENT_389	[p25l1214t933r1408b989],
2	G	NNP	PERSON	G	_	0	SENT_389	[p25l1422t936r1475b986],
3	,	,	O	,	_	0	SENT_389	[p25l1422t936r1475b986],
4	N	NNP	O	N	nn	6	SENT_389	[p25l1492t937r1534b977],
5	ovello	NN	O	ovello	nn	6	SENT_389	[p25l1536t933r1674b977],
6	S	NN	O	s	appos	2	SENT_389	[p25l1691t936r1729b986],
7	,	,	O	,	_	0	SENT_389	[p25l1691t936r1729b986],
8	Torri	NNP	PERSON	Torri	nn	9	SENT_389	[p25l1745t933r1862b977],
9	V	NNP	PERSON	V	appos	2	SENT_389	[p25l1874t937r1913b986],
10	,	,	O	,	_	0	SENT_389	[p25l1874t937r1913b986],
11	et	FW	O	et	nn	12	SENT_389	[p25l1931t942r1974b977],
12	al.	FW	O	al.	appos	2	SENT_389	[p25l1985t933r2038b977],
13	.	.	O	.	_	0	SENT_389	[p25l1985t933r2038b977],

1	Epidermal	JJ	O	epidermal	amod	3	SENT_390	[p25l2055t933r2151b989, p25l1117t1004r1285b1048],
2	growth	NN	O	growth	nn	3	SENT_390	[p25l1304t1004r1477b1060],
3	factor	NN	O	factor	nsubj	6	SENT_390	[p25l1496t1003r1637b1048],
4	receptor	NN	O	receptor	nn	5	SENT_390	[p25l1654t1013r1856b1060],
5	overexpression	NN	O	overexpression	dep	3	SENT_390	[p25l1873t1018r2151b1060, p25l1117t1075r1215b1119],
6	correlates	VBZ	O	correlate	_	0	SENT_390	[p25l1227t1075r1452b1119],
7	with	IN	O	with	_	0	SENT_390	[p25l1461t1075r1566b1119],
8	a	DT	O	a	det	10	SENT_390	[p25l1577t1089r1601b1119],
9	poor	JJ	O	poor	amod	10	SENT_390	[p25l1611t1089r1723b1131],
10	prognosis	NN	O	prognosis	prep_with	6	SENT_390	[p25l1731t1075r1965b1131],
11	in	IN	O	in	_	0	SENT_390	[p25l1976t1075r2022b1118],
12	completely	RB	O	completely	advmod	13	SENT_390	[p25l2033t1089r2152b1119, p25l1116t1146r1271b1202],
13	resected	JJ	O	resected	amod	16	SENT_390	[p25l1286t1146r1480b1190],
14	non-small-cell	JJ	O	non-small-cell	amod	16	SENT_390	[p25l1498t1146r1843b1190],
15	lung	NN	O	lung	nn	16	SENT_390	[p25l1860t1146r1969b1202],
16	cancer	NN	O	cancer	prep_in	10	SENT_390	[p25l1985t1160r2148b1190],
17	.	.	O	.	_	0	SENT_390	[p25l1985t1160r2148b1190],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_391	[p25l1115t1221r1214b1260],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_391	[p25l1228t1217r1371b1261],
3	2004	CD	DATE	2004	num	2	SENT_391	[p25l1385t1220r1745b1270],
4	;	:	O	;	_	0	SENT_391	[p25l1385t1220r1745b1270],
5	15:28	CD	TIME	15:28	number	6	SENT_391	[p25l1385t1220r1745b1270],
6	-32	CD	NUMBER	-32	dep	2	SENT_391	[p25l1385t1220r1745b1270],
7	.	.	O	.	_	0	SENT_391	[p25l1385t1220r1745b1270],

1	12	CD	NUMBER	12	_	0	SENT_392	[p25l1118t1293r1183b1332],
2	.	.	O	.	_	0	SENT_392	[p25l1118t1293r1183b1332],

1	Hirsch	NNP	PERSON	Hirsch	nn	2	SENT_393	[p25l1213t1288r1372b1332],
2	FR	NN	O	fr	_	0	SENT_393	[p25l1394t1292r1472b1341],
3	,	,	O	,	_	0	SENT_393	[p25l1394t1292r1472b1341],
4	Varella	NNP	PERSON	Varella	appos	2	SENT_393	[p25l1496t1288r1834b1332],
5	.	.	O	.	_	0	SENT_393	[p25l1496t1288r1834b1332],

1	—	NN	O	—	_	0	SENT_394	[p25l1496t1288r1834b1332],
2	.	.	O	.	_	0	SENT_394	[p25l1496t1288r1834b1332],

1	Garcia	NNP	PERSON	Garcia	nn	2	SENT_395	[p25l1496t1288r1834b1332],
2	M	NNP	O	M	_	0	SENT_395	[p25l1854t1292r1915b1341],
3	,	,	O	,	_	0	SENT_395	[p25l1854t1292r1915b1341],
4	Bunn	NNP	PERSON	Bunn	nn	6	SENT_395	[p25l1940t1292r2068b1332],
5	PA	NN	PERSON	pa	nn	6	SENT_395	[p25l2090t1292r2153b1331],
6	Jr	NNP	PERSON	Jr	appos	2	SENT_395	[p25l1111t1363r1162b1412],
7	,	,	O	,	_	0	SENT_395	[p25l1111t1363r1162b1412],
8	et	FW	O	et	nn	9	SENT_395	[p25l1180t1368r1223b1403],
9	al.	FW	O	al.	appos	6	SENT_395	[p25l1234t1359r1287b1403],
10	.	.	O	.	_	0	SENT_395	[p25l1234t1359r1287b1403],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_396	[p25l1303t1359r1549b1415],
2	growth	NN	O	growth	nn	4	SENT_396	[p25l1563t1359r1733b1415],
3	factor	NN	O	factor	nn	4	SENT_396	[p25l1747t1358r1885b1403],
4	receptor	NN	O	receptor	_	0	SENT_396	[p25l1897t1368r2095b1415],
5	in	IN	O	in	_	0	SENT_396	[p25l2106t1359r2152b1402],
6	non-small-cell	JJ	O	non-small-cell	amod	8	SENT_396	[p25l1117t1430r1461b1474],
7	lung	NN	O	lung	nn	8	SENT_396	[p25l1473t1430r1581b1486],
8	carcinomas	NNS	O	carcinoma	prep_in	4	SENT_396	[p25l1592t1430r1879b1474],
9	:	:	O	:	_	0	SENT_396	[p25l1592t1430r1879b1474],
10	correlation	NN	O	correlation	dep	4	SENT_396	[p25l1893t1430r2152b1474],
11	between	IN	O	between	_	0	SENT_396	[p25l1117t1501r1316b1545],
12	gene	NN	O	gene	nn	14	SENT_396	[p25l1331t1515r1444b1557],
13	copy	NN	O	copy	nn	14	SENT_396	[p25l1459t1515r1572b1557],
14	number	NN	O	number	prep_between	10	SENT_396	[p25l1584t1501r1776b1545],
15	and	CC	O	and	_	0	SENT_396	[p25l1788t1501r1877b1545],
16	protein	NN	O	protein	nn	17	SENT_396	[p25l1891t1501r2067b1557],
17	expression	NN	O	expression	prep_between	10	SENT_396	[p25l2082t1515r2151b1545, p25l1116t1572r1326b1628],
18	and	CC	O	and	_	0	SENT_396	[p25l1347t1572r1436b1616],
19	impact	NN	O	impact	prep_between	10	SENT_396	[p25l1458t1572r1628b1628],
20	on	IN	O	on	_	0	SENT_396	[p25l1648t1586r1709b1616],
21	prognosis	NN	O	prognosis	prep_on	14	SENT_396	[p25l1730t1572r1990b1628],
22	.	.	O	.	_	0	SENT_396	[p25l1730t1572r1990b1628],

1	J	NNP	O	J	nn	3	SENT_397	[p25l2009t1576r2031b1623],
2	Clin	NNP	O	Clin	nn	3	SENT_397	[p25l2051t1572r2151b1616],
3	Oncol	NNP	O	Oncol	_	0	SENT_397	[p25l1117t1643r1262b1687],
4	2003	CD	DATE	2003	num	3	SENT_397	[p25l1278t1646r1729b1696],
5	;	:	O	;	_	0	SENT_397	[p25l1278t1646r1729b1696],
6	21:3798	CD	NUMBER	21:3798	num	7	SENT_397	[p25l1278t1646r1729b1696],
7	—	NN	O	—	dep	3	SENT_397	[p25l1278t1646r1729b1696],
8	807	CD	NUMBER	807	dep	7	SENT_397	[p25l1278t1646r1729b1696],
9	.	.	O	.	_	0	SENT_397	[p25l1278t1646r1729b1696],

1	13	CD	NUMBER	13	_	0	SENT_398	[p25l1118t1719r1183b1758],
2	.	.	O	.	_	0	SENT_398	[p25l1118t1719r1183b1758],

1	Swinson	NNP	PERSON	Swinson	nn	2	SENT_399	[p25l1214t1714r1416b1758],
2	DE	NN	PERSON	de	_	0	SENT_399	[p25l1433t1718r1517b1767],
3	,	,	O	,	_	0	SENT_399	[p25l1433t1718r1517b1767],
4	Cox	NN	ORGANIZATION	cox	nn	5	SENT_399	[p25l1538t1717r1630b1758],
5	G	NN	ORGANIZATION	g	appos	2	SENT_399	[p25l1646t1717r1700b1767],
6	,	,	O	,	_	0	SENT_399	[p25l1646t1717r1700b1767],
7	O’Byrne	NN	O	o’byrne	nn	8	SENT_399	[p25l1721t1717r1912b1770],
8	KJ	NN	O	kj	appos	5	SENT_399	[p25l1930t1718r1995b1765],
9	.	.	O	.	_	0	SENT_399	[p25l1930t1718r1995b1765],

1	Coexpression	NN	O	coexpression	nsubjpass	11	SENT_400	[p25l2016t1717r2151b1758, p25l1116t1785r1319b1841],
2	of	IN	O	of	_	0	SENT_400	[p25l1339t1784r1395b1829],
3	epidermal	JJ	O	epidermal	amod	6	SENT_400	[p25l1404t1785r1643b1841],
4	growth	NN	O	growth	nn	6	SENT_400	[p25l1662t1785r1832b1841],
5	factor	NN	O	factor	nn	6	SENT_400	[p25l1851t1784r1989b1829],
6	receptor	NN	O	receptor	prep_of	1	SENT_400	[p25l2006t1799r2151b1841, p25l1117t1865r1185b1900],
7	with	IN	O	with	_	0	SENT_400	[p25l1200t1856r1306b1900],
8	related	JJ	O	related	amod	9	SENT_400	[p25l1325t1856r1485b1900],
9	factors	NNS	O	factor	prep_with	6	SENT_400	[p25l1505t1855r1665b1900],
10	is	VBZ	O	be	auxpass	11	SENT_400	[p25l1685t1856r1721b1900],
11	associated	VBN	O	associate	_	0	SENT_400	[p25l1741t1856r1986b1900],
12	with	IN	O	with	_	0	SENT_400	[p25l2003t1856r2109b1900],
13	a	DT	O	a	det	15	SENT_400	[p25l2128t1870r2153b1900],
14	poor	JJ	O	poor	amod	15	SENT_400	[p25l1116t1941r1229b1983],
15	prognosis	NN	O	prognosis	prep_with	11	SENT_400	[p25l1245t1927r1482b1983],
16	in	IN	O	in	_	0	SENT_400	[p25l1501t1927r1547b1970],
17	non-small-cell	JJ	O	non-small-cell	amod	19	SENT_400	[p25l1565t1927r1909b1971],
18	lung	NN	O	lung	nn	19	SENT_400	[p25l1926t1927r2036b1983],
19	cancer	NN	O	cancer	prep_in	15	SENT_400	[p25l2052t1941r2151b1971, p25l1117t2012r1197b2042],
20	.	.	O	.	_	0	SENT_400	[p25l2052t1941r2151b1971, p25l1117t2012r1197b2042],

1	BrJ	NN	O	brj	nn	2	SENT_401	[p25l1213t2002r1296b2049],
2	Cancer	NN	O	cancer	_	0	SENT_401	[p25l1309t2001r1475b2042],
3	2004	CD	DATE	2004	dep	2	SENT_401	[p25l1487t2001r1876b2051],
4	;	:	O	;	_	0	SENT_401	[p25l1487t2001r1876b2051],
5	91:1301	CD	NUMBER	91:1301	num	6	SENT_401	[p25l1487t2001r1876b2051],
6	-7	CD	NUMBER	-7	dep	2	SENT_401	[p25l1487t2001r1876b2051],
7	.	.	O	.	_	0	SENT_401	[p25l1487t2001r1876b2051],

1	14	CD	NUMBER	14	_	0	SENT_402	[p25l1118t2074r1183b2113],
2	.	.	O	.	_	0	SENT_402	[p25l1118t2074r1183b2113],

1	Meert	NNP	PERSON	Meert	nn	2	SENT_403	[p25l1211t2073r1352b2113],
2	A-P	NNP	O	A-P	_	0	SENT_403	[p25l1369t2073r1460b2122],
3	,	,	O	,	_	0	SENT_403	[p25l1369t2073r1460b2122],
4	Martin	NNP	PERSON	Martin	nn	5	SENT_403	[p25l1482t2069r1643b2113],
5	B	NNP	PERSON	B	appos	2	SENT_403	[p25l1664t2073r1709b2122],
6	,	,	O	,	_	0	SENT_403	[p25l1664t2073r1709b2122],
7	Delmotte	NNP	PERSON	Delmotte	nn	8	SENT_403	[p25l1733t2069r1953b2113],
8	P	NN	O	p	appos	2	SENT_403	[p25l1974t2073r2009b2122],
9	,	,	O	,	_	0	SENT_403	[p25l1974t2073r2009b2122],
10	et	FW	O	et	nn	11	SENT_403	[p25l2034t2078r2077b2113],
11	al.	FW	O	al.	appos	2	SENT_403	[p25l2095t2069r2148b2113],
12	.	.	O	.	_	0	SENT_403	[p25l2095t2069r2148b2113],

1	The	DT	O	the	det	2	SENT_404	[p25l1115t2140r1204b2184],
2	role	NN	O	role	_	0	SENT_404	[p25l1218t2140r1307b2184],
3	of	IN	O	of	_	0	SENT_404	[p25l1321t2139r1377b2184],
4	EGF-R	NN	O	egf-r	nn	5	SENT_404	[p25l1379t2143r1542b2187],
5	expression	NN	O	expression	prep_of	2	SENT_404	[p25l1550t2140r1800b2196],
6	on	IN	O	on	_	0	SENT_404	[p25l1814t2154r1873b2184],
7	patient	NN	O	patient	nn	8	SENT_404	[p25l1886t2140r2051b2196],
8	survival	NN	O	survival	prep_on	5	SENT_404	[p25l2062t2154r2152b2184, p25l1114t2211r1218b2256],
9	in	IN	O	in	_	0	SENT_404	[p25l1230t2211r1275b2254],
10	lung	NN	O	lung	nn	11	SENT_404	[p25l1287t2211r1396b2267],
11	cancer	NN	O	cancer	prep_in	8	SENT_404	[p25l1407t2225r1574b2255],
12	:	:	O	:	_	0	SENT_404	[p25l1407t2225r1574b2255],
13	a	DT	O	a	det	15	SENT_404	[p25l1588t2225r1614b2255],
14	systematic	JJ	O	systematic	amod	15	SENT_404	[p25l1626t2211r1873b2267],
15	review	NN	O	review	dep	2	SENT_404	[p25l1885t2211r2037b2255],
16	with	IN	O	with	_	0	SENT_404	[p25l2046t2211r2152b2255],
17	meta-analysis	NN	O	meta-analysis	prep_with	15	SENT_404	[p25l1117t2282r1456b2338],
18	.	.	O	.	_	0	SENT_404	[p25l1117t2282r1456b2338],

1	Eur	NNP	MISC	Eur	nn	2	SENT_405	[p25l1471t2286r1555b2326],
2	RespirJ	NNP	O	RespirJ	_	0	SENT_405	[p25l1565t2282r1748b2338],
3	2002	CD	DATE	2002	num	2	SENT_405	[p25l1759t2285r2149b2335],
4	;	:	O	;	_	0	SENT_405	[p25l1759t2285r2149b2335],
5	20:975	CD	NUMBER	20:975	number	6	SENT_405	[p25l1759t2285r2149b2335],
6	-81	CD	NUMBER	-81	dep	2	SENT_405	[p25l1759t2285r2149b2335],
7	.	.	O	.	_	0	SENT_405	[p25l1759t2285r2149b2335],

1	15	CD	NUMBER	15	_	0	SENT_406	[p25l1118t2358r1183b2397],
2	.	.	O	.	_	0	SENT_406	[p25l1118t2358r1183b2397],

1	Sridhar	NNP	O	Sridhar	nn	2	SENT_407	[p25l1214t2353r1389b2397],
2	SS	NNP	O	SS	_	0	SENT_407	[p25l1400t2356r1468b2406],
3	,	,	O	,	_	0	SENT_407	[p25l1400t2356r1468b2406],
4	Seymour	NNP	PERSON	Seymour	nn	5	SENT_407	[p25l1485t2356r1693b2409],
5	L	NNP	PERSON	L	appos	2	SENT_407	[p25l1702t2357r1743b2406],
6	,	,	O	,	_	0	SENT_407	[p25l1702t2357r1743b2406],
7	Shepherd	NNP	ORGANIZATION	Shepherd	nn	8	SENT_407	[p25l1760t2353r1985b2409],
8	FA	NNP	ORGANIZATION	FA	appos	5	SENT_407	[p25l1996t2357r2069b2397],
9	.	.	O	.	_	0	SENT_407	[p25l1996t2357r2069b2397],

1	Inhibitors	NNS	O	inhibitor	_	0	SENT_408	[p25l2083t2357r2151b2396, p25l1117t2424r1301b2468],
2	of	IN	O	of	_	0	SENT_408	[p25l1325t2423r1381b2468],
3	epidermal-growth-factor	NN	O	epidermal-growth-factor	nn	4	SENT_408	[p25l1394t2423r1985b2480],
4	receptors	NNS	O	receptor	prep_of	1	SENT_408	[p25l2006t2438r2151b2480, p25l1117t2504r1221b2539],
5	:	:	O	:	_	0	SENT_408	[p25l2006t2438r2151b2480, p25l1117t2504r1221b2539],
6	a	DT	O	a	det	7	SENT_408	[p25l1238t2509r1263b2539],
7	review	NN	O	review	dep	1	SENT_408	[p25l1278t2495r1430b2539],
8	of	IN	O	of	_	0	SENT_408	[p25l1444t2494r1500b2539],
9	clinical	JJ	O	clinical	amod	10	SENT_408	[p25l1505t2495r1674b2539],
10	research	NN	O	research	prep_of	7	SENT_408	[p25l1689t2495r1888b2539],
11	in	IN	O	in	_	0	SENT_408	[p25l1903t2495r1949b2538],
12	patients	NNS	O	patient	prep_in	10	SENT_408	[p25l1963t2495r2151b2551],
13	with	IN	O	with	_	0	SENT_408	[p25l1114t2566r1220b2610],
14	a	DT	O	a	det	15	SENT_408	[p25l1237t2580r1262b2610],
15	focus	NN	O	focus	prep_with	12	SENT_408	[p25l1279t2565r1404b2610],
16	on	IN	O	on	_	0	SENT_408	[p25l1423t2580r1483b2610],
17	non-small-cell	JJ	O	non-small-cell	amod	19	SENT_408	[p25l1500t2566r1844b2610],
18	lung	NN	O	lung	nn	19	SENT_408	[p25l1861t2566r1970b2622],
19	cancer	NN	O	cancer	prep_on	15	SENT_408	[p25l1985t2580r2148b2610],
20	.	.	O	.	_	0	SENT_408	[p25l1985t2580r2148b2610],

1	Lancet	NNP	O	Lancet	nn	2	SENT_409	[p25l1116t2641r1274b2681],
2	Oncol	NNP	O	Oncol	_	0	SENT_409	[p25l1285t2637r1428b2681],
3	2003	CD	DATE	2003	num	2	SENT_409	[p25l1441t2640r1831b2690],
4	;	:	O	;	_	0	SENT_409	[p25l1441t2640r1831b2690],
5	4:397	CD	NUMBER	4:397	number	6	SENT_409	[p25l1441t2640r1831b2690],
6	-406	CD	NUMBER	-406	dep	2	SENT_409	[p25l1441t2640r1831b2690],
7	.	.	O	.	_	0	SENT_409	[p25l1441t2640r1831b2690],

1	16	CD	NUMBER	16	_	0	SENT_410	[p25l1118t2713r1183b2752],
2	.	.	O	.	_	0	SENT_410	[p25l1118t2713r1183b2752],

1	Fukuoka	NNP	LOCATION	Fukuoka	nn	2	SENT_411	[p25l1212t2708r1420b2753],
2	M	NNP	O	M	_	0	SENT_411	[p25l1437t2712r1498b2761],
3	,	,	O	,	_	0	SENT_411	[p25l1437t2712r1498b2761],
4	Yano	NNP	PERSON	Yano	nn	5	SENT_411	[p25l1519t2712r1635b2752],
5	S	NNP	O	S	appos	2	SENT_411	[p25l1657t2711r1695b2761],
6	,	,	O	,	_	0	SENT_411	[p25l1657t2711r1695b2761],
7	Giaccone	NNP	PERSON	Giaccone	nn	8	SENT_411	[p25l1718t2708r1939b2752],
8	G	NNP	O	G	appos	2	SENT_411	[p25l1959t2711r2012b2761],
9	,	,	O	,	_	0	SENT_411	[p25l1959t2711r2012b2761],
10	et	FW	O	et	nn	11	SENT_411	[p25l2036t2717r2079b2752],
11	al.	FW	O	al.	appos	2	SENT_411	[p25l2096t2708r2149b2752],
12	.	.	O	.	_	0	SENT_411	[p25l2096t2708r2149b2752],

1	Multi-institutional	JJ	O	multi-institutional	_	0	SENT_412	[p25l1115t2779r1554b2823],
2	randomized	VBN	O	randomize	dep	1	SENT_412	[p25l1571t2779r1858b2823],
3	phase	NN	O	phase	nn	5	SENT_412	[p25l1874t2779r2012b2835],
4	II	CD	NUMBER	ii	num	5	SENT_412	[p25l2029t2783r2065b2822],
5	trial	NN	O	trial	dobj	2	SENT_412	[p25l2082t2779r2151b2823, p25l1116t2850r1156b2894],
6	of	IN	O	of	_	0	SENT_412	[p25l1186t2849r1243b2894],
7	geﬁtinib	NN	O	geﬁtinib	prep_of	5	SENT_412	[p25l1263t2849r1469b2906],
8	for	IN	O	for	_	0	SENT_412	[p25l1500t2849r1571b2894],
9	previously	RB	DATE	previously	advmod	10	SENT_412	[p25l1598t2850r1850b2906],
10	treated	VBN	O	treat	amod	11	SENT_412	[p25l1878t2850r2045b2894],
11	patients	NNS	O	patient	prep_for	2	SENT_412	[p25l2074t2864r2150b2906, p25l1117t2922r1250b2965],
12	with	IN	O	with	_	0	SENT_412	[p25l1276t2921r1385b2965],
13	advanced	JJ	O	advanced	amod	16	SENT_412	[p25l1411t2921r1636b2965],
14	non-small	JJ	O	non-small	amod	16	SENT_412	[p25l1662t2921r1910b2965],
15	cell	NN	O	cell	nn	16	SENT_412	[p25l1936t2921r2017b2965],
16	lung	NN	O	lung	prep_with	11	SENT_412	[p25l2042t2921r2153b2977],

1	0.73	CD	NUMBER	0.73	num	2	SENT_413	[p25l11t3176r226b3262],
2	)	NN	O	)	nsubj	4	SENT_413	[p25l11t3176r226b3262],
3	was	VBD	O	be	cop	4	SENT_413	[p25l260t3197r423b3250],
4	similar	JJ	O	similar	_	0	SENT_413	[p25l460t3170r762b3249],
5	to	TO	O	to	_	0	SENT_413	[p25l793t3187r873b3249],
6	that	DT	O	that	prep_to	4	SENT_413	[p25l908t3171r1077b3249],
7	observed	VBN	O	observe	partmod	6	SENT_413	[p25l1106t3170r1489b3250],
8	in	IN	O	in	_	0	SENT_413	[p25l1522t3171r1604b3248],
9	the	DT	O	the	det	10	SENT_413	[p25l1637t3171r1769b3249],
10	population	NN	O	population	prep_in	7	SENT_413	[p25l1801t3171r2133b3271, p25l11t3300r180b3378],
11	as	IN	O	as	_	0	SENT_413	[p25l207t3326r292b3377],
12	a	DT	O	a	det	16	SENT_413	[p25l321t3326r365b3377],
13	whole	JJ	O	whole	amod	16	SENT_413	[p25l386t3300r644b3379],
14	(	NN	O	(	nn	16	SENT_413	[p25l674t3299r992b3390],
15	hazard	NN	O	hazard	nn	16	SENT_413	[p25l674t3299r992b3390],
16	ratio	NN	O	ratio	prep_as	10	SENT_413	[p25l1016t3300r1233b3394],
17	,	,	O	,	_	0	SENT_413	[p25l1016t3300r1233b3394],
18	0.70	CD	NUMBER	0.70	num	19	SENT_413	[p25l1264t3305r1504b3390],
19	)	NN	O	)	appos	16	SENT_413	[p25l1264t3305r1504b3390],
20	.	.	O	.	_	0	SENT_413	[p25l1264t3305r1504b3390],

1	In	IN	O	in	_	0	SENT_414	[p25l138t3443r225b3513],
2	summary	NN	O	summary	prep_in	6	SENT_414	[p25l257t3462r667b3536],
3	,	,	O	,	_	0	SENT_414	[p25l257t3462r667b3536],
4	multivariate	JJ	O	multivariate	amod	5	SENT_414	[p25l703t3436r1206b3515],
5	analysis	NN	O	analysis	nsubj	6	SENT_414	[p25l1236t3436r1566b3536],
6	revealed	VBD	O	reveal	_	0	SENT_414	[p25l1599t3435r1943b3515],
7	that	IN	O	that	complm	27	SENT_414	[p25l1974t3436r2140b3514],
8	expression	NN	O	expression	nsubjpass	27	SENT_414	[p25l11t3572r465b3672],
9	of	IN	O	of	_	0	SENT_414	[p25l504t3571r605b3650],
10	EGFR	NN	ORGANIZATION	egfr	prep_of	8	SENT_414	[p25l623t3577r882b3655],
11	and	CC	O	and	_	0	SENT_414	[p25l909t3572r1065b3650],
12	an	DT	O	a	det	14	SENT_414	[p25l1103t3597r1203b3650],
13	increased	VBN	O	increase	amod	14	SENT_414	[p25l1241t3571r1642b3650],
14	number	NN	O	number	nsubjpass	27	SENT_414	[p25l1681t3571r2017b3651],
15	of	IN	O	of	_	0	SENT_414	[p25l2053t3571r2153b3650],
16	copies	NNS	O	copy	prep_of	14	SENT_414	[p25l11t3685r276b3785],
17	of	IN	O	of	_	0	SENT_414	[p25l301t3684r402b3763],
18	EGFR	NN	ORGANIZATION	egfr	prep_of	16	SENT_414	[p25l404t3691r635b3780],
19	,	,	O	,	_	0	SENT_414	[p25l404t3691r635b3780],
20	but	CC	O	but	_	0	SENT_414	[p25l663t3685r803b3764],
21	not	RB	O	not	_	0	SENT_414	[p25l820t3701r964b3763],
22	mutations	NNS	O	mutation	prep_of	14	SENT_414	[p25l981t3685r1412b3764],
23	in	IN	O	in	_	0	SENT_414	[p25l1436t3685r1517b3762],
24	EGFR	NN	ORGANIZATION	egfr	prep_in	22	SENT_414	[p25l1537t3691r1767b3780],
25	,	,	O	,	_	0	SENT_414	[p25l1537t3691r1767b3780],
26	were	VBD	O	be	auxpass	27	SENT_414	[p25l1790t3711r1992b3764],
27	associated	VBN	O	associate	ccomp	6	SENT_414	[p25l2015t3711r2134b3763, p26l12t21r364b100],

1	with	IN	O	with	_	0	SENT_415	[p26l392t22r584b101],
2	responsiveness	NN	O	responsiveness	pobj	1	SENT_415	[p26l618t22r1270b122],
3	to	TO	O	to	_	0	SENT_415	[p26l1305t38r1385b100],
4	erlotinib	NN	O	erlotinib	prep_to	2	SENT_415	[p26l1421t22r1788b100],
5	but	CC	O	but	cc	2	SENT_415	[p26l1823t21r1966b101],
6	not	RB	O	not	advmod	2	SENT_415	[p26l1994t38r2139b100],
7	with	IN	O	with	_	0	SENT_415	[p26l6t158r196b237],
8	increased	VBN	O	increase	amod	9	SENT_415	[p26l234t157r644b236],
9	survival	NN	O	survival	prep_with	6	SENT_415	[p26l683t158r1033b237],
10	.	.	O	.	_	0	SENT_415	[p26l683t158r1033b237],

1	Our	PRP$	O	we	poss	2	SENT_416	[p26l1077t163r1243b237],
2	results	NNS	O	result	nsubj	3	SENT_416	[p26l1278t158r1561b237],
3	suggest	VBP	O	suggest	_	0	SENT_416	[p26l1603t174r1936b258],
4	that	IN	O	that	complm	9	SENT_416	[p26l1970t158r2139b236],
5	mutational	JJ	O	mutational	amod	6	SENT_416	[p26l11t294r469b373],
6	analysis	NN	O	analysis	nsubj	9	SENT_416	[p26l500t293r824b394],
7	is	VBZ	O	be	cop	9	SENT_416	[p26l857t294r921b372],
8	not	RB	O	not	neg	9	SENT_416	[p26l955t310r1097b372],
9	necessary	JJ	O	necessary	ccomp	3	SENT_416	[p26l1123t319r1525b394],
10	to	TO	O	to	aux	11	SENT_416	[p26l1552t310r1631b372],
11	identify	VB	O	identify	xcomp	9	SENT_416	[p26l1663t293r1978b394],
12	patients	NNS	O	patient	dobj	11	SENT_416	[p26l2004t320r2135b394, p26l11t430r237b508],
13	in	IN	O	in	_	0	SENT_416	[p26l263t430r343b507],
14	whom	WP	O	whom	rel	20	SENT_416	[p26l367t430r642b509],
15	treatment	NN	O	treatment	nsubj	20	SENT_416	[p26l671t446r1094b508],
16	with	IN	O	with	_	0	SENT_416	[p26l1113t429r1306b509],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_416	[p26l1333t435r1596b513],
18	inhibitors	NNS	O	inhibitor	prep_with	15	SENT_416	[p26l1612t429r2037b508],
19	is	VBZ	O	be	cop	20	SENT_416	[p26l2066t430r2133b508],
20	appropriate	JJ	O	appropriate	rcmod	12	SENT_416	[p26l10t542r538b641],
21	.	.	O	.	_	0	SENT_416	[p26l10t542r538b641],

1	Supported	VBN	O	support	_	0	SENT_417	[p26l97t672r425b747],
2	by	IN	O	by	_	0	SENT_417	[p26l451t672r525b747],
3	grants	NNS	O	grant	prep_by	1	SENT_417	[p26l546t684r744b747],
4	(	CD	NUMBER	(	num	5	SENT_417	[p26l776t676r1197b741],
5	NCIC	NN	ORGANIZATION	ncic	dep	3	SENT_417	[p26l776t676r1197b741],
6	.	.	O	.	_	0	SENT_417	[p26l776t676r1197b741],

1	—	NN	O	—	_	0	SENT_418	[p26l776t676r1197b741],
2	.	.	O	.	_	0	SENT_418	[p26l776t676r1197b741],

1	OO448	NN	O	oo448	_	0	SENT_419	[p26l776t676r1197b741],
2	and	CC	O	and	_	0	SENT_419	[p26l1224t672r1340b731],
3	NCIC	NN	ORGANIZATION	ncic	conj_and	1	SENT_419	[p26l1364t676r1828b740],
4	—	CD	NUMBER	—	number	5	SENT_419	[p26l1364t676r1828b740],
5	015469	CD	NUMBER	015469	num	6	SENT_419	[p26l1364t676r1828b740],
6	)	CD	NUMBER	)	dep	1	SENT_419	[p26l1364t676r1828b740],
7	from	IN	O	from	_	0	SENT_419	[p26l1857t671r2014b731],
8	the	DT	O	the	det	9	SENT_419	[p26l2039t672r2136b731],
9	N	NN	O	n	prep_from	6	SENT_419	[p26l8t773r64b827],
10	CIC	NNP	ORGANIZATION	CIC	dep	1	SENT_419	[p26l67t772r201b840],
11	,	,	O	,	_	0	SENT_419	[p26l67t772r201b840],
12	grants	NNS	O	grant	appos	10	SENT_419	[p26l220t780r415b843],
13	from	IN	O	from	_	0	SENT_419	[p26l431t767r585b827],
14	OSI	NNP	ORGANIZATION	OSI	nn	15	SENT_419	[p26l599t772r715b827],
15	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_from	12	SENT_419	[p26l728t768r1258b839],
16	,	,	O	,	_	0	SENT_419	[p26l728t768r1258b839],
17	a	DT	O	a	det	19	SENT_419	[p26l1276t788r1309b826],
18	research	NN	O	research	nn	19	SENT_419	[p26l1323t768r1585b827],
19	grant	NN	O	grant	appos	1	SENT_419	[p26l1599t780r1768b843],
20	(	CD	NUMBER	(	num	21	SENT_419	[p26l1782t772r2136b836],
21	OCRN-O3	NN	O	ocrn-o3	dep	19	SENT_419	[p26l1782t772r2136b836],
22	—	CD	NUMBER	—	num	23	SENT_419	[p26l1782t772r2136b836],
23	APR	NN	DATE	apr	dep	1	SENT_419	[p26l7t867r346b931],
24	—	CD	DATE	—	number	25	SENT_419	[p26l7t867r346b931],
25	0324	CD	DATE	0324	dep	23	SENT_419	[p26l7t867r346b931],
26	)	CD	NUMBER	)	dep	1	SENT_419	[p26l7t867r346b931],
27	from	IN	O	from	_	0	SENT_419	[p26l369t862r525b922],
28	the	DT	O	the	det	32	SENT_419	[p26l544t863r641b921],
29	Ontario	NNP	ORGANIZATION	Ontario	nn	32	SENT_419	[p26l660t864r904b922],
30	Cancer	NNP	ORGANIZATION	Cancer	nn	32	SENT_419	[p26l924t867r1147b922],
31	Research	NNP	ORGANIZATION	Research	nn	32	SENT_419	[p26l1162t863r1451b925],
32	Network	NNP	ORGANIZATION	Network	prep_from	26	SENT_419	[p26l1468t863r1762b934],
33	,	,	O	,	_	0	SENT_419	[p26l1468t863r1762b934],
34	a	DT	O	a	det	36	SENT_419	[p26l1785t882r1819b921],
35	Canadian	JJ	ORGANIZATION	canadian	amod	36	SENT_419	[p26l1837t863r2136b922],
36	Institutes	NNPS	ORGANIZATION	Institutes	appos	1	SENT_419	[p26l8t960r304b1019],
37	of	IN	ORGANIZATION	of	_	0	SENT_419	[p26l327t958r403b1018],
38	Health	NNP	ORGANIZATION	Health	nn	39	SENT_419	[p26l408t959r622b1018],
39	Research	NNP	ORGANIZATION	Research	prep_of	36	SENT_419	[p26l641t959r930b1021],
40	(	CD	NUMBER	(	num	41	SENT_419	[p26l953t963r1175b1027],
41	CIHR	NN	O	cihr	dep	1	SENT_419	[p26l953t963r1175b1027],
42	)	CD	NUMBER	)	num	43	SENT_419	[p26l953t963r1175b1027],
43	grant	NN	O	grant	dep	41	SENT_419	[p26l1199t971r1370b1034],
44	(	CD	NUMBER	(	num	46	SENT_419	[p26l1390t963r1838b1030],
45	MOP-62797	NN	O	mop-62797	nn	46	SENT_419	[p26l1390t963r1838b1030],
46	)	NN	O	)	dep	1	SENT_419	[p26l1390t963r1838b1030],
47	,	,	O	,	_	0	SENT_419	[p26l1390t963r1838b1030],
48	and	CC	O	and	_	0	SENT_419	[p26l1863t959r1979b1018],
49	a	DT	O	a	det	51	SENT_419	[p26l1999t978r2033b1017],
50	research	NN	O	research	nn	51	SENT_419	[p26l2052t978r2136b1018, p26l11t1055r214b1113],
51	award	NN	O	award	conj_and	46	SENT_419	[p26l243t1055r436b1115],
52	from	IN	O	from	_	0	SENT_419	[p26l466t1054r622b1114],
53	the	DT	O	the	det	57	SENT_419	[p26l652t1055r749b1113],
54	Jacqueline	NNP	ORGANIZATION	Jacqueline	nn	57	SENT_419	[p26l772t1055r1104b1130],
55	Seroussi	NNP	ORGANIZATION	Seroussi	nn	57	SENT_419	[p26l1137t1056r1402b1115],
56	Memorial	NNP	ORGANIZATION	Memorial	nn	57	SENT_419	[p26l1429t1055r1740b1114],
57	Foundation	NNP	ORGANIZATION	Foundation	prep_from	51	SENT_419	[p26l1769t1055r2137b1115],
58	for	IN	ORGANIZATION	for	_	0	SENT_419	[p26l10t1150r102b1210],
59	Cancer	NNP	ORGANIZATION	Cancer	nn	60	SENT_419	[p26l134t1155r356b1210],
60	Research	NNP	ORGANIZATION	Research	prep_for	51	SENT_419	[p26l386t1151r693b1213],
61	.	.	O	.	_	0	SENT_419	[p26l386t1151r693b1213],

1	Dr.	NNP	O	Dr.	nn	2	SENT_420	[p26l730t1156r823b1210],
2	Cutz	NNP	O	Cutz	nsubjpass	4	SENT_420	[p26l861t1155r1006b1211],
3	is	VBZ	O	be	auxpass	4	SENT_420	[p26l1039t1152r1089b1209],
4	supported	VBN	O	support	_	0	SENT_420	[p26l1125t1151r1447b1226],
5	by	IN	O	by	_	0	SENT_420	[p26l1481t1151r1554b1226],
6	a	DT	O	a	det	11	SENT_420	[p26l1584t1170r1617b1209],
7	CIHR	NNP	O	CIHR	nn	11	SENT_420	[p26l1650t1155r1835b1213],
8	Strategic	NNP	O	Strategic	nn	11	SENT_420	[p26l1862t1152r2137b1226],
9	Training	NNP	O	Training	nn	11	SENT_420	[p26l7t1248r283b1322],
10	Program	NNP	O	Program	nn	11	SENT_420	[p26l298t1252r574b1322],
11	Grant	NNP	O	Grant	agent	4	SENT_420	[p26l593t1251r780b1306],
12	for	IN	O	for	_	0	SENT_420	[p26l795t1246r887b1306],
13	Clinician	NNP	O	Clinician	nn	14	SENT_420	[p26l904t1247r1188b1306],
14	Scientists	NNS	O	scientist	prep_for	4	SENT_420	[p26l1208t1248r1506b1306],
15	in	IN	O	in	_	0	SENT_420	[p26l1526t1248r1587b1305],
16	Molecular	JJ	O	molecular	amod	18	SENT_420	[p26l1603t1247r1925b1307],
17	Oncologic	JJ	O	oncologic	amod	18	SENT_420	[p26l1941t1251r2136b1306, p26l9t1343r164b1419],
18	Pathology	NN	O	pathology	prep_in	4	SENT_420	[p26l180t1343r498b1419],
19	(	CD	NUMBER	(	num	21	SENT_420	[p26l517t1347r928b1411],
20	STP-53912	NN	O	stp-53912	nn	21	SENT_420	[p26l517t1347r928b1411],
21	)	NN	O	)	dep	18	SENT_420	[p26l517t1347r928b1411],
22	.	.	O	.	_	0	SENT_420	[p26l517t1347r928b1411],

1	Dr.	NNP	O	Dr.	nn	4	SENT_421	[p26l949t1348r1042b1402],
2	da	NNP	PERSON	da	nn	4	SENT_421	[p26l1064t1343r1138b1402],
3	Cunha	NNP	PERSON	Cunha	nn	4	SENT_421	[p26l1154t1343r1364b1402],
4	Santos	NNP	PERSON	Santos	nsubjpass	6	SENT_421	[p26l1382t1347r1590b1402],
5	is	VBZ	O	be	auxpass	6	SENT_421	[p26l1608t1344r1657b1401],
6	supported	VBN	O	support	_	0	SENT_421	[p26l1678t1343r2000b1418],
7	by	IN	O	by	_	0	SENT_421	[p26l2017t1343r2090b1418],
8	a	DT	O	a	det	9	SENT_421	[p26l2104t1362r2137b1401],
9	grant	NN	O	grant	agent	6	SENT_421	[p26l10t1451r181b1514],
10	from	IN	O	from	_	0	SENT_421	[p26l195t1438r351b1497],
11	the	DT	O	the	det	12	SENT_421	[p26l370t1438r467b1496],
12	Ministry	NNP	ORGANIZATION	Ministry	prep_from	6	SENT_421	[p26l483t1439r752b1513],
13	of	IN	ORGANIZATION	of	_	0	SENT_421	[p26l768t1438r844b1497],
14	Education	NNP	ORGANIZATION	Education	prep_of	12	SENT_421	[p26l847t1438r1168b1497],
15	of	IN	O	of	_	0	SENT_421	[p26l1187t1438r1263b1497],
16	Brazil	NNP	LOCATION	Brazil	prep_of	14	SENT_421	[p26l1266t1438r1468b1497],
17	.	.	O	.	_	0	SENT_421	[p26l1266t1438r1468b1497],

1	We	PRP	O	we	nsubj	3	SENT_422	[p26l93t1539r193b1593],
2	are	VBP	O	be	cop	3	SENT_422	[p26l212t1554r307b1593],
3	indebted	JJ	O	indebted	_	0	SENT_422	[p26l326t1534r603b1593],
4	to	TO	O	to	_	0	SENT_422	[p26l623t1547r682b1593],
5	Dr.	NNP	O	Dr.	nn	7	SENT_422	[p26l701t1539r794b1593],
6	Lois	NNP	PERSON	Lois	nn	7	SENT_422	[p26l816t1535r947b1593],
7	Shepherd	NNP	PERSON	Shepherd	prep_to	3	SENT_422	[p26l969t1534r1287b1609],
8	,	,	O	,	_	0	SENT_422	[p26l969t1534r1287b1609],
9	Shakeel	NNP	PERSON	Shakeel	nn	10	SENT_422	[p26l1313t1534r1555b1594],
10	Virk	NNP	PERSON	Virk	conj_and	7	SENT_422	[p26l1571t1534r1722b1606],
11	,	,	O	,	_	0	SENT_422	[p26l1571t1534r1722b1606],
12	and	CC	O	and	_	0	SENT_422	[p26l1745t1534r1862b1593],
13	the	DT	O	the	det	15	SENT_422	[p26l1881t1534r1978b1593],
14	staff	NN	O	staff	nn	15	SENT_422	[p26l1998t1534r2149b1593],
15	members	NNS	O	member	conj_and	7	SENT_422	[p26l10t1629r307b1688],
16	of	IN	O	of	_	0	SENT_422	[p26l340t1629r415b1688],
17	the	DT	O	the	det	19	SENT_422	[p26l433t1629r530b1687],
18	Correlative	NNP	ORGANIZATION	Correlative	nn	19	SENT_422	[p26l561t1629r904b1688],
19	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	15	SENT_422	[p26l937t1630r1202b1688],
20	and	CC	O	and	_	0	SENT_422	[p26l1234t1629r1352b1688],
21	Tumour	NNP	ORGANIZATION	Tumour	nn	24	SENT_422	[p26l1379t1634r1638b1688],
22	Bank	NNP	ORGANIZATION	Bank	nn	24	SENT_422	[p26l1666t1629r1832b1689],
23	Working	NNP	ORGANIZATION	Working	nn	24	SENT_422	[p26l1856t1629r2138b1705],
24	Group	NNP	ORGANIZATION	Group	conj_and	19	SENT_422	[p26l10t1729r214b1800],
25	of	IN	ORGANIZATION	of	_	0	SENT_422	[p26l234t1725r309b1784],
26	the	DT	ORGANIZATION	the	det	29	SENT_422	[p26l314t1725r411b1784],
27	N	NN	ORGANIZATION	n	nn	29	SENT_422	[p26l428t1730r484b1785],
28	CIC	NNP	ORGANIZATION	CIC	nn	29	SENT_422	[p26l486t1729r603b1784],
29	CTG	NNP	ORGANIZATION	CTG	prep_of	19	SENT_422	[p26l623t1729r769b1784],
30	for	IN	O	for	_	0	SENT_422	[p26l788t1725r880b1784],
31	the	DT	O	the	det	32	SENT_422	[p26l896t1725r993b1784],
32	collection	NN	O	collection	prep_for	3	SENT_422	[p26l1012t1725r1321b1784],
33	and	CC	O	and	_	0	SENT_422	[p26l1339t1725r1455b1784],
34	preparation	NN	O	preparation	conj_and	32	SENT_422	[p26l1472t1726r1843b1800],
35	of	IN	O	of	_	0	SENT_422	[p26l1862t1725r1938b1784],
36	tumor	NN	O	tumor	nn	37	SENT_422	[p26l1942t1738r2139b1785],
37	samples	NNS	O	sample	prep_of	32	SENT_422	[p26l11t1821r287b1896],
38	.	.	O	.	_	0	SENT_422	[p26l11t1821r287b1896],

1	cancer	NN	O	cancer	_	0	SENT_423	[p26l18t2200r412b2296],
2	.	.	O	.	_	0	SENT_423	[p26l18t2200r412b2296],

1	J	NNP	O	J	nn	3	SENT_424	[p26l18t2200r412b2296],
2	Clin	NNP	O	Clin	nn	3	SENT_424	[p26l445t2192r641b2281],
3	Oncol	NNP	O	Oncol	_	0	SENT_424	[p26l667t2192r955b2281],
4	2003	CD	DATE	2003	num	3	SENT_424	[p26l982t2198r1824b2300],
5	;	:	O	;	_	0	SENT_424	[p26l982t2198r1824b2300],
6	21:2237	CD	NUMBER	21:2237	number	7	SENT_424	[p26l982t2198r1824b2300],
7	—	CD	NUMBER	—	dep	3	SENT_424	[p26l982t2198r1824b2300],
8	46	CD	NUMBER	46	dep	7	SENT_424	[p26l982t2198r1824b2300],
9	.	.	O	.	_	0	SENT_424	[p26l982t2198r1824b2300],

1	[	NN	O	[	nn	2	SENT_425	[p26l1867t2200r2132b2294, p26l18t2347r300b2447],
2	Erratum	NN	O	erratum	_	0	SENT_425	[p26l1867t2200r2132b2294, p26l18t2347r300b2447],
3	,	,	O	,	_	0	SENT_425	[p26l1867t2200r2132b2294, p26l18t2347r300b2447],
4	]	CD	NUMBER	]	appos	2	SENT_425	[p26l1867t2200r2132b2294, p26l18t2347r300b2447],
5	Clin	NNP	O	Clin	nn	6	SENT_425	[p26l335t2339r538b2428],
6	Oncol	NNP	O	Oncol	dep	2	SENT_425	[p26l568t2339r860b2428],
7	2004	CD	DATE	2004	rcmod	6	SENT_425	[p26l887t2345r1623b2447],
8	;	:	O	;	_	0	SENT_425	[p26l887t2345r1623b2447],
9	22:4811	CD	NUMBER	22:4811	dep	7	SENT_425	[p26l887t2345r1623b2447],
10	.	.	O	.	_	0	SENT_425	[p26l887t2345r1623b2447],
11	]	SYM	O	]	dep	7	SENT_425	[p26l887t2345r1623b2447],

1	17	CD	NUMBER	17	_	0	SENT_426	[p26l22t2497r152b2575],
2	.	.	O	.	_	0	SENT_426	[p26l22t2497r152b2575],

1	Kris	NNP	PERSON	Kris	nn	2	SENT_427	[p26l215t2488r412b2578],
2	MG	NN	PERSON	mg	_	0	SENT_427	[p26l454t2492r669b2594],
3	,	,	O	,	_	0	SENT_427	[p26l454t2492r669b2594],
4	Natale	NNP	PERSON	Natale	nn	5	SENT_427	[p26l716t2486r1037b2576],
5	RB	NN	O	rb	appos	2	SENT_427	[p26l1079t2494r1250b2594],
6	,	,	O	,	_	0	SENT_427	[p26l1079t2494r1250b2594],
7	Herbst	NNP	ORGANIZATION	Herbst	nn	8	SENT_427	[p26l1299t2486r1641b2575],
8	RS	NN	ORGANIZATION	r	appos	2	SENT_427	[p26l1676t2492r1838b2594],
9	,	,	O	,	_	0	SENT_427	[p26l1676t2492r1838b2594],
10	et	FW	O	et	nn	11	SENT_427	[p26l1889t2505r1978b2575],
11	al.	FW	O	al.	appos	2	SENT_427	[p26l2015t2486r2125b2575],
12	.	.	O	.	_	0	SENT_427	[p26l2015t2486r2125b2575],

1	Efficacy	NN	O	efficacy	nn	2	SENT_428	[p26l16t2631r406b2747],
2	ofgeﬁtinib	NN	O	ofgeﬁtinib	_	0	SENT_428	[p26l430t2631r1000b2747],
3	,	,	O	,	_	0	SENT_428	[p26l430t2631r1000b2747],
4	an	DT	O	a	det	5	SENT_428	[p26l1033t2662r1150b2722],
5	inhibitor	NN	O	inhibitor	appos	2	SENT_428	[p26l1177t2633r1617b2722],
6	of	IN	O	of	_	0	SENT_428	[p26l1642t2631r1759b2722],
7	the	DT	O	the	det	13	SENT_428	[p26l1767t2633r1917b2722],
8	epidermal	JJ	O	epidermal	amod	13	SENT_428	[p26l1946t2633r2131b2747, p26l18t2780r363b2869],
9	growth	NN	O	growth	nn	13	SENT_428	[p26l402t2780r757b2894],
10	factor	NN	O	factor	nn	13	SENT_428	[p26l796t2778r1085b2869],
11	receptor	NN	O	receptor	nn	13	SENT_428	[p26l1122t2799r1532b2894],
12	tyrosine	NN	O	tyrosine	nn	13	SENT_428	[p26l1569t2780r1962b2894],
13	kinase	NN	O	kinase	prep_of	5	SENT_428	[p26l2003t2780r2131b2871, p26l18t2956r268b3035],
14	,	,	O	,	_	0	SENT_428	[p26l2003t2780r2131b2871, p26l18t2956r268b3035],
15	in	IN	O	in	_	0	SENT_428	[p26l327t2927r422b3015],
16	symptomatic	JJ	O	symptomatic	amod	17	SENT_428	[p26l477t2927r1124b3041],
17	patients	NNS	O	patient	prep_in	2	SENT_428	[p26l1175t2927r1572b3041],
18	with	IN	O	with	_	0	SENT_428	[p26l1622t2927r1845b3017],
19	nonsmall	JJ	O	nonsmall	amod	22	SENT_428	[p26l1897t2956r2130b3016, p26l20t3074r288b3163],
20	cell	NN	O	cell	nn	22	SENT_428	[p26l335t3074r499b3163],
21	lung	NN	O	lung	nn	22	SENT_428	[p26l538t3074r761b3188],
22	cancer	NN	O	cancer	prep_with	17	SENT_428	[p26l801t3103r1142b3163],
23	:	:	O	:	_	0	SENT_428	[p26l801t3103r1142b3163],
24	a	DT	O	a	det	26	SENT_428	[p26l1189t3103r1240b3163],
25	randomized	JJ	O	randomized	amod	26	SENT_428	[p26l1280t3074r1867b3163],
26	trial	NN	O	trial	dep	17	SENT_428	[p26l1909t3074r2126b3163],
27	.	.	O	.	_	0	SENT_428	[p26l1909t3074r2126b3163],

1	JAMA	NNP	O	JAMA	_	0	SENT_429	[p26l6t3230r298b3327],
2	2003	CD	DATE	2003	num	1	SENT_429	[p26l323t3228r1240b3331],
3	;	:	O	;	_	0	SENT_429	[p26l323t3228r1240b3331],
4	290:2149	CD	NUMBER	290:2149	number	5	SENT_429	[p26l323t3228r1240b3331],
5	—	CD	NUMBER	—	dep	1	SENT_429	[p26l323t3228r1240b3331],
6	58	CD	NUMBER	58	dep	5	SENT_429	[p26l323t3228r1240b3331],
7	.	.	O	.	_	0	SENT_429	[p26l323t3228r1240b3331],

1	18	CD	NUMBER	18	_	0	SENT_430	[p26l22t3378r152b3460],
2	.	.	O	.	_	0	SENT_430	[p26l22t3378r152b3460],

1	Pérez	NNP	PERSON	Pérez	_	0	SENT_431	[p26l213t3366r767b3459],
2	.	.	O	.	_	0	SENT_431	[p26l213t3366r767b3459],

1	—	NN	O	—	_	0	SENT_432	[p26l213t3366r767b3459],
2	.	.	O	.	_	0	SENT_432	[p26l213t3366r767b3459],

1	Soler	NNP	PERSON	Soler	nn	2	SENT_433	[p26l213t3366r767b3459],
2	R	NNP	PERSON	R	_	0	SENT_433	[p26l799t3378r897b3478],
3	,	,	O	,	_	0	SENT_433	[p26l799t3378r897b3478],
4	Chachoua	NNP	O	Chachoua	nn	5	SENT_433	[p26l942t3370r1430b3460],
5	A	NNP	O	A	appos	2	SENT_433	[p26l1461t3378r1560b3478],
6	,	,	O	,	_	0	SENT_433	[p26l1461t3378r1560b3478],
7	Hammond	NNP	ORGANIZATION	Hammond	nn	8	SENT_433	[p26l1603t3370r2133b3459],
8	LA	NNP	ORGANIZATION	LA	appos	2	SENT_433	[p26l16t3525r174b3625],
9	,	,	O	,	_	0	SENT_433	[p26l16t3525r174b3625],
10	et	FW	O	et	nn	11	SENT_433	[p26l225t3535r313b3606],
11	al.	FW	O	al.	appos	2	SENT_433	[p26l351t3517r458b3606],
12	.	.	O	.	_	0	SENT_433	[p26l351t3517r458b3606],

1	Determinants	NNS	O	determinant	_	0	SENT_434	[p26l507t3517r1171b3606],
2	of	IN	O	of	_	0	SENT_434	[p26l1218t3515r1333b3606],
3	tumor	NN	O	tumor	nn	4	SENT_434	[p26l1356t3536r1658b3607],
4	response	NN	O	response	prep_of	1	SENT_434	[p26l1698t3546r2133b3631],
5	and	CC	O	and	_	0	SENT_434	[p26l17t3664r196b3753],
6	survival	NN	O	survival	prep_of	1	SENT_434	[p26l240t3664r605b3754],
7	with	IN	O	with	_	0	SENT_434	[p26l643t3664r860b3754],
8	erlotinib	NN	O	erlotinib	prep_with	1	SENT_434	[p26l903t3664r1313b3753],
9	in	IN	O	in	_	0	SENT_434	[p26l1358t3664r1451b3752],
10	patients	NNS	O	patient	prep_in	1	SENT_434	[p26l1492t3666r1875b3778],
11	with	IN	O	with	_	0	SENT_434	[p26l1916t3664r2133b3754],
12	non	JJ	O	non	amod	18	SENT_434	[p27l18t23r698b112],
13	—	JJ	O	—	amod	18	SENT_434	[p27l18t23r698b112],
14	small	JJ	O	small	amod	18	SENT_434	[p27l18t23r698b112],
15	—	NN	O	—	nn	18	SENT_434	[p27l18t23r698b112],
16	cell	NN	O	cell	nn	18	SENT_434	[p27l18t23r698b112],
17	lung	NN	O	lung	nn	18	SENT_434	[p27l717t23r935b137],
18	cancer	NN	O	cancer	prep_with	10	SENT_434	[p27l952t52r1274b112],
19	.	.	O	.	_	0	SENT_434	[p27l952t52r1274b112],

1	J	NNP	O	J	nn	3	SENT_435	[p27l1290t31r1333b127],
2	Clin	NNP	O	Clin	nn	3	SENT_435	[p27l1352t23r1546b112],
3	Oncol	NNP	O	Oncol	_	0	SENT_435	[p27l1566t23r1851b112],
4	2004	CD	DATE	2004	num	3	SENT_435	[p27l1871t29r2130b131],
5	;	:	O	;	_	0	SENT_435	[p27l1871t29r2130b131],
6	22:3238	CD	NUMBER	22:3238	number	7	SENT_435	[p27l18t176r598b261],
7	-47	CD	NUMBER	-47	dep	3	SENT_435	[p27l18t176r598b261],
8	.	.	O	.	_	0	SENT_435	[p27l18t176r598b261],

1	19	CD	NUMBER	19	_	0	SENT_436	[p27l22t328r152b407],
2	.	.	O	.	_	0	SENT_436	[p27l22t328r152b407],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_437	[p27l213t318r503b432],
2	T	NN	O	t	nn	3	SENT_437	[p27l523t324r651b426],
3	]	NN	O	]	_	0	SENT_437	[p27l523t324r651b426],
4	,	,	O	,	_	0	SENT_437	[p27l523t324r651b426],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_437	[p27l680t318r864b407],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_437	[p27l886t326r1084b426],
7	,	,	O	,	_	0	SENT_437	[p27l886t326r1084b426],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_437	[p27l1118t318r1510b407],
9	R	NNP	PERSON	R	appos	3	SENT_437	[p27l1532t326r1629b426],
10	,	,	O	,	_	0	SENT_437	[p27l1532t326r1629b426],
11	et	FW	O	et	nn	12	SENT_437	[p27l1662t336r1749b407],
12	al.	FW	O	al.	appos	3	SENT_437	[p27l1767t318r1875b407],
13	.	.	O	.	_	0	SENT_437	[p27l1767t318r1875b407],

1	Activating	VBG	O	activate	amod	2	SENT_438	[p27l1902t318r2131b407, p27l12t467r320b579],
2	mutations	NNS	O	mutation	_	0	SENT_438	[p27l359t465r862b556],
3	in	IN	O	in	_	0	SENT_438	[p27l907t465r1000b553],
4	the	DT	O	the	det	7	SENT_438	[p27l1043t465r1195b554],
5	epidermal	JJ	O	epidermal	amod	7	SENT_438	[p27l1238t465r1737b579],
6	growth	NN	O	growth	nn	7	SENT_438	[p27l1778t465r2132b579],
7	factor	NN	O	factor	prep_in	2	SENT_438	[p27l18t610r306b701],
8	receptor	NN	O	receptor	nn	10	SENT_438	[p27l363t630r767b726],
9	underlying	VBG	O	underlie	amod	10	SENT_438	[p27l820t612r1347b726],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_438	[p27l1398t612r2130b726],
11	of	IN	O	of	_	0	SENT_438	[p27l18t757r136b848],
12	non	JJ	O	non	amod	18	SENT_438	[p27l152t759r893b848],
13	—	JJ	O	—	amod	18	SENT_438	[p27l152t759r893b848],
14	small	JJ	O	small	amod	18	SENT_438	[p27l152t759r893b848],
15	—	NN	O	—	nn	18	SENT_438	[p27l152t759r893b848],
16	cell	NN	O	cell	nn	18	SENT_438	[p27l152t759r893b848],
17	lung	NN	O	lung	nn	18	SENT_438	[p27l929t759r1156b873],
18	cancer	NN	O	cancer	prep_of	10	SENT_438	[p27l1191t788r1512b848],
19	to	TO	O	to	_	0	SENT_438	[p27l1548t777r1640b848],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_438	[p27l1680t757r2126b873],
21	.	.	O	.	_	0	SENT_438	[p27l1680t757r2126b873],

1	N	NN	O	n	nn	2	SENT_439	[p27l16t914r101b996],
2	EnglJ	NN	O	englj	nsubj	3	SENT_439	[p27l140t906r424b1020],
3	Med	VBD	O	med	_	0	SENT_439	[p27l447t906r661b995],
4	2004	CD	DATE	2004	dobj	3	SENT_439	[p27l690t912r1607b1014],
5	;	:	O	;	_	0	SENT_439	[p27l690t912r1607b1014],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_439	[p27l690t912r1607b1014],
7	—	CD	NUMBER	—	dep	4	SENT_439	[p27l690t912r1607b1014],
8	39	CD	NUMBER	39	dep	7	SENT_439	[p27l690t912r1607b1014],
9	.	.	O	.	_	0	SENT_439	[p27l690t912r1607b1014],

1	20	CD	NUMBER	20	_	0	SENT_440	[p27l16t1061r152b1142],
2	.	.	O	.	_	0	SENT_440	[p27l16t1061r152b1142],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_441	[p27l213t1061r436b1142],
2	JG	NNP	O	JG	_	0	SENT_441	[p27l463t1059r621b1161],
3	,	,	O	,	_	0	SENT_441	[p27l463t1059r621b1161],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_441	[p27l656t1061r939b1157],
5	PA	NN	PERSON	pa	appos	2	SENT_441	[p27l978t1061r1134b1161],
6	,	,	O	,	_	0	SENT_441	[p27l978t1061r1134b1161],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_441	[p27l1179t1061r1343b1142],
8	JC	NNP	PERSON	JC	appos	2	SENT_441	[p27l1372t1059r1516b1161],
9	,	,	O	,	_	0	SENT_441	[p27l1372t1059r1516b1161],
10	et	FW	O	et	nn	11	SENT_441	[p27l1564t1071r1654b1142],
11	al.	FW	O	al.	appos	2	SENT_441	[p27l1687t1053r1798b1142],
12	.	.	O	.	_	0	SENT_441	[p27l1687t1053r1798b1142],

1	EGPR	NN	O	egpr	nn	2	SENT_442	[p27l1842t1059r2143b1147],
2	mutations	NNS	O	mutation	_	0	SENT_442	[p27l18t1200r521b1290],
3	in	IN	O	in	_	0	SENT_442	[p27l560t1200r655b1288],
4	lung	NN	O	lung	nn	5	SENT_442	[p27l690t1200r915b1314],
5	cancer	NN	O	cancer	prep_in	2	SENT_442	[p27l948t1229r1297b1289],
6	:	:	O	:	_	0	SENT_442	[p27l948t1229r1297b1289],
7	correlation	NN	O	correlation	dep	2	SENT_442	[p27l1339t1200r1879b1289],
8	with	IN	O	with	_	0	SENT_442	[p27l1911t1200r2132b1291],
9	clinical	JJ	O	clinical	amod	10	SENT_442	[p27l18t1347r373b1436],
10	response	NN	O	response	prep_with	7	SENT_442	[p27l418t1376r862b1461],
11	to	TO	O	to	_	0	SENT_442	[p27l909t1365r1000b1436],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_442	[p27l1049t1345r1465b1461],
13	therapy	NN	O	therapy	prep_to	10	SENT_442	[p27l1512t1347r1897b1461],
14	.	.	O	.	_	0	SENT_442	[p27l1512t1347r1897b1461],

1	Science	NNP	O	Science	_	0	SENT_443	[p27l1952t1347r2129b1436, p27l18t1525r239b1584],
2	2004	CD	DATE	2004	num	1	SENT_443	[p27l270t1501r1250b1604],
3	;	:	O	;	_	0	SENT_443	[p27l270t1501r1250b1604],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_443	[p27l270t1501r1250b1604],
5	—	CD	NUMBER	—	dep	1	SENT_443	[p27l270t1501r1250b1604],
6	500	CD	NUMBER	500	dep	5	SENT_443	[p27l270t1501r1250b1604],
7	.	.	O	.	_	0	SENT_443	[p27l270t1501r1250b1604],

1	21	CD	NUMBER	21	_	0	SENT_444	[p27l16t1653r152b1732],
2	.	.	O	.	_	0	SENT_444	[p27l16t1653r152b1732],

1	Pao	NNP	O	Pao	nn	2	SENT_445	[p27l213t1651r387b1732],
2	W	NNP	O	W	_	0	SENT_445	[p27l416t1651r535b1751],
3	,	,	O	,	_	0	SENT_445	[p27l416t1651r535b1751],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_445	[p27l570t1643r864b1732],
5	V	NNP	O	V	appos	2	SENT_445	[p27l888t1651r968b1751],
6	,	,	O	,	_	0	SENT_445	[p27l888t1651r968b1751],
7	Zakovvski	NNP	O	Zakovvski	nn	8	SENT_445	[p27l1005t1643r1473b1733],
8	M	NNP	O	M	appos	2	SENT_445	[p27l1500t1651r1625b1751],
9	,	,	O	,	_	0	SENT_445	[p27l1500t1651r1625b1751],
10	et	FW	O	et	nn	11	SENT_445	[p27l1664t1661r1753b1732],
11	al.	FW	O	al.	appos	2	SENT_445	[p27l1778t1643r1885b1732],
12	.	.	O	.	_	0	SENT_445	[p27l1778t1643r1885b1732],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_446	[p27l1922t1649r2131b1732],
2	receptor	NN	O	receptor	nn	4	SENT_446	[p27l18t1809r434b1904],
3	gene	NN	O	gene	nn	4	SENT_446	[p27l483t1819r718b1904],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_446	[p27l771t1792r1280b1881],
5	are	VBP	O	be	cop	6	SENT_446	[p27l1335t1819r1483b1879],
6	common	JJ	O	common	_	0	SENT_446	[p27l1538t1819r1983b1879],
7	in	IN	O	in	_	0	SENT_446	[p27l2035t1790r2131b1878],
8	lung	NN	O	lung	nn	9	SENT_446	[p27l16t1937r245b2051],
9	cancers	NNS	O	cancer	prep_in	6	SENT_446	[p27l276t1966r639b2026],
10	from	IN	O	from	_	0	SENT_446	[p27l672t1935r911b2026],
11	“	CD	NUMBER	“	prep_from	9	SENT_446	[p27l944t1941r1256b2027],
12	never	RB	O	never	advmod	9	SENT_446	[p27l944t1941r1256b2027],
13	smokers	NNS	O	smoker	dep	9	SENT_446	[p27l1285t1937r1745b2028],
14	”	CD	NUMBER	”	tmod	6	SENT_446	[p27l1285t1937r1745b2028],
15	and	CC	O	and	_	0	SENT_446	[p27l1780t1937r1958b2026],
16	are	VBP	O	be	auxpass	17	SENT_446	[p27l1987t1966r2133b2026],
17	associated	VBN	O	associate	conj_and	6	SENT_446	[p27l17t2084r519b2173],
18	with	IN	O	with	_	0	SENT_446	[p27l542t2084r759b2174],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_446	[p27l789t2084r1270b2198],
20	of	IN	O	of	_	0	SENT_446	[p27l1293t2082r1410b2173],
21	tumors	NNS	O	tumor	prep_of	19	SENT_446	[p27l1417t2102r1763b2174],
22	to	TO	O	to	_	0	SENT_446	[p27l1794t2103r1885b2173],
23	geﬁtinib	NN	O	geﬁtinib	prep_to	17	SENT_446	[p27l1914t2082r2132b2198, p27l18t2231r239b2320],
24	and	CC	O	and	_	0	SENT_446	[p27l272t2231r450b2320],
25	erlotinib	NN	O	erlotinib	conj_and	23	SENT_446	[p27l481t2231r921b2320],
26	.	.	O	.	_	0	SENT_446	[p27l481t2231r921b2320],

1	Proc	NNP	O	Proc	nn	7	SENT_447	[p27l956t2239r1172b2320],
2	Natl	NNP	O	Natl	nn	7	SENT_447	[p27l1199t2231r1406b2322],
3	Acad	NNP	O	Acad	nn	7	SENT_447	[p27l1431t2231r1674b2320],
4	Sci	NNP	O	Sci	nn	7	SENT_447	[p27l1707t2231r1843b2322],
5	U	NNP	O	U	nn	7	SENT_447	[p27l1873t2239r1952b2322],
6	S	NNP	O	S	nn	7	SENT_447	[p27l1983t2237r2031b2320],
7	A	NNP	O	A	_	0	SENT_447	[p27l2060t2239r2137b2320],

1	2004	CD	DATE	2004	_	0	SENT_448	[p27l18t2386r996b2489],
2	;	:	O	;	_	0	SENT_448	[p27l18t2386r996b2489],
3	101:13306	CD	NUMBER	101:13306	number	4	SENT_448	[p27l18t2386r996b2489],
4	-11	CD	NUMBER	-11	dep	1	SENT_448	[p27l18t2386r996b2489],
5	.	.	O	.	_	0	SENT_448	[p27l18t2386r996b2489],

1	22	CD	NUMBER	22	_	0	SENT_449	[p27l16t2538r152b2617],
2	.	.	O	.	_	0	SENT_449	[p27l16t2538r152b2617],

1	Cappuzzo	NNP	PERSON	Cappuzzo	nn	2	SENT_450	[p27l215t2534r700b2642],
2	F	NN	O	f	_	0	SENT_450	[p27l725t2536r797b2636],
3	,	,	O	,	_	0	SENT_450	[p27l725t2536r797b2636],
4	Hirsch	NNP	PERSON	Hirsch	nn	5	SENT_450	[p27l828t2528r1154b2617],
5	F	NN	O	f	appos	2	SENT_450	[p27l1177t2536r1250b2636],
6	,	,	O	,	_	0	SENT_450	[p27l1177t2536r1250b2636],
7	Rossi	NNP	PERSON	Rossi	nn	8	SENT_450	[p27l1280t2528r1546b2623],
8	E	NNP	O	E	appos	2	SENT_450	[p27l1569t2536r1658b2636],
9	,	,	O	,	_	0	SENT_450	[p27l1569t2536r1658b2636],
10	et	FW	O	et	nn	11	SENT_450	[p27l1690t2547r1779b2617],
11	al.	FW	O	al.	appos	2	SENT_450	[p27l1796t2528r1905b2617],
12	.	.	O	.	_	0	SENT_450	[p27l1796t2528r1905b2617],

1	Epidermal	JJ	O	epidermal	amod	3	SENT_451	[p27l1936t2530r2131b2642, p27l18t2675r355b2764],
2	growth	NN	O	growth	nn	3	SENT_451	[p27l380t2675r726b2789],
3	factor	NN	O	factor	_	0	SENT_451	[p27l751t2673r1031b2764],
4	receptor	NN	O	receptor	nn	5	SENT_451	[p27l1055t2693r1453b2789],
5	gene	NN	O	gene	dep	3	SENT_451	[p27l1476t2704r1702b2789],
6	and	CC	O	and	_	0	SENT_451	[p27l1729t2675r1907b2764],
7	protein	NN	O	protein	nn	10	SENT_451	[p27l1930t2704r2132b2789, p27l18t2822r197b2911],
8	and	CC	O	and	_	0	SENT_451	[p27l219t2822r397b2911],
9	geﬁtinib	NN	O	geﬁtinib	nn	10	SENT_451	[p27l420t2820r822b2936],
10	sensitivity	NN	O	sensitivity	dep	3	SENT_451	[p27l850t2822r1325b2936],
11	in	IN	O	in	_	0	SENT_451	[p27l1342t2822r1435b2910],
12	non	JJ	O	non	amod	17	SENT_451	[p27l1459t2822r1950b2911],
13	—	JJ	O	—	amod	17	SENT_451	[p27l1459t2822r1950b2911],
14	small	JJ	O	small	amod	17	SENT_451	[p27l1459t2822r1950b2911],
15	cell	NN	O	cell	nn	17	SENT_451	[p27l1972t2822r2133b2911],
16	lung	NN	O	lung	nn	17	SENT_451	[p27l16t2969r239b3083],
17	cancer	NN	O	cancer	prep_in	3	SENT_451	[p27l262t2998r596b3058],
18	.	.	O	.	_	0	SENT_451	[p27l262t2998r596b3058],

1	J	NNP	O	J	nn	4	SENT_452	[p27l617t2977r661b3073],
2	Natl	NNP	O	Natl	nn	4	SENT_452	[p27l680t2969r887b3059],
3	Cancer	NNP	O	Cancer	nn	4	SENT_452	[p27l913t2975r1252b3058],
4	Inst	NNP	O	Inst	_	0	SENT_452	[p27l1274t2977r1465b3058],
5	2005	CD	DATE	2005	num	4	SENT_452	[p27l1485t2975r1719b3058],
6	;	:	O	;	_	0	SENT_452	[p27l1735t2975r2132b3077],
7	97:643	CD	NUMBER	97:643	number	8	SENT_452	[p27l1735t2975r2132b3077],
8	—	CD	NUMBER	—	dep	4	SENT_452	[p27l1735t2975r2132b3077],
9	55	CD	NUMBER	55	dep	8	SENT_452	[p27l20t3124r160b3205],
10	.	.	O	.	_	0	SENT_452	[p27l20t3124r160b3205],

1	23	CD	NUMBER	23	_	0	SENT_453	[p27l16t3274r152b3353],
2	.	.	O	.	_	0	SENT_453	[p27l16t3274r152b3353],

1	Kosaka	NNP	PERSON	Kosaka	nn	2	SENT_454	[p27l215t3264r570b3356],
2	T	NN	O	t	_	0	SENT_454	[p27l605t3270r690b3372],
3	,	,	O	,	_	0	SENT_454	[p27l605t3270r690b3372],
4	Yatabe	NNP	PERSON	Yatabe	nn	5	SENT_454	[p27l733t3264r1051b3353],
5	Y	NN	PERSON	y	appos	2	SENT_454	[p27l1088t3272r1167b3372],
6	,	,	O	,	_	0	SENT_454	[p27l1088t3272r1167b3372],
7	Endoh	NN	PERSON	endoh	nn	8	SENT_454	[p27l1212t3264r1532b3353],
8	H	NN	PERSON	h	appos	2	SENT_454	[p27l1573t3272r1684b3372],
9	,	,	O	,	_	0	SENT_454	[p27l1573t3272r1684b3372],
10	Kuvvano	NN	PERSON	kuvvano	nn	11	SENT_454	[p27l1731t3272r2131b3356],
11	H	NN	PERSON	h	appos	2	SENT_454	[p27l16t3419r128b3519],
12	,	,	O	,	_	0	SENT_454	[p27l16t3419r128b3519],
13	Takahashi	NNP	PERSON	Takahashi	nn	14	SENT_454	[p27l165t3411r663b3501],
14	T	NN	O	t	appos	2	SENT_454	[p27l692t3417r777b3519],
15	,	,	O	,	_	0	SENT_454	[p27l692t3417r777b3519],
16	Mitsudomi	NNP	O	Mitsudomi	nn	18	SENT_454	[p27l814t3411r1351b3501],
17	T.	NNP	O	T.	nn	18	SENT_454	[p27l1382t3417r1465b3500],
18	Mutations	NNS	O	mutation	appos	2	SENT_454	[p27l1502t3411r2000b3501],
19	of	IN	O	of	_	0	SENT_454	[p27l2038t3409r2153b3500],
20	the	DT	O	the	det	25	SENT_454	[p27l18t3558r166b3647],
21	epidermal	JJ	O	epidermal	amod	25	SENT_454	[p27l213t3558r700b3672],
22	growth	NN	O	growth	nn	25	SENT_454	[p27l745t3558r1092b3672],
23	factor	NN	O	factor	nn	25	SENT_454	[p27l1137t3556r1420b3647],
24	receptor	NN	O	receptor	nn	25	SENT_454	[p27l1461t3576r1863b3672],
25	gene	NN	O	gene	prep_of	18	SENT_454	[p27l1905t3587r2133b3672],
26	in	IN	O	in	_	0	SENT_454	[p28l16t23r111b111],
27	lung	NN	O	lung	nn	28	SENT_454	[p28l136t23r359b137],
28	cancer	NN	O	cancer	prep_in	25	SENT_454	[p28l383t52r724b112],
29	:	:	O	:	_	0	SENT_454	[p28l383t52r724b112],
30	biological	JJ	O	biological	dep	2	SENT_454	[p28l757t23r1235b137],
31	and	CC	O	and	_	0	SENT_454	[p28l1262t23r1440b112],
32	clinical	JJ	O	clinical	amod	35	SENT_454	[p28l1467t23r1812b112],
33	impli	JJ	O	impli	amod	35	SENT_454	[p28l1839t23r2132b137],
34	—	NN	O	—	nn	35	SENT_454	[p28l1839t23r2132b137],
35	cations	NNS	O	cation	conj_and	30	SENT_454	[p28l18t170r391b259],
36	.	.	O	.	_	0	SENT_454	[p28l18t170r391b259],

1	Cancer	NNP	O	Cancer	nn	2	SENT_455	[p28l426t176r765b259],
2	Res	NNP	O	Res	_	0	SENT_455	[p28l788t178r960b264],
3	2004	CD	DATE	2004	num	2	SENT_455	[p28l991t176r1848b278],
4	;	:	O	;	_	0	SENT_455	[p28l991t176r1848b278],
5	64:8919	CD	NUMBER	64:8919	number	6	SENT_455	[p28l991t176r1848b278],
6	—	CD	NUMBER	—	dep	2	SENT_455	[p28l991t176r1848b278],
7	23	CD	NUMBER	23	dep	6	SENT_455	[p28l991t176r1848b278],
8	.	.	O	.	_	0	SENT_455	[p28l991t176r1848b278],

1	24	CD	NUMBER	24	_	0	SENT_456	[p28l16t327r152b406],
2	.	.	O	.	_	0	SENT_456	[p28l16t327r152b406],

1	Huang	NNP	PERSON	Huang	nsubj	2	SENT_457	[p28l215t325r548b431],
2	S	NN	O	s	_	0	SENT_457	[p28l585t323r753b425],
3	.	.	O	.	_	0	SENT_457	[p28l585t323r753b425],

1	—	NN	O	—	_	0	SENT_458	[p28l585t323r753b425],
2	.	.	O	.	_	0	SENT_458	[p28l585t323r753b425],

1	F	NN	O	f	_	0	SENT_459	[p28l585t323r753b425],
2	,	,	O	,	_	0	SENT_459	[p28l585t323r753b425],
3	Liu	NNP	PERSON	Liu	nn	4	SENT_459	[p28l796t319r949b407],
4	H	NNP	O	H	appos	1	SENT_459	[p28l986t325r1187b425],
5	.	.	O	.	_	0	SENT_459	[p28l986t325r1187b425],

1	—	NN	O	—	_	0	SENT_460	[p28l986t325r1187b425],
2	.	.	O	.	_	0	SENT_460	[p28l986t325r1187b425],

1	P	NN	O	p	_	0	SENT_461	[p28l986t325r1187b425],
2	,	,	O	,	_	0	SENT_461	[p28l986t325r1187b425],
3	Li	NNP	PERSON	Li	nn	4	SENT_461	[p28l1230t317r1321b405],
4	L	NNP	PERSON	L	appos	1	SENT_461	[p28l1356t325r1569b425],
5	.	.	O	.	_	0	SENT_461	[p28l1356t325r1569b425],

1	—	NN	O	—	_	0	SENT_462	[p28l1356t325r1569b425],
2	.	.	O	.	_	0	SENT_462	[p28l1356t325r1569b425],

1	H	NN	O	h	_	0	SENT_463	[p28l1356t325r1569b425],
2	,	,	O	,	_	0	SENT_463	[p28l1356t325r1569b425],
3	et	FW	O	et	nn	4	SENT_463	[p28l1615t336r1704b406],
4	al.	FW	O	al.	appos	1	SENT_463	[p28l1735t317r1844b406],
5	.	.	O	.	_	0	SENT_463	[p28l1735t317r1844b406],

1	High	JJ	O	high	_	0	SENT_464	[p28l1889t317r2133b431],

1	GLJ	NN	O	glj	nn	2	SENT_465	[p28l591t507r640b529],
2	MED	NN	O	med	_	0	SENT_465	[p28l655t508r708b523],
3	353	CD	NUMBER	353	dep	2	SENT_465	[p28l720t507r784b529],
4	;	:	O	;	_	0	SENT_465	[p28l720t507r784b529],
5	2	CD	NUMBER	2	num	7	SENT_465	[p28l720t507r784b529],
6	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	7	SENT_465	[p28l818t507r1030b529],
7	JULY14	NN	O	july14	dep	3	SENT_465	[p28l1063t508r1170b529],
8	,	,	O	,	_	0	SENT_465	[p28l1063t508r1170b529],
9	2005	CD	DATE	2005	number	10	SENT_465	[p28l1183t507r1247b529],
10	143	CD	NUMBER	143	appos	7	SENT_465	[p28l1961t506r2016b528],

1	The	DT	O	the	det	4	SENT_466	[p28l702t540r753b564],
2	New	NNP	O	New	nn	4	SENT_466	[p28l762t541r824b564],
3	England	NNP	O	England	nn	4	SENT_466	[p28l833t540r944b571],
4	Joumal	NNP	O	Joumal	_	0	SENT_466	[p28l953t540r1050b564],
5	of	IN	O	of	_	0	SENT_466	[p28l1060t540r1089b564],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_466	[p28l1095t540r1221b564],

1	Downloaded	VBN	O	download	_	0	SENT_467	[p28l144t581r314b604],
2	from	IN	O	from	_	0	SENT_467	[p28l323t581r387b604],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_467	[p28l396t581r514b611],
4	at	IN	O	at	_	0	SENT_467	[p28l525t585r548b604],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_467	[p28l556t581r739b604],
6	on	IN	O	on	_	0	SENT_467	[p28l748t588r781b604],
7	January	NNP	DATE	January	prep_on	1	SENT_467	[p28l789t581r892b611],
8	5	CD	DATE	5	num	7	SENT_467	[p28l902t581r925b608],
9	,	,	DATE	,	_	0	SENT_467	[p28l902t581r925b608],
10	2014	CD	DATE	2014	num	7	SENT_467	[p28l935t581r1007b604],
11	.	.	O	.	_	0	SENT_467	[p28l935t581r1007b604],

1	or	CC	O	or	dep	4	SENT_468	[p28l1037t588r1064b604],
2	ersonal	JJ	O	ersonal	amod	3	SENT_468	[p28l1090t581r1185b604],
3	use	NN	O	use	npadvmod	4	SENT_468	[p28l1194t588r1238b604],
4	only	RB	O	only	_	0	SENT_468	[p28l1247t581r1312b611],
5	.	.	O	.	_	0	SENT_468	[p28l1247t581r1312b611],

1	No	DT	O	no	det	3	SENT_469	[p28l1323t581r1363b604],
2	other	JJ	O	other	amod	3	SENT_469	[p28l1373t581r1441b604],
3	uses	NNS	O	use	_	0	SENT_469	[p28l1449t588r1505b604],
4	without	IN	O	without	_	0	SENT_469	[p28l1515t581r1616b604],
5	permission	NN	O	permission	prep_without	3	SENT_469	[p28l1624t581r1777b611],
6	.	.	O	.	_	0	SENT_469	[p28l1624t581r1777b611],

1	Copyright	NN	O	copyright	nn	5	SENT_470	[p28l494t622r629b653],
2	©	CD	NUMBER	©	num	5	SENT_470	[p28l638t622r661b646],
3	2005	CD	DATE	2005	num	5	SENT_470	[p28l672t622r736b646],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_470	[p28l746t622r937b646],
5	Medica	NNP	ORGANIZATION	Medica	_	0	SENT_470	[p28l947t622r1047b646],
6	ociety	NN	O	ociety	dep	5	SENT_470	[p28l1084t622r1171b653],
7	.	.	O	.	_	0	SENT_470	[p28l1084t622r1171b653],

1	All	DT	O	all	det	2	SENT_471	[p28l1182t622r1223b646],
2	rights	NNS	O	rights	nsubj	3	SENT_471	[p28l1232t622r1307b653],
3	reserved	VBN	O	reserve	_	0	SENT_471	[p28l1317t622r1436b646],
4	.	.	O	.	_	0	SENT_471	[p28l1317t622r1436b646],

1	RRRRRRRRRRRRRRRRRRRRRRRRRRR	NN	O	rrrrrrrrrrrrrrrrrrrrrrrrrrr	nn	2	SENT_472	[p28l736t728r1377b747],
2	ER	NN	O	er	_	0	SENT_472	[p28l1382t728r1424b747],

1	frequency	NN	O	frequency	nsubj	16	SENT_473	[p28l17t1037r486b1149],
2	of	IN	O	of	_	0	SENT_473	[p28l509t1037r621b1126],
3	epidermal	JJ	O	epidermal	amod	7	SENT_473	[p28l628t1037r1106b1149],
4	growth	NN	O	growth	nn	7	SENT_473	[p28l1131t1037r1473b1151],
5	factor	NN	O	factor	nn	7	SENT_473	[p28l1499t1037r1775b1126],
6	receptor	NN	O	receptor	nn	7	SENT_473	[p28l1800t1066r2090b1149, p28l17t1201r153b1271],
7	mutations	NNS	O	mutation	prep_of	1	SENT_473	[p28l173t1184r658b1271],
8	with	IN	O	with	_	0	SENT_473	[p28l679t1182r892b1271],
9	complex	JJ	O	complex	amod	10	SENT_473	[p28l916t1184r1321b1296],
10	patterns	NNS	O	pattern	prep_with	7	SENT_473	[p28l1340t1201r1727b1296],
11	in	IN	O	in	_	0	SENT_473	[p28l1752t1184r1845b1269],
12	nonsmall	JJ	O	nonsmall	amod	15	SENT_473	[p28l1868t1211r2090b1271, p28l19t1329r275b1416],
13	cell	NN	O	cell	nn	15	SENT_473	[p28l321t1327r480b1416],
14	lung	NN	O	lung	nn	15	SENT_473	[p28l524t1327r743b1441],
15	cancers	NNS	O	cancer	prep_in	10	SENT_473	[p28l785t1356r1139b1416],
16	related	VBN	O	relate	_	0	SENT_473	[p28l1187t1327r1508b1416],
17	to	TO	O	to	_	0	SENT_473	[p28l1555t1346r1644b1416],
18	gefitinib	NN	O	gefitinib	nn	19	SENT_473	[p28l1692t1327r2090b1441],
19	responsiveness	NN	O	responsiveness	prep_to	16	SENT_473	[p28l17t1474r735b1586],
20	in	IN	O	in	_	0	SENT_473	[p28l775t1474r868b1559],
21	Taiwan	NNP	LOCATION	Taiwan	prep_in	19	SENT_473	[p28l903t1474r1271b1561],
22	.	.	O	.	_	0	SENT_473	[p28l903t1474r1271b1561],

1	Clin	NNP	O	Clin	nn	3	SENT_474	[p28l1318t1474r1512b1561],
2	Cancer	NNP	O	Cancer	nn	3	SENT_474	[p28l1553t1480r1885b1561],
3	Res	NNP	O	Res	_	0	SENT_474	[p28l1920t1480r2088b1567],
4	2004	CD	DATE	2004	num	3	SENT_474	[p28l17t1625r917b1726],
5	;	:	O	;	_	0	SENT_474	[p28l17t1625r917b1726],
6	10:8195	CD	NUMBER	10:8195	number	7	SENT_474	[p28l17t1625r917b1726],
7	-203	CD	NUMBER	-203	dep	3	SENT_474	[p28l17t1625r917b1726],
8	.	.	O	.	_	0	SENT_474	[p28l17t1625r917b1726],

1	25	CD	NUMBER	25	_	0	SENT_475	[p28l16t1774r149b1852],
2	.	.	O	.	_	0	SENT_475	[p28l16t1774r149b1852],

1	Marchetti	NNP	PERSON	Marchetti	nn	2	SENT_476	[p28l207t1763r667b1852],
2	A	NNP	O	A	_	0	SENT_476	[p28l706t1771r803b1871],
3	,	,	O	,	_	0	SENT_476	[p28l706t1771r803b1871],
4	Martella	NNP	PERSON	Martella	nn	5	SENT_476	[p28l849t1763r1244b1852],
5	C	NNP	O	C	appos	2	SENT_476	[p28l1286t1770r1379b1871],
6	,	,	O	,	_	0	SENT_476	[p28l1286t1770r1379b1871],
7	Felicioni	NNP	O	Felicioni	nn	8	SENT_476	[p28l1427t1763r1837b1852],
8	L	NNP	O	L	appos	2	SENT_476	[p28l1879t1771r1961b1871],
9	,	,	O	,	_	0	SENT_476	[p28l1879t1771r1961b1871],
10	et	FW	O	et	nn	11	SENT_476	[p28l2011t1782r2096b1852],
11	al.	FW	O	al.	appos	2	SENT_476	[p28l16t1910r122b1997],
12	.	.	O	.	_	0	SENT_476	[p28l16t1910r122b1997],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_477	[p28l168t1916r459b2003],
2	mutations	NNS	O	mutation	_	0	SENT_477	[p28l488t1910r973b1997],
3	in	IN	O	in	_	0	SENT_477	[p28l1015t1910r1106b1995],
4	non	JJ	O	non	amod	10	SENT_477	[p28l1147t1908r1837b1997],
5	—	JJ	O	—	amod	10	SENT_477	[p28l1147t1908r1837b1997],
6	small	JJ	O	small	amod	10	SENT_477	[p28l1147t1908r1837b1997],
7	—	NN	O	—	nn	10	SENT_477	[p28l1147t1908r1837b1997],
8	cell	NN	O	cell	nn	10	SENT_477	[p28l1147t1908r1837b1997],
9	lung	NN	O	lung	nn	10	SENT_477	[p28l1876t1910r2094b2022],
10	cancer	NN	O	cancer	prep_in	2	SENT_477	[p28l18t2082r352b2142],
11	:	:	O	:	_	0	SENT_477	[p28l18t2082r352b2142],
12	analysis	NN	O	analysis	dep	2	SENT_477	[p28l381t2053r753b2167],
13	of	IN	O	of	_	0	SENT_477	[p28l781t2053r895b2142],
14	a	DT	O	a	det	16	SENT_477	[p28l899t2084r949b2142],
15	large	JJ	O	large	amod	16	SENT_477	[p28l971t2053r1205b2167],
16	series	NN	O	series	prep_of	12	SENT_477	[p28l1233t2055r1499b2142],
17	of	IN	O	of	_	0	SENT_477	[p28l1527t2053r1640b2142],
18	cases	NNS	O	case	prep_of	16	SENT_477	[p28l1645t2084r1889b2142],
19	and	CC	O	and	_	0	SENT_477	[p28l1916t2053r2092b2142],
20	development	NN	O	development	conj_and	18	SENT_477	[p28l18t2198r636b2312],
21	of	IN	O	of	_	0	SENT_477	[p28l667t2198r780b2287],
22	a	DT	O	a	det	26	SENT_477	[p28l793t2229r843b2287],
23	rapid	JJ	O	rapid	amod	26	SENT_477	[p28l876t2198r1122b2312],
24	and	CC	O	and	_	0	SENT_477	[p28l1156t2198r1332b2287],
25	sensitive	JJ	O	sensitive	conj_and	23	SENT_477	[p28l1369t2200r1773b2287],
26	method	NN	O	method	prep_of	12	SENT_477	[p28l1808t2198r2090b2287, p28l18t2343r136b2432],
27	for	IN	O	for	_	0	SENT_477	[p28l182t2343r321b2432],
28	diagnostic	JJ	O	diagnostic	amod	29	SENT_477	[p28l366t2343r859b2457],
29	screening	NN	O	screening	prep_for	26	SENT_477	[p28l909t2345r1371b2457],
30	with	IN	O	with	_	0	SENT_477	[p28l1410t2343r1623b2432],
31	potential	JJ	O	potential	amod	32	SENT_477	[p28l1669t2345r2092b2457],
32	implications	NNS	O	implication	prep_with	29	SENT_477	[p28l16t2490r623b2602],
33	on	IN	O	on	_	0	SENT_477	[p28l661t2517r783b2577],
34	pharmacologic	JJ	O	pharmacologic	amod	35	SENT_477	[p28l818t2488r1551b2602],
35	treatment	NN	O	treatment	prep_on	32	SENT_477	[p28l1587t2507r2084b2577],
36	.	.	O	.	_	0	SENT_477	[p28l1587t2507r2084b2577],

1	J	NNP	O	J	nn	3	SENT_478	[p28l6t2642r49b2735],
2	Clin	NNP	O	Clin	nn	3	SENT_478	[p28l87t2633r286b2722],
3	Oncol	NNP	O	Oncol	_	0	SENT_478	[p28l315t2635r603b2722],
4	2005	CD	DATE	2005	num	3	SENT_478	[p28l630t2641r1412b2741],
5	;	:	O	;	_	0	SENT_478	[p28l630t2641r1412b2741],
6	23:857	CD	NUMBER	23:857	number	7	SENT_478	[p28l630t2641r1412b2741],
7	—	CD	NUMBER	—	dep	3	SENT_478	[p28l630t2641r1412b2741],
8	65	CD	NUMBER	65	dep	7	SENT_478	[p28l630t2641r1412b2741],
9	.	.	O	.	_	0	SENT_478	[p28l630t2641r1412b2741],

1	26	CD	NUMBER	26	_	0	SENT_479	[p28l15t2789r149b2867],
2	.	.	O	.	_	0	SENT_479	[p28l15t2789r149b2867],

1	Han	NNP	O	Han	nsubj	2	SENT_480	[p28l209t2786r410b2867],
2	S	NN	O	s	_	0	SENT_480	[p28l462t2785r665b2886],
3	.	.	O	.	_	0	SENT_480	[p28l462t2785r665b2886],

1	—	NN	O	—	_	0	SENT_481	[p28l462t2785r665b2886],
2	.	.	O	.	_	0	SENT_481	[p28l462t2785r665b2886],

1	VV	NN	O	vv	_	0	SENT_482	[p28l462t2785r665b2886],
2	,	,	O	,	_	0	SENT_482	[p28l462t2785r665b2886],
3	Kim	NNP	PERSON	Kim	nn	4	SENT_482	[p28l721t2780r921b2869],
4	T	NN	O	t	appos	1	SENT_482	[p28l967t2785r1139b2886],
5	.	.	O	.	_	0	SENT_482	[p28l967t2785r1139b2886],

1	—	NN	O	—	_	0	SENT_483	[p28l967t2785r1139b2886],
2	.	.	O	.	_	0	SENT_483	[p28l967t2785r1139b2886],

1	Y	NN	O	y	_	0	SENT_484	[p28l967t2785r1139b2886],
2	,	,	O	,	_	0	SENT_484	[p28l967t2785r1139b2886],
3	Hwang	NNP	PERSON	Hwang	nn	4	SENT_484	[p28l1195t2786r1541b2892],
4	P	NN	O	p	appos	1	SENT_484	[p28l1585t2785r1793b2886],
5	.	.	O	.	_	0	SENT_484	[p28l1585t2785r1793b2886],

1	—	NN	O	—	_	0	SENT_485	[p28l1585t2785r1793b2886],
2	.	.	O	.	_	0	SENT_485	[p28l1585t2785r1793b2886],

1	G	NN	O	g	_	0	SENT_486	[p28l1585t2785r1793b2886],
2	,	,	O	,	_	0	SENT_486	[p28l1585t2785r1793b2886],
3	et	FW	O	et	nn	4	SENT_486	[p28l1849t2797r1936b2867],
4	al.	FW	O	al.	appos	1	SENT_486	[p28l1978t2778r2085b2867],
5	.	.	O	.	_	0	SENT_486	[p28l1978t2778r2085b2867],

1	Predictive	JJ	O	predictive	amod	4	SENT_487	[p28l15t2923r476b3012],
2	and	CC	O	and	_	0	SENT_487	[p28l510t2923r685b3012],
3	prognostic	JJ	O	prognostic	conj_and	1	SENT_487	[p28l718t2925r1234b3037],
4	impact	NN	O	impact	nsubj	18	SENT_487	[p28l1267t2925r1599b3037],
5	of	IN	O	of	_	0	SENT_487	[p28l1630t2923r1742b3012],
6	epidermal	JJ	O	epidermal	amod	10	SENT_487	[p28l1757t2923r2090b3037, p28l17t3068r192b3157],
7	growth	NN	O	growth	nn	10	SENT_487	[p28l220t3068r555b3182],
8	factor	NN	O	factor	nn	10	SENT_487	[p28l584t3068r857b3157],
9	receptor	NN	O	receptor	nn	10	SENT_487	[p28l882t3087r1269b3182],
10	mutation	NN	O	mutation	prep_of	4	SENT_487	[p28l1294t3070r1725b3157],
11	in	IN	O	in	_	0	SENT_487	[p28l1752t3070r1843b3155],
12	nonsmall	JJ	O	nonsmall	amod	17	SENT_487	[p28l1870t3097r2090b3157, p28l19t3213r474b3302],
13	—	NN	O	—	nn	17	SENT_487	[p28l1870t3097r2090b3157, p28l19t3213r474b3302],
14	cell	NN	O	cell	nn	17	SENT_487	[p28l1870t3097r2090b3157, p28l19t3213r474b3302],
15	lung	NN	O	lung	nn	17	SENT_487	[p28l509t3213r727b3327],
16	cancer	NN	O	cancer	nn	17	SENT_487	[p28l762t3242r1071b3302],
17	patients	NNS	O	patient	prep_in	10	SENT_487	[p28l1104t3215r1481b3327],
18	treated	VBN	O	treat	_	0	SENT_487	[p28l1521t3213r1847b3302],
19	with	IN	O	with	_	0	SENT_487	[p28l1879t3215r2092b3302],
20	gefitinib	NN	O	gefitinib	prep_with	18	SENT_487	[p28l17t3358r443b3472],
21	.	.	O	.	_	0	SENT_487	[p28l17t3358r443b3472],

1	J	NNP	O	J	nn	3	SENT_488	[p28l466t3367r509b3461],
2	Clin	NNP	O	Clin	nn	3	SENT_488	[p28l534t3360r729b3447],
3	Oncol	NNP	O	Oncol	_	0	SENT_488	[p28l758t3358r1044b3447],
4	2005	CD	DATE	2005	num	3	SENT_488	[p28l1071t3366r1970b3466],
5	;	:	O	;	_	0	SENT_488	[p28l1071t3366r1970b3466],
6	23:2493	CD	NUMBER	23:2493	num	7	SENT_488	[p28l1071t3366r1970b3466],
7	—	NN	O	—	dep	3	SENT_488	[p28l1071t3366r1970b3466],
8	501	CD	NUMBER	501	dep	7	SENT_488	[p28l1071t3366r1970b3466],
9	.	.	O	.	_	0	SENT_488	[p28l1071t3366r1970b3466],

1	27	CD	NUMBER	27	_	0	SENT_489	[p28l16t3514r149b3592],
2	.	.	O	.	_	0	SENT_489	[p28l16t3514r149b3592],

1	Shigematsu	NN	PERSON	shigematsu	nn	2	SENT_490	[p28l213t3503r770b3617],
2	H	NN	PERSON	h	_	0	SENT_490	[p28l798t3511r907b3611],
3	,	,	O	,	_	0	SENT_490	[p28l798t3511r907b3611],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_490	[p28l942t3505r1094b3590],
5	L	NNP	PERSON	L	appos	2	SENT_490	[p28l1121t3511r1203b3611],
6	,	,	O	,	_	0	SENT_490	[p28l1121t3511r1203b3611],
7	Takahashi	NNP	PERSON	Takahashi	nn	8	SENT_490	[p28l1236t3503r1723b3592],
8	T	NN	O	t	appos	2	SENT_490	[p28l1748t3510r1831b3611],
9	,	,	O	,	_	0	SENT_490	[p28l1748t3510r1831b3611],
10	et	FW	O	et	nn	11	SENT_490	[p28l1868t3522r1955b3592],
11	al.	FW	O	al.	appos	2	SENT_490	[p28l1978t3503r2084b3592],
12	.	.	O	.	_	0	SENT_490	[p28l1978t3503r2084b3592],

1	Clinical	JJ	O	clinical	amod	4	SENT_491	[p28l17t3648r387b3737],
2	and	CC	O	and	_	0	SENT_491	[p28l426t3648r604b3737],
3	biological	JJ	O	biological	conj_and	1	SENT_491	[p28l646t3648r1125b3762],
4	features	NNS	O	feature	nsubj	5	SENT_491	[p28l1164t3648r1547b3737],
5	associated	VBN	O	associate	_	0	SENT_491	[p28l1589t3648r2090b3737],
6	with	IN	O	with	_	0	SENT_491	[p29l12t22r228b111],
7	epidermal	JJ	O	epidermal	amod	12	SENT_491	[p29l261t22r743b136],
8	growth	NN	O	growth	nn	12	SENT_491	[p29l772t24r1114b136],
9	factor	NN	O	factor	nn	12	SENT_491	[p29l1143t22r1419b111],
10	receptor	NN	O	receptor	nn	12	SENT_491	[p29l1446t41r1841b136],
11	gene	NN	O	gene	nn	12	SENT_491	[p29l1866t51r2090b136],
12	mutations	NNS	O	mutation	prep_with	5	SENT_491	[p29l17t169r493b256],
13	in	IN	O	in	_	0	SENT_491	[p29l522t169r613b254],
14	lung	NN	O	lung	nn	15	SENT_491	[p29l638t169r853b281],
15	cancers	NNS	O	cancer	prep_in	12	SENT_491	[p29l878t196r1251b256],
16	.	.	O	.	_	0	SENT_491	[p29l878t196r1251b256],

1	J	NNP	O	J	nn	4	SENT_492	[p29l1274t176r1317b270],
2	Natl	NNP	O	Natl	nn	4	SENT_492	[p29l1338t167r1537b256],
3	Cancer	NNP	O	Cancer	nn	4	SENT_492	[p29l1564t175r1891b256],
4	Inst	NNP	O	Inst	_	0	SENT_492	[p29l1914t176r2098b256],

1	28	CD	NUMBER	28	_	0	SENT_493	[p29l15t467r149b547],
2	.	.	O	.	_	0	SENT_493	[p29l15t467r149b547],

1	Tol	NN	O	tol	dep	4	SENT_494	[p29l207t458r603b547],
2	<	JJR	O	<	dep	1	SENT_494	[p29l207t458r603b547],
3	umo	CD	NUMBER	umo	num	4	SENT_494	[p29l207t458r603b547],
4	M	NN	O	m	_	0	SENT_494	[p29l623t466r743b566],
5	,	,	O	,	_	0	SENT_494	[p29l623t466r743b566],
6	Toyooka	NNP	LOCATION	Toyooka	nn	7	SENT_494	[p29l766t458r1162b570],
7	S	NNP	LOCATION	S	appos	4	SENT_494	[p29l1185t465r1261b566],
8	,	,	O	,	_	0	SENT_494	[p29l1185t465r1261b566],
9	Idura	NNP	PERSON	Idura	nn	10	SENT_494	[p29l1288t460r1543b549],
10	K	NNP	PERSON	K	appos	4	SENT_494	[p29l1562t466r1659b566],
11	,	,	O	,	_	0	SENT_494	[p29l1562t466r1659b566],
12	et	FW	O	et	nn	13	SENT_494	[p29l1686t477r1771b547],
13	al.	FW	O	al.	appos	4	SENT_494	[p29l1787t458r1889b547],
14	.	.	O	.	_	0	SENT_494	[p29l1787t458r1889b547],

1	The	DT	O	the	det	2	SENT_495	[p29l1913t458r2092b547],
2	relationship	NN	O	relationship	_	0	SENT_495	[p29l17t603r575b717],
3	between	IN	O	between	_	0	SENT_495	[p29l609t603r1002b692],
4	epidermal	JJ	O	epidermal	amod	6	SENT_495	[p29l1034t603r1514b717],
5	growth	NN	O	growth	nn	6	SENT_495	[p29l1545t603r1885b717],
6	factor	NN	O	factor	prep_between	2	SENT_495	[p29l1918t603r2090b692, p29l17t767r155b837],

1	receptor	NN	O	receptor	nn	2	SENT_496	[p29l207t767r609b862],
2	mutations	NNS	O	mutation	_	0	SENT_496	[p29l661t750r1155b837],
3	and	CC	O	and	_	0	SENT_496	[p29l1212t748r1389b837],
4	clinicopathologic	JJ	O	clinicopathologic	conj_and	2	SENT_496	[p29l1444t748r2088b862, p29l16t893r248b1007],

1	features	NNS	O	feature	_	0	SENT_497	[p29l271t893r640b982],
2	in	IN	O	in	_	0	SENT_497	[p29l667t895r758b980],
3	non-small	JJ	O	non-small	amod	6	SENT_497	[p29l782t893r1265b982],
4	cell	NN	O	cell	nn	6	SENT_497	[p29l1290t893r1447b982],
5	lung	NN	O	lung	nn	6	SENT_497	[p29l1469t893r1686b1007],
6	cancers	NNS	O	cancer	prep_in	1	SENT_497	[p29l1707t922r2084b982],
7	.	.	O	.	_	0	SENT_497	[p29l1707t922r2084b982],

1	Clin	NNP	O	Clin	nn	3	SENT_498	[p29l17t1038r211b1127],
2	Cancer	NNP	O	Cancer	nn	3	SENT_498	[p29l240t1046r573b1127],
3	Res	NNP	O	Res	_	0	SENT_498	[p29l596t1046r764b1133],
4	2005	CD	DATE	2005	num	3	SENT_498	[p29l795t1046r1634b1146],
5	;	:	O	;	_	0	SENT_498	[p29l795t1046r1634b1146],
6	11:1167	CD	NUMBER	11:1167	number	7	SENT_498	[p29l795t1046r1634b1146],
7	-73	CD	NUMBER	-73	dep	3	SENT_498	[p29l795t1046r1634b1146],
8	.	.	O	.	_	0	SENT_498	[p29l795t1046r1634b1146],

1	29	CD	NUMBER	29	_	0	SENT_499	[p29l16t1194r149b1272],
2	.	.	O	.	_	0	SENT_499	[p29l16t1194r149b1272],

1	Yang	NNP	PERSON	Yang	nn	2	SENT_500	[p29l207t1191r441b1297],
2	SH	NNP	O	SH	_	0	SENT_500	[p29l466t1190r627b1291],
3	,	,	O	,	_	0	SENT_500	[p29l466t1190r627b1291],
4	Mechanic	NNP	O	Mechanic	nn	5	SENT_500	[p29l657t1183r1110b1272],
5	LE	NNP	O	LE	appos	2	SENT_500	[p29l1133t1191r1278b1291],
6	,	,	O	,	_	0	SENT_500	[p29l1133t1191r1278b1291],
7	Yang	NNP	PERSON	Yang	nn	8	SENT_500	[p29l1305t1191r1537b1297],
8	P	NN	PERSON	p	appos	2	SENT_500	[p29l1558t1191r1628b1291],
9	,	,	O	,	_	0	SENT_500	[p29l1558t1191r1628b1291],
10	et	FW	O	et	nn	11	SENT_500	[p29l1661t1202r1746b1272],
11	al.	FW	O	al.	appos	2	SENT_500	[p29l1765t1183r1868b1272],
12	.	.	O	.	_	0	SENT_500	[p29l1765t1183r1868b1272],

1	Mutations	NNS	O	mutation	_	0	SENT_501	[p29l1898t1191r2090b1272, p29l48t1734r203b1777],

1	in	IN	O	in	_	0	SENT_502	[p29l219t1734r263b1776],
2	the	DT	O	the	det	5	SENT_502	[p29l279t1734r350b1777],
3	tyrosine	NN	O	tyrosine	nn	5	SENT_502	[p29l367t1734r551b1789],
4	kinase	NN	O	kinase	nn	5	SENT_502	[p29l568t1733r717b1777],
5	domain	NN	O	domain	pobj	1	SENT_502	[p29l735t1733r913b1777],
6	of	IN	O	of	_	0	SENT_502	[p29l930t1733r986b1777],
7	the	DT	O	the	det	11	SENT_502	[p29l992t1734r1064b1777],
8	epidermal	JJ	O	epidermal	amod	11	SENT_502	[p29l49t1803r287b1859],
9	growth	NN	O	growth	nn	11	SENT_502	[p29l310t1804r480b1859],
10	factor	NN	O	factor	nn	11	SENT_502	[p29l504t1803r642b1847],
11	receptor	NN	O	receptor	prep_of	5	SENT_502	[p29l664t1812r862b1859],
12	in	IN	O	in	_	0	SENT_502	[p29l883t1804r929b1846],
13	nonsmall	JJ	O	nonsmall	amod	16	SENT_502	[p29l952t1817r1063b1847, p29l49t1874r177b1917],
14	cell	NN	O	cell	nn	16	SENT_502	[p29l208t1873r288b1917],
15	lung	NN	O	lung	nn	16	SENT_502	[p29l318t1873r427b1929],
16	cancer	NN	O	cancer	prep_in	11	SENT_502	[p29l457t1887r621b1917],
17	.	.	O	.	_	0	SENT_502	[p29l457t1887r621b1917],

1	Clin	NNP	O	Clin	nn	3	SENT_503	[p29l655t1873r752b1917],
2	Cancer	NNP	O	Cancer	nn	3	SENT_503	[p29l783t1877r949b1917],
3	Res	NNP	O	Res	_	0	SENT_503	[p29l978t1877r1062b1920],
4	2005	CD	DATE	2005	num	3	SENT_503	[p29l48t1947r464b1996],
5	;	:	O	;	_	0	SENT_503	[p29l48t1947r464b1996],
6	11:2106	CD	DATE	11:2106	number	7	SENT_503	[p29l48t1947r464b1996],
7	-10	CD	DATE	-10	dep	3	SENT_503	[p29l48t1947r464b1996],
8	.	.	O	.	_	0	SENT_503	[p29l48t1947r464b1996],

1	30	CD	NUMBER	30	_	0	SENT_504	[p29l48t2018r113b2057],
2	.	.	O	.	_	0	SENT_504	[p29l48t2018r113b2057],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_505	[p29l143t2014r241b2058],
2	KS	NN	O	k	_	0	SENT_505	[p29l256t2016r333b2066],
3	,	,	O	,	_	0	SENT_505	[p29l256t2016r333b2066],
4	Ieong	NNP	O	Ieong	nn	5	SENT_505	[p29l346t2017r484b2069],
5	JY	NN	O	jy	appos	2	SENT_505	[p29l492t2017r550b2066],
6	,	,	O	,	_	0	SENT_505	[p29l492t2017r550b2066],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_505	[p29l568t2014r667b2058],
8	YC	NNP	PERSON	YC	appos	2	SENT_505	[p29l680t2016r757b2066],
9	,	,	O	,	_	0	SENT_505	[p29l680t2016r757b2066],
10	et	FW	O	et	nn	11	SENT_505	[p29l776t2022r818b2057],
11	al.	FW	O	al.	appos	2	SENT_505	[p29l831t2013r883b2057],
12	.	.	O	.	_	0	SENT_505	[p29l831t2013r883b2057],

1	Predictors	NNS	O	predictor	_	0	SENT_506	[p29l901t2013r1063b2057, p29l48t2092r136b2127],
2	of	IN	O	of	_	0	SENT_506	[p29l151t2083r206b2127],
3	the	DT	O	the	det	4	SENT_506	[p29l209t2083r281b2127],
4	response	NN	O	response	prep_of	1	SENT_506	[p29l294t2097r502b2139],
5	to	TO	O	to	_	0	SENT_506	[p29l516t2092r560b2127],
6	geﬁtinib	NN	O	geﬁtinib	prep_to	4	SENT_506	[p29l573t2083r769b2139],
7	in	IN	O	in	_	0	SENT_506	[p29l782t2084r827b2126],
8	refractory	JJ	O	refractory	amod	12	SENT_506	[p29l840t2083r1067b2139],
9	non-small	JJ	O	non-small	amod	12	SENT_506	[p29l48t2153r287b2197],
10	cell	NN	O	cell	nn	12	SENT_506	[p29l302t2153r380b2197],
11	lung	NN	O	lung	nn	12	SENT_506	[p29l395t2154r501b2209],
12	cancer	NN	O	cancer	prep_in	1	SENT_506	[p29l515t2167r675b2197],
13	.	.	O	.	_	0	SENT_506	[p29l515t2167r675b2197],

1	Clin	NNP	O	Clin	nn	3	SENT_507	[p29l693t2153r789b2197],
2	Cancer	NNP	O	Cancer	nn	3	SENT_507	[p29l804t2157r967b2197],
3	Res	NNP	O	Res	_	0	SENT_507	[p29l980t2157r1063b2200],
4	2005	CD	DATE	2005	num	3	SENT_507	[p29l48t2227r460b2276],
5	;	:	O	;	_	0	SENT_507	[p29l48t2227r460b2276],
6	11:2244	CD	NUMBER	11:2244	number	7	SENT_507	[p29l48t2227r460b2276],
7	-51	CD	NUMBER	-51	dep	3	SENT_507	[p29l48t2227r460b2276],
8	.	.	O	.	_	0	SENT_507	[p29l48t2227r460b2276],

1	31	CD	NUMBER	31	_	0	SENT_508	[p29l48t2298r113b2337],
2	.	.	O	.	_	0	SENT_508	[p29l48t2298r113b2337],

1	Pedersen	NNP	PERSON	Pedersen	nn	2	SENT_509	[p29l142t2293r353b2337],
2	MW	NNP	O	MW	_	0	SENT_509	[p29l367t2297r472b2346],
3	,	,	O	,	_	0	SENT_509	[p29l367t2297r472b2346],
4	Meltorn	NNP	O	Meltorn	nn	5	SENT_509	[p29l490t2293r677b2337],
5	M	NNP	O	M	appos	2	SENT_509	[p29l692t2297r752b2346],
6	,	,	O	,	_	0	SENT_509	[p29l692t2297r752b2346],
7	Damstrup	NNP	PERSON	Damstrup	nn	8	SENT_509	[p29l771t2297r1004b2348],
8	L	NNP	PERSON	L	appos	2	SENT_509	[p29l1021t2297r1061b2346],
9	,	,	O	,	_	0	SENT_509	[p29l1021t2297r1061b2346],
10	Poulsen	NNP	PERSON	Poulsen	nn	11	SENT_509	[p29l47t2363r232b2407],
11	HS	NN	O	h	appos	2	SENT_509	[p29l250t2367r332b2407],
12	.	.	O	.	_	0	SENT_509	[p29l250t2367r332b2407],

1	The	DT	O	the	det	8	SENT_510	[p29l352t2363r441b2407],
2	type	NN	O	type	amod	8	SENT_510	[p29l460t2372r554b2419],
3	III	CD	NUMBER	iii	number	2	SENT_510	[p29l573t2367r626b2406],
4	epidermal	JJ	O	epidermal	amod	8	SENT_510	[p29l644t2363r879b2419],
5	growth	NN	O	growth	nn	8	SENT_510	[p29l897t2363r1064b2419],
6	factor	NN	O	factor	nn	8	SENT_510	[p29l48t2433r184b2477],
7	receptor	NN	O	receptor	nn	8	SENT_510	[p29l198t2442r392b2489],
8	mutation	NN	O	mutation	_	0	SENT_510	[p29l406t2434r634b2477],
9	:	:	O	:	_	0	SENT_510	[p29l406t2434r634b2477],
10	biological	JJ	O	biological	amod	11	SENT_510	[p29l652t2433r882b2489],
11	signiﬁcance	NN	O	signiﬁcance	dep	8	SENT_510	[p29l899t2433r1063b2489, p29l49t2517r178b2547],
12	and	CC	O	and	_	0	SENT_510	[p29l205t2503r290b2547],
13	potential	JJ	O	potential	amod	14	SENT_510	[p29l316t2503r523b2559],
14	target	NN	O	target	conj_and	11	SENT_510	[p29l550t2512r687b2559],
15	for	IN	O	for	_	0	SENT_510	[p29l711t2503r779b2547],
16	anti-cancer	JJ	O	anti-cancer	amod	17	SENT_510	[p29l804t2504r1065b2547],
17	therapy	NN	O	therapy	prep_for	11	SENT_510	[p29l48t2573r229b2629],
18	.	.	O	.	_	0	SENT_510	[p29l48t2573r229b2629],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_511	[p29l244t2577r342b2616],
2	Oncol	NNP	PERSON	Oncol	_	0	SENT_511	[p29l356t2574r496b2617],
3	2001	CD	DATE	2001	num	2	SENT_511	[p29l509t2577r891b2626],
4	;	:	O	;	_	0	SENT_511	[p29l509t2577r891b2626],
5	12:745	CD	NUMBER	12:745	number	6	SENT_511	[p29l509t2577r891b2626],
6	-60	CD	NUMBER	-60	dep	2	SENT_511	[p29l509t2577r891b2626],
7	.	.	O	.	_	0	SENT_511	[p29l509t2577r891b2626],

1	32	CD	NUMBER	32	_	0	SENT_512	[p29l48t2648r113b2687],
2	.	.	O	.	_	0	SENT_512	[p29l48t2648r113b2687],

1	Stephens	NNP	PERSON	Stephens	nn	2	SENT_513	[p29l144t2643r358b2698],
2	P	NN	O	p	_	0	SENT_513	[p29l377t2647r412b2696],
3	,	,	O	,	_	0	SENT_513	[p29l377t2647r412b2696],
4	Hunter	NNP	PERSON	Hunter	nn	5	SENT_513	[p29l434t2647r604b2687],
5	C	NNP	O	C	appos	2	SENT_513	[p29l620t2646r667b2696],
6	,	,	O	,	_	0	SENT_513	[p29l620t2646r667b2696],
7	Bignell	NNP	PERSON	Bignell	nn	8	SENT_513	[p29l688t2643r856b2699],
8	G	NNP	O	G	appos	2	SENT_513	[p29l874t2646r927b2696],
9	,	,	O	,	_	0	SENT_513	[p29l874t2646r927b2696],
10	et	FW	O	et	nn	11	SENT_513	[p29l949t2652r992b2687],
11	al.	FW	O	al.	appos	2	SENT_513	[p29l1007t2643r1060b2687],
12	.	.	O	.	_	0	SENT_513	[p29l1007t2643r1060b2687],

1	Lung	NN	O	lung	nn	2	SENT_514	[p29l48t2717r170b2769],
2	cancer	NN	O	cancer	_	0	SENT_514	[p29l183t2728r351b2757],
3	:	:	O	:	_	0	SENT_514	[p29l183t2728r351b2757],
4	intragenic	JJ	O	intragenic	amod	7	SENT_514	[p29l367t2714r608b2769],
5	ERBB2	NN	O	erbb2	nn	7	SENT_514	[p29l621t2717r786b2760],
6	kinase	NN	O	kinase	nn	7	SENT_514	[p29l801t2714r953b2757],
7	mutations	NNS	O	mutation	dep	2	SENT_514	[p29l968t2728r1063b2757, p29l48t2784r211b2827],
8	in	IN	O	in	_	0	SENT_514	[p29l232t2784r277b2826],
9	tumours	NNS	O	tumour	prep_in	7	SENT_514	[p29l297t2792r512b2827],
10	.	.	O	.	_	0	SENT_514	[p29l297t2792r512b2827],

1	Nature	NNP	O	Nature	_	0	SENT_515	[p29l533t2787r696b2827],
2	2004	CD	DATE	2004	num	1	SENT_515	[p29l716t2787r1063b2836, p29l48t2857r88b2897],
3	;	:	O	;	_	0	SENT_515	[p29l716t2787r1063b2836, p29l48t2857r88b2897],
4	431:5256	CD	NUMBER	431:5256	dep	1	SENT_515	[p29l716t2787r1063b2836, p29l48t2857r88b2897],
5	.	.	O	.	_	0	SENT_515	[p29l716t2787r1063b2836, p29l48t2857r88b2897],

1	33	CD	NUMBER	33	_	0	SENT_516	[p29l48t2928r113b2967],
2	.	.	O	.	_	0	SENT_516	[p29l48t2928r113b2967],

1	Shepherd	NNP	ORGANIZATION	Shepherd	nn	2	SENT_517	[p29l144t2923r369b2978],
2	FA	NNP	ORGANIZATION	FA	_	0	SENT_517	[p29l384t2927r457b2976],
3	,	,	O	,	_	0	SENT_517	[p29l384t2927r457b2976],
4	Pereira	NNP	PERSON	Pereira	nn	5	SENT_517	[p29l475t2924r640b2966],
5	JR	NNP	O	JR	appos	2	SENT_517	[p29l649t2927r719b2976],
6	,	,	O	,	_	0	SENT_517	[p29l649t2927r719b2976],
7	Ciuleanu	NNP	ORGANIZATION	Ciuleanu	nn	8	SENT_517	[p29l738t2923r949b2967],
8	T	NN	ORGANIZATION	t	appos	2	SENT_517	[p29l963t2927r1004b2976],
9	,	,	O	,	_	0	SENT_517	[p29l963t2927r1004b2976],
10	et	FW	O	et	nn	11	SENT_517	[p29l1023t2932r1066b2967],
11	al.	FW	O	al.	appos	2	SENT_517	[p29l48t2994r101b3037],
12	.	.	O	.	_	0	SENT_517	[p29l48t2994r101b3037],

1	Erlotinib	NNP	O	Erlotinib	nsubj	4	SENT_518	[p29l139t2993r349b3037],
2	in	IN	O	in	prep	1	SENT_518	[p29l385t2994r430b3036],
3	previously	RB	DATE	previously	pcomp	2	SENT_518	[p29l465t2993r710b3049],
4	treated	VBN	O	treat	_	0	SENT_518	[p29l743t2993r906b3037],
5	nonsmall-cell	JJ	O	nonsmall-cell	amod	7	SENT_518	[p29l941t3007r1065b3037, p29l49t3063r282b3107],
6	lung	NN	O	lung	nn	7	SENT_518	[p29l299t3063r409b3119],
7	cancer	NN	O	cancer	dobj	4	SENT_518	[p29l425t3077r590b3107],
8	.	.	O	.	_	0	SENT_518	[p29l425t3077r590b3107],

1	N	NN	O	n	nn	2	SENT_519	[p29l608t3067r650b3107],
2	EnglJ	NN	O	englj	nsubj	3	SENT_519	[p29l664t3063r802b3119],
3	Med	VBD	O	med	_	0	SENT_519	[p29l815t3063r918b3107],
4	2005	CD	DATE	2005	dobj	3	SENT_519	[p29l934t3067r1062b3116],
5	;	:	O	;	_	0	SENT_519	[p29l934t3067r1062b3116],
6	353:123	CD	NUMBER	353:123	num	7	SENT_519	[p29l49t3137r327b3177],
7	-32	CD	NUMBER	-32	dep	4	SENT_519	[p29l49t3137r327b3177],
8	.	.	O	.	_	0	SENT_519	[p29l49t3137r327b3177],

1	34	CD	NUMBER	34	_	0	SENT_520	[p29l48t3208r113b3247],
2	.	.	O	.	_	0	SENT_520	[p29l48t3208r113b3247],

1	Therasse	NN	O	therasse	nn	2	SENT_521	[p29l141t3203r350b3247],
2	P	NN	O	p	_	0	SENT_521	[p29l366t3207r401b3256],
3	,	,	O	,	_	0	SENT_521	[p29l366t3207r401b3256],
4	Arbuck	NNP	O	Arbuck	nn	5	SENT_521	[p29l419t3203r592b3247],
5	SG	NNP	O	SG	appos	2	SENT_521	[p29l608t3206r687b3256],
6	,	,	O	,	_	0	SENT_521	[p29l608t3206r687b3256],
7	Eisenhauer	NNP	PERSON	Eisenhauer	nn	8	SENT_521	[p29l707t3203r968b3247],
8	EA	NN	PERSON	ea	appos	2	SENT_521	[p29l983t3207r1061b3256],
9	,	,	O	,	_	0	SENT_521	[p29l983t3207r1061b3256],
10	et	FW	O	et	nn	11	SENT_521	[p29l49t3282r91b3317],
11	al.	FW	O	al.	appos	2	SENT_521	[p29l99t3273r150b3317],
12	.	.	O	.	_	0	SENT_521	[p29l99t3273r150b3317],

1	New	NNP	O	New	nn	2	SENT_522	[p29l163t3277r270b3317],
2	guidelines	NNS	O	guideline	nsubj	4	SENT_522	[p29l279t3273r514b3329],
3	to	TO	O	to	aux	4	SENT_522	[p29l527t3282r570b3317],
4	evaluate	VB	O	evaluate	_	0	SENT_522	[p29l582t3273r765b3317],
5	the	DT	O	the	det	6	SENT_522	[p29l777t3273r847b3317],
6	response	NN	O	response	dobj	4	SENT_522	[p29l859t3287r1063b3329],
7	to	TO	O	to	_	0	SENT_522	[p29l48t3352r92b3387],
8	treatment	NN	O	treatment	prep_to	4	SENT_522	[p29l112t3352r340b3387],
9	in	IN	O	in	_	0	SENT_522	[p29l356t3344r401b3386],
10	solid	JJ	O	solid	amod	11	SENT_522	[p29l421t3343r532b3387],
11	tumors	NNS	O	tumor	prep_in	8	SENT_522	[p29l551t3352r731b3387],
12	.	.	O	.	_	0	SENT_522	[p29l551t3352r731b3387],

1	J	NNP	O	J	nn	4	SENT_523	[p29l748t3347r769b3394],
2	Natl	NNP	O	Natl	nn	4	SENT_523	[p29l785t3343r884b3387],
3	Cancer	NNP	O	Cancer	nn	4	SENT_523	[p29l903t3347r1066b3387],
4	Inst	NNP	O	Inst	_	0	SENT_523	[p29l48t3417r139b3457],
5	2000	CD	DATE	2000	num	4	SENT_523	[p29l150t3417r532b3466],
6	;	:	O	;	_	0	SENT_523	[p29l150t3417r532b3466],
7	92:205	CD	NUMBER	92:205	number	8	SENT_523	[p29l150t3417r532b3466],
8	-16	CD	NUMBER	-16	dep	4	SENT_523	[p29l150t3417r532b3466],
9	.	.	O	.	_	0	SENT_523	[p29l150t3417r532b3466],

1	35	CD	NUMBER	35	_	0	SENT_524	[p29l48t3488r113b3527],
2	.	.	O	.	_	0	SENT_524	[p29l48t3488r113b3527],

1	Miller	NNP	ORGANIZATION	Miller	nn	2	SENT_525	[p29l141t3483r282b3527],
2	VA	NNP	ORGANIZATION	VA	_	0	SENT_525	[p29l292t3487r369b3536],
3	,	,	O	,	_	0	SENT_525	[p29l292t3487r369b3536],
4	Kris	NNP	PERSON	Kris	nn	5	SENT_525	[p29l386t3484r479b3528],
5	MG	NN	PERSON	mg	appos	2	SENT_525	[p29l493t3486r595b3536],
6	,	,	O	,	_	0	SENT_525	[p29l493t3486r595b3536],
7	Shah	NNP	PERSON	Shah	nn	8	SENT_525	[p29l613t3483r727b3527],
8	N	NNP	O	N	appos	2	SENT_525	[p29l740t3487r792b3536],
9	,	,	O	,	_	0	SENT_525	[p29l740t3487r792b3536],
10	et	FW	O	et	nn	11	SENT_525	[p29l809t3492r851b3527],
11	al.	FW	O	al.	appos	2	SENT_525	[p29l862t3483r914b3527],
12	.	.	O	.	_	0	SENT_525	[p29l862t3483r914b3527],

1	Bronchioloalveolar	JJ	PERSON	bronchioloalveolar	amod	3	SENT_526	[p29l931t3487r1063b3527, p29l49t3553r370b3597],
2	pathologic	JJ	O	pathologic	amod	3	SENT_526	[p29l379t3553r625b3609],
3	subtype	NN	O	subtype	nsubj	7	SENT_526	[p29l637t3553r812b3609],
4	and	CC	O	and	_	0	SENT_526	[p29l824t3553r908b3597],
5	smoking	NN	O	smoking	nn	6	SENT_526	[p29l921t3553r1063b3597, p29l48t3624r124b3679],
6	history	NN	O	history	conj_and	3	SENT_526	[p29l139t3623r301b3679],
7	predict	VBP	O	predict	_	0	SENT_526	[p29l316t3623r481b3679],
8	sensitivity	NN	O	sensitivity	dobj	7	SENT_526	[p29l497t3624r728b3679],
9	to	TO	O	to	_	0	SENT_526	[p29l744t3632r787b3667],
10	geﬁtinib	NN	O	geﬁtinib	prep_to	7	SENT_526	[p29l806t3623r1001b3679],
11	in	IN	O	in	_	0	SENT_526	[p29l1019t3624r1064b3666],
12	advanced	JJ	O	advanced	amod	15	SENT_526	[p29l1137t1733r1356b1777],
13	non-small-cell	JJ	O	non-small-cell	amod	15	SENT_526	[p29l1369t1733r1715b1777],
14	lung	NN	O	lung	nn	15	SENT_526	[p29l1727t1733r1836b1789],
15	cancer	NN	O	cancer	prep_in	10	SENT_526	[p29l1847t1747r2011b1777],
16	.	.	O	.	_	0	SENT_526	[p29l1847t1747r2011b1777],

1	J	NNP	O	J	nn	3	SENT_527	[p29l2022t1737r2042b1784],
2	Clin	NNP	O	Clin	nn	3	SENT_527	[p29l2054t1733r2151b1777],
3	Oncol	NNP	O	Oncol	_	0	SENT_527	[p29l1137t1803r1279b1847],
4	2004	CD	DATE	2004	num	3	SENT_527	[p29l1294t1807r1677b1856],
5	;	:	O	;	_	0	SENT_527	[p29l1294t1807r1677b1856],
6	22:1103	CD	NUMBER	22:1103	number	7	SENT_527	[p29l1294t1807r1677b1856],
7	-9	CD	NUMBER	-9	dep	3	SENT_527	[p29l1294t1807r1677b1856],
8	.	.	O	.	_	0	SENT_527	[p29l1294t1807r1677b1856],

1	36	CD	NUMBER	36	_	0	SENT_528	[p29l1137t1878r1202b1917],
2	.	.	O	.	_	0	SENT_528	[p29l1137t1878r1202b1917],

1	Janne	NNP	PERSON	Janne	nn	2	SENT_529	[p29l1226t1877r1360b1923],
2	PA	NN	PERSON	pa	_	0	SENT_529	[p29l1378t1877r1452b1926],
3	,	,	O	,	_	0	SENT_529	[p29l1378t1877r1452b1926],
4	Gurubhagavatula	NNP	LOCATION	Gurubhagavatula	nn	5	SENT_529	[p29l1473t1873r1877b1929],
5	S	NNP	LOCATION	S	appos	2	SENT_529	[p29l1896t1876r1934b1926],
6	,	,	O	,	_	0	SENT_529	[p29l1896t1876r1934b1926],
7	Yeap	NNP	PERSON	Yeap	nn	8	SENT_529	[p29l1954t1877r2060b1928],
8	BY	NNP	O	BY	appos	2	SENT_529	[p29l2079t1877r2149b1926],
9	,	,	O	,	_	0	SENT_529	[p29l2079t1877r2149b1926],
10	et	FW	O	et	nn	11	SENT_529	[p29l1137t1952r1180b1987],
11	al.	FW	O	al.	appos	2	SENT_529	[p29l1199t1943r1251b1987],
12	.	.	O	.	_	0	SENT_529	[p29l1199t1943r1251b1987],

1	Outcomes	NNS	O	outcome	nsubj	10	SENT_530	[p29l1277t1947r1513b1987],
2	of	IN	O	of	_	0	SENT_530	[p29l1537t1943r1593b1987],
3	patients	NNS	O	patient	prep_of	1	SENT_530	[p29l1605t1944r1789b1999],
4	with	IN	O	with	_	0	SENT_530	[p29l1810t1944r1915b1987],
5	advanced	JJ	O	advanced	amod	9	SENT_530	[p29l1937t1943r2153b1987],
6	non-small	JJ	O	non-small	amod	9	SENT_530	[p29l1137t2013r1375b2057],
7	cell	NN	O	cell	nn	9	SENT_530	[p29l1389t2013r1467b2057],
8	lung	NN	O	lung	nn	9	SENT_530	[p29l1479t2013r1586b2069],
9	cancer	NN	O	cancer	prep_with	3	SENT_530	[p29l1597t2027r1749b2057],
10	treated	VBN	O	treat	_	0	SENT_530	[p29l1761t2013r1920b2057],
11	with	IN	O	with	_	0	SENT_530	[p29l1930t2013r2035b2057],
12	geﬁtinib	NN	O	geﬁtinib	nn	14	SENT_530	[p29l2048t2013r2152b2069, p29l1137t2084r1244b2127],
13	(	CD	NUMBER	(	num	14	SENT_530	[p29l1260t2087r1474b2136],
14	ZD1839	NN	O	zd1839	prep_with	10	SENT_530	[p29l1260t2087r1474b2136],
15	,	,	O	,	_	0	SENT_530	[p29l1260t2087r1474b2136],
16	“	CD	NUMBER	“	num	17	SENT_530	[p29l1492t2086r1694b2134],
17	Iressa	NN	MISC	iressa	appos	14	SENT_530	[p29l1492t2086r1694b2134],
18	”	CD	NUMBER	”	num	19	SENT_530	[p29l1492t2086r1694b2134],
19	)	NN	O	)	dep	17	SENT_530	[p29l1492t2086r1694b2134],
20	on	IN	O	on	_	0	SENT_530	[p29l1710t2097r1769b2127],
21	an	DT	O	a	det	24	SENT_530	[p29l1781t2097r1836b2127],
22	expanded	JJ	O	expanded	amod	24	SENT_530	[p29l1850t2083r2073b2139],
23	access	NN	O	access	nn	24	SENT_530	[p29l2085t2098r2152b2127, p29l1137t2168r1231b2197],
24	study	NN	O	study	prep_on	10	SENT_530	[p29l1247t2153r1377b2209],
25	.	.	O	.	_	0	SENT_530	[p29l1247t2153r1377b2209],

1	Lung	NN	O	lung	nn	2	SENT_531	[p29l1393t2157r1514b2209],
2	Cancer	NN	O	cancer	_	0	SENT_531	[p29l1526t2157r1689b2197],
3	2004	CD	DATE	2004	dep	2	SENT_531	[p29l1701t2157r2083b2206],
4	;	:	O	;	_	0	SENT_531	[p29l1701t2157r2083b2206],
5	44:221	CD	NUMBER	44:221	num	6	SENT_531	[p29l1701t2157r2083b2206],
6	-30	CD	NUMBER	-30	dep	2	SENT_531	[p29l1701t2157r2083b2206],
7	.	.	O	.	_	0	SENT_531	[p29l1701t2157r2083b2206],

1	37	CD	NUMBER	37	_	0	SENT_532	[p29l1137t2228r1202b2267],
2	.	.	O	.	_	0	SENT_532	[p29l1137t2228r1202b2267],

1	Dancey	NNP	O	Dancey	_	0	SENT_533	[p29l1231t2227r1402b2278],
2	IE	NN	O	ie	dep	1	SENT_533	[p29l1410t2227r1474b2273],
3	.	.	O	.	_	0	SENT_533	[p29l1410t2227r1474b2273],

1	Predictive	JJ	O	predictive	amod	2	SENT_534	[p29l1492t2223r1718b2267],
2	factors	NNS	O	factor	nsubj	9	SENT_534	[p29l1733t2223r1890b2267],
3	for	IN	O	for	_	0	SENT_534	[p29l1907t2223r1975b2267],
4	epidermal	JJ	O	epidermal	amod	8	SENT_534	[p29l1989t2223r2152b2278, p29l1137t2294r1224b2337],
5	growth	NN	O	growth	nn	8	SENT_534	[p29l1237t2293r1404b2349],
6	factor	NN	O	factor	nn	8	SENT_534	[p29l1417t2293r1553b2337],
7	receptor	NN	O	receptor	nn	8	SENT_534	[p29l1565t2302r1759b2349],
8	inhibitors	NNS	O	inhibitor	prep_for	2	SENT_534	[p29l1770t2293r1998b2337],
9	—	VBP	O	—	_	0	SENT_534	[p29l2011t2318r2070b2323],
10	the	DT	O	the	det	11	SENT_534	[p29l2081t2293r2153b2337],
11	bull	NN	O	bull	dep	9	SENT_534	[p29l1137t2363r1358b2419],
12	’s	POS	O	’s	possessive	11	SENT_534	[p29l1137t2363r1358b2419],
13	-	:	O	-	_	0	SENT_534	[p29l1137t2363r1358b2419],
14	eye	NN	O	eye	nsubj	15	SENT_534	[p29l1137t2363r1358b2419],
15	hits	VBZ	O	hit	parataxis	9	SENT_534	[p29l1377t2363r1461b2407],
16	the	DT	O	the	det	17	SENT_534	[p29l1481t2363r1552b2407],
17	arrow	NN	O	arrow	dobj	15	SENT_534	[p29l1570t2377r1713b2407],
18	.	.	O	.	_	0	SENT_534	[p29l1570t2377r1713b2407],

1	Cancer	NN	O	cancer	nn	2	SENT_535	[p29l1735t2367r1898b2407],
2	Cell	NN	O	cell	_	0	SENT_535	[p29l1915t2363r2004b2407],
3	2004	CD	DATE	2004	dep	2	SENT_535	[p29l2022t2367r2150b2416],
4	;	:	O	;	_	0	SENT_535	[p29l2022t2367r2150b2416],
5	5	CD	NUMBER	5	number	6	SENT_535	[p29l1138t2437r1162b2477],
6	:411	CD	NUMBER	:411	dep	2	SENT_535	[p29l1169t2437r1328b2477],
7	-5	CD	NUMBER	-5	dep	6	SENT_535	[p29l1169t2437r1328b2477],
8	.	.	O	.	_	0	SENT_535	[p29l1169t2437r1328b2477],

1	38	CD	NUMBER	38	_	0	SENT_536	[p29l1137t2508r1202b2547],
2	.	.	O	.	_	0	SENT_536	[p29l1137t2508r1202b2547],

1	Parra	NNP	O	Parra	nn	2	SENT_537	[p29l1231t2507r1352b2546],
2	HS	NN	O	h	_	0	SENT_537	[p29l1384t2506r1466b2556],
3	,	,	O	,	_	0	SENT_537	[p29l1384t2506r1466b2556],
4	Cavina	NNP	PERSON	Cavina	nn	5	SENT_537	[p29l1503t2504r1659b2547],
5	R	NNP	PERSON	R	appos	2	SENT_537	[p29l1690t2507r1738b2556],
6	,	,	O	,	_	0	SENT_537	[p29l1690t2507r1738b2556],
7	Latteri	NNP	O	Latteri	nn	8	SENT_537	[p29l1773t2504r1922b2547],
8	F	NN	O	f	appos	2	SENT_537	[p29l1954t2507r1988b2556],
9	,	,	O	,	_	0	SENT_537	[p29l1954t2507r1988b2556],
10	et	FW	O	et	nn	11	SENT_537	[p29l2025t2512r2067b2547],
11	al.	FW	O	al.	appos	2	SENT_537	[p29l2097t2503r2149b2547],
12	.	.	O	.	_	0	SENT_537	[p29l2097t2503r2149b2547],

1	Analysis	NN	O	analysis	_	0	SENT_538	[p29l1135t2574r1328b2629],
2	of	IN	O	of	_	0	SENT_538	[p29l1349t2573r1405b2617],
3	epidermal	JJ	O	epidermal	amod	7	SENT_538	[p29l1415t2573r1649b2629],
4	growth	NN	O	growth	nn	7	SENT_538	[p29l1669t2573r1836b2629],
5	factor	NN	O	factor	nn	7	SENT_538	[p29l1856t2573r1991b2617],
6	receptor	NN	O	receptor	nn	7	SENT_538	[p29l2010t2588r2152b2629, p29l1137t2652r1204b2687],
7	expression	NN	O	expression	prep_of	1	SENT_538	[p29l1222t2644r1473b2699],
8	as	IN	O	as	_	0	SENT_538	[p29l1492t2658r1539b2687],
9	a	DT	O	a	det	11	SENT_538	[p29l1560t2658r1584b2687],
10	predictive	JJ	O	predictive	amod	11	SENT_538	[p29l1603t2643r1830b2699],
11	factor	NN	O	factor	prep_as	7	SENT_538	[p29l1850t2643r1986b2687],
12	for	IN	O	for	_	0	SENT_538	[p29l2004t2643r2072b2687],
13	response	NN	O	response	prep_for	11	SENT_538	[p29l2091t2658r2152b2687, p29l1138t2727r1299b2769],
14	to	TO	O	to	aux	15	SENT_538	[p29l1331t2722r1375b2757],
15	geﬁtinib	VB	O	geﬁtinib	infmod	1	SENT_538	[p29l1406t2713r1598b2769],
16	(	CD	NUMBER	(	number	17	SENT_538	[p29l1632t2716r1844b2766],
17	“	CD	NUMBER	“	dobj	15	SENT_538	[p29l1632t2716r1844b2766],
18	Iressa	NNP	MISC	Iressa	nn	19	SENT_538	[p29l1632t2716r1844b2766],
19	”	NN	O	”	dep	17	SENT_538	[p29l1632t2716r1844b2766],
20	,	,	O	,	_	0	SENT_538	[p29l1632t2716r1844b2766],
21	ZD1839	NN	O	zd1839	nn	22	SENT_538	[p29l1876t2717r2076b2764],
22	)	NN	O	)	appos	17	SENT_538	[p29l1876t2717r2076b2764],
23	in	IN	O	in	_	0	SENT_538	[p29l2109t2714r2153b2756],
24	non-small-cell	JJ	O	non-small-cell	amod	26	SENT_538	[p29l1137t2783r1470b2827],
25	lung	NN	O	lung	nn	26	SENT_538	[p29l1507t2783r1614b2839],
26	cancer	NN	O	cancer	prep_in	22	SENT_538	[p29l1650t2797r1810b2827],
27	.	.	O	.	_	0	SENT_538	[p29l1650t2797r1810b2827],

1	Br	NN	O	br	nn	3	SENT_539	[p29l1850t2787r1904b2827],
2	J	NN	O	j	nn	3	SENT_539	[p29l1934t2787r1955b2834],
3	Cancer	NN	O	cancer	_	0	SENT_539	[p29l1991t2787r2154b2827],
4	2004	CD	DATE	2004	dep	3	SENT_539	[p29l1137t2857r1519b2906],
5	;	:	O	;	_	0	SENT_539	[p29l1137t2857r1519b2906],
6	91:208	CD	NUMBER	91:208	num	7	SENT_539	[p29l1137t2857r1519b2906],
7	-12	CD	NUMBER	-12	dep	3	SENT_539	[p29l1137t2857r1519b2906],
8	.	.	O	.	_	0	SENT_539	[p29l1137t2857r1519b2906],

1	39	CD	NUMBER	39	_	0	SENT_540	[p29l1137t2928r1202b2967],
2	.	.	O	.	_	0	SENT_540	[p29l1137t2928r1202b2967],

1	Weber	NNP	PERSON	Weber	nn	2	SENT_541	[p29l1230t2923r1381b2967],
2	F	NN	O	f	_	0	SENT_541	[p29l1392t2927r1426b2976],
3	,	,	O	,	_	0	SENT_541	[p29l1392t2927r1426b2976],
4	Fukino	NN	PERSON	fukino	nn	5	SENT_541	[p29l1442t2923r1605b2967],
5	K	NN	PERSON	k	appos	2	SENT_541	[p29l1618t2927r1666b2976],
6	,	,	O	,	_	0	SENT_541	[p29l1618t2927r1666b2976],
7	Sawada	NNP	PERSON	Sawada	nn	8	SENT_541	[p29l1683t2923r1857b2967],
8	T	NN	O	t	appos	2	SENT_541	[p29l1867t2927r1908b2976],
9	,	,	O	,	_	0	SENT_541	[p29l1867t2927r1908b2976],
10	et	FW	O	et	nn	11	SENT_541	[p29l1924t2932r1967b2966],
11	al.	FW	O	al.	appos	2	SENT_541	[p29l1976t2923r2028b2967],
12	.	.	O	.	_	0	SENT_541	[p29l1976t2923r2028b2967],

1	Variability	NN	O	variability	nsubj	16	SENT_542	[p29l2042t2924r2151b2966, p29l1137t2993r1280b3049],
2	in	IN	O	in	_	0	SENT_542	[p29l1304t2994r1348b3036],
3	organ-speciﬁc	JJ	O	organ-speciﬁc	amod	6	SENT_542	[p29l1375t2993r1708b3049],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_542	[p29l1734t2997r1876b3040],
5	mutational	JJ	O	mutational	amod	6	SENT_542	[p29l1897t2993r2152b3037],
6	spectra	NNS	O	spectrum	prep_in	1	SENT_542	[p29l1138t3072r1304b3119],
7	in	IN	O	in	_	0	SENT_542	[p29l1329t3064r1373b3106],
8	tumour	NN	O	tumour	nn	9	SENT_542	[p29l1400t3072r1575b3107],
9	epithelium	NN	O	epithelium	prep_in	6	SENT_542	[p29l1600t3063r1852b3119],
10	and	CC	O	and	_	0	SENT_542	[p29l1878t3063r1964b3107],
11	stroma	NN	O	stroma	conj_and	9	SENT_542	[p29l1991t3073r2154b3107],
12	may	MD	O	may	aux	16	SENT_542	[p29l1137t3148r1236b3189],
13	be	VB	O	be	cop	16	SENT_542	[p29l1250t3133r1304b3177],
14	the	DT	O	the	det	16	SENT_542	[p29l1321t3133r1394b3177],
15	biological	JJ	O	biological	amod	16	SENT_542	[p29l1411t3133r1648b3189],
16	basis	NN	O	basis	_	0	SENT_542	[p29l1665t3133r1784b3177],
17	for	IN	O	for	_	0	SENT_542	[p29l1802t3133r1871b3177],
18	differential	JJ	O	differential	amod	19	SENT_542	[p29l1886t3133r2152b3177],
19	responses	NNS	O	response	prep_for	16	SENT_542	[p29l1137t3217r1376b3259],
20	to	TO	O	to	_	0	SENT_542	[p29l1393t3212r1437b3247],
21	tyrosine	NN	O	tyrosine	nn	23	SENT_542	[p29l1454t3204r1645b3259],
22	kinase	NN	O	kinase	nn	23	SENT_542	[p29l1661t3203r1814b3247],
23	inhibitors	NNS	O	inhibitor	prep_to	16	SENT_542	[p29l1830t3203r2081b3247],
24	.	.	O	.	_	0	SENT_542	[p29l1830t3203r2081b3247],

1	Br	NN	O	br	nn	3	SENT_543	[p29l2099t3207r2154b3247],
2	J	NN	O	j	nn	3	SENT_543	[p29l1131t3277r1152b3324],
3	Cancer	NN	O	cancer	_	0	SENT_543	[p29l1166t3277r1334b3317],
4	2005	CD	DATE	2005	dep	3	SENT_543	[p29l1347t3277r1732b3326],
5	;	:	O	;	_	0	SENT_543	[p29l1347t3277r1732b3326],
6	92:1922	CD	NUMBER	92:1922	num	7	SENT_543	[p29l1347t3277r1732b3326],
7	-6	CD	NUMBER	-6	dep	3	SENT_543	[p29l1347t3277r1732b3326],
8	.	.	O	.	_	0	SENT_543	[p29l1347t3277r1732b3326],

1	40	CD	NUMBER	40	_	0	SENT_544	[p29l1136t3348r1202b3387],
2	.	.	O	.	_	0	SENT_544	[p29l1136t3348r1202b3387],

1	Nagahara	NN	O	nagahara	nn	2	SENT_545	[p29l1231t3343r1457b3399],
2	H	NN	O	h	_	0	SENT_545	[p29l1477t3347r1530b3396],
3	,	,	O	,	_	0	SENT_545	[p29l1477t3347r1530b3396],
4	Mimori	NNP	PERSON	Mimori	nn	5	SENT_545	[p29l1553t3344r1729b3387],
5	K	NNP	PERSON	K	appos	2	SENT_545	[p29l1749t3347r1797b3396],
6	,	,	O	,	_	0	SENT_545	[p29l1749t3347r1797b3396],
7	Ohta	NNP	PERSON	Ohta	nn	8	SENT_545	[p29l1821t3343r1935b3387],
8	M	NNP	O	M	appos	2	SENT_545	[p29l1953t3347r2013b3396],
9	,	,	O	,	_	0	SENT_545	[p29l1953t3347r2013b3396],
10	et	FW	O	et	nn	11	SENT_545	[p29l2037t3352r2080b3387],
11	al.	FW	O	al.	appos	2	SENT_545	[p29l2097t3343r2149b3387],
12	.	.	O	.	_	0	SENT_545	[p29l2097t3343r2149b3387],

1	Somatic	JJ	MISC	somatic	amod	2	SENT_546	[p29l1138t3414r1325b3457],
2	mutations	NNS	O	mutation	_	0	SENT_546	[p29l1336t3414r1573b3457],
3	of	IN	O	of	_	0	SENT_546	[p29l1586t3413r1641b3457],
4	epidermal	JJ	O	epidermal	amod	7	SENT_546	[p29l1643t3413r1878b3469],
5	growth	NN	O	growth	nn	7	SENT_546	[p29l1889t3414r2056b3469],
6	factor	NN	O	factor	nn	7	SENT_546	[p29l2067t3413r2152b3457, p29l1137t3492r1204b3527],
7	receptor	NN	O	receptor	prep_of	2	SENT_546	[p29l1225t3492r1423b3539],
8	in	IN	O	in	_	0	SENT_546	[p29l1443t3484r1489b3526],
9	colorectal	JJ	O	colorectal	amod	10	SENT_546	[p29l1511t3483r1744b3527],
10	carcinoma	NN	O	carcinoma	prep_in	2	SENT_546	[p29l1767t3484r2029b3527],
11	.	.	O	.	_	0	SENT_546	[p29l1767t3484r2029b3527],

1	Clin	NNP	O	Clin	nn	3	SENT_547	[p29l2054t3483r2152b3527],
2	Cancer	NNP	O	Cancer	nn	3	SENT_547	[p29l1137t3557r1303b3597],
3	Res	NNP	O	Res	_	0	SENT_547	[p29l1315t3557r1398b3600],
4	2005	CD	DATE	2005	num	3	SENT_547	[p29l1413t3557r1525b3597],
5	;	:	O	;	_	0	SENT_547	[p29l1532t3557r1824b3606],
6	11:1368	CD	NUMBER	11:1368	number	7	SENT_547	[p29l1532t3557r1824b3606],
7	-71	CD	NUMBER	-71	dep	3	SENT_547	[p29l1532t3557r1824b3606],
8	.	.	O	.	_	0	SENT_547	[p29l1532t3557r1824b3606],

1	Copyright	NN	O	copyright	_	0	SENT_548	[p29l1138t3630r1314b3678],
2	©	CD	NUMBER	©	num	6	SENT_548	[p29l1329t3634r1368b3674],
3	2005	CD	DATE	2005	num	6	SENT_548	[p29l1386t3633r1478b3667],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_548	[p29l1493t3630r1759b3666],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_548	[p29l1774t3630r1919b3667],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_548	[p29l1932t3632r2066b3677],
7	.	.	O	.	_	0	SENT_548	[p29l1932t3632r2066b3677],

1	JOURNAL	NN	O	journal	_	0	SENT_549	[p30l1164t120r1290b143],
2	IN	IN	O	in	dep	1	SENT_549	[p30l1304t121r1330b137],
3	DEX	NN	MISC	dex	pobj	2	SENT_549	[p30l1337t121r1386b137],

1	The	DT	O	the	det	2	SENT_550	[p30l761t172r809b195],
2	index	NN	O	index	nsubj	11	SENT_550	[p30l818t172r887b195],
3	to	TO	O	to	_	0	SENT_550	[p30l896t177r919b195],
4	volume	NN	O	volume	prep_to	2	SENT_550	[p30l928t172r1020b195],
5	352	CD	NUMBER	352	num	4	SENT_550	[p30l1030t173r1075b195],
6	of	IN	O	of	_	0	SENT_550	[p30l1085t171r1115b195],
7	the	DT	O	the	det	8	SENT_550	[p30l1119t172r1157b195],
8	journal	NN	O	journal	prep_of	4	SENT_550	[p30l1162t172r1247b201],
9	will	MD	O	will	aux	11	SENT_550	[p30l1255t172r1302b195],
10	be	VB	O	be	cop	11	SENT_550	[p30l1311t172r1339b195],
11	available	JJ	O	available	_	0	SENT_550	[p30l1349t172r1457b195],
12	on	IN	O	on	_	0	SENT_550	[p30l1467t179r1498b195],
13	August	NNP	DATE	August	prep_on	11	SENT_550	[p30l1507t174r1598b201],
14	18	CD	DATE	18	num	13	SENT_550	[p30l1606t173r1642b200],
15	,	,	DATE	,	_	0	SENT_550	[p30l1606t173r1642b200],
16	2005	CD	DATE	2005	num	13	SENT_550	[p30l1653t173r1722b195],
17	.	.	O	.	_	0	SENT_550	[p30l1653t173r1722b195],

1	At	IN	O	at	_	0	SENT_551	[p30l1732t174r1761b195],
2	that	DT	O	that	det	3	SENT_551	[p30l763t211r812b234],
3	time	NN	O	time	prep_at	8	SENT_551	[p30l820t212r883b239],
4	,	,	O	,	_	0	SENT_551	[p30l820t212r883b239],
5	it	PRP	O	it	nsubjpass	18	SENT_551	[p30l893t212r911b234],
6	can	MD	O	can	aux	8	SENT_551	[p30l919t219r962b234],
7	be	VB	O	be	auxpass	8	SENT_551	[p30l972t211r1000b234],
8	downloaded	VBN	O	download	_	0	SENT_551	[p30l1009t211r1164b235],
9	free	JJ	O	free	advmod	8	SENT_551	[p30l1173t211r1220b234],
10	in	IN	O	in	_	0	SENT_551	[p30l1229t212r1253b234],
11	PDF	NN	O	pdf	nn	12	SENT_551	[p30l1262t213r1314b234],
12	format	NN	O	format	prep_in	9	SENT_551	[p30l1324t211r1410b234],
13	from	IN	O	from	_	0	SENT_551	[p30l1418t211r1479b234],
14	www.nejm.org	NN	O	www.nejm.org	prep_from	8	SENT_551	[p30l1487t211r1681b241],
15	or	CC	O	or	_	0	SENT_551	[p30l1689t219r1716b234],
16	can	MD	O	can	aux	18	SENT_551	[p30l1724t219r1767b234],
17	be	VB	O	be	auxpass	18	SENT_551	[p30l762t251r791b274],
18	ordered	VBN	O	order	conj_or	8	SENT_551	[p30l800t251r897b274],
19	in	IN	O	in	_	0	SENT_551	[p30l906t251r930b274],
20	a	DT	O	a	det	24	SENT_551	[p30l940t259r953b274],
21	printed	VBN	O	print	amod	24	SENT_551	[p30l961t251r1053b280],
22	and	CC	O	and	_	0	SENT_551	[p30l1062t251r1108b274],
23	bound	VBN	O	bind	conj_and	21	SENT_551	[p30l1117t251r1198b274],
24	format	NN	O	format	prep_in	18	SENT_551	[p30l1207t251r1299b274],
25	.	.	O	.	_	0	SENT_551	[p30l1207t251r1299b274],

1	To	TO	O	to	aux	2	SENT_552	[p30l1309t253r1340b274],
2	order	VB	O	order	_	0	SENT_552	[p30l1350t251r1417b274],
3	a	DT	O	a	det	5	SENT_552	[p30l1426t259r1439b274],
4	bound	VBN	O	bind	amod	5	SENT_552	[p30l1448t251r1528b274],
5	copy	NN	O	copy	dobj	2	SENT_552	[p30l1538t259r1600b281],
6	,	,	O	,	_	0	SENT_552	[p30l1538t259r1600b281],
7	please	VB	O	please	dep	2	SENT_552	[p30l1610t251r1688b281],
8	call	NN	O	call	dobj	7	SENT_552	[p30l1698t251r1741b274],
9	1	CD	NUMBER	1	num	10	SENT_552	[p30l763t292r961b314],
10	—	NN	O	—	dep	15	SENT_552	[p30l763t292r961b314],
11	800	CD	NUMBER	800	dep	10	SENT_552	[p30l763t292r961b314],
12	—	NN	O	—	dep	15	SENT_552	[p30l763t292r961b314],
13	217	CD	NUMBER	217	num	12	SENT_552	[p30l763t292r961b314],
14	—	CD	NUMBER	—	number	15	SENT_552	[p30l763t292r961b314],
15	7874	CD	NUMBER	7874	dep	33	SENT_552	[p30l763t292r961b314],
16	from	IN	O	from	_	0	SENT_552	[p30l969t290r1030b314],
17	the	DT	O	the	det	19	SENT_552	[p30l1038t291r1076b314],
18	United	NNP	LOCATION	United	nn	19	SENT_552	[p30l1084t291r1168b314],
19	States	NNPS	LOCATION	States	prep_from	15	SENT_552	[p30l1177t292r1248b314],
20	and	CC	O	and	_	0	SENT_552	[p30l1257t291r1302b314],
21	Canada	NNP	LOCATION	Canada	dep	33	SENT_552	[p30l1311t291r1403b314],
22	(	CD	NUMBER	(	num	21	SENT_552	[p30l1412t291r1463b317],
23	call	NN	O	call	dep	21	SENT_552	[p30l1412t291r1463b317],
24	651-582-3800	CD	NUMBER	651-582-3800	num	23	SENT_552	[p30l1471t292r1644b314],
25	from	IN	O	from	_	0	SENT_552	[p30l1653t290r1713b314],
26	other	JJ	O	other	amod	27	SENT_552	[p30l1722t291r1787b314],
27	countries	NNS	O	country	prep_from	23	SENT_552	[p30l763t331r888b357],
28	)	CD	NUMBER	)	dep	27	SENT_552	[p30l763t331r888b357],
29	or	CC	O	or	cc	28	SENT_552	[p30l899t338r926b353],
30	e	SYM	O	e	dep	32	SENT_552	[p30l934t330r1013b353],
31	—	CD	NUMBER	—	num	32	SENT_552	[p30l934t330r1013b353],
32	mail	NN	O	mail	dep	23	SENT_552	[p30l934t330r1013b353],
33	info@valeoip.com	NNP	O	info@valeoip.com	dep	7	SENT_552	[p30l1022t330r1259b360],
34	.	.	O	.	_	0	SENT_552	[p30l1022t330r1259b360],

1	pk	NN	O	pk	_	0	SENT_553	[p30l149t469r205b490],
2	i	FW	O	i	nsubj	6	SENT_553	[p30l149t469r205b490],
3	+	CC	O	+	_	0	SENT_553	[p30l149t469r205b490],
4	N	NN	O	n	nn	5	SENT_553	[p30l918t471r932b486],
5	ENGLJ	NN	O	englj	conj_+	2	SENT_553	[p30l947t470r1031b492],
6	MED	VBD	O	med	rcmod	1	SENT_553	[p30l1046t471r1099b486],
7	3532	CD	NUMBER	3532	num	9	SENT_553	[p30l1111t470r1175b492],
8	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	9	SENT_553	[p30l1210t470r1421b492],
9	JULY14	NN	O	july14	dobj	6	SENT_553	[p30l1455t470r1562b492],
10	,	,	O	,	_	0	SENT_553	[p30l1455t470r1562b492],
11	2005	CD	DATE	2005	appos	9	SENT_553	[p30l1575t470r1638b492],

1	The	DT	O	the	det	4	SENT_554	[p30l935t503r986b527],
2	New	NNP	O	New	nn	4	SENT_554	[p30l995t504r1057b527],
3	England	NNP	O	England	nn	4	SENT_554	[p30l1066t503r1177b534],
4	Journal	NNP	O	Journal	_	0	SENT_554	[p30l1186t503r1283b527],
5	of	IN	O	of	_	0	SENT_554	[p30l1293t503r1322b527],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_554	[p30l1329t503r1454b527],

1	Downloaded	VBN	O	download	_	0	SENT_555	[p30l377t544r547b567],
2	from	IN	O	from	_	0	SENT_555	[p30l556t544r620b567],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_555	[p30l629t544r747b574],
4	at	IN	O	at	_	0	SENT_555	[p30l758t548r781b567],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_555	[p30l789t544r972b567],
6	on	IN	O	on	_	0	SENT_555	[p30l981t551r1014b567],
7	January	NNP	DATE	January	prep_on	1	SENT_555	[p30l1022t544r1125b574],
8	5	CD	DATE	5	num	7	SENT_555	[p30l1135t544r1158b571],
9	,	,	DATE	,	_	0	SENT_555	[p30l1135t544r1158b571],
10	2014	CD	DATE	2014	num	7	SENT_555	[p30l1169t544r1241b567],
11	.	.	O	.	_	0	SENT_555	[p30l1169t544r1241b567],

1	For	IN	O	for	_	0	SENT_556	[p30l1251t544r1298b567],
2	personal	JJ	O	personal	amod	3	SENT_556	[p30l1306t544r1418b574],
3	use	NN	O	use	pobj	1	SENT_556	[p30l1427t551r1471b567],
4	only	RB	O	only	advmod	3	SENT_556	[p30l1481t544r1545b574],
5	.	.	O	.	_	0	SENT_556	[p30l1481t544r1545b574],

1	No	DT	O	no	det	3	SENT_557	[p30l1556t544r1596b567],
2	other	JJ	O	other	amod	3	SENT_557	[p30l1606t544r1674b567],
3	uses	NNS	O	use	_	0	SENT_557	[p30l1682t551r1738b567],
4	without	IN	O	without	_	0	SENT_557	[p30l1748t544r1849b567],
5	permission	NN	O	permission	prep_without	3	SENT_557	[p30l1858t544r2010b574],
6	.	.	O	.	_	0	SENT_557	[p30l1858t544r2010b574],

